data_1d5g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1d5g _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.759 0 CA-C-O 121.175 0.319 . . . . 0.0 112.92 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -82.6 153.11 25.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.164 -1.198 . . . . 0.0 113.455 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.33 128.79 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 124.703 1.201 . . . . 0.0 109.78 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -137.27 160.99 37.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.489 -1.382 . . . . 0.0 110.404 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -113.56 140.61 48.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.871 -1.143 . . . . 0.0 112.145 175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -102.54 138.69 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 124.195 0.998 . . . . 0.0 109.367 172.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -121.15 101.92 7.97 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 125.514 1.525 . . . . 0.0 107.951 168.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -133.87 -175.5 3.86 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.421 -0.799 . . . . 0.0 109.918 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.26 174.66 15.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.934 -1.104 . . . . 0.0 110.285 174.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -69.98 123.32 21.25 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -121.32 -81.89 0.64 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.539 1.536 . . . . 0.0 111.784 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.85 -57.24 3.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.106 1.763 . . . . 0.0 108.61 170.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -142.24 -139.1 0.11 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 156.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 p -85.49 -85.62 0.14 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.007 -1.683 . . . . 0.0 111.997 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.9 mt -101.18 -74.46 0.61 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.334 -1.479 . . . . 0.0 113.335 -171.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.59 54.33 1.45 Allowed Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 124.839 1.209 . . . . 0.0 110.446 -174.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.9 tt -146.23 155.29 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.477 -1.013 . . . . 0.0 110.625 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 t -121.09 151.9 39.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.409 -1.432 . . . . 0.0 109.088 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -124.24 152.33 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.509 1.524 . . . . 0.0 110.319 -164.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 t -138.65 138.25 37.64 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 120.494 -1.379 . . . . 0.0 110.11 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.69 -137.71 20.53 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.832 1.682 . . . . 0.0 114.349 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.33 23.67 46.88 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 117.6 1.8 . . . . 0.0 117.6 166.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 m -87.27 -119.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 119.491 1.646 . . . . 0.0 114.848 -171.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -71.37 -45.34 63.08 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.875 -2.391 . . . . 0.0 113.117 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 t -138.56 170.94 15.12 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 148.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -156.01 -69.05 0.11 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.444 -1.41 . . . . 0.0 111.357 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 t -92.62 -56.51 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 124.291 1.036 . . . . 0.0 111.939 -168.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -141.12 -92.1 0.15 Allowed 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 121.475 -0.765 . . . . 0.0 109.997 -170.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -117.58 52.35 0.99 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.651 1.691 . . . . 0.0 107.617 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.81 -142.52 17.53 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 107.309 -2.317 . . . . 0.0 107.309 -166.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.08 148.29 23.49 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 124.675 1.131 . . . . 0.0 113.398 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.61 151.31 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.17 143.94 50.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.252 1.021 . . . . 0.0 111.186 -171.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.8 t -73.08 129.6 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.693 -1.254 . . . . 0.0 111.657 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -81.54 -62.77 1.55 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 109.62 171.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.45 167.54 15.61 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -92.35 136.84 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 124.835 1.254 . . . . 0.0 110.668 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.6 mm -83.83 120.34 74.91 Favored Pre-proline 0 N--CA 1.43 -1.427 0 O-C-N 120.314 -1.491 . . . . 0.0 109.005 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.12 65.0 8.93 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 CA-C-N 124.801 2.75 . . . . 0.0 113.277 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -141.7 -1.4 1.28 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.894 1.278 . . . . 0.0 112.897 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -141.87 -161.68 8.85 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 120.251 -1.531 . . . . 0.0 114.826 -171.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.69 -37.15 86.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 -173.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.27 92.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.274 1.03 . . . . 0.0 113.383 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -68.63 -55.88 10.06 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.375 1.07 . . . . 0.0 112.943 167.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.8 t -59.29 -56.99 15.04 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.324 1.45 . . . . 0.0 114.906 -170.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -81.11 -37.83 28.25 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.446 -1.409 . . . . 0.0 110.572 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.76 90.29 1.33 Allowed Glycine 0 N--CA 1.429 -1.78 0 O-C-N 120.519 -1.363 . . . . 0.0 111.397 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -137.18 -41.79 0.57 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 121.418 -1.048 . . . . 0.0 111.189 -171.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 mt -129.11 143.13 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.34 -173.54 3.3 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.313 -1.492 . . . . 0.0 111.179 170.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -55.97 132.57 50.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.39 9.86 86.59 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 118.236 2.054 . . . . 0.0 118.236 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -74.23 155.47 38.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 119.496 1.648 . . . . 0.0 112.167 172.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -124.55 144.0 50.37 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.105 -1.622 . . . . 0.0 110.719 -170.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 m -101.39 154.02 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 119.802 -1.811 . . . . 0.0 112.605 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.15 -91.18 0.56 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.209 1.404 . . . . 0.0 108.128 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.31 148.28 23.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.886 -1.133 . . . . 0.0 113.89 -166.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.36 100.91 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.086 1.354 . . . . 0.0 107.796 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.5 t30 56.77 61.06 2.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.269 1.828 . . . . 0.0 112.393 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.87 -39.02 2.95 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.922 -1.111 . . . . 0.0 115.336 -176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.08 128.06 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.453 -1.616 . . . . 0.0 112.603 -166.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -77.36 124.2 27.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.881 -1.137 . . . . 0.0 111.819 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.9 mp -87.36 74.22 9.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.115 1.436 . . . . 0.0 110.503 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -68.81 99.8 1.09 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.265 -1.522 . . . . 0.0 113.293 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.75 23.17 53.96 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.481 0.952 . . . . 0.0 115.481 172.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.35 136.35 39.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.384 -1.068 . . . . 0.0 112.526 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.6 p -80.13 172.21 14.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.572 1.149 . . . . 0.0 113.063 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.584 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 2.9 t60 -61.63 -41.25 97.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.257 -1.527 . . . . 0.0 113.252 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -59.02 -40.24 84.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -69.87 -41.63 74.55 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.29 -1.506 . . . . 0.0 111.773 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.82 97.23 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.678 -1.264 . . . . 0.0 114.082 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.13 -43.29 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.417 -1.427 . . . . 0.0 113.096 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -62.06 -42.25 99.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.433 -1.417 . . . . 0.0 113.729 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.3 p -70.15 -17.51 63.19 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.26 -1.525 . . . . 0.0 115.052 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.4 mt -80.32 -39.01 29.53 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 120.424 -1.422 . . . . 0.0 113.454 171.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -86.61 -27.43 23.86 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.484 -1.385 . . . . 0.0 113.932 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -83.42 60.56 5.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.68 -1.888 . . . . 0.0 112.55 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.5 p -109.06 -89.85 0.47 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.693 1.597 . . . . 0.0 112.518 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.44 -129.25 8.09 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 107.416 -2.274 . . . . 0.0 107.416 -166.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -81.25 -51.44 8.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -165.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -104.16 145.96 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.623 -1.298 . . . . 0.0 113.764 -159.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.24 105.73 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 125.022 1.329 . . . . 0.0 110.101 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -116.86 120.85 39.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.889 -1.132 . . . . 0.0 108.623 168.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.58 166.86 27.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.503 -1.373 . . . . 0.0 111.911 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -120.21 137.38 54.23 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mp -125.53 156.75 38.55 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.312 1.445 . . . . 0.0 108.363 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -113.49 132.59 55.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 166.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.6 tptt -68.86 138.16 54.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.789 -1.194 . . . . 0.0 112.693 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.76 0 O-C-N 120.795 -1.191 . . . . 0.0 114.667 -172.642 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -128.25 145.91 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 125.386 1.474 . . . . 0.0 109.271 -164.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' SER . . . . . 0.584 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 9.1 p -126.3 163.31 23.51 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.463 1.505 . . . . 0.0 111.822 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.19 159.02 43.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.514 -0.741 . . . . 0.0 109.579 162.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.261 1.671 0 C-N-CA 124.048 0.939 . . . . 0.0 109.012 177.665 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.703 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -74.17 145.98 43.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 118.842 1.321 . . . . 0.0 113.429 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.4 mt -89.44 137.64 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.251 1.42 . . . . 0.0 110.106 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -146.56 161.26 40.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.972 -1.08 . . . . 0.0 109.99 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -115.52 141.07 48.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.146 -0.971 . . . . 0.0 108.878 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.4 147.39 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 124.045 0.938 . . . . 0.0 112.632 173.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -113.67 123.33 49.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 123.746 0.818 . . . . 0.0 109.058 168.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.5 mt -132.83 157.91 43.83 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.442 -1.411 . . . . 0.0 110.427 165.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.66 139.26 27.89 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -70.41 96.68 1.17 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -92.29 -66.36 0.93 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.123 1.769 . . . . 0.0 109.703 171.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -88.7 -71.37 0.59 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.173 1.789 . . . . 0.0 109.186 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -136.55 166.45 23.5 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -171.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -83.06 -71.19 0.51 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -167.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.85 -83.27 0.46 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.138 -1.601 . . . . 0.0 110.028 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.4 39.35 2.82 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.688 -1.258 . . . . 0.0 114.932 170.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.86 169.58 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.093 -1.239 . . . . 0.0 108.774 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.7 p -122.45 146.51 47.31 Favored 'General case' 0 N--CA 1.429 -1.513 0 O-C-N 119.968 -1.708 . . . . 0.0 108.75 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 t -125.32 149.83 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 125.168 1.387 . . . . 0.0 110.044 -161.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -136.29 142.11 43.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.062 1.411 . . . . 0.0 109.774 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.71 -130.77 9.91 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 125.761 1.648 . . . . 0.0 114.191 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.93 62.42 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 121.404 -1.056 . . . . 0.0 114.531 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.36 168.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -67.73 -26.8 66.32 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 125.984 1.714 . . . . 0.0 113.163 -163.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 t -129.74 128.18 41.92 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 152.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 p -155.39 -89.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.853 -1.154 . . . . 0.0 110.672 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -78.25 -47.2 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.3 -1.5 . . . . 0.0 109.457 171.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.95 -153.18 0.52 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 167.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -76.55 89.84 3.3 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.399 -1.438 . . . . 0.0 109.278 163.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.69 -154.35 30.9 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -162.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.39 136.93 9.11 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-O 122.858 1.254 . . . . 0.0 112.465 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.5 mm -124.89 133.75 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.4 -1.647 . . . . 0.0 107.574 -164.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.96 141.4 51.99 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.677 1.191 . . . . 0.0 108.311 -170.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.7 t -80.03 130.53 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.906 -1.121 . . . . 0.0 110.911 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -86.75 -57.34 3.02 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 120.139 -1.6 . . . . 0.0 110.783 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.87 155.56 29.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.853 1.261 . . . . 0.0 109.514 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -94.78 131.16 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 122.519 1.152 . . . . 0.0 110.689 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.7 mm -82.93 123.06 78.18 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 120.523 -1.361 . . . . 0.0 110.42 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.11 40.9 1.0 Allowed 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.041 2.494 . . . . 0.0 114.051 -172.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -144.78 53.85 1.23 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.19 174.29 45.91 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 120.419 -1.426 . . . . 0.0 113.896 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.78 -36.09 73.86 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.475 1.91 . . . . 0.0 114.4 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.65 -53.78 47.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.35 -49.95 50.87 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.284 1.434 . . . . 0.0 112.346 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -61.19 -39.87 91.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -82.07 -47.92 12.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.838 -1.164 . . . . 0.0 111.236 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.96 62.63 1.98 Allowed Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 117.109 1.604 . . . . 0.0 117.109 168.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -135.5 -1.08 2.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.472 -1.605 . . . . 0.0 111.841 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.3 mt -129.28 149.47 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.464 ' CE1' ' HZ2' ' A' ' 91' ' ' LYS . 0.8 OUTLIER -126.8 173.68 9.36 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 120.287 -1.508 . . . . 0.0 111.531 172.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -58.12 135.9 57.11 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.945 1.298 . . . . 0.0 114.214 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.76 18.51 78.84 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 117.559 1.784 . . . . 0.0 117.559 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -82.7 162.51 21.78 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 120.341 2.07 . . . . 0.0 111.543 166.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -126.33 123.4 37.93 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.714 -1.241 . . . . 0.0 110.384 -172.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -85.56 155.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.118 -1.614 . . . . 0.0 113.284 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.04 -86.13 0.65 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.707 1.203 . . . . 0.0 111.229 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.52 144.94 28.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.63 96.25 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 124.468 1.107 . . . . 0.0 108.329 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.296 9.5 t-20 57.19 47.59 16.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.854 1.661 . . . . 0.0 113.343 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.79 -34.3 5.86 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.582 -1.324 . . . . 0.0 114.278 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 t -100.9 109.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 118.368 1.084 . . . . 0.0 112.159 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.9 m -79.61 110.22 14.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.665 1.586 . . . . 0.0 112.392 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.14 85.4 4.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.577 -1.952 . . . . 0.0 110.555 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.03 135.11 51.79 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.921 -1.737 . . . . 0.0 113.652 174.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.56 7.23 63.45 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 124.685 1.136 . . . . 0.0 114.371 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.86 130.8 39.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.825 -1.397 . . . . 0.0 112.903 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.3 p -80.76 171.61 14.8 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 123.126 1.441 . . . . 0.0 110.252 168.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' B' ' 13' ' ' SER . 1.9 t60 -56.25 -41.7 76.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.641 1.977 . . . . 0.0 114.093 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -52.32 -45.72 65.73 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.511 1.524 . . . . 0.0 114.859 171.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -72.06 -38.51 69.43 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.841 1.256 . . . . 0.0 111.722 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.12 76.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.621 1.168 . . . . 0.0 113.852 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.3 t -63.21 -48.14 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.628 1.971 . . . . 0.0 113.331 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -53.59 -46.46 70.37 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.483 1.135 . . . . 0.0 113.271 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.7 m -65.91 -41.71 91.11 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.029 2.132 . . . . 0.0 113.218 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.8 mt -85.81 -27.31 25.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.139 -1.601 . . . . 0.0 114.83 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 44.6 mtt180 -65.47 -45.93 81.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.775 -1.828 . . . . 0.0 112.625 173.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -83.46 60.39 5.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.017 1.389 . . . . 0.0 112.26 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.89 -80.85 0.37 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.47 1.908 . . . . 0.0 109.192 175.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.16 -78.79 0.4 Allowed Glycine 0 N--CA 1.429 -1.774 0 O-C-N 121.294 -0.879 . . . . 0.0 114.257 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -81.51 -58.74 2.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.503 -0.998 . . . . 0.0 113.472 -175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.43 149.21 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.777 1.231 . . . . 0.0 110.487 -166.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.6 t -129.45 112.31 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.073 1.349 . . . . 0.0 107.786 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -127.98 104.44 7.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.637 -1.289 . . . . 0.0 110.857 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.3 mt -127.7 162.59 26.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 111.313 -169.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.24 136.32 54.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.514 1.526 . . . . 0.0 107.15 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.74 161.24 42.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.802 0.811 . . . . 0.0 111.822 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -114.29 134.8 54.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.857 1.663 . . . . 0.0 109.652 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.464 ' HZ2' ' CE1' ' A' ' 53' ' ' HIS . 55.3 mmtt -62.65 135.2 57.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 173.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.748 0 CA-C-O 123.281 1.489 . . . . 0.0 116.175 -178.119 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.81 123.86 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.261 1.824 . . . . 0.0 107.699 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' SER . . . . . 0.515 ' HB2' ' CE1' ' A' ' 71' ' ' HIS . 15.0 m -129.59 133.06 46.96 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.707 -1.246 . . . . 0.0 113.154 -171.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.02 155.9 34.61 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.644 -1.285 . . . . 0.0 112.544 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 C--O 1.26 1.633 0 C-N-CA 126.636 1.974 . . . . 0.0 107.858 173.798 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.747 0 CA-C-O 121.244 0.358 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -82.18 178.97 7.98 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 120.898 -1.354 . . . . 0.0 113.624 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -85.67 133.99 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.326 -1.483 . . . . 0.0 108.376 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -135.96 146.65 47.49 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 121.201 -0.937 . . . . 0.0 108.781 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -106.68 134.82 49.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.027 -1.046 . . . . 0.0 109.36 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.9 t -102.06 115.44 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -120.38 95.44 4.74 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.801 1.24 . . . . 0.0 108.63 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.462 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 11.0 tp -134.49 -155.95 0.69 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.174 -0.954 . . . . 0.0 109.368 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.462 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -154.53 168.19 27.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -71.96 129.64 39.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -120.98 -69.88 0.82 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.825 1.25 . . . . 0.0 110.722 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -76.56 -62.62 1.57 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.657 -1.277 . . . . 0.0 109.188 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -137.79 -131.11 0.13 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 139.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.7 p -89.81 -78.15 0.37 Allowed 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 120.19 1.359 . . . . 0.0 112.187 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.1 mt -103.21 -99.31 0.3 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.372 -1.455 . . . . 0.0 113.921 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.42 52.43 1.71 Allowed Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -157.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.95 147.05 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.956 -1.32 . . . . 0.0 108.366 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 t -122.48 148.21 45.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.727 -1.233 . . . . 0.0 109.223 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.62 157.01 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 122.343 1.068 . . . . 0.0 110.11 -164.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.2 t -137.06 112.71 9.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 122.75 1.262 . . . . 0.0 107.834 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.46 175.38 50.7 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-O 122.934 1.296 . . . . 0.0 115.004 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.43 67.84 0.7 Allowed Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.1 m -97.21 -130.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 125.135 1.374 . . . . 0.0 110.694 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -71.1 -39.12 72.3 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.028 -2.295 . . . . 0.0 112.714 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.8 t -151.99 143.14 23.22 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 163.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 t -156.55 -69.25 0.11 Allowed 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.081 -1.637 . . . . 0.0 113.285 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.37 -58.32 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.558 -1.339 . . . . 0.0 112.734 -164.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -125.52 -83.64 0.63 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 124.078 0.951 . . . . 0.0 109.295 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.39 53.71 1.93 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 165.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.3 -140.42 16.27 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 -161.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.15 150.24 19.94 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 117.955 0.877 . . . . 0.0 113.522 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 22.0 mm -125.67 148.91 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -125.85 135.62 52.16 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.858 -1.151 . . . . 0.0 112.052 -169.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.3 t -78.65 130.32 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 120.398 -1.438 . . . . 0.0 112.333 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -89.52 -59.35 2.23 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.903 -1.123 . . . . 0.0 110.536 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.86 163.33 23.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.765 0.793 . . . . 0.0 110.24 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.4 131.72 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.122 1.369 . . . . 0.0 109.152 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.4 mm -83.58 120.31 75.15 Favored Pre-proline 0 N--CA 1.431 -1.381 0 O-C-N 120.926 -1.109 . . . . 0.0 109.816 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.8 67.56 8.57 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 124.022 2.472 . . . . 0.0 112.88 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -145.4 9.72 1.23 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 123.997 0.919 . . . . 0.0 111.835 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 -158.82 18.49 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 119.664 -1.898 . . . . 0.0 114.565 -172.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.34 -43.51 79.13 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.512 2.325 . . . . 0.0 116.26 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.98 90.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -73.79 -49.98 22.71 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.714 1.206 . . . . 0.0 111.583 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 t -55.05 -55.45 30.83 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.522 2.329 . . . . 0.0 114.485 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -79.2 -44.44 21.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.641 -1.287 . . . . 0.0 111.772 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.49 91.48 0.55 Allowed Glycine 0 N--CA 1.431 -1.686 0 C-N-CA 124.223 0.916 . . . . 0.0 113.443 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -136.16 -45.7 0.63 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.168 -1.195 . . . . 0.0 110.436 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.6 mt -126.04 133.45 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 -169.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.82 -178.19 3.97 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.598 1.19 . . . . 0.0 112.101 -176.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -56.42 125.03 20.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.49 16.79 80.45 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 117.588 1.795 . . . . 0.0 117.588 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -72.07 161.8 30.38 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.346 1.573 . . . . 0.0 112.634 167.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -123.16 115.18 21.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 121.029 -1.044 . . . . 0.0 109.314 -173.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.96 148.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 119.872 -1.767 . . . . 0.0 110.136 172.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.3 mt -128.98 -81.01 0.57 Allowed 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 121.41 -0.806 . . . . 0.0 111.46 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.5 138.12 34.56 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.553 -1.342 . . . . 0.0 114.455 -167.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.93 90.91 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 126.394 1.877 . . . . 0.0 109.411 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.292 3.3 t-20 56.37 50.65 12.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.945 1.698 . . . . 0.0 112.324 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.23 -36.8 3.89 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 120.678 -1.264 . . . . 0.0 113.675 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -85.23 124.05 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 O-C-N 121.305 -1.115 . . . . 0.0 112.293 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 t -77.98 129.52 35.39 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.677 -1.264 . . . . 0.0 110.864 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tp -95.08 51.84 1.39 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.972 -1.705 . . . . 0.0 112.808 -164.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.98 123.81 21.25 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.652 1.581 . . . . 0.0 114.512 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.39 -4.8 80.51 Favored Glycine 0 N--CA 1.429 -1.78 0 O-C-N 120.26 -1.525 . . . . 0.0 114.358 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.35 143.41 40.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 121.258 -1.142 . . . . 0.0 112.976 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.8 p -85.96 175.84 8.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.16 1.384 . . . . 0.0 111.006 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.614 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 21.8 t60 -59.73 -43.67 94.11 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.205 1.402 . . . . 0.0 112.488 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.88 -40.99 90.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.528 2.331 . . . . 0.0 115.386 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -72.1 -37.46 69.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.189 -1.57 . . . . 0.0 112.354 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.46 77.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.931 -1.106 . . . . 0.0 113.494 171.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.6 -51.58 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.365 1.466 . . . . 0.0 113.069 170.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -60.46 -40.28 90.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.635 -1.291 . . . . 0.0 114.328 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 p -70.48 -18.55 62.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.321 -1.487 . . . . 0.0 113.86 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mt -85.67 -19.13 31.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.01 -1.681 . . . . 0.0 113.253 170.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -78.54 -44.16 24.96 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.237 -1.539 . . . . 0.0 110.924 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -82.95 64.91 7.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.879 1.272 . . . . 0.0 112.942 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.5 p -99.72 -74.08 0.61 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.156 1.782 . . . . 0.0 111.015 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.37 -131.19 9.56 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 125.702 1.62 . . . . 0.0 111.01 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -76.79 -44.21 33.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.003 -1.292 . . . . 0.0 113.481 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -109.31 164.42 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 123.915 0.886 . . . . 0.0 111.055 -167.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.0 t -134.15 127.75 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.225 1.41 . . . . 0.0 109.38 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -142.43 115.68 8.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.397 -0.814 . . . . 0.0 109.078 171.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -149.05 162.36 40.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.243 -1.536 . . . . 0.0 112.019 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.3 mp -121.01 124.41 44.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.282 1.039 . . . . 0.0 108.982 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -117.86 166.06 12.93 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.527 1.131 . . . . 0.0 108.944 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -117.33 131.6 56.76 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 162.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -73.71 124.53 26.19 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.941 -1.099 . . . . 0.0 111.051 -174.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.725 0 O-C-N 121.232 -0.917 . . . . 0.0 115.055 -166.112 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 N--CA 1.43 -1.426 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.98 160.21 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 127.709 2.404 . . . . 0.0 106.994 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' SER . . . . . 0.614 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 30.2 p -150.01 154.73 38.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.451 -2.031 . . . . 0.0 114.639 -174.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.95 164.42 38.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.296 1.038 . . . . 0.0 112.009 170.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.26 1.627 0 C-N-CA 125.648 1.579 . . . . 0.0 108.977 176.351 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.705 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.87 179.02 7.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.932 1.349 . . . . 0.0 113.22 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.92 133.51 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.431 1.492 . . . . 0.0 108.98 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -138.47 157.55 45.98 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.959 -1.088 . . . . 0.0 112.497 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -126.92 114.19 17.53 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.992 1.317 . . . . 0.0 112.477 -172.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.2 t -102.9 141.66 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.673 -1.267 . . . . 0.0 110.208 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -117.83 122.09 42.46 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 160.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -133.91 162.33 32.33 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.838 -1.163 . . . . 0.0 108.936 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.61 147.75 27.79 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.406 -1.434 . . . . 0.0 107.585 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -64.03 120.88 12.87 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 122.994 1.378 . . . . 0.0 114.703 -168.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -98.35 -88.21 0.32 Allowed 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 125.15 1.38 . . . . 0.0 108.816 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.55 -46.77 36.82 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.559 -1.338 . . . . 0.0 109.623 170.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -156.9 -158.06 0.74 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 169.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 p -83.53 -82.05 0.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.745 -1.222 . . . . 0.0 112.39 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.4 mt -102.49 -97.53 0.29 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.824 -1.798 . . . . 0.0 114.437 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.43 51.23 1.59 Allowed Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -162.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.9 tt -140.95 161.06 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 121.072 -1.252 . . . . 0.0 110.361 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -122.47 142.5 50.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 120.352 -1.467 . . . . 0.0 108.029 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -123.64 152.65 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 125.446 1.499 . . . . 0.0 107.861 -171.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.5 t -136.42 120.3 17.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.463 1.601 . . . . 0.0 110.786 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.67 -147.71 42.31 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 124.746 1.165 . . . . 0.0 113.695 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.88 38.39 6.92 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 121.997 0.776 . . . . 0.0 112.346 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.2 m -80.95 -112.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 126.219 1.808 . . . . 0.0 113.318 -169.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -71.7 -51.91 20.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.876 -1.765 . . . . 0.0 111.482 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -151.45 153.4 34.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.1 t -154.6 -69.14 0.13 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.286 -0.884 . . . . 0.0 112.134 -175.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.9 t -91.97 -61.44 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 120.494 -1.379 . . . . 0.0 112.682 -163.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -124.93 -71.03 0.72 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.049 1.34 . . . . 0.0 111.78 -161.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -141.71 39.54 1.68 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.7 -144.48 17.96 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 -157.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.69 158.68 33.31 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.401 -1.058 . . . . 0.0 113.197 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 mm -126.36 145.28 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -125.94 138.7 53.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.084 -1.01 . . . . 0.0 111.715 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.7 t -85.83 127.72 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 124.937 1.295 . . . . 0.0 111.799 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -83.4 -63.72 1.3 Allowed 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 125.195 1.398 . . . . 0.0 111.175 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.09 171.64 5.71 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.816 0.846 . . . . 0.0 109.083 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.38 139.19 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.312 1.045 . . . . 0.0 111.737 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.1 mm -85.79 109.65 23.97 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 119.938 -1.726 . . . . 0.0 108.647 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -82.46 57.24 6.05 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 123.361 2.707 . . . . 0.0 114.14 -163.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -141.16 22.28 2.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.028 1.331 . . . . 0.0 110.427 -174.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.25 -160.91 19.79 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 120.179 -1.576 . . . . 0.0 115.044 -173.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.4 -45.57 88.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.893 2.077 . . . . 0.0 115.574 -166.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.08 79.04 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -77.63 -41.75 37.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.416 1.086 . . . . 0.0 111.948 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.8 t -70.14 -46.57 64.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -82.14 -61.52 1.88 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.723 -1.236 . . . . 0.0 111.684 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.64 99.42 1.08 Allowed Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.195 -0.941 . . . . 0.0 114.923 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -138.56 -37.15 0.55 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.97 -1.312 . . . . 0.0 110.929 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.6 mt -127.47 134.58 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -170.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -119.86 -176.68 3.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.842 -1.161 . . . . 0.0 113.523 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -55.2 127.88 31.3 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.97 1.708 . . . . 0.0 114.846 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.37 11.17 84.41 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.18 156.1 39.96 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.059 1.429 . . . . 0.0 111.576 169.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -123.76 102.06 7.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.134 -0.978 . . . . 0.0 109.772 -167.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -80.2 132.73 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.666 -1.271 . . . . 0.0 111.169 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.1 mt -122.04 -74.07 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.69 -1.256 . . . . 0.0 110.958 -170.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.35 151.67 20.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.7 t -113.65 101.18 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.611 1.965 . . . . 0.0 107.397 173.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.312 16.3 t-20 56.56 48.39 16.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.518 1.927 . . . . 0.0 113.536 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.73 -14.09 57.01 Favored Glycine 0 N--CA 1.43 -1.761 0 O-C-N 120.035 -1.666 . . . . 0.0 114.894 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 t -100.93 117.34 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 120.989 -1.301 . . . . 0.0 109.992 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -79.15 144.14 34.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.504 -1.372 . . . . 0.0 113.449 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mp -93.42 44.93 1.15 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.022 1.391 . . . . 0.0 112.517 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.89 114.41 6.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.096 -1.627 . . . . 0.0 112.824 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.08 7.89 73.01 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 120.817 -1.177 . . . . 0.0 113.875 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.5 143.03 38.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.013 -1.287 . . . . 0.0 110.871 168.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.2 p -90.33 176.07 6.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.349 -1.47 . . . . 0.0 110.285 165.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.593 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 47.9 t60 -59.62 -38.41 81.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -175.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -52.98 -41.6 64.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.519 -1.363 . . . . 0.0 113.768 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -71.23 -35.98 71.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.882 1.273 . . . . 0.0 112.356 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.82 84.57 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.455 -1.403 . . . . 0.0 113.908 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.23 -42.53 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 124.954 1.302 . . . . 0.0 112.07 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -61.08 -37.39 82.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.313 -1.492 . . . . 0.0 112.845 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.3 p -70.45 -22.96 62.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 171.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 mt -79.23 -40.84 29.68 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.998 -1.689 . . . . 0.0 112.739 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -63.78 -43.39 96.47 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.882 -1.137 . . . . 0.0 111.217 173.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -93.5 58.98 2.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.189 -1.57 . . . . 0.0 112.469 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 p -88.45 -72.46 0.54 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.708 1.203 . . . . 0.0 108.516 166.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.96 -128.26 8.04 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -76.67 -46.73 24.57 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.03 148.87 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 124.714 1.206 . . . . 0.0 112.351 -170.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.33 116.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 127.175 2.19 . . . . 0.0 108.652 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -117.62 115.35 24.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.252 -1.53 . . . . 0.0 107.316 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -144.03 157.95 44.01 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.985 -1.072 . . . . 0.0 112.705 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mp -122.11 134.58 54.75 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.985 0.914 . . . . 0.0 109.114 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.34 170.1 13.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.959 1.304 . . . . 0.0 109.879 -169.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -116.4 135.38 53.9 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 158.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -74.73 131.46 40.86 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.758 0 C-N-CA 125.99 1.757 . . . . 0.0 116.726 -178.224 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.22 171.46 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.335 2.254 . . . . 0.0 105.215 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' SER . . . . . 0.593 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 9.7 p -144.66 141.84 29.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.62 -1.925 . . . . 0.0 115.141 175.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.87 133.4 49.34 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.94 1.696 . . . . 0.0 111.428 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.261 1.67 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.148 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.737 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -82.18 171.06 14.73 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.6 130.44 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 167.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -133.73 166.53 22.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.227 1.013 . . . . 0.0 111.311 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -125.16 136.74 53.89 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.238 1.015 . . . . 0.0 109.293 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.9 m -102.06 135.59 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.707 -1.246 . . . . 0.0 108.849 173.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -126.04 87.36 2.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.26 1.024 . . . . 0.0 109.796 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tp -134.51 -174.38 3.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.654 -1.279 . . . . 0.0 110.311 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.64 165.64 24.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.325 -1.484 . . . . 0.0 107.642 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -71.92 121.46 19.11 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.236 1.017 . . . . 0.0 111.786 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -107.5 -92.04 0.41 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.486 1.514 . . . . 0.0 107.755 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -78.78 -41.64 29.94 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.139 1.376 . . . . 0.0 109.997 163.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.8 161.51 37.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 123.81 0.844 . . . . 0.0 110.403 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -83.49 -68.37 0.72 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.439 1.095 . . . . 0.0 110.521 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.77 -79.15 0.52 Allowed 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.821 -1.174 . . . . 0.0 111.101 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.68 50.25 4.27 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 124.576 1.084 . . . . 0.0 113.475 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 tt -138.43 -178.61 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 121.617 -0.931 . . . . 0.0 109.579 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.0 p -127.4 142.47 51.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.842 -2.411 . . . . 0.0 110.31 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 t -123.77 155.82 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 123.855 0.862 . . . . 0.0 111.464 -163.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 t -137.02 141.93 42.5 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.255 -1.528 . . . . 0.0 108.707 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.1 -175.84 50.3 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 116.476 1.351 . . . . 0.0 116.476 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.95 44.05 0.97 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 121.865 -0.785 . . . . 0.0 112.823 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.402 ' CG1' ' H ' ' A' ' 27' ' ' ASN . 25.8 t -80.78 176.66 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.69 -1.476 . . . . 0.0 108.847 174.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.402 ' H ' ' CG1' ' A' ' 26' ' ' VAL . 5.8 p30 -69.07 -24.78 64.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.377 -2.077 . . . . 0.0 114.814 -160.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.6 t -135.15 133.33 39.04 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 150.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.9 p -155.81 -86.4 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.685 -1.259 . . . . 0.0 112.639 -165.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.13 -48.02 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 126.825 2.05 . . . . 0.0 109.062 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -129.02 -154.47 0.64 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 159.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.33 70.29 9.24 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.234 -2.166 . . . . 0.0 111.389 164.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.63 -171.87 13.95 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 108.118 -1.993 . . . . 0.0 108.118 -166.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.09 136.0 7.96 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -172.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.9 mm -127.21 149.41 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -170.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.92 139.49 53.78 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.924 -1.735 . . . . 0.0 111.225 -169.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.7 t -81.98 126.12 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 120.275 -1.516 . . . . 0.0 111.313 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -87.6 -70.12 0.65 Allowed 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.653 -1.279 . . . . 0.0 111.051 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.8 159.97 38.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.277 -0.89 . . . . 0.0 110.101 -171.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 p -103.09 132.6 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.93 1.347 . . . . 0.0 112.221 -170.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.6 mm -83.7 119.42 73.65 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 120.149 -1.594 . . . . 0.0 110.163 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -81.05 58.97 7.26 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 124.393 2.605 . . . . 0.0 112.966 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -141.39 -0.42 1.41 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.296 1.038 . . . . 0.0 112.094 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.36 -172.75 30.19 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.27 -1.518 . . . . 0.0 115.477 -170.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.3 -50.61 2.01 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.696 3.198 . . . . 0.0 118.159 -171.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.1 -45.34 68.19 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.213 1.405 . . . . 0.0 114.76 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -80.59 -52.66 7.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.958 1.303 . . . . 0.0 110.826 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.5 m -62.5 -38.48 90.04 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -172.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.3 -52.44 6.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.914 -1.116 . . . . 0.0 110.117 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.62 84.94 1.47 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 121.14 -0.975 . . . . 0.0 113.589 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -138.99 -21.82 0.95 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.19 149.58 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -119.64 172.57 7.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.592 -1.317 . . . . 0.0 111.702 177.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -56.54 138.73 51.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.43 22.11 76.24 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 116.905 1.522 . . . . 0.0 116.905 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.58 166.49 19.19 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 118.915 1.358 . . . . 0.0 111.693 169.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -124.1 105.43 9.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.748 -1.22 . . . . 0.0 110.25 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 m -93.74 141.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 120.459 -1.401 . . . . 0.0 111.519 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.24 -87.25 0.56 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 111.253 -166.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.63 153.84 20.02 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.591 -1.943 . . . . 0.0 112.903 -172.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 63.8 t -116.41 108.53 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.256 9.1 t-20 56.25 50.15 13.92 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 126.03 1.732 . . . . 0.0 113.76 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.5 -29.42 6.72 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.659 -1.276 . . . . 0.0 114.774 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.2 t -88.06 99.03 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.586 -1.538 . . . . 0.0 111.209 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -78.59 99.56 6.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.302 1.041 . . . . 0.0 110.514 167.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.03 92.91 7.08 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.07 1.414 . . . . 0.0 109.591 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 67' ' ' GLU . 6.1 pt-20 -67.59 129.97 41.56 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.383 1.473 . . . . 0.0 112.644 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.48 -6.24 74.6 Favored Glycine 0 N--CA 1.429 -1.795 0 O-C-N 121.001 -1.062 . . . . 0.0 114.565 -174.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.99 133.27 40.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 119.595 1.698 . . . . 0.0 114.041 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.3 p -84.31 177.86 8.0 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.258 1.423 . . . . 0.0 112.613 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -56.94 -45.41 82.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.322 2.249 . . . . 0.0 113.942 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -58.39 -43.31 88.5 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 172.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -70.37 -39.21 74.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.761 -1.212 . . . . 0.0 111.995 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.41 67.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.666 1.186 . . . . 0.0 113.393 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.47 -35.99 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 120.291 -1.506 . . . . 0.0 113.076 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -58.24 -47.08 84.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.141 -1.599 . . . . 0.0 113.72 168.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.4 m -63.23 -36.25 83.02 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.823 1.649 . . . . 0.0 113.141 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 74.4 mt -78.89 -35.84 42.99 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 120.114 -1.616 . . . . 0.0 113.462 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -67.31 -28.16 67.76 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.961 -1.712 . . . . 0.0 112.639 172.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -90.93 48.81 1.56 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.18 -1.575 . . . . 0.0 112.78 172.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.74 -70.4 0.6 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.507 1.523 . . . . 0.0 109.766 173.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.13 -87.33 1.2 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 121.238 -0.914 . . . . 0.0 112.603 170.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -83.93 -61.4 1.83 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.216 -1.167 . . . . 0.0 113.753 173.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.74 142.51 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 122.22 1.01 . . . . 0.0 113.233 -164.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.9 t -121.05 92.39 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 125.408 1.483 . . . . 0.0 107.543 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -126.57 98.39 5.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.567 -1.333 . . . . 0.0 111.18 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.9 mt -127.35 154.22 45.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.81 -1.181 . . . . 0.0 111.409 -162.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -120.79 134.0 55.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.623 1.169 . . . . 0.0 109.047 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.07 153.06 37.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.534 0.683 . . . . 0.0 111.356 -171.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -112.19 120.96 43.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.822 1.649 . . . . 0.0 109.992 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -54.1 135.55 43.26 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -165.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 0 C-N-CA 126.165 1.84 . . . . 0.0 115.611 176.52 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 N--CA 1.429 -1.491 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 t -122.56 149.09 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.364 1.866 . . . . 0.0 106.789 -173.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -138.33 166.83 23.22 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.273 -1.517 . . . . 0.0 112.58 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.88 147.12 50.79 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.614 1.966 . . . . 0.0 109.735 162.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.26 1.647 0 C-N-CA 127.4 2.28 . . . . 0.0 105.299 170.037 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.633 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -83.55 165.42 19.09 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.4 mt -81.37 131.86 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 122.182 0.992 . . . . 0.0 111.524 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -136.98 168.93 18.65 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.711 -1.243 . . . . 0.0 109.847 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -122.49 137.52 54.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.766 0.826 . . . . 0.0 111.003 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.6 m -103.98 143.75 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 124.395 1.078 . . . . 0.0 111.716 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -127.9 106.68 9.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.652 1.181 . . . . 0.0 109.159 -170.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.1 mt -129.69 159.39 36.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.997 -1.689 . . . . 0.0 110.657 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.66 164.44 27.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 160.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -72.25 114.18 10.08 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.437 -1.414 . . . . 0.0 113.933 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -101.9 -70.89 0.73 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 162.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.43 -74.69 0.43 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.362 1.865 . . . . 0.0 110.789 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -136.49 148.76 47.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -165.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.1 m -80.83 -62.82 1.55 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.924 -1.735 . . . . 0.0 113.268 -159.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.8 mp -101.52 -86.09 0.42 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.886 -1.134 . . . . 0.0 111.001 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.2 45.71 2.53 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.638 -1.289 . . . . 0.0 115.338 171.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.65 172.33 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 120.696 -1.473 . . . . 0.0 109.032 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.7 p -121.16 145.05 48.23 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.723 -1.861 . . . . 0.0 108.539 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.07 154.3 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 125.757 1.623 . . . . 0.0 108.073 -165.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.6 t -139.0 161.36 37.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 169.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.03 -132.38 15.18 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.635 -1.29 . . . . 0.0 114.335 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.97 0.81 89.0 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 120.708 -1.466 . . . . 0.0 115.899 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.0 t -73.69 166.93 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.156 2.182 . . . . 0.0 110.901 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -69.77 -15.35 63.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.383 1.873 . . . . 0.0 115.429 -164.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.5 t -134.99 118.0 16.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.507 -1.996 . . . . 0.0 107.084 148.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 p -146.87 -83.25 0.12 Allowed 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.878 -1.139 . . . . 0.0 109.445 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.61 -51.14 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 126.62 1.968 . . . . 0.0 110.245 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -130.35 -158.05 0.86 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 161.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.38 56.71 1.79 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.406 -2.059 . . . . 0.0 112.851 165.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.34 168.69 12.4 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 126.412 1.958 . . . . 0.0 110.423 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.91 152.31 24.76 Favored Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 125.099 1.333 . . . . 0.0 111.079 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.2 mm -126.47 149.17 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 121.097 -1.237 . . . . 0.0 109.501 -161.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.65 137.12 53.85 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.358 -1.463 . . . . 0.0 109.64 -172.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.7 t -86.02 132.94 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.441 -1.412 . . . . 0.0 112.104 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -87.76 -70.08 0.65 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.569 -1.332 . . . . 0.0 110.875 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.81 163.29 40.01 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 122.157 0.979 . . . . 0.0 111.112 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.8 p -88.27 130.06 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.424 0 C-N-CA 124.925 1.29 . . . . 0.0 111.642 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mm -84.45 118.83 72.05 Favored Pre-proline 0 N--CA 1.43 -1.471 0 O-C-N 120.201 -1.562 . . . . 0.0 109.256 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.39 45.28 1.68 Allowed 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 124.715 2.72 . . . . 0.0 113.061 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -143.02 34.41 1.36 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.146 0.978 . . . . 0.0 109.217 -171.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.19 -172.69 39.62 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 119.938 -1.726 . . . . 0.0 113.105 -171.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.54 -35.83 78.86 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.951 1.7 . . . . 0.0 114.598 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.98 -49.17 69.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.16 -53.51 36.73 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.37 1.868 . . . . 0.0 112.079 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.6 m -66.27 -29.31 69.51 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.58 -53.93 6.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.91 1.684 . . . . 0.0 111.967 170.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.71 65.98 1.67 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 120.393 -1.442 . . . . 0.0 114.173 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -138.34 -13.74 1.33 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.01 -1.288 . . . . 0.0 113.232 -166.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.04 144.68 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -121.23 -177.62 3.56 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 122.998 1.38 . . . . 0.0 111.473 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.9 pttt -58.56 132.84 54.98 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.183 -1.573 . . . . 0.0 114.707 168.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.49 12.59 84.38 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 117.807 1.883 . . . . 0.0 117.807 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -74.08 160.86 30.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.352 1.576 . . . . 0.0 110.747 167.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ttm-85 -122.89 106.47 10.9 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.591 -1.318 . . . . 0.0 109.427 -166.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 m -102.42 126.37 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.313 1.53 . . . . 0.0 111.134 -166.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.04 -88.52 0.62 Allowed 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.085 -1.635 . . . . 0.0 112.172 -160.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.54 134.71 33.99 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 121.107 -0.996 . . . . 0.0 112.564 -166.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.58 105.24 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.85 -1.156 . . . . 0.0 108.879 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.264 1.4 t-20 55.92 43.09 27.99 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.093 2.157 . . . . 0.0 113.337 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.69 -28.39 15.73 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 124.469 1.033 . . . . 0.0 113.635 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.4 t -84.18 109.14 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 124.451 1.1 . . . . 0.0 113.122 -166.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -78.52 98.61 6.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.053 1.341 . . . . 0.0 110.435 172.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.39 75.21 1.6 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.151 1.453 . . . . 0.0 109.674 -170.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.42 143.67 54.98 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.687 -1.883 . . . . 0.0 112.986 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.16 7.37 65.72 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.478 -1.389 . . . . 0.0 114.668 -175.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.79 147.03 37.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.584 -1.539 . . . . 0.0 113.709 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 p -93.09 170.57 9.54 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.739 1.616 . . . . 0.0 109.494 166.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -60.79 -41.67 96.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.815 -1.178 . . . . 0.0 112.761 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -49.07 -51.32 32.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.815 1.646 . . . . 0.0 114.84 168.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -70.77 -36.19 72.95 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.23 -1.544 . . . . 0.0 112.826 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.09 98.19 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.017 -1.677 . . . . 0.0 113.433 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.0 t -67.66 -43.73 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 C-N-CA 125.35 1.46 . . . . 0.0 111.914 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.88 -12.91 60.81 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 120.251 -1.53 . . . . 0.0 114.195 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.4 m -71.17 -57.65 4.3 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.993 -2.317 . . . . 0.0 110.214 171.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.8 -20.45 42.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -72.5 -23.23 60.99 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.831 -1.793 . . . . 0.0 112.795 166.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -90.64 52.82 2.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 119.502 -1.999 . . . . 0.0 111.865 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.2 p -109.04 -94.06 0.41 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.893 1.677 . . . . 0.0 110.478 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.02 -59.86 0.57 Allowed Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 124.825 1.202 . . . . 0.0 112.565 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -84.68 -77.17 0.28 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.957 -1.32 . . . . 0.0 114.097 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.84 143.2 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.818 1.647 . . . . 0.0 111.445 -161.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.4 t -126.5 128.97 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.93 1.692 . . . . 0.0 109.941 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -143.02 115.21 8.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.662 -1.899 . . . . 0.0 109.763 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.3 mt -128.2 153.77 46.54 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.587 -1.321 . . . . 0.0 111.306 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.8 130.9 55.15 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.65 151.56 37.45 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -103.6 134.59 46.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -74.99 137.64 41.69 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.655 -1.278 . . . . 0.0 114.398 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.729 0 CA-C-O 122.889 1.272 . . . . 0.0 116.201 -167.826 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.9 t -120.05 138.93 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.591 -1.318 . . . . 0.0 109.873 -152.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 13.9 m -128.21 157.42 40.89 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.802 -1.186 . . . . 0.0 112.666 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.27 154.74 45.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.061 -1.025 . . . . 0.0 110.095 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.259 1.578 0 C-N-CA 125.378 1.471 . . . . 0.0 107.45 169.413 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.661 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -82.89 171.68 13.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.3 mp -89.14 132.43 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.38 -1.45 . . . . 0.0 110.968 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.439 ' CE1' ' HG ' ' A' ' 89' ' ' LEU . 7.3 p90 -133.16 161.73 33.65 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.751 -1.218 . . . . 0.0 111.834 177.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -109.91 134.62 51.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 124.86 1.264 . . . . 0.0 110.924 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -103.18 149.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.503 -1.373 . . . . 0.0 111.21 163.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.9 105.89 8.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 167.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.2 tp -134.43 -179.32 5.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.875 -1.141 . . . . 0.0 108.402 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.61 172.67 12.39 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 120.16 -1.587 . . . . 0.0 109.906 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -71.9 111.97 7.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.598 1.559 . . . . 0.0 110.889 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -113.71 -83.28 0.6 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.377 1.071 . . . . 0.0 110.176 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -82.86 -47.42 11.86 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.768 -1.208 . . . . 0.0 109.513 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -137.6 -172.69 3.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 167.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 t -83.85 -72.55 0.46 Allowed 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.916 -1.115 . . . . 0.0 111.452 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.38 -84.4 0.45 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.963 -1.086 . . . . 0.0 110.379 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.82 54.34 0.68 Allowed Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 116.175 1.23 . . . . 0.0 116.175 170.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.65 174.12 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 119.195 1.498 . . . . 0.0 112.437 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.8 p -122.63 135.91 54.74 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.152 1.381 . . . . 0.0 109.545 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -123.36 142.7 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.497 1.519 . . . . 0.0 110.634 -163.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.1 t -136.4 111.3 8.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.653 1.692 . . . . 0.0 111.589 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -134.15 11.86 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 125.242 1.401 . . . . 0.0 111.503 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.1 23.39 32.44 Favored Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.84 -127.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 121.018 -1.284 . . . . 0.0 113.11 -172.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -79.38 -44.25 21.86 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.073 -1.642 . . . . 0.0 112.75 -164.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -151.98 103.19 2.88 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 166.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.9 p -134.71 -75.94 0.46 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.327 -1.483 . . . . 0.0 110.44 -172.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.16 -54.84 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 124.704 1.202 . . . . 0.0 110.272 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -134.18 -164.12 1.46 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.03 78.39 3.57 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.911 -1.743 . . . . 0.0 111.508 166.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.75 -177.4 21.19 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -166.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.48 148.6 12.45 Favored Glycine 0 N--CA 1.431 -1.687 0 O-C-N 121.458 -1.025 . . . . 0.0 111.119 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.9 mm -127.23 142.31 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -171.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.44 130.91 53.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.69 -1.256 . . . . 0.0 109.589 -169.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.3 t -84.22 134.94 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 124.38 1.072 . . . . 0.0 111.438 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -88.83 -59.26 2.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.31 1.444 . . . . 0.0 111.199 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.9 159.49 29.75 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 123.575 0.75 . . . . 0.0 111.463 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 p -91.59 128.15 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 122.586 1.184 . . . . 0.0 113.017 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.2 mm -84.45 131.69 49.42 Favored Pre-proline 0 N--CA 1.43 -1.458 0 C-N-CA 126.175 1.79 . . . . 0.0 110.866 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.36 41.64 1.17 Allowed 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 123.546 2.831 . . . . 0.0 114.593 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -147.48 66.34 1.13 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.664 1.585 . . . . 0.0 107.235 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.74 175.79 46.34 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 119.69 -1.881 . . . . 0.0 115.438 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.15 -34.93 78.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.305 1.042 . . . . 0.0 112.275 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.37 -56.02 24.92 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.744 1.618 . . . . 0.0 113.936 175.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.61 -47.16 67.39 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.044 -1.035 . . . . 0.0 112.372 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.3 m -60.18 -47.77 84.56 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.68 -51.9 30.45 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.562 -1.336 . . . . 0.0 112.538 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.07 78.62 0.95 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 120.82 -1.175 . . . . 0.0 111.575 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.6 ttt85 -138.82 -34.61 0.6 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.956 -0.731 . . . . 0.0 112.315 -158.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 mt -128.9 170.25 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -140.95 -177.8 5.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.293 -2.754 . . . . 0.0 112.036 165.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.45 143.05 30.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.774 -1.829 . . . . 0.0 113.743 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.87 8.15 81.98 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 117.576 1.79 . . . . 0.0 117.576 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -80.77 154.69 27.07 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 119.274 1.537 . . . . 0.0 109.157 163.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -137.05 128.66 28.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.976 -1.703 . . . . 0.0 112.39 -164.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.0 m -80.13 162.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.972 -1.705 . . . . 0.0 115.292 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 mp -119.88 -86.68 0.65 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.23 1.812 . . . . 0.0 106.981 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 160.49 14.25 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -170.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.1 t -108.78 98.54 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.49 1.516 . . . . 0.0 107.108 165.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 56.38 54.51 7.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.671 1.588 . . . . 0.0 114.233 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.7 -32.02 4.39 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.434 -1.416 . . . . 0.0 114.18 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.91 121.82 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 124.627 1.171 . . . . 0.0 112.254 -171.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.1 m -77.72 133.59 38.28 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 120.632 -1.293 . . . . 0.0 112.216 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.49 63.3 7.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.506 -1.371 . . . . 0.0 109.677 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.52 104.0 1.17 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.029 1.731 . . . . 0.0 114.417 -168.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.08 29.26 74.62 Favored Glycine 0 N--CA 1.429 -1.775 0 O-C-N 120.43 -1.418 . . . . 0.0 114.888 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.2 158.15 30.5 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.229 1.412 . . . . 0.0 114.203 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 p -80.8 162.06 24.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.809 -1.182 . . . . 0.0 111.589 167.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -60.87 -42.25 97.52 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.365 1.466 . . . . 0.0 111.586 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -47.03 -46.07 21.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.266 1.826 . . . . 0.0 114.747 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -71.52 -38.69 71.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.288 -1.507 . . . . 0.0 113.436 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.7 96.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.965 -1.085 . . . . 0.0 113.412 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.66 -47.3 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 126.391 1.876 . . . . 0.0 112.772 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -54.51 -43.64 72.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.753 -1.217 . . . . 0.0 113.332 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.1 m -62.56 -50.3 71.88 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.128 1.771 . . . . 0.0 112.724 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.69 -12.27 59.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.955 -1.716 . . . . 0.0 115.594 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.31 -30.7 57.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.553 -1.967 . . . . 0.0 112.214 167.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -100.47 65.64 1.21 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.189 -1.569 . . . . 0.0 114.591 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.5 p -92.74 -68.24 0.81 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.157 -1.589 . . . . 0.0 112.091 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.66 -127.83 7.43 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 125.581 1.562 . . . . 0.0 110.76 -172.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -83.35 -45.65 13.5 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 p -115.4 145.46 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 121.287 -0.883 . . . . 0.0 113.286 -166.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.8 t -124.96 112.5 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.215 1.806 . . . . 0.0 110.48 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -120.46 110.91 17.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.244 -1.535 . . . . 0.0 110.412 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.4 mt -131.99 151.73 51.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.696 -1.252 . . . . 0.0 111.157 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.84 128.15 52.57 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.439 ' HG ' ' CE1' ' A' ' 7' ' ' PHE . 1.6 pt? -147.48 157.19 43.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.886 0.85 . . . . 0.0 111.262 -171.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -109.21 137.28 47.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.618 1.167 . . . . 0.0 109.069 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.28 130.4 41.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.487 1.136 . . . . 0.0 112.075 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.756 0 C-N-CA 125.867 1.699 . . . . 0.0 114.645 -175.057 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 . . . . . 0 N--CA 1.431 -1.416 0 CA-C-O 121.317 0.579 . . . . 0.0 112.14 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -121.67 136.43 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.012 1.725 . . . . 0.0 106.735 -170.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.2 m -128.37 167.95 16.25 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 120.579 -1.325 . . . . 0.0 111.427 -172.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.34 134.14 16.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 123.032 0.533 . . . . 0.0 110.337 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--O 1.259 1.593 0 C-N-CA 126.667 1.987 . . . . 0.0 108.45 172.572 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.749 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -82.73 -177.1 6.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.78 133.83 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.23 1.412 . . . . 0.0 109.712 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -132.81 158.67 41.89 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.105 -1.622 . . . . 0.0 111.339 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -117.68 140.2 49.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.147 0.975 . . . . 0.0 110.961 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.08 142.99 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.865 -1.147 . . . . 0.0 109.47 166.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -128.55 76.3 1.7 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 tp -113.35 171.1 7.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.564 -1.335 . . . . 0.0 110.505 -167.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.27 161.34 39.83 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.358 -1.464 . . . . 0.0 109.033 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -68.35 112.97 5.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.98 -1.075 . . . . 0.0 112.762 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -115.04 -78.98 0.58 Allowed 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 124.977 1.311 . . . . 0.0 109.743 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -82.38 -43.91 16.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.494 -1.379 . . . . 0.0 110.417 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -143.3 -177.63 5.46 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.752 1.221 . . . . 0.0 107.726 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.3 t -83.29 -83.14 0.14 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 124.726 1.211 . . . . 0.0 108.901 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.1 mp -101.85 -99.9 0.27 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.168 -0.957 . . . . 0.0 108.865 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.39 60.08 0.79 Allowed Glycine 0 N--CA 1.43 -1.74 0 O-C-N 120.276 -1.515 . . . . 0.0 115.313 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.52 175.09 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 121.284 -1.127 . . . . 0.0 108.028 170.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.2 p -121.31 145.53 47.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.542 -1.974 . . . . 0.0 108.663 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.6 t -123.76 167.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.247 1.419 . . . . 0.0 107.409 -168.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.9 t -136.99 67.59 1.44 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.314 2.007 . . . . 0.0 108.714 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.83 -137.17 18.32 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 120.237 -1.539 . . . . 0.0 112.513 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.9 93.9 1.47 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -166.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.29 -113.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 121.793 -0.827 . . . . 0.0 111.08 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -93.3 -62.69 1.32 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.725 -1.234 . . . . 0.0 111.36 -165.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 t -134.24 97.98 3.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.212 1.482 . . . . 0.0 108.52 166.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.2 p -134.64 -84.08 0.42 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.841 -1.162 . . . . 0.0 111.14 -162.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.13 -51.37 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 125.807 1.643 . . . . 0.0 110.154 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -138.17 -166.22 1.94 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 158.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.67 66.89 9.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.135 -1.603 . . . . 0.0 111.286 168.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.64 141.31 5.67 Favored Glycine 0 N--CA 1.429 -1.784 0 O-C-N 120.877 -1.14 . . . . 0.0 110.868 -171.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.8 155.17 26.16 Favored Glycine 0 N--CA 1.43 -1.72 0 O-C-N 121.488 -1.007 . . . . 0.0 111.946 -170.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.1 mm -133.44 152.33 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 124.821 1.248 . . . . 0.0 108.784 -164.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.85 124.76 43.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.158 -1.589 . . . . 0.0 110.66 -168.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.5 t -74.05 135.34 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.27 -1.519 . . . . 0.0 112.744 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -91.93 -68.01 0.82 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.921 -1.112 . . . . 0.0 112.372 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.89 157.69 35.32 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.162 -0.961 . . . . 0.0 109.914 -173.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.4 p -88.35 131.93 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.716 1.246 . . . . 0.0 113.167 -175.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.4 mm -84.61 126.15 69.54 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 117.514 -1.232 . . . . 0.0 108.315 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -81.5 34.93 0.56 Allowed 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 123.351 2.701 . . . . 0.0 113.797 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -144.84 64.1 1.29 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.661 1.984 . . . . 0.0 107.078 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.37 174.39 46.02 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 120.565 -1.334 . . . . 0.0 112.589 -177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.67 82.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.747 1.619 . . . . 0.0 113.432 -174.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.02 -49.2 66.75 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.063 1.745 . . . . 0.0 114.897 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.46 -35.69 34.56 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 124.092 0.957 . . . . 0.0 112.554 176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.8 m -59.38 -51.51 69.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.971 -1.706 . . . . 0.0 114.018 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.3 -41.03 42.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 111.115 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.79 66.63 1.45 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 120.623 -1.298 . . . . 0.0 111.628 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 ttt85 -137.59 -20.86 1.16 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -160.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.52 154.21 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -139.95 178.87 6.96 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.965 -1.709 . . . . 0.0 111.14 171.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.84 138.06 56.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.94 19.5 79.91 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 116.964 1.546 . . . . 0.0 116.964 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -83.1 162.04 21.45 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 119.173 1.487 . . . . 0.0 109.41 164.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.9 ttm105 -127.59 123.98 37.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.964 -1.71 . . . . 0.0 110.353 -171.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.6 m -93.71 147.5 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.442 -1.411 . . . . 0.0 111.728 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.4 -88.67 0.62 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 123.923 0.889 . . . . 0.0 109.823 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.8 148.03 22.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.893 -1.754 . . . . 0.0 114.498 -169.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -109.83 88.64 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.32 1.448 . . . . 0.0 109.647 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 57.14 60.14 3.1 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.062 1.745 . . . . 0.0 114.946 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.47 -36.57 3.8 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 124.422 1.011 . . . . 0.0 113.101 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 t -95.85 114.14 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.804 -1.41 . . . . 0.0 112.261 -169.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.4 m -78.03 132.41 37.76 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.33 -1.481 . . . . 0.0 110.206 161.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.87 76.48 5.56 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.623 1.201 . . . . 0.0 109.848 -171.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.18 103.31 0.75 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 -165.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.64 14.23 72.3 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.397 -1.44 . . . . 0.0 114.325 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.9 141.88 40.35 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.688 1.195 . . . . 0.0 112.4 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 p -76.28 172.98 11.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.303 1.841 . . . . 0.0 113.475 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -60.59 -38.12 83.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.33 1.452 . . . . 0.0 113.591 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -58.84 -50.35 74.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.345 -1.472 . . . . 0.0 113.558 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -71.43 -39.46 71.02 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.247 1.419 . . . . 0.0 112.951 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.96 -42.57 99.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.278 -1.514 . . . . 0.0 113.804 175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -72.1 -38.79 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 119.854 -1.779 . . . . 0.0 111.815 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -58.41 -35.99 72.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.624 -1.297 . . . . 0.0 113.657 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.0 m -67.78 -41.23 83.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.526 1.93 . . . . 0.0 113.048 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 mt -80.47 -19.35 46.19 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.196 -1.565 . . . . 0.0 114.202 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -72.53 -25.8 61.51 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.855 -1.778 . . . . 0.0 112.307 166.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -88.91 70.83 8.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.942 -1.099 . . . . 0.0 112.625 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.0 p -104.41 -78.1 0.57 Allowed 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.997 -1.064 . . . . 0.0 110.131 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.24 -117.86 4.36 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -82.85 -49.62 9.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.13 147.29 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.785 -1.197 . . . . 0.0 113.24 -166.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.84 110.72 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.451 1.501 . . . . 0.0 110.024 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -124.16 111.3 15.74 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.934 -1.729 . . . . 0.0 111.328 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 69.6 mt -129.95 153.15 48.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.428 -0.795 . . . . 0.0 111.087 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.36 127.13 52.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.47 156.93 43.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.024 0.916 . . . . 0.0 111.88 -170.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -105.35 136.27 45.19 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.712 1.205 . . . . 0.0 109.119 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -70.03 131.85 44.98 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.302 1.041 . . . . 0.0 112.541 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.755 0 N-CA-C 116.677 1.431 . . . . 0.0 116.677 178.187 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 121.33 0.586 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.36 141.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 126.304 1.842 . . . . 0.0 106.61 -173.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 68.9 m -132.96 161.76 33.44 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.067 1.347 . . . . 0.0 112.635 -160.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.95 152.79 52.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.566 1.147 . . . . 0.0 111.901 170.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.26 1.609 0 C-N-CA 127.419 2.288 . . . . 0.0 107.553 168.509 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.737 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -81.65 159.56 23.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.985 -1.303 . . . . 0.0 113.728 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 mp -81.87 135.7 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.569 1.547 . . . . 0.0 109.509 -174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -138.53 150.58 46.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.404 1.082 . . . . 0.0 111.115 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.33 113.63 21.73 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.969 -1.082 . . . . 0.0 109.577 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.1 m -102.17 146.83 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.842 -1.162 . . . . 0.0 112.573 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.71 134.32 55.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.054 0.942 . . . . 0.0 108.524 172.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.2 mt -130.93 148.02 52.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 161.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.97 135.3 46.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -66.92 118.63 10.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -119.1 -84.06 0.65 Allowed 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.58 -1.325 . . . . 0.0 111.657 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -77.35 -42.17 37.62 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.668 1.987 . . . . 0.0 109.888 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -156.43 -172.04 3.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 m -92.64 -73.88 0.54 Allowed 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.167 -0.958 . . . . 0.0 110.3 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.07 -91.06 0.34 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 118.93 0.786 . . . . 0.0 111.808 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.71 52.18 1.22 Allowed Glycine 0 N--CA 1.431 -1.687 0 O-C-N 120.0 -1.687 . . . . 0.0 111.465 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.2 tt -145.88 158.05 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 121.228 -1.16 . . . . 0.0 111.405 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.0 p -122.02 149.4 43.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.491 -1.381 . . . . 0.0 110.113 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.29 164.05 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.22 1.01 . . . . 0.0 108.549 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -137.7 151.99 48.8 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.408 -2.057 . . . . 0.0 105.691 165.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.64 -144.51 17.21 Favored Glycine 0 N--CA 1.431 -1.678 0 O-C-N 120.969 -1.082 . . . . 0.0 112.466 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.3 -4.46 86.03 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 124.745 1.164 . . . . 0.0 113.868 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -100.34 161.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 124.611 1.164 . . . . 0.0 108.792 -168.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -68.36 -19.51 64.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.131 2.172 . . . . 0.0 114.471 -162.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.5 t -130.34 126.97 38.47 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 152.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.5 p -156.21 -101.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.628 -1.295 . . . . 0.0 109.292 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.48 -41.97 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.317 -1.49 . . . . 0.0 110.876 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -131.86 -145.18 0.26 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 162.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -79.5 55.63 1.99 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.45 2.3 . . . . 0.0 111.014 168.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.99 -160.1 14.81 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 107.111 -2.396 . . . . 0.0 107.111 -163.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.54 150.2 26.22 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 122.234 0.908 . . . . 0.0 112.345 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mm -125.91 132.73 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.238 -1.154 . . . . 0.0 108.208 -170.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.55 140.47 52.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 124.561 1.144 . . . . 0.0 108.707 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.9 t -78.97 127.65 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 O-C-N 120.36 -1.462 . . . . 0.0 110.961 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -90.12 -62.26 1.5 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.587 -1.32 . . . . 0.0 110.843 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.82 156.87 25.81 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.2 t -91.0 133.45 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.1 mm -83.21 127.62 68.16 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.967 -1.492 . . . . 0.0 108.643 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -80.35 41.79 1.2 Allowed 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 123.841 3.027 . . . . 0.0 113.386 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -145.58 53.12 1.17 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.92 2.488 . . . . 0.0 106.313 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.97 161.81 33.1 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.225 -1.547 . . . . 0.0 114.914 -174.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.76 -32.53 65.69 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 127.9 2.48 . . . . 0.0 115.766 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.66 -38.19 66.64 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 170.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -78.94 -39.2 35.22 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.427 1.091 . . . . 0.0 111.689 174.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.2 m -57.58 -48.24 79.92 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.413 -1.43 . . . . 0.0 113.179 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -73.96 -65.74 0.8 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.821 1.248 . . . . 0.0 112.827 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.63 79.21 0.79 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.342 -1.474 . . . . 0.0 114.852 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -138.87 -30.3 0.75 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.515 1.526 . . . . 0.0 110.882 -174.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.5 mt -125.73 138.65 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -140.16 -173.9 3.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.499 -1.376 . . . . 0.0 110.117 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -57.52 134.75 56.38 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.59 11.22 85.42 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 118.656 2.222 . . . . 0.0 118.656 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -76.45 154.68 34.54 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.238 2.019 . . . . 0.0 111.002 169.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.453 HH21 ' CD ' ' A' ' 90' ' ' GLU . 2.5 tmm_? -124.4 115.13 20.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.076 -1.64 . . . . 0.0 110.11 -161.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.3 m -94.82 154.08 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 119.658 -1.901 . . . . 0.0 114.191 -170.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.5 mt -121.81 -89.51 0.6 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.3 1.04 . . . . 0.0 110.33 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.83 141.5 31.54 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -165.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.1 t -95.4 102.64 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 124.473 1.109 . . . . 0.0 108.026 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.256 59.3 t30 57.94 42.42 22.95 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.859 1.663 . . . . 0.0 114.191 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.63 -27.25 21.06 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.535 -1.353 . . . . 0.0 113.959 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.1 t -91.33 113.31 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.345 -1.091 . . . . 0.0 111.967 -174.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -81.05 111.77 17.83 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.984 -1.072 . . . . 0.0 111.749 167.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.96 82.78 1.86 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.744 -1.223 . . . . 0.0 108.749 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.37 144.0 53.55 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.343 -2.098 . . . . 0.0 114.495 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.68 -15.31 52.91 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 120.693 -1.254 . . . . 0.0 114.897 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.68 128.58 37.15 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.836 1.655 . . . . 0.0 115.376 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 p -73.38 164.26 26.91 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.065 1.412 . . . . 0.0 111.01 172.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.12 -42.28 94.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -168.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HZ1' ' CD ' ' A' ' 76' ' ' GLU . 42.5 tptt -55.71 -38.22 69.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.356 1.862 . . . . 0.0 114.463 172.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -71.37 -43.63 66.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.253 1.421 . . . . 0.0 111.276 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.73 -48.82 70.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.82 -1.175 . . . . 0.0 113.539 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.13 -52.22 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 124.79 1.236 . . . . 0.0 113.503 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.422 ' CD ' ' HZ1' ' A' ' 72' ' ' LYS . 34.9 mt-10 -71.46 -21.88 61.9 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 120.077 -1.639 . . . . 0.0 114.587 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.3 m -64.77 -40.49 95.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.354 -1.466 . . . . 0.0 111.57 169.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.61 -26.36 37.85 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.524 -1.36 . . . . 0.0 113.837 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -66.55 -43.35 85.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.021 -1.675 . . . . 0.0 112.154 168.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -78.14 53.85 1.27 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.719 1.608 . . . . 0.0 113.592 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.3 p -108.5 -86.6 0.51 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.85 2.06 . . . . 0.0 108.817 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.87 -57.45 1.83 Allowed Glycine 0 N--CA 1.43 -1.749 0 O-C-N 120.29 -1.506 . . . . 0.0 114.936 171.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -83.15 -68.23 0.72 Allowed 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 120.516 -1.579 . . . . 0.0 112.609 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.45 141.64 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 122.555 1.169 . . . . 0.0 110.249 -173.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.1 t -114.99 109.04 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 126.651 1.98 . . . . 0.0 107.489 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -117.24 127.68 54.33 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.841 -1.162 . . . . 0.0 110.478 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.5 mt -141.42 152.46 44.3 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 123.847 0.859 . . . . 0.0 111.78 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -122.32 123.9 42.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.827 1.251 . . . . 0.0 107.951 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.43 165.82 29.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.635 1.207 . . . . 0.0 111.622 -173.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.453 ' CD ' HH21 ' A' ' 57' ' ' ARG . 29.8 tt0 -112.03 141.33 45.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.303 1.841 . . . . 0.0 108.325 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -71.64 137.7 48.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.525 -1.359 . . . . 0.0 112.093 171.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.686 0 CA-C-O 123.467 1.593 . . . . 0.0 115.915 -176.177 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 68.6 t -120.86 139.27 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.199 2.2 . . . . 0.0 105.482 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 11.6 m -132.28 140.54 48.66 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.164 1.386 . . . . 0.0 114.563 -156.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.54 157.58 31.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.972 1.709 . . . . 0.0 112.088 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.262 1.719 0 C-N-CA 125.211 1.404 . . . . 0.0 108.809 -179.474 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.655 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -80.57 155.98 26.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 123.334 1.54 . . . . 0.0 114.381 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.8 mt -86.55 135.86 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 125.645 1.578 . . . . 0.0 109.121 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -145.13 166.52 25.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.203 1.001 . . . . 0.0 108.84 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -124.63 143.7 50.58 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.282 -0.886 . . . . 0.0 109.869 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.6 m -103.43 148.75 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 123.425 0.69 . . . . 0.0 109.799 171.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -129.39 93.48 3.57 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.8 tp -122.61 163.06 20.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -172.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.88 172.14 13.4 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.045 -1.659 . . . . 0.0 109.014 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -71.63 103.83 3.15 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.997 -1.064 . . . . 0.0 113.115 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -97.97 -70.87 0.71 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.902 1.281 . . . . 0.0 109.465 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -70.43 -76.91 0.09 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.724 2.01 . . . . 0.0 110.003 172.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -138.21 -176.86 4.59 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.818 -3.031 . . . . 0.0 102.818 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 t -79.48 -61.46 2.0 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.775 -1.828 . . . . 0.0 112.881 -162.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.2 mp -101.76 -88.18 0.38 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.175 -1.578 . . . . 0.0 111.32 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.6 45.08 2.01 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tt -152.41 147.34 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 120.948 -1.325 . . . . 0.0 110.49 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 t -122.17 158.52 29.19 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.899 -1.126 . . . . 0.0 109.926 -174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.416 HG12 ' CE1' ' A' ' 71' ' ' HIS . 33.0 t -121.4 162.48 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.042 1.337 . . . . 0.0 109.299 -158.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 t -147.69 149.68 32.91 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 165.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.81 -149.87 43.73 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.62 12.88 57.69 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 118.231 2.052 . . . . 0.0 118.231 168.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.04 -107.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 119.128 1.464 . . . . 0.0 114.491 -161.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -89.89 -41.47 11.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.361 -2.087 . . . . 0.0 110.793 -172.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 t -136.31 152.64 50.9 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 158.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -155.37 -93.04 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.431 -1.418 . . . . 0.0 110.835 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.47 -52.67 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 C-N-CA 125.044 1.337 . . . . 0.0 110.016 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.5 ptt-85 -125.98 -139.05 0.27 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.446 -1.686 . . . . 0.0 106.446 154.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -75.67 67.35 2.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.773 1.749 . . . . 0.0 110.823 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.45 -176.58 16.42 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 126.181 1.848 . . . . 0.0 109.333 -171.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.63 151.52 27.02 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.68 159.3 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.52 157.21 35.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.468 -1.395 . . . . 0.0 109.747 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 t -92.53 128.25 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 124.963 1.305 . . . . 0.0 111.849 -174.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -97.17 -67.39 0.85 Allowed 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.691 -1.256 . . . . 0.0 113.342 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.21 153.05 28.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.827 -1.17 . . . . 0.0 112.637 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.94 119.87 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 126.309 1.843 . . . . 0.0 109.246 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.4 mm -84.54 131.52 49.71 Favored Pre-proline 0 N--CA 1.43 -1.451 0 C-N-CA 125.054 1.341 . . . . 0.0 109.685 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -77.11 64.23 7.79 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 CA-C-N 124.295 2.57 . . . . 0.0 112.65 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -160.33 53.95 0.33 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.869 1.319 . . . . 0.0 109.202 173.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.72 179.95 45.7 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.385 -2.072 . . . . 0.0 112.908 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.36 -32.79 72.71 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.734 1.614 . . . . 0.0 114.703 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.75 -42.35 71.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.845 1.658 . . . . 0.0 114.411 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -91.33 -47.18 7.62 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.779 1.232 . . . . 0.0 112.0 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.4 m -68.39 -36.6 79.39 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -173.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -84.4 -49.2 8.9 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.189 1.359 . . . . 0.0 109.327 165.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.89 90.43 2.16 Favored Glycine 0 N--CA 1.43 -1.701 0 O-C-N 121.02 -1.05 . . . . 0.0 111.672 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -137.83 -54.5 0.66 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -166.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.0 mt -126.36 145.98 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 119.197 -2.189 . . . . 0.0 107.387 -165.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -119.2 174.05 6.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.462 1.125 . . . . 0.0 112.386 -170.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -61.12 136.03 57.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 167.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 26.51 62.63 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 119.154 2.422 . . . . 0.0 119.154 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -79.9 176.18 9.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 118.776 1.288 . . . . 0.0 110.737 162.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -124.75 121.09 33.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.969 -1.707 . . . . 0.0 109.248 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -94.17 153.46 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 120.028 -1.67 . . . . 0.0 112.193 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.0 tp -125.9 -81.42 0.62 Allowed 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 121.059 -1.025 . . . . 0.0 112.073 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.88 151.18 21.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.527 -1.358 . . . . 0.0 114.385 -166.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.75 92.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 125.999 1.719 . . . . 0.0 107.066 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 56.37 54.61 7.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.468 1.507 . . . . 0.0 114.555 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.27 -40.31 2.47 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 124.329 0.966 . . . . 0.0 114.649 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 t -99.31 136.17 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 O-C-N 121.425 -1.044 . . . . 0.0 111.381 -169.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 t -77.72 144.99 36.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.87 -1.769 . . . . 0.0 110.97 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -90.89 -9.43 46.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.455 -1.403 . . . . 0.0 113.305 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.02 144.53 33.87 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -172.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.1 -43.84 1.87 Allowed Glycine 0 N--CA 1.431 -1.699 0 O-C-N 121.176 -0.953 . . . . 0.0 113.017 -161.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.01 160.0 28.42 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.614 -1.521 . . . . 0.0 114.516 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.8 p -84.85 167.74 15.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.444 1.898 . . . . 0.0 111.174 175.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.416 ' CE1' HG12 ' A' ' 22' ' ' VAL . 11.1 t60 -60.67 -37.45 81.64 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.42 1.488 . . . . 0.0 114.052 171.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -54.5 -45.86 73.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.956 2.102 . . . . 0.0 114.221 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -76.18 -34.23 59.33 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.086 -1.634 . . . . 0.0 112.723 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.84 96.74 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.551 1.541 . . . . 0.0 114.481 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.7 m -73.88 -24.06 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.974 -1.704 . . . . 0.0 113.787 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -67.91 -45.26 74.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.406 -1.434 . . . . 0.0 112.183 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.6 m -59.97 -33.12 71.51 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 126.745 2.018 . . . . 0.0 112.828 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.26 -54.71 5.7 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.76 -1.213 . . . . 0.0 112.574 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -68.5 -5.43 19.45 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -169.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -85.49 11.96 9.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.152 -1.592 . . . . 0.0 115.192 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 p -102.14 -103.84 0.27 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.471 1.508 . . . . 0.0 110.015 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.95 -57.57 0.47 Allowed Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.201 -1.562 . . . . 0.0 113.376 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -71.33 -67.94 0.48 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.8 p -109.46 140.43 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 122.459 1.123 . . . . 0.0 112.057 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.9 t -119.82 112.1 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 125.155 1.382 . . . . 0.0 109.774 -175.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -116.53 115.35 25.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.017 -1.052 . . . . 0.0 108.378 168.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.2 tp -128.41 146.35 50.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.932 1.293 . . . . 0.0 108.595 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -120.74 123.02 41.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.32 157.65 44.58 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 122.243 1.021 . . . . 0.0 110.5 -170.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -104.68 141.37 36.56 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -65.23 135.45 55.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.629 1.204 . . . . 0.0 113.457 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.694 0 CA-C-O 122.596 1.109 . . . . 0.0 113.175 176.465 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 . . . . . 0 N--CA 1.429 -1.484 0 CA-C-O 121.244 0.545 . . . . 0.0 111.681 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -121.3 158.33 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.069 2.148 . . . . 0.0 107.752 -169.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.8 m -141.71 159.29 42.53 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.08 -1.637 . . . . 0.0 112.987 -168.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.53 161.77 38.99 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.475 0.655 . . . . 0.0 111.721 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.504 1.922 . . . . 0.0 106.437 174.559 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.71 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.31 168.62 18.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.8 135.06 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 126.424 1.89 . . . . 0.0 109.409 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -146.99 169.62 18.82 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.797 1.284 . . . . 0.0 113.568 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.09 125.94 40.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.994 1.318 . . . . 0.0 111.457 -174.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.2 m -104.78 147.91 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.303 -1.498 . . . . 0.0 113.805 172.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -130.85 104.08 6.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.132 1.373 . . . . 0.0 109.833 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.421 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 7.1 tp -123.28 174.9 7.01 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.795 1.238 . . . . 0.0 108.199 -177.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.421 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -143.23 163.52 32.72 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.669 -1.894 . . . . 0.0 105.928 166.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -62.38 120.61 11.37 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -117.92 -89.07 0.6 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.617 1.167 . . . . 0.0 109.298 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.12 -49.66 41.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.68 1.592 . . . . 0.0 110.976 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -151.5 -162.83 1.62 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -84.63 -61.54 1.77 Allowed 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 120.511 1.505 . . . . 0.0 110.018 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 mp -104.1 -93.55 0.34 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.504 -1.373 . . . . 0.0 111.723 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.87 51.74 1.25 Allowed Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 124.793 1.187 . . . . 0.0 110.602 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.7 tt -150.2 163.57 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 121.329 -1.101 . . . . 0.0 110.791 -174.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -121.85 148.02 45.24 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.405 -1.435 . . . . 0.0 110.135 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -126.01 156.78 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 126.04 1.736 . . . . 0.0 109.633 -166.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -138.69 151.17 46.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.182 -0.949 . . . . 0.0 109.532 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.78 -149.8 50.8 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 125.641 1.591 . . . . 0.0 115.804 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.03 36.88 13.79 Favored Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 116.677 1.431 . . . . 0.0 116.677 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.54 -108.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -166.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -90.25 -52.48 4.91 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.802 -1.811 . . . . 0.0 110.852 -169.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -137.38 135.42 36.96 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 161.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 t -155.72 -84.27 0.06 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.107 -1.621 . . . . 0.0 110.325 -163.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.48 -58.5 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -116.89 -138.36 0.36 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 161.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 66.06 2.19 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.979 -1.7 . . . . 0.0 110.711 164.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.99 -147.3 16.46 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -168.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.63 145.32 14.91 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 121.712 -0.875 . . . . 0.0 111.3 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.6 mm -123.47 145.7 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.485 -1.597 . . . . 0.0 108.969 -160.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.75 141.23 52.11 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.118 1.367 . . . . 0.0 110.078 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.82 136.32 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.77 -1.207 . . . . 0.0 112.897 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -97.11 -66.64 0.89 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.058 1.343 . . . . 0.0 112.05 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.25 159.28 39.93 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.17 -0.956 . . . . 0.0 110.456 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.33 131.85 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 125.673 1.589 . . . . 0.0 110.781 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.5 mm -83.83 122.27 76.26 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 117.451 -1.262 . . . . 0.0 108.104 170.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.9 40.99 1.03 Allowed 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.474 2.782 . . . . 0.0 113.11 -171.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -160.59 78.0 0.62 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.23 170.39 43.51 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.76 -34.47 74.51 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.743 1.217 . . . . 0.0 113.07 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.91 -42.95 69.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -92.2 -37.7 12.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.861 1.264 . . . . 0.0 112.993 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.3 m -68.0 -35.57 78.54 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.282 -1.511 . . . . 0.0 114.549 -177.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.13 -60.27 2.44 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.103 0.954 . . . . 0.0 109.782 167.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.39 68.63 0.61 Allowed Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -136.72 -42.4 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.839 -0.801 . . . . 0.0 112.27 -155.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 mt -127.84 121.14 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -117.85 -179.63 3.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.317 1.056 . . . . 0.0 111.086 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -59.58 142.13 53.44 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.07 6.41 82.72 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 119.284 2.473 . . . . 0.0 119.284 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.76 170.51 16.45 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.684 1.742 . . . . 0.0 113.019 173.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -131.84 91.09 2.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.951 -1.718 . . . . 0.0 111.016 -166.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.09 160.63 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.43 -2.044 . . . . 0.0 113.288 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.1 tp -141.79 -82.97 0.2 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.728 -1.232 . . . . 0.0 113.041 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.32 146.88 24.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.33 -1.482 . . . . 0.0 114.796 -165.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.3 t -113.71 89.48 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 126.723 2.009 . . . . 0.0 107.71 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.7 t30 57.55 58.47 3.76 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.602 1.561 . . . . 0.0 112.712 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.44 -41.54 3.09 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.842 -1.161 . . . . 0.0 113.963 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.0 122.28 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.559 -1.553 . . . . 0.0 110.963 -173.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -77.39 141.14 39.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.105 -1.622 . . . . 0.0 111.417 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 pp -88.23 -2.8 58.81 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.19 142.89 57.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -171.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.05 -29.72 11.58 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 120.619 -1.301 . . . . 0.0 113.153 -166.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.86 153.84 32.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 p -83.0 170.6 14.72 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.856 -1.153 . . . . 0.0 112.039 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -55.29 -46.26 76.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.545 1.538 . . . . 0.0 114.985 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -60.14 -40.7 90.74 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -72.25 -38.98 68.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.326 -1.484 . . . . 0.0 111.964 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.45 96.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.783 1.633 . . . . 0.0 114.527 175.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.9 m -69.26 -37.49 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.395 -1.441 . . . . 0.0 113.163 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.78 -40.68 89.1 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.927 1.291 . . . . 0.0 112.915 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.1 m -58.35 -38.53 77.39 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.202 2.201 . . . . 0.0 113.202 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.84 -33.02 30.88 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.792 1.237 . . . . 0.0 112.993 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -69.99 -47.08 63.65 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.766 -1.209 . . . . 0.0 113.92 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.347 0.0 OUTLIER -89.97 42.45 1.09 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.8 p -93.1 -71.88 0.63 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.444 1.498 . . . . 0.0 109.669 171.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.94 -99.55 0.89 Allowed Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.08 1.8 . . . . 0.0 113.509 172.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -79.66 -47.68 14.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -159.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.31 146.7 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 121.046 -1.033 . . . . 0.0 111.993 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.32 112.76 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 120.311 -1.493 . . . . 0.0 110.092 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -114.84 118.85 34.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 163.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.6 tt -145.67 143.77 30.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.401 -0.812 . . . . 0.0 110.091 -170.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.06 126.49 49.98 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -173.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.23 164.66 29.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.06 1.409 . . . . 0.0 112.011 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -117.74 141.51 48.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 174.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -73.61 138.35 44.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.247 1.023 . . . . 0.0 111.582 175.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.761 0 CA-C-O 123.049 1.361 . . . . 0.0 116.024 -174.673 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.38 146.18 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.901 -1.124 . . . . 0.0 109.519 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.8 m -136.96 176.56 8.6 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.573 -1.329 . . . . 0.0 113.07 -172.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.91 157.22 42.96 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.099 1.36 . . . . 0.0 108.827 168.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 C--O 1.258 1.549 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 176.808 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.744 0 CA-C-O 119.802 -0.443 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.97 138.13 47.81 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.882 1.325 . . . . 0.0 114.57 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.61 140.65 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.25 1.82 . . . . 0.0 108.595 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -161.04 161.91 31.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.195 -0.941 . . . . 0.0 110.566 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.51 127.89 54.95 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 120.977 -1.077 . . . . 0.0 109.212 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.28 131.95 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 122.587 1.184 . . . . 0.0 111.284 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -116.63 123.47 47.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.414 1.102 . . . . 0.0 109.846 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.4 tp -135.22 168.23 19.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.99 160.73 31.0 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.0 tttp -70.88 103.65 2.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.107 -0.996 . . . . 0.0 111.05 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -100.66 -93.66 0.28 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.16 1.784 . . . . 0.0 109.401 -166.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.0 -47.44 45.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.297 -1.502 . . . . 0.0 109.133 167.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -147.66 -153.83 0.51 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 167.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 p -83.47 -90.94 0.08 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.231 -1.543 . . . . 0.0 111.361 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.64 -85.22 0.43 Allowed 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 120.459 -1.4 . . . . 0.0 113.317 -173.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.46 42.74 1.44 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 125.327 1.441 . . . . 0.0 110.985 -168.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.3 tt -134.89 152.66 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 121.124 -1.221 . . . . 0.0 109.552 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.2 p -122.27 153.87 38.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.478 -1.389 . . . . 0.0 111.738 -171.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.66 159.6 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.133 1.373 . . . . 0.0 108.982 -164.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.2 t -138.04 142.36 40.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.67 -149.3 50.44 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.781 1.658 . . . . 0.0 114.921 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.82 34.29 5.78 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 124.5 1.048 . . . . 0.0 115.456 165.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.14 -92.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 121.663 -0.904 . . . . 0.0 111.216 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -98.32 -51.09 4.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.453 -1.404 . . . . 0.0 110.103 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.9 131.41 14.8 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.83 -1.169 . . . . 0.0 110.832 175.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -154.83 -74.2 0.11 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.285 1.034 . . . . 0.0 110.661 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -79.46 -48.71 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.459 -1.401 . . . . 0.0 110.137 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -132.08 -159.67 0.98 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 161.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -71.7 110.76 6.46 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 120.329 -1.482 . . . . 0.0 108.76 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.22 -179.76 23.86 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 121.063 -1.023 . . . . 0.0 113.905 -167.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.79 161.45 27.79 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.451 -1.617 . . . . 0.0 112.075 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.8 mm -126.68 142.51 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.3 1.84 . . . . 0.0 107.986 -162.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.88 138.46 52.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.968 1.307 . . . . 0.0 109.451 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.86 133.58 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.712 -1.242 . . . . 0.0 112.714 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -90.85 -65.64 1.0 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.216 1.007 . . . . 0.0 110.87 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.73 160.9 31.95 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.356 -0.84 . . . . 0.0 111.946 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.05 125.59 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.998 1.319 . . . . 0.0 110.46 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.08 133.99 47.09 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.967 -1.492 . . . . 0.0 109.085 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.35 43.31 1.46 Allowed 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 124.772 2.74 . . . . 0.0 114.089 -173.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -153.57 47.66 0.66 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.851 -1.156 . . . . 0.0 109.721 -166.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.01 -172.7 39.51 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 120.237 -1.539 . . . . 0.0 112.517 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.85 -29.35 69.79 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.626 1.97 . . . . 0.0 113.214 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.29 94.62 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 125.987 1.715 . . . . 0.0 114.044 174.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -73.71 -43.59 58.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.804 1.242 . . . . 0.0 111.909 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 t -62.16 -55.56 27.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.182 1.393 . . . . 0.0 114.149 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.69 -60.32 2.37 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.915 -1.116 . . . . 0.0 111.091 175.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.31 87.13 1.43 Allowed Glycine 0 N--CA 1.43 -1.756 0 O-C-N 121.371 -0.831 . . . . 0.0 112.105 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.43 -26.77 0.98 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 121.238 -1.154 . . . . 0.0 112.789 -164.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.5 mm -126.56 136.89 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -119.33 171.31 8.41 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.678 -1.264 . . . . 0.0 112.546 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.14 143.91 42.26 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.44 15.21 81.68 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 116.445 1.338 . . . . 0.0 116.445 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -82.43 158.39 23.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.092 1.357 . . . . 0.0 113.496 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -127.17 114.43 17.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.888 1.675 . . . . 0.0 111.715 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 m -79.93 157.49 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.864 -1.772 . . . . 0.0 113.717 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 mp -121.53 -90.97 0.57 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 125.643 1.577 . . . . 0.0 107.41 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.19 159.48 16.04 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.312 -2.117 . . . . 0.0 114.213 -166.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.94 80.13 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.389 1.875 . . . . 0.0 106.658 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.5 t30 57.86 69.7 0.71 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.849 1.66 . . . . 0.0 112.768 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.55 -55.62 2.71 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 120.592 -1.318 . . . . 0.0 114.456 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -86.12 138.36 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.545 1.164 . . . . 0.0 113.171 -170.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -79.26 155.43 28.54 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.539 -1.351 . . . . 0.0 113.1 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 pp -85.91 4.25 38.3 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 125.307 1.443 . . . . 0.0 113.874 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -62.13 120.33 10.68 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.617 -1.302 . . . . 0.0 114.249 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.68 -39.58 2.65 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 125.77 1.653 . . . . 0.0 112.984 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.65 140.33 51.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -168.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.68 -178.56 5.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.337 1.455 . . . . 0.0 109.377 172.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.603 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 16.8 t60 -60.29 -49.95 75.56 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.402 -1.436 . . . . 0.0 114.483 -171.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -54.27 -43.12 70.74 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 125.136 1.374 . . . . 0.0 113.77 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -71.67 -41.2 69.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.016 -1.053 . . . . 0.0 112.717 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.51 92.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.333 -1.48 . . . . 0.0 114.374 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -72.15 -40.25 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.003 -1.685 . . . . 0.0 112.351 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -72.37 -31.81 65.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.283 -1.511 . . . . 0.0 114.117 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.5 p -70.42 -26.15 63.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.222 -1.549 . . . . 0.0 113.157 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.23 -40.52 26.89 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 121.062 -1.024 . . . . 0.0 112.011 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -60.68 -56.0 26.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.545 -1.347 . . . . 0.0 113.676 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -84.03 59.32 5.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.673 -1.267 . . . . 0.0 111.379 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.49 -69.63 0.63 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.044 2.138 . . . . 0.0 107.59 166.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.71 -117.74 3.95 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -65.5 -63.62 1.05 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.71 138.04 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 122.488 1.137 . . . . 0.0 111.478 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.19 87.42 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 125.646 1.578 . . . . 0.0 106.791 -175.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -116.29 126.02 52.98 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 120.273 -1.517 . . . . 0.0 108.996 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . 0.266 0.0 OUTLIER -147.34 162.67 38.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.637 -1.289 . . . . 0.0 111.927 -179.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -121.41 131.2 54.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.679 1.592 . . . . 0.0 107.729 -170.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -140.87 162.99 34.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.515 1.15 . . . . 0.0 111.602 -171.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -134.89 120.19 18.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.426 1.49 . . . . 0.0 107.527 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -62.39 143.91 56.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -174.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.728 0 O-C-N 121.299 -0.876 . . . . 0.0 113.93 -175.423 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.4 157.79 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.739 -1.851 . . . . 0.0 109.423 -159.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' SER . . . . . 0.603 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 29.5 p -139.21 168.0 20.82 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.328 -1.482 . . . . 0.0 114.429 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.54 160.19 43.68 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.188 1.395 . . . . 0.0 108.812 162.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 74.1 t . . . . . 0 C--O 1.26 1.644 0 N-CA-C 106.041 -1.836 . . . . 0.0 106.041 176.71 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.672 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -82.78 168.02 17.57 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.394 1.092 . . . . 0.0 112.495 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -78.39 135.54 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.186 1.794 . . . . 0.0 108.946 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -136.23 156.04 49.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.522 -1.361 . . . . 0.0 110.479 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -116.09 134.11 55.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 121.044 -1.035 . . . . 0.0 111.334 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.8 t -102.9 125.08 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 124.563 1.145 . . . . 0.0 109.597 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -124.72 70.89 1.14 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.524 1.53 . . . . 0.0 108.032 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tp -112.69 -160.88 0.73 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.468 -1.395 . . . . 0.0 110.38 -166.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.45 151.68 30.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.546 -1.346 . . . . 0.0 107.977 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -73.57 101.98 3.74 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.908 -1.12 . . . . 0.0 112.464 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -90.75 -71.39 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.264 1.026 . . . . 0.0 110.187 172.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -86.6 -69.2 0.69 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.488 1.515 . . . . 0.0 111.325 174.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -136.76 165.5 25.78 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 102.132 -3.284 . . . . 0.0 102.132 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 p -83.05 -51.24 7.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.458 -1.401 . . . . 0.0 112.241 -174.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 mt -102.36 -89.95 0.36 Allowed 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 121.057 -1.027 . . . . 0.0 113.457 172.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.49 53.78 1.93 Allowed Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -159.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 tt -145.79 159.13 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 121.1 -1.235 . . . . 0.0 110.782 -173.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -123.22 147.67 46.65 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.688 -1.883 . . . . 0.0 109.686 -175.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.14 147.49 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 125.691 1.596 . . . . 0.0 111.107 -167.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -137.96 126.59 23.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.437 1.113 . . . . 0.0 111.604 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.43 65.43 3.17 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 118.449 2.14 . . . . 0.0 118.449 164.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.66 75.78 0.32 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.58 -108.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 124.602 1.161 . . . . 0.0 111.044 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -72.63 -76.42 0.12 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.735 2.014 . . . . 0.0 111.633 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -144.26 121.1 11.27 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.225 -1.547 . . . . 0.0 109.315 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 p -138.87 -73.97 0.39 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.738 -1.226 . . . . 0.0 112.878 -170.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -66.13 -60.63 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 126.224 1.81 . . . . 0.0 111.564 -172.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ttm-85 -125.0 -115.83 0.29 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.11 62.6 2.56 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.101 1.36 . . . . 0.0 109.067 167.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.95 -139.56 14.45 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -163.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.78 155.94 28.29 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-O 121.939 0.744 . . . . 0.0 112.927 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.93 142.4 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -135.55 132.76 37.6 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.65 1.98 . . . . 0.0 110.351 -168.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.0 t -80.32 128.61 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.482 -1.386 . . . . 0.0 112.863 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -84.74 -55.1 4.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.067 1.747 . . . . 0.0 111.812 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.08 165.39 15.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.439 -0.788 . . . . 0.0 110.141 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 t -98.52 130.86 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 C-N-CA 125.64 1.576 . . . . 0.0 111.381 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mm -82.85 124.91 76.51 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 124.932 1.293 . . . . 0.0 109.65 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.36 32.22 0.52 Allowed 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 123.42 2.747 . . . . 0.0 114.326 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -142.79 52.57 1.4 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.863 1.265 . . . . 0.0 108.589 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -166.58 173.3 41.97 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 119.993 -1.692 . . . . 0.0 111.452 -176.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.71 73.04 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.461 1.504 . . . . 0.0 114.731 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.05 78.56 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 175.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -77.62 -28.93 51.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.761 1.224 . . . . 0.0 112.736 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.3 t -64.69 -56.4 13.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.578 -1.326 . . . . 0.0 113.381 173.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -79.63 -47.51 15.3 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.955 1.302 . . . . 0.0 112.005 -172.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.87 80.61 1.42 Allowed Glycine 0 N--CA 1.431 -1.644 0 O-C-N 121.035 -1.04 . . . . 0.0 111.217 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -139.87 -51.77 0.51 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.834 0.854 . . . . 0.0 112.714 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.1 mt -126.92 136.36 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 -168.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.81 -166.51 2.36 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 -175.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.13 125.16 21.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.7 15.88 81.21 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 117.307 1.683 . . . . 0.0 117.307 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -75.69 155.26 35.88 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 118.93 1.365 . . . . 0.0 111.131 167.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.87 131.32 40.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.461 -1.4 . . . . 0.0 109.562 -173.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.58 153.29 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.647 -1.908 . . . . 0.0 113.766 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.69 -84.51 0.66 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.807 1.643 . . . . 0.0 107.397 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 143.57 29.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.3 t -120.14 90.99 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.289 1.436 . . . . 0.0 108.398 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.275 22.2 t-20 57.24 64.48 1.6 Allowed 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 125.896 1.679 . . . . 0.0 112.281 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.17 -61.87 1.06 Allowed Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 124.691 1.139 . . . . 0.0 113.506 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.0 m -83.86 134.05 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.984 -1.304 . . . . 0.0 113.381 -164.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.3 t -77.79 124.98 28.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.779 -1.201 . . . . 0.0 110.376 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.8 tp -85.67 47.58 1.46 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 123.811 1.767 . . . . 0.0 113.995 -163.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -70.07 134.88 48.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.137 1.775 . . . . 0.0 112.6 166.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.82 -14.45 60.27 Favored Glycine 0 N--CA 1.431 -1.681 0 O-C-N 120.979 -1.076 . . . . 0.0 114.212 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.9 138.49 41.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.91 -1.347 . . . . 0.0 114.159 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 p -93.73 173.96 7.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.983 1.713 . . . . 0.0 109.369 166.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.629 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 1.2 t60 -61.46 -38.45 87.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -169.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -72.14 -27.4 62.59 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.549 -1.344 . . . . 0.0 113.68 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -78.55 -41.16 32.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.153 -1.592 . . . . 0.0 111.086 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.05 96.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.87 -44.31 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.892 -1.755 . . . . 0.0 112.942 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -66.31 -46.51 76.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.93 1.692 . . . . 0.0 113.788 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.8 p -64.54 -33.17 75.28 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.827 1.651 . . . . 0.0 114.434 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.6 mt -92.44 -16.7 25.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -76.35 -55.04 5.92 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.241 -1.537 . . . . 0.0 111.496 168.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -91.55 65.33 5.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.871 1.32 . . . . 0.0 112.175 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.9 p -86.65 -58.56 2.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.862 2.065 . . . . 0.0 109.923 171.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.77 -128.48 7.81 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 125.426 1.489 . . . . 0.0 111.126 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -81.36 -43.86 18.43 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.903 -1.351 . . . . 0.0 112.308 -170.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 p -104.82 140.96 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 122.113 0.959 . . . . 0.0 110.999 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.6 t -119.64 100.91 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 124.496 1.118 . . . . 0.0 108.832 -168.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -117.61 115.07 24.36 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 110.953 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.42 157.12 43.27 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 121.206 -0.934 . . . . 0.0 110.926 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -120.87 144.61 48.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -139.54 159.04 43.09 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 123.889 0.876 . . . . 0.0 109.596 -173.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -107.89 125.46 51.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 167.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -74.6 146.44 42.5 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.922 -1.111 . . . . 0.0 112.144 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.787 0 CA-C-O 123.578 1.655 . . . . 0.0 116.825 -172.363 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 N--CA 1.429 -1.475 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.47 155.28 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.604 1.561 . . . . 0.0 109.515 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' SER . . . . . 0.629 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 20.4 p -140.04 149.61 43.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.143 -0.973 . . . . 0.0 112.815 -172.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.42 150.87 49.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.977 1.311 . . . . 0.0 111.879 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.259 1.597 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.524 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.675 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -79.67 140.38 37.06 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 121.519 -0.989 . . . . 0.0 109.117 172.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 mp -82.61 134.05 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.421 -1.424 . . . . 0.0 108.532 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -133.5 151.74 51.8 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.551 -1.343 . . . . 0.0 111.049 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -103.91 130.43 51.51 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.265 1.026 . . . . 0.0 109.296 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.4 t -103.07 117.72 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.375 -1.453 . . . . 0.0 109.823 168.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -113.0 101.38 9.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 168.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.8 tp -135.48 170.57 15.75 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.176 0.988 . . . . 0.0 109.499 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.36 161.39 41.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.492 -2.005 . . . . 0.0 108.603 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -71.47 105.43 3.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.311 1.445 . . . . 0.0 112.365 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -102.55 -62.68 1.24 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.902 1.281 . . . . 0.0 110.408 167.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -86.12 -66.04 0.95 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.104 1.361 . . . . 0.0 109.154 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -137.5 176.36 8.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.694 1.598 . . . . 0.0 107.022 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.7 t -83.15 -69.05 0.66 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.445 -1.409 . . . . 0.0 111.509 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.9 mp -104.04 -105.46 0.29 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.954 -1.716 . . . . 0.0 112.101 170.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.32 57.21 1.01 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.917 -1.114 . . . . 0.0 111.81 -171.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 tt -144.19 164.7 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 121.45 -1.029 . . . . 0.0 108.444 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 t -122.09 138.39 54.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.506 -1.996 . . . . 0.0 110.394 -175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.56 154.8 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 124.654 1.182 . . . . 0.0 108.787 -166.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -137.44 94.13 2.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.757 1.742 . . . . 0.0 111.195 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.01 -152.06 41.57 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 164.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.31 79.34 1.45 Allowed Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -168.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -117.72 -104.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.419 -1.047 . . . . 0.0 113.406 -162.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -77.15 -51.54 10.82 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.708 -1.87 . . . . 0.0 109.94 -161.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -150.21 137.58 19.68 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 155.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.9 m -151.53 -86.93 0.07 Allowed 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 119.703 -1.873 . . . . 0.0 110.772 -166.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 t -73.9 -59.43 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 124.823 1.249 . . . . 0.0 109.145 -175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -144.23 -123.33 0.08 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -85.3 65.32 9.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.97 -1.706 . . . . 0.0 110.712 172.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.57 -129.33 9.68 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 -165.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.45 133.0 2.9 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 125.629 1.585 . . . . 0.0 112.152 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.3 mm -125.58 137.13 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.4 129.97 50.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.719 -1.238 . . . . 0.0 111.408 -163.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -76.22 135.85 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.562 -1.336 . . . . 0.0 112.292 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -88.2 -61.3 1.75 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.584 1.554 . . . . 0.0 111.039 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.12 162.65 34.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.56 134.3 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 122.193 0.997 . . . . 0.0 111.064 174.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 mm -84.02 134.66 43.39 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 116.652 -1.642 . . . . 0.0 107.495 171.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.11 77.02 2.87 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 125.718 3.078 . . . . 0.0 112.437 170.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -141.13 -40.94 0.39 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -168.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.2 -144.39 4.34 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.301 -1.499 . . . . 0.0 112.155 -167.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.17 -39.97 96.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.904 2.081 . . . . 0.0 114.752 -162.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.34 -50.7 72.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.959 1.704 . . . . 0.0 114.028 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.62 -37.42 50.19 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.075 1.35 . . . . 0.0 112.549 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.7 t -62.38 -47.99 81.73 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.951 -1.718 . . . . 0.0 114.186 -175.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -81.14 -47.05 14.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.828 -1.17 . . . . 0.0 110.571 171.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.88 73.06 1.2 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -139.63 -41.25 0.45 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -164.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.61 134.55 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -140.51 -160.97 1.13 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.344 0.974 . . . . 0.0 112.947 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -54.93 133.81 48.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.304 1.842 . . . . 0.0 114.343 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.37 -2.11 63.27 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 117.992 1.957 . . . . 0.0 117.992 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -75.56 151.28 37.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.055 1.928 . . . . 0.0 112.271 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -123.89 138.93 54.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.581 -1.324 . . . . 0.0 109.783 -165.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.56 155.32 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.692 -1.88 . . . . 0.0 111.948 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.7 mt -119.01 -88.27 0.62 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.23 145.23 29.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.679 1.192 . . . . 0.0 110.802 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 p -102.78 92.17 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 123.039 1.4 . . . . 0.0 110.68 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 58.35 55.52 4.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.861 -1.774 . . . . 0.0 113.163 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.12 -12.82 59.21 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 120.631 -1.293 . . . . 0.0 115.16 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.4 t -103.14 125.51 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 118.561 1.181 . . . . 0.0 109.863 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -77.38 158.96 29.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.547 -1.346 . . . . 0.0 114.562 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -117.43 36.7 4.15 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.052 1.341 . . . . 0.0 109.028 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.93 115.82 7.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.056 -1.652 . . . . 0.0 113.452 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.71 15.76 78.8 Favored Glycine 0 N--CA 1.431 -1.66 0 O-C-N 119.626 -1.921 . . . . 0.0 115.33 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.48 148.16 35.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.847 -1.384 . . . . 0.0 113.104 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.6 p -90.37 174.28 7.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.766 1.227 . . . . 0.0 108.591 163.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -61.34 -37.63 84.01 Favored 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 120.367 -1.458 . . . . 0.0 114.576 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 -40.87 90.75 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.091 -1.631 . . . . 0.0 112.602 175.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -70.14 -41.32 74.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.498 1.519 . . . . 0.0 111.627 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.11 -48.71 70.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . 0.265 35.4 m -63.14 -37.23 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -172.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -64.25 -45.06 89.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 120.516 1.507 . . . . 0.0 112.612 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.7 m -60.09 -36.28 77.05 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.829 1.651 . . . . 0.0 112.385 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.69 -36.74 31.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.325 1.85 . . . . 0.0 115.693 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -63.91 -44.04 94.15 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.156 -1.59 . . . . 0.0 113.067 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -85.0 49.61 1.77 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.595 1.188 . . . . 0.0 113.665 -166.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.7 p -98.48 -76.27 0.54 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.44 2.296 . . . . 0.0 109.563 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.02 -106.84 2.44 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 125.106 1.336 . . . . 0.0 113.179 167.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -68.19 -53.54 24.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -172.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.7 m -108.58 138.84 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.188 0.994 . . . . 0.0 110.346 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.3 t -126.01 95.46 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -135.63 92.02 2.78 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.102 -1.624 . . . . 0.0 110.699 -171.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.15 176.93 9.15 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -165.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.65 131.05 54.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.397 1.079 . . . . 0.0 109.611 -170.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -126.13 167.33 15.54 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.746 1.618 . . . . 0.0 110.397 -174.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -124.58 141.01 52.41 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.992 1.317 . . . . 0.0 107.538 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -72.77 144.83 47.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.759 0 O-C-N 120.668 -1.27 . . . . 0.0 114.095 -179.508 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 . . . . . 0 N--CA 1.429 -1.491 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.57 154.68 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.048 -1.657 . . . . 0.0 108.379 171.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m -140.91 155.87 46.2 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.38 -0.825 . . . . 0.0 111.288 -172.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.3 159.44 42.06 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.84 0.829 . . . . 0.0 110.032 168.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.259 1.585 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.801 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.79 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.29 177.3 8.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.058 -1.26 . . . . 0.0 113.63 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.7 mt -74.95 143.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.803 -1.81 . . . . 0.0 112.944 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -147.01 160.36 42.47 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.804 -1.185 . . . . 0.0 110.708 170.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -127.26 123.15 35.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.723 -1.236 . . . . 0.0 111.358 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -105.32 132.93 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.689 -1.257 . . . . 0.0 111.878 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -112.43 121.46 44.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 108.794 158.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 10.1 tp -132.82 -167.7 1.95 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.713 1.205 . . . . 0.0 108.418 176.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.449 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -155.59 168.94 25.51 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.12 -1.613 . . . . 0.0 109.195 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -72.01 104.74 3.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.561 1.144 . . . . 0.0 112.841 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -91.28 -85.96 0.23 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.14 -0.975 . . . . 0.0 110.869 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -86.5 -44.92 11.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.75 1.62 . . . . 0.0 110.808 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -138.24 177.9 7.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.183 2.193 . . . . 0.0 105.162 174.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.8 p -84.03 -66.34 0.9 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.503 -1.373 . . . . 0.0 112.151 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.7 mt -101.04 -79.92 0.5 Allowed 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 119.7 1.136 . . . . 0.0 111.865 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.15 47.82 2.35 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 121.1 -1.0 . . . . 0.0 112.069 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 tt -145.81 157.89 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.827 -1.396 . . . . 0.0 112.669 -170.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 t -123.56 146.31 48.22 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.413 -1.429 . . . . 0.0 109.266 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 t -122.05 149.95 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.167 1.387 . . . . 0.0 109.898 -163.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 t -137.27 108.37 6.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.585 1.659 . . . . 0.0 111.137 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.35 -117.29 5.49 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 125.103 1.335 . . . . 0.0 111.689 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.79 35.53 61.97 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 115.843 1.097 . . . . 0.0 115.843 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 m -107.61 -120.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 121.468 -1.019 . . . . 0.0 112.667 -170.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -79.65 -81.12 0.12 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.986 1.715 . . . . 0.0 113.294 -171.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.6 t -128.92 115.57 18.06 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -155.32 -85.93 0.05 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.361 -0.837 . . . . 0.0 109.917 -166.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.1 -52.41 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 120.088 -1.633 . . . . 0.0 110.961 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -133.46 -153.84 0.57 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 158.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -74.5 96.96 3.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.496 1.118 . . . . 0.0 108.405 155.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.71 -172.7 50.63 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 120.267 -1.52 . . . . 0.0 114.423 -169.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.73 147.32 22.32 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -162.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.9 mm -124.77 140.72 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -123.4 143.13 50.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -167.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -87.2 132.3 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 O-C-N 121.031 -1.043 . . . . 0.0 111.366 -173.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -85.46 -51.7 6.35 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.291 1.036 . . . . 0.0 110.873 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.62 157.74 12.63 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.432 HG13 ' CE1' ' A' ' 53' ' ' HIS . 6.8 p -91.69 137.83 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 121.491 0.662 . . . . 0.0 109.886 171.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -84.09 121.62 75.65 Favored Pre-proline 0 N--CA 1.429 -1.504 0 O-C-N 120.325 -1.485 . . . . 0.0 109.093 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -78.84 60.05 7.56 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.363 2.709 . . . . 0.0 112.383 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.33 32.94 0.28 Allowed 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 122.262 1.029 . . . . 0.0 108.401 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.63 176.94 46.16 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 119.729 -1.857 . . . . 0.0 112.619 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -37.35 -45.67 0.71 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.199 2.999 . . . . 0.0 118.54 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.1 89.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -175.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -85.53 -40.62 16.12 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.927 1.291 . . . . 0.0 111.324 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.9 m -60.32 -55.97 27.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.43 -29.38 52.88 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.558 -1.339 . . . . 0.0 110.09 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.46 76.87 1.21 Allowed Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.106 -0.996 . . . . 0.0 112.506 167.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -136.87 -53.7 0.71 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.551 -0.97 . . . . 0.0 112.5 -167.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.6 mt -127.62 125.95 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -166.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.432 ' CE1' HG13 ' A' ' 40' ' ' VAL . 4.9 m-70 -134.56 -171.13 2.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -56.73 128.87 38.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.137 1.375 . . . . 0.0 114.141 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.26 21.79 74.86 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 117.697 1.839 . . . . 0.0 117.697 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -81.36 159.0 24.48 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 119.545 1.672 . . . . 0.0 109.629 161.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.0 ttp85 -122.22 116.51 24.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.559 -1.338 . . . . 0.0 108.705 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.54 138.11 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 121.064 -1.022 . . . . 0.0 109.917 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.5 tp -121.07 -86.47 0.65 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.143 -0.973 . . . . 0.0 109.999 -170.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.06 132.4 33.83 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.848 -1.782 . . . . 0.0 113.277 -170.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.8 p -103.61 93.76 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.552 1.644 . . . . 0.0 108.251 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.268 58.7 t30 56.19 54.15 8.14 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.384 1.874 . . . . 0.0 113.7 -173.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.26 -46.01 1.49 Allowed Glycine 0 N--CA 1.431 -1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 113.621 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.01 128.66 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 121.094 -1.239 . . . . 0.0 111.286 -170.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 t -78.3 156.81 29.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.496 -1.378 . . . . 0.0 112.345 176.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 -13.86 23.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.061 1.344 . . . . 0.0 113.952 -175.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -66.41 128.38 35.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -168.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.1 -51.34 0.71 Allowed Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -170.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.24 151.94 32.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.352 1.461 . . . . 0.0 112.416 170.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.9 p -94.38 -179.11 4.8 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.681 -1.887 . . . . 0.0 112.147 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -50.04 -37.79 34.8 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.252 3.021 . . . . 0.0 115.064 172.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -56.54 -46.85 80.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.396 1.878 . . . . 0.0 114.112 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -77.81 -34.49 52.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.003 1.321 . . . . 0.0 111.185 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.48 77.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.577 1.551 . . . . 0.0 114.378 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.97 -29.34 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.385 -1.447 . . . . 0.0 114.056 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -70.63 -38.66 73.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.591 -1.943 . . . . 0.0 112.527 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.3 m -65.78 -43.49 88.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.415 -1.428 . . . . 0.0 112.236 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 tt -79.72 -46.84 16.33 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -59.12 -35.85 74.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.967 -1.708 . . . . 0.0 114.289 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -92.07 56.01 2.76 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.812 -1.18 . . . . 0.0 110.956 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 p -109.87 -69.25 0.87 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.687 1.995 . . . . 0.0 109.771 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.37 -105.68 1.31 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 124.312 0.958 . . . . 0.0 113.634 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -81.2 -45.11 16.82 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -163.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.04 155.16 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.958 -1.089 . . . . 0.0 112.004 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -130.19 112.8 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -128.44 117.83 22.05 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.354 -1.466 . . . . 0.0 109.804 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.13 160.5 42.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.539 -1.351 . . . . 0.0 113.957 -174.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.81 128.0 52.46 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.104 1.362 . . . . 0.0 107.436 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.86 159.59 27.86 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.041 1.336 . . . . 0.0 110.584 -174.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -109.08 127.33 54.05 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 153.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -69.44 137.06 52.36 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.04 1.336 . . . . 0.0 113.874 -171.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.804 0 O-C-N 120.546 -1.346 . . . . 0.0 110.694 170.575 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 17.6 m -125.94 155.9 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 125.969 1.708 . . . . 0.0 110.633 -173.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -142.06 143.49 33.13 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.716 0.769 . . . . 0.0 111.109 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.69 146.78 47.99 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.199 1.4 . . . . 0.0 112.618 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.261 1.663 0 C-N-CA 126.176 1.79 . . . . 0.0 106.422 170.073 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.742 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.66 179.22 7.85 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 mt -81.71 149.96 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.539 1.536 . . . . 0.0 111.617 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.11 139.87 21.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.478 -1.389 . . . . 0.0 112.247 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -105.96 105.86 16.1 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.665 1.586 . . . . 0.0 111.155 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.08 134.17 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 120.347 -1.471 . . . . 0.0 112.182 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -111.74 127.39 55.77 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 168.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.1 tp -135.73 -159.46 0.96 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.943 -1.098 . . . . 0.0 109.613 172.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.87 168.11 27.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.311 -1.493 . . . . 0.0 108.605 172.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -72.4 112.68 8.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.612 -1.305 . . . . 0.0 110.287 163.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -93.27 -88.56 0.22 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.92 -53.92 6.3 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.028 1.331 . . . . 0.0 109.171 165.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -135.91 172.79 12.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.856 -1.153 . . . . 0.0 108.289 -172.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -81.89 -88.53 0.08 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.065 0.946 . . . . 0.0 109.828 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.6 mt -102.71 -89.39 0.38 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.31 -1.494 . . . . 0.0 112.474 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.6 48.24 3.51 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -165.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 tt -134.26 161.04 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 121.288 -1.125 . . . . 0.0 108.364 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.4 t -121.27 142.55 49.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.365 -1.459 . . . . 0.0 107.242 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.6 t -122.74 152.56 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -160.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 t -145.54 134.34 22.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.685 -1.884 . . . . 0.0 112.832 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.11 -141.54 20.81 Favored Glycine 0 N--CA 1.43 -1.703 0 C-N-CA 126.971 2.224 . . . . 0.0 114.203 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.62 33.7 67.21 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 124.669 1.128 . . . . 0.0 115.614 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -93.32 -124.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 121.039 -1.271 . . . . 0.0 113.549 -170.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -71.59 -57.72 4.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.748 -1.845 . . . . 0.0 111.274 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.4 t -140.51 154.19 46.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 148.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.4 t -155.84 -103.71 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -164.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 p -62.08 -58.43 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.066 1.747 . . . . 0.0 110.074 161.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -143.29 -163.28 1.61 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 161.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -78.89 44.13 0.54 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.257 1.823 . . . . 0.0 112.822 173.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.48 151.59 5.53 Favored Glycine 0 N--CA 1.43 -1.743 0 O-C-N 120.195 -1.566 . . . . 0.0 110.661 -169.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.81 143.39 11.88 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -168.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.38 162.54 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -172.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.93 151.34 43.68 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.296 -1.503 . . . . 0.0 107.791 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -82.81 134.83 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 120.72 -1.237 . . . . 0.0 110.964 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -85.24 -59.91 2.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.63 1.172 . . . . 0.0 110.583 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.79 168.82 12.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.049 0.94 . . . . 0.0 108.491 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -95.22 136.26 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 122.694 1.235 . . . . 0.0 111.79 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.3 mm -82.73 132.22 52.33 Favored Pre-proline 0 N--CA 1.429 -1.5 0 O-C-N 120.38 -1.45 . . . . 0.0 107.187 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -80.5 35.57 0.58 Allowed 'Trans proline' 0 N--CA 1.434 -2.014 0 C-N-CA 123.242 2.628 . . . . 0.0 113.039 -172.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 62.5 0.9 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.629 1.572 . . . . 0.0 107.438 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.52 161.3 31.07 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.629 -1.294 . . . . 0.0 112.129 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.54 -38.12 19.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.871 2.068 . . . . 0.0 116.298 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.5 -41.82 77.32 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.5 -52.52 10.48 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 125.884 1.674 . . . . 0.0 111.476 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.0 m -56.2 -53.24 59.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -81.62 -36.42 28.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.272 1.029 . . . . 0.0 110.17 -177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.27 79.43 1.32 Allowed Glycine 0 N--CA 1.429 -1.768 0 O-C-N 120.837 -1.164 . . . . 0.0 112.006 169.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -136.18 -43.72 0.63 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -157.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.4 mt -128.86 142.42 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -131.15 178.24 6.85 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 123.321 1.534 . . . . 0.0 111.937 -170.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -56.39 123.12 13.59 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.71 20.06 76.95 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 118.45 2.14 . . . . 0.0 118.45 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -71.96 156.92 38.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 120.24 2.02 . . . . 0.0 111.552 166.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -122.66 114.07 20.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.612 -1.305 . . . . 0.0 108.977 -173.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 m -100.16 156.98 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 120.164 -1.585 . . . . 0.0 111.564 -174.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.9 tp -131.88 -81.48 0.51 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.017 -1.052 . . . . 0.0 111.279 173.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.85 128.23 45.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.704 -1.248 . . . . 0.0 113.649 -160.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.49 112.78 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 122.628 1.204 . . . . 0.0 109.131 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.27 35.8 t30 56.96 31.97 20.78 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 126.844 2.058 . . . . 0.0 114.018 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.4 -12.32 58.38 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.447 -1.408 . . . . 0.0 115.002 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.3 t -96.25 116.35 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 118.692 1.246 . . . . 0.0 111.824 -173.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -76.14 131.32 39.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.206 -1.559 . . . . 0.0 112.012 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -13.34 47.44 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.353 1.461 . . . . 0.0 113.49 -173.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -51.33 129.13 24.21 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.49 1.516 . . . . 0.0 115.088 -167.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.55 -35.19 5.11 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 124.13 0.872 . . . . 0.0 112.321 -160.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.81 155.26 33.19 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.481 -1.599 . . . . 0.0 112.113 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.0 p -93.28 159.99 15.03 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.978 0.894 . . . . 0.0 109.92 167.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.409 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 46.1 t60 -41.01 -44.93 2.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.665 2.786 . . . . 0.0 117.027 173.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -60.75 -37.65 82.52 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.781 -1.2 . . . . 0.0 114.212 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -78.45 -41.06 33.87 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.755 1.222 . . . . 0.0 112.002 174.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.33 -38.09 82.66 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.524 -1.36 . . . . 0.0 114.266 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 p -71.06 -33.8 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 O-C-N 120.293 -1.505 . . . . 0.0 112.98 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.61 -46.11 91.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.312 -1.492 . . . . 0.0 112.743 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.3 m -56.15 -48.34 76.47 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.612 1.565 . . . . 0.0 112.457 173.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.09 -36.37 40.87 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -172.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -59.61 -37.01 77.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.196 -1.565 . . . . 0.0 113.905 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -95.42 60.71 2.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.735 -1.228 . . . . 0.0 112.8 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -99.49 -73.3 0.63 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.512 2.325 . . . . 0.0 111.339 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.17 -116.63 3.77 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.295 1.426 . . . . 0.0 112.63 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -78.62 -36.26 44.34 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 121.473 -1.016 . . . . 0.0 113.633 -168.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.3 m -104.54 162.31 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.73 -1.231 . . . . 0.0 112.241 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.6 t -138.1 130.89 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 124.81 1.244 . . . . 0.0 108.708 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -141.2 127.97 20.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.652 -1.28 . . . . 0.0 108.072 161.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -149.27 159.06 44.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.276 -1.515 . . . . 0.0 113.082 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.5 mp -120.53 120.41 35.78 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.21 161.85 24.88 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.68 1.192 . . . . 0.0 110.227 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.65 135.47 54.12 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.36 1.464 . . . . 0.0 107.204 162.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -74.98 133.98 41.58 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.378 1.085 . . . . 0.0 112.874 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.753 0 CA-C-O 123.297 1.498 . . . . 0.0 115.056 178.435 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 121.247 0.546 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -122.87 158.19 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 124.757 1.223 . . . . 0.0 110.544 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' SER . . . . . 0.409 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 58.8 m -138.11 149.64 46.12 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.662 -1.274 . . . . 0.0 113.777 -173.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -124.0 150.48 44.81 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 125.121 1.368 . . . . 0.0 111.503 169.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.261 1.666 0 C-N-CA 127.621 2.368 . . . . 0.0 106.702 160.811 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.748 0 N-CA-C 111.956 -0.458 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.32 146.5 30.34 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.17 -1.194 . . . . 0.0 111.194 167.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 mp -89.97 144.53 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.04 2.136 . . . . 0.0 111.252 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -145.75 165.59 28.37 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.306 -1.496 . . . . 0.0 112.184 171.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -113.93 134.95 54.5 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 122.372 1.082 . . . . 0.0 112.241 -177.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.39 111.82 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.482 -1.386 . . . . 0.0 108.964 168.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -112.26 102.37 10.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 170.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tp -134.8 176.67 8.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.674 1.226 . . . . 0.0 111.463 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.01 158.71 42.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 168.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -70.44 152.64 43.83 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -121.17 -83.88 0.66 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.507 -1.371 . . . . 0.0 108.789 166.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -76.99 -51.46 11.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.704 -1.248 . . . . 0.0 109.196 172.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -138.2 177.64 7.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.0 m -82.47 -58.76 2.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.82 0.848 . . . . 0.0 111.32 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.6 mt -102.3 -90.64 0.35 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.142 1.337 . . . . 0.0 112.458 172.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.43 50.58 0.8 Allowed Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -165.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tt -137.62 165.01 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.941 -1.329 . . . . 0.0 110.688 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 t -122.95 136.64 54.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.891 1.677 . . . . 0.0 107.702 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.8 t -123.69 144.04 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 124.675 1.19 . . . . 0.0 110.03 -161.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -138.87 131.17 28.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.032 1.396 . . . . 0.0 112.914 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.43 -162.64 25.83 Favored Glycine 0 N--CA 1.429 -1.777 0 C-N-CA 126.87 2.176 . . . . 0.0 114.236 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.12 42.12 2.47 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.7 -0.882 . . . . 0.0 113.791 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -106.08 -107.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.287 1.042 . . . . 0.0 110.044 -172.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -91.28 -59.78 2.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.099 2.159 . . . . 0.0 110.054 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 t -133.24 138.95 46.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 163.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -145.23 -79.65 0.18 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.941 -1.099 . . . . 0.0 108.828 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -91.8 -51.73 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 O-C-N 120.531 -1.356 . . . . 0.0 108.238 171.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.2 mmt85 -119.44 -142.2 0.35 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.56 65.15 1.26 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.392 -1.442 . . . . 0.0 111.715 170.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.37 -137.52 13.63 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 -166.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.2 147.3 9.1 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-O 122.206 0.892 . . . . 0.0 112.978 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.6 mm -122.21 130.74 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 -159.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.08 149.28 49.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 123.831 0.852 . . . . 0.0 110.296 -169.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.4 t -79.69 124.68 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 120.833 -1.167 . . . . 0.0 111.22 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -80.58 -63.25 1.45 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.687 -1.258 . . . . 0.0 109.973 173.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.5 161.41 35.36 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.427 -0.796 . . . . 0.0 109.341 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.29 137.15 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-O 122.497 1.142 . . . . 0.0 110.663 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -85.43 123.63 72.65 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 119.945 -1.722 . . . . 0.0 108.598 173.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.64 32.26 0.51 Allowed 'Trans proline' 0 N--CA 1.434 -1.995 0 CA-C-N 125.291 2.925 . . . . 0.0 114.373 -173.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.61 61.74 1.38 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 123.158 1.456 . . . . 0.0 107.741 -175.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.85 170.52 43.66 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 120.413 -1.43 . . . . 0.0 109.852 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.74 -38.66 22.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.335 2.254 . . . . 0.0 115.541 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.7 -47.45 67.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.13 1.772 . . . . 0.0 115.1 174.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -87.36 -34.85 18.67 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.895 -1.128 . . . . 0.0 111.774 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.6 m -54.22 -54.7 36.4 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.491 1.516 . . . . 0.0 113.858 174.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.26 -53.85 6.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.276 -0.89 . . . . 0.0 110.809 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.05 100.93 2.63 Favored Glycine 0 N--CA 1.429 -1.807 0 O-C-N 121.188 -0.945 . . . . 0.0 110.982 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.94 -43.5 0.43 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -163.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -128.76 174.43 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.534 -1.354 . . . . 0.0 108.301 -168.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.409 ' H ' HG22 ' A' ' 52' ' ' ILE . 31.1 m-70 -131.61 162.24 30.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.132 -1.605 . . . . 0.0 110.538 169.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -56.99 136.72 56.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 167.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.17 20.78 78.93 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 116.884 1.513 . . . . 0.0 116.884 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -83.47 172.43 12.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.977 1.311 . . . . 0.0 112.265 167.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -124.6 133.12 53.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 121.054 -1.029 . . . . 0.0 111.828 176.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.1 m -79.76 158.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 119.783 -1.823 . . . . 0.0 110.857 167.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tt -121.61 -80.46 0.62 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.549 -1.344 . . . . 0.0 109.414 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.32 150.59 22.84 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.664 -1.273 . . . . 0.0 113.57 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.9 p -111.92 103.33 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 C-N-CA 126.279 1.831 . . . . 0.0 108.409 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.505 13.8 p30 56.52 38.73 29.87 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.859 2.064 . . . . 0.0 116.298 -177.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.98 -24.58 30.15 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 125.641 1.591 . . . . 0.0 113.455 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.98 134.69 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 124.918 1.287 . . . . 0.0 110.868 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 p -77.2 159.82 29.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.537 -1.977 . . . . 0.0 113.095 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -93.89 -14.84 25.61 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -54.24 129.55 35.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -167.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.31 -27.23 7.42 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 124.143 0.878 . . . . 0.0 111.163 -175.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.17 144.4 38.39 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.3 p -90.65 -179.41 5.54 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.161 -0.962 . . . . 0.0 108.819 155.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.617 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 7.3 t60 -60.38 -44.6 95.48 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -169.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -59.22 -34.56 72.32 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.542 -1.348 . . . . 0.0 114.585 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -43.31 67.16 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.235 -1.541 . . . . 0.0 111.049 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.32 -43.43 97.81 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 120.419 -1.426 . . . . 0.0 114.576 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 m -67.58 -41.52 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 120.461 -1.399 . . . . 0.0 114.352 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -68.08 -28.72 67.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.505 -1.372 . . . . 0.0 112.904 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.9 m -57.48 -50.78 71.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.305 1.442 . . . . 0.0 112.677 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.54 -33.98 35.85 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.565 -1.334 . . . . 0.0 112.799 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -61.2 -32.01 71.77 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.758 -1.839 . . . . 0.0 114.487 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -85.7 51.92 2.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.35 -1.468 . . . . 0.0 112.839 170.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.1 p -110.93 -74.14 0.66 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.466 1.507 . . . . 0.0 110.631 166.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.66 -82.99 0.35 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.857 -1.152 . . . . 0.0 113.219 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -82.1 -51.3 8.13 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -174.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.37 137.97 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 120.94 -1.1 . . . . 0.0 111.023 -166.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.95 90.03 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.5 -1.375 . . . . 0.0 110.676 -172.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -119.76 120.79 37.56 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.566 -1.959 . . . . 0.0 111.452 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -150.22 165.89 31.57 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 112.241 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.8 mt -121.64 137.84 54.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.03 1.332 . . . . 0.0 107.715 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mp -135.76 158.2 44.98 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.593 0.757 . . . . 0.0 110.334 -171.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -119.6 148.29 43.51 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -70.71 127.48 32.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.621 -1.3 . . . . 0.0 112.125 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.799 0 O-C-N 120.587 -1.32 . . . . 0.0 113.724 179.787 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 . . . . . 0 N--CA 1.431 -1.418 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.09 148.55 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 127.121 2.168 . . . . 0.0 107.279 -171.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' SER . . . . . 0.617 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 29.1 p -134.37 171.26 14.52 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.702 -1.249 . . . . 0.0 113.209 -168.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.7 155.06 41.35 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 120.976 -1.077 . . . . 0.0 111.355 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.26 1.611 0 C-N-CA 125.542 1.537 . . . . 0.0 108.951 -177.151 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.684 0 CA-C-O 121.326 0.403 . . . . 0.0 113.412 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.11 -177.16 6.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.243 1.497 . . . . 0.0 113.66 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 mt -85.21 136.43 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 125.217 1.407 . . . . 0.0 110.806 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -133.07 145.08 50.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.499 1.142 . . . . 0.0 111.26 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -112.52 123.59 50.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.178 -0.951 . . . . 0.0 109.515 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.5 m -102.92 149.68 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 122.687 1.232 . . . . 0.0 111.802 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -139.58 87.16 2.16 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -134.07 176.65 8.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.808 -1.183 . . . . 0.0 110.508 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.49 172.82 12.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 124.901 1.28 . . . . 0.0 109.125 170.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -68.55 134.22 49.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.953 1.701 . . . . 0.0 113.484 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -122.08 -102.75 0.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.606 -1.309 . . . . 0.0 109.664 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.99 -33.3 65.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.025 -1.672 . . . . 0.0 111.502 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -149.25 -176.55 5.41 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.3 t -82.35 -67.99 0.74 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.836 1.254 . . . . 0.0 108.829 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.89 -81.74 0.48 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.685 -1.259 . . . . 0.0 110.807 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.02 52.86 1.14 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -167.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 tt -139.12 162.34 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 121.679 -0.895 . . . . 0.0 110.218 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.1 t -122.59 141.93 51.17 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 171.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.56 145.77 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 125.917 1.687 . . . . 0.0 108.114 -167.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 t -136.72 114.56 11.29 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.965 1.365 . . . . 0.0 110.075 -172.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.62 178.91 26.79 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-O 122.942 1.301 . . . . 0.0 116.222 169.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.54 64.66 0.35 Allowed Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 122.265 0.925 . . . . 0.0 112.132 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.51 -64.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 124.389 1.076 . . . . 0.0 111.579 -173.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -110.5 -96.54 0.41 Allowed 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.029 -1.044 . . . . 0.0 112.818 -166.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.6 p -130.0 90.96 3.04 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.71 -1.869 . . . . 0.0 108.096 -175.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.6 p -134.4 -89.84 0.36 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.355 -0.841 . . . . 0.0 109.551 -175.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.8 -58.37 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.63 1.972 . . . . 0.0 110.89 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -127.57 -153.27 0.56 Allowed 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 165.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.53 88.56 7.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.476 -1.39 . . . . 0.0 109.55 163.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.89 -158.84 35.48 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -158.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.96 140.35 11.26 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.974 -1.309 . . . . 0.0 112.301 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.2 mm -124.21 136.4 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 121.016 -1.285 . . . . 0.0 108.927 -156.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.19 141.13 52.28 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.91 -1.119 . . . . 0.0 111.29 -170.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.57 134.96 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 120.687 -1.258 . . . . 0.0 112.046 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -84.28 -57.81 3.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.084 1.354 . . . . 0.0 110.441 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.63 165.23 18.91 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 124.069 0.947 . . . . 0.0 109.568 174.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.48 123.85 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 124.847 1.259 . . . . 0.0 110.59 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mm -83.18 130.38 57.23 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 120.824 -1.172 . . . . 0.0 110.215 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.15 80.65 1.84 Allowed 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 123.147 2.565 . . . . 0.0 112.434 172.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -141.55 -39.32 0.39 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.719 1.207 . . . . 0.0 112.071 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.88 -146.78 4.44 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.456 -1.402 . . . . 0.0 114.988 -173.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.5 -41.57 63.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.169 2.588 . . . . 0.0 116.95 -166.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.25 -47.7 80.72 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -72.56 -54.62 8.67 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.639 1.576 . . . . 0.0 112.176 173.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.0 t -60.28 -55.96 27.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.229 1.412 . . . . 0.0 114.312 -171.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.76 -39.19 70.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.092 0.957 . . . . 0.0 110.525 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.43 77.59 1.38 Allowed Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -137.03 -51.45 0.66 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -153.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.91 133.75 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -120.26 174.22 6.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 122.65 1.214 . . . . 0.0 114.123 -168.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -57.54 114.21 2.14 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.811 1.645 . . . . 0.0 114.573 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.1 26.03 65.13 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 120.555 -1.341 . . . . 0.0 115.529 -177.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -80.88 159.58 24.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 119.039 1.42 . . . . 0.0 110.779 168.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -124.12 128.92 50.0 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.034 -1.041 . . . . 0.0 109.904 -173.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.45 166.17 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 120.129 -1.607 . . . . 0.0 110.877 176.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.9 mt -131.76 -82.01 0.51 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.594 -1.316 . . . . 0.0 110.333 169.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 144.19 28.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.761 -1.212 . . . . 0.0 112.036 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.78 104.07 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 122.866 1.317 . . . . 0.0 110.781 174.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 57.4 50.56 11.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.16 2.184 . . . . 0.0 113.18 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.33 -24.91 8.67 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.066 -1.021 . . . . 0.0 114.459 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.2 t -85.6 101.29 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 120.441 -1.623 . . . . 0.0 110.969 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 p -79.2 125.93 30.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.684 1.194 . . . . 0.0 110.017 163.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.2 55.96 0.63 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.586 1.66 . . . . 0.0 110.891 -173.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -66.89 133.99 51.15 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -170.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.91 3.14 89.24 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.856 -1.153 . . . . 0.0 115.584 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.74 155.77 35.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.899 -1.354 . . . . 0.0 113.661 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.7 p -87.11 174.97 8.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.766 -1.208 . . . . 0.0 111.086 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -60.47 -46.45 90.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.357 -1.464 . . . . 0.0 114.277 -166.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -69.15 -36.16 77.12 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -71.14 -33.92 70.52 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.102 -1.624 . . . . 0.0 112.368 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.57 -53.04 57.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.965 -1.085 . . . . 0.0 113.567 169.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.7 m -75.02 -20.0 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.64 -1.912 . . . . 0.0 114.616 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -66.39 -42.45 87.89 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.89 -1.756 . . . . 0.0 110.94 167.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.4 m -63.92 -29.92 71.05 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.301 1.841 . . . . 0.0 113.021 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt -78.19 -37.28 46.04 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.647 -1.283 . . . . 0.0 112.188 174.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -69.11 -37.98 78.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.188 -1.57 . . . . 0.0 114.699 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.322 0.4 OUTLIER -79.33 55.7 1.95 Allowed 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 119.973 -1.705 . . . . 0.0 113.743 172.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -103.73 -76.63 0.59 Allowed 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.118 2.567 . . . . 0.0 107.632 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.94 -112.76 2.69 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 125.535 1.541 . . . . 0.0 112.958 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -81.62 -31.49 32.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.169 -1.195 . . . . 0.0 113.775 -172.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.8 p -105.14 138.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.449 1.1 . . . . 0.0 110.622 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.44 80.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 125.072 1.349 . . . . 0.0 108.52 -172.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -118.79 109.56 16.2 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.455 -1.403 . . . . 0.0 109.971 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -149.08 169.96 19.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.016 -1.678 . . . . 0.0 113.25 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.8 tp -122.78 121.55 36.56 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.654 1.581 . . . . 0.0 109.423 -170.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -131.78 169.96 15.49 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.835 0.826 . . . . 0.0 112.739 -166.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -130.25 135.72 48.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.663 1.985 . . . . 0.0 109.969 166.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 135.32 40.52 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.19 1.396 . . . . 0.0 110.327 173.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.743 0 CA-C-O 123.48 1.6 . . . . 0.0 117.07 -170.004 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 . . . . . 0 N--CA 1.431 -1.418 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.97 158.04 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 102.719 -3.067 . . . . 0.0 102.719 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 31.0 m -139.42 157.23 46.21 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 121.114 1.779 . . . . 0.0 113.171 -167.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -152.11 146.97 25.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.877 -1.14 . . . . 0.0 110.553 174.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--O 1.26 1.606 0 C-N-CA 125.774 1.63 . . . . 0.0 107.48 -179.83 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.761 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -82.81 -176.12 6.14 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 123.208 1.48 . . . . 0.0 113.39 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.4 mt -78.96 143.92 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 127.195 2.198 . . . . 0.0 111.301 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.76 156.37 41.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.726 0.81 . . . . 0.0 109.657 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.83 116.92 20.19 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.168 0.985 . . . . 0.0 111.077 -175.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.18 131.4 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.791 1.236 . . . . 0.0 112.509 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -111.44 117.9 34.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.527 1.531 . . . . 0.0 109.665 171.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.9 tp -134.84 167.01 21.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.378 1.471 . . . . 0.0 109.031 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.72 154.75 49.88 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 119.811 -1.806 . . . . 0.0 110.941 170.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -56.98 129.64 42.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.837 2.055 . . . . 0.0 114.735 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -121.56 -97.65 0.45 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.362 1.465 . . . . 0.0 110.39 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.67 -58.23 6.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.159 1.784 . . . . 0.0 109.252 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -137.11 -179.64 5.83 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 p -84.39 -80.51 0.2 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.105 0.962 . . . . 0.0 111.635 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.4 mt -103.19 -90.55 0.37 Allowed 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.455 -1.403 . . . . 0.0 113.297 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.95 56.36 1.97 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.717 -1.239 . . . . 0.0 112.572 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.7 tt -139.56 171.69 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 t -123.41 148.73 45.82 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.158 -2.214 . . . . 0.0 109.723 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.69 157.07 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.452 1.501 . . . . 0.0 108.975 -168.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.4 t -138.37 152.8 48.76 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.913 -1.742 . . . . 0.0 109.189 170.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.48 -137.99 37.89 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 126.909 2.195 . . . . 0.0 116.205 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.66 14.44 82.08 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 124.582 1.087 . . . . 0.0 115.19 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.49 -126.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.962 -1.317 . . . . 0.0 113.698 -170.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -71.61 -58.74 3.22 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.421 -2.049 . . . . 0.0 111.305 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.0 t -130.38 143.72 50.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 163.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -155.04 -111.65 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -170.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.34 -47.47 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 124.994 1.318 . . . . 0.0 111.596 171.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -141.72 -147.93 0.23 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.528 1.931 . . . . 0.0 106.616 158.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -76.57 52.6 0.81 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.614 2.766 . . . . 0.0 112.101 172.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.86 177.32 20.12 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 -165.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.31 138.79 10.44 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -165.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.1 mm -127.01 140.74 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -166.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.64 141.55 52.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.623 -1.298 . . . . 0.0 109.514 -169.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.31 125.86 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.982 -1.074 . . . . 0.0 112.115 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -82.67 -59.16 2.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.454 1.502 . . . . 0.0 110.6 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.14 172.24 6.47 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 123.77 0.828 . . . . 0.0 109.779 175.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.78 139.71 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 124.779 1.232 . . . . 0.0 112.306 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -85.44 120.74 73.42 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-O 116.549 -1.691 . . . . 0.0 108.109 165.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.69 34.12 0.52 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 125.869 3.132 . . . . 0.0 113.472 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.35 68.77 1.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.64 169.87 42.97 Favored Glycine 0 N--CA 1.432 -1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 111.227 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.66 -29.86 68.43 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 124.982 1.313 . . . . 0.0 114.365 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.41 -52.74 64.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -60.43 -46.43 90.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.031 1.332 . . . . 0.0 113.253 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.9 m -60.5 -54.71 42.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.66 1.584 . . . . 0.0 115.057 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.21 -37.84 57.25 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.787 -1.196 . . . . 0.0 112.223 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.55 88.33 1.09 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 125.517 1.532 . . . . 0.0 111.719 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -138.4 -58.39 0.64 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.453 -1.027 . . . . 0.0 113.665 -158.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.4 mt -127.98 130.97 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -118.17 171.67 7.95 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.618 1.199 . . . . 0.0 111.257 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -60.11 120.64 10.12 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.32 25.27 63.94 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -75.66 154.19 36.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.499 -1.589 . . . . 0.0 110.023 160.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -124.63 110.56 14.57 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.614 -1.304 . . . . 0.0 109.284 -170.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.4 m -102.24 152.62 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.645 -1.284 . . . . 0.0 111.776 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.5 tp -124.83 -77.58 0.59 Allowed 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 121.332 -0.855 . . . . 0.0 110.964 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.82 133.99 36.63 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 120.697 -1.252 . . . . 0.0 112.766 -166.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 p -101.7 90.36 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.762 1.625 . . . . 0.0 107.807 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.8 t30 56.64 61.57 2.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.162 1.785 . . . . 0.0 112.949 -170.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.18 -43.96 2.95 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 120.294 -1.503 . . . . 0.0 114.042 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.1 t -88.27 125.14 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 121.119 -1.224 . . . . 0.0 112.577 -170.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.6 t -75.17 149.75 38.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.28 -1.512 . . . . 0.0 111.715 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.72 -8.23 38.29 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 120.596 -1.315 . . . . 0.0 112.924 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.23 126.35 27.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -168.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.6 -46.42 1.16 Allowed Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.713 -1.242 . . . . 0.0 111.721 -162.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.46 165.67 24.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.785 1.234 . . . . 0.0 114.106 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.8 p -93.29 167.69 11.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.092 1.425 . . . . 0.0 111.175 172.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -42.38 -50.83 5.06 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 129.639 3.175 . . . . 0.0 116.794 170.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -70.06 -28.85 65.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.91 1.284 . . . . 0.0 113.591 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -74.07 -46.7 41.42 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.131 -1.606 . . . . 0.0 111.286 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.34 77.87 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.695 1.598 . . . . 0.0 115.164 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.3 p -71.37 -30.21 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.694 -1.879 . . . . 0.0 112.346 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -63.72 -47.66 80.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.091 -1.63 . . . . 0.0 113.118 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.4 m -55.68 -40.06 71.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.797 1.639 . . . . 0.0 113.306 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 tt -80.96 -33.09 34.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -175.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -71.68 -31.81 67.18 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.031 -1.668 . . . . 0.0 113.392 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -89.17 63.52 6.62 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.661 -1.274 . . . . 0.0 111.966 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 p -108.4 -81.27 0.57 Allowed 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.16 1.784 . . . . 0.0 110.388 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.86 -93.44 0.63 Allowed Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 125.865 1.698 . . . . 0.0 112.79 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -81.37 -57.37 3.52 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -168.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.2 m -104.94 144.45 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 123.251 1.501 . . . . 0.0 112.581 -169.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.04 94.25 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -119.32 121.69 40.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.613 -1.305 . . . . 0.0 108.501 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.51 163.97 35.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.633 -1.292 . . . . 0.0 112.941 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 mp -121.14 121.57 38.14 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.96 168.29 11.65 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.996 1.318 . . . . 0.0 109.757 -173.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -123.58 130.97 53.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.335 1.454 . . . . 0.0 107.302 161.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.8 139.27 53.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 125.07 1.348 . . . . 0.0 113.184 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.685 0 N-CA-C 116.839 1.495 . . . . 0.0 116.839 -175.729 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.36 152.39 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 126.039 1.736 . . . . 0.0 110.94 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 36.2 m -134.71 169.23 17.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.508 1.923 . . . . 0.0 112.561 -174.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.11 152.08 30.03 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 124.789 1.236 . . . . 0.0 110.989 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.998 2.119 . . . . 0.0 108.102 162.817 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.745 0 CA-C-O 121.13 0.295 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.27 154.22 26.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 121.307 -1.113 . . . . 0.0 112.757 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.87 133.69 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.764 -1.21 . . . . 0.0 109.394 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.5 153.95 41.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.089 -1.632 . . . . 0.0 111.549 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -125.67 119.81 29.02 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.908 -1.12 . . . . 0.0 112.619 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 t -104.58 137.17 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.958 -1.714 . . . . 0.0 112.015 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -111.07 127.07 55.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.71 1.204 . . . . 0.0 110.639 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 11.9 tp -135.03 -173.2 3.25 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.574 1.15 . . . . 0.0 109.929 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.407 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -141.75 157.6 44.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.272 -1.517 . . . . 0.0 107.913 171.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.8 tttm -71.8 112.33 7.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 122.67 1.224 . . . . 0.0 112.779 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -99.88 -93.44 0.27 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.521 1.528 . . . . 0.0 109.389 -172.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.12 -42.77 16.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.663 1.585 . . . . 0.0 108.248 161.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -137.66 178.66 6.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 p -84.29 -72.0 0.49 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.436 1.494 . . . . 0.0 110.651 174.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.4 mt -102.36 -75.56 0.6 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.511 1.124 . . . . 0.0 110.543 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.89 50.45 2.87 Favored Glycine 0 N--CA 1.431 -1.69 0 O-C-N 120.199 -1.563 . . . . 0.0 113.229 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.422 HG13 ' HA ' ' A' ' 40' ' ' VAL . 7.2 tt -143.12 146.3 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 122.314 1.054 . . . . 0.0 112.229 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 t -86.41 145.82 26.7 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.838 -1.788 . . . . 0.0 111.582 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.8 t -109.28 151.44 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.052 1.341 . . . . 0.0 111.13 -167.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -138.1 115.66 11.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.29 1.519 . . . . 0.0 110.964 170.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.35 -123.69 7.38 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.167 -1.583 . . . . 0.0 112.924 169.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.46 27.47 63.43 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 115.954 1.142 . . . . 0.0 115.954 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 m -105.64 -148.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 121.175 -1.191 . . . . 0.0 111.703 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -71.62 -37.18 70.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.853 1.661 . . . . 0.0 113.359 -166.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 t -130.89 117.73 19.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 163.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.9 t -151.07 -105.2 0.06 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.768 -1.832 . . . . 0.0 106.826 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.01 -52.13 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 125.119 1.368 . . . . 0.0 109.91 173.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -131.7 -158.84 0.92 Allowed 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 169.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -77.29 88.92 3.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.758 1.223 . . . . 0.0 108.594 162.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.32 172.87 32.05 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 119.798 -1.814 . . . . 0.0 113.555 -168.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.62 145.53 19.28 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -167.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.0 mm -125.05 142.83 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 120.463 -1.61 . . . . 0.0 108.925 -158.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -124.82 142.24 51.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 124.482 1.113 . . . . 0.0 110.683 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.9 t -90.94 133.98 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.887 -1.133 . . . . 0.0 113.155 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -91.01 -63.54 1.25 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.258 1.423 . . . . 0.0 113.114 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.45 158.22 11.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 -174.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.422 ' HA ' HG13 ' A' ' 20' ' ' ILE . 9.3 p -87.46 135.71 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 124.249 1.02 . . . . 0.0 112.821 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -85.44 120.8 73.48 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.741 -1.599 . . . . 0.0 109.861 171.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -73.81 44.85 1.0 Allowed 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 125.089 2.853 . . . . 0.0 116.266 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.93 43.12 0.55 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.952 1.358 . . . . 0.0 110.238 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.96 -171.93 38.8 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.047 -1.658 . . . . 0.0 112.3 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.19 -43.2 70.5 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.861 2.064 . . . . 0.0 116.114 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.78 -44.13 66.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.453 1.501 . . . . 0.0 114.975 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.56 -61.4 1.78 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.357 1.463 . . . . 0.0 112.045 171.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.1 m -56.21 -50.54 70.94 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -173.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -82.45 -27.9 31.61 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 121.308 -0.87 . . . . 0.0 111.183 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.81 73.09 1.28 Allowed Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 124.664 1.126 . . . . 0.0 110.913 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.411 HH22 ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -138.3 -44.26 0.5 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -152.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -128.35 134.28 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 120.615 1.552 . . . . 0.0 107.866 -170.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -125.14 171.13 10.55 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 122.734 1.254 . . . . 0.0 112.131 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -57.22 133.6 55.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.797 2.039 . . . . 0.0 115.763 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.42 12.16 84.81 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -79.95 167.06 20.97 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 118.819 1.309 . . . . 0.0 110.801 167.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -131.31 135.67 47.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.392 -1.443 . . . . 0.0 108.484 -172.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.57 145.76 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 120.103 1.319 . . . . 0.0 110.15 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.9 tp -135.49 -60.07 0.76 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.48 138.46 38.46 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.606 -1.934 . . . . 0.0 113.39 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.22 106.33 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.752 -1.217 . . . . 0.0 109.683 170.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 t30 56.03 40.42 30.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 170.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.22 -0.81 84.05 Favored Glycine 0 N--CA 1.431 -1.671 0 O-C-N 119.968 -1.708 . . . . 0.0 115.05 -176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.29 106.71 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 120.791 -1.417 . . . . 0.0 109.404 168.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 t -78.27 123.56 27.08 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.694 -1.879 . . . . 0.0 111.416 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -93.27 28.51 2.18 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.607 -1.308 . . . . 0.0 112.606 177.233 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.39 137.24 58.22 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.177 -1.577 . . . . 0.0 110.811 163.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.37 -35.44 2.99 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 119.16 -2.212 . . . . 0.0 114.406 -173.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.92 142.29 42.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.924 -1.339 . . . . 0.0 113.355 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.4 p -84.95 163.91 18.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.031 1.732 . . . . 0.0 111.851 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -48.13 -53.71 15.76 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.674 2.389 . . . . 0.0 116.688 -174.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -68.25 -29.91 68.83 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.289 1.042 . . . . 0.0 113.791 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -73.8 -46.68 43.88 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.889 1.275 . . . . 0.0 111.45 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.08 -41.48 86.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.273 1.829 . . . . 0.0 114.643 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 p -63.14 -34.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.089 -1.632 . . . . 0.0 113.084 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.29 -36.51 84.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.417 -1.427 . . . . 0.0 113.766 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.4 m -67.44 -35.05 78.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.033 1.733 . . . . 0.0 112.733 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -78.03 -37.83 46.02 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.538 -1.351 . . . . 0.0 112.093 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -62.99 -50.24 71.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.972 1.309 . . . . 0.0 113.165 173.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -85.38 60.83 6.49 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.168 -1.582 . . . . 0.0 112.002 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 p -99.02 -61.21 1.4 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.448 2.299 . . . . 0.0 108.008 168.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.84 -104.2 1.34 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 124.262 0.934 . . . . 0.0 113.606 160.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -81.92 -53.0 6.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.444 -1.033 . . . . 0.0 112.881 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.4 m -112.24 146.78 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 124.832 1.253 . . . . 0.0 109.359 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.57 123.7 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.243 -0.911 . . . . 0.0 108.99 -172.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -136.02 124.09 22.93 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.691 -1.255 . . . . 0.0 110.517 171.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -148.8 162.69 39.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.838 -1.164 . . . . 0.0 112.991 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.71 127.94 54.03 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -171.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.411 ' CD2' HH22 ' A' ' 51' ' ' ARG . 4.9 mp -118.21 159.49 23.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.928 1.291 . . . . 0.0 109.413 -175.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -120.03 126.27 50.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -68.04 147.54 52.24 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.623 -1.298 . . . . 0.0 112.69 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.709 0 N-CA-C 116.911 1.525 . . . . 0.0 116.911 -174.776 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.95 153.25 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.153 -1.592 . . . . 0.0 111.239 -177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -137.14 178.14 7.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.029 1.332 . . . . 0.0 110.334 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -151.25 149.08 28.98 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 124.378 1.071 . . . . 0.0 108.563 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.261 1.66 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 173.359 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo . . . . . 0 CA--C 1.489 -1.738 0 N-CA-C 109.629 -0.95 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -77.26 156.09 81.72 Favored Pre-proline 0 N--CA 1.43 -1.426 0 O-C-N 120.968 -1.083 . . . . 0.0 111.632 174.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -65.75 -49.62 2.18 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 123.076 2.134 . . . . 0.0 114.697 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.55 56.46 4.17 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 118.904 0.775 . . . . 0.0 112.92 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -82.6 153.11 25.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.164 -1.198 . . . . 0.0 113.455 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.33 128.79 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 124.703 1.201 . . . . 0.0 109.78 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -137.27 160.99 37.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.489 -1.382 . . . . 0.0 110.404 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -113.56 140.61 48.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.871 -1.143 . . . . 0.0 112.145 175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -102.54 138.69 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 124.195 0.998 . . . . 0.0 109.367 172.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -121.15 101.92 7.97 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 125.514 1.525 . . . . 0.0 107.951 168.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -133.87 -175.5 3.86 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.421 -0.799 . . . . 0.0 109.918 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.26 174.66 15.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.934 -1.104 . . . . 0.0 110.285 174.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -69.98 123.32 21.25 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -121.32 -81.89 0.64 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.539 1.536 . . . . 0.0 111.784 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.85 -57.24 3.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.106 1.763 . . . . 0.0 108.61 170.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -142.24 -139.1 0.11 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 156.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 p -85.49 -85.62 0.14 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.007 -1.683 . . . . 0.0 111.997 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.9 mt -101.18 -74.46 0.61 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.334 -1.479 . . . . 0.0 113.335 -171.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.59 54.33 1.45 Allowed Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 124.839 1.209 . . . . 0.0 110.446 -174.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.9 tt -146.23 155.29 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.477 -1.013 . . . . 0.0 110.625 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 t -121.09 151.9 39.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.409 -1.432 . . . . 0.0 109.088 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -124.24 152.33 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.509 1.524 . . . . 0.0 110.319 -164.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 t -138.65 138.25 37.64 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 120.494 -1.379 . . . . 0.0 110.11 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.69 -137.71 20.53 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.832 1.682 . . . . 0.0 114.349 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.33 23.67 46.88 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 117.6 1.8 . . . . 0.0 117.6 166.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 m -87.27 -119.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 119.491 1.646 . . . . 0.0 114.848 -171.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -71.37 -45.34 63.08 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.875 -2.391 . . . . 0.0 113.117 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 t -138.56 170.94 15.12 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 148.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -156.01 -69.05 0.11 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.444 -1.41 . . . . 0.0 111.357 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 t -92.62 -56.51 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 124.291 1.036 . . . . 0.0 111.939 -168.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -141.12 -92.1 0.15 Allowed 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 121.475 -0.765 . . . . 0.0 109.997 -170.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -117.58 52.35 0.99 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.651 1.691 . . . . 0.0 107.617 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.81 -142.52 17.53 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 107.309 -2.317 . . . . 0.0 107.309 -166.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.08 148.29 23.49 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 124.675 1.131 . . . . 0.0 113.398 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.61 151.31 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.17 143.94 50.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.252 1.021 . . . . 0.0 111.186 -171.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.8 t -73.08 129.6 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.693 -1.254 . . . . 0.0 111.657 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -81.54 -62.77 1.55 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 109.62 171.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.45 167.54 15.61 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -92.35 136.84 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 124.835 1.254 . . . . 0.0 110.668 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.6 mm -83.83 120.34 74.91 Favored Pre-proline 0 N--CA 1.43 -1.427 0 O-C-N 120.314 -1.491 . . . . 0.0 109.005 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.12 65.0 8.93 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 CA-C-N 124.801 2.75 . . . . 0.0 113.277 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -141.7 -1.4 1.28 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.894 1.278 . . . . 0.0 112.897 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -141.87 -161.68 8.85 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 120.251 -1.531 . . . . 0.0 114.826 -171.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.69 -37.15 86.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 -173.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.27 92.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.274 1.03 . . . . 0.0 113.383 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -68.63 -55.88 10.06 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.375 1.07 . . . . 0.0 112.943 167.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.8 t -59.29 -56.99 15.04 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.324 1.45 . . . . 0.0 114.906 -170.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -81.11 -37.83 28.25 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.446 -1.409 . . . . 0.0 110.572 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.76 90.29 1.33 Allowed Glycine 0 N--CA 1.429 -1.78 0 O-C-N 120.519 -1.363 . . . . 0.0 111.397 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -137.18 -41.79 0.57 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 121.418 -1.048 . . . . 0.0 111.189 -171.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 mt -129.11 143.13 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.34 -173.54 3.3 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.313 -1.492 . . . . 0.0 111.179 170.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -55.97 132.57 50.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.39 9.86 86.59 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 118.236 2.054 . . . . 0.0 118.236 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -74.23 155.47 38.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 119.496 1.648 . . . . 0.0 112.167 172.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -124.55 144.0 50.37 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.105 -1.622 . . . . 0.0 110.719 -170.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 m -101.39 154.02 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 119.802 -1.811 . . . . 0.0 112.605 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.15 -91.18 0.56 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.209 1.404 . . . . 0.0 108.128 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.31 148.28 23.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.886 -1.133 . . . . 0.0 113.89 -166.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.36 100.91 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.086 1.354 . . . . 0.0 107.796 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.5 t30 56.77 61.06 2.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.269 1.828 . . . . 0.0 112.393 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.87 -39.02 2.95 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.922 -1.111 . . . . 0.0 115.336 -176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.08 128.06 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.453 -1.616 . . . . 0.0 112.603 -166.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -77.36 124.2 27.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.881 -1.137 . . . . 0.0 111.819 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.9 mp -87.36 74.22 9.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.115 1.436 . . . . 0.0 110.503 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -68.81 99.8 1.09 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.265 -1.522 . . . . 0.0 113.293 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.75 23.17 53.96 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.481 0.952 . . . . 0.0 115.481 172.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.35 136.35 39.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.384 -1.068 . . . . 0.0 112.526 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.6 p -80.13 172.21 14.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.572 1.149 . . . . 0.0 113.063 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.584 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 2.9 t60 -61.63 -41.25 97.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.257 -1.527 . . . . 0.0 113.252 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -59.02 -40.24 84.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -69.87 -41.63 74.55 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.29 -1.506 . . . . 0.0 111.773 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.82 97.23 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.678 -1.264 . . . . 0.0 114.082 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.13 -43.29 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.417 -1.427 . . . . 0.0 113.096 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -62.06 -42.25 99.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.433 -1.417 . . . . 0.0 113.729 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.3 p -70.15 -17.51 63.19 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.26 -1.525 . . . . 0.0 115.052 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.4 mt -80.32 -39.01 29.53 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 120.424 -1.422 . . . . 0.0 113.454 171.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -86.61 -27.43 23.86 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.484 -1.385 . . . . 0.0 113.932 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -83.42 60.56 5.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.68 -1.888 . . . . 0.0 112.55 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.5 p -109.06 -89.85 0.47 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.693 1.597 . . . . 0.0 112.518 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.44 -129.25 8.09 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 107.416 -2.274 . . . . 0.0 107.416 -166.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -81.25 -51.44 8.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -165.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -104.16 145.96 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.623 -1.298 . . . . 0.0 113.764 -159.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.24 105.73 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 125.022 1.329 . . . . 0.0 110.101 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -116.86 120.85 39.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.889 -1.132 . . . . 0.0 108.623 168.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.58 166.86 27.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.503 -1.373 . . . . 0.0 111.911 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -120.21 137.38 54.23 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mp -125.53 156.75 38.55 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.312 1.445 . . . . 0.0 108.363 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -113.49 132.59 55.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 166.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.6 tptt -68.86 138.16 54.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.789 -1.194 . . . . 0.0 112.693 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.93 -90.95 0.26 Allowed Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.795 -1.191 . . . . 0.0 114.667 -172.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -102.39 176.73 5.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.334 1.453 . . . . 0.0 111.775 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.3 m -74.73 126.65 88.27 Favored Pre-proline 0 N--CA 1.431 -1.422 0 O-C-N 120.434 -1.416 . . . . 0.0 113.118 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.65 -62.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 123.844 2.409 . . . . 0.0 112.653 169.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 C--O 1.26 1.63 0 CA-C-N 119.715 1.143 . . . . 0.0 111.183 170.897 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 . . . . . 0 CA--C 1.49 -1.331 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.97 -175.3 3.5 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.774 -1.203 . . . . 0.0 112.384 -177.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 62.81 35.94 13.4 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.865 2.066 . . . . 0.0 114.755 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 25.9 t -146.65 -78.04 0.17 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.958 -1.714 . . . . 0.0 112.416 -167.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -104.57 -69.22 0.82 Allowed 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.103 -0.998 . . . . 0.0 113.258 -160.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.17 144.69 30.11 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.563 -1.336 . . . . 0.0 111.31 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -117.26 -177.44 3.22 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 125.481 1.512 . . . . 0.0 107.213 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -97.33 109.54 22.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.497 -1.377 . . . . 0.0 109.898 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.25 27.82 0.67 Allowed 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -121.94 76.14 1.27 Allowed 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.534 -1.354 . . . . 0.0 108.818 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -133.58 -122.16 0.18 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.494 1.118 . . . . 0.0 108.773 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -128.25 145.91 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 125.386 1.474 . . . . 0.0 109.271 -164.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' SER . . . . . 0.584 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 9.1 p -126.3 163.31 23.51 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.463 1.505 . . . . 0.0 111.822 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.19 159.02 43.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.514 -0.741 . . . . 0.0 109.579 162.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.261 1.671 0 C-N-CA 124.048 0.939 . . . . 0.0 109.012 177.665 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 CA--C 1.49 -1.709 0 N-CA-C 108.669 -1.319 . . . . 0.0 108.669 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -78.25 165.01 53.36 Favored Pre-proline 0 N--CA 1.429 -1.499 0 CA-C-O 117.589 -1.196 . . . . 0.0 110.065 167.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.97 -19.28 18.07 Favored 'Trans proline' 0 N--CA 1.434 -1.991 0 CA-C-N 125.305 2.93 . . . . 0.0 113.051 -164.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.73 88.44 0.57 Allowed Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 165.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -74.17 145.98 43.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 118.842 1.321 . . . . 0.0 113.429 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.4 mt -89.44 137.64 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.251 1.42 . . . . 0.0 110.106 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -146.56 161.26 40.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.972 -1.08 . . . . 0.0 109.99 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -115.52 141.07 48.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.146 -0.971 . . . . 0.0 108.878 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.4 147.39 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 124.045 0.938 . . . . 0.0 112.632 173.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -113.67 123.33 49.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 123.746 0.818 . . . . 0.0 109.058 168.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.5 mt -132.83 157.91 43.83 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.442 -1.411 . . . . 0.0 110.427 165.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.66 139.26 27.89 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -70.41 96.68 1.17 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -92.29 -66.36 0.93 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.123 1.769 . . . . 0.0 109.703 171.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -88.7 -71.37 0.59 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.173 1.789 . . . . 0.0 109.186 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -136.55 166.45 23.5 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -171.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -83.06 -71.19 0.51 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -167.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.85 -83.27 0.46 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.138 -1.601 . . . . 0.0 110.028 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.4 39.35 2.82 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.688 -1.258 . . . . 0.0 114.932 170.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.86 169.58 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.093 -1.239 . . . . 0.0 108.774 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.7 p -122.45 146.51 47.31 Favored 'General case' 0 N--CA 1.429 -1.513 0 O-C-N 119.968 -1.708 . . . . 0.0 108.75 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 t -125.32 149.83 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 125.168 1.387 . . . . 0.0 110.044 -161.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -136.29 142.11 43.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.062 1.411 . . . . 0.0 109.774 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.71 -130.77 9.91 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 125.761 1.648 . . . . 0.0 114.191 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.93 62.42 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 121.404 -1.056 . . . . 0.0 114.531 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.36 168.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -67.73 -26.8 66.32 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 125.984 1.714 . . . . 0.0 113.163 -163.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 t -129.74 128.18 41.92 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 152.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 p -155.39 -89.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.853 -1.154 . . . . 0.0 110.672 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -78.25 -47.2 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.3 -1.5 . . . . 0.0 109.457 171.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.95 -153.18 0.52 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 167.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -76.55 89.84 3.3 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.399 -1.438 . . . . 0.0 109.278 163.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.69 -154.35 30.9 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -162.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.39 136.93 9.11 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-O 122.858 1.254 . . . . 0.0 112.465 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.5 mm -124.89 133.75 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.4 -1.647 . . . . 0.0 107.574 -164.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.96 141.4 51.99 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.677 1.191 . . . . 0.0 108.311 -170.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.7 t -80.03 130.53 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.906 -1.121 . . . . 0.0 110.911 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -86.75 -57.34 3.02 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 120.139 -1.6 . . . . 0.0 110.783 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.87 155.56 29.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.853 1.261 . . . . 0.0 109.514 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -94.78 131.16 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 122.519 1.152 . . . . 0.0 110.689 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.7 mm -82.93 123.06 78.18 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 120.523 -1.361 . . . . 0.0 110.42 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.11 40.9 1.0 Allowed 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.041 2.494 . . . . 0.0 114.051 -172.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -144.78 53.85 1.23 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.19 174.29 45.91 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 120.419 -1.426 . . . . 0.0 113.896 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.78 -36.09 73.86 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.475 1.91 . . . . 0.0 114.4 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.65 -53.78 47.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.35 -49.95 50.87 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.284 1.434 . . . . 0.0 112.346 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -61.19 -39.87 91.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -82.07 -47.92 12.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.838 -1.164 . . . . 0.0 111.236 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.96 62.63 1.98 Allowed Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 117.109 1.604 . . . . 0.0 117.109 168.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -135.5 -1.08 2.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.472 -1.605 . . . . 0.0 111.841 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.3 mt -129.28 149.47 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.464 ' CE1' ' HZ2' ' A' ' 91' ' ' LYS . 0.8 OUTLIER -126.8 173.68 9.36 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 120.287 -1.508 . . . . 0.0 111.531 172.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -58.12 135.9 57.11 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.945 1.298 . . . . 0.0 114.214 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.76 18.51 78.84 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 117.559 1.784 . . . . 0.0 117.559 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -82.7 162.51 21.78 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 120.341 2.07 . . . . 0.0 111.543 166.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -126.33 123.4 37.93 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.714 -1.241 . . . . 0.0 110.384 -172.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -85.56 155.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.118 -1.614 . . . . 0.0 113.284 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.04 -86.13 0.65 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.707 1.203 . . . . 0.0 111.229 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.52 144.94 28.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.63 96.25 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 124.468 1.107 . . . . 0.0 108.329 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.296 9.5 t-20 57.19 47.59 16.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.854 1.661 . . . . 0.0 113.343 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.79 -34.3 5.86 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.582 -1.324 . . . . 0.0 114.278 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 t -100.9 109.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 118.368 1.084 . . . . 0.0 112.159 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.9 m -79.61 110.22 14.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.665 1.586 . . . . 0.0 112.392 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.14 85.4 4.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.577 -1.952 . . . . 0.0 110.555 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.03 135.11 51.79 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.921 -1.737 . . . . 0.0 113.652 174.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.56 7.23 63.45 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 124.685 1.136 . . . . 0.0 114.371 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.86 130.8 39.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.825 -1.397 . . . . 0.0 112.903 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.3 p -80.76 171.61 14.8 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 123.126 1.441 . . . . 0.0 110.252 168.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.515 ' CE1' ' HB2' ' B' ' 13' ' ' SER . 1.9 t60 -56.25 -41.7 76.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.641 1.977 . . . . 0.0 114.093 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -52.32 -45.72 65.73 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.511 1.524 . . . . 0.0 114.859 171.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -72.06 -38.51 69.43 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.841 1.256 . . . . 0.0 111.722 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.12 76.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.621 1.168 . . . . 0.0 113.852 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.3 t -63.21 -48.14 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.628 1.971 . . . . 0.0 113.331 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -53.59 -46.46 70.37 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.483 1.135 . . . . 0.0 113.271 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.7 m -65.91 -41.71 91.11 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.029 2.132 . . . . 0.0 113.218 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.8 mt -85.81 -27.31 25.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.139 -1.601 . . . . 0.0 114.83 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 44.6 mtt180 -65.47 -45.93 81.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.775 -1.828 . . . . 0.0 112.625 173.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -83.46 60.39 5.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.017 1.389 . . . . 0.0 112.26 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.89 -80.85 0.37 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.47 1.908 . . . . 0.0 109.192 175.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.16 -78.79 0.4 Allowed Glycine 0 N--CA 1.429 -1.774 0 O-C-N 121.294 -0.879 . . . . 0.0 114.257 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -81.51 -58.74 2.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.503 -0.998 . . . . 0.0 113.472 -175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.43 149.21 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.777 1.231 . . . . 0.0 110.487 -166.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.6 t -129.45 112.31 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.073 1.349 . . . . 0.0 107.786 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -127.98 104.44 7.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.637 -1.289 . . . . 0.0 110.857 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.3 mt -127.7 162.59 26.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 111.313 -169.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.24 136.32 54.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.514 1.526 . . . . 0.0 107.15 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.74 161.24 42.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.802 0.811 . . . . 0.0 111.822 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -114.29 134.8 54.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.857 1.663 . . . . 0.0 109.652 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.464 ' HZ2' ' CE1' ' A' ' 53' ' ' HIS . 55.3 mmtt -62.65 135.2 57.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 173.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.47 -139.07 4.21 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 123.281 1.489 . . . . 0.0 116.175 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -94.91 155.13 16.9 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.544 1.538 . . . . 0.0 111.177 176.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 t -73.64 141.95 80.09 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -79.27 139.62 14.93 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 123.294 2.212 . . . . 0.0 114.022 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 C--O 1.259 1.589 0 C-N-CA 125.019 1.327 . . . . 0.0 110.533 175.109 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 CA--C 1.49 -1.338 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.8 -55.02 4.31 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.883 -1.761 . . . . 0.0 115.497 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 72.4 58.06 0.14 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.017 2.527 . . . . 0.0 111.3 -167.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.2 m -136.68 168.34 19.7 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -74.5 -95.82 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -158.02 133.46 8.89 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.001 -1.062 . . . . 0.0 111.459 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -128.81 63.8 1.46 Allowed 'General case' 0 N--CA 1.428 -1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.83 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . 0.35 22.4 mt-10 58.09 -165.04 0.17 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 173.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -137.35 169.62 17.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.028 -1.67 . . . . 0.0 110.93 -163.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -134.99 162.72 31.65 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.612 1.565 . . . . 0.0 106.843 168.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -149.17 -170.74 3.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.845 -1.159 . . . . 0.0 113.439 -174.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.81 123.86 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.261 1.824 . . . . 0.0 107.699 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' SER . . . . . 0.515 ' HB2' ' CE1' ' A' ' 71' ' ' HIS . 15.0 m -129.59 133.06 46.96 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.707 -1.246 . . . . 0.0 113.154 -171.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.02 155.9 34.61 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.644 -1.285 . . . . 0.0 112.544 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 C--O 1.26 1.633 0 C-N-CA 126.636 1.974 . . . . 0.0 107.858 173.798 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo . . . . . 0 CA--C 1.489 -1.755 0 N-CA-C 108.025 -1.567 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -81.12 162.71 58.37 Favored Pre-proline 0 N--CA 1.431 -1.383 0 CA-C-O 117.707 -1.139 . . . . 0.0 110.949 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.26 -40.54 2.31 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 CA-C-N 123.948 2.446 . . . . 0.0 113.708 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.54 71.84 0.23 Allowed Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 124.816 1.198 . . . . 0.0 112.455 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -82.18 178.97 7.98 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 120.898 -1.354 . . . . 0.0 113.624 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -85.67 133.99 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.326 -1.483 . . . . 0.0 108.376 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -135.96 146.65 47.49 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 121.201 -0.937 . . . . 0.0 108.781 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -106.68 134.82 49.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.027 -1.046 . . . . 0.0 109.36 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.9 t -102.06 115.44 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -120.38 95.44 4.74 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.801 1.24 . . . . 0.0 108.63 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.462 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 11.0 tp -134.49 -155.95 0.69 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.174 -0.954 . . . . 0.0 109.368 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.462 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -154.53 168.19 27.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -71.96 129.64 39.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -120.98 -69.88 0.82 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.825 1.25 . . . . 0.0 110.722 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -76.56 -62.62 1.57 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.657 -1.277 . . . . 0.0 109.188 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -137.79 -131.11 0.13 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 139.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.7 p -89.81 -78.15 0.37 Allowed 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 120.19 1.359 . . . . 0.0 112.187 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.1 mt -103.21 -99.31 0.3 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.372 -1.455 . . . . 0.0 113.921 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.42 52.43 1.71 Allowed Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -157.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.95 147.05 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.956 -1.32 . . . . 0.0 108.366 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 t -122.48 148.21 45.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.727 -1.233 . . . . 0.0 109.223 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.62 157.01 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 122.343 1.068 . . . . 0.0 110.11 -164.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.2 t -137.06 112.71 9.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 122.75 1.262 . . . . 0.0 107.834 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.46 175.38 50.7 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-O 122.934 1.296 . . . . 0.0 115.004 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.43 67.84 0.7 Allowed Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.1 m -97.21 -130.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 125.135 1.374 . . . . 0.0 110.694 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -71.1 -39.12 72.3 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.028 -2.295 . . . . 0.0 112.714 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.8 t -151.99 143.14 23.22 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 163.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 t -156.55 -69.25 0.11 Allowed 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.081 -1.637 . . . . 0.0 113.285 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.37 -58.32 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.558 -1.339 . . . . 0.0 112.734 -164.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -125.52 -83.64 0.63 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 124.078 0.951 . . . . 0.0 109.295 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.39 53.71 1.93 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 165.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.3 -140.42 16.27 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 -161.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.15 150.24 19.94 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 117.955 0.877 . . . . 0.0 113.522 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 22.0 mm -125.67 148.91 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -125.85 135.62 52.16 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.858 -1.151 . . . . 0.0 112.052 -169.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.3 t -78.65 130.32 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 120.398 -1.438 . . . . 0.0 112.333 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -89.52 -59.35 2.23 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.903 -1.123 . . . . 0.0 110.536 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.86 163.33 23.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.765 0.793 . . . . 0.0 110.24 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.4 131.72 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.122 1.369 . . . . 0.0 109.152 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.4 mm -83.58 120.31 75.15 Favored Pre-proline 0 N--CA 1.431 -1.381 0 O-C-N 120.926 -1.109 . . . . 0.0 109.816 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.8 67.56 8.57 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 124.022 2.472 . . . . 0.0 112.88 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -145.4 9.72 1.23 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 123.997 0.919 . . . . 0.0 111.835 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 -158.82 18.49 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 119.664 -1.898 . . . . 0.0 114.565 -172.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.34 -43.51 79.13 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.512 2.325 . . . . 0.0 116.26 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.98 90.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -73.79 -49.98 22.71 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.714 1.206 . . . . 0.0 111.583 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 t -55.05 -55.45 30.83 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.522 2.329 . . . . 0.0 114.485 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -79.2 -44.44 21.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.641 -1.287 . . . . 0.0 111.772 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.49 91.48 0.55 Allowed Glycine 0 N--CA 1.431 -1.686 0 C-N-CA 124.223 0.916 . . . . 0.0 113.443 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -136.16 -45.7 0.63 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.168 -1.195 . . . . 0.0 110.436 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.6 mt -126.04 133.45 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 -169.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.82 -178.19 3.97 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.598 1.19 . . . . 0.0 112.101 -176.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -56.42 125.03 20.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.49 16.79 80.45 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 117.588 1.795 . . . . 0.0 117.588 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -72.07 161.8 30.38 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.346 1.573 . . . . 0.0 112.634 167.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -123.16 115.18 21.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 121.029 -1.044 . . . . 0.0 109.314 -173.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.96 148.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 119.872 -1.767 . . . . 0.0 110.136 172.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.3 mt -128.98 -81.01 0.57 Allowed 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 121.41 -0.806 . . . . 0.0 111.46 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.5 138.12 34.56 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.553 -1.342 . . . . 0.0 114.455 -167.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.93 90.91 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 126.394 1.877 . . . . 0.0 109.411 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.292 3.3 t-20 56.37 50.65 12.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.945 1.698 . . . . 0.0 112.324 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.23 -36.8 3.89 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 120.678 -1.264 . . . . 0.0 113.675 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -85.23 124.05 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 O-C-N 121.305 -1.115 . . . . 0.0 112.293 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 t -77.98 129.52 35.39 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.677 -1.264 . . . . 0.0 110.864 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tp -95.08 51.84 1.39 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.972 -1.705 . . . . 0.0 112.808 -164.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.98 123.81 21.25 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.652 1.581 . . . . 0.0 114.512 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.39 -4.8 80.51 Favored Glycine 0 N--CA 1.429 -1.78 0 O-C-N 120.26 -1.525 . . . . 0.0 114.358 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.35 143.41 40.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 121.258 -1.142 . . . . 0.0 112.976 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.8 p -85.96 175.84 8.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.16 1.384 . . . . 0.0 111.006 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.614 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 21.8 t60 -59.73 -43.67 94.11 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.205 1.402 . . . . 0.0 112.488 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.88 -40.99 90.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.528 2.331 . . . . 0.0 115.386 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -72.1 -37.46 69.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.189 -1.57 . . . . 0.0 112.354 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.46 77.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.931 -1.106 . . . . 0.0 113.494 171.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.6 -51.58 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.365 1.466 . . . . 0.0 113.069 170.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -60.46 -40.28 90.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.635 -1.291 . . . . 0.0 114.328 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 p -70.48 -18.55 62.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.321 -1.487 . . . . 0.0 113.86 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mt -85.67 -19.13 31.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.01 -1.681 . . . . 0.0 113.253 170.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -78.54 -44.16 24.96 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.237 -1.539 . . . . 0.0 110.924 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -82.95 64.91 7.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.879 1.272 . . . . 0.0 112.942 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.5 p -99.72 -74.08 0.61 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.156 1.782 . . . . 0.0 111.015 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.37 -131.19 9.56 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 125.702 1.62 . . . . 0.0 111.01 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -76.79 -44.21 33.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.003 -1.292 . . . . 0.0 113.481 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -109.31 164.42 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 123.915 0.886 . . . . 0.0 111.055 -167.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.0 t -134.15 127.75 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.225 1.41 . . . . 0.0 109.38 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -142.43 115.68 8.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.397 -0.814 . . . . 0.0 109.078 171.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -149.05 162.36 40.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.243 -1.536 . . . . 0.0 112.019 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.3 mp -121.01 124.41 44.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.282 1.039 . . . . 0.0 108.982 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -117.86 166.06 12.93 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.527 1.131 . . . . 0.0 108.944 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -117.33 131.6 56.76 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 162.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -73.71 124.53 26.19 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.941 -1.099 . . . . 0.0 111.051 -174.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.81 -76.38 1.2 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 121.232 -0.917 . . . . 0.0 115.055 -166.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -99.94 140.39 34.22 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 123.838 0.855 . . . . 0.0 110.404 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.4 m -72.46 141.9 83.51 Favored Pre-proline 0 N--CA 1.429 -1.488 0 O-C-N 120.909 -1.12 . . . . 0.0 112.385 -176.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -62.78 -66.0 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.057 0 C-N-CA 123.139 2.559 . . . . 0.0 112.282 162.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.26 1.653 0 CA-C-N 119.092 0.86 . . . . 0.0 109.517 157.449 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 120.247 0.07 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.94 162.84 28.24 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 64.05 38.64 8.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.128 2.171 . . . . 0.0 113.845 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 5.1 t -119.07 -70.93 0.76 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.613 -1.304 . . . . 0.0 109.847 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -93.51 -86.88 0.25 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.859 -1.151 . . . . 0.0 113.08 -173.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.13 167.37 27.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.224 -0.922 . . . . 0.0 111.5 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.69 -174.65 4.39 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.807 1.243 . . . . 0.0 111.159 171.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -76.06 95.13 3.56 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.813 1.645 . . . . 0.0 110.502 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -109.71 -14.32 14.35 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.589 -1.319 . . . . 0.0 113.554 -168.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -122.17 99.28 6.34 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.768 -1.208 . . . . 0.0 111.408 -164.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -153.98 -122.84 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.075 -1.64 . . . . 0.0 112.777 174.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.98 160.21 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 127.709 2.404 . . . . 0.0 106.994 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' SER . . . . . 0.614 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 30.2 p -150.01 154.73 38.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.451 -2.031 . . . . 0.0 114.639 -174.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.95 164.42 38.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.296 1.038 . . . . 0.0 112.009 170.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.26 1.627 0 C-N-CA 125.648 1.579 . . . . 0.0 108.977 176.351 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 CA--C 1.49 -1.678 0 N-CA-C 107.564 -1.745 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -85.88 147.56 46.07 Favored Pre-proline 0 N--CA 1.43 -1.472 0 O-C-N 121.089 -1.007 . . . . 0.0 110.493 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.93 -33.1 6.53 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 122.395 1.891 . . . . 0.0 110.983 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.18 61.73 1.85 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 124.998 1.285 . . . . 0.0 111.311 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.87 179.02 7.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.932 1.349 . . . . 0.0 113.22 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.92 133.51 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.431 1.492 . . . . 0.0 108.98 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -138.47 157.55 45.98 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.959 -1.088 . . . . 0.0 112.497 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -126.92 114.19 17.53 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.992 1.317 . . . . 0.0 112.477 -172.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.2 t -102.9 141.66 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.673 -1.267 . . . . 0.0 110.208 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -117.83 122.09 42.46 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 160.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -133.91 162.33 32.33 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.838 -1.163 . . . . 0.0 108.936 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.61 147.75 27.79 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.406 -1.434 . . . . 0.0 107.585 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -64.03 120.88 12.87 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 122.994 1.378 . . . . 0.0 114.703 -168.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -98.35 -88.21 0.32 Allowed 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 125.15 1.38 . . . . 0.0 108.816 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.55 -46.77 36.82 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.559 -1.338 . . . . 0.0 109.623 170.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -156.9 -158.06 0.74 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 169.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 p -83.53 -82.05 0.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.745 -1.222 . . . . 0.0 112.39 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.4 mt -102.49 -97.53 0.29 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.824 -1.798 . . . . 0.0 114.437 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.43 51.23 1.59 Allowed Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -162.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.9 tt -140.95 161.06 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 121.072 -1.252 . . . . 0.0 110.361 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -122.47 142.5 50.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 120.352 -1.467 . . . . 0.0 108.029 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -123.64 152.65 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 125.446 1.499 . . . . 0.0 107.861 -171.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.5 t -136.42 120.3 17.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.463 1.601 . . . . 0.0 110.786 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.67 -147.71 42.31 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 124.746 1.165 . . . . 0.0 113.695 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.88 38.39 6.92 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 121.997 0.776 . . . . 0.0 112.346 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.2 m -80.95 -112.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 126.219 1.808 . . . . 0.0 113.318 -169.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -71.7 -51.91 20.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.876 -1.765 . . . . 0.0 111.482 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -151.45 153.4 34.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.1 t -154.6 -69.14 0.13 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.286 -0.884 . . . . 0.0 112.134 -175.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.9 t -91.97 -61.44 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 120.494 -1.379 . . . . 0.0 112.682 -163.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -124.93 -71.03 0.72 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.049 1.34 . . . . 0.0 111.78 -161.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -141.71 39.54 1.68 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.7 -144.48 17.96 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 -157.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.69 158.68 33.31 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.401 -1.058 . . . . 0.0 113.197 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 mm -126.36 145.28 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -125.94 138.7 53.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.084 -1.01 . . . . 0.0 111.715 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.7 t -85.83 127.72 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 124.937 1.295 . . . . 0.0 111.799 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -83.4 -63.72 1.3 Allowed 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 125.195 1.398 . . . . 0.0 111.175 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.09 171.64 5.71 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.816 0.846 . . . . 0.0 109.083 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.38 139.19 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.312 1.045 . . . . 0.0 111.737 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.1 mm -85.79 109.65 23.97 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 119.938 -1.726 . . . . 0.0 108.647 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -82.46 57.24 6.05 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 123.361 2.707 . . . . 0.0 114.14 -163.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -141.16 22.28 2.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.028 1.331 . . . . 0.0 110.427 -174.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.25 -160.91 19.79 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 120.179 -1.576 . . . . 0.0 115.044 -173.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.4 -45.57 88.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.893 2.077 . . . . 0.0 115.574 -166.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.08 79.04 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -77.63 -41.75 37.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.416 1.086 . . . . 0.0 111.948 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.8 t -70.14 -46.57 64.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -82.14 -61.52 1.88 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.723 -1.236 . . . . 0.0 111.684 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.64 99.42 1.08 Allowed Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.195 -0.941 . . . . 0.0 114.923 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -138.56 -37.15 0.55 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.97 -1.312 . . . . 0.0 110.929 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.6 mt -127.47 134.58 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -170.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -119.86 -176.68 3.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.842 -1.161 . . . . 0.0 113.523 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -55.2 127.88 31.3 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.97 1.708 . . . . 0.0 114.846 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.37 11.17 84.41 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.18 156.1 39.96 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.059 1.429 . . . . 0.0 111.576 169.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -123.76 102.06 7.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.134 -0.978 . . . . 0.0 109.772 -167.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -80.2 132.73 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.666 -1.271 . . . . 0.0 111.169 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.1 mt -122.04 -74.07 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.69 -1.256 . . . . 0.0 110.958 -170.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.35 151.67 20.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.7 t -113.65 101.18 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.611 1.965 . . . . 0.0 107.397 173.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.312 16.3 t-20 56.56 48.39 16.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.518 1.927 . . . . 0.0 113.536 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.73 -14.09 57.01 Favored Glycine 0 N--CA 1.43 -1.761 0 O-C-N 120.035 -1.666 . . . . 0.0 114.894 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 t -100.93 117.34 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 120.989 -1.301 . . . . 0.0 109.992 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -79.15 144.14 34.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.504 -1.372 . . . . 0.0 113.449 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mp -93.42 44.93 1.15 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.022 1.391 . . . . 0.0 112.517 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.89 114.41 6.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.096 -1.627 . . . . 0.0 112.824 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.08 7.89 73.01 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 120.817 -1.177 . . . . 0.0 113.875 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.5 143.03 38.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.013 -1.287 . . . . 0.0 110.871 168.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.2 p -90.33 176.07 6.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.349 -1.47 . . . . 0.0 110.285 165.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.593 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 47.9 t60 -59.62 -38.41 81.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -175.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -52.98 -41.6 64.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.519 -1.363 . . . . 0.0 113.768 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -71.23 -35.98 71.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.882 1.273 . . . . 0.0 112.356 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.82 84.57 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.455 -1.403 . . . . 0.0 113.908 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.23 -42.53 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 124.954 1.302 . . . . 0.0 112.07 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -61.08 -37.39 82.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.313 -1.492 . . . . 0.0 112.845 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.3 p -70.45 -22.96 62.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 171.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 mt -79.23 -40.84 29.68 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.998 -1.689 . . . . 0.0 112.739 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -63.78 -43.39 96.47 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.882 -1.137 . . . . 0.0 111.217 173.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -93.5 58.98 2.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.189 -1.57 . . . . 0.0 112.469 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 p -88.45 -72.46 0.54 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.708 1.203 . . . . 0.0 108.516 166.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.96 -128.26 8.04 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -76.67 -46.73 24.57 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.03 148.87 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 124.714 1.206 . . . . 0.0 112.351 -170.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.33 116.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 127.175 2.19 . . . . 0.0 108.652 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -117.62 115.35 24.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.252 -1.53 . . . . 0.0 107.316 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -144.03 157.95 44.01 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.985 -1.072 . . . . 0.0 112.705 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mp -122.11 134.58 54.75 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.985 0.914 . . . . 0.0 109.114 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.34 170.1 13.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.959 1.304 . . . . 0.0 109.879 -169.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -116.4 135.38 53.9 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 158.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -74.73 131.46 40.86 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.4 -111.17 0.62 Allowed Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 125.99 1.757 . . . . 0.0 116.726 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -77.42 154.25 32.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.971 -1.311 . . . . 0.0 114.536 -166.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 74.3 m -94.54 138.06 22.43 Favored Pre-proline 0 N--CA 1.431 -1.414 0 O-C-N 120.712 -1.243 . . . . 0.0 109.197 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -70.83 -47.14 0.64 Allowed 'Trans proline' 0 C--N 1.3 -1.982 0 CA-C-N 122.769 2.025 . . . . 0.0 114.377 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 C--O 1.261 1.663 0 C-N-CA 125.973 1.709 . . . . 0.0 109.678 -172.107 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.0 178.56 7.21 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -166.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 66.08 20.43 11.21 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 127.653 2.381 . . . . 0.0 114.759 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -106.31 -81.68 0.54 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.39 -1.444 . . . . 0.0 110.943 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -83.53 -79.51 0.2 Allowed 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 120.321 -1.487 . . . . 0.0 112.556 -173.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.93 163.66 18.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.95 -97.27 0.06 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.44 -0.787 . . . . 0.0 111.13 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.74 142.96 43.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.544 -1.348 . . . . 0.0 110.703 -174.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . 0.254 16.4 p30 -110.38 -54.84 2.54 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -173.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -121.57 138.08 54.46 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.463 -2.023 . . . . 0.0 112.021 -169.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -154.97 -132.21 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.402 -0.811 . . . . 0.0 112.006 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.22 171.46 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.335 2.254 . . . . 0.0 105.215 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' SER . . . . . 0.593 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 9.7 p -144.66 141.84 29.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.62 -1.925 . . . . 0.0 115.141 175.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.87 133.4 49.34 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.94 1.696 . . . . 0.0 111.428 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.261 1.67 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.148 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 CA--C 1.489 -1.735 0 N-CA-C 108.455 -1.402 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.2 pttp -92.33 157.03 41.16 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 117.641 -1.171 . . . . 0.0 111.109 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -77.17 -21.25 12.16 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 123.598 2.321 . . . . 0.0 113.888 -171.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.34 64.03 2.3 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 119.824 1.193 . . . . 0.0 111.454 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -82.18 171.06 14.73 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.6 130.44 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 167.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -133.73 166.53 22.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.227 1.013 . . . . 0.0 111.311 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -125.16 136.74 53.89 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.238 1.015 . . . . 0.0 109.293 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.9 m -102.06 135.59 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.707 -1.246 . . . . 0.0 108.849 173.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -126.04 87.36 2.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.26 1.024 . . . . 0.0 109.796 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 tp -134.51 -174.38 3.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.654 -1.279 . . . . 0.0 110.311 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.64 165.64 24.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.325 -1.484 . . . . 0.0 107.642 174.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -71.92 121.46 19.11 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.236 1.017 . . . . 0.0 111.786 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -107.5 -92.04 0.41 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.486 1.514 . . . . 0.0 107.755 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -78.78 -41.64 29.94 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.139 1.376 . . . . 0.0 109.997 163.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.8 161.51 37.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 123.81 0.844 . . . . 0.0 110.403 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -83.49 -68.37 0.72 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.439 1.095 . . . . 0.0 110.521 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.77 -79.15 0.52 Allowed 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.821 -1.174 . . . . 0.0 111.101 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.68 50.25 4.27 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 124.576 1.084 . . . . 0.0 113.475 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 tt -138.43 -178.61 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 121.617 -0.931 . . . . 0.0 109.579 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.0 p -127.4 142.47 51.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.842 -2.411 . . . . 0.0 110.31 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 t -123.77 155.82 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 123.855 0.862 . . . . 0.0 111.464 -163.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 t -137.02 141.93 42.5 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.255 -1.528 . . . . 0.0 108.707 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.1 -175.84 50.3 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 116.476 1.351 . . . . 0.0 116.476 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.95 44.05 0.97 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 121.865 -0.785 . . . . 0.0 112.823 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.402 ' CG1' ' H ' ' A' ' 27' ' ' ASN . 25.8 t -80.78 176.66 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.69 -1.476 . . . . 0.0 108.847 174.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.402 ' H ' ' CG1' ' A' ' 26' ' ' VAL . 5.8 p30 -69.07 -24.78 64.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.377 -2.077 . . . . 0.0 114.814 -160.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.6 t -135.15 133.33 39.04 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 150.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.9 p -155.81 -86.4 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.685 -1.259 . . . . 0.0 112.639 -165.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.13 -48.02 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 126.825 2.05 . . . . 0.0 109.062 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -129.02 -154.47 0.64 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 159.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.33 70.29 9.24 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.234 -2.166 . . . . 0.0 111.389 164.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.63 -171.87 13.95 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 108.118 -1.993 . . . . 0.0 108.118 -166.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.09 136.0 7.96 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -172.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.9 mm -127.21 149.41 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -170.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.92 139.49 53.78 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.924 -1.735 . . . . 0.0 111.225 -169.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.7 t -81.98 126.12 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 120.275 -1.516 . . . . 0.0 111.313 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -87.6 -70.12 0.65 Allowed 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.653 -1.279 . . . . 0.0 111.051 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.8 159.97 38.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.277 -0.89 . . . . 0.0 110.101 -171.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 p -103.09 132.6 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.93 1.347 . . . . 0.0 112.221 -170.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.6 mm -83.7 119.42 73.65 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 120.149 -1.594 . . . . 0.0 110.163 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -81.05 58.97 7.26 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 124.393 2.605 . . . . 0.0 112.966 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -141.39 -0.42 1.41 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.296 1.038 . . . . 0.0 112.094 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.36 -172.75 30.19 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.27 -1.518 . . . . 0.0 115.477 -170.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.3 -50.61 2.01 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.696 3.198 . . . . 0.0 118.159 -171.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.1 -45.34 68.19 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.213 1.405 . . . . 0.0 114.76 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -80.59 -52.66 7.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.958 1.303 . . . . 0.0 110.826 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.5 m -62.5 -38.48 90.04 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -172.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.3 -52.44 6.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.914 -1.116 . . . . 0.0 110.117 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.62 84.94 1.47 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 121.14 -0.975 . . . . 0.0 113.589 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -138.99 -21.82 0.95 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.19 149.58 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -119.64 172.57 7.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.592 -1.317 . . . . 0.0 111.702 177.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -56.54 138.73 51.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.43 22.11 76.24 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 116.905 1.522 . . . . 0.0 116.905 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.58 166.49 19.19 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 118.915 1.358 . . . . 0.0 111.693 169.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -124.1 105.43 9.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.748 -1.22 . . . . 0.0 110.25 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 m -93.74 141.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 120.459 -1.401 . . . . 0.0 111.519 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.24 -87.25 0.56 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 111.253 -166.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.63 153.84 20.02 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.591 -1.943 . . . . 0.0 112.903 -172.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 63.8 t -116.41 108.53 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.256 9.1 t-20 56.25 50.15 13.92 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 126.03 1.732 . . . . 0.0 113.76 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.5 -29.42 6.72 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.659 -1.276 . . . . 0.0 114.774 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.2 t -88.06 99.03 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.586 -1.538 . . . . 0.0 111.209 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -78.59 99.56 6.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.302 1.041 . . . . 0.0 110.514 167.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.03 92.91 7.08 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.07 1.414 . . . . 0.0 109.591 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 67' ' ' GLU . 6.1 pt-20 -67.59 129.97 41.56 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.383 1.473 . . . . 0.0 112.644 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.48 -6.24 74.6 Favored Glycine 0 N--CA 1.429 -1.795 0 O-C-N 121.001 -1.062 . . . . 0.0 114.565 -174.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.99 133.27 40.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 119.595 1.698 . . . . 0.0 114.041 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.3 p -84.31 177.86 8.0 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.258 1.423 . . . . 0.0 112.613 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -56.94 -45.41 82.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.322 2.249 . . . . 0.0 113.942 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -58.39 -43.31 88.5 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 172.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -70.37 -39.21 74.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.761 -1.212 . . . . 0.0 111.995 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.41 67.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.666 1.186 . . . . 0.0 113.393 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.47 -35.99 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 120.291 -1.506 . . . . 0.0 113.076 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -58.24 -47.08 84.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.141 -1.599 . . . . 0.0 113.72 168.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.4 m -63.23 -36.25 83.02 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.823 1.649 . . . . 0.0 113.141 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 74.4 mt -78.89 -35.84 42.99 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 120.114 -1.616 . . . . 0.0 113.462 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -67.31 -28.16 67.76 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.961 -1.712 . . . . 0.0 112.639 172.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -90.93 48.81 1.56 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.18 -1.575 . . . . 0.0 112.78 172.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.74 -70.4 0.6 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.507 1.523 . . . . 0.0 109.766 173.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.13 -87.33 1.2 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 121.238 -0.914 . . . . 0.0 112.603 170.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -83.93 -61.4 1.83 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.216 -1.167 . . . . 0.0 113.753 173.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.74 142.51 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 122.22 1.01 . . . . 0.0 113.233 -164.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.9 t -121.05 92.39 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 125.408 1.483 . . . . 0.0 107.543 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -126.57 98.39 5.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.567 -1.333 . . . . 0.0 111.18 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.9 mt -127.35 154.22 45.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.81 -1.181 . . . . 0.0 111.409 -162.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -120.79 134.0 55.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.623 1.169 . . . . 0.0 109.047 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.07 153.06 37.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.534 0.683 . . . . 0.0 111.356 -171.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -112.19 120.96 43.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.822 1.649 . . . . 0.0 109.992 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -54.1 135.55 43.26 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -165.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.39 169.81 54.89 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 126.165 1.84 . . . . 0.0 115.611 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -95.92 176.83 5.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.072 1.349 . . . . 0.0 112.797 -170.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 t -85.06 136.63 38.12 Favored Pre-proline 0 N--CA 1.43 -1.458 0 O-C-N 120.815 -1.178 . . . . 0.0 111.793 -175.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.62 176.59 9.86 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 122.197 1.931 . . . . 0.0 112.619 160.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 C--O 1.26 1.636 0 C-N-CA 125.679 1.592 . . . . 0.0 110.687 175.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.57 -70.98 0.69 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 84.18 86.72 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.615 2.766 . . . . 0.0 111.207 -172.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.4 m -131.96 161.64 32.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.72 -1.238 . . . . 0.0 112.749 -166.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 178.24 4.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 124.498 1.119 . . . . 0.0 109.726 164.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.61 112.27 24.78 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -167.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -92.49 82.56 4.87 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.837 -1.789 . . . . 0.0 110.764 172.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . 0.25 37.5 mt-10 63.09 -171.34 0.17 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -105.84 121.49 44.18 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.779 -1.826 . . . . 0.0 111.301 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -123.25 111.66 16.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 170.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.55 -148.97 0.32 Allowed 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.329 -1.482 . . . . 0.0 112.982 -165.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 t -122.56 149.09 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.364 1.866 . . . . 0.0 106.789 -173.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -138.33 166.83 23.22 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.273 -1.517 . . . . 0.0 112.58 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.88 147.12 50.79 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.614 1.966 . . . . 0.0 109.735 162.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.26 1.647 0 C-N-CA 127.4 2.28 . . . . 0.0 105.299 170.037 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 CA--C 1.49 -1.683 0 N-CA-C 108.399 -1.423 . . . . 0.0 108.399 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -77.22 164.57 57.82 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 118.112 -0.947 . . . . 0.0 111.533 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -75.57 -25.66 10.79 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 124.141 2.515 . . . . 0.0 113.3 -168.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.56 69.86 0.26 Allowed Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 171.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -83.55 165.42 19.09 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.4 mt -81.37 131.86 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 122.182 0.992 . . . . 0.0 111.524 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -136.98 168.93 18.65 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.711 -1.243 . . . . 0.0 109.847 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -122.49 137.52 54.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.766 0.826 . . . . 0.0 111.003 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.6 m -103.98 143.75 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 124.395 1.078 . . . . 0.0 111.716 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -127.9 106.68 9.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.652 1.181 . . . . 0.0 109.159 -170.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.1 mt -129.69 159.39 36.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.997 -1.689 . . . . 0.0 110.657 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.66 164.44 27.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 160.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -72.25 114.18 10.08 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.437 -1.414 . . . . 0.0 113.933 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -101.9 -70.89 0.73 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 162.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.43 -74.69 0.43 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.362 1.865 . . . . 0.0 110.789 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -136.49 148.76 47.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -165.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.1 m -80.83 -62.82 1.55 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.924 -1.735 . . . . 0.0 113.268 -159.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.8 mp -101.52 -86.09 0.42 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.886 -1.134 . . . . 0.0 111.001 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.2 45.71 2.53 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.638 -1.289 . . . . 0.0 115.338 171.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.65 172.33 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 120.696 -1.473 . . . . 0.0 109.032 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.7 p -121.16 145.05 48.23 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.723 -1.861 . . . . 0.0 108.539 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.07 154.3 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 125.757 1.623 . . . . 0.0 108.073 -165.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.6 t -139.0 161.36 37.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 169.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.03 -132.38 15.18 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.635 -1.29 . . . . 0.0 114.335 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.97 0.81 89.0 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 120.708 -1.466 . . . . 0.0 115.899 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.0 t -73.69 166.93 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.156 2.182 . . . . 0.0 110.901 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -69.77 -15.35 63.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.383 1.873 . . . . 0.0 115.429 -164.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.5 t -134.99 118.0 16.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.507 -1.996 . . . . 0.0 107.084 148.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 p -146.87 -83.25 0.12 Allowed 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.878 -1.139 . . . . 0.0 109.445 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.61 -51.14 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 126.62 1.968 . . . . 0.0 110.245 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -130.35 -158.05 0.86 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 161.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.38 56.71 1.79 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.406 -2.059 . . . . 0.0 112.851 165.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.34 168.69 12.4 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 126.412 1.958 . . . . 0.0 110.423 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.91 152.31 24.76 Favored Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 125.099 1.333 . . . . 0.0 111.079 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.2 mm -126.47 149.17 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 121.097 -1.237 . . . . 0.0 109.501 -161.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.65 137.12 53.85 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.358 -1.463 . . . . 0.0 109.64 -172.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.7 t -86.02 132.94 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.441 -1.412 . . . . 0.0 112.104 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -87.76 -70.08 0.65 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.569 -1.332 . . . . 0.0 110.875 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.81 163.29 40.01 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 122.157 0.979 . . . . 0.0 111.112 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.8 p -88.27 130.06 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.424 0 C-N-CA 124.925 1.29 . . . . 0.0 111.642 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mm -84.45 118.83 72.05 Favored Pre-proline 0 N--CA 1.43 -1.471 0 O-C-N 120.201 -1.562 . . . . 0.0 109.256 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.39 45.28 1.68 Allowed 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 124.715 2.72 . . . . 0.0 113.061 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -143.02 34.41 1.36 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.146 0.978 . . . . 0.0 109.217 -171.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.19 -172.69 39.62 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 119.938 -1.726 . . . . 0.0 113.105 -171.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.54 -35.83 78.86 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.951 1.7 . . . . 0.0 114.598 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.98 -49.17 69.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.16 -53.51 36.73 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.37 1.868 . . . . 0.0 112.079 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.6 m -66.27 -29.31 69.51 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.58 -53.93 6.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.91 1.684 . . . . 0.0 111.967 170.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.71 65.98 1.67 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 120.393 -1.442 . . . . 0.0 114.173 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -138.34 -13.74 1.33 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.01 -1.288 . . . . 0.0 113.232 -166.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.04 144.68 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -121.23 -177.62 3.56 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 122.998 1.38 . . . . 0.0 111.473 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.9 pttt -58.56 132.84 54.98 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.183 -1.573 . . . . 0.0 114.707 168.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.49 12.59 84.38 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 117.807 1.883 . . . . 0.0 117.807 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -74.08 160.86 30.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.352 1.576 . . . . 0.0 110.747 167.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ttm-85 -122.89 106.47 10.9 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.591 -1.318 . . . . 0.0 109.427 -166.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 m -102.42 126.37 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.313 1.53 . . . . 0.0 111.134 -166.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.04 -88.52 0.62 Allowed 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.085 -1.635 . . . . 0.0 112.172 -160.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.54 134.71 33.99 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 121.107 -0.996 . . . . 0.0 112.564 -166.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.58 105.24 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.85 -1.156 . . . . 0.0 108.879 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.264 1.4 t-20 55.92 43.09 27.99 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.093 2.157 . . . . 0.0 113.337 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.69 -28.39 15.73 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 124.469 1.033 . . . . 0.0 113.635 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.4 t -84.18 109.14 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 124.451 1.1 . . . . 0.0 113.122 -166.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -78.52 98.61 6.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.053 1.341 . . . . 0.0 110.435 172.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.39 75.21 1.6 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.151 1.453 . . . . 0.0 109.674 -170.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.42 143.67 54.98 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.687 -1.883 . . . . 0.0 112.986 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.16 7.37 65.72 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.478 -1.389 . . . . 0.0 114.668 -175.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.79 147.03 37.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.584 -1.539 . . . . 0.0 113.709 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 p -93.09 170.57 9.54 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.739 1.616 . . . . 0.0 109.494 166.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -60.79 -41.67 96.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.815 -1.178 . . . . 0.0 112.761 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -49.07 -51.32 32.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.815 1.646 . . . . 0.0 114.84 168.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -70.77 -36.19 72.95 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.23 -1.544 . . . . 0.0 112.826 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.09 98.19 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.017 -1.677 . . . . 0.0 113.433 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.0 t -67.66 -43.73 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 C-N-CA 125.35 1.46 . . . . 0.0 111.914 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.88 -12.91 60.81 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 120.251 -1.53 . . . . 0.0 114.195 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.4 m -71.17 -57.65 4.3 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.993 -2.317 . . . . 0.0 110.214 171.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.8 -20.45 42.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -72.5 -23.23 60.99 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.831 -1.793 . . . . 0.0 112.795 166.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -90.64 52.82 2.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 119.502 -1.999 . . . . 0.0 111.865 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.2 p -109.04 -94.06 0.41 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.893 1.677 . . . . 0.0 110.478 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.02 -59.86 0.57 Allowed Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 124.825 1.202 . . . . 0.0 112.565 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -84.68 -77.17 0.28 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.957 -1.32 . . . . 0.0 114.097 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.84 143.2 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.818 1.647 . . . . 0.0 111.445 -161.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.4 t -126.5 128.97 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.93 1.692 . . . . 0.0 109.941 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -143.02 115.21 8.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.662 -1.899 . . . . 0.0 109.763 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.3 mt -128.2 153.77 46.54 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.587 -1.321 . . . . 0.0 111.306 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.8 130.9 55.15 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.65 151.56 37.45 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -103.6 134.59 46.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -74.99 137.64 41.69 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.655 -1.278 . . . . 0.0 114.398 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.99 -174.93 50.1 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 122.889 1.272 . . . . 0.0 116.201 -167.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -80.22 159.59 25.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.308 -1.113 . . . . 0.0 112.845 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.2 t -68.08 134.23 91.68 Favored Pre-proline 0 N--CA 1.43 -1.472 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -170.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.69 167.28 27.57 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 122.417 2.078 . . . . 0.0 113.133 172.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.2 p . . . . . 0 C--O 1.259 1.586 0 C-N-CA 127.049 2.139 . . . . 0.0 112.854 -163.001 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.46 -40.49 13.43 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.226 -1.546 . . . . 0.0 114.133 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 59.45 51.19 6.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.135 1.774 . . . . 0.0 113.813 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 71.2 m -109.97 172.78 6.66 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.483 1.513 . . . . 0.0 109.57 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -74.65 -173.94 1.96 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.794 -1.191 . . . . 0.0 111.687 172.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.61 135.41 36.58 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.238 -2.164 . . . . 0.0 113.535 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -116.9 74.77 0.93 Allowed 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 124.071 0.948 . . . . 0.0 108.863 170.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 44.23 -152.24 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.289 2.636 . . . . 0.0 116.748 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -135.37 142.88 45.81 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.522 -1.986 . . . . 0.0 107.838 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -122.95 102.69 8.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -123.54 -169.19 1.9 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.645 1.178 . . . . 0.0 112.384 -170.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.9 t -120.05 138.93 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.591 -1.318 . . . . 0.0 109.873 -152.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 13.9 m -128.21 157.42 40.89 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.802 -1.186 . . . . 0.0 112.666 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.27 154.74 45.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.061 -1.025 . . . . 0.0 110.095 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.259 1.578 0 C-N-CA 125.378 1.471 . . . . 0.0 107.45 169.413 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.491 -1.662 0 N-CA-C 109.338 -1.062 . . . . 0.0 109.338 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -77.33 162.85 67.63 Favored Pre-proline 0 N--CA 1.43 -1.431 0 CA-C-O 117.561 -1.209 . . . . 0.0 110.663 172.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -74.33 -15.1 22.71 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 124.313 2.576 . . . . 0.0 113.691 -169.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.51 71.6 0.23 Allowed Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 123.886 0.755 . . . . 0.0 111.538 166.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -82.89 171.68 13.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.3 mp -89.14 132.43 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.38 -1.45 . . . . 0.0 110.968 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.439 ' CE1' ' HG ' ' A' ' 89' ' ' LEU . 7.3 p90 -133.16 161.73 33.65 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.751 -1.218 . . . . 0.0 111.834 177.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -109.91 134.62 51.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 124.86 1.264 . . . . 0.0 110.924 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -103.18 149.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.503 -1.373 . . . . 0.0 111.21 163.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.9 105.89 8.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 167.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.2 tp -134.43 -179.32 5.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.875 -1.141 . . . . 0.0 108.402 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.61 172.67 12.39 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 120.16 -1.587 . . . . 0.0 109.906 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -71.9 111.97 7.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.598 1.559 . . . . 0.0 110.889 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -113.71 -83.28 0.6 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.377 1.071 . . . . 0.0 110.176 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -82.86 -47.42 11.86 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.768 -1.208 . . . . 0.0 109.513 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -137.6 -172.69 3.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 167.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 t -83.85 -72.55 0.46 Allowed 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.916 -1.115 . . . . 0.0 111.452 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.38 -84.4 0.45 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.963 -1.086 . . . . 0.0 110.379 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.82 54.34 0.68 Allowed Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 116.175 1.23 . . . . 0.0 116.175 170.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.65 174.12 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 119.195 1.498 . . . . 0.0 112.437 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.8 p -122.63 135.91 54.74 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.152 1.381 . . . . 0.0 109.545 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -123.36 142.7 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.497 1.519 . . . . 0.0 110.634 -163.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.1 t -136.4 111.3 8.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.653 1.692 . . . . 0.0 111.589 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -134.15 11.86 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 125.242 1.401 . . . . 0.0 111.503 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.1 23.39 32.44 Favored Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.84 -127.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 121.018 -1.284 . . . . 0.0 113.11 -172.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -79.38 -44.25 21.86 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.073 -1.642 . . . . 0.0 112.75 -164.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -151.98 103.19 2.88 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 166.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.9 p -134.71 -75.94 0.46 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.327 -1.483 . . . . 0.0 110.44 -172.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.16 -54.84 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 124.704 1.202 . . . . 0.0 110.272 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -134.18 -164.12 1.46 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.03 78.39 3.57 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.911 -1.743 . . . . 0.0 111.508 166.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.75 -177.4 21.19 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -166.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.48 148.6 12.45 Favored Glycine 0 N--CA 1.431 -1.687 0 O-C-N 121.458 -1.025 . . . . 0.0 111.119 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.9 mm -127.23 142.31 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -171.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.44 130.91 53.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.69 -1.256 . . . . 0.0 109.589 -169.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.3 t -84.22 134.94 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 124.38 1.072 . . . . 0.0 111.438 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -88.83 -59.26 2.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.31 1.444 . . . . 0.0 111.199 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.9 159.49 29.75 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 123.575 0.75 . . . . 0.0 111.463 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 p -91.59 128.15 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 122.586 1.184 . . . . 0.0 113.017 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.2 mm -84.45 131.69 49.42 Favored Pre-proline 0 N--CA 1.43 -1.458 0 C-N-CA 126.175 1.79 . . . . 0.0 110.866 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.36 41.64 1.17 Allowed 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 123.546 2.831 . . . . 0.0 114.593 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -147.48 66.34 1.13 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.664 1.585 . . . . 0.0 107.235 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.74 175.79 46.34 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 119.69 -1.881 . . . . 0.0 115.438 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.15 -34.93 78.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.305 1.042 . . . . 0.0 112.275 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.37 -56.02 24.92 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.744 1.618 . . . . 0.0 113.936 175.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.61 -47.16 67.39 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.044 -1.035 . . . . 0.0 112.372 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.3 m -60.18 -47.77 84.56 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.68 -51.9 30.45 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.562 -1.336 . . . . 0.0 112.538 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.07 78.62 0.95 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 120.82 -1.175 . . . . 0.0 111.575 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.6 ttt85 -138.82 -34.61 0.6 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.956 -0.731 . . . . 0.0 112.315 -158.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 mt -128.9 170.25 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -140.95 -177.8 5.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.293 -2.754 . . . . 0.0 112.036 165.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.45 143.05 30.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.774 -1.829 . . . . 0.0 113.743 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.87 8.15 81.98 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 117.576 1.79 . . . . 0.0 117.576 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -80.77 154.69 27.07 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 119.274 1.537 . . . . 0.0 109.157 163.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -137.05 128.66 28.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.976 -1.703 . . . . 0.0 112.39 -164.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.0 m -80.13 162.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.972 -1.705 . . . . 0.0 115.292 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 mp -119.88 -86.68 0.65 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.23 1.812 . . . . 0.0 106.981 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 160.49 14.25 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -170.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.1 t -108.78 98.54 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.49 1.516 . . . . 0.0 107.108 165.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 56.38 54.51 7.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.671 1.588 . . . . 0.0 114.233 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.7 -32.02 4.39 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.434 -1.416 . . . . 0.0 114.18 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.91 121.82 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 124.627 1.171 . . . . 0.0 112.254 -171.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.1 m -77.72 133.59 38.28 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 120.632 -1.293 . . . . 0.0 112.216 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.49 63.3 7.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.506 -1.371 . . . . 0.0 109.677 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.52 104.0 1.17 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.029 1.731 . . . . 0.0 114.417 -168.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.08 29.26 74.62 Favored Glycine 0 N--CA 1.429 -1.775 0 O-C-N 120.43 -1.418 . . . . 0.0 114.888 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.2 158.15 30.5 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.229 1.412 . . . . 0.0 114.203 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 p -80.8 162.06 24.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.809 -1.182 . . . . 0.0 111.589 167.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -60.87 -42.25 97.52 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.365 1.466 . . . . 0.0 111.586 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -47.03 -46.07 21.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.266 1.826 . . . . 0.0 114.747 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -71.52 -38.69 71.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.288 -1.507 . . . . 0.0 113.436 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.7 96.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.965 -1.085 . . . . 0.0 113.412 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.66 -47.3 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 126.391 1.876 . . . . 0.0 112.772 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -54.51 -43.64 72.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.753 -1.217 . . . . 0.0 113.332 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.1 m -62.56 -50.3 71.88 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.128 1.771 . . . . 0.0 112.724 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.69 -12.27 59.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.955 -1.716 . . . . 0.0 115.594 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.31 -30.7 57.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.553 -1.967 . . . . 0.0 112.214 167.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -100.47 65.64 1.21 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.189 -1.569 . . . . 0.0 114.591 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.5 p -92.74 -68.24 0.81 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.157 -1.589 . . . . 0.0 112.091 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.66 -127.83 7.43 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 125.581 1.562 . . . . 0.0 110.76 -172.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -83.35 -45.65 13.5 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 p -115.4 145.46 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 121.287 -0.883 . . . . 0.0 113.286 -166.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.8 t -124.96 112.5 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.215 1.806 . . . . 0.0 110.48 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -120.46 110.91 17.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.244 -1.535 . . . . 0.0 110.412 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.4 mt -131.99 151.73 51.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.696 -1.252 . . . . 0.0 111.157 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.84 128.15 52.57 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.439 ' HG ' ' CE1' ' A' ' 7' ' ' PHE . 1.6 pt? -147.48 157.19 43.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.886 0.85 . . . . 0.0 111.262 -171.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -109.21 137.28 47.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.618 1.167 . . . . 0.0 109.069 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.28 130.4 41.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.487 1.136 . . . . 0.0 112.075 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.57 171.51 49.58 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 125.867 1.699 . . . . 0.0 114.645 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -92.01 -177.94 4.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -170.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.9 t -78.82 139.58 58.0 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 120.375 -1.453 . . . . 0.0 114.219 -163.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -68.32 160.55 48.54 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 C-N-CA 122.685 2.257 . . . . 0.0 112.421 159.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.26 1.653 0 C-N-CA 124.484 1.114 . . . . 0.0 112.037 -173.51 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 119.653 -0.213 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.49 -69.26 0.65 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . 0.276 40.7 m-20 49.78 45.39 24.74 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.135 2.174 . . . . 0.0 114.797 -166.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.0 m -100.52 179.45 4.43 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.9 1.68 . . . . 0.0 109.795 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -90.62 164.18 14.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.551 -1.343 . . . . 0.0 110.843 164.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.38 139.84 33.82 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.952 -1.093 . . . . 0.0 112.898 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -88.63 83.4 6.76 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 166.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . 0.345 15.1 tt0 42.93 -112.79 0.22 Allowed 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.714 2.406 . . . . 0.0 116.618 -168.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -144.12 149.33 36.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.57 -1.331 . . . . 0.0 112.656 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -126.05 133.32 51.74 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.594 1.558 . . . . 0.0 109.18 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -151.87 -157.75 0.83 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.941 -1.099 . . . . 0.0 112.14 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -121.67 136.43 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.012 1.725 . . . . 0.0 106.735 -170.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.2 m -128.37 167.95 16.25 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 120.579 -1.325 . . . . 0.0 111.427 -172.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.34 134.14 16.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 123.032 0.533 . . . . 0.0 110.337 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--O 1.259 1.593 0 C-N-CA 126.667 1.987 . . . . 0.0 108.45 172.572 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.718 0 N-CA-C 110.591 -0.58 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -77.29 163.37 64.99 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-O 117.814 -1.089 . . . . 0.0 110.453 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.03 -14.61 32.18 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 CA-C-N 123.498 2.285 . . . . 0.0 113.798 -169.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.32 81.48 0.34 Allowed Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 165.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -82.73 -177.1 6.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.78 133.83 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.23 1.412 . . . . 0.0 109.712 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -132.81 158.67 41.89 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.105 -1.622 . . . . 0.0 111.339 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -117.68 140.2 49.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.147 0.975 . . . . 0.0 110.961 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.08 142.99 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.865 -1.147 . . . . 0.0 109.47 166.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -128.55 76.3 1.7 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 tp -113.35 171.1 7.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.564 -1.335 . . . . 0.0 110.505 -167.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.27 161.34 39.83 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.358 -1.464 . . . . 0.0 109.033 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -68.35 112.97 5.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.98 -1.075 . . . . 0.0 112.762 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -115.04 -78.98 0.58 Allowed 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 124.977 1.311 . . . . 0.0 109.743 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -82.38 -43.91 16.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.494 -1.379 . . . . 0.0 110.417 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -143.3 -177.63 5.46 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.752 1.221 . . . . 0.0 107.726 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.3 t -83.29 -83.14 0.14 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 124.726 1.211 . . . . 0.0 108.901 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.1 mp -101.85 -99.9 0.27 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.168 -0.957 . . . . 0.0 108.865 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.39 60.08 0.79 Allowed Glycine 0 N--CA 1.43 -1.74 0 O-C-N 120.276 -1.515 . . . . 0.0 115.313 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.52 175.09 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 121.284 -1.127 . . . . 0.0 108.028 170.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.2 p -121.31 145.53 47.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.542 -1.974 . . . . 0.0 108.663 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.6 t -123.76 167.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.247 1.419 . . . . 0.0 107.409 -168.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.9 t -136.99 67.59 1.44 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.314 2.007 . . . . 0.0 108.714 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.83 -137.17 18.32 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 120.237 -1.539 . . . . 0.0 112.513 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.9 93.9 1.47 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -166.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.29 -113.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 121.793 -0.827 . . . . 0.0 111.08 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -93.3 -62.69 1.32 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.725 -1.234 . . . . 0.0 111.36 -165.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 t -134.24 97.98 3.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.212 1.482 . . . . 0.0 108.52 166.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.2 p -134.64 -84.08 0.42 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.841 -1.162 . . . . 0.0 111.14 -162.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.13 -51.37 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 125.807 1.643 . . . . 0.0 110.154 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -138.17 -166.22 1.94 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 158.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.67 66.89 9.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.135 -1.603 . . . . 0.0 111.286 168.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.64 141.31 5.67 Favored Glycine 0 N--CA 1.429 -1.784 0 O-C-N 120.877 -1.14 . . . . 0.0 110.868 -171.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.8 155.17 26.16 Favored Glycine 0 N--CA 1.43 -1.72 0 O-C-N 121.488 -1.007 . . . . 0.0 111.946 -170.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.1 mm -133.44 152.33 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 124.821 1.248 . . . . 0.0 108.784 -164.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.85 124.76 43.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.158 -1.589 . . . . 0.0 110.66 -168.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.5 t -74.05 135.34 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.27 -1.519 . . . . 0.0 112.744 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -91.93 -68.01 0.82 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.921 -1.112 . . . . 0.0 112.372 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.89 157.69 35.32 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.162 -0.961 . . . . 0.0 109.914 -173.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.4 p -88.35 131.93 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.716 1.246 . . . . 0.0 113.167 -175.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.4 mm -84.61 126.15 69.54 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 117.514 -1.232 . . . . 0.0 108.315 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -81.5 34.93 0.56 Allowed 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 123.351 2.701 . . . . 0.0 113.797 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -144.84 64.1 1.29 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.661 1.984 . . . . 0.0 107.078 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.37 174.39 46.02 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 120.565 -1.334 . . . . 0.0 112.589 -177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.67 82.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.747 1.619 . . . . 0.0 113.432 -174.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.02 -49.2 66.75 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.063 1.745 . . . . 0.0 114.897 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.46 -35.69 34.56 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 124.092 0.957 . . . . 0.0 112.554 176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.8 m -59.38 -51.51 69.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.971 -1.706 . . . . 0.0 114.018 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.3 -41.03 42.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 111.115 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.79 66.63 1.45 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 120.623 -1.298 . . . . 0.0 111.628 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 ttt85 -137.59 -20.86 1.16 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -160.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.52 154.21 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -139.95 178.87 6.96 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.965 -1.709 . . . . 0.0 111.14 171.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.84 138.06 56.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.94 19.5 79.91 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 116.964 1.546 . . . . 0.0 116.964 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -83.1 162.04 21.45 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 119.173 1.487 . . . . 0.0 109.41 164.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.9 ttm105 -127.59 123.98 37.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.964 -1.71 . . . . 0.0 110.353 -171.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.6 m -93.71 147.5 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.442 -1.411 . . . . 0.0 111.728 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.4 -88.67 0.62 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 123.923 0.889 . . . . 0.0 109.823 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.8 148.03 22.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.893 -1.754 . . . . 0.0 114.498 -169.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -109.83 88.64 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.32 1.448 . . . . 0.0 109.647 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 57.14 60.14 3.1 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.062 1.745 . . . . 0.0 114.946 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.47 -36.57 3.8 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 124.422 1.011 . . . . 0.0 113.101 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 t -95.85 114.14 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.804 -1.41 . . . . 0.0 112.261 -169.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.4 m -78.03 132.41 37.76 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.33 -1.481 . . . . 0.0 110.206 161.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.87 76.48 5.56 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.623 1.201 . . . . 0.0 109.848 -171.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.18 103.31 0.75 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 -165.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.64 14.23 72.3 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.397 -1.44 . . . . 0.0 114.325 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.9 141.88 40.35 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.688 1.195 . . . . 0.0 112.4 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 p -76.28 172.98 11.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.303 1.841 . . . . 0.0 113.475 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -60.59 -38.12 83.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.33 1.452 . . . . 0.0 113.591 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -58.84 -50.35 74.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.345 -1.472 . . . . 0.0 113.558 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -71.43 -39.46 71.02 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.247 1.419 . . . . 0.0 112.951 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.96 -42.57 99.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.278 -1.514 . . . . 0.0 113.804 175.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -72.1 -38.79 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 119.854 -1.779 . . . . 0.0 111.815 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -58.41 -35.99 72.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.624 -1.297 . . . . 0.0 113.657 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.0 m -67.78 -41.23 83.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.526 1.93 . . . . 0.0 113.048 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 mt -80.47 -19.35 46.19 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.196 -1.565 . . . . 0.0 114.202 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -72.53 -25.8 61.51 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.855 -1.778 . . . . 0.0 112.307 166.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -88.91 70.83 8.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.942 -1.099 . . . . 0.0 112.625 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.0 p -104.41 -78.1 0.57 Allowed 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.997 -1.064 . . . . 0.0 110.131 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.24 -117.86 4.36 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -82.85 -49.62 9.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.13 147.29 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.785 -1.197 . . . . 0.0 113.24 -166.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.84 110.72 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.451 1.501 . . . . 0.0 110.024 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -124.16 111.3 15.74 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.934 -1.729 . . . . 0.0 111.328 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 69.6 mt -129.95 153.15 48.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.428 -0.795 . . . . 0.0 111.087 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.36 127.13 52.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.47 156.93 43.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.024 0.916 . . . . 0.0 111.88 -170.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -105.35 136.27 45.19 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.712 1.205 . . . . 0.0 109.119 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -70.03 131.85 44.98 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.302 1.041 . . . . 0.0 112.541 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.74 -162.55 14.9 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 116.677 1.431 . . . . 0.0 116.677 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -101.2 175.49 5.57 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.817 1.647 . . . . 0.0 113.78 -169.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.1 t -75.98 148.85 82.13 Favored Pre-proline 0 N--CA 1.428 -1.565 0 O-C-N 120.057 -1.652 . . . . 0.0 112.871 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.85 163.55 38.09 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 122.637 1.977 . . . . 0.0 111.648 158.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.26 1.612 0 C-N-CA 125.705 1.602 . . . . 0.0 108.865 179.231 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.03 -72.26 0.56 Allowed 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 120.288 -1.507 . . . . 0.0 114.506 -172.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 59.26 48.78 9.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.681 1.993 . . . . 0.0 113.778 -172.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 70.0 m -96.68 174.19 6.95 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.547 1.539 . . . . 0.0 110.264 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.49 167.69 11.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.696 -1.253 . . . . 0.0 109.997 172.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.64 111.98 23.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.396 -1.44 . . . . 0.0 112.366 -176.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.34 89.18 6.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.366 -1.458 . . . . 0.0 108.851 172.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 64.49 -135.0 0.28 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.088 1.755 . . . . 0.0 114.436 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -134.84 131.12 37.04 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.465 -1.397 . . . . 0.0 110.436 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -123.48 110.52 15.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.07 0.948 . . . . 0.0 110.167 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -136.71 -158.59 0.88 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.365 -1.459 . . . . 0.0 112.216 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.36 141.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 126.304 1.842 . . . . 0.0 106.61 -173.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 68.9 m -132.96 161.76 33.44 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.067 1.347 . . . . 0.0 112.635 -160.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.95 152.79 52.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.566 1.147 . . . . 0.0 111.901 170.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.26 1.609 0 C-N-CA 127.419 2.288 . . . . 0.0 107.553 168.509 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.49 -1.685 0 N-CA-C 109.06 -1.169 . . . . 0.0 109.06 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -82.09 171.0 13.0 Favored Pre-proline 0 N--CA 1.431 -1.415 0 CA-C-O 117.895 -1.05 . . . . 0.0 111.605 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -66.11 -32.7 42.83 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 CA-C-N 123.379 2.243 . . . . 0.0 114.418 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.02 72.52 0.86 Allowed Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 172.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -81.65 159.56 23.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.985 -1.303 . . . . 0.0 113.728 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 mp -81.87 135.7 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.569 1.547 . . . . 0.0 109.509 -174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -138.53 150.58 46.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.404 1.082 . . . . 0.0 111.115 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.33 113.63 21.73 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.969 -1.082 . . . . 0.0 109.577 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.1 m -102.17 146.83 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.842 -1.162 . . . . 0.0 112.573 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.71 134.32 55.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.054 0.942 . . . . 0.0 108.524 172.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.2 mt -130.93 148.02 52.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 161.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.97 135.3 46.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -66.92 118.63 10.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -119.1 -84.06 0.65 Allowed 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.58 -1.325 . . . . 0.0 111.657 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -77.35 -42.17 37.62 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.668 1.987 . . . . 0.0 109.888 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -156.43 -172.04 3.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 m -92.64 -73.88 0.54 Allowed 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.167 -0.958 . . . . 0.0 110.3 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.07 -91.06 0.34 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 118.93 0.786 . . . . 0.0 111.808 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.71 52.18 1.22 Allowed Glycine 0 N--CA 1.431 -1.687 0 O-C-N 120.0 -1.687 . . . . 0.0 111.465 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.2 tt -145.88 158.05 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 121.228 -1.16 . . . . 0.0 111.405 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.0 p -122.02 149.4 43.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.491 -1.381 . . . . 0.0 110.113 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.29 164.05 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.22 1.01 . . . . 0.0 108.549 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -137.7 151.99 48.8 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.408 -2.057 . . . . 0.0 105.691 165.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.64 -144.51 17.21 Favored Glycine 0 N--CA 1.431 -1.678 0 O-C-N 120.969 -1.082 . . . . 0.0 112.466 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.3 -4.46 86.03 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 124.745 1.164 . . . . 0.0 113.868 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -100.34 161.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 124.611 1.164 . . . . 0.0 108.792 -168.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -68.36 -19.51 64.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.131 2.172 . . . . 0.0 114.471 -162.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.5 t -130.34 126.97 38.47 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 152.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.5 p -156.21 -101.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.628 -1.295 . . . . 0.0 109.292 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.48 -41.97 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.317 -1.49 . . . . 0.0 110.876 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -131.86 -145.18 0.26 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 162.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -79.5 55.63 1.99 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.45 2.3 . . . . 0.0 111.014 168.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.99 -160.1 14.81 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 107.111 -2.396 . . . . 0.0 107.111 -163.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.54 150.2 26.22 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 122.234 0.908 . . . . 0.0 112.345 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mm -125.91 132.73 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.238 -1.154 . . . . 0.0 108.208 -170.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.55 140.47 52.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 124.561 1.144 . . . . 0.0 108.707 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.9 t -78.97 127.65 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 O-C-N 120.36 -1.462 . . . . 0.0 110.961 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -90.12 -62.26 1.5 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.587 -1.32 . . . . 0.0 110.843 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.82 156.87 25.81 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.2 t -91.0 133.45 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.1 mm -83.21 127.62 68.16 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.967 -1.492 . . . . 0.0 108.643 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -80.35 41.79 1.2 Allowed 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 123.841 3.027 . . . . 0.0 113.386 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -145.58 53.12 1.17 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.92 2.488 . . . . 0.0 106.313 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.97 161.81 33.1 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.225 -1.547 . . . . 0.0 114.914 -174.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.76 -32.53 65.69 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 127.9 2.48 . . . . 0.0 115.766 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.66 -38.19 66.64 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 170.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -78.94 -39.2 35.22 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.427 1.091 . . . . 0.0 111.689 174.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.2 m -57.58 -48.24 79.92 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.413 -1.43 . . . . 0.0 113.179 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -73.96 -65.74 0.8 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.821 1.248 . . . . 0.0 112.827 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.63 79.21 0.79 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.342 -1.474 . . . . 0.0 114.852 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -138.87 -30.3 0.75 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.515 1.526 . . . . 0.0 110.882 -174.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.5 mt -125.73 138.65 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -140.16 -173.9 3.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.499 -1.376 . . . . 0.0 110.117 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -57.52 134.75 56.38 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.59 11.22 85.42 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 118.656 2.222 . . . . 0.0 118.656 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -76.45 154.68 34.54 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.238 2.019 . . . . 0.0 111.002 169.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.453 HH21 ' CD ' ' A' ' 90' ' ' GLU . 2.5 tmm_? -124.4 115.13 20.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.076 -1.64 . . . . 0.0 110.11 -161.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.3 m -94.82 154.08 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 119.658 -1.901 . . . . 0.0 114.191 -170.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.5 mt -121.81 -89.51 0.6 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.3 1.04 . . . . 0.0 110.33 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.83 141.5 31.54 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -165.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.1 t -95.4 102.64 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 124.473 1.109 . . . . 0.0 108.026 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.256 59.3 t30 57.94 42.42 22.95 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.859 1.663 . . . . 0.0 114.191 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.63 -27.25 21.06 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.535 -1.353 . . . . 0.0 113.959 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.1 t -91.33 113.31 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.345 -1.091 . . . . 0.0 111.967 -174.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -81.05 111.77 17.83 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.984 -1.072 . . . . 0.0 111.749 167.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.96 82.78 1.86 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.744 -1.223 . . . . 0.0 108.749 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.37 144.0 53.55 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.343 -2.098 . . . . 0.0 114.495 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.68 -15.31 52.91 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 120.693 -1.254 . . . . 0.0 114.897 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.68 128.58 37.15 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.836 1.655 . . . . 0.0 115.376 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 p -73.38 164.26 26.91 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.065 1.412 . . . . 0.0 111.01 172.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.12 -42.28 94.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -168.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HZ1' ' CD ' ' A' ' 76' ' ' GLU . 42.5 tptt -55.71 -38.22 69.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.356 1.862 . . . . 0.0 114.463 172.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -71.37 -43.63 66.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.253 1.421 . . . . 0.0 111.276 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.73 -48.82 70.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.82 -1.175 . . . . 0.0 113.539 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.13 -52.22 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 124.79 1.236 . . . . 0.0 113.503 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.422 ' CD ' ' HZ1' ' A' ' 72' ' ' LYS . 34.9 mt-10 -71.46 -21.88 61.9 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 120.077 -1.639 . . . . 0.0 114.587 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.3 m -64.77 -40.49 95.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.354 -1.466 . . . . 0.0 111.57 169.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.61 -26.36 37.85 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.524 -1.36 . . . . 0.0 113.837 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -66.55 -43.35 85.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.021 -1.675 . . . . 0.0 112.154 168.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -78.14 53.85 1.27 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.719 1.608 . . . . 0.0 113.592 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.3 p -108.5 -86.6 0.51 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.85 2.06 . . . . 0.0 108.817 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.87 -57.45 1.83 Allowed Glycine 0 N--CA 1.43 -1.749 0 O-C-N 120.29 -1.506 . . . . 0.0 114.936 171.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -83.15 -68.23 0.72 Allowed 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 120.516 -1.579 . . . . 0.0 112.609 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.45 141.64 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 122.555 1.169 . . . . 0.0 110.249 -173.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.1 t -114.99 109.04 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 126.651 1.98 . . . . 0.0 107.489 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -117.24 127.68 54.33 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.841 -1.162 . . . . 0.0 110.478 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.5 mt -141.42 152.46 44.3 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 123.847 0.859 . . . . 0.0 111.78 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -122.32 123.9 42.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.827 1.251 . . . . 0.0 107.951 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.43 165.82 29.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.635 1.207 . . . . 0.0 111.622 -173.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.453 ' CD ' HH21 ' A' ' 57' ' ' ARG . 29.8 tt0 -112.03 141.33 45.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.303 1.841 . . . . 0.0 108.325 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -71.64 137.7 48.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.525 -1.359 . . . . 0.0 112.093 171.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.26 -143.44 5.85 Favored Glycine 0 N--CA 1.431 -1.686 0 CA-C-O 123.467 1.593 . . . . 0.0 115.915 -176.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -88.35 168.38 12.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 121.048 -1.266 . . . . 0.0 112.05 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.3 t -84.5 159.66 58.12 Favored Pre-proline 0 N--CA 1.431 -1.425 0 C-N-CA 124.885 1.274 . . . . 0.0 110.97 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -67.1 173.72 8.02 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 123.179 2.586 . . . . 0.0 115.356 168.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.26 1.622 0 C-N-CA 124.439 1.096 . . . . 0.0 111.905 -179.646 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 . . . . . 0 CA--C 1.491 -1.316 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.43 -74.62 0.58 Allowed 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.755 -1.215 . . . . 0.0 113.317 -175.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 59.55 65.58 1.13 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.775 2.43 . . . . 0.0 115.509 -172.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 6.1 t -117.37 -164.07 0.97 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.11 1.364 . . . . 0.0 109.087 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -108.51 -68.59 0.9 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.412 -1.43 . . . . 0.0 108.144 171.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.74 82.44 4.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.365 1.616 . . . . 0.0 115.365 -165.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -83.08 -64.07 1.24 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.452 1.101 . . . . 0.0 111.308 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . 0.331 21.2 mt-10 72.42 -128.81 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.694 1.998 . . . . 0.0 113.556 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -150.35 157.66 43.3 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.189 -1.569 . . . . 0.0 113.938 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -124.09 154.4 40.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 158.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -122.75 178.4 5.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.189 1.359 . . . . 0.0 113.911 -168.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 68.6 t -120.86 139.27 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.199 2.2 . . . . 0.0 105.482 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 11.6 m -132.28 140.54 48.66 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.164 1.386 . . . . 0.0 114.563 -156.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.54 157.58 31.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.972 1.709 . . . . 0.0 112.088 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.262 1.719 0 C-N-CA 125.211 1.404 . . . . 0.0 108.809 -179.474 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 CA--C 1.49 -1.688 0 N-CA-C 108.866 -1.244 . . . . 0.0 108.866 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -78.99 168.28 28.26 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 125.052 1.341 . . . . 0.0 110.984 169.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -65.25 -31.18 53.88 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 CA-C-N 124.18 2.529 . . . . 0.0 114.798 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.39 81.74 1.68 Allowed Glycine 0 N--CA 1.431 -1.655 0 CA-C-N 119.487 1.039 . . . . 0.0 110.515 167.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -80.57 155.98 26.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 123.334 1.54 . . . . 0.0 114.381 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.8 mt -86.55 135.86 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 125.645 1.578 . . . . 0.0 109.121 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -145.13 166.52 25.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.203 1.001 . . . . 0.0 108.84 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -124.63 143.7 50.58 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.282 -0.886 . . . . 0.0 109.869 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.6 m -103.43 148.75 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 123.425 0.69 . . . . 0.0 109.799 171.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -129.39 93.48 3.57 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.8 tp -122.61 163.06 20.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -172.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.88 172.14 13.4 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.045 -1.659 . . . . 0.0 109.014 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -71.63 103.83 3.15 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.997 -1.064 . . . . 0.0 113.115 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -97.97 -70.87 0.71 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.902 1.281 . . . . 0.0 109.465 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -70.43 -76.91 0.09 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.724 2.01 . . . . 0.0 110.003 172.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -138.21 -176.86 4.59 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.818 -3.031 . . . . 0.0 102.818 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 t -79.48 -61.46 2.0 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.775 -1.828 . . . . 0.0 112.881 -162.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.2 mp -101.76 -88.18 0.38 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.175 -1.578 . . . . 0.0 111.32 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.6 45.08 2.01 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tt -152.41 147.34 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 120.948 -1.325 . . . . 0.0 110.49 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 t -122.17 158.52 29.19 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.899 -1.126 . . . . 0.0 109.926 -174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.416 HG12 ' CE1' ' A' ' 71' ' ' HIS . 33.0 t -121.4 162.48 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.042 1.337 . . . . 0.0 109.299 -158.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 t -147.69 149.68 32.91 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 165.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.81 -149.87 43.73 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.62 12.88 57.69 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 118.231 2.052 . . . . 0.0 118.231 168.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.04 -107.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 119.128 1.464 . . . . 0.0 114.491 -161.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -89.89 -41.47 11.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.361 -2.087 . . . . 0.0 110.793 -172.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 t -136.31 152.64 50.9 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 158.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -155.37 -93.04 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.431 -1.418 . . . . 0.0 110.835 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.47 -52.67 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 C-N-CA 125.044 1.337 . . . . 0.0 110.016 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.5 ptt-85 -125.98 -139.05 0.27 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.446 -1.686 . . . . 0.0 106.446 154.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -75.67 67.35 2.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.773 1.749 . . . . 0.0 110.823 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.45 -176.58 16.42 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 126.181 1.848 . . . . 0.0 109.333 -171.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.63 151.52 27.02 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.68 159.3 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.52 157.21 35.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.468 -1.395 . . . . 0.0 109.747 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 t -92.53 128.25 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 124.963 1.305 . . . . 0.0 111.849 -174.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -97.17 -67.39 0.85 Allowed 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.691 -1.256 . . . . 0.0 113.342 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.21 153.05 28.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.827 -1.17 . . . . 0.0 112.637 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.94 119.87 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 126.309 1.843 . . . . 0.0 109.246 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.4 mm -84.54 131.52 49.71 Favored Pre-proline 0 N--CA 1.43 -1.451 0 C-N-CA 125.054 1.341 . . . . 0.0 109.685 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -77.11 64.23 7.79 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 CA-C-N 124.295 2.57 . . . . 0.0 112.65 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -160.33 53.95 0.33 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.869 1.319 . . . . 0.0 109.202 173.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.72 179.95 45.7 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.385 -2.072 . . . . 0.0 112.908 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.36 -32.79 72.71 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.734 1.614 . . . . 0.0 114.703 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.75 -42.35 71.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.845 1.658 . . . . 0.0 114.411 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -91.33 -47.18 7.62 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.779 1.232 . . . . 0.0 112.0 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.4 m -68.39 -36.6 79.39 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -173.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -84.4 -49.2 8.9 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.189 1.359 . . . . 0.0 109.327 165.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.89 90.43 2.16 Favored Glycine 0 N--CA 1.43 -1.701 0 O-C-N 121.02 -1.05 . . . . 0.0 111.672 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -137.83 -54.5 0.66 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -166.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.0 mt -126.36 145.98 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 119.197 -2.189 . . . . 0.0 107.387 -165.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -119.2 174.05 6.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.462 1.125 . . . . 0.0 112.386 -170.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -61.12 136.03 57.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 167.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 26.51 62.63 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 119.154 2.422 . . . . 0.0 119.154 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -79.9 176.18 9.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 118.776 1.288 . . . . 0.0 110.737 162.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -124.75 121.09 33.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.969 -1.707 . . . . 0.0 109.248 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -94.17 153.46 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 120.028 -1.67 . . . . 0.0 112.193 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.0 tp -125.9 -81.42 0.62 Allowed 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 121.059 -1.025 . . . . 0.0 112.073 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.88 151.18 21.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.527 -1.358 . . . . 0.0 114.385 -166.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.75 92.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 125.999 1.719 . . . . 0.0 107.066 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 56.37 54.61 7.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.468 1.507 . . . . 0.0 114.555 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.27 -40.31 2.47 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 124.329 0.966 . . . . 0.0 114.649 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 t -99.31 136.17 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 O-C-N 121.425 -1.044 . . . . 0.0 111.381 -169.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 t -77.72 144.99 36.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.87 -1.769 . . . . 0.0 110.97 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -90.89 -9.43 46.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.455 -1.403 . . . . 0.0 113.305 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.02 144.53 33.87 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -172.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.1 -43.84 1.87 Allowed Glycine 0 N--CA 1.431 -1.699 0 O-C-N 121.176 -0.953 . . . . 0.0 113.017 -161.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.01 160.0 28.42 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.614 -1.521 . . . . 0.0 114.516 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.8 p -84.85 167.74 15.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.444 1.898 . . . . 0.0 111.174 175.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.416 ' CE1' HG12 ' A' ' 22' ' ' VAL . 11.1 t60 -60.67 -37.45 81.64 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.42 1.488 . . . . 0.0 114.052 171.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -54.5 -45.86 73.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.956 2.102 . . . . 0.0 114.221 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -76.18 -34.23 59.33 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.086 -1.634 . . . . 0.0 112.723 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.84 96.74 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.551 1.541 . . . . 0.0 114.481 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.7 m -73.88 -24.06 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.974 -1.704 . . . . 0.0 113.787 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -67.91 -45.26 74.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.406 -1.434 . . . . 0.0 112.183 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.6 m -59.97 -33.12 71.51 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 126.745 2.018 . . . . 0.0 112.828 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.26 -54.71 5.7 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.76 -1.213 . . . . 0.0 112.574 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -68.5 -5.43 19.45 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -169.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -85.49 11.96 9.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.152 -1.592 . . . . 0.0 115.192 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 p -102.14 -103.84 0.27 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.471 1.508 . . . . 0.0 110.015 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.95 -57.57 0.47 Allowed Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.201 -1.562 . . . . 0.0 113.376 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -71.33 -67.94 0.48 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.8 p -109.46 140.43 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 122.459 1.123 . . . . 0.0 112.057 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.9 t -119.82 112.1 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 125.155 1.382 . . . . 0.0 109.774 -175.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -116.53 115.35 25.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.017 -1.052 . . . . 0.0 108.378 168.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.2 tp -128.41 146.35 50.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.932 1.293 . . . . 0.0 108.595 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -120.74 123.02 41.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.32 157.65 44.58 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 122.243 1.021 . . . . 0.0 110.5 -170.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -104.68 141.37 36.56 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -65.23 135.45 55.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.629 1.204 . . . . 0.0 113.457 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.6 163.95 53.0 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-O 122.596 1.109 . . . . 0.0 113.175 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -83.35 172.05 12.9 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.559 1.171 . . . . 0.0 112.007 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.1 t -71.4 -43.11 12.06 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 116.014 -1.945 . . . . 0.0 115.198 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -76.02 45.05 1.43 Allowed 'Trans proline' 0 N--CA 1.434 -2.009 0 CA-C-N 125.926 3.152 . . . . 0.0 117.983 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.261 1.696 0 C-N-CA 125.43 1.492 . . . . 0.0 108.287 167.174 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 CA--C 1.491 -1.317 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.59 -103.63 0.17 Allowed 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 120.476 -1.39 . . . . 0.0 109.919 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -90.55 -179.74 5.64 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.273 -1.517 . . . . 0.0 108.752 170.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.7 m -94.55 -170.82 2.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.208 -2.183 . . . . 0.0 111.89 -173.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -115.25 -84.14 0.62 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.652 -1.28 . . . . 0.0 108.739 164.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.09 100.51 7.78 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.455 -1.403 . . . . 0.0 108.343 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -134.77 130.74 36.62 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 124.601 1.161 . . . . 0.0 110.354 -167.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -148.74 -171.81 3.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.949 -1.095 . . . . 0.0 109.327 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -92.82 175.75 6.69 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.199 -1.563 . . . . 0.0 111.813 -169.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -122.99 -117.33 0.29 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 170.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -134.7 170.27 16.07 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.576 -1.953 . . . . 0.0 111.681 160.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -121.3 158.33 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.069 2.148 . . . . 0.0 107.752 -169.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.8 m -141.71 159.29 42.53 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.08 -1.637 . . . . 0.0 112.987 -168.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.53 161.77 38.99 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.475 0.655 . . . . 0.0 111.721 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.504 1.922 . . . . 0.0 106.437 174.559 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo . . . . . 0 CA--C 1.491 -1.637 0 N-CA-C 108.804 -1.268 . . . . 0.0 108.804 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -78.11 176.94 3.1 Favored Pre-proline 0 N--CA 1.431 -1.4 0 C-N-CA 125.904 1.682 . . . . 0.0 112.224 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -63.13 -31.55 75.29 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 CA-C-N 124.111 2.504 . . . . 0.0 115.631 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.43 86.05 0.55 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 124.056 0.836 . . . . 0.0 112.637 172.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.31 168.62 18.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.8 135.06 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 126.424 1.89 . . . . 0.0 109.409 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -146.99 169.62 18.82 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.797 1.284 . . . . 0.0 113.568 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.09 125.94 40.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.994 1.318 . . . . 0.0 111.457 -174.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.2 m -104.78 147.91 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.303 -1.498 . . . . 0.0 113.805 172.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -130.85 104.08 6.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.132 1.373 . . . . 0.0 109.833 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.421 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 7.1 tp -123.28 174.9 7.01 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.795 1.238 . . . . 0.0 108.199 -177.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -143.23 163.52 32.72 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.669 -1.894 . . . . 0.0 105.928 166.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -62.38 120.61 11.37 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -117.92 -89.07 0.6 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.617 1.167 . . . . 0.0 109.298 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.12 -49.66 41.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.68 1.592 . . . . 0.0 110.976 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -151.5 -162.83 1.62 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -84.63 -61.54 1.77 Allowed 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 120.511 1.505 . . . . 0.0 110.018 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 mp -104.1 -93.55 0.34 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.504 -1.373 . . . . 0.0 111.723 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.87 51.74 1.25 Allowed Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 124.793 1.187 . . . . 0.0 110.602 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.7 tt -150.2 163.57 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 121.329 -1.101 . . . . 0.0 110.791 -174.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -121.85 148.02 45.24 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.405 -1.435 . . . . 0.0 110.135 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -126.01 156.78 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 126.04 1.736 . . . . 0.0 109.633 -166.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -138.69 151.17 46.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.182 -0.949 . . . . 0.0 109.532 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.78 -149.8 50.8 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 125.641 1.591 . . . . 0.0 115.804 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.03 36.88 13.79 Favored Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 116.677 1.431 . . . . 0.0 116.677 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.54 -108.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -166.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -90.25 -52.48 4.91 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.802 -1.811 . . . . 0.0 110.852 -169.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -137.38 135.42 36.96 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 161.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 t -155.72 -84.27 0.06 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.107 -1.621 . . . . 0.0 110.325 -163.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.48 -58.5 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -116.89 -138.36 0.36 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 161.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 66.06 2.19 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.979 -1.7 . . . . 0.0 110.711 164.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.99 -147.3 16.46 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -168.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.63 145.32 14.91 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 121.712 -0.875 . . . . 0.0 111.3 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.6 mm -123.47 145.7 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.485 -1.597 . . . . 0.0 108.969 -160.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.75 141.23 52.11 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.118 1.367 . . . . 0.0 110.078 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.82 136.32 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.77 -1.207 . . . . 0.0 112.897 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -97.11 -66.64 0.89 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.058 1.343 . . . . 0.0 112.05 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.25 159.28 39.93 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.17 -0.956 . . . . 0.0 110.456 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.33 131.85 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 125.673 1.589 . . . . 0.0 110.781 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.5 mm -83.83 122.27 76.26 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 117.451 -1.262 . . . . 0.0 108.104 170.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.9 40.99 1.03 Allowed 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.474 2.782 . . . . 0.0 113.11 -171.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -160.59 78.0 0.62 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.23 170.39 43.51 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.76 -34.47 74.51 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.743 1.217 . . . . 0.0 113.07 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.91 -42.95 69.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -92.2 -37.7 12.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.861 1.264 . . . . 0.0 112.993 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.3 m -68.0 -35.57 78.54 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.282 -1.511 . . . . 0.0 114.549 -177.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.13 -60.27 2.44 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.103 0.954 . . . . 0.0 109.782 167.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.39 68.63 0.61 Allowed Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -136.72 -42.4 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.839 -0.801 . . . . 0.0 112.27 -155.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 mt -127.84 121.14 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -117.85 -179.63 3.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.317 1.056 . . . . 0.0 111.086 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -59.58 142.13 53.44 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.07 6.41 82.72 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 119.284 2.473 . . . . 0.0 119.284 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.76 170.51 16.45 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.684 1.742 . . . . 0.0 113.019 173.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -131.84 91.09 2.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.951 -1.718 . . . . 0.0 111.016 -166.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.09 160.63 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.43 -2.044 . . . . 0.0 113.288 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.1 tp -141.79 -82.97 0.2 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.728 -1.232 . . . . 0.0 113.041 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.32 146.88 24.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.33 -1.482 . . . . 0.0 114.796 -165.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.3 t -113.71 89.48 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 126.723 2.009 . . . . 0.0 107.71 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.7 t30 57.55 58.47 3.76 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.602 1.561 . . . . 0.0 112.712 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.44 -41.54 3.09 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.842 -1.161 . . . . 0.0 113.963 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.0 122.28 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.559 -1.553 . . . . 0.0 110.963 -173.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -77.39 141.14 39.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.105 -1.622 . . . . 0.0 111.417 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 pp -88.23 -2.8 58.81 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.19 142.89 57.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -171.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.05 -29.72 11.58 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 120.619 -1.301 . . . . 0.0 113.153 -166.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.86 153.84 32.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 p -83.0 170.6 14.72 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.856 -1.153 . . . . 0.0 112.039 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -55.29 -46.26 76.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.545 1.538 . . . . 0.0 114.985 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -60.14 -40.7 90.74 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -72.25 -38.98 68.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.326 -1.484 . . . . 0.0 111.964 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.45 96.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.783 1.633 . . . . 0.0 114.527 175.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.9 m -69.26 -37.49 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.395 -1.441 . . . . 0.0 113.163 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.78 -40.68 89.1 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.927 1.291 . . . . 0.0 112.915 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.1 m -58.35 -38.53 77.39 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.202 2.201 . . . . 0.0 113.202 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.84 -33.02 30.88 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.792 1.237 . . . . 0.0 112.993 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -69.99 -47.08 63.65 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.766 -1.209 . . . . 0.0 113.92 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.347 0.0 OUTLIER -89.97 42.45 1.09 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.8 p -93.1 -71.88 0.63 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.444 1.498 . . . . 0.0 109.669 171.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.94 -99.55 0.89 Allowed Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.08 1.8 . . . . 0.0 113.509 172.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -79.66 -47.68 14.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -159.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.31 146.7 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 121.046 -1.033 . . . . 0.0 111.993 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.32 112.76 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 120.311 -1.493 . . . . 0.0 110.092 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -114.84 118.85 34.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 163.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.6 tt -145.67 143.77 30.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.401 -0.812 . . . . 0.0 110.091 -170.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.06 126.49 49.98 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -173.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.23 164.66 29.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.06 1.409 . . . . 0.0 112.011 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -117.74 141.51 48.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 174.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -73.61 138.35 44.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.247 1.023 . . . . 0.0 111.582 175.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.4 -129.47 1.85 Allowed Glycine 0 N--CA 1.43 -1.761 0 CA-C-O 123.049 1.361 . . . . 0.0 116.024 -174.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -87.31 127.46 35.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.201 -1.176 . . . . 0.0 113.672 -167.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.6 m -88.33 -56.73 0.3 Allowed Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-O 116.336 -1.793 . . . . 0.0 114.509 176.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.74 64.72 8.58 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 126.216 3.256 . . . . 0.0 113.431 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.26 1.614 0 C-N-CA 124.751 1.22 . . . . 0.0 112.093 176.478 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 121.096 0.474 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.7 -92.48 0.53 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.403 1.081 . . . . 0.0 109.389 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -105.53 164.29 12.0 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 166.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.9 p -80.71 -36.34 32.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -161.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 68.58 65.36 0.32 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.734 1.614 . . . . 0.0 111.993 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . 77.4 91.93 0.07 Allowed 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 128.299 2.64 . . . . 0.0 113.858 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.58 135.55 33.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.515 1.526 . . . . 0.0 110.456 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -165.21 -171.28 2.14 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.9 1.28 . . . . 0.0 108.083 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -113.97 -175.75 2.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.504 -1.372 . . . . 0.0 109.457 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -122.68 -74.33 0.62 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.68 -1.262 . . . . 0.0 109.179 174.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -139.19 165.73 26.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.404 -1.435 . . . . 0.0 109.463 174.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.38 146.18 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.901 -1.124 . . . . 0.0 109.519 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.8 m -136.96 176.56 8.6 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.573 -1.329 . . . . 0.0 113.07 -172.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.91 157.22 42.96 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.099 1.36 . . . . 0.0 108.827 168.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 C--O 1.258 1.549 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 176.808 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.489 -1.732 0 N-CA-C 109.314 -1.071 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -78.3 151.37 78.07 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 118.146 -0.93 . . . . 0.0 111.167 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -82.62 29.48 0.55 Allowed 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 123.547 2.831 . . . . 0.0 115.19 -161.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.82 80.9 0.31 Allowed Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.892 -1.13 . . . . 0.0 112.249 172.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.97 138.13 47.81 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.882 1.325 . . . . 0.0 114.57 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.61 140.65 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.25 1.82 . . . . 0.0 108.595 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -161.04 161.91 31.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.195 -0.941 . . . . 0.0 110.566 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.51 127.89 54.95 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 120.977 -1.077 . . . . 0.0 109.212 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.28 131.95 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 122.587 1.184 . . . . 0.0 111.284 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -116.63 123.47 47.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.414 1.102 . . . . 0.0 109.846 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.4 tp -135.22 168.23 19.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.99 160.73 31.0 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.0 tttp -70.88 103.65 2.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.107 -0.996 . . . . 0.0 111.05 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -100.66 -93.66 0.28 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.16 1.784 . . . . 0.0 109.401 -166.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.0 -47.44 45.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.297 -1.502 . . . . 0.0 109.133 167.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -147.66 -153.83 0.51 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 167.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 p -83.47 -90.94 0.08 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.231 -1.543 . . . . 0.0 111.361 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.64 -85.22 0.43 Allowed 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 120.459 -1.4 . . . . 0.0 113.317 -173.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.46 42.74 1.44 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 125.327 1.441 . . . . 0.0 110.985 -168.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.3 tt -134.89 152.66 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 121.124 -1.221 . . . . 0.0 109.552 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.2 p -122.27 153.87 38.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.478 -1.389 . . . . 0.0 111.738 -171.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.66 159.6 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.133 1.373 . . . . 0.0 108.982 -164.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.2 t -138.04 142.36 40.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.67 -149.3 50.44 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.781 1.658 . . . . 0.0 114.921 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.82 34.29 5.78 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 124.5 1.048 . . . . 0.0 115.456 165.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.14 -92.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 121.663 -0.904 . . . . 0.0 111.216 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -98.32 -51.09 4.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.453 -1.404 . . . . 0.0 110.103 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.9 131.41 14.8 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.83 -1.169 . . . . 0.0 110.832 175.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -154.83 -74.2 0.11 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.285 1.034 . . . . 0.0 110.661 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -79.46 -48.71 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.459 -1.401 . . . . 0.0 110.137 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -132.08 -159.67 0.98 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 161.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -71.7 110.76 6.46 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 120.329 -1.482 . . . . 0.0 108.76 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.22 -179.76 23.86 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 121.063 -1.023 . . . . 0.0 113.905 -167.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.79 161.45 27.79 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.451 -1.617 . . . . 0.0 112.075 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.8 mm -126.68 142.51 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.3 1.84 . . . . 0.0 107.986 -162.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.88 138.46 52.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.968 1.307 . . . . 0.0 109.451 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.86 133.58 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.712 -1.242 . . . . 0.0 112.714 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -90.85 -65.64 1.0 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.216 1.007 . . . . 0.0 110.87 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.73 160.9 31.95 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.356 -0.84 . . . . 0.0 111.946 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.05 125.59 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.998 1.319 . . . . 0.0 110.46 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.08 133.99 47.09 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.967 -1.492 . . . . 0.0 109.085 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.35 43.31 1.46 Allowed 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 124.772 2.74 . . . . 0.0 114.089 -173.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -153.57 47.66 0.66 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.851 -1.156 . . . . 0.0 109.721 -166.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.01 -172.7 39.51 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 120.237 -1.539 . . . . 0.0 112.517 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.85 -29.35 69.79 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.626 1.97 . . . . 0.0 113.214 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.29 94.62 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 125.987 1.715 . . . . 0.0 114.044 174.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -73.71 -43.59 58.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.804 1.242 . . . . 0.0 111.909 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 t -62.16 -55.56 27.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.182 1.393 . . . . 0.0 114.149 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.69 -60.32 2.37 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.915 -1.116 . . . . 0.0 111.091 175.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.31 87.13 1.43 Allowed Glycine 0 N--CA 1.43 -1.756 0 O-C-N 121.371 -0.831 . . . . 0.0 112.105 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.43 -26.77 0.98 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 121.238 -1.154 . . . . 0.0 112.789 -164.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.5 mm -126.56 136.89 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -119.33 171.31 8.41 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.678 -1.264 . . . . 0.0 112.546 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.14 143.91 42.26 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.44 15.21 81.68 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 116.445 1.338 . . . . 0.0 116.445 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -82.43 158.39 23.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.092 1.357 . . . . 0.0 113.496 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -127.17 114.43 17.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.888 1.675 . . . . 0.0 111.715 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 m -79.93 157.49 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.864 -1.772 . . . . 0.0 113.717 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 mp -121.53 -90.97 0.57 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 125.643 1.577 . . . . 0.0 107.41 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.19 159.48 16.04 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.312 -2.117 . . . . 0.0 114.213 -166.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.94 80.13 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.389 1.875 . . . . 0.0 106.658 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.5 t30 57.86 69.7 0.71 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.849 1.66 . . . . 0.0 112.768 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.55 -55.62 2.71 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 120.592 -1.318 . . . . 0.0 114.456 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -86.12 138.36 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.545 1.164 . . . . 0.0 113.171 -170.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -79.26 155.43 28.54 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.539 -1.351 . . . . 0.0 113.1 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 pp -85.91 4.25 38.3 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 125.307 1.443 . . . . 0.0 113.874 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -62.13 120.33 10.68 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.617 -1.302 . . . . 0.0 114.249 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.68 -39.58 2.65 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 125.77 1.653 . . . . 0.0 112.984 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.65 140.33 51.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -168.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.68 -178.56 5.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.337 1.455 . . . . 0.0 109.377 172.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.603 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 16.8 t60 -60.29 -49.95 75.56 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.402 -1.436 . . . . 0.0 114.483 -171.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -54.27 -43.12 70.74 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 125.136 1.374 . . . . 0.0 113.77 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -71.67 -41.2 69.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.016 -1.053 . . . . 0.0 112.717 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.51 92.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.333 -1.48 . . . . 0.0 114.374 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -72.15 -40.25 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.003 -1.685 . . . . 0.0 112.351 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -72.37 -31.81 65.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.283 -1.511 . . . . 0.0 114.117 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.5 p -70.42 -26.15 63.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.222 -1.549 . . . . 0.0 113.157 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.23 -40.52 26.89 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 121.062 -1.024 . . . . 0.0 112.011 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -60.68 -56.0 26.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.545 -1.347 . . . . 0.0 113.676 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -84.03 59.32 5.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.673 -1.267 . . . . 0.0 111.379 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.49 -69.63 0.63 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.044 2.138 . . . . 0.0 107.59 166.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.71 -117.74 3.95 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -65.5 -63.62 1.05 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.71 138.04 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 122.488 1.137 . . . . 0.0 111.478 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.19 87.42 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 125.646 1.578 . . . . 0.0 106.791 -175.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -116.29 126.02 52.98 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 120.273 -1.517 . . . . 0.0 108.996 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . 0.266 0.0 OUTLIER -147.34 162.67 38.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.637 -1.289 . . . . 0.0 111.927 -179.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -121.41 131.2 54.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.679 1.592 . . . . 0.0 107.729 -170.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -140.87 162.99 34.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.515 1.15 . . . . 0.0 111.602 -171.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -134.89 120.19 18.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.426 1.49 . . . . 0.0 107.527 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -62.39 143.91 56.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -174.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.37 145.11 38.55 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 121.299 -0.876 . . . . 0.0 113.93 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -93.76 138.0 32.41 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 121.24 -1.153 . . . . 0.0 111.283 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.8 m -75.65 161.6 75.58 Favored Pre-proline 0 N--CA 1.43 -1.468 0 C-N-CA 125.505 1.522 . . . . 0.0 112.861 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.74 173.06 14.02 Favored 'Trans proline' 0 N--CA 1.434 -2.029 0 C-N-CA 122.766 2.311 . . . . 0.0 111.672 166.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.4 p . . . . . 0 C--O 1.261 1.666 0 C-N-CA 123.903 0.881 . . . . 0.0 112.567 -173.603 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 32.2 p90 . . . . . 0 CA--C 1.49 -1.327 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.99 -128.46 0.06 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -85.43 150.02 25.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.94 1.296 . . . . 0.0 109.931 172.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 4.5 t -143.23 -86.58 0.14 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.49 -1.381 . . . . 0.0 111.9 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.27 -162.83 0.86 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.111 -1.618 . . . . 0.0 110.792 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.81 -80.65 0.51 Allowed 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 120.549 -1.344 . . . . 0.0 114.023 -171.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.55 158.37 19.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -162.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -139.55 -93.17 0.17 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.591 1.556 . . . . 0.0 108.96 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -89.58 174.45 7.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.121 -1.612 . . . . 0.0 110.978 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -121.85 105.59 10.5 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.591 -1.318 . . . . 0.0 109.154 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -143.08 -131.21 0.09 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.718 -1.239 . . . . 0.0 113.601 173.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.4 157.79 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.739 -1.851 . . . . 0.0 109.423 -159.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' SER . . . . . 0.603 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 29.5 p -139.21 168.0 20.82 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.328 -1.482 . . . . 0.0 114.429 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.54 160.19 43.68 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.188 1.395 . . . . 0.0 108.812 162.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 74.1 t . . . . . 0 C--O 1.26 1.644 0 N-CA-C 106.041 -1.836 . . . . 0.0 106.041 176.71 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.68 0 N-CA-C 110.758 -0.516 . . . . 0.0 110.758 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -88.36 172.98 6.81 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 125.177 1.391 . . . . 0.0 111.624 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -66.32 -41.41 12.4 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 C-N-CA 122.306 2.004 . . . . 0.0 115.238 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.07 62.31 0.57 Allowed Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 124.134 0.874 . . . . 0.0 111.653 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -82.78 168.02 17.57 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.394 1.092 . . . . 0.0 112.495 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -78.39 135.54 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.186 1.794 . . . . 0.0 108.946 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -136.23 156.04 49.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.522 -1.361 . . . . 0.0 110.479 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -116.09 134.11 55.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 121.044 -1.035 . . . . 0.0 111.334 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.8 t -102.9 125.08 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 124.563 1.145 . . . . 0.0 109.597 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -124.72 70.89 1.14 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.524 1.53 . . . . 0.0 108.032 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tp -112.69 -160.88 0.73 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.468 -1.395 . . . . 0.0 110.38 -166.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.45 151.68 30.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.546 -1.346 . . . . 0.0 107.977 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -73.57 101.98 3.74 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.908 -1.12 . . . . 0.0 112.464 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -90.75 -71.39 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.264 1.026 . . . . 0.0 110.187 172.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -86.6 -69.2 0.69 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.488 1.515 . . . . 0.0 111.325 174.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -136.76 165.5 25.78 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 102.132 -3.284 . . . . 0.0 102.132 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 p -83.05 -51.24 7.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.458 -1.401 . . . . 0.0 112.241 -174.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 mt -102.36 -89.95 0.36 Allowed 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 121.057 -1.027 . . . . 0.0 113.457 172.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.49 53.78 1.93 Allowed Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -159.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 tt -145.79 159.13 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 121.1 -1.235 . . . . 0.0 110.782 -173.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -123.22 147.67 46.65 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.688 -1.883 . . . . 0.0 109.686 -175.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.14 147.49 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 125.691 1.596 . . . . 0.0 111.107 -167.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -137.96 126.59 23.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.437 1.113 . . . . 0.0 111.604 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.43 65.43 3.17 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 118.449 2.14 . . . . 0.0 118.449 164.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.66 75.78 0.32 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.58 -108.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 124.602 1.161 . . . . 0.0 111.044 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -72.63 -76.42 0.12 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.735 2.014 . . . . 0.0 111.633 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -144.26 121.1 11.27 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.225 -1.547 . . . . 0.0 109.315 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 p -138.87 -73.97 0.39 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.738 -1.226 . . . . 0.0 112.878 -170.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -66.13 -60.63 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 126.224 1.81 . . . . 0.0 111.564 -172.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ttm-85 -125.0 -115.83 0.29 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.11 62.6 2.56 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.101 1.36 . . . . 0.0 109.067 167.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.95 -139.56 14.45 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -163.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.78 155.94 28.29 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-O 121.939 0.744 . . . . 0.0 112.927 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.93 142.4 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -135.55 132.76 37.6 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.65 1.98 . . . . 0.0 110.351 -168.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.0 t -80.32 128.61 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.482 -1.386 . . . . 0.0 112.863 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -84.74 -55.1 4.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.067 1.747 . . . . 0.0 111.812 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.08 165.39 15.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.439 -0.788 . . . . 0.0 110.141 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 t -98.52 130.86 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 C-N-CA 125.64 1.576 . . . . 0.0 111.381 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mm -82.85 124.91 76.51 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 124.932 1.293 . . . . 0.0 109.65 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.36 32.22 0.52 Allowed 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 123.42 2.747 . . . . 0.0 114.326 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -142.79 52.57 1.4 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.863 1.265 . . . . 0.0 108.589 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -166.58 173.3 41.97 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 119.993 -1.692 . . . . 0.0 111.452 -176.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.71 73.04 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.461 1.504 . . . . 0.0 114.731 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.05 78.56 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 175.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -77.62 -28.93 51.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.761 1.224 . . . . 0.0 112.736 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.3 t -64.69 -56.4 13.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.578 -1.326 . . . . 0.0 113.381 173.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -79.63 -47.51 15.3 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.955 1.302 . . . . 0.0 112.005 -172.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.87 80.61 1.42 Allowed Glycine 0 N--CA 1.431 -1.644 0 O-C-N 121.035 -1.04 . . . . 0.0 111.217 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -139.87 -51.77 0.51 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.834 0.854 . . . . 0.0 112.714 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.1 mt -126.92 136.36 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 -168.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.81 -166.51 2.36 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 -175.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.13 125.16 21.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.7 15.88 81.21 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 117.307 1.683 . . . . 0.0 117.307 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -75.69 155.26 35.88 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 118.93 1.365 . . . . 0.0 111.131 167.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.87 131.32 40.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.461 -1.4 . . . . 0.0 109.562 -173.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.58 153.29 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.647 -1.908 . . . . 0.0 113.766 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.69 -84.51 0.66 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.807 1.643 . . . . 0.0 107.397 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 143.57 29.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.3 t -120.14 90.99 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.289 1.436 . . . . 0.0 108.398 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.275 22.2 t-20 57.24 64.48 1.6 Allowed 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 125.896 1.679 . . . . 0.0 112.281 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.17 -61.87 1.06 Allowed Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 124.691 1.139 . . . . 0.0 113.506 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.0 m -83.86 134.05 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.984 -1.304 . . . . 0.0 113.381 -164.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.3 t -77.79 124.98 28.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.779 -1.201 . . . . 0.0 110.376 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.8 tp -85.67 47.58 1.46 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 123.811 1.767 . . . . 0.0 113.995 -163.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -70.07 134.88 48.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.137 1.775 . . . . 0.0 112.6 166.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.82 -14.45 60.27 Favored Glycine 0 N--CA 1.431 -1.681 0 O-C-N 120.979 -1.076 . . . . 0.0 114.212 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.9 138.49 41.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.91 -1.347 . . . . 0.0 114.159 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 p -93.73 173.96 7.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.983 1.713 . . . . 0.0 109.369 166.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.629 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 1.2 t60 -61.46 -38.45 87.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -169.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -72.14 -27.4 62.59 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.549 -1.344 . . . . 0.0 113.68 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -78.55 -41.16 32.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.153 -1.592 . . . . 0.0 111.086 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.05 96.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.87 -44.31 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.892 -1.755 . . . . 0.0 112.942 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -66.31 -46.51 76.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.93 1.692 . . . . 0.0 113.788 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.8 p -64.54 -33.17 75.28 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.827 1.651 . . . . 0.0 114.434 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.6 mt -92.44 -16.7 25.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -76.35 -55.04 5.92 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.241 -1.537 . . . . 0.0 111.496 168.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -91.55 65.33 5.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.871 1.32 . . . . 0.0 112.175 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.9 p -86.65 -58.56 2.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.862 2.065 . . . . 0.0 109.923 171.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.77 -128.48 7.81 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 125.426 1.489 . . . . 0.0 111.126 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -81.36 -43.86 18.43 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.903 -1.351 . . . . 0.0 112.308 -170.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 p -104.82 140.96 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 122.113 0.959 . . . . 0.0 110.999 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.6 t -119.64 100.91 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 124.496 1.118 . . . . 0.0 108.832 -168.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -117.61 115.07 24.36 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 110.953 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.42 157.12 43.27 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 121.206 -0.934 . . . . 0.0 110.926 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -120.87 144.61 48.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -139.54 159.04 43.09 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 123.889 0.876 . . . . 0.0 109.596 -173.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -107.89 125.46 51.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 167.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -74.6 146.44 42.5 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.922 -1.111 . . . . 0.0 112.144 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.29 -135.87 0.62 Allowed Glycine 0 N--CA 1.429 -1.787 0 CA-C-O 123.578 1.655 . . . . 0.0 116.825 -172.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -94.54 146.79 23.86 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.577 -1.543 . . . . 0.0 110.933 -173.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.6 m -79.94 140.98 54.35 Favored Pre-proline 0 N--CA 1.431 -1.415 0 O-C-N 120.985 -1.072 . . . . 0.0 111.108 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -66.11 -47.64 3.31 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 C-N-CA 122.543 2.162 . . . . 0.0 113.002 163.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.26 1.614 0 C-N-CA 124.45 1.1 . . . . 0.0 110.636 171.037 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.04 175.01 7.11 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.012 -1.055 . . . . 0.0 113.772 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 54.28 59.02 4.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.086 2.155 . . . . 0.0 114.232 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 19.9 t -149.16 -69.6 0.21 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.013 -1.054 . . . . 0.0 110.097 -174.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -100.0 -129.31 0.21 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.117 0.967 . . . . 0.0 110.498 -172.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.15 151.74 19.66 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.08 -1.638 . . . . 0.0 113.675 -173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -117.45 38.27 3.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.63 1.172 . . . . 0.0 111.557 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 49.63 66.95 0.98 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 172.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -141.92 71.99 1.37 Allowed 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.273 -1.517 . . . . 0.0 113.971 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -122.74 80.1 1.71 Allowed 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.403 -2.061 . . . . 0.0 111.303 173.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -139.27 -130.5 0.12 Allowed 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.194 -1.566 . . . . 0.0 114.188 -172.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.47 155.28 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.604 1.561 . . . . 0.0 109.515 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' SER . . . . . 0.629 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 20.4 p -140.04 149.61 43.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.143 -0.973 . . . . 0.0 112.815 -172.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.42 150.87 49.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.977 1.311 . . . . 0.0 111.879 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.259 1.597 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.524 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo . . . . . 0 CA--C 1.491 -1.671 0 N-CA-C 108.63 -1.335 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -91.8 167.57 15.04 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 117.68 -1.153 . . . . 0.0 110.227 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -65.81 -35.74 34.79 Favored 'Trans proline' 0 N--CA 1.434 -1.976 0 CA-C-N 123.151 2.161 . . . . 0.0 113.942 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.72 73.01 0.88 Allowed Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 171.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -79.67 140.38 37.06 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 121.519 -0.989 . . . . 0.0 109.117 172.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 mp -82.61 134.05 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.421 -1.424 . . . . 0.0 108.532 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -133.5 151.74 51.8 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.551 -1.343 . . . . 0.0 111.049 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -103.91 130.43 51.51 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.265 1.026 . . . . 0.0 109.296 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.4 t -103.07 117.72 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.375 -1.453 . . . . 0.0 109.823 168.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -113.0 101.38 9.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 168.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.8 tp -135.48 170.57 15.75 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.176 0.988 . . . . 0.0 109.499 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.36 161.39 41.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.492 -2.005 . . . . 0.0 108.603 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -71.47 105.43 3.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.311 1.445 . . . . 0.0 112.365 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -102.55 -62.68 1.24 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.902 1.281 . . . . 0.0 110.408 167.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -86.12 -66.04 0.95 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.104 1.361 . . . . 0.0 109.154 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -137.5 176.36 8.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.694 1.598 . . . . 0.0 107.022 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.7 t -83.15 -69.05 0.66 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.445 -1.409 . . . . 0.0 111.509 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.9 mp -104.04 -105.46 0.29 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.954 -1.716 . . . . 0.0 112.101 170.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.32 57.21 1.01 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.917 -1.114 . . . . 0.0 111.81 -171.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 tt -144.19 164.7 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 121.45 -1.029 . . . . 0.0 108.444 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 t -122.09 138.39 54.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.506 -1.996 . . . . 0.0 110.394 -175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.56 154.8 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 124.654 1.182 . . . . 0.0 108.787 -166.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -137.44 94.13 2.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.757 1.742 . . . . 0.0 111.195 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.01 -152.06 41.57 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 164.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.31 79.34 1.45 Allowed Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -168.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -117.72 -104.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.419 -1.047 . . . . 0.0 113.406 -162.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -77.15 -51.54 10.82 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.708 -1.87 . . . . 0.0 109.94 -161.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -150.21 137.58 19.68 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 155.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.9 m -151.53 -86.93 0.07 Allowed 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 119.703 -1.873 . . . . 0.0 110.772 -166.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 t -73.9 -59.43 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 124.823 1.249 . . . . 0.0 109.145 -175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -144.23 -123.33 0.08 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -85.3 65.32 9.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.97 -1.706 . . . . 0.0 110.712 172.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.57 -129.33 9.68 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 -165.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.45 133.0 2.9 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 125.629 1.585 . . . . 0.0 112.152 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.3 mm -125.58 137.13 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.4 129.97 50.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.719 -1.238 . . . . 0.0 111.408 -163.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -76.22 135.85 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.562 -1.336 . . . . 0.0 112.292 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -88.2 -61.3 1.75 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.584 1.554 . . . . 0.0 111.039 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.12 162.65 34.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.56 134.3 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 122.193 0.997 . . . . 0.0 111.064 174.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 mm -84.02 134.66 43.39 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 116.652 -1.642 . . . . 0.0 107.495 171.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.11 77.02 2.87 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 125.718 3.078 . . . . 0.0 112.437 170.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -141.13 -40.94 0.39 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -168.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.2 -144.39 4.34 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.301 -1.499 . . . . 0.0 112.155 -167.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.17 -39.97 96.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.904 2.081 . . . . 0.0 114.752 -162.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.34 -50.7 72.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.959 1.704 . . . . 0.0 114.028 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.62 -37.42 50.19 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.075 1.35 . . . . 0.0 112.549 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.7 t -62.38 -47.99 81.73 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.951 -1.718 . . . . 0.0 114.186 -175.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -81.14 -47.05 14.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.828 -1.17 . . . . 0.0 110.571 171.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.88 73.06 1.2 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -139.63 -41.25 0.45 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -164.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.61 134.55 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -140.51 -160.97 1.13 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.344 0.974 . . . . 0.0 112.947 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -54.93 133.81 48.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.304 1.842 . . . . 0.0 114.343 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.37 -2.11 63.27 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 117.992 1.957 . . . . 0.0 117.992 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -75.56 151.28 37.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.055 1.928 . . . . 0.0 112.271 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -123.89 138.93 54.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.581 -1.324 . . . . 0.0 109.783 -165.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.56 155.32 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.692 -1.88 . . . . 0.0 111.948 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.7 mt -119.01 -88.27 0.62 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.23 145.23 29.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.679 1.192 . . . . 0.0 110.802 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 p -102.78 92.17 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 123.039 1.4 . . . . 0.0 110.68 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 58.35 55.52 4.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.861 -1.774 . . . . 0.0 113.163 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.12 -12.82 59.21 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 120.631 -1.293 . . . . 0.0 115.16 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.4 t -103.14 125.51 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 118.561 1.181 . . . . 0.0 109.863 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -77.38 158.96 29.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.547 -1.346 . . . . 0.0 114.562 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -117.43 36.7 4.15 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.052 1.341 . . . . 0.0 109.028 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.93 115.82 7.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.056 -1.652 . . . . 0.0 113.452 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.71 15.76 78.8 Favored Glycine 0 N--CA 1.431 -1.66 0 O-C-N 119.626 -1.921 . . . . 0.0 115.33 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.48 148.16 35.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.847 -1.384 . . . . 0.0 113.104 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.6 p -90.37 174.28 7.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.766 1.227 . . . . 0.0 108.591 163.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -61.34 -37.63 84.01 Favored 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 120.367 -1.458 . . . . 0.0 114.576 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 -40.87 90.75 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.091 -1.631 . . . . 0.0 112.602 175.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -70.14 -41.32 74.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.498 1.519 . . . . 0.0 111.627 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.11 -48.71 70.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . 0.265 35.4 m -63.14 -37.23 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -172.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -64.25 -45.06 89.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 120.516 1.507 . . . . 0.0 112.612 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.7 m -60.09 -36.28 77.05 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.829 1.651 . . . . 0.0 112.385 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.69 -36.74 31.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.325 1.85 . . . . 0.0 115.693 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -63.91 -44.04 94.15 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.156 -1.59 . . . . 0.0 113.067 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -85.0 49.61 1.77 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.595 1.188 . . . . 0.0 113.665 -166.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.7 p -98.48 -76.27 0.54 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.44 2.296 . . . . 0.0 109.563 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.02 -106.84 2.44 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 125.106 1.336 . . . . 0.0 113.179 167.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -68.19 -53.54 24.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -172.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.7 m -108.58 138.84 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.188 0.994 . . . . 0.0 110.346 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.3 t -126.01 95.46 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -135.63 92.02 2.78 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.102 -1.624 . . . . 0.0 110.699 -171.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.15 176.93 9.15 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -165.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.65 131.05 54.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.397 1.079 . . . . 0.0 109.611 -170.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -126.13 167.33 15.54 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.746 1.618 . . . . 0.0 110.397 -174.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -124.58 141.01 52.41 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.992 1.317 . . . . 0.0 107.538 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -72.77 144.83 47.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.25 156.06 48.22 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 120.668 -1.27 . . . . 0.0 114.095 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -75.75 167.74 21.32 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -167.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 78.4 p -84.25 152.85 62.09 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 124.464 1.106 . . . . 0.0 112.459 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -67.28 -53.25 0.5 Allowed 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 121.975 1.783 . . . . 0.0 116.503 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.5 p . . . . . 0 C--O 1.261 1.683 0 C-N-CA 124.162 0.985 . . . . 0.0 111.972 -166.886 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 . . . . . 0 CA--C 1.49 -1.35 0 N-CA-C 111.266 0.098 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.11 -63.45 1.44 Allowed 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.257 -0.902 . . . . 0.0 111.628 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -81.96 173.1 12.53 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 124.467 1.107 . . . . 0.0 111.634 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 68.5 p -78.54 -102.93 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -164.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 66.79 174.61 0.25 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 128.178 2.591 . . . . 0.0 114.343 -167.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.81 62.04 2.89 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -75.61 -59.07 2.91 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 123.845 0.858 . . . . 0.0 112.004 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -101.58 142.73 32.49 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.877 -1.139 . . . . 0.0 110.243 168.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -128.64 -146.63 0.33 Allowed 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.702 -1.249 . . . . 0.0 109.476 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -123.43 -85.24 0.65 Allowed 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 120.47 -1.394 . . . . 0.0 109.388 -177.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -145.63 169.6 18.12 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.596 -1.94 . . . . 0.0 109.023 169.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.57 154.68 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.048 -1.657 . . . . 0.0 108.379 171.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m -140.91 155.87 46.2 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.38 -0.825 . . . . 0.0 111.288 -172.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.3 159.44 42.06 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.84 0.829 . . . . 0.0 110.032 168.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.259 1.585 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.801 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 CA--C 1.49 -1.689 0 N-CA-C 106.368 -2.205 . . . . 0.0 106.368 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -78.33 159.4 75.14 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 119.457 1.026 . . . . 0.0 110.981 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -67.99 -39.42 10.98 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 122.092 1.861 . . . . 0.0 111.002 171.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.32 65.64 0.32 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 123.981 0.8 . . . . 0.0 111.937 170.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.29 177.3 8.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.058 -1.26 . . . . 0.0 113.63 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.7 mt -74.95 143.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.803 -1.81 . . . . 0.0 112.944 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -147.01 160.36 42.47 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.804 -1.185 . . . . 0.0 110.708 170.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -127.26 123.15 35.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.723 -1.236 . . . . 0.0 111.358 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -105.32 132.93 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.689 -1.257 . . . . 0.0 111.878 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -112.43 121.46 44.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 108.794 158.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 10.1 tp -132.82 -167.7 1.95 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.713 1.205 . . . . 0.0 108.418 176.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.449 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -155.59 168.94 25.51 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.12 -1.613 . . . . 0.0 109.195 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -72.01 104.74 3.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.561 1.144 . . . . 0.0 112.841 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -91.28 -85.96 0.23 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.14 -0.975 . . . . 0.0 110.869 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -86.5 -44.92 11.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.75 1.62 . . . . 0.0 110.808 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -138.24 177.9 7.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.183 2.193 . . . . 0.0 105.162 174.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.8 p -84.03 -66.34 0.9 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.503 -1.373 . . . . 0.0 112.151 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.7 mt -101.04 -79.92 0.5 Allowed 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 119.7 1.136 . . . . 0.0 111.865 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.15 47.82 2.35 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 121.1 -1.0 . . . . 0.0 112.069 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 tt -145.81 157.89 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.827 -1.396 . . . . 0.0 112.669 -170.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 t -123.56 146.31 48.22 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.413 -1.429 . . . . 0.0 109.266 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 t -122.05 149.95 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.167 1.387 . . . . 0.0 109.898 -163.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 t -137.27 108.37 6.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.585 1.659 . . . . 0.0 111.137 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.35 -117.29 5.49 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 125.103 1.335 . . . . 0.0 111.689 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.79 35.53 61.97 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 115.843 1.097 . . . . 0.0 115.843 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 m -107.61 -120.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 121.468 -1.019 . . . . 0.0 112.667 -170.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -79.65 -81.12 0.12 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.986 1.715 . . . . 0.0 113.294 -171.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.6 t -128.92 115.57 18.06 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -155.32 -85.93 0.05 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.361 -0.837 . . . . 0.0 109.917 -166.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.1 -52.41 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 120.088 -1.633 . . . . 0.0 110.961 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -133.46 -153.84 0.57 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 158.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -74.5 96.96 3.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.496 1.118 . . . . 0.0 108.405 155.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.71 -172.7 50.63 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 120.267 -1.52 . . . . 0.0 114.423 -169.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.73 147.32 22.32 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -162.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.9 mm -124.77 140.72 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -123.4 143.13 50.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -167.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -87.2 132.3 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 O-C-N 121.031 -1.043 . . . . 0.0 111.366 -173.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -85.46 -51.7 6.35 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.291 1.036 . . . . 0.0 110.873 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.62 157.74 12.63 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.432 HG13 ' CE1' ' A' ' 53' ' ' HIS . 6.8 p -91.69 137.83 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 121.491 0.662 . . . . 0.0 109.886 171.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -84.09 121.62 75.65 Favored Pre-proline 0 N--CA 1.429 -1.504 0 O-C-N 120.325 -1.485 . . . . 0.0 109.093 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -78.84 60.05 7.56 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.363 2.709 . . . . 0.0 112.383 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.33 32.94 0.28 Allowed 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 122.262 1.029 . . . . 0.0 108.401 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.63 176.94 46.16 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 119.729 -1.857 . . . . 0.0 112.619 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -37.35 -45.67 0.71 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.199 2.999 . . . . 0.0 118.54 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.1 89.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -175.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -85.53 -40.62 16.12 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.927 1.291 . . . . 0.0 111.324 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.9 m -60.32 -55.97 27.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.43 -29.38 52.88 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.558 -1.339 . . . . 0.0 110.09 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.46 76.87 1.21 Allowed Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.106 -0.996 . . . . 0.0 112.506 167.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -136.87 -53.7 0.71 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.551 -0.97 . . . . 0.0 112.5 -167.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.6 mt -127.62 125.95 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -166.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.432 ' CE1' HG13 ' A' ' 40' ' ' VAL . 4.9 m-70 -134.56 -171.13 2.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -56.73 128.87 38.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.137 1.375 . . . . 0.0 114.141 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.26 21.79 74.86 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 117.697 1.839 . . . . 0.0 117.697 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -81.36 159.0 24.48 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 119.545 1.672 . . . . 0.0 109.629 161.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.0 ttp85 -122.22 116.51 24.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.559 -1.338 . . . . 0.0 108.705 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.54 138.11 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 121.064 -1.022 . . . . 0.0 109.917 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.5 tp -121.07 -86.47 0.65 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.143 -0.973 . . . . 0.0 109.999 -170.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.06 132.4 33.83 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.848 -1.782 . . . . 0.0 113.277 -170.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.8 p -103.61 93.76 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.552 1.644 . . . . 0.0 108.251 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.268 58.7 t30 56.19 54.15 8.14 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.384 1.874 . . . . 0.0 113.7 -173.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.26 -46.01 1.49 Allowed Glycine 0 N--CA 1.431 -1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 113.621 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.01 128.66 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 121.094 -1.239 . . . . 0.0 111.286 -170.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 t -78.3 156.81 29.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.496 -1.378 . . . . 0.0 112.345 176.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 -13.86 23.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.061 1.344 . . . . 0.0 113.952 -175.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -66.41 128.38 35.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -168.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.1 -51.34 0.71 Allowed Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -170.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.24 151.94 32.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.352 1.461 . . . . 0.0 112.416 170.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.9 p -94.38 -179.11 4.8 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.681 -1.887 . . . . 0.0 112.147 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -50.04 -37.79 34.8 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.252 3.021 . . . . 0.0 115.064 172.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -56.54 -46.85 80.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.396 1.878 . . . . 0.0 114.112 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -77.81 -34.49 52.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.003 1.321 . . . . 0.0 111.185 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.48 77.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.577 1.551 . . . . 0.0 114.378 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.97 -29.34 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.385 -1.447 . . . . 0.0 114.056 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -70.63 -38.66 73.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.591 -1.943 . . . . 0.0 112.527 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.3 m -65.78 -43.49 88.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.415 -1.428 . . . . 0.0 112.236 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 tt -79.72 -46.84 16.33 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -59.12 -35.85 74.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.967 -1.708 . . . . 0.0 114.289 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -92.07 56.01 2.76 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.812 -1.18 . . . . 0.0 110.956 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 p -109.87 -69.25 0.87 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.687 1.995 . . . . 0.0 109.771 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.37 -105.68 1.31 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 124.312 0.958 . . . . 0.0 113.634 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -81.2 -45.11 16.82 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -163.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.04 155.16 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.958 -1.089 . . . . 0.0 112.004 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -130.19 112.8 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -128.44 117.83 22.05 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.354 -1.466 . . . . 0.0 109.804 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.13 160.5 42.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.539 -1.351 . . . . 0.0 113.957 -174.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.81 128.0 52.46 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.104 1.362 . . . . 0.0 107.436 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.86 159.59 27.86 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.041 1.336 . . . . 0.0 110.584 -174.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -109.08 127.33 54.05 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 153.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -69.44 137.06 52.36 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.04 1.336 . . . . 0.0 113.874 -171.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.48 148.17 24.89 Favored Glycine 0 N--CA 1.429 -1.804 0 O-C-N 120.546 -1.346 . . . . 0.0 110.694 170.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -87.12 126.18 34.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.314 -1.698 . . . . 0.0 110.319 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 t -77.3 151.03 80.8 Favored Pre-proline 0 N--CA 1.431 -1.4 0 CA-C-O 117.665 -1.159 . . . . 0.0 113.933 -153.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -67.03 175.61 5.4 Favored 'Trans proline' 0 C--N 1.299 -2.061 0 C-N-CA 122.98 2.453 . . . . 0.0 115.663 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.26 1.615 0 C-N-CA 124.594 1.158 . . . . 0.0 109.666 177.26 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 27.7 p90 . . . . . 0 CA--C 1.491 -1.322 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.92 85.73 0.09 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 175.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -96.81 -158.0 0.63 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.355 1.462 . . . . 0.0 108.292 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 49.1 p -86.44 -78.76 0.27 Allowed 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 119.82 -1.8 . . . . 0.0 114.319 -168.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -67.79 130.57 43.41 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -168.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.14 157.41 18.3 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.405 1.482 . . . . 0.0 114.716 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -139.97 80.07 1.75 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.528 -1.357 . . . . 0.0 111.393 -167.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -113.9 -94.14 0.47 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.694 -1.253 . . . . 0.0 111.091 174.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . 0.274 58.8 m-80 68.87 61.9 0.33 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.106 2.162 . . . . 0.0 116.574 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -127.68 153.44 46.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 153.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -121.69 -161.89 0.95 Allowed 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.961 -1.712 . . . . 0.0 111.817 -166.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 17.6 m -125.94 155.9 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 125.969 1.708 . . . . 0.0 110.633 -173.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -142.06 143.49 33.13 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.716 0.769 . . . . 0.0 111.109 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.69 146.78 47.99 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.199 1.4 . . . . 0.0 112.618 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.261 1.663 0 C-N-CA 126.176 1.79 . . . . 0.0 106.422 170.073 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 CA--C 1.49 -1.678 0 N-CA-C 106.65 -2.096 . . . . 0.0 106.65 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -93.06 166.9 15.33 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 119.267 0.939 . . . . 0.0 111.526 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -70.04 -52.08 0.33 Allowed 'Trans proline' 0 C--N 1.299 -2.029 0 CA-C-N 122.477 1.92 . . . . 0.0 111.412 173.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.1 90.55 0.71 Allowed Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 168.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.66 179.22 7.85 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 mt -81.71 149.96 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.539 1.536 . . . . 0.0 111.617 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.11 139.87 21.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.478 -1.389 . . . . 0.0 112.247 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -105.96 105.86 16.1 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.665 1.586 . . . . 0.0 111.155 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.08 134.17 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 120.347 -1.471 . . . . 0.0 112.182 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -111.74 127.39 55.77 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 168.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.1 tp -135.73 -159.46 0.96 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.943 -1.098 . . . . 0.0 109.613 172.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.87 168.11 27.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.311 -1.493 . . . . 0.0 108.605 172.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -72.4 112.68 8.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.612 -1.305 . . . . 0.0 110.287 163.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -93.27 -88.56 0.22 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.92 -53.92 6.3 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.028 1.331 . . . . 0.0 109.171 165.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -135.91 172.79 12.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.856 -1.153 . . . . 0.0 108.289 -172.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -81.89 -88.53 0.08 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.065 0.946 . . . . 0.0 109.828 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.6 mt -102.71 -89.39 0.38 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.31 -1.494 . . . . 0.0 112.474 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.6 48.24 3.51 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -165.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 tt -134.26 161.04 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 121.288 -1.125 . . . . 0.0 108.364 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.4 t -121.27 142.55 49.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.365 -1.459 . . . . 0.0 107.242 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.6 t -122.74 152.56 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -160.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 t -145.54 134.34 22.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.685 -1.884 . . . . 0.0 112.832 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.11 -141.54 20.81 Favored Glycine 0 N--CA 1.43 -1.703 0 C-N-CA 126.971 2.224 . . . . 0.0 114.203 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.62 33.7 67.21 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 124.669 1.128 . . . . 0.0 115.614 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -93.32 -124.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 121.039 -1.271 . . . . 0.0 113.549 -170.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -71.59 -57.72 4.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.748 -1.845 . . . . 0.0 111.274 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.4 t -140.51 154.19 46.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 148.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.4 t -155.84 -103.71 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -164.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 p -62.08 -58.43 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.066 1.747 . . . . 0.0 110.074 161.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -143.29 -163.28 1.61 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 161.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -78.89 44.13 0.54 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.257 1.823 . . . . 0.0 112.822 173.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.48 151.59 5.53 Favored Glycine 0 N--CA 1.43 -1.743 0 O-C-N 120.195 -1.566 . . . . 0.0 110.661 -169.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.81 143.39 11.88 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -168.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.38 162.54 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -172.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.93 151.34 43.68 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.296 -1.503 . . . . 0.0 107.791 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -82.81 134.83 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 120.72 -1.237 . . . . 0.0 110.964 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -85.24 -59.91 2.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.63 1.172 . . . . 0.0 110.583 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.79 168.82 12.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.049 0.94 . . . . 0.0 108.491 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -95.22 136.26 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 122.694 1.235 . . . . 0.0 111.79 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.3 mm -82.73 132.22 52.33 Favored Pre-proline 0 N--CA 1.429 -1.5 0 O-C-N 120.38 -1.45 . . . . 0.0 107.187 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -80.5 35.57 0.58 Allowed 'Trans proline' 0 N--CA 1.434 -2.014 0 C-N-CA 123.242 2.628 . . . . 0.0 113.039 -172.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 62.5 0.9 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.629 1.572 . . . . 0.0 107.438 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.52 161.3 31.07 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.629 -1.294 . . . . 0.0 112.129 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.54 -38.12 19.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.871 2.068 . . . . 0.0 116.298 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.5 -41.82 77.32 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.5 -52.52 10.48 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 125.884 1.674 . . . . 0.0 111.476 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.0 m -56.2 -53.24 59.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -81.62 -36.42 28.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.272 1.029 . . . . 0.0 110.17 -177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.27 79.43 1.32 Allowed Glycine 0 N--CA 1.429 -1.768 0 O-C-N 120.837 -1.164 . . . . 0.0 112.006 169.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -136.18 -43.72 0.63 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -157.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.4 mt -128.86 142.42 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -131.15 178.24 6.85 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 123.321 1.534 . . . . 0.0 111.937 -170.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -56.39 123.12 13.59 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.71 20.06 76.95 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 118.45 2.14 . . . . 0.0 118.45 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -71.96 156.92 38.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 120.24 2.02 . . . . 0.0 111.552 166.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -122.66 114.07 20.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.612 -1.305 . . . . 0.0 108.977 -173.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 m -100.16 156.98 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 120.164 -1.585 . . . . 0.0 111.564 -174.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.9 tp -131.88 -81.48 0.51 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.017 -1.052 . . . . 0.0 111.279 173.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.85 128.23 45.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.704 -1.248 . . . . 0.0 113.649 -160.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.49 112.78 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 122.628 1.204 . . . . 0.0 109.131 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.27 35.8 t30 56.96 31.97 20.78 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 126.844 2.058 . . . . 0.0 114.018 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.4 -12.32 58.38 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.447 -1.408 . . . . 0.0 115.002 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.3 t -96.25 116.35 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 118.692 1.246 . . . . 0.0 111.824 -173.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -76.14 131.32 39.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.206 -1.559 . . . . 0.0 112.012 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -13.34 47.44 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.353 1.461 . . . . 0.0 113.49 -173.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -51.33 129.13 24.21 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.49 1.516 . . . . 0.0 115.088 -167.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.55 -35.19 5.11 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 124.13 0.872 . . . . 0.0 112.321 -160.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.81 155.26 33.19 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.481 -1.599 . . . . 0.0 112.113 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.0 p -93.28 159.99 15.03 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.978 0.894 . . . . 0.0 109.92 167.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.409 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 46.1 t60 -41.01 -44.93 2.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.665 2.786 . . . . 0.0 117.027 173.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -60.75 -37.65 82.52 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.781 -1.2 . . . . 0.0 114.212 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -78.45 -41.06 33.87 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.755 1.222 . . . . 0.0 112.002 174.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.33 -38.09 82.66 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.524 -1.36 . . . . 0.0 114.266 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 p -71.06 -33.8 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 O-C-N 120.293 -1.505 . . . . 0.0 112.98 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.61 -46.11 91.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.312 -1.492 . . . . 0.0 112.743 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.3 m -56.15 -48.34 76.47 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.612 1.565 . . . . 0.0 112.457 173.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.09 -36.37 40.87 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -172.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -59.61 -37.01 77.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.196 -1.565 . . . . 0.0 113.905 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -95.42 60.71 2.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.735 -1.228 . . . . 0.0 112.8 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -99.49 -73.3 0.63 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.512 2.325 . . . . 0.0 111.339 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.17 -116.63 3.77 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.295 1.426 . . . . 0.0 112.63 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -78.62 -36.26 44.34 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 121.473 -1.016 . . . . 0.0 113.633 -168.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.3 m -104.54 162.31 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.73 -1.231 . . . . 0.0 112.241 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.6 t -138.1 130.89 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 124.81 1.244 . . . . 0.0 108.708 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -141.2 127.97 20.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.652 -1.28 . . . . 0.0 108.072 161.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -149.27 159.06 44.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.276 -1.515 . . . . 0.0 113.082 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.5 mp -120.53 120.41 35.78 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.21 161.85 24.88 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.68 1.192 . . . . 0.0 110.227 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.65 135.47 54.12 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.36 1.464 . . . . 0.0 107.204 162.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -74.98 133.98 41.58 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.378 1.085 . . . . 0.0 112.874 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.47 -176.42 51.37 Favored Glycine 0 N--CA 1.43 -1.753 0 CA-C-O 123.297 1.498 . . . . 0.0 115.056 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -76.91 142.98 39.88 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.167 -1.196 . . . . 0.0 113.775 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.0 t -86.33 117.67 69.07 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 120.571 -1.33 . . . . 0.0 111.085 177.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.46 162.01 28.03 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 122.647 2.231 . . . . 0.0 113.642 -168.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.26 1.617 0 C-N-CA 124.378 1.071 . . . . 0.0 112.166 176.276 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 30.6 p90 . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.63 83.54 0.11 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.763 2.025 . . . . 0.0 116.206 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -83.7 170.13 14.56 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.646 -1.909 . . . . 0.0 110.593 170.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 15.9 p -88.97 -57.2 2.99 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.639 -1.288 . . . . 0.0 113.684 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -86.09 152.01 23.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -165.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.05 151.2 34.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.36 1.464 . . . . 0.0 110.877 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -160.42 87.34 0.76 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.846 -1.158 . . . . 0.0 112.278 -173.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -115.69 -50.58 2.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.055 1.342 . . . . 0.0 110.96 173.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 67.99 52.39 0.7 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 169.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -122.93 168.41 12.34 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 125.388 1.475 . . . . 0.0 107.799 167.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -121.49 171.96 8.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.78 -1.2 . . . . 0.0 112.02 -164.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -122.87 158.19 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 124.757 1.223 . . . . 0.0 110.544 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' SER . . . . . 0.409 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 58.8 m -138.11 149.64 46.12 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.662 -1.274 . . . . 0.0 113.777 -173.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -124.0 150.48 44.81 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 125.121 1.368 . . . . 0.0 111.503 169.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.261 1.666 0 C-N-CA 127.621 2.368 . . . . 0.0 106.702 160.811 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.49 -1.704 0 N-CA-C 109.9 -0.846 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -104.66 151.08 39.22 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 160.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -64.79 -35.35 45.88 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 C-N-CA 122.71 2.273 . . . . 0.0 112.001 169.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.46 72.11 0.28 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 124.76 1.171 . . . . 0.0 111.956 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.32 146.5 30.34 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.17 -1.194 . . . . 0.0 111.194 167.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 mp -89.97 144.53 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.04 2.136 . . . . 0.0 111.252 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -145.75 165.59 28.37 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.306 -1.496 . . . . 0.0 112.184 171.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -113.93 134.95 54.5 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 122.372 1.082 . . . . 0.0 112.241 -177.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.39 111.82 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.482 -1.386 . . . . 0.0 108.964 168.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -112.26 102.37 10.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 170.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tp -134.8 176.67 8.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.674 1.226 . . . . 0.0 111.463 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.01 158.71 42.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 168.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -70.44 152.64 43.83 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -121.17 -83.88 0.66 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.507 -1.371 . . . . 0.0 108.789 166.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -76.99 -51.46 11.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.704 -1.248 . . . . 0.0 109.196 172.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -138.2 177.64 7.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.0 m -82.47 -58.76 2.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.82 0.848 . . . . 0.0 111.32 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.6 mt -102.3 -90.64 0.35 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.142 1.337 . . . . 0.0 112.458 172.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.43 50.58 0.8 Allowed Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -165.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tt -137.62 165.01 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.941 -1.329 . . . . 0.0 110.688 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 t -122.95 136.64 54.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.891 1.677 . . . . 0.0 107.702 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.8 t -123.69 144.04 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 124.675 1.19 . . . . 0.0 110.03 -161.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -138.87 131.17 28.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.032 1.396 . . . . 0.0 112.914 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.43 -162.64 25.83 Favored Glycine 0 N--CA 1.429 -1.777 0 C-N-CA 126.87 2.176 . . . . 0.0 114.236 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.12 42.12 2.47 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.7 -0.882 . . . . 0.0 113.791 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -106.08 -107.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.287 1.042 . . . . 0.0 110.044 -172.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -91.28 -59.78 2.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.099 2.159 . . . . 0.0 110.054 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 t -133.24 138.95 46.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 163.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -145.23 -79.65 0.18 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.941 -1.099 . . . . 0.0 108.828 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -91.8 -51.73 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 O-C-N 120.531 -1.356 . . . . 0.0 108.238 171.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.2 mmt85 -119.44 -142.2 0.35 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.56 65.15 1.26 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.392 -1.442 . . . . 0.0 111.715 170.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.37 -137.52 13.63 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 -166.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.2 147.3 9.1 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-O 122.206 0.892 . . . . 0.0 112.978 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.6 mm -122.21 130.74 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 -159.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.08 149.28 49.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 123.831 0.852 . . . . 0.0 110.296 -169.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.4 t -79.69 124.68 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 120.833 -1.167 . . . . 0.0 111.22 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -80.58 -63.25 1.45 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.687 -1.258 . . . . 0.0 109.973 173.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.5 161.41 35.36 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.427 -0.796 . . . . 0.0 109.341 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.29 137.15 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-O 122.497 1.142 . . . . 0.0 110.663 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -85.43 123.63 72.65 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 119.945 -1.722 . . . . 0.0 108.598 173.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.64 32.26 0.51 Allowed 'Trans proline' 0 N--CA 1.434 -1.995 0 CA-C-N 125.291 2.925 . . . . 0.0 114.373 -173.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.61 61.74 1.38 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 123.158 1.456 . . . . 0.0 107.741 -175.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.85 170.52 43.66 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 120.413 -1.43 . . . . 0.0 109.852 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.74 -38.66 22.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.335 2.254 . . . . 0.0 115.541 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.7 -47.45 67.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.13 1.772 . . . . 0.0 115.1 174.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -87.36 -34.85 18.67 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.895 -1.128 . . . . 0.0 111.774 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.6 m -54.22 -54.7 36.4 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.491 1.516 . . . . 0.0 113.858 174.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.26 -53.85 6.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.276 -0.89 . . . . 0.0 110.809 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.05 100.93 2.63 Favored Glycine 0 N--CA 1.429 -1.807 0 O-C-N 121.188 -0.945 . . . . 0.0 110.982 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.94 -43.5 0.43 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -163.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -128.76 174.43 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.534 -1.354 . . . . 0.0 108.301 -168.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.409 ' H ' HG22 ' A' ' 52' ' ' ILE . 31.1 m-70 -131.61 162.24 30.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.132 -1.605 . . . . 0.0 110.538 169.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -56.99 136.72 56.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 167.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.17 20.78 78.93 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 116.884 1.513 . . . . 0.0 116.884 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -83.47 172.43 12.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.977 1.311 . . . . 0.0 112.265 167.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -124.6 133.12 53.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 121.054 -1.029 . . . . 0.0 111.828 176.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.1 m -79.76 158.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 119.783 -1.823 . . . . 0.0 110.857 167.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tt -121.61 -80.46 0.62 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.549 -1.344 . . . . 0.0 109.414 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.32 150.59 22.84 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.664 -1.273 . . . . 0.0 113.57 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.9 p -111.92 103.33 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 C-N-CA 126.279 1.831 . . . . 0.0 108.409 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.505 13.8 p30 56.52 38.73 29.87 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.859 2.064 . . . . 0.0 116.298 -177.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.98 -24.58 30.15 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 125.641 1.591 . . . . 0.0 113.455 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.98 134.69 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 124.918 1.287 . . . . 0.0 110.868 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 p -77.2 159.82 29.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.537 -1.977 . . . . 0.0 113.095 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -93.89 -14.84 25.61 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -54.24 129.55 35.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -167.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.31 -27.23 7.42 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 124.143 0.878 . . . . 0.0 111.163 -175.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.17 144.4 38.39 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.3 p -90.65 -179.41 5.54 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.161 -0.962 . . . . 0.0 108.819 155.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.617 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 7.3 t60 -60.38 -44.6 95.48 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -169.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -59.22 -34.56 72.32 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.542 -1.348 . . . . 0.0 114.585 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -43.31 67.16 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.235 -1.541 . . . . 0.0 111.049 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.32 -43.43 97.81 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 120.419 -1.426 . . . . 0.0 114.576 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 m -67.58 -41.52 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 120.461 -1.399 . . . . 0.0 114.352 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -68.08 -28.72 67.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.505 -1.372 . . . . 0.0 112.904 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.9 m -57.48 -50.78 71.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.305 1.442 . . . . 0.0 112.677 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.54 -33.98 35.85 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.565 -1.334 . . . . 0.0 112.799 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -61.2 -32.01 71.77 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.758 -1.839 . . . . 0.0 114.487 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -85.7 51.92 2.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.35 -1.468 . . . . 0.0 112.839 170.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.1 p -110.93 -74.14 0.66 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.466 1.507 . . . . 0.0 110.631 166.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.66 -82.99 0.35 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.857 -1.152 . . . . 0.0 113.219 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -82.1 -51.3 8.13 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -174.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.37 137.97 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 120.94 -1.1 . . . . 0.0 111.023 -166.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.95 90.03 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.5 -1.375 . . . . 0.0 110.676 -172.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -119.76 120.79 37.56 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.566 -1.959 . . . . 0.0 111.452 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -150.22 165.89 31.57 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 112.241 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.8 mt -121.64 137.84 54.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.03 1.332 . . . . 0.0 107.715 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mp -135.76 158.2 44.98 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.593 0.757 . . . . 0.0 110.334 -171.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -119.6 148.29 43.51 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -70.71 127.48 32.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.621 -1.3 . . . . 0.0 112.125 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.23 -162.08 35.24 Favored Glycine 0 N--CA 1.429 -1.799 0 O-C-N 120.587 -1.32 . . . . 0.0 113.724 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -87.71 138.83 31.12 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.806 -1.408 . . . . 0.0 111.45 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.5 t -86.15 -62.49 0.24 Allowed Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 116.016 -1.945 . . . . 0.0 114.11 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -85.91 50.0 2.44 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 CA-C-N 125.892 3.14 . . . . 0.0 113.897 -166.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.26 1.633 0 O-C-N 120.239 -1.538 . . . . 0.0 111.617 178.407 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 . . . . . 0 CA--C 1.491 -1.296 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.67 -71.27 0.53 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.597 -1.315 . . . . 0.0 110.887 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -82.65 140.77 32.97 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 122.845 1.307 . . . . 0.0 112.702 -175.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 70.5 m -100.34 -32.64 10.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.195 -0.941 . . . . 0.0 113.42 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.25 97.74 10.94 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.847 1.259 . . . . 0.0 111.116 -166.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.83 -76.36 0.13 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.07 -1.019 . . . . 0.0 111.798 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -85.74 -34.31 21.24 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 -169.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -78.44 64.95 3.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 -160.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -84.64 149.78 25.61 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.759 -1.838 . . . . 0.0 109.691 171.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -124.92 84.9 2.34 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.593 -1.317 . . . . 0.0 113.28 -154.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -123.58 -147.07 0.37 Allowed 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.779 -1.826 . . . . 0.0 112.67 -172.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.09 148.55 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 127.121 2.168 . . . . 0.0 107.279 -171.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' SER . . . . . 0.617 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 29.1 p -134.37 171.26 14.52 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.702 -1.249 . . . . 0.0 113.209 -168.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.7 155.06 41.35 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 120.976 -1.077 . . . . 0.0 111.355 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.26 1.611 0 C-N-CA 125.542 1.537 . . . . 0.0 108.951 -177.151 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.491 -1.651 0 N-CA-C 109.666 -0.936 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -91.6 171.94 7.23 Favored Pre-proline 0 N--CA 1.43 -1.449 0 C-N-CA 124.772 1.229 . . . . 0.0 110.631 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -64.3 -44.58 11.53 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 122.627 2.218 . . . . 0.0 112.892 168.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.45 49.95 2.1 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 124.015 0.817 . . . . 0.0 113.412 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.11 -177.16 6.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.243 1.497 . . . . 0.0 113.66 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 mt -85.21 136.43 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 125.217 1.407 . . . . 0.0 110.806 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -133.07 145.08 50.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.499 1.142 . . . . 0.0 111.26 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -112.52 123.59 50.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.178 -0.951 . . . . 0.0 109.515 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.5 m -102.92 149.68 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 122.687 1.232 . . . . 0.0 111.802 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -139.58 87.16 2.16 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -134.07 176.65 8.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.808 -1.183 . . . . 0.0 110.508 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.49 172.82 12.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 124.901 1.28 . . . . 0.0 109.125 170.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -68.55 134.22 49.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.953 1.701 . . . . 0.0 113.484 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -122.08 -102.75 0.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.606 -1.309 . . . . 0.0 109.664 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.99 -33.3 65.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.025 -1.672 . . . . 0.0 111.502 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -149.25 -176.55 5.41 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.3 t -82.35 -67.99 0.74 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.836 1.254 . . . . 0.0 108.829 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.89 -81.74 0.48 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.685 -1.259 . . . . 0.0 110.807 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.02 52.86 1.14 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -167.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 tt -139.12 162.34 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 121.679 -0.895 . . . . 0.0 110.218 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.1 t -122.59 141.93 51.17 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 171.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.56 145.77 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 125.917 1.687 . . . . 0.0 108.114 -167.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 t -136.72 114.56 11.29 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.965 1.365 . . . . 0.0 110.075 -172.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.62 178.91 26.79 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-O 122.942 1.301 . . . . 0.0 116.222 169.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.54 64.66 0.35 Allowed Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 122.265 0.925 . . . . 0.0 112.132 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.51 -64.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 124.389 1.076 . . . . 0.0 111.579 -173.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -110.5 -96.54 0.41 Allowed 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.029 -1.044 . . . . 0.0 112.818 -166.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.6 p -130.0 90.96 3.04 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.71 -1.869 . . . . 0.0 108.096 -175.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.6 p -134.4 -89.84 0.36 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.355 -0.841 . . . . 0.0 109.551 -175.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.8 -58.37 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.63 1.972 . . . . 0.0 110.89 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -127.57 -153.27 0.56 Allowed 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 165.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.53 88.56 7.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.476 -1.39 . . . . 0.0 109.55 163.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.89 -158.84 35.48 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -158.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.96 140.35 11.26 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.974 -1.309 . . . . 0.0 112.301 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.2 mm -124.21 136.4 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 121.016 -1.285 . . . . 0.0 108.927 -156.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.19 141.13 52.28 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.91 -1.119 . . . . 0.0 111.29 -170.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.57 134.96 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 120.687 -1.258 . . . . 0.0 112.046 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -84.28 -57.81 3.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.084 1.354 . . . . 0.0 110.441 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.63 165.23 18.91 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 124.069 0.947 . . . . 0.0 109.568 174.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.48 123.85 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 124.847 1.259 . . . . 0.0 110.59 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mm -83.18 130.38 57.23 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 120.824 -1.172 . . . . 0.0 110.215 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.15 80.65 1.84 Allowed 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 123.147 2.565 . . . . 0.0 112.434 172.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -141.55 -39.32 0.39 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.719 1.207 . . . . 0.0 112.071 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.88 -146.78 4.44 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.456 -1.402 . . . . 0.0 114.988 -173.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.5 -41.57 63.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.169 2.588 . . . . 0.0 116.95 -166.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.25 -47.7 80.72 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -72.56 -54.62 8.67 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.639 1.576 . . . . 0.0 112.176 173.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.0 t -60.28 -55.96 27.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.229 1.412 . . . . 0.0 114.312 -171.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.76 -39.19 70.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.092 0.957 . . . . 0.0 110.525 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.43 77.59 1.38 Allowed Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -137.03 -51.45 0.66 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -153.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.91 133.75 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -120.26 174.22 6.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 122.65 1.214 . . . . 0.0 114.123 -168.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -57.54 114.21 2.14 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.811 1.645 . . . . 0.0 114.573 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.1 26.03 65.13 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 120.555 -1.341 . . . . 0.0 115.529 -177.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -80.88 159.58 24.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 119.039 1.42 . . . . 0.0 110.779 168.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -124.12 128.92 50.0 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.034 -1.041 . . . . 0.0 109.904 -173.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.45 166.17 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 120.129 -1.607 . . . . 0.0 110.877 176.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.9 mt -131.76 -82.01 0.51 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.594 -1.316 . . . . 0.0 110.333 169.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 144.19 28.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.761 -1.212 . . . . 0.0 112.036 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.78 104.07 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 122.866 1.317 . . . . 0.0 110.781 174.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 57.4 50.56 11.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.16 2.184 . . . . 0.0 113.18 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.33 -24.91 8.67 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.066 -1.021 . . . . 0.0 114.459 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.2 t -85.6 101.29 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 120.441 -1.623 . . . . 0.0 110.969 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 p -79.2 125.93 30.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.684 1.194 . . . . 0.0 110.017 163.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.2 55.96 0.63 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.586 1.66 . . . . 0.0 110.891 -173.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -66.89 133.99 51.15 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -170.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.91 3.14 89.24 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.856 -1.153 . . . . 0.0 115.584 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.74 155.77 35.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.899 -1.354 . . . . 0.0 113.661 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.7 p -87.11 174.97 8.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.766 -1.208 . . . . 0.0 111.086 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -60.47 -46.45 90.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.357 -1.464 . . . . 0.0 114.277 -166.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -69.15 -36.16 77.12 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -71.14 -33.92 70.52 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.102 -1.624 . . . . 0.0 112.368 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.57 -53.04 57.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.965 -1.085 . . . . 0.0 113.567 169.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.7 m -75.02 -20.0 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.64 -1.912 . . . . 0.0 114.616 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -66.39 -42.45 87.89 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.89 -1.756 . . . . 0.0 110.94 167.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.4 m -63.92 -29.92 71.05 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.301 1.841 . . . . 0.0 113.021 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt -78.19 -37.28 46.04 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.647 -1.283 . . . . 0.0 112.188 174.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -69.11 -37.98 78.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.188 -1.57 . . . . 0.0 114.699 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.322 0.4 OUTLIER -79.33 55.7 1.95 Allowed 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 119.973 -1.705 . . . . 0.0 113.743 172.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -103.73 -76.63 0.59 Allowed 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.118 2.567 . . . . 0.0 107.632 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.94 -112.76 2.69 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 125.535 1.541 . . . . 0.0 112.958 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -81.62 -31.49 32.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.169 -1.195 . . . . 0.0 113.775 -172.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.8 p -105.14 138.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.449 1.1 . . . . 0.0 110.622 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.44 80.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 125.072 1.349 . . . . 0.0 108.52 -172.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -118.79 109.56 16.2 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.455 -1.403 . . . . 0.0 109.971 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -149.08 169.96 19.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.016 -1.678 . . . . 0.0 113.25 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.8 tp -122.78 121.55 36.56 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.654 1.581 . . . . 0.0 109.423 -170.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -131.78 169.96 15.49 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.835 0.826 . . . . 0.0 112.739 -166.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -130.25 135.72 48.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.663 1.985 . . . . 0.0 109.969 166.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 135.32 40.52 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.19 1.396 . . . . 0.0 110.327 173.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.56 -134.34 2.05 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 123.48 1.6 . . . . 0.0 117.07 -170.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -75.13 153.74 38.1 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.641 -1.506 . . . . 0.0 113.406 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 72.2 m -71.27 161.92 75.58 Favored Pre-proline 0 N--CA 1.43 -1.47 0 O-C-N 120.885 -1.134 . . . . 0.0 112.92 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -68.58 138.47 41.91 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 123.325 2.223 . . . . 0.0 116.105 -165.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.8 p . . . . . 0 C--O 1.26 1.645 0 C-N-CA 124.867 1.267 . . . . 0.0 109.61 174.317 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 77.71 173.07 0.2 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.778 2.031 . . . . 0.0 113.214 -177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -129.46 -72.89 0.58 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.011 0.924 . . . . 0.0 109.68 -174.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 8.5 t -138.19 -119.24 0.14 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.218 -1.551 . . . . 0.0 111.238 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.23 -64.13 1.26 Allowed 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.437 -1.414 . . . . 0.0 112.026 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . 47.39 50.79 14.28 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.625 2.37 . . . . 0.0 115.861 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -92.83 130.91 38.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.712 -1.242 . . . . 0.0 111.666 -170.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -120.38 -155.09 0.61 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 121.242 -0.911 . . . . 0.0 112.376 -169.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -93.85 129.61 40.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.421 -1.425 . . . . 0.0 110.87 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -134.06 122.38 22.87 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.243 -1.536 . . . . 0.0 109.465 -175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -122.38 -134.22 0.29 Allowed 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.896 -1.128 . . . . 0.0 112.668 -172.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.97 158.04 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 102.719 -3.067 . . . . 0.0 102.719 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 31.0 m -139.42 157.23 46.21 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 121.114 1.779 . . . . 0.0 113.171 -167.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -152.11 146.97 25.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.877 -1.14 . . . . 0.0 110.553 174.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--O 1.26 1.606 0 C-N-CA 125.774 1.63 . . . . 0.0 107.48 -179.83 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 CA--C 1.491 -1.631 0 N-CA-C 108.059 -1.554 . . . . 0.0 108.059 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -98.05 159.12 31.57 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.075 173.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.18 -38.83 8.47 Favored 'Trans proline' 0 N--CA 1.432 -2.089 0 C-N-CA 122.471 2.114 . . . . 0.0 111.717 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.31 75.72 0.26 Allowed Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 165.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -82.81 -176.12 6.14 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 123.208 1.48 . . . . 0.0 113.39 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.4 mt -78.96 143.92 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 127.195 2.198 . . . . 0.0 111.301 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.76 156.37 41.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.726 0.81 . . . . 0.0 109.657 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.83 116.92 20.19 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.168 0.985 . . . . 0.0 111.077 -175.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.18 131.4 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.791 1.236 . . . . 0.0 112.509 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -111.44 117.9 34.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.527 1.531 . . . . 0.0 109.665 171.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.9 tp -134.84 167.01 21.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.378 1.471 . . . . 0.0 109.031 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.72 154.75 49.88 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 119.811 -1.806 . . . . 0.0 110.941 170.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -56.98 129.64 42.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.837 2.055 . . . . 0.0 114.735 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -121.56 -97.65 0.45 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.362 1.465 . . . . 0.0 110.39 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.67 -58.23 6.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.159 1.784 . . . . 0.0 109.252 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -137.11 -179.64 5.83 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 p -84.39 -80.51 0.2 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.105 0.962 . . . . 0.0 111.635 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.4 mt -103.19 -90.55 0.37 Allowed 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.455 -1.403 . . . . 0.0 113.297 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.95 56.36 1.97 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.717 -1.239 . . . . 0.0 112.572 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.7 tt -139.56 171.69 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 t -123.41 148.73 45.82 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.158 -2.214 . . . . 0.0 109.723 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.69 157.07 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.452 1.501 . . . . 0.0 108.975 -168.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.4 t -138.37 152.8 48.76 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.913 -1.742 . . . . 0.0 109.189 170.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.48 -137.99 37.89 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 126.909 2.195 . . . . 0.0 116.205 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.66 14.44 82.08 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 124.582 1.087 . . . . 0.0 115.19 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.49 -126.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.962 -1.317 . . . . 0.0 113.698 -170.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -71.61 -58.74 3.22 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.421 -2.049 . . . . 0.0 111.305 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.0 t -130.38 143.72 50.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 163.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -155.04 -111.65 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -170.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.34 -47.47 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 124.994 1.318 . . . . 0.0 111.596 171.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -141.72 -147.93 0.23 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.528 1.931 . . . . 0.0 106.616 158.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -76.57 52.6 0.81 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.614 2.766 . . . . 0.0 112.101 172.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.86 177.32 20.12 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 -165.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.31 138.79 10.44 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -165.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.1 mm -127.01 140.74 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -166.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.64 141.55 52.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.623 -1.298 . . . . 0.0 109.514 -169.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.31 125.86 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.982 -1.074 . . . . 0.0 112.115 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -82.67 -59.16 2.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.454 1.502 . . . . 0.0 110.6 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.14 172.24 6.47 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 123.77 0.828 . . . . 0.0 109.779 175.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.78 139.71 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 124.779 1.232 . . . . 0.0 112.306 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -85.44 120.74 73.42 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-O 116.549 -1.691 . . . . 0.0 108.109 165.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.69 34.12 0.52 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 125.869 3.132 . . . . 0.0 113.472 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.35 68.77 1.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.64 169.87 42.97 Favored Glycine 0 N--CA 1.432 -1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 111.227 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.66 -29.86 68.43 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 124.982 1.313 . . . . 0.0 114.365 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.41 -52.74 64.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -60.43 -46.43 90.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.031 1.332 . . . . 0.0 113.253 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.9 m -60.5 -54.71 42.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.66 1.584 . . . . 0.0 115.057 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.21 -37.84 57.25 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.787 -1.196 . . . . 0.0 112.223 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.55 88.33 1.09 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 125.517 1.532 . . . . 0.0 111.719 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -138.4 -58.39 0.64 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.453 -1.027 . . . . 0.0 113.665 -158.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.4 mt -127.98 130.97 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -118.17 171.67 7.95 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.618 1.199 . . . . 0.0 111.257 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -60.11 120.64 10.12 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.32 25.27 63.94 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -75.66 154.19 36.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.499 -1.589 . . . . 0.0 110.023 160.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -124.63 110.56 14.57 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.614 -1.304 . . . . 0.0 109.284 -170.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.4 m -102.24 152.62 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.645 -1.284 . . . . 0.0 111.776 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.5 tp -124.83 -77.58 0.59 Allowed 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 121.332 -0.855 . . . . 0.0 110.964 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.82 133.99 36.63 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 120.697 -1.252 . . . . 0.0 112.766 -166.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 p -101.7 90.36 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.762 1.625 . . . . 0.0 107.807 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.8 t30 56.64 61.57 2.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.162 1.785 . . . . 0.0 112.949 -170.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.18 -43.96 2.95 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 120.294 -1.503 . . . . 0.0 114.042 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.1 t -88.27 125.14 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 121.119 -1.224 . . . . 0.0 112.577 -170.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.6 t -75.17 149.75 38.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.28 -1.512 . . . . 0.0 111.715 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.72 -8.23 38.29 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 120.596 -1.315 . . . . 0.0 112.924 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.23 126.35 27.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -168.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.6 -46.42 1.16 Allowed Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.713 -1.242 . . . . 0.0 111.721 -162.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.46 165.67 24.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.785 1.234 . . . . 0.0 114.106 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.8 p -93.29 167.69 11.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.092 1.425 . . . . 0.0 111.175 172.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -42.38 -50.83 5.06 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 129.639 3.175 . . . . 0.0 116.794 170.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -70.06 -28.85 65.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.91 1.284 . . . . 0.0 113.591 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -74.07 -46.7 41.42 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.131 -1.606 . . . . 0.0 111.286 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.34 77.87 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.695 1.598 . . . . 0.0 115.164 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.3 p -71.37 -30.21 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.694 -1.879 . . . . 0.0 112.346 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -63.72 -47.66 80.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.091 -1.63 . . . . 0.0 113.118 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.4 m -55.68 -40.06 71.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.797 1.639 . . . . 0.0 113.306 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 tt -80.96 -33.09 34.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -175.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -71.68 -31.81 67.18 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.031 -1.668 . . . . 0.0 113.392 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -89.17 63.52 6.62 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.661 -1.274 . . . . 0.0 111.966 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 p -108.4 -81.27 0.57 Allowed 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.16 1.784 . . . . 0.0 110.388 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.86 -93.44 0.63 Allowed Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 125.865 1.698 . . . . 0.0 112.79 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -81.37 -57.37 3.52 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -168.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.2 m -104.94 144.45 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 123.251 1.501 . . . . 0.0 112.581 -169.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.04 94.25 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -119.32 121.69 40.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.613 -1.305 . . . . 0.0 108.501 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.51 163.97 35.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.633 -1.292 . . . . 0.0 112.941 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 mp -121.14 121.57 38.14 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.96 168.29 11.65 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.996 1.318 . . . . 0.0 109.757 -173.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -123.58 130.97 53.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.335 1.454 . . . . 0.0 107.302 161.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.8 139.27 53.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 125.07 1.348 . . . . 0.0 113.184 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.58 -155.82 10.44 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 116.839 1.495 . . . . 0.0 116.839 -175.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -96.5 156.81 16.18 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.508 1.523 . . . . 0.0 111.107 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.7 t -81.11 123.83 81.52 Favored Pre-proline 0 N--CA 1.43 -1.475 0 CA-C-O 117.765 -1.112 . . . . 0.0 111.926 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.99 127.44 10.69 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 123.28 2.654 . . . . 0.0 113.921 -170.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 t . . . . . 0 C--O 1.259 1.598 0 CA-C-O 118.351 -0.833 . . . . 0.0 112.781 177.28 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . 0.268 18.7 p90 . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 72.07 42.07 0.61 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.172 1.789 . . . . 0.0 114.207 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -89.29 138.52 31.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.041 1.336 . . . . 0.0 110.05 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 76.0 p -76.42 -51.13 12.43 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.964 -1.71 . . . . 0.0 114.632 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -77.03 146.8 37.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -170.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.52 154.84 34.74 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.726 1.61 . . . . 0.0 107.953 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -154.57 78.32 1.07 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.978 -1.077 . . . . 0.0 110.946 -166.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -103.15 -54.46 2.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.271 -1.518 . . . . 0.0 111.454 -176.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 67.41 69.6 0.37 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.051 2.14 . . . . 0.0 115.777 177.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -126.47 173.73 9.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.802 -1.186 . . . . 0.0 108.835 160.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -122.53 168.31 12.3 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.705 -1.872 . . . . 0.0 112.698 -163.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.36 152.39 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 126.039 1.736 . . . . 0.0 110.94 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 36.2 m -134.71 169.23 17.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.508 1.923 . . . . 0.0 112.561 -174.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.11 152.08 30.03 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 124.789 1.236 . . . . 0.0 110.989 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.998 2.119 . . . . 0.0 108.102 162.817 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo . . . . . 0 CA--C 1.489 -1.749 0 N-CA-C 106.622 -2.107 . . . . 0.0 106.622 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -86.09 171.33 10.62 Favored Pre-proline 0 N--CA 1.431 -1.423 0 CA-C-N 119.724 1.147 . . . . 0.0 112.052 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -63.66 -41.35 25.3 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 122.537 2.158 . . . . 0.0 112.848 160.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.17 61.55 0.46 Allowed Glycine 0 N--CA 1.43 -1.745 0 C-N-CA 124.826 1.203 . . . . 0.0 112.899 171.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.27 154.22 26.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 121.307 -1.113 . . . . 0.0 112.757 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.87 133.69 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.764 -1.21 . . . . 0.0 109.394 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.5 153.95 41.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.089 -1.632 . . . . 0.0 111.549 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -125.67 119.81 29.02 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.908 -1.12 . . . . 0.0 112.619 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 t -104.58 137.17 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.958 -1.714 . . . . 0.0 112.015 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -111.07 127.07 55.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.71 1.204 . . . . 0.0 110.639 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 11.9 tp -135.03 -173.2 3.25 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.574 1.15 . . . . 0.0 109.929 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.407 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -141.75 157.6 44.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.272 -1.517 . . . . 0.0 107.913 171.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.8 tttm -71.8 112.33 7.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 122.67 1.224 . . . . 0.0 112.779 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -99.88 -93.44 0.27 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.521 1.528 . . . . 0.0 109.389 -172.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.12 -42.77 16.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.663 1.585 . . . . 0.0 108.248 161.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -137.66 178.66 6.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 p -84.29 -72.0 0.49 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.436 1.494 . . . . 0.0 110.651 174.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.4 mt -102.36 -75.56 0.6 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.511 1.124 . . . . 0.0 110.543 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.89 50.45 2.87 Favored Glycine 0 N--CA 1.431 -1.69 0 O-C-N 120.199 -1.563 . . . . 0.0 113.229 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.422 HG13 ' HA ' ' A' ' 40' ' ' VAL . 7.2 tt -143.12 146.3 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 122.314 1.054 . . . . 0.0 112.229 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 t -86.41 145.82 26.7 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.838 -1.788 . . . . 0.0 111.582 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.8 t -109.28 151.44 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.052 1.341 . . . . 0.0 111.13 -167.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -138.1 115.66 11.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.29 1.519 . . . . 0.0 110.964 170.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.35 -123.69 7.38 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.167 -1.583 . . . . 0.0 112.924 169.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.46 27.47 63.43 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 115.954 1.142 . . . . 0.0 115.954 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 m -105.64 -148.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 121.175 -1.191 . . . . 0.0 111.703 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -71.62 -37.18 70.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.853 1.661 . . . . 0.0 113.359 -166.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 t -130.89 117.73 19.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 163.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.9 t -151.07 -105.2 0.06 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.768 -1.832 . . . . 0.0 106.826 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.01 -52.13 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 125.119 1.368 . . . . 0.0 109.91 173.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -131.7 -158.84 0.92 Allowed 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 169.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -77.29 88.92 3.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.758 1.223 . . . . 0.0 108.594 162.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.32 172.87 32.05 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 119.798 -1.814 . . . . 0.0 113.555 -168.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.62 145.53 19.28 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -167.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.0 mm -125.05 142.83 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 120.463 -1.61 . . . . 0.0 108.925 -158.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -124.82 142.24 51.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 124.482 1.113 . . . . 0.0 110.683 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.9 t -90.94 133.98 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.887 -1.133 . . . . 0.0 113.155 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -91.01 -63.54 1.25 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.258 1.423 . . . . 0.0 113.114 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.45 158.22 11.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 -174.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.422 ' HA ' HG13 ' A' ' 20' ' ' ILE . 9.3 p -87.46 135.71 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 124.249 1.02 . . . . 0.0 112.821 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -85.44 120.8 73.48 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.741 -1.599 . . . . 0.0 109.861 171.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -73.81 44.85 1.0 Allowed 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 125.089 2.853 . . . . 0.0 116.266 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.93 43.12 0.55 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.952 1.358 . . . . 0.0 110.238 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.96 -171.93 38.8 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.047 -1.658 . . . . 0.0 112.3 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.19 -43.2 70.5 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.861 2.064 . . . . 0.0 116.114 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.78 -44.13 66.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.453 1.501 . . . . 0.0 114.975 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.56 -61.4 1.78 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.357 1.463 . . . . 0.0 112.045 171.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.1 m -56.21 -50.54 70.94 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -173.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -82.45 -27.9 31.61 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 121.308 -0.87 . . . . 0.0 111.183 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.81 73.09 1.28 Allowed Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 124.664 1.126 . . . . 0.0 110.913 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.411 HH22 ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -138.3 -44.26 0.5 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -152.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -128.35 134.28 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 120.615 1.552 . . . . 0.0 107.866 -170.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -125.14 171.13 10.55 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 122.734 1.254 . . . . 0.0 112.131 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -57.22 133.6 55.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.797 2.039 . . . . 0.0 115.763 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.42 12.16 84.81 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -79.95 167.06 20.97 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 118.819 1.309 . . . . 0.0 110.801 167.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -131.31 135.67 47.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.392 -1.443 . . . . 0.0 108.484 -172.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.57 145.76 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 120.103 1.319 . . . . 0.0 110.15 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.9 tp -135.49 -60.07 0.76 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.48 138.46 38.46 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.606 -1.934 . . . . 0.0 113.39 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.22 106.33 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.752 -1.217 . . . . 0.0 109.683 170.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 t30 56.03 40.42 30.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 170.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.22 -0.81 84.05 Favored Glycine 0 N--CA 1.431 -1.671 0 O-C-N 119.968 -1.708 . . . . 0.0 115.05 -176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.29 106.71 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 120.791 -1.417 . . . . 0.0 109.404 168.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 t -78.27 123.56 27.08 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.694 -1.879 . . . . 0.0 111.416 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -93.27 28.51 2.18 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.607 -1.308 . . . . 0.0 112.606 177.233 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.39 137.24 58.22 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.177 -1.577 . . . . 0.0 110.811 163.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.37 -35.44 2.99 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 119.16 -2.212 . . . . 0.0 114.406 -173.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.92 142.29 42.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.924 -1.339 . . . . 0.0 113.355 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.4 p -84.95 163.91 18.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.031 1.732 . . . . 0.0 111.851 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -48.13 -53.71 15.76 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.674 2.389 . . . . 0.0 116.688 -174.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -68.25 -29.91 68.83 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.289 1.042 . . . . 0.0 113.791 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -73.8 -46.68 43.88 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.889 1.275 . . . . 0.0 111.45 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.08 -41.48 86.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.273 1.829 . . . . 0.0 114.643 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 p -63.14 -34.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.089 -1.632 . . . . 0.0 113.084 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.29 -36.51 84.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.417 -1.427 . . . . 0.0 113.766 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.4 m -67.44 -35.05 78.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.033 1.733 . . . . 0.0 112.733 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -78.03 -37.83 46.02 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.538 -1.351 . . . . 0.0 112.093 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -62.99 -50.24 71.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.972 1.309 . . . . 0.0 113.165 173.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -85.38 60.83 6.49 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.168 -1.582 . . . . 0.0 112.002 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 p -99.02 -61.21 1.4 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.448 2.299 . . . . 0.0 108.008 168.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.84 -104.2 1.34 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 124.262 0.934 . . . . 0.0 113.606 160.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -81.92 -53.0 6.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.444 -1.033 . . . . 0.0 112.881 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.4 m -112.24 146.78 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 124.832 1.253 . . . . 0.0 109.359 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.57 123.7 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.243 -0.911 . . . . 0.0 108.99 -172.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -136.02 124.09 22.93 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.691 -1.255 . . . . 0.0 110.517 171.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -148.8 162.69 39.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.838 -1.164 . . . . 0.0 112.991 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.71 127.94 54.03 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -171.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.411 ' CD2' HH22 ' A' ' 51' ' ' ARG . 4.9 mp -118.21 159.49 23.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.928 1.291 . . . . 0.0 109.413 -175.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -120.03 126.27 50.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -68.04 147.54 52.24 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.623 -1.298 . . . . 0.0 112.69 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.71 -135.44 1.59 Allowed Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 116.911 1.525 . . . . 0.0 116.911 -174.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -100.22 158.07 16.13 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.016 1.726 . . . . 0.0 112.881 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.0 t -88.57 129.11 50.27 Favored Pre-proline 0 N--CA 1.429 -1.483 0 CA-C-O 116.852 -1.547 . . . . 0.0 110.344 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.81 -173.52 1.57 Allowed 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 124.112 3.208 . . . . 0.0 115.803 -165.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 C--O 1.261 1.671 0 C-N-CA 125.545 1.538 . . . . 0.0 113.448 -172.594 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 4.7 p90 . . . . . 0 CA--C 1.489 -1.368 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.37 44.39 9.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.276 2.324 . . . . 0.0 117.276 170.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.85 138.42 37.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 159.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 80.4 p -83.97 176.92 8.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.894 1.278 . . . . 0.0 110.953 171.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 64.83 84.06 0.16 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.022 1.729 . . . . 0.0 114.538 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.13 117.06 29.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.856 -1.777 . . . . 0.0 109.583 169.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -101.39 71.65 1.37 Allowed 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.646 1.212 . . . . 0.0 108.229 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -97.4 -2.06 43.05 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 40.66 70.62 0.24 Allowed 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 120.285 3.439 . . . . 0.0 120.285 168.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -139.54 161.99 36.15 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 157.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -121.91 -157.88 0.75 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.541 -1.35 . . . . 0.0 112.694 -163.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.95 153.25 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.153 -1.592 . . . . 0.0 111.239 -177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -137.14 178.14 7.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.029 1.332 . . . . 0.0 110.334 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -151.25 149.08 28.98 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 124.378 1.071 . . . . 0.0 108.563 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.261 1.66 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 173.359 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.759 0 CA-C-O 121.175 0.319 . . . . 0.0 112.92 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -82.6 153.11 25.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.164 -1.198 . . . . 0.0 113.455 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.33 128.79 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 124.703 1.201 . . . . 0.0 109.78 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -137.27 160.99 37.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.489 -1.382 . . . . 0.0 110.404 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -113.56 140.61 48.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.871 -1.143 . . . . 0.0 112.145 175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -102.54 138.69 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 124.195 0.998 . . . . 0.0 109.367 172.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -121.15 101.92 7.97 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 125.514 1.525 . . . . 0.0 107.951 168.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -133.87 -175.5 3.86 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.421 -0.799 . . . . 0.0 109.918 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.26 174.66 15.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.934 -1.104 . . . . 0.0 110.285 174.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -69.98 123.32 21.25 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -121.32 -81.89 0.64 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.539 1.536 . . . . 0.0 111.784 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.85 -57.24 3.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.106 1.763 . . . . 0.0 108.61 170.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -142.24 -139.1 0.11 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 156.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 p -85.49 -85.62 0.14 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.007 -1.683 . . . . 0.0 111.997 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.9 mt -101.18 -74.46 0.61 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.334 -1.479 . . . . 0.0 113.335 -171.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.59 54.33 1.45 Allowed Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 124.839 1.209 . . . . 0.0 110.446 -174.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.9 tt -146.23 155.29 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.477 -1.013 . . . . 0.0 110.625 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 t -121.09 151.9 39.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.409 -1.432 . . . . 0.0 109.088 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -124.24 152.33 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.509 1.524 . . . . 0.0 110.319 -164.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 t -138.65 138.25 37.64 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 120.494 -1.379 . . . . 0.0 110.11 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.69 -137.71 20.53 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.832 1.682 . . . . 0.0 114.349 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.33 23.67 46.88 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 117.6 1.8 . . . . 0.0 117.6 166.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 m -87.27 -119.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 119.491 1.646 . . . . 0.0 114.848 -171.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -71.37 -45.34 63.08 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.875 -2.391 . . . . 0.0 113.117 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 t -138.56 170.94 15.12 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 148.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -156.01 -69.05 0.11 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.444 -1.41 . . . . 0.0 111.357 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 t -92.62 -56.51 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 124.291 1.036 . . . . 0.0 111.939 -168.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -141.12 -92.1 0.15 Allowed 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 121.475 -0.765 . . . . 0.0 109.997 -170.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -117.58 52.35 0.99 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.651 1.691 . . . . 0.0 107.617 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.81 -142.52 17.53 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 107.309 -2.317 . . . . 0.0 107.309 -166.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.08 148.29 23.49 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 124.675 1.131 . . . . 0.0 113.398 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.61 151.31 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.17 143.94 50.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.252 1.021 . . . . 0.0 111.186 -171.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.8 t -73.08 129.6 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.693 -1.254 . . . . 0.0 111.657 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -81.54 -62.77 1.55 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 109.62 171.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.45 167.54 15.61 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -92.35 136.84 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 124.835 1.254 . . . . 0.0 110.668 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.6 mm -83.83 120.34 74.91 Favored Pre-proline 0 N--CA 1.43 -1.427 0 O-C-N 120.314 -1.491 . . . . 0.0 109.005 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.12 65.0 8.93 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 CA-C-N 124.801 2.75 . . . . 0.0 113.277 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -141.7 -1.4 1.28 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.894 1.278 . . . . 0.0 112.897 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -141.87 -161.68 8.85 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 120.251 -1.531 . . . . 0.0 114.826 -171.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.69 -37.15 86.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 -173.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.27 92.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.274 1.03 . . . . 0.0 113.383 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -68.63 -55.88 10.06 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.375 1.07 . . . . 0.0 112.943 167.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.8 t -59.29 -56.99 15.04 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.324 1.45 . . . . 0.0 114.906 -170.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -81.11 -37.83 28.25 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.446 -1.409 . . . . 0.0 110.572 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.76 90.29 1.33 Allowed Glycine 0 N--CA 1.429 -1.78 0 O-C-N 120.519 -1.363 . . . . 0.0 111.397 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -137.18 -41.79 0.57 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 121.418 -1.048 . . . . 0.0 111.189 -171.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 mt -129.11 143.13 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.34 -173.54 3.3 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.313 -1.492 . . . . 0.0 111.179 170.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -55.97 132.57 50.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.39 9.86 86.59 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 118.236 2.054 . . . . 0.0 118.236 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -74.23 155.47 38.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 119.496 1.648 . . . . 0.0 112.167 172.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -124.55 144.0 50.37 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.105 -1.622 . . . . 0.0 110.719 -170.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 m -101.39 154.02 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 119.802 -1.811 . . . . 0.0 112.605 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.15 -91.18 0.56 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.209 1.404 . . . . 0.0 108.128 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.31 148.28 23.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.886 -1.133 . . . . 0.0 113.89 -166.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.36 100.91 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.086 1.354 . . . . 0.0 107.796 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.5 t30 56.77 61.06 2.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.269 1.828 . . . . 0.0 112.393 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.87 -39.02 2.95 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.922 -1.111 . . . . 0.0 115.336 -176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.08 128.06 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.453 -1.616 . . . . 0.0 112.603 -166.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -77.36 124.2 27.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.881 -1.137 . . . . 0.0 111.819 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.9 mp -87.36 74.22 9.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.115 1.436 . . . . 0.0 110.503 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -68.81 99.8 1.09 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.265 -1.522 . . . . 0.0 113.293 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.75 23.17 53.96 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.481 0.952 . . . . 0.0 115.481 172.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.35 136.35 39.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.384 -1.068 . . . . 0.0 112.526 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.6 p -80.13 172.21 14.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.572 1.149 . . . . 0.0 113.063 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.403 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 10.2 t-160 -61.63 -41.25 97.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.257 -1.527 . . . . 0.0 113.252 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -59.02 -40.24 84.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -69.87 -41.63 74.55 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.29 -1.506 . . . . 0.0 111.773 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.82 97.23 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.678 -1.264 . . . . 0.0 114.082 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.13 -43.29 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.417 -1.427 . . . . 0.0 113.096 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -62.06 -42.25 99.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.433 -1.417 . . . . 0.0 113.729 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.3 p -70.15 -17.51 63.19 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.26 -1.525 . . . . 0.0 115.052 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.4 mt -80.32 -39.01 29.53 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 120.424 -1.422 . . . . 0.0 113.454 171.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -86.61 -27.43 23.86 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.484 -1.385 . . . . 0.0 113.932 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -83.42 60.56 5.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.68 -1.888 . . . . 0.0 112.55 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.5 p -109.06 -89.85 0.47 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.693 1.597 . . . . 0.0 112.518 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.44 -129.25 8.09 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 107.416 -2.274 . . . . 0.0 107.416 -166.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -81.25 -51.44 8.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -165.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -104.16 145.96 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.623 -1.298 . . . . 0.0 113.764 -159.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.24 105.73 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 125.022 1.329 . . . . 0.0 110.101 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -116.86 120.85 39.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.889 -1.132 . . . . 0.0 108.623 168.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.58 166.86 27.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.503 -1.373 . . . . 0.0 111.911 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -120.21 137.38 54.23 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mp -125.53 156.75 38.55 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.312 1.445 . . . . 0.0 108.363 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -113.49 132.59 55.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 166.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.6 tptt -68.86 138.16 54.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.789 -1.194 . . . . 0.0 112.693 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.76 0 O-C-N 120.795 -1.191 . . . . 0.0 114.667 -172.642 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -128.25 145.91 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 125.386 1.474 . . . . 0.0 109.271 -164.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.403 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 9.1 p -126.3 163.31 23.51 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.463 1.505 . . . . 0.0 111.822 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.19 159.02 43.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.514 -0.741 . . . . 0.0 109.579 162.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.261 1.671 0 C-N-CA 124.048 0.939 . . . . 0.0 109.012 177.665 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.703 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -74.17 145.98 43.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 118.842 1.321 . . . . 0.0 113.429 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.4 mt -89.44 137.64 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.251 1.42 . . . . 0.0 110.106 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -146.56 161.26 40.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.972 -1.08 . . . . 0.0 109.99 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -115.52 141.07 48.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.146 -0.971 . . . . 0.0 108.878 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.4 147.39 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 124.045 0.938 . . . . 0.0 112.632 173.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -113.67 123.33 49.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 123.746 0.818 . . . . 0.0 109.058 168.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.5 mt -132.83 157.91 43.83 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.442 -1.411 . . . . 0.0 110.427 165.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.66 139.26 27.89 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -70.41 96.68 1.17 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -92.29 -66.36 0.93 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.123 1.769 . . . . 0.0 109.703 171.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -88.7 -71.37 0.59 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.173 1.789 . . . . 0.0 109.186 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -136.55 166.45 23.5 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -171.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -83.06 -71.19 0.51 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -167.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.85 -83.27 0.46 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.138 -1.601 . . . . 0.0 110.028 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.4 39.35 2.82 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.688 -1.258 . . . . 0.0 114.932 170.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.86 169.58 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.093 -1.239 . . . . 0.0 108.774 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.7 p -122.45 146.51 47.31 Favored 'General case' 0 N--CA 1.429 -1.513 0 O-C-N 119.968 -1.708 . . . . 0.0 108.75 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 t -125.32 149.83 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 125.168 1.387 . . . . 0.0 110.044 -161.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -136.29 142.11 43.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.062 1.411 . . . . 0.0 109.774 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.71 -130.77 9.91 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 125.761 1.648 . . . . 0.0 114.191 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.93 62.42 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 121.404 -1.056 . . . . 0.0 114.531 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 27' ' ' ASN . 46.5 t -89.36 168.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.435 ' H ' HG12 ' A' ' 26' ' ' VAL . 10.1 p30 -67.73 -26.8 66.32 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 125.984 1.714 . . . . 0.0 113.163 -163.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 t -129.74 128.18 41.92 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 152.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 p -155.39 -89.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.853 -1.154 . . . . 0.0 110.672 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -78.25 -47.2 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.3 -1.5 . . . . 0.0 109.457 171.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.95 -153.18 0.52 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 167.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -76.55 89.84 3.3 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.399 -1.438 . . . . 0.0 109.278 163.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.69 -154.35 30.9 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -162.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.39 136.93 9.11 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-O 122.858 1.254 . . . . 0.0 112.465 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.5 mm -124.89 133.75 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.4 -1.647 . . . . 0.0 107.574 -164.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.96 141.4 51.99 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.677 1.191 . . . . 0.0 108.311 -170.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.7 t -80.03 130.53 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.906 -1.121 . . . . 0.0 110.911 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -86.75 -57.34 3.02 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 120.139 -1.6 . . . . 0.0 110.783 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.87 155.56 29.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.853 1.261 . . . . 0.0 109.514 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -94.78 131.16 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 122.519 1.152 . . . . 0.0 110.689 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.7 mm -82.93 123.06 78.18 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 120.523 -1.361 . . . . 0.0 110.42 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.11 40.9 1.0 Allowed 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.041 2.494 . . . . 0.0 114.051 -172.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -144.78 53.85 1.23 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.19 174.29 45.91 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 120.419 -1.426 . . . . 0.0 113.896 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.78 -36.09 73.86 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.475 1.91 . . . . 0.0 114.4 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.65 -53.78 47.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.35 -49.95 50.87 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.284 1.434 . . . . 0.0 112.346 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -61.19 -39.87 91.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -82.07 -47.92 12.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.838 -1.164 . . . . 0.0 111.236 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.96 62.63 1.98 Allowed Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 117.109 1.604 . . . . 0.0 117.109 168.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -135.5 -1.08 2.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.472 -1.605 . . . . 0.0 111.841 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.3 mt -129.28 149.47 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -126.8 173.68 9.36 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 120.287 -1.508 . . . . 0.0 111.531 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -58.12 135.9 57.11 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.945 1.298 . . . . 0.0 114.214 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.76 18.51 78.84 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 117.559 1.784 . . . . 0.0 117.559 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -82.7 162.51 21.78 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 120.341 2.07 . . . . 0.0 111.543 166.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -126.33 123.4 37.93 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.714 -1.241 . . . . 0.0 110.384 -172.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -85.56 155.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.118 -1.614 . . . . 0.0 113.284 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.04 -86.13 0.65 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.707 1.203 . . . . 0.0 111.229 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.52 144.94 28.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.63 96.25 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 124.468 1.107 . . . . 0.0 108.329 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.296 9.5 t-20 57.19 47.59 16.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.854 1.661 . . . . 0.0 113.343 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.79 -34.3 5.86 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.582 -1.324 . . . . 0.0 114.278 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 t -100.9 109.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 118.368 1.084 . . . . 0.0 112.159 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.9 m -79.61 110.22 14.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.665 1.586 . . . . 0.0 112.392 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.14 85.4 4.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.577 -1.952 . . . . 0.0 110.555 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.03 135.11 51.79 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.921 -1.737 . . . . 0.0 113.652 174.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.56 7.23 63.45 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 124.685 1.136 . . . . 0.0 114.371 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.86 130.8 39.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.825 -1.397 . . . . 0.0 112.903 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.3 p -80.76 171.61 14.8 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 123.126 1.441 . . . . 0.0 110.252 168.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.459 ' CE1' ' HB2' ' B' ' 13' ' ' SER . 1.9 t60 -56.25 -41.7 76.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.641 1.977 . . . . 0.0 114.093 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -52.32 -45.72 65.73 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.511 1.524 . . . . 0.0 114.859 171.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -72.06 -38.51 69.43 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.841 1.256 . . . . 0.0 111.722 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.12 76.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.621 1.168 . . . . 0.0 113.852 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.3 t -63.21 -48.14 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.628 1.971 . . . . 0.0 113.331 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -53.59 -46.46 70.37 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.483 1.135 . . . . 0.0 113.271 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.7 m -65.91 -41.71 91.11 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.029 2.132 . . . . 0.0 113.218 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.8 mt -85.81 -27.31 25.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.139 -1.601 . . . . 0.0 114.83 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 44.6 mtt180 -65.47 -45.93 81.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.775 -1.828 . . . . 0.0 112.625 173.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -83.46 60.39 5.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.017 1.389 . . . . 0.0 112.26 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.89 -80.85 0.37 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.47 1.908 . . . . 0.0 109.192 175.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.16 -78.79 0.4 Allowed Glycine 0 N--CA 1.429 -1.774 0 O-C-N 121.294 -0.879 . . . . 0.0 114.257 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -81.51 -58.74 2.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.503 -0.998 . . . . 0.0 113.472 -175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.43 149.21 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.777 1.231 . . . . 0.0 110.487 -166.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.6 t -129.45 112.31 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.073 1.349 . . . . 0.0 107.786 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -127.98 104.44 7.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.637 -1.289 . . . . 0.0 110.857 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.3 mt -127.7 162.59 26.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 111.313 -169.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.24 136.32 54.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.514 1.526 . . . . 0.0 107.15 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.74 161.24 42.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.802 0.811 . . . . 0.0 111.822 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -114.29 134.8 54.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.857 1.663 . . . . 0.0 109.652 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -62.65 135.2 57.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.748 0 CA-C-O 123.281 1.489 . . . . 0.0 116.175 -178.119 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.81 123.86 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.261 1.824 . . . . 0.0 107.699 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.459 ' HB2' ' CE1' ' A' ' 71' ' ' HIS . 15.0 m -129.59 133.06 46.96 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.707 -1.246 . . . . 0.0 113.154 -171.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.02 155.9 34.61 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.644 -1.285 . . . . 0.0 112.544 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 C--O 1.26 1.633 0 C-N-CA 126.636 1.974 . . . . 0.0 107.858 173.798 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.747 0 CA-C-O 121.244 0.358 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -82.18 178.97 7.98 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 120.898 -1.354 . . . . 0.0 113.624 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -85.67 133.99 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.326 -1.483 . . . . 0.0 108.376 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -135.96 146.65 47.49 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 121.201 -0.937 . . . . 0.0 108.781 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -106.68 134.82 49.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.027 -1.046 . . . . 0.0 109.36 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.9 t -102.06 115.44 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -120.38 95.44 4.74 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.801 1.24 . . . . 0.0 108.63 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.496 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 11.0 tp -134.49 -155.95 0.69 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.174 -0.954 . . . . 0.0 109.368 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.496 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -154.53 168.19 27.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -71.96 129.64 39.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -120.98 -69.88 0.82 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.825 1.25 . . . . 0.0 110.722 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -76.56 -62.62 1.57 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.657 -1.277 . . . . 0.0 109.188 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -137.79 -131.11 0.13 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 139.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.7 p -89.81 -78.15 0.37 Allowed 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 120.19 1.359 . . . . 0.0 112.187 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.1 mt -103.21 -99.31 0.3 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.372 -1.455 . . . . 0.0 113.921 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.42 52.43 1.71 Allowed Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -157.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.95 147.05 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.956 -1.32 . . . . 0.0 108.366 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 t -122.48 148.21 45.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.727 -1.233 . . . . 0.0 109.223 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.62 157.01 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 122.343 1.068 . . . . 0.0 110.11 -164.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.2 t -137.06 112.71 9.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 122.75 1.262 . . . . 0.0 107.834 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.46 175.38 50.7 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-O 122.934 1.296 . . . . 0.0 115.004 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.43 67.84 0.7 Allowed Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.1 m -97.21 -130.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 125.135 1.374 . . . . 0.0 110.694 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -71.1 -39.12 72.3 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.028 -2.295 . . . . 0.0 112.714 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.8 t -151.99 143.14 23.22 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 163.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 t -156.55 -69.25 0.11 Allowed 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.081 -1.637 . . . . 0.0 113.285 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.37 -58.32 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.558 -1.339 . . . . 0.0 112.734 -164.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -125.52 -83.64 0.63 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 124.078 0.951 . . . . 0.0 109.295 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.39 53.71 1.93 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 165.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.3 -140.42 16.27 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 -161.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.15 150.24 19.94 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 117.955 0.877 . . . . 0.0 113.522 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 22.0 mm -125.67 148.91 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -125.85 135.62 52.16 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.858 -1.151 . . . . 0.0 112.052 -169.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.3 t -78.65 130.32 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 120.398 -1.438 . . . . 0.0 112.333 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -89.52 -59.35 2.23 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.903 -1.123 . . . . 0.0 110.536 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.86 163.33 23.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.765 0.793 . . . . 0.0 110.24 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.4 131.72 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.122 1.369 . . . . 0.0 109.152 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.4 mm -83.58 120.31 75.15 Favored Pre-proline 0 N--CA 1.431 -1.381 0 O-C-N 120.926 -1.109 . . . . 0.0 109.816 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.8 67.56 8.57 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 124.022 2.472 . . . . 0.0 112.88 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -145.4 9.72 1.23 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 123.997 0.919 . . . . 0.0 111.835 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 -158.82 18.49 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 119.664 -1.898 . . . . 0.0 114.565 -172.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.34 -43.51 79.13 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.512 2.325 . . . . 0.0 116.26 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.98 90.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -73.79 -49.98 22.71 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.714 1.206 . . . . 0.0 111.583 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 t -55.05 -55.45 30.83 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.522 2.329 . . . . 0.0 114.485 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -79.2 -44.44 21.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.641 -1.287 . . . . 0.0 111.772 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.49 91.48 0.55 Allowed Glycine 0 N--CA 1.431 -1.686 0 C-N-CA 124.223 0.916 . . . . 0.0 113.443 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -136.16 -45.7 0.63 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.168 -1.195 . . . . 0.0 110.436 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.6 mt -126.04 133.45 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 -169.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.82 -178.19 3.97 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.598 1.19 . . . . 0.0 112.101 -176.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -56.42 125.03 20.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.49 16.79 80.45 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 117.588 1.795 . . . . 0.0 117.588 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -72.07 161.8 30.38 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.346 1.573 . . . . 0.0 112.634 167.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -123.16 115.18 21.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 121.029 -1.044 . . . . 0.0 109.314 -173.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.96 148.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 119.872 -1.767 . . . . 0.0 110.136 172.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.3 mt -128.98 -81.01 0.57 Allowed 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 121.41 -0.806 . . . . 0.0 111.46 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.5 138.12 34.56 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.553 -1.342 . . . . 0.0 114.455 -167.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.93 90.91 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 126.394 1.877 . . . . 0.0 109.411 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.292 3.3 t-20 56.37 50.65 12.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.945 1.698 . . . . 0.0 112.324 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.23 -36.8 3.89 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 120.678 -1.264 . . . . 0.0 113.675 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -85.23 124.05 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 O-C-N 121.305 -1.115 . . . . 0.0 112.293 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 t -77.98 129.52 35.39 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.677 -1.264 . . . . 0.0 110.864 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tp -95.08 51.84 1.39 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.972 -1.705 . . . . 0.0 112.808 -164.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.98 123.81 21.25 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.652 1.581 . . . . 0.0 114.512 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.39 -4.8 80.51 Favored Glycine 0 N--CA 1.429 -1.78 0 O-C-N 120.26 -1.525 . . . . 0.0 114.358 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.35 143.41 40.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 121.258 -1.142 . . . . 0.0 112.976 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.8 p -85.96 175.84 8.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.16 1.384 . . . . 0.0 111.006 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -59.73 -43.67 94.11 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.205 1.402 . . . . 0.0 112.488 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.88 -40.99 90.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.528 2.331 . . . . 0.0 115.386 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -72.1 -37.46 69.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.189 -1.57 . . . . 0.0 112.354 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.46 77.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.931 -1.106 . . . . 0.0 113.494 171.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.6 -51.58 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.365 1.466 . . . . 0.0 113.069 170.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -60.46 -40.28 90.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.635 -1.291 . . . . 0.0 114.328 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 p -70.48 -18.55 62.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.321 -1.487 . . . . 0.0 113.86 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mt -85.67 -19.13 31.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.01 -1.681 . . . . 0.0 113.253 170.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -78.54 -44.16 24.96 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.237 -1.539 . . . . 0.0 110.924 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -82.95 64.91 7.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.879 1.272 . . . . 0.0 112.942 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.5 p -99.72 -74.08 0.61 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.156 1.782 . . . . 0.0 111.015 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.37 -131.19 9.56 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 125.702 1.62 . . . . 0.0 111.01 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -76.79 -44.21 33.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.003 -1.292 . . . . 0.0 113.481 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -109.31 164.42 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 123.915 0.886 . . . . 0.0 111.055 -167.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.0 t -134.15 127.75 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.225 1.41 . . . . 0.0 109.38 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -142.43 115.68 8.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.397 -0.814 . . . . 0.0 109.078 171.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -149.05 162.36 40.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.243 -1.536 . . . . 0.0 112.019 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.3 mp -121.01 124.41 44.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.282 1.039 . . . . 0.0 108.982 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -117.86 166.06 12.93 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.527 1.131 . . . . 0.0 108.944 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -117.33 131.6 56.76 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 162.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -73.71 124.53 26.19 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.941 -1.099 . . . . 0.0 111.051 -174.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.725 0 O-C-N 121.232 -0.917 . . . . 0.0 115.055 -166.112 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 N--CA 1.43 -1.426 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.98 160.21 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 127.709 2.404 . . . . 0.0 106.994 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 30.2 p -150.01 154.73 38.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.451 -2.031 . . . . 0.0 114.639 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.95 164.42 38.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.296 1.038 . . . . 0.0 112.009 170.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.26 1.627 0 C-N-CA 125.648 1.579 . . . . 0.0 108.977 176.351 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.705 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.87 179.02 7.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.932 1.349 . . . . 0.0 113.22 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.92 133.51 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.431 1.492 . . . . 0.0 108.98 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -138.47 157.55 45.98 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.959 -1.088 . . . . 0.0 112.497 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -126.92 114.19 17.53 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.992 1.317 . . . . 0.0 112.477 -172.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.2 t -102.9 141.66 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.673 -1.267 . . . . 0.0 110.208 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -117.83 122.09 42.46 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 160.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -133.91 162.33 32.33 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.838 -1.163 . . . . 0.0 108.936 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.61 147.75 27.79 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.406 -1.434 . . . . 0.0 107.585 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -64.03 120.88 12.87 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 122.994 1.378 . . . . 0.0 114.703 -168.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -98.35 -88.21 0.32 Allowed 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 125.15 1.38 . . . . 0.0 108.816 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.55 -46.77 36.82 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.559 -1.338 . . . . 0.0 109.623 170.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -156.9 -158.06 0.74 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 169.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 p -83.53 -82.05 0.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.745 -1.222 . . . . 0.0 112.39 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.4 mt -102.49 -97.53 0.29 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.824 -1.798 . . . . 0.0 114.437 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.43 51.23 1.59 Allowed Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -162.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.9 tt -140.95 161.06 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 121.072 -1.252 . . . . 0.0 110.361 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -122.47 142.5 50.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 120.352 -1.467 . . . . 0.0 108.029 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -123.64 152.65 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 125.446 1.499 . . . . 0.0 107.861 -171.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.5 t -136.42 120.3 17.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.463 1.601 . . . . 0.0 110.786 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.67 -147.71 42.31 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 124.746 1.165 . . . . 0.0 113.695 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.88 38.39 6.92 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 121.997 0.776 . . . . 0.0 112.346 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 26' ' ' VAL . 13.2 m -80.95 -112.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 126.219 1.808 . . . . 0.0 113.318 -169.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -71.7 -51.91 20.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.876 -1.765 . . . . 0.0 111.482 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -151.45 153.4 34.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.1 t -154.6 -69.14 0.13 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.286 -0.884 . . . . 0.0 112.134 -175.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.9 t -91.97 -61.44 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 120.494 -1.379 . . . . 0.0 112.682 -163.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -124.93 -71.03 0.72 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.049 1.34 . . . . 0.0 111.78 -161.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -141.71 39.54 1.68 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.7 -144.48 17.96 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 -157.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.69 158.68 33.31 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.401 -1.058 . . . . 0.0 113.197 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 mm -126.36 145.28 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -125.94 138.7 53.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.084 -1.01 . . . . 0.0 111.715 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.7 t -85.83 127.72 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 124.937 1.295 . . . . 0.0 111.799 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -83.4 -63.72 1.3 Allowed 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 125.195 1.398 . . . . 0.0 111.175 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.09 171.64 5.71 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.816 0.846 . . . . 0.0 109.083 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.38 139.19 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.312 1.045 . . . . 0.0 111.737 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.1 mm -85.79 109.65 23.97 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 119.938 -1.726 . . . . 0.0 108.647 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -82.46 57.24 6.05 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 123.361 2.707 . . . . 0.0 114.14 -163.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -141.16 22.28 2.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.028 1.331 . . . . 0.0 110.427 -174.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.25 -160.91 19.79 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 120.179 -1.576 . . . . 0.0 115.044 -173.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.4 -45.57 88.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.893 2.077 . . . . 0.0 115.574 -166.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.08 79.04 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -77.63 -41.75 37.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.416 1.086 . . . . 0.0 111.948 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.8 t -70.14 -46.57 64.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -82.14 -61.52 1.88 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.723 -1.236 . . . . 0.0 111.684 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.64 99.42 1.08 Allowed Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.195 -0.941 . . . . 0.0 114.923 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -138.56 -37.15 0.55 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.97 -1.312 . . . . 0.0 110.929 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.6 mt -127.47 134.58 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -170.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.86 -176.68 3.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.842 -1.161 . . . . 0.0 113.523 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -55.2 127.88 31.3 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.97 1.708 . . . . 0.0 114.846 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.37 11.17 84.41 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.18 156.1 39.96 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.059 1.429 . . . . 0.0 111.576 169.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -123.76 102.06 7.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.134 -0.978 . . . . 0.0 109.772 -167.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -80.2 132.73 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.666 -1.271 . . . . 0.0 111.169 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.1 mt -122.04 -74.07 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.69 -1.256 . . . . 0.0 110.958 -170.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.35 151.67 20.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.7 t -113.65 101.18 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.611 1.965 . . . . 0.0 107.397 173.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.312 16.3 t-20 56.56 48.39 16.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.518 1.927 . . . . 0.0 113.536 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.73 -14.09 57.01 Favored Glycine 0 N--CA 1.43 -1.761 0 O-C-N 120.035 -1.666 . . . . 0.0 114.894 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 t -100.93 117.34 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 120.989 -1.301 . . . . 0.0 109.992 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -79.15 144.14 34.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.504 -1.372 . . . . 0.0 113.449 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mp -93.42 44.93 1.15 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.022 1.391 . . . . 0.0 112.517 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.89 114.41 6.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.096 -1.627 . . . . 0.0 112.824 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.08 7.89 73.01 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 120.817 -1.177 . . . . 0.0 113.875 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.5 143.03 38.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.013 -1.287 . . . . 0.0 110.871 168.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.2 p -90.33 176.07 6.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.349 -1.47 . . . . 0.0 110.285 165.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -59.62 -38.41 81.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -52.98 -41.6 64.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.519 -1.363 . . . . 0.0 113.768 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -71.23 -35.98 71.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.882 1.273 . . . . 0.0 112.356 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.82 84.57 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.455 -1.403 . . . . 0.0 113.908 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.23 -42.53 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 124.954 1.302 . . . . 0.0 112.07 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -61.08 -37.39 82.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.313 -1.492 . . . . 0.0 112.845 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.3 p -70.45 -22.96 62.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 171.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 mt -79.23 -40.84 29.68 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.998 -1.689 . . . . 0.0 112.739 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -63.78 -43.39 96.47 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.882 -1.137 . . . . 0.0 111.217 173.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -93.5 58.98 2.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.189 -1.57 . . . . 0.0 112.469 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 p -88.45 -72.46 0.54 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.708 1.203 . . . . 0.0 108.516 166.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.96 -128.26 8.04 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -76.67 -46.73 24.57 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.03 148.87 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 124.714 1.206 . . . . 0.0 112.351 -170.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.33 116.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 127.175 2.19 . . . . 0.0 108.652 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -117.62 115.35 24.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.252 -1.53 . . . . 0.0 107.316 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -144.03 157.95 44.01 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.985 -1.072 . . . . 0.0 112.705 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mp -122.11 134.58 54.75 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.985 0.914 . . . . 0.0 109.114 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.34 170.1 13.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.959 1.304 . . . . 0.0 109.879 -169.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -116.4 135.38 53.9 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 158.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -74.73 131.46 40.86 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.758 0 C-N-CA 125.99 1.757 . . . . 0.0 116.726 -178.224 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.22 171.46 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.335 2.254 . . . . 0.0 105.215 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.7 p -144.66 141.84 29.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.62 -1.925 . . . . 0.0 115.141 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.87 133.4 49.34 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.94 1.696 . . . . 0.0 111.428 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.261 1.67 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.148 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.737 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -82.18 171.06 14.73 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.6 130.44 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 167.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -133.73 166.53 22.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.227 1.013 . . . . 0.0 111.311 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -125.16 136.74 53.89 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.238 1.015 . . . . 0.0 109.293 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.9 m -102.06 135.59 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.707 -1.246 . . . . 0.0 108.849 173.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -126.04 87.36 2.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.26 1.024 . . . . 0.0 109.796 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 9.1 tp -134.51 -174.38 3.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.654 -1.279 . . . . 0.0 110.311 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.414 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -133.64 165.64 24.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.325 -1.484 . . . . 0.0 107.642 174.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -71.92 121.46 19.11 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.236 1.017 . . . . 0.0 111.786 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -107.5 -92.04 0.41 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.486 1.514 . . . . 0.0 107.755 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -78.78 -41.64 29.94 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.139 1.376 . . . . 0.0 109.997 163.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.8 161.51 37.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 123.81 0.844 . . . . 0.0 110.403 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -83.49 -68.37 0.72 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.439 1.095 . . . . 0.0 110.521 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.77 -79.15 0.52 Allowed 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.821 -1.174 . . . . 0.0 111.101 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.68 50.25 4.27 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 124.576 1.084 . . . . 0.0 113.475 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 tt -138.43 -178.61 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 121.617 -0.931 . . . . 0.0 109.579 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.0 p -127.4 142.47 51.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.842 -2.411 . . . . 0.0 110.31 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 t -123.77 155.82 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 123.855 0.862 . . . . 0.0 111.464 -163.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 t -137.02 141.93 42.5 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.255 -1.528 . . . . 0.0 108.707 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.1 -175.84 50.3 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 116.476 1.351 . . . . 0.0 116.476 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.95 44.05 0.97 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 121.865 -0.785 . . . . 0.0 112.823 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 27' ' ' ASN . 25.8 t -80.78 176.66 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.69 -1.476 . . . . 0.0 108.847 174.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.662 ' H ' HG12 ' A' ' 26' ' ' VAL . 5.8 p30 -69.07 -24.78 64.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.377 -2.077 . . . . 0.0 114.814 -160.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.6 t -135.15 133.33 39.04 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 150.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.9 p -155.81 -86.4 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.685 -1.259 . . . . 0.0 112.639 -165.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.13 -48.02 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 126.825 2.05 . . . . 0.0 109.062 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -129.02 -154.47 0.64 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 159.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.33 70.29 9.24 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.234 -2.166 . . . . 0.0 111.389 164.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.63 -171.87 13.95 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 108.118 -1.993 . . . . 0.0 108.118 -166.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.09 136.0 7.96 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -172.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.9 mm -127.21 149.41 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -170.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.92 139.49 53.78 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.924 -1.735 . . . . 0.0 111.225 -169.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.7 t -81.98 126.12 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 120.275 -1.516 . . . . 0.0 111.313 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -87.6 -70.12 0.65 Allowed 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.653 -1.279 . . . . 0.0 111.051 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.8 159.97 38.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.277 -0.89 . . . . 0.0 110.101 -171.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 p -103.09 132.6 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.93 1.347 . . . . 0.0 112.221 -170.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.6 mm -83.7 119.42 73.65 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 120.149 -1.594 . . . . 0.0 110.163 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -81.05 58.97 7.26 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 124.393 2.605 . . . . 0.0 112.966 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -141.39 -0.42 1.41 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.296 1.038 . . . . 0.0 112.094 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.36 -172.75 30.19 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.27 -1.518 . . . . 0.0 115.477 -170.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.3 -50.61 2.01 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.696 3.198 . . . . 0.0 118.159 -171.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.1 -45.34 68.19 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.213 1.405 . . . . 0.0 114.76 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -80.59 -52.66 7.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.958 1.303 . . . . 0.0 110.826 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.5 m -62.5 -38.48 90.04 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -172.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.3 -52.44 6.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.914 -1.116 . . . . 0.0 110.117 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.62 84.94 1.47 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 121.14 -0.975 . . . . 0.0 113.589 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -138.99 -21.82 0.95 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.19 149.58 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -119.64 172.57 7.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.592 -1.317 . . . . 0.0 111.702 177.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -56.54 138.73 51.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.43 22.11 76.24 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 116.905 1.522 . . . . 0.0 116.905 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.58 166.49 19.19 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 118.915 1.358 . . . . 0.0 111.693 169.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -124.1 105.43 9.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.748 -1.22 . . . . 0.0 110.25 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 m -93.74 141.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 120.459 -1.401 . . . . 0.0 111.519 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.24 -87.25 0.56 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 111.253 -166.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -90.63 153.84 20.02 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.591 -1.943 . . . . 0.0 112.903 -172.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 63.8 t -116.41 108.53 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.256 9.1 t-20 56.25 50.15 13.92 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 126.03 1.732 . . . . 0.0 113.76 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.5 -29.42 6.72 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.659 -1.276 . . . . 0.0 114.774 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.2 t -88.06 99.03 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.586 -1.538 . . . . 0.0 111.209 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -78.59 99.56 6.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.302 1.041 . . . . 0.0 110.514 167.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.03 92.91 7.08 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.07 1.414 . . . . 0.0 109.591 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.59 129.97 41.56 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.383 1.473 . . . . 0.0 112.644 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.48 -6.24 74.6 Favored Glycine 0 N--CA 1.429 -1.795 0 O-C-N 121.001 -1.062 . . . . 0.0 114.565 -174.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.99 133.27 40.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 119.595 1.698 . . . . 0.0 114.041 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.3 p -84.31 177.86 8.0 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.258 1.423 . . . . 0.0 112.613 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -56.94 -45.41 82.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.322 2.249 . . . . 0.0 113.942 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -58.39 -43.31 88.5 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 172.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -70.37 -39.21 74.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.761 -1.212 . . . . 0.0 111.995 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.41 67.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.666 1.186 . . . . 0.0 113.393 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.47 -35.99 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 120.291 -1.506 . . . . 0.0 113.076 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -58.24 -47.08 84.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.141 -1.599 . . . . 0.0 113.72 168.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.4 m -63.23 -36.25 83.02 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.823 1.649 . . . . 0.0 113.141 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 74.4 mt -78.89 -35.84 42.99 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 120.114 -1.616 . . . . 0.0 113.462 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -67.31 -28.16 67.76 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.961 -1.712 . . . . 0.0 112.639 172.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -90.93 48.81 1.56 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.18 -1.575 . . . . 0.0 112.78 172.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.74 -70.4 0.6 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.507 1.523 . . . . 0.0 109.766 173.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.13 -87.33 1.2 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 121.238 -0.914 . . . . 0.0 112.603 170.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -83.93 -61.4 1.83 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.216 -1.167 . . . . 0.0 113.753 173.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.74 142.51 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 122.22 1.01 . . . . 0.0 113.233 -164.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.9 t -121.05 92.39 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 125.408 1.483 . . . . 0.0 107.543 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -126.57 98.39 5.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.567 -1.333 . . . . 0.0 111.18 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.9 mt -127.35 154.22 45.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.81 -1.181 . . . . 0.0 111.409 -162.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 3.9 mm? -120.79 134.0 55.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.623 1.169 . . . . 0.0 109.047 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.07 153.06 37.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.534 0.683 . . . . 0.0 111.356 -171.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -112.19 120.96 43.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.822 1.649 . . . . 0.0 109.992 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -54.1 135.55 43.26 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -165.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 0 C-N-CA 126.165 1.84 . . . . 0.0 115.611 176.52 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 N--CA 1.429 -1.491 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 t -122.56 149.09 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.364 1.866 . . . . 0.0 106.789 -173.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -138.33 166.83 23.22 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.273 -1.517 . . . . 0.0 112.58 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.88 147.12 50.79 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.614 1.966 . . . . 0.0 109.735 162.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.26 1.647 0 C-N-CA 127.4 2.28 . . . . 0.0 105.299 170.037 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.633 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -83.55 165.42 19.09 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.4 mt -81.37 131.86 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 122.182 0.992 . . . . 0.0 111.524 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -136.98 168.93 18.65 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.711 -1.243 . . . . 0.0 109.847 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -122.49 137.52 54.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.766 0.826 . . . . 0.0 111.003 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.6 m -103.98 143.75 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 124.395 1.078 . . . . 0.0 111.716 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -127.9 106.68 9.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.652 1.181 . . . . 0.0 109.159 -170.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.1 mt -129.69 159.39 36.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.997 -1.689 . . . . 0.0 110.657 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.66 164.44 27.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 160.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -72.25 114.18 10.08 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.437 -1.414 . . . . 0.0 113.933 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -101.9 -70.89 0.73 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 162.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.43 -74.69 0.43 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.362 1.865 . . . . 0.0 110.789 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -136.49 148.76 47.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -165.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.1 m -80.83 -62.82 1.55 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.924 -1.735 . . . . 0.0 113.268 -159.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.8 mp -101.52 -86.09 0.42 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.886 -1.134 . . . . 0.0 111.001 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.2 45.71 2.53 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.638 -1.289 . . . . 0.0 115.338 171.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.65 172.33 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 120.696 -1.473 . . . . 0.0 109.032 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.7 p -121.16 145.05 48.23 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.723 -1.861 . . . . 0.0 108.539 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.07 154.3 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 125.757 1.623 . . . . 0.0 108.073 -165.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.6 t -139.0 161.36 37.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 169.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.03 -132.38 15.18 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.635 -1.29 . . . . 0.0 114.335 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.97 0.81 89.0 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 120.708 -1.466 . . . . 0.0 115.899 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.0 t -73.69 166.93 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.156 2.182 . . . . 0.0 110.901 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -69.77 -15.35 63.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.383 1.873 . . . . 0.0 115.429 -164.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.5 t -134.99 118.0 16.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.507 -1.996 . . . . 0.0 107.084 148.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 p -146.87 -83.25 0.12 Allowed 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.878 -1.139 . . . . 0.0 109.445 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.61 -51.14 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 126.62 1.968 . . . . 0.0 110.245 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -130.35 -158.05 0.86 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 161.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.38 56.71 1.79 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.406 -2.059 . . . . 0.0 112.851 165.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.34 168.69 12.4 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 126.412 1.958 . . . . 0.0 110.423 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.91 152.31 24.76 Favored Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 125.099 1.333 . . . . 0.0 111.079 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.2 mm -126.47 149.17 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 121.097 -1.237 . . . . 0.0 109.501 -161.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.65 137.12 53.85 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.358 -1.463 . . . . 0.0 109.64 -172.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.7 t -86.02 132.94 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.441 -1.412 . . . . 0.0 112.104 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -87.76 -70.08 0.65 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.569 -1.332 . . . . 0.0 110.875 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.81 163.29 40.01 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 122.157 0.979 . . . . 0.0 111.112 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.8 p -88.27 130.06 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.424 0 C-N-CA 124.925 1.29 . . . . 0.0 111.642 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mm -84.45 118.83 72.05 Favored Pre-proline 0 N--CA 1.43 -1.471 0 O-C-N 120.201 -1.562 . . . . 0.0 109.256 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.39 45.28 1.68 Allowed 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 124.715 2.72 . . . . 0.0 113.061 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -143.02 34.41 1.36 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.146 0.978 . . . . 0.0 109.217 -171.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.19 -172.69 39.62 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 119.938 -1.726 . . . . 0.0 113.105 -171.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.54 -35.83 78.86 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.951 1.7 . . . . 0.0 114.598 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.98 -49.17 69.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.16 -53.51 36.73 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.37 1.868 . . . . 0.0 112.079 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.6 m -66.27 -29.31 69.51 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.58 -53.93 6.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.91 1.684 . . . . 0.0 111.967 170.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.71 65.98 1.67 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 120.393 -1.442 . . . . 0.0 114.173 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -138.34 -13.74 1.33 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.01 -1.288 . . . . 0.0 113.232 -166.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.04 144.68 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.23 -177.62 3.56 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 122.998 1.38 . . . . 0.0 111.473 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.9 pttt -58.56 132.84 54.98 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.183 -1.573 . . . . 0.0 114.707 168.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.49 12.59 84.38 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 117.807 1.883 . . . . 0.0 117.807 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -74.08 160.86 30.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.352 1.576 . . . . 0.0 110.747 167.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ttm-85 -122.89 106.47 10.9 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.591 -1.318 . . . . 0.0 109.427 -166.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 m -102.42 126.37 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.313 1.53 . . . . 0.0 111.134 -166.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.04 -88.52 0.62 Allowed 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.085 -1.635 . . . . 0.0 112.172 -160.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.54 134.71 33.99 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 121.107 -0.996 . . . . 0.0 112.564 -166.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.58 105.24 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.85 -1.156 . . . . 0.0 108.879 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.264 58.3 t30 55.92 43.09 27.99 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.093 2.157 . . . . 0.0 113.337 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.69 -28.39 15.73 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 124.469 1.033 . . . . 0.0 113.635 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.4 t -84.18 109.14 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 124.451 1.1 . . . . 0.0 113.122 -166.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -78.52 98.61 6.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.053 1.341 . . . . 0.0 110.435 172.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.39 75.21 1.6 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.151 1.453 . . . . 0.0 109.674 -170.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.42 143.67 54.98 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.687 -1.883 . . . . 0.0 112.986 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.16 7.37 65.72 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.478 -1.389 . . . . 0.0 114.668 -175.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.79 147.03 37.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.584 -1.539 . . . . 0.0 113.709 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 p -93.09 170.57 9.54 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.739 1.616 . . . . 0.0 109.494 166.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -60.79 -41.67 96.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.815 -1.178 . . . . 0.0 112.761 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -49.07 -51.32 32.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.815 1.646 . . . . 0.0 114.84 168.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -70.77 -36.19 72.95 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.23 -1.544 . . . . 0.0 112.826 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.09 98.19 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.017 -1.677 . . . . 0.0 113.433 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.0 t -67.66 -43.73 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 C-N-CA 125.35 1.46 . . . . 0.0 111.914 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.88 -12.91 60.81 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 120.251 -1.53 . . . . 0.0 114.195 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.4 m -71.17 -57.65 4.3 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.993 -2.317 . . . . 0.0 110.214 171.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.8 -20.45 42.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -72.5 -23.23 60.99 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.831 -1.793 . . . . 0.0 112.795 166.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -90.64 52.82 2.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 119.502 -1.999 . . . . 0.0 111.865 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.2 p -109.04 -94.06 0.41 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.893 1.677 . . . . 0.0 110.478 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.02 -59.86 0.57 Allowed Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 124.825 1.202 . . . . 0.0 112.565 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -84.68 -77.17 0.28 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.957 -1.32 . . . . 0.0 114.097 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.84 143.2 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.818 1.647 . . . . 0.0 111.445 -161.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.4 t -126.5 128.97 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.93 1.692 . . . . 0.0 109.941 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -143.02 115.21 8.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.662 -1.899 . . . . 0.0 109.763 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.3 mt -128.2 153.77 46.54 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.587 -1.321 . . . . 0.0 111.306 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.8 130.9 55.15 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.65 151.56 37.45 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -103.6 134.59 46.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -74.99 137.64 41.69 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.655 -1.278 . . . . 0.0 114.398 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.729 0 CA-C-O 122.889 1.272 . . . . 0.0 116.201 -167.826 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.9 t -120.05 138.93 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.591 -1.318 . . . . 0.0 109.873 -152.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 13.9 m -128.21 157.42 40.89 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.802 -1.186 . . . . 0.0 112.666 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.27 154.74 45.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.061 -1.025 . . . . 0.0 110.095 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.259 1.578 0 C-N-CA 125.378 1.471 . . . . 0.0 107.45 169.413 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.661 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -82.89 171.68 13.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.3 mp -89.14 132.43 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.38 -1.45 . . . . 0.0 110.968 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -133.16 161.73 33.65 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.751 -1.218 . . . . 0.0 111.834 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -109.91 134.62 51.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 124.86 1.264 . . . . 0.0 110.924 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -103.18 149.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.503 -1.373 . . . . 0.0 111.21 163.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.9 105.89 8.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 167.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.409 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 12.2 tp -134.43 -179.32 5.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.875 -1.141 . . . . 0.0 108.402 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.409 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -140.61 172.67 12.39 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 120.16 -1.587 . . . . 0.0 109.906 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -71.9 111.97 7.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.598 1.559 . . . . 0.0 110.889 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -113.71 -83.28 0.6 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.377 1.071 . . . . 0.0 110.176 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -82.86 -47.42 11.86 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.768 -1.208 . . . . 0.0 109.513 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -137.6 -172.69 3.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 167.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 t -83.85 -72.55 0.46 Allowed 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.916 -1.115 . . . . 0.0 111.452 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.38 -84.4 0.45 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.963 -1.086 . . . . 0.0 110.379 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.82 54.34 0.68 Allowed Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 116.175 1.23 . . . . 0.0 116.175 170.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.65 174.12 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 119.195 1.498 . . . . 0.0 112.437 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.8 p -122.63 135.91 54.74 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.152 1.381 . . . . 0.0 109.545 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -123.36 142.7 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.497 1.519 . . . . 0.0 110.634 -163.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.1 t -136.4 111.3 8.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.653 1.692 . . . . 0.0 111.589 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -134.15 11.86 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 125.242 1.401 . . . . 0.0 111.503 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.1 23.39 32.44 Favored Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.84 -127.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 121.018 -1.284 . . . . 0.0 113.11 -172.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -79.38 -44.25 21.86 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.073 -1.642 . . . . 0.0 112.75 -164.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -151.98 103.19 2.88 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 166.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.9 p -134.71 -75.94 0.46 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.327 -1.483 . . . . 0.0 110.44 -172.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.16 -54.84 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 124.704 1.202 . . . . 0.0 110.272 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -134.18 -164.12 1.46 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.03 78.39 3.57 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.911 -1.743 . . . . 0.0 111.508 166.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.75 -177.4 21.19 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -166.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.48 148.6 12.45 Favored Glycine 0 N--CA 1.431 -1.687 0 O-C-N 121.458 -1.025 . . . . 0.0 111.119 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.9 mm -127.23 142.31 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -171.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.44 130.91 53.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.69 -1.256 . . . . 0.0 109.589 -169.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.3 t -84.22 134.94 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 124.38 1.072 . . . . 0.0 111.438 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -88.83 -59.26 2.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.31 1.444 . . . . 0.0 111.199 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.9 159.49 29.75 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 123.575 0.75 . . . . 0.0 111.463 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 p -91.59 128.15 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 122.586 1.184 . . . . 0.0 113.017 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.2 mm -84.45 131.69 49.42 Favored Pre-proline 0 N--CA 1.43 -1.458 0 C-N-CA 126.175 1.79 . . . . 0.0 110.866 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.36 41.64 1.17 Allowed 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 123.546 2.831 . . . . 0.0 114.593 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -147.48 66.34 1.13 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.664 1.585 . . . . 0.0 107.235 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.74 175.79 46.34 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 119.69 -1.881 . . . . 0.0 115.438 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.15 -34.93 78.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.305 1.042 . . . . 0.0 112.275 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.37 -56.02 24.92 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.744 1.618 . . . . 0.0 113.936 175.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.61 -47.16 67.39 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.044 -1.035 . . . . 0.0 112.372 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.3 m -60.18 -47.77 84.56 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.68 -51.9 30.45 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.562 -1.336 . . . . 0.0 112.538 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.07 78.62 0.95 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 120.82 -1.175 . . . . 0.0 111.575 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.6 ttt85 -138.82 -34.61 0.6 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.956 -0.731 . . . . 0.0 112.315 -158.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 mt -128.9 170.25 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -140.95 -177.8 5.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.293 -2.754 . . . . 0.0 112.036 165.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.45 143.05 30.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.774 -1.829 . . . . 0.0 113.743 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.87 8.15 81.98 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 117.576 1.79 . . . . 0.0 117.576 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -80.77 154.69 27.07 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 119.274 1.537 . . . . 0.0 109.157 163.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -137.05 128.66 28.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.976 -1.703 . . . . 0.0 112.39 -164.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.0 m -80.13 162.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.972 -1.705 . . . . 0.0 115.292 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 mp -119.88 -86.68 0.65 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.23 1.812 . . . . 0.0 106.981 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 160.49 14.25 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -170.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.1 t -108.78 98.54 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.49 1.516 . . . . 0.0 107.108 165.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 56.38 54.51 7.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.671 1.588 . . . . 0.0 114.233 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.7 -32.02 4.39 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.434 -1.416 . . . . 0.0 114.18 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.91 121.82 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 124.627 1.171 . . . . 0.0 112.254 -171.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.1 m -77.72 133.59 38.28 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 120.632 -1.293 . . . . 0.0 112.216 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.49 63.3 7.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.506 -1.371 . . . . 0.0 109.677 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.52 104.0 1.17 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.029 1.731 . . . . 0.0 114.417 -168.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.08 29.26 74.62 Favored Glycine 0 N--CA 1.429 -1.775 0 O-C-N 120.43 -1.418 . . . . 0.0 114.888 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.2 158.15 30.5 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.229 1.412 . . . . 0.0 114.203 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 p -80.8 162.06 24.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.809 -1.182 . . . . 0.0 111.589 167.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -60.87 -42.25 97.52 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.365 1.466 . . . . 0.0 111.586 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -47.03 -46.07 21.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.266 1.826 . . . . 0.0 114.747 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -71.52 -38.69 71.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.288 -1.507 . . . . 0.0 113.436 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.7 96.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.965 -1.085 . . . . 0.0 113.412 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.66 -47.3 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 126.391 1.876 . . . . 0.0 112.772 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -54.51 -43.64 72.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.753 -1.217 . . . . 0.0 113.332 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.1 m -62.56 -50.3 71.88 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.128 1.771 . . . . 0.0 112.724 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.69 -12.27 59.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.955 -1.716 . . . . 0.0 115.594 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.31 -30.7 57.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.553 -1.967 . . . . 0.0 112.214 167.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -100.47 65.64 1.21 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.189 -1.569 . . . . 0.0 114.591 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.5 p -92.74 -68.24 0.81 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.157 -1.589 . . . . 0.0 112.091 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.66 -127.83 7.43 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 125.581 1.562 . . . . 0.0 110.76 -172.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -83.35 -45.65 13.5 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 p -115.4 145.46 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 121.287 -0.883 . . . . 0.0 113.286 -166.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.8 t -124.96 112.5 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.215 1.806 . . . . 0.0 110.48 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -120.46 110.91 17.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.244 -1.535 . . . . 0.0 110.412 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.4 mt -131.99 151.73 51.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.696 -1.252 . . . . 0.0 111.157 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.84 128.15 52.57 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.48 157.19 43.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.886 0.85 . . . . 0.0 111.262 -171.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -109.21 137.28 47.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.618 1.167 . . . . 0.0 109.069 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.28 130.4 41.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.487 1.136 . . . . 0.0 112.075 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.756 0 C-N-CA 125.867 1.699 . . . . 0.0 114.645 -175.057 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 . . . . . 0 N--CA 1.431 -1.416 0 CA-C-O 121.317 0.579 . . . . 0.0 112.14 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -121.67 136.43 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.012 1.725 . . . . 0.0 106.735 -170.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.2 m -128.37 167.95 16.25 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 120.579 -1.325 . . . . 0.0 111.427 -172.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.34 134.14 16.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 123.032 0.533 . . . . 0.0 110.337 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--O 1.259 1.593 0 C-N-CA 126.667 1.987 . . . . 0.0 108.45 172.572 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.749 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -82.73 -177.1 6.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.78 133.83 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.23 1.412 . . . . 0.0 109.712 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -132.81 158.67 41.89 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.105 -1.622 . . . . 0.0 111.339 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -117.68 140.2 49.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.147 0.975 . . . . 0.0 110.961 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.08 142.99 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.865 -1.147 . . . . 0.0 109.47 166.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -128.55 76.3 1.7 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 tp -113.35 171.1 7.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.564 -1.335 . . . . 0.0 110.505 -167.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.27 161.34 39.83 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.358 -1.464 . . . . 0.0 109.033 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -68.35 112.97 5.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.98 -1.075 . . . . 0.0 112.762 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -115.04 -78.98 0.58 Allowed 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 124.977 1.311 . . . . 0.0 109.743 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -82.38 -43.91 16.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.494 -1.379 . . . . 0.0 110.417 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -143.3 -177.63 5.46 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.752 1.221 . . . . 0.0 107.726 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.3 t -83.29 -83.14 0.14 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 124.726 1.211 . . . . 0.0 108.901 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.1 mp -101.85 -99.9 0.27 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.168 -0.957 . . . . 0.0 108.865 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.39 60.08 0.79 Allowed Glycine 0 N--CA 1.43 -1.74 0 O-C-N 120.276 -1.515 . . . . 0.0 115.313 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.52 175.09 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 121.284 -1.127 . . . . 0.0 108.028 170.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.2 p -121.31 145.53 47.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.542 -1.974 . . . . 0.0 108.663 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.6 t -123.76 167.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.247 1.419 . . . . 0.0 107.409 -168.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.9 t -136.99 67.59 1.44 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.314 2.007 . . . . 0.0 108.714 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.83 -137.17 18.32 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 120.237 -1.539 . . . . 0.0 112.513 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.9 93.9 1.47 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -166.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.29 -113.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 121.793 -0.827 . . . . 0.0 111.08 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -93.3 -62.69 1.32 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.725 -1.234 . . . . 0.0 111.36 -165.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 t -134.24 97.98 3.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.212 1.482 . . . . 0.0 108.52 166.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.2 p -134.64 -84.08 0.42 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.841 -1.162 . . . . 0.0 111.14 -162.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.13 -51.37 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 125.807 1.643 . . . . 0.0 110.154 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -138.17 -166.22 1.94 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 158.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.67 66.89 9.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.135 -1.603 . . . . 0.0 111.286 168.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.64 141.31 5.67 Favored Glycine 0 N--CA 1.429 -1.784 0 O-C-N 120.877 -1.14 . . . . 0.0 110.868 -171.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.8 155.17 26.16 Favored Glycine 0 N--CA 1.43 -1.72 0 O-C-N 121.488 -1.007 . . . . 0.0 111.946 -170.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.1 mm -133.44 152.33 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 124.821 1.248 . . . . 0.0 108.784 -164.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.85 124.76 43.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.158 -1.589 . . . . 0.0 110.66 -168.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.5 t -74.05 135.34 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.27 -1.519 . . . . 0.0 112.744 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -91.93 -68.01 0.82 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.921 -1.112 . . . . 0.0 112.372 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.89 157.69 35.32 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.162 -0.961 . . . . 0.0 109.914 -173.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.4 p -88.35 131.93 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.716 1.246 . . . . 0.0 113.167 -175.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.4 mm -84.61 126.15 69.54 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 117.514 -1.232 . . . . 0.0 108.315 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -81.5 34.93 0.56 Allowed 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 123.351 2.701 . . . . 0.0 113.797 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -144.84 64.1 1.29 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.661 1.984 . . . . 0.0 107.078 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.37 174.39 46.02 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 120.565 -1.334 . . . . 0.0 112.589 -177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.67 82.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.747 1.619 . . . . 0.0 113.432 -174.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.02 -49.2 66.75 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.063 1.745 . . . . 0.0 114.897 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.46 -35.69 34.56 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 124.092 0.957 . . . . 0.0 112.554 176.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.8 m -59.38 -51.51 69.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.971 -1.706 . . . . 0.0 114.018 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.3 -41.03 42.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 111.115 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.79 66.63 1.45 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 120.623 -1.298 . . . . 0.0 111.628 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 ttt85 -137.59 -20.86 1.16 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -160.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.52 154.21 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -139.95 178.87 6.96 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.965 -1.709 . . . . 0.0 111.14 171.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.84 138.06 56.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.94 19.5 79.91 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 116.964 1.546 . . . . 0.0 116.964 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -83.1 162.04 21.45 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 119.173 1.487 . . . . 0.0 109.41 164.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.9 ttm105 -127.59 123.98 37.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.964 -1.71 . . . . 0.0 110.353 -171.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.6 m -93.71 147.5 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.442 -1.411 . . . . 0.0 111.728 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.4 -88.67 0.62 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 123.923 0.889 . . . . 0.0 109.823 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.8 148.03 22.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.893 -1.754 . . . . 0.0 114.498 -169.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -109.83 88.64 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.32 1.448 . . . . 0.0 109.647 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 57.14 60.14 3.1 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.062 1.745 . . . . 0.0 114.946 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.47 -36.57 3.8 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 124.422 1.011 . . . . 0.0 113.101 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 t -95.85 114.14 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.804 -1.41 . . . . 0.0 112.261 -169.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.4 m -78.03 132.41 37.76 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.33 -1.481 . . . . 0.0 110.206 161.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.87 76.48 5.56 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.623 1.201 . . . . 0.0 109.848 -171.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.18 103.31 0.75 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 -165.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.64 14.23 72.3 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.397 -1.44 . . . . 0.0 114.325 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.9 141.88 40.35 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.688 1.195 . . . . 0.0 112.4 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 p -76.28 172.98 11.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.303 1.841 . . . . 0.0 113.475 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -60.59 -38.12 83.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.33 1.452 . . . . 0.0 113.591 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -58.84 -50.35 74.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.345 -1.472 . . . . 0.0 113.558 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -71.43 -39.46 71.02 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.247 1.419 . . . . 0.0 112.951 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.96 -42.57 99.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.278 -1.514 . . . . 0.0 113.804 175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -72.1 -38.79 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 119.854 -1.779 . . . . 0.0 111.815 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -58.41 -35.99 72.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.624 -1.297 . . . . 0.0 113.657 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.0 m -67.78 -41.23 83.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.526 1.93 . . . . 0.0 113.048 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 mt -80.47 -19.35 46.19 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.196 -1.565 . . . . 0.0 114.202 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -72.53 -25.8 61.51 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.855 -1.778 . . . . 0.0 112.307 166.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -88.91 70.83 8.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.942 -1.099 . . . . 0.0 112.625 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.0 p -104.41 -78.1 0.57 Allowed 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.997 -1.064 . . . . 0.0 110.131 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.24 -117.86 4.36 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -82.85 -49.62 9.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.13 147.29 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.785 -1.197 . . . . 0.0 113.24 -166.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.84 110.72 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.451 1.501 . . . . 0.0 110.024 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -124.16 111.3 15.74 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.934 -1.729 . . . . 0.0 111.328 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 69.6 mt -129.95 153.15 48.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.428 -0.795 . . . . 0.0 111.087 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.36 127.13 52.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.47 156.93 43.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.024 0.916 . . . . 0.0 111.88 -170.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -105.35 136.27 45.19 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.712 1.205 . . . . 0.0 109.119 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -70.03 131.85 44.98 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.302 1.041 . . . . 0.0 112.541 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.755 0 N-CA-C 116.677 1.431 . . . . 0.0 116.677 178.187 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 121.33 0.586 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.36 141.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 126.304 1.842 . . . . 0.0 106.61 -173.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 68.9 m -132.96 161.76 33.44 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.067 1.347 . . . . 0.0 112.635 -160.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.95 152.79 52.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.566 1.147 . . . . 0.0 111.901 170.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.26 1.609 0 C-N-CA 127.419 2.288 . . . . 0.0 107.553 168.509 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.737 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -81.65 159.56 23.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.985 -1.303 . . . . 0.0 113.728 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 mp -81.87 135.7 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.569 1.547 . . . . 0.0 109.509 -174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -138.53 150.58 46.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.404 1.082 . . . . 0.0 111.115 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.33 113.63 21.73 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.969 -1.082 . . . . 0.0 109.577 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.432 HG21 HD11 ' A' ' 52' ' ' ILE . 22.1 m -102.17 146.83 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.842 -1.162 . . . . 0.0 112.573 -173.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.71 134.32 55.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.054 0.942 . . . . 0.0 108.524 172.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.2 mt -130.93 148.02 52.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 161.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.97 135.3 46.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -66.92 118.63 10.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -119.1 -84.06 0.65 Allowed 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.58 -1.325 . . . . 0.0 111.657 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -77.35 -42.17 37.62 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.668 1.987 . . . . 0.0 109.888 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -156.43 -172.04 3.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 m -92.64 -73.88 0.54 Allowed 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.167 -0.958 . . . . 0.0 110.3 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.07 -91.06 0.34 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 118.93 0.786 . . . . 0.0 111.808 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.71 52.18 1.22 Allowed Glycine 0 N--CA 1.431 -1.687 0 O-C-N 120.0 -1.687 . . . . 0.0 111.465 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.2 tt -145.88 158.05 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 121.228 -1.16 . . . . 0.0 111.405 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.0 p -122.02 149.4 43.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.491 -1.381 . . . . 0.0 110.113 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.29 164.05 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.22 1.01 . . . . 0.0 108.549 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -137.7 151.99 48.8 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.408 -2.057 . . . . 0.0 105.691 165.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.64 -144.51 17.21 Favored Glycine 0 N--CA 1.431 -1.678 0 O-C-N 120.969 -1.082 . . . . 0.0 112.466 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.3 -4.46 86.03 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 124.745 1.164 . . . . 0.0 113.868 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -100.34 161.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 124.611 1.164 . . . . 0.0 108.792 -168.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -68.36 -19.51 64.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.131 2.172 . . . . 0.0 114.471 -162.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.5 t -130.34 126.97 38.47 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 152.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.5 p -156.21 -101.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.628 -1.295 . . . . 0.0 109.292 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.48 -41.97 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.317 -1.49 . . . . 0.0 110.876 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.438 ' HB3' ' H ' ' A' ' 32' ' ' HIS . 3.2 mmp_? -131.86 -145.18 0.26 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 162.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.438 ' H ' ' HB3' ' A' ' 31' ' ' ARG . 22.4 p-80 -79.5 55.63 1.99 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.45 2.3 . . . . 0.0 111.014 168.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.99 -160.1 14.81 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 107.111 -2.396 . . . . 0.0 107.111 -163.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.54 150.2 26.22 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 122.234 0.908 . . . . 0.0 112.345 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mm -125.91 132.73 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.238 -1.154 . . . . 0.0 108.208 -170.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.55 140.47 52.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 124.561 1.144 . . . . 0.0 108.707 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.9 t -78.97 127.65 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 O-C-N 120.36 -1.462 . . . . 0.0 110.961 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -90.12 -62.26 1.5 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.587 -1.32 . . . . 0.0 110.843 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.82 156.87 25.81 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.2 t -91.0 133.45 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.1 mm -83.21 127.62 68.16 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.967 -1.492 . . . . 0.0 108.643 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -80.35 41.79 1.2 Allowed 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 123.841 3.027 . . . . 0.0 113.386 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -145.58 53.12 1.17 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.92 2.488 . . . . 0.0 106.313 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.97 161.81 33.1 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.225 -1.547 . . . . 0.0 114.914 -174.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.76 -32.53 65.69 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 127.9 2.48 . . . . 0.0 115.766 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.66 -38.19 66.64 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 170.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -78.94 -39.2 35.22 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.427 1.091 . . . . 0.0 111.689 174.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.2 m -57.58 -48.24 79.92 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.413 -1.43 . . . . 0.0 113.179 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -73.96 -65.74 0.8 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.821 1.248 . . . . 0.0 112.827 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.63 79.21 0.79 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.342 -1.474 . . . . 0.0 114.852 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -138.87 -30.3 0.75 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.515 1.526 . . . . 0.0 110.882 -174.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.432 HD11 HG21 ' A' ' 9' ' ' VAL . 40.5 mt -125.73 138.65 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -140.16 -173.9 3.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.499 -1.376 . . . . 0.0 110.117 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -57.52 134.75 56.38 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.59 11.22 85.42 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 118.656 2.222 . . . . 0.0 118.656 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -76.45 154.68 34.54 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.238 2.019 . . . . 0.0 111.002 169.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.473 HH21 ' CD ' ' A' ' 90' ' ' GLU . 2.5 tmm_? -124.4 115.13 20.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.076 -1.64 . . . . 0.0 110.11 -161.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.3 m -94.82 154.08 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 119.658 -1.901 . . . . 0.0 114.191 -170.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.5 mt -121.81 -89.51 0.6 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.3 1.04 . . . . 0.0 110.33 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.83 141.5 31.54 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -165.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.1 t -95.4 102.64 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 124.473 1.109 . . . . 0.0 108.026 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.256 59.3 t30 57.94 42.42 22.95 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.859 1.663 . . . . 0.0 114.191 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.63 -27.25 21.06 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.535 -1.353 . . . . 0.0 113.959 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.1 t -91.33 113.31 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.345 -1.091 . . . . 0.0 111.967 -174.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -81.05 111.77 17.83 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.984 -1.072 . . . . 0.0 111.749 167.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.96 82.78 1.86 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.744 -1.223 . . . . 0.0 108.749 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.37 144.0 53.55 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.343 -2.098 . . . . 0.0 114.495 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.68 -15.31 52.91 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 120.693 -1.254 . . . . 0.0 114.897 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.68 128.58 37.15 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.836 1.655 . . . . 0.0 115.376 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 p -73.38 164.26 26.91 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.065 1.412 . . . . 0.0 111.01 172.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.12 -42.28 94.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -168.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -55.71 -38.22 69.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.356 1.862 . . . . 0.0 114.463 172.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -71.37 -43.63 66.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.253 1.421 . . . . 0.0 111.276 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.73 -48.82 70.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.82 -1.175 . . . . 0.0 113.539 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.13 -52.22 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 124.79 1.236 . . . . 0.0 113.503 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -71.46 -21.88 61.9 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 120.077 -1.639 . . . . 0.0 114.587 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.3 m -64.77 -40.49 95.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.354 -1.466 . . . . 0.0 111.57 169.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.61 -26.36 37.85 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.524 -1.36 . . . . 0.0 113.837 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -66.55 -43.35 85.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.021 -1.675 . . . . 0.0 112.154 168.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -78.14 53.85 1.27 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.719 1.608 . . . . 0.0 113.592 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.3 p -108.5 -86.6 0.51 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.85 2.06 . . . . 0.0 108.817 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.87 -57.45 1.83 Allowed Glycine 0 N--CA 1.43 -1.749 0 O-C-N 120.29 -1.506 . . . . 0.0 114.936 171.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -83.15 -68.23 0.72 Allowed 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 120.516 -1.579 . . . . 0.0 112.609 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.45 141.64 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 122.555 1.169 . . . . 0.0 110.249 -173.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.1 t -114.99 109.04 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 126.651 1.98 . . . . 0.0 107.489 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -117.24 127.68 54.33 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.841 -1.162 . . . . 0.0 110.478 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.5 mt -141.42 152.46 44.3 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 123.847 0.859 . . . . 0.0 111.78 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -122.32 123.9 42.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.827 1.251 . . . . 0.0 107.951 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.43 165.82 29.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.635 1.207 . . . . 0.0 111.622 -173.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.473 ' CD ' HH21 ' A' ' 57' ' ' ARG . 29.8 tt0 -112.03 141.33 45.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.303 1.841 . . . . 0.0 108.325 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -71.64 137.7 48.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.525 -1.359 . . . . 0.0 112.093 171.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.686 0 CA-C-O 123.467 1.593 . . . . 0.0 115.915 -176.177 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 68.6 t -120.86 139.27 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.199 2.2 . . . . 0.0 105.482 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 11.6 m -132.28 140.54 48.66 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.164 1.386 . . . . 0.0 114.563 -156.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.54 157.58 31.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.972 1.709 . . . . 0.0 112.088 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.262 1.719 0 C-N-CA 125.211 1.404 . . . . 0.0 108.809 -179.474 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.655 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -80.57 155.98 26.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 123.334 1.54 . . . . 0.0 114.381 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.8 mt -86.55 135.86 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 125.645 1.578 . . . . 0.0 109.121 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -145.13 166.52 25.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.203 1.001 . . . . 0.0 108.84 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -124.63 143.7 50.58 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.282 -0.886 . . . . 0.0 109.869 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.6 m -103.43 148.75 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 123.425 0.69 . . . . 0.0 109.799 171.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -129.39 93.48 3.57 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.8 tp -122.61 163.06 20.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -172.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.88 172.14 13.4 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.045 -1.659 . . . . 0.0 109.014 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -71.63 103.83 3.15 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.997 -1.064 . . . . 0.0 113.115 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -97.97 -70.87 0.71 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.902 1.281 . . . . 0.0 109.465 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -70.43 -76.91 0.09 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.724 2.01 . . . . 0.0 110.003 172.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -138.21 -176.86 4.59 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.818 -3.031 . . . . 0.0 102.818 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 t -79.48 -61.46 2.0 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.775 -1.828 . . . . 0.0 112.881 -162.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.2 mp -101.76 -88.18 0.38 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.175 -1.578 . . . . 0.0 111.32 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.6 45.08 2.01 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tt -152.41 147.34 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 120.948 -1.325 . . . . 0.0 110.49 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 t -122.17 158.52 29.19 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.899 -1.126 . . . . 0.0 109.926 -174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.576 HG11 ' CE1' ' A' ' 71' ' ' HIS . 33.0 t -121.4 162.48 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.042 1.337 . . . . 0.0 109.299 -158.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 t -147.69 149.68 32.91 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 165.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.81 -149.87 43.73 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.62 12.88 57.69 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 118.231 2.052 . . . . 0.0 118.231 168.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.04 -107.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 119.128 1.464 . . . . 0.0 114.491 -161.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -89.89 -41.47 11.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.361 -2.087 . . . . 0.0 110.793 -172.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 t -136.31 152.64 50.9 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 158.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -155.37 -93.04 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.431 -1.418 . . . . 0.0 110.835 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.47 -52.67 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 C-N-CA 125.044 1.337 . . . . 0.0 110.016 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.5 ptt-85 -125.98 -139.05 0.27 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.446 -1.686 . . . . 0.0 106.446 154.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -75.67 67.35 2.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.773 1.749 . . . . 0.0 110.823 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.45 -176.58 16.42 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 126.181 1.848 . . . . 0.0 109.333 -171.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.63 151.52 27.02 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.68 159.3 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.52 157.21 35.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.468 -1.395 . . . . 0.0 109.747 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 t -92.53 128.25 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 124.963 1.305 . . . . 0.0 111.849 -174.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -97.17 -67.39 0.85 Allowed 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.691 -1.256 . . . . 0.0 113.342 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.21 153.05 28.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.827 -1.17 . . . . 0.0 112.637 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.94 119.87 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 126.309 1.843 . . . . 0.0 109.246 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.4 mm -84.54 131.52 49.71 Favored Pre-proline 0 N--CA 1.43 -1.451 0 C-N-CA 125.054 1.341 . . . . 0.0 109.685 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -77.11 64.23 7.79 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 CA-C-N 124.295 2.57 . . . . 0.0 112.65 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -160.33 53.95 0.33 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.869 1.319 . . . . 0.0 109.202 173.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.72 179.95 45.7 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.385 -2.072 . . . . 0.0 112.908 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.36 -32.79 72.71 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.734 1.614 . . . . 0.0 114.703 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.75 -42.35 71.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.845 1.658 . . . . 0.0 114.411 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -91.33 -47.18 7.62 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.779 1.232 . . . . 0.0 112.0 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.4 m -68.39 -36.6 79.39 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -173.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -84.4 -49.2 8.9 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.189 1.359 . . . . 0.0 109.327 165.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.89 90.43 2.16 Favored Glycine 0 N--CA 1.43 -1.701 0 O-C-N 121.02 -1.05 . . . . 0.0 111.672 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -137.83 -54.5 0.66 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -166.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.0 mt -126.36 145.98 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 119.197 -2.189 . . . . 0.0 107.387 -165.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -119.2 174.05 6.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.462 1.125 . . . . 0.0 112.386 -170.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -61.12 136.03 57.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 167.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 26.51 62.63 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 119.154 2.422 . . . . 0.0 119.154 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -79.9 176.18 9.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 118.776 1.288 . . . . 0.0 110.737 162.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -124.75 121.09 33.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.969 -1.707 . . . . 0.0 109.248 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -94.17 153.46 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 120.028 -1.67 . . . . 0.0 112.193 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.0 tp -125.9 -81.42 0.62 Allowed 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 121.059 -1.025 . . . . 0.0 112.073 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.88 151.18 21.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.527 -1.358 . . . . 0.0 114.385 -166.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.75 92.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 125.999 1.719 . . . . 0.0 107.066 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 56.37 54.61 7.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.468 1.507 . . . . 0.0 114.555 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.27 -40.31 2.47 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 124.329 0.966 . . . . 0.0 114.649 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 t -99.31 136.17 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 O-C-N 121.425 -1.044 . . . . 0.0 111.381 -169.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 t -77.72 144.99 36.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.87 -1.769 . . . . 0.0 110.97 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -90.89 -9.43 46.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.455 -1.403 . . . . 0.0 113.305 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.02 144.53 33.87 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -172.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.1 -43.84 1.87 Allowed Glycine 0 N--CA 1.431 -1.699 0 O-C-N 121.176 -0.953 . . . . 0.0 113.017 -161.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.01 160.0 28.42 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.614 -1.521 . . . . 0.0 114.516 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.8 p -84.85 167.74 15.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.444 1.898 . . . . 0.0 111.174 175.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.576 ' CE1' HG11 ' A' ' 22' ' ' VAL . 11.1 t60 -60.67 -37.45 81.64 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.42 1.488 . . . . 0.0 114.052 171.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -54.5 -45.86 73.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.956 2.102 . . . . 0.0 114.221 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -76.18 -34.23 59.33 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.086 -1.634 . . . . 0.0 112.723 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.84 96.74 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.551 1.541 . . . . 0.0 114.481 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.7 m -73.88 -24.06 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.974 -1.704 . . . . 0.0 113.787 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -67.91 -45.26 74.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.406 -1.434 . . . . 0.0 112.183 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.6 m -59.97 -33.12 71.51 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 126.745 2.018 . . . . 0.0 112.828 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.26 -54.71 5.7 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.76 -1.213 . . . . 0.0 112.574 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -68.5 -5.43 19.45 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -169.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -85.49 11.96 9.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.152 -1.592 . . . . 0.0 115.192 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 p -102.14 -103.84 0.27 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.471 1.508 . . . . 0.0 110.015 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.95 -57.57 0.47 Allowed Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.201 -1.562 . . . . 0.0 113.376 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -71.33 -67.94 0.48 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.8 p -109.46 140.43 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 122.459 1.123 . . . . 0.0 112.057 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.9 t -119.82 112.1 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 125.155 1.382 . . . . 0.0 109.774 -175.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -116.53 115.35 25.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.017 -1.052 . . . . 0.0 108.378 168.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.2 tp -128.41 146.35 50.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.932 1.293 . . . . 0.0 108.595 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -120.74 123.02 41.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.32 157.65 44.58 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 122.243 1.021 . . . . 0.0 110.5 -170.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -104.68 141.37 36.56 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -65.23 135.45 55.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.629 1.204 . . . . 0.0 113.457 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.694 0 CA-C-O 122.596 1.109 . . . . 0.0 113.175 176.465 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 . . . . . 0 N--CA 1.429 -1.484 0 CA-C-O 121.244 0.545 . . . . 0.0 111.681 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -121.3 158.33 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.069 2.148 . . . . 0.0 107.752 -169.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.8 m -141.71 159.29 42.53 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.08 -1.637 . . . . 0.0 112.987 -168.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.53 161.77 38.99 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.475 0.655 . . . . 0.0 111.721 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.504 1.922 . . . . 0.0 106.437 174.559 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.71 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.31 168.62 18.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.8 135.06 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 126.424 1.89 . . . . 0.0 109.409 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -146.99 169.62 18.82 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.797 1.284 . . . . 0.0 113.568 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.09 125.94 40.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.994 1.318 . . . . 0.0 111.457 -174.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.2 m -104.78 147.91 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.303 -1.498 . . . . 0.0 113.805 172.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -130.85 104.08 6.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.132 1.373 . . . . 0.0 109.833 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 tp -123.28 174.9 7.01 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.795 1.238 . . . . 0.0 108.199 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.23 163.52 32.72 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.669 -1.894 . . . . 0.0 105.928 166.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -62.38 120.61 11.37 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -117.92 -89.07 0.6 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.617 1.167 . . . . 0.0 109.298 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.12 -49.66 41.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.68 1.592 . . . . 0.0 110.976 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -151.5 -162.83 1.62 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -84.63 -61.54 1.77 Allowed 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 120.511 1.505 . . . . 0.0 110.018 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 mp -104.1 -93.55 0.34 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.504 -1.373 . . . . 0.0 111.723 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.87 51.74 1.25 Allowed Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 124.793 1.187 . . . . 0.0 110.602 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.7 tt -150.2 163.57 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 121.329 -1.101 . . . . 0.0 110.791 -174.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -121.85 148.02 45.24 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.405 -1.435 . . . . 0.0 110.135 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -126.01 156.78 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 126.04 1.736 . . . . 0.0 109.633 -166.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -138.69 151.17 46.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.182 -0.949 . . . . 0.0 109.532 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.78 -149.8 50.8 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 125.641 1.591 . . . . 0.0 115.804 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.03 36.88 13.79 Favored Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 116.677 1.431 . . . . 0.0 116.677 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.54 -108.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -166.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -90.25 -52.48 4.91 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.802 -1.811 . . . . 0.0 110.852 -169.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -137.38 135.42 36.96 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 161.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 t -155.72 -84.27 0.06 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.107 -1.621 . . . . 0.0 110.325 -163.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.48 -58.5 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -116.89 -138.36 0.36 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 161.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 66.06 2.19 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.979 -1.7 . . . . 0.0 110.711 164.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.99 -147.3 16.46 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -168.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.63 145.32 14.91 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 121.712 -0.875 . . . . 0.0 111.3 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.6 mm -123.47 145.7 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.485 -1.597 . . . . 0.0 108.969 -160.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.75 141.23 52.11 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.118 1.367 . . . . 0.0 110.078 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.82 136.32 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.77 -1.207 . . . . 0.0 112.897 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -97.11 -66.64 0.89 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.058 1.343 . . . . 0.0 112.05 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.25 159.28 39.93 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.17 -0.956 . . . . 0.0 110.456 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.33 131.85 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 125.673 1.589 . . . . 0.0 110.781 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.5 mm -83.83 122.27 76.26 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 117.451 -1.262 . . . . 0.0 108.104 170.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.9 40.99 1.03 Allowed 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.474 2.782 . . . . 0.0 113.11 -171.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -160.59 78.0 0.62 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.23 170.39 43.51 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.76 -34.47 74.51 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.743 1.217 . . . . 0.0 113.07 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.91 -42.95 69.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -92.2 -37.7 12.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.861 1.264 . . . . 0.0 112.993 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.3 m -68.0 -35.57 78.54 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.282 -1.511 . . . . 0.0 114.549 -177.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.13 -60.27 2.44 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.103 0.954 . . . . 0.0 109.782 167.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.39 68.63 0.61 Allowed Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -136.72 -42.4 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.839 -0.801 . . . . 0.0 112.27 -155.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 mt -127.84 121.14 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -117.85 -179.63 3.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.317 1.056 . . . . 0.0 111.086 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -59.58 142.13 53.44 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.07 6.41 82.72 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 119.284 2.473 . . . . 0.0 119.284 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.76 170.51 16.45 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.684 1.742 . . . . 0.0 113.019 173.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -131.84 91.09 2.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.951 -1.718 . . . . 0.0 111.016 -166.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.09 160.63 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.43 -2.044 . . . . 0.0 113.288 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.1 tp -141.79 -82.97 0.2 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.728 -1.232 . . . . 0.0 113.041 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.32 146.88 24.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.33 -1.482 . . . . 0.0 114.796 -165.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.3 t -113.71 89.48 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 126.723 2.009 . . . . 0.0 107.71 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.7 t30 57.55 58.47 3.76 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.602 1.561 . . . . 0.0 112.712 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.44 -41.54 3.09 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.842 -1.161 . . . . 0.0 113.963 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.0 122.28 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.559 -1.553 . . . . 0.0 110.963 -173.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -77.39 141.14 39.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.105 -1.622 . . . . 0.0 111.417 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 pp -88.23 -2.8 58.81 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.19 142.89 57.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -171.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.05 -29.72 11.58 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 120.619 -1.301 . . . . 0.0 113.153 -166.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.86 153.84 32.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 p -83.0 170.6 14.72 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.856 -1.153 . . . . 0.0 112.039 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -55.29 -46.26 76.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.545 1.538 . . . . 0.0 114.985 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -60.14 -40.7 90.74 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -72.25 -38.98 68.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.326 -1.484 . . . . 0.0 111.964 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.45 96.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.783 1.633 . . . . 0.0 114.527 175.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.9 m -69.26 -37.49 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.395 -1.441 . . . . 0.0 113.163 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.78 -40.68 89.1 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.927 1.291 . . . . 0.0 112.915 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.1 m -58.35 -38.53 77.39 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.202 2.201 . . . . 0.0 113.202 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.84 -33.02 30.88 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.792 1.237 . . . . 0.0 112.993 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -69.99 -47.08 63.65 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.766 -1.209 . . . . 0.0 113.92 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.347 0.0 OUTLIER -89.97 42.45 1.09 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.8 p -93.1 -71.88 0.63 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.444 1.498 . . . . 0.0 109.669 171.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.94 -99.55 0.89 Allowed Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.08 1.8 . . . . 0.0 113.509 172.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -79.66 -47.68 14.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -159.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.31 146.7 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 121.046 -1.033 . . . . 0.0 111.993 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.32 112.76 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 120.311 -1.493 . . . . 0.0 110.092 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -114.84 118.85 34.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 163.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.6 tt -145.67 143.77 30.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.401 -0.812 . . . . 0.0 110.091 -170.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.06 126.49 49.98 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -173.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.23 164.66 29.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.06 1.409 . . . . 0.0 112.011 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -117.74 141.51 48.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 174.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -73.61 138.35 44.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.247 1.023 . . . . 0.0 111.582 175.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.761 0 CA-C-O 123.049 1.361 . . . . 0.0 116.024 -174.673 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.38 146.18 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.901 -1.124 . . . . 0.0 109.519 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.8 m -136.96 176.56 8.6 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.573 -1.329 . . . . 0.0 113.07 -172.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.91 157.22 42.96 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.099 1.36 . . . . 0.0 108.827 168.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 C--O 1.258 1.549 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 176.808 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.744 0 CA-C-O 119.802 -0.443 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.97 138.13 47.81 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.882 1.325 . . . . 0.0 114.57 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.61 140.65 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.25 1.82 . . . . 0.0 108.595 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.501 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -161.04 161.91 31.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.195 -0.941 . . . . 0.0 110.566 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.51 127.89 54.95 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 120.977 -1.077 . . . . 0.0 109.212 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.28 131.95 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 122.587 1.184 . . . . 0.0 111.284 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -116.63 123.47 47.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.414 1.102 . . . . 0.0 109.846 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.4 tp -135.22 168.23 19.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.99 160.73 31.0 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.0 tttp -70.88 103.65 2.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.107 -0.996 . . . . 0.0 111.05 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -100.66 -93.66 0.28 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.16 1.784 . . . . 0.0 109.401 -166.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.0 -47.44 45.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.297 -1.502 . . . . 0.0 109.133 167.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -147.66 -153.83 0.51 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 167.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 p -83.47 -90.94 0.08 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.231 -1.543 . . . . 0.0 111.361 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.64 -85.22 0.43 Allowed 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 120.459 -1.4 . . . . 0.0 113.317 -173.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.46 42.74 1.44 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 125.327 1.441 . . . . 0.0 110.985 -168.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.3 tt -134.89 152.66 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 121.124 -1.221 . . . . 0.0 109.552 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.2 p -122.27 153.87 38.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.478 -1.389 . . . . 0.0 111.738 -171.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.66 159.6 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.133 1.373 . . . . 0.0 108.982 -164.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.2 t -138.04 142.36 40.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.67 -149.3 50.44 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.781 1.658 . . . . 0.0 114.921 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.82 34.29 5.78 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 124.5 1.048 . . . . 0.0 115.456 165.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.14 -92.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 121.663 -0.904 . . . . 0.0 111.216 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -98.32 -51.09 4.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.453 -1.404 . . . . 0.0 110.103 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.9 131.41 14.8 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.83 -1.169 . . . . 0.0 110.832 175.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -154.83 -74.2 0.11 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.285 1.034 . . . . 0.0 110.661 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -79.46 -48.71 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.459 -1.401 . . . . 0.0 110.137 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -132.08 -159.67 0.98 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 161.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -71.7 110.76 6.46 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 120.329 -1.482 . . . . 0.0 108.76 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.22 -179.76 23.86 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 121.063 -1.023 . . . . 0.0 113.905 -167.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.79 161.45 27.79 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.451 -1.617 . . . . 0.0 112.075 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.8 mm -126.68 142.51 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.3 1.84 . . . . 0.0 107.986 -162.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.88 138.46 52.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.968 1.307 . . . . 0.0 109.451 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.86 133.58 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.712 -1.242 . . . . 0.0 112.714 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -90.85 -65.64 1.0 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.216 1.007 . . . . 0.0 110.87 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.73 160.9 31.95 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.356 -0.84 . . . . 0.0 111.946 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.05 125.59 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.998 1.319 . . . . 0.0 110.46 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.08 133.99 47.09 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.967 -1.492 . . . . 0.0 109.085 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.35 43.31 1.46 Allowed 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 124.772 2.74 . . . . 0.0 114.089 -173.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -153.57 47.66 0.66 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.851 -1.156 . . . . 0.0 109.721 -166.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.01 -172.7 39.51 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 120.237 -1.539 . . . . 0.0 112.517 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.85 -29.35 69.79 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.626 1.97 . . . . 0.0 113.214 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.29 94.62 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 125.987 1.715 . . . . 0.0 114.044 174.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -73.71 -43.59 58.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.804 1.242 . . . . 0.0 111.909 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 t -62.16 -55.56 27.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.182 1.393 . . . . 0.0 114.149 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.69 -60.32 2.37 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.915 -1.116 . . . . 0.0 111.091 175.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.31 87.13 1.43 Allowed Glycine 0 N--CA 1.43 -1.756 0 O-C-N 121.371 -0.831 . . . . 0.0 112.105 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.43 -26.77 0.98 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 121.238 -1.154 . . . . 0.0 112.789 -164.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.5 mm -126.56 136.89 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -119.33 171.31 8.41 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.678 -1.264 . . . . 0.0 112.546 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.14 143.91 42.26 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.44 15.21 81.68 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 116.445 1.338 . . . . 0.0 116.445 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -82.43 158.39 23.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.092 1.357 . . . . 0.0 113.496 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -127.17 114.43 17.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.888 1.675 . . . . 0.0 111.715 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 m -79.93 157.49 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.864 -1.772 . . . . 0.0 113.717 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 mp -121.53 -90.97 0.57 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 125.643 1.577 . . . . 0.0 107.41 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.19 159.48 16.04 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.312 -2.117 . . . . 0.0 114.213 -166.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.94 80.13 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.389 1.875 . . . . 0.0 106.658 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.5 t30 57.86 69.7 0.71 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.849 1.66 . . . . 0.0 112.768 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.55 -55.62 2.71 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 120.592 -1.318 . . . . 0.0 114.456 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -86.12 138.36 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.545 1.164 . . . . 0.0 113.171 -170.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -79.26 155.43 28.54 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.539 -1.351 . . . . 0.0 113.1 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 pp -85.91 4.25 38.3 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 125.307 1.443 . . . . 0.0 113.874 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -62.13 120.33 10.68 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.617 -1.302 . . . . 0.0 114.249 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.68 -39.58 2.65 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 125.77 1.653 . . . . 0.0 112.984 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.65 140.33 51.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -168.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.68 -178.56 5.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.337 1.455 . . . . 0.0 109.377 172.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -60.29 -49.95 75.56 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.402 -1.436 . . . . 0.0 114.483 -171.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -54.27 -43.12 70.74 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 125.136 1.374 . . . . 0.0 113.77 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -71.67 -41.2 69.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.016 -1.053 . . . . 0.0 112.717 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.51 92.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.333 -1.48 . . . . 0.0 114.374 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -72.15 -40.25 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.003 -1.685 . . . . 0.0 112.351 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -72.37 -31.81 65.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.283 -1.511 . . . . 0.0 114.117 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.5 p -70.42 -26.15 63.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.222 -1.549 . . . . 0.0 113.157 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.23 -40.52 26.89 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 121.062 -1.024 . . . . 0.0 112.011 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -60.68 -56.0 26.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.545 -1.347 . . . . 0.0 113.676 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -84.03 59.32 5.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.673 -1.267 . . . . 0.0 111.379 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.49 -69.63 0.63 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.044 2.138 . . . . 0.0 107.59 166.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.71 -117.74 3.95 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -65.5 -63.62 1.05 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.71 138.04 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 122.488 1.137 . . . . 0.0 111.478 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.19 87.42 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 125.646 1.578 . . . . 0.0 106.791 -175.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -116.29 126.02 52.98 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 120.273 -1.517 . . . . 0.0 108.996 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . 0.266 0.0 OUTLIER -147.34 162.67 38.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.637 -1.289 . . . . 0.0 111.927 -179.1 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -121.41 131.2 54.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.679 1.592 . . . . 0.0 107.729 -170.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.501 HD11 ' CZ ' ' A' ' 7' ' ' PHE . 1.3 pt? -140.87 162.99 34.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.515 1.15 . . . . 0.0 111.602 -171.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -134.89 120.19 18.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.426 1.49 . . . . 0.0 107.527 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -62.39 143.91 56.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -174.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.728 0 O-C-N 121.299 -0.876 . . . . 0.0 113.93 -175.423 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.4 157.79 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.739 -1.851 . . . . 0.0 109.423 -159.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.5 p -139.21 168.0 20.82 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.328 -1.482 . . . . 0.0 114.429 -172.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.54 160.19 43.68 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.188 1.395 . . . . 0.0 108.812 162.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 74.1 t . . . . . 0 C--O 1.26 1.644 0 N-CA-C 106.041 -1.836 . . . . 0.0 106.041 176.71 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.672 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -82.78 168.02 17.57 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.394 1.092 . . . . 0.0 112.495 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -78.39 135.54 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.186 1.794 . . . . 0.0 108.946 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -136.23 156.04 49.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.522 -1.361 . . . . 0.0 110.479 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -116.09 134.11 55.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 121.044 -1.035 . . . . 0.0 111.334 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.8 t -102.9 125.08 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 124.563 1.145 . . . . 0.0 109.597 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -124.72 70.89 1.14 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.524 1.53 . . . . 0.0 108.032 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tp -112.69 -160.88 0.73 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.468 -1.395 . . . . 0.0 110.38 -166.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.45 151.68 30.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.546 -1.346 . . . . 0.0 107.977 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -73.57 101.98 3.74 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.908 -1.12 . . . . 0.0 112.464 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -90.75 -71.39 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.264 1.026 . . . . 0.0 110.187 172.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -86.6 -69.2 0.69 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.488 1.515 . . . . 0.0 111.325 174.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -136.76 165.5 25.78 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 102.132 -3.284 . . . . 0.0 102.132 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 p -83.05 -51.24 7.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.458 -1.401 . . . . 0.0 112.241 -174.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 mt -102.36 -89.95 0.36 Allowed 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 121.057 -1.027 . . . . 0.0 113.457 172.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.49 53.78 1.93 Allowed Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -159.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 tt -145.79 159.13 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 121.1 -1.235 . . . . 0.0 110.782 -173.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -123.22 147.67 46.65 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.688 -1.883 . . . . 0.0 109.686 -175.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.14 147.49 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 125.691 1.596 . . . . 0.0 111.107 -167.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -137.96 126.59 23.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.437 1.113 . . . . 0.0 111.604 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.43 65.43 3.17 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 118.449 2.14 . . . . 0.0 118.449 164.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.66 75.78 0.32 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.58 -108.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 124.602 1.161 . . . . 0.0 111.044 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -72.63 -76.42 0.12 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.735 2.014 . . . . 0.0 111.633 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -144.26 121.1 11.27 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.225 -1.547 . . . . 0.0 109.315 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 p -138.87 -73.97 0.39 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.738 -1.226 . . . . 0.0 112.878 -170.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -66.13 -60.63 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 126.224 1.81 . . . . 0.0 111.564 -172.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ttm-85 -125.0 -115.83 0.29 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 62.6 2.56 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.101 1.36 . . . . 0.0 109.067 167.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.95 -139.56 14.45 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -163.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.78 155.94 28.29 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-O 121.939 0.744 . . . . 0.0 112.927 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.93 142.4 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -135.55 132.76 37.6 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.65 1.98 . . . . 0.0 110.351 -168.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.0 t -80.32 128.61 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.482 -1.386 . . . . 0.0 112.863 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -84.74 -55.1 4.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.067 1.747 . . . . 0.0 111.812 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.08 165.39 15.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.439 -0.788 . . . . 0.0 110.141 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 t -98.52 130.86 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 C-N-CA 125.64 1.576 . . . . 0.0 111.381 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mm -82.85 124.91 76.51 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 124.932 1.293 . . . . 0.0 109.65 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.36 32.22 0.52 Allowed 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 123.42 2.747 . . . . 0.0 114.326 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -142.79 52.57 1.4 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.863 1.265 . . . . 0.0 108.589 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -166.58 173.3 41.97 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 119.993 -1.692 . . . . 0.0 111.452 -176.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.71 73.04 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.461 1.504 . . . . 0.0 114.731 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.05 78.56 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 175.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -77.62 -28.93 51.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.761 1.224 . . . . 0.0 112.736 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.3 t -64.69 -56.4 13.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.578 -1.326 . . . . 0.0 113.381 173.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -79.63 -47.51 15.3 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.955 1.302 . . . . 0.0 112.005 -172.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.87 80.61 1.42 Allowed Glycine 0 N--CA 1.431 -1.644 0 O-C-N 121.035 -1.04 . . . . 0.0 111.217 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -139.87 -51.77 0.51 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.834 0.854 . . . . 0.0 112.714 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.1 mt -126.92 136.36 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 -168.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.81 -166.51 2.36 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 -175.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.13 125.16 21.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.7 15.88 81.21 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 117.307 1.683 . . . . 0.0 117.307 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -75.69 155.26 35.88 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 118.93 1.365 . . . . 0.0 111.131 167.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.87 131.32 40.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.461 -1.4 . . . . 0.0 109.562 -173.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.58 153.29 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.647 -1.908 . . . . 0.0 113.766 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.69 -84.51 0.66 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.807 1.643 . . . . 0.0 107.397 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 143.57 29.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.3 t -120.14 90.99 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.289 1.436 . . . . 0.0 108.398 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.275 4.8 t30 57.24 64.48 1.6 Allowed 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 125.896 1.679 . . . . 0.0 112.281 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.17 -61.87 1.06 Allowed Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 124.691 1.139 . . . . 0.0 113.506 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.0 m -83.86 134.05 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.984 -1.304 . . . . 0.0 113.381 -164.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.3 t -77.79 124.98 28.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.779 -1.201 . . . . 0.0 110.376 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.8 tp -85.67 47.58 1.46 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 123.811 1.767 . . . . 0.0 113.995 -163.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -70.07 134.88 48.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.137 1.775 . . . . 0.0 112.6 166.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.82 -14.45 60.27 Favored Glycine 0 N--CA 1.431 -1.681 0 O-C-N 120.979 -1.076 . . . . 0.0 114.212 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.9 138.49 41.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.91 -1.347 . . . . 0.0 114.159 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 p -93.73 173.96 7.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.983 1.713 . . . . 0.0 109.369 166.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -61.46 -38.45 87.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -169.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -72.14 -27.4 62.59 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.549 -1.344 . . . . 0.0 113.68 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -78.55 -41.16 32.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.153 -1.592 . . . . 0.0 111.086 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.05 96.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.87 -44.31 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.892 -1.755 . . . . 0.0 112.942 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -66.31 -46.51 76.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.93 1.692 . . . . 0.0 113.788 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.8 p -64.54 -33.17 75.28 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.827 1.651 . . . . 0.0 114.434 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.6 mt -92.44 -16.7 25.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -76.35 -55.04 5.92 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.241 -1.537 . . . . 0.0 111.496 168.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -91.55 65.33 5.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.871 1.32 . . . . 0.0 112.175 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.9 p -86.65 -58.56 2.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.862 2.065 . . . . 0.0 109.923 171.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.77 -128.48 7.81 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 125.426 1.489 . . . . 0.0 111.126 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -81.36 -43.86 18.43 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.903 -1.351 . . . . 0.0 112.308 -170.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 p -104.82 140.96 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 122.113 0.959 . . . . 0.0 110.999 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.6 t -119.64 100.91 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 124.496 1.118 . . . . 0.0 108.832 -168.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -117.61 115.07 24.36 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 110.953 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.42 157.12 43.27 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 121.206 -0.934 . . . . 0.0 110.926 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -120.87 144.61 48.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -139.54 159.04 43.09 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 123.889 0.876 . . . . 0.0 109.596 -173.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -107.89 125.46 51.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 167.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -74.6 146.44 42.5 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.922 -1.111 . . . . 0.0 112.144 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.787 0 CA-C-O 123.578 1.655 . . . . 0.0 116.825 -172.363 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 N--CA 1.429 -1.475 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.47 155.28 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.604 1.561 . . . . 0.0 109.515 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 20.4 p -140.04 149.61 43.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.143 -0.973 . . . . 0.0 112.815 -172.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.42 150.87 49.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.977 1.311 . . . . 0.0 111.879 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.259 1.597 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.524 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.675 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -79.67 140.38 37.06 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 121.519 -0.989 . . . . 0.0 109.117 172.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 mp -82.61 134.05 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.421 -1.424 . . . . 0.0 108.532 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -133.5 151.74 51.8 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.551 -1.343 . . . . 0.0 111.049 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -103.91 130.43 51.51 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.265 1.026 . . . . 0.0 109.296 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.4 t -103.07 117.72 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.375 -1.453 . . . . 0.0 109.823 168.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -113.0 101.38 9.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 168.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.8 tp -135.48 170.57 15.75 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.176 0.988 . . . . 0.0 109.499 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.36 161.39 41.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.492 -2.005 . . . . 0.0 108.603 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -71.47 105.43 3.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.311 1.445 . . . . 0.0 112.365 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -102.55 -62.68 1.24 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.902 1.281 . . . . 0.0 110.408 167.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -86.12 -66.04 0.95 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.104 1.361 . . . . 0.0 109.154 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -137.5 176.36 8.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.694 1.598 . . . . 0.0 107.022 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.7 t -83.15 -69.05 0.66 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.445 -1.409 . . . . 0.0 111.509 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.448 HD22 HG13 ' B' ' 15' ' ' VAL . 7.9 mp -104.04 -105.46 0.29 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.954 -1.716 . . . . 0.0 112.101 170.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.32 57.21 1.01 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.917 -1.114 . . . . 0.0 111.81 -171.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 tt -144.19 164.7 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 121.45 -1.029 . . . . 0.0 108.444 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 t -122.09 138.39 54.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.506 -1.996 . . . . 0.0 110.394 -175.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.56 154.8 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 124.654 1.182 . . . . 0.0 108.787 -166.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -137.44 94.13 2.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.757 1.742 . . . . 0.0 111.195 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.01 -152.06 41.57 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 164.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.31 79.34 1.45 Allowed Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -168.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -117.72 -104.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.419 -1.047 . . . . 0.0 113.406 -162.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -77.15 -51.54 10.82 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.708 -1.87 . . . . 0.0 109.94 -161.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -150.21 137.58 19.68 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 155.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.9 m -151.53 -86.93 0.07 Allowed 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 119.703 -1.873 . . . . 0.0 110.772 -166.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 t -73.9 -59.43 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 124.823 1.249 . . . . 0.0 109.145 -175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -144.23 -123.33 0.08 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -85.3 65.32 9.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.97 -1.706 . . . . 0.0 110.712 172.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.57 -129.33 9.68 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 -165.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.45 133.0 2.9 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 125.629 1.585 . . . . 0.0 112.152 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.3 mm -125.58 137.13 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.4 129.97 50.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.719 -1.238 . . . . 0.0 111.408 -163.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -76.22 135.85 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.562 -1.336 . . . . 0.0 112.292 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -88.2 -61.3 1.75 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.584 1.554 . . . . 0.0 111.039 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.12 162.65 34.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.56 134.3 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 122.193 0.997 . . . . 0.0 111.064 174.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 mm -84.02 134.66 43.39 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 116.652 -1.642 . . . . 0.0 107.495 171.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.11 77.02 2.87 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 125.718 3.078 . . . . 0.0 112.437 170.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -141.13 -40.94 0.39 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -168.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.2 -144.39 4.34 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.301 -1.499 . . . . 0.0 112.155 -167.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.17 -39.97 96.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.904 2.081 . . . . 0.0 114.752 -162.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.34 -50.7 72.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.959 1.704 . . . . 0.0 114.028 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.62 -37.42 50.19 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.075 1.35 . . . . 0.0 112.549 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.7 t -62.38 -47.99 81.73 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.951 -1.718 . . . . 0.0 114.186 -175.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -81.14 -47.05 14.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.828 -1.17 . . . . 0.0 110.571 171.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.88 73.06 1.2 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -139.63 -41.25 0.45 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -164.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.61 134.55 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -140.51 -160.97 1.13 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.344 0.974 . . . . 0.0 112.947 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -54.93 133.81 48.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.304 1.842 . . . . 0.0 114.343 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.37 -2.11 63.27 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 117.992 1.957 . . . . 0.0 117.992 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -75.56 151.28 37.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.055 1.928 . . . . 0.0 112.271 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -123.89 138.93 54.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.581 -1.324 . . . . 0.0 109.783 -165.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.56 155.32 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.692 -1.88 . . . . 0.0 111.948 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.7 mt -119.01 -88.27 0.62 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.23 145.23 29.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.679 1.192 . . . . 0.0 110.802 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 p -102.78 92.17 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 123.039 1.4 . . . . 0.0 110.68 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 58.35 55.52 4.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.861 -1.774 . . . . 0.0 113.163 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.12 -12.82 59.21 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 120.631 -1.293 . . . . 0.0 115.16 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.4 t -103.14 125.51 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 118.561 1.181 . . . . 0.0 109.863 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -77.38 158.96 29.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.547 -1.346 . . . . 0.0 114.562 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -117.43 36.7 4.15 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.052 1.341 . . . . 0.0 109.028 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.93 115.82 7.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.056 -1.652 . . . . 0.0 113.452 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.71 15.76 78.8 Favored Glycine 0 N--CA 1.431 -1.66 0 O-C-N 119.626 -1.921 . . . . 0.0 115.33 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.48 148.16 35.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.847 -1.384 . . . . 0.0 113.104 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.6 p -90.37 174.28 7.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.766 1.227 . . . . 0.0 108.591 163.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -61.34 -37.63 84.01 Favored 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 120.367 -1.458 . . . . 0.0 114.576 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 -40.87 90.75 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.091 -1.631 . . . . 0.0 112.602 175.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -70.14 -41.32 74.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.498 1.519 . . . . 0.0 111.627 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.11 -48.71 70.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . 0.265 35.4 m -63.14 -37.23 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -172.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -64.25 -45.06 89.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 120.516 1.507 . . . . 0.0 112.612 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.7 m -60.09 -36.28 77.05 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.829 1.651 . . . . 0.0 112.385 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.69 -36.74 31.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.325 1.85 . . . . 0.0 115.693 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -63.91 -44.04 94.15 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.156 -1.59 . . . . 0.0 113.067 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -85.0 49.61 1.77 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.595 1.188 . . . . 0.0 113.665 -166.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.7 p -98.48 -76.27 0.54 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.44 2.296 . . . . 0.0 109.563 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.02 -106.84 2.44 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 125.106 1.336 . . . . 0.0 113.179 167.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -68.19 -53.54 24.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -172.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.7 m -108.58 138.84 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.188 0.994 . . . . 0.0 110.346 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.3 t -126.01 95.46 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -135.63 92.02 2.78 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.102 -1.624 . . . . 0.0 110.699 -171.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.15 176.93 9.15 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -165.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.65 131.05 54.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.397 1.079 . . . . 0.0 109.611 -170.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -126.13 167.33 15.54 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.746 1.618 . . . . 0.0 110.397 -174.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -124.58 141.01 52.41 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.992 1.317 . . . . 0.0 107.538 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -72.77 144.83 47.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.759 0 O-C-N 120.668 -1.27 . . . . 0.0 114.095 -179.508 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 . . . . . 0 N--CA 1.429 -1.491 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.57 154.68 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.048 -1.657 . . . . 0.0 108.379 171.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m -140.91 155.87 46.2 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.38 -0.825 . . . . 0.0 111.288 -172.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.3 159.44 42.06 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.84 0.829 . . . . 0.0 110.032 168.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' VAL . . . . . 0.448 HG13 HD22 ' A' ' 18' ' ' LEU . 3.5 p . . . . . 0 C--O 1.259 1.585 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.79 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.29 177.3 8.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.058 -1.26 . . . . 0.0 113.63 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.7 mt -74.95 143.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.803 -1.81 . . . . 0.0 112.944 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -147.01 160.36 42.47 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.804 -1.185 . . . . 0.0 110.708 170.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -127.26 123.15 35.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.723 -1.236 . . . . 0.0 111.358 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -105.32 132.93 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.689 -1.257 . . . . 0.0 111.878 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -112.43 121.46 44.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 108.794 158.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.491 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 10.1 tp -132.82 -167.7 1.95 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.713 1.205 . . . . 0.0 108.418 176.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.491 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -155.59 168.94 25.51 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.12 -1.613 . . . . 0.0 109.195 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -72.01 104.74 3.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.561 1.144 . . . . 0.0 112.841 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -91.28 -85.96 0.23 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.14 -0.975 . . . . 0.0 110.869 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -86.5 -44.92 11.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.75 1.62 . . . . 0.0 110.808 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -138.24 177.9 7.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.183 2.193 . . . . 0.0 105.162 174.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.8 p -84.03 -66.34 0.9 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.503 -1.373 . . . . 0.0 112.151 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.7 mt -101.04 -79.92 0.5 Allowed 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 119.7 1.136 . . . . 0.0 111.865 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.15 47.82 2.35 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 121.1 -1.0 . . . . 0.0 112.069 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 tt -145.81 157.89 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.827 -1.396 . . . . 0.0 112.669 -170.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 t -123.56 146.31 48.22 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.413 -1.429 . . . . 0.0 109.266 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 t -122.05 149.95 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.167 1.387 . . . . 0.0 109.898 -163.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 t -137.27 108.37 6.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.585 1.659 . . . . 0.0 111.137 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.35 -117.29 5.49 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 125.103 1.335 . . . . 0.0 111.689 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.79 35.53 61.97 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 115.843 1.097 . . . . 0.0 115.843 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 m -107.61 -120.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 121.468 -1.019 . . . . 0.0 112.667 -170.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -79.65 -81.12 0.12 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.986 1.715 . . . . 0.0 113.294 -171.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.6 t -128.92 115.57 18.06 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -155.32 -85.93 0.05 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.361 -0.837 . . . . 0.0 109.917 -166.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.1 -52.41 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 120.088 -1.633 . . . . 0.0 110.961 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -133.46 -153.84 0.57 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 158.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -74.5 96.96 3.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.496 1.118 . . . . 0.0 108.405 155.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.71 -172.7 50.63 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 120.267 -1.52 . . . . 0.0 114.423 -169.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.73 147.32 22.32 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -162.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.9 mm -124.77 140.72 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -123.4 143.13 50.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -167.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -87.2 132.3 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 O-C-N 121.031 -1.043 . . . . 0.0 111.366 -173.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -85.46 -51.7 6.35 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.291 1.036 . . . . 0.0 110.873 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.62 157.74 12.63 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.8 p -91.69 137.83 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 121.491 0.662 . . . . 0.0 109.886 171.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -84.09 121.62 75.65 Favored Pre-proline 0 N--CA 1.429 -1.504 0 O-C-N 120.325 -1.485 . . . . 0.0 109.093 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -78.84 60.05 7.56 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.363 2.709 . . . . 0.0 112.383 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.33 32.94 0.28 Allowed 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 122.262 1.029 . . . . 0.0 108.401 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.63 176.94 46.16 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 119.729 -1.857 . . . . 0.0 112.619 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -37.35 -45.67 0.71 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.199 2.999 . . . . 0.0 118.54 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.1 89.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -175.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -85.53 -40.62 16.12 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.927 1.291 . . . . 0.0 111.324 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.9 m -60.32 -55.97 27.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.43 -29.38 52.88 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.558 -1.339 . . . . 0.0 110.09 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.46 76.87 1.21 Allowed Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.106 -0.996 . . . . 0.0 112.506 167.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -136.87 -53.7 0.71 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.551 -0.97 . . . . 0.0 112.5 -167.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.6 mt -127.62 125.95 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -166.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -134.56 -171.13 2.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -56.73 128.87 38.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.137 1.375 . . . . 0.0 114.141 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.26 21.79 74.86 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 117.697 1.839 . . . . 0.0 117.697 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -81.36 159.0 24.48 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 119.545 1.672 . . . . 0.0 109.629 161.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.0 ttp85 -122.22 116.51 24.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.559 -1.338 . . . . 0.0 108.705 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.54 138.11 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 121.064 -1.022 . . . . 0.0 109.917 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.5 tp -121.07 -86.47 0.65 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.143 -0.973 . . . . 0.0 109.999 -170.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.06 132.4 33.83 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.848 -1.782 . . . . 0.0 113.277 -170.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.8 p -103.61 93.76 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.552 1.644 . . . . 0.0 108.251 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.268 58.7 t30 56.19 54.15 8.14 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.384 1.874 . . . . 0.0 113.7 -173.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.26 -46.01 1.49 Allowed Glycine 0 N--CA 1.431 -1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 113.621 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.01 128.66 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 121.094 -1.239 . . . . 0.0 111.286 -170.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 t -78.3 156.81 29.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.496 -1.378 . . . . 0.0 112.345 176.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 -13.86 23.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.061 1.344 . . . . 0.0 113.952 -175.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -66.41 128.38 35.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -168.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.1 -51.34 0.71 Allowed Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -170.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.24 151.94 32.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.352 1.461 . . . . 0.0 112.416 170.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.9 p -94.38 -179.11 4.8 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.681 -1.887 . . . . 0.0 112.147 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -50.04 -37.79 34.8 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.252 3.021 . . . . 0.0 115.064 172.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -56.54 -46.85 80.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.396 1.878 . . . . 0.0 114.112 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -77.81 -34.49 52.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.003 1.321 . . . . 0.0 111.185 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.48 77.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.577 1.551 . . . . 0.0 114.378 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.97 -29.34 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.385 -1.447 . . . . 0.0 114.056 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -70.63 -38.66 73.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.591 -1.943 . . . . 0.0 112.527 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.3 m -65.78 -43.49 88.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.415 -1.428 . . . . 0.0 112.236 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 tt -79.72 -46.84 16.33 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -59.12 -35.85 74.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.967 -1.708 . . . . 0.0 114.289 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -92.07 56.01 2.76 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.812 -1.18 . . . . 0.0 110.956 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 p -109.87 -69.25 0.87 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.687 1.995 . . . . 0.0 109.771 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.37 -105.68 1.31 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 124.312 0.958 . . . . 0.0 113.634 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -81.2 -45.11 16.82 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -163.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.04 155.16 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.958 -1.089 . . . . 0.0 112.004 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -130.19 112.8 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -128.44 117.83 22.05 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.354 -1.466 . . . . 0.0 109.804 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.13 160.5 42.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.539 -1.351 . . . . 0.0 113.957 -174.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.81 128.0 52.46 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.104 1.362 . . . . 0.0 107.436 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.86 159.59 27.86 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.041 1.336 . . . . 0.0 110.584 -174.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -109.08 127.33 54.05 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 153.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -69.44 137.06 52.36 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.04 1.336 . . . . 0.0 113.874 -171.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.804 0 O-C-N 120.546 -1.346 . . . . 0.0 110.694 170.575 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 17.6 m -125.94 155.9 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 125.969 1.708 . . . . 0.0 110.633 -173.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -142.06 143.49 33.13 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.716 0.769 . . . . 0.0 111.109 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.69 146.78 47.99 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.199 1.4 . . . . 0.0 112.618 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.261 1.663 0 C-N-CA 126.176 1.79 . . . . 0.0 106.422 170.073 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.742 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.66 179.22 7.85 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 mt -81.71 149.96 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.539 1.536 . . . . 0.0 111.617 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.11 139.87 21.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.478 -1.389 . . . . 0.0 112.247 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -105.96 105.86 16.1 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.665 1.586 . . . . 0.0 111.155 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.08 134.17 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 120.347 -1.471 . . . . 0.0 112.182 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -111.74 127.39 55.77 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 168.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 8.1 tp -135.73 -159.46 0.96 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.943 -1.098 . . . . 0.0 109.613 172.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -153.87 168.11 27.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.311 -1.493 . . . . 0.0 108.605 172.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -72.4 112.68 8.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.612 -1.305 . . . . 0.0 110.287 163.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -93.27 -88.56 0.22 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.92 -53.92 6.3 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.028 1.331 . . . . 0.0 109.171 165.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -135.91 172.79 12.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.856 -1.153 . . . . 0.0 108.289 -172.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -81.89 -88.53 0.08 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.065 0.946 . . . . 0.0 109.828 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.6 mt -102.71 -89.39 0.38 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.31 -1.494 . . . . 0.0 112.474 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.6 48.24 3.51 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -165.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 tt -134.26 161.04 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 121.288 -1.125 . . . . 0.0 108.364 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.4 t -121.27 142.55 49.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.365 -1.459 . . . . 0.0 107.242 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.6 t -122.74 152.56 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -160.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 t -145.54 134.34 22.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.685 -1.884 . . . . 0.0 112.832 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.11 -141.54 20.81 Favored Glycine 0 N--CA 1.43 -1.703 0 C-N-CA 126.971 2.224 . . . . 0.0 114.203 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.62 33.7 67.21 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 124.669 1.128 . . . . 0.0 115.614 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -93.32 -124.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 121.039 -1.271 . . . . 0.0 113.549 -170.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -71.59 -57.72 4.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.748 -1.845 . . . . 0.0 111.274 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.4 t -140.51 154.19 46.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 148.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.4 t -155.84 -103.71 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -164.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.413 HG13 ' H ' ' A' ' 31' ' ' ARG . 3.0 p -62.08 -58.43 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.066 1.747 . . . . 0.0 110.074 161.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.413 ' H ' HG13 ' A' ' 30' ' ' VAL . 91.3 mtt180 -143.29 -163.28 1.61 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 161.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -78.89 44.13 0.54 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.257 1.823 . . . . 0.0 112.822 173.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.48 151.59 5.53 Favored Glycine 0 N--CA 1.43 -1.743 0 O-C-N 120.195 -1.566 . . . . 0.0 110.661 -169.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.81 143.39 11.88 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -168.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.38 162.54 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -172.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.93 151.34 43.68 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.296 -1.503 . . . . 0.0 107.791 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -82.81 134.83 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 120.72 -1.237 . . . . 0.0 110.964 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -85.24 -59.91 2.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.63 1.172 . . . . 0.0 110.583 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.79 168.82 12.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.049 0.94 . . . . 0.0 108.491 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -95.22 136.26 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 122.694 1.235 . . . . 0.0 111.79 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.3 mm -82.73 132.22 52.33 Favored Pre-proline 0 N--CA 1.429 -1.5 0 O-C-N 120.38 -1.45 . . . . 0.0 107.187 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -80.5 35.57 0.58 Allowed 'Trans proline' 0 N--CA 1.434 -2.014 0 C-N-CA 123.242 2.628 . . . . 0.0 113.039 -172.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 62.5 0.9 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.629 1.572 . . . . 0.0 107.438 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.52 161.3 31.07 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.629 -1.294 . . . . 0.0 112.129 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.54 -38.12 19.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.871 2.068 . . . . 0.0 116.298 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.5 -41.82 77.32 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.5 -52.52 10.48 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 125.884 1.674 . . . . 0.0 111.476 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.0 m -56.2 -53.24 59.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -81.62 -36.42 28.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.272 1.029 . . . . 0.0 110.17 -177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.27 79.43 1.32 Allowed Glycine 0 N--CA 1.429 -1.768 0 O-C-N 120.837 -1.164 . . . . 0.0 112.006 169.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -136.18 -43.72 0.63 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -157.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.4 mt -128.86 142.42 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -131.15 178.24 6.85 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 123.321 1.534 . . . . 0.0 111.937 -170.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -56.39 123.12 13.59 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.71 20.06 76.95 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 118.45 2.14 . . . . 0.0 118.45 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -71.96 156.92 38.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 120.24 2.02 . . . . 0.0 111.552 166.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -122.66 114.07 20.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.612 -1.305 . . . . 0.0 108.977 -173.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 m -100.16 156.98 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 120.164 -1.585 . . . . 0.0 111.564 -174.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.9 tp -131.88 -81.48 0.51 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.017 -1.052 . . . . 0.0 111.279 173.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.85 128.23 45.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.704 -1.248 . . . . 0.0 113.649 -160.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.49 112.78 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 122.628 1.204 . . . . 0.0 109.131 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.27 35.8 t30 56.96 31.97 20.78 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 126.844 2.058 . . . . 0.0 114.018 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.4 -12.32 58.38 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.447 -1.408 . . . . 0.0 115.002 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.3 t -96.25 116.35 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 118.692 1.246 . . . . 0.0 111.824 -173.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -76.14 131.32 39.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.206 -1.559 . . . . 0.0 112.012 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -13.34 47.44 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.353 1.461 . . . . 0.0 113.49 -173.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -51.33 129.13 24.21 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.49 1.516 . . . . 0.0 115.088 -167.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.55 -35.19 5.11 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 124.13 0.872 . . . . 0.0 112.321 -160.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.81 155.26 33.19 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.481 -1.599 . . . . 0.0 112.113 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.0 p -93.28 159.99 15.03 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.978 0.894 . . . . 0.0 109.92 167.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.418 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 46.1 t60 -41.01 -44.93 2.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.665 2.786 . . . . 0.0 117.027 173.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -60.75 -37.65 82.52 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.781 -1.2 . . . . 0.0 114.212 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -78.45 -41.06 33.87 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.755 1.222 . . . . 0.0 112.002 174.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.33 -38.09 82.66 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.524 -1.36 . . . . 0.0 114.266 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 p -71.06 -33.8 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 O-C-N 120.293 -1.505 . . . . 0.0 112.98 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.61 -46.11 91.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.312 -1.492 . . . . 0.0 112.743 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.3 m -56.15 -48.34 76.47 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.612 1.565 . . . . 0.0 112.457 173.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.09 -36.37 40.87 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -172.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -59.61 -37.01 77.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.196 -1.565 . . . . 0.0 113.905 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -95.42 60.71 2.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.735 -1.228 . . . . 0.0 112.8 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -99.49 -73.3 0.63 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.512 2.325 . . . . 0.0 111.339 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.17 -116.63 3.77 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.295 1.426 . . . . 0.0 112.63 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -78.62 -36.26 44.34 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 121.473 -1.016 . . . . 0.0 113.633 -168.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.3 m -104.54 162.31 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.73 -1.231 . . . . 0.0 112.241 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.6 t -138.1 130.89 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 124.81 1.244 . . . . 0.0 108.708 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -141.2 127.97 20.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.652 -1.28 . . . . 0.0 108.072 161.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -149.27 159.06 44.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.276 -1.515 . . . . 0.0 113.082 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.5 mp -120.53 120.41 35.78 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.21 161.85 24.88 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.68 1.192 . . . . 0.0 110.227 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.65 135.47 54.12 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.36 1.464 . . . . 0.0 107.204 162.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -74.98 133.98 41.58 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.378 1.085 . . . . 0.0 112.874 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.753 0 CA-C-O 123.297 1.498 . . . . 0.0 115.056 178.435 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 121.247 0.546 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -122.87 158.19 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 124.757 1.223 . . . . 0.0 110.544 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.418 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 58.8 m -138.11 149.64 46.12 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.662 -1.274 . . . . 0.0 113.777 -173.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -124.0 150.48 44.81 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 125.121 1.368 . . . . 0.0 111.503 169.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.261 1.666 0 C-N-CA 127.621 2.368 . . . . 0.0 106.702 160.811 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.748 0 N-CA-C 111.956 -0.458 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.32 146.5 30.34 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.17 -1.194 . . . . 0.0 111.194 167.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 mp -89.97 144.53 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.04 2.136 . . . . 0.0 111.252 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -145.75 165.59 28.37 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.306 -1.496 . . . . 0.0 112.184 171.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -113.93 134.95 54.5 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 122.372 1.082 . . . . 0.0 112.241 -177.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.39 111.82 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.482 -1.386 . . . . 0.0 108.964 168.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -112.26 102.37 10.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 170.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tp -134.8 176.67 8.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.674 1.226 . . . . 0.0 111.463 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.01 158.71 42.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 168.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -70.44 152.64 43.83 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -121.17 -83.88 0.66 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.507 -1.371 . . . . 0.0 108.789 166.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -76.99 -51.46 11.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.704 -1.248 . . . . 0.0 109.196 172.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -138.2 177.64 7.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.0 m -82.47 -58.76 2.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.82 0.848 . . . . 0.0 111.32 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.6 mt -102.3 -90.64 0.35 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.142 1.337 . . . . 0.0 112.458 172.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.43 50.58 0.8 Allowed Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -165.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tt -137.62 165.01 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.941 -1.329 . . . . 0.0 110.688 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 t -122.95 136.64 54.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.891 1.677 . . . . 0.0 107.702 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.8 t -123.69 144.04 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 124.675 1.19 . . . . 0.0 110.03 -161.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -138.87 131.17 28.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.032 1.396 . . . . 0.0 112.914 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.43 -162.64 25.83 Favored Glycine 0 N--CA 1.429 -1.777 0 C-N-CA 126.87 2.176 . . . . 0.0 114.236 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.12 42.12 2.47 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.7 -0.882 . . . . 0.0 113.791 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -106.08 -107.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.287 1.042 . . . . 0.0 110.044 -172.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -91.28 -59.78 2.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.099 2.159 . . . . 0.0 110.054 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 t -133.24 138.95 46.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 163.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -145.23 -79.65 0.18 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.941 -1.099 . . . . 0.0 108.828 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -91.8 -51.73 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 O-C-N 120.531 -1.356 . . . . 0.0 108.238 171.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.2 mmt85 -119.44 -142.2 0.35 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.56 65.15 1.26 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.392 -1.442 . . . . 0.0 111.715 170.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.37 -137.52 13.63 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 -166.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.2 147.3 9.1 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-O 122.206 0.892 . . . . 0.0 112.978 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.6 mm -122.21 130.74 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 -159.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.08 149.28 49.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 123.831 0.852 . . . . 0.0 110.296 -169.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.4 t -79.69 124.68 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 120.833 -1.167 . . . . 0.0 111.22 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -80.58 -63.25 1.45 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.687 -1.258 . . . . 0.0 109.973 173.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.5 161.41 35.36 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.427 -0.796 . . . . 0.0 109.341 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.29 137.15 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-O 122.497 1.142 . . . . 0.0 110.663 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -85.43 123.63 72.65 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 119.945 -1.722 . . . . 0.0 108.598 173.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.64 32.26 0.51 Allowed 'Trans proline' 0 N--CA 1.434 -1.995 0 CA-C-N 125.291 2.925 . . . . 0.0 114.373 -173.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.61 61.74 1.38 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 123.158 1.456 . . . . 0.0 107.741 -175.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.85 170.52 43.66 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 120.413 -1.43 . . . . 0.0 109.852 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.74 -38.66 22.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.335 2.254 . . . . 0.0 115.541 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.7 -47.45 67.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.13 1.772 . . . . 0.0 115.1 174.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -87.36 -34.85 18.67 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.895 -1.128 . . . . 0.0 111.774 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.6 m -54.22 -54.7 36.4 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.491 1.516 . . . . 0.0 113.858 174.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.26 -53.85 6.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.276 -0.89 . . . . 0.0 110.809 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.05 100.93 2.63 Favored Glycine 0 N--CA 1.429 -1.807 0 O-C-N 121.188 -0.945 . . . . 0.0 110.982 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.94 -43.5 0.43 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -163.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -128.76 174.43 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.534 -1.354 . . . . 0.0 108.301 -168.66 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.441 ' H ' HG22 ' A' ' 52' ' ' ILE . 31.1 m-70 -131.61 162.24 30.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.132 -1.605 . . . . 0.0 110.538 169.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -56.99 136.72 56.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 167.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.17 20.78 78.93 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 116.884 1.513 . . . . 0.0 116.884 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -83.47 172.43 12.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.977 1.311 . . . . 0.0 112.265 167.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -124.6 133.12 53.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 121.054 -1.029 . . . . 0.0 111.828 176.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.1 m -79.76 158.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 119.783 -1.823 . . . . 0.0 110.857 167.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tt -121.61 -80.46 0.62 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.549 -1.344 . . . . 0.0 109.414 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.32 150.59 22.84 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.664 -1.273 . . . . 0.0 113.57 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.9 p -111.92 103.33 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 C-N-CA 126.279 1.831 . . . . 0.0 108.409 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.505 13.8 p30 56.52 38.73 29.87 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.859 2.064 . . . . 0.0 116.298 -177.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.98 -24.58 30.15 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 125.641 1.591 . . . . 0.0 113.455 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.98 134.69 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 124.918 1.287 . . . . 0.0 110.868 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 p -77.2 159.82 29.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.537 -1.977 . . . . 0.0 113.095 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -93.89 -14.84 25.61 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -54.24 129.55 35.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -167.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.31 -27.23 7.42 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 124.143 0.878 . . . . 0.0 111.163 -175.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.17 144.4 38.39 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.3 p -90.65 -179.41 5.54 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.161 -0.962 . . . . 0.0 108.819 155.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -60.38 -44.6 95.48 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -169.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -59.22 -34.56 72.32 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.542 -1.348 . . . . 0.0 114.585 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -43.31 67.16 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.235 -1.541 . . . . 0.0 111.049 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.32 -43.43 97.81 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 120.419 -1.426 . . . . 0.0 114.576 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 m -67.58 -41.52 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 120.461 -1.399 . . . . 0.0 114.352 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -68.08 -28.72 67.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.505 -1.372 . . . . 0.0 112.904 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.9 m -57.48 -50.78 71.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.305 1.442 . . . . 0.0 112.677 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.54 -33.98 35.85 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.565 -1.334 . . . . 0.0 112.799 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -61.2 -32.01 71.77 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.758 -1.839 . . . . 0.0 114.487 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -85.7 51.92 2.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.35 -1.468 . . . . 0.0 112.839 170.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.1 p -110.93 -74.14 0.66 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.466 1.507 . . . . 0.0 110.631 166.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.66 -82.99 0.35 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.857 -1.152 . . . . 0.0 113.219 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -82.1 -51.3 8.13 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -174.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.37 137.97 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 120.94 -1.1 . . . . 0.0 111.023 -166.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.95 90.03 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.5 -1.375 . . . . 0.0 110.676 -172.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -119.76 120.79 37.56 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.566 -1.959 . . . . 0.0 111.452 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -150.22 165.89 31.57 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 112.241 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.8 mt -121.64 137.84 54.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.03 1.332 . . . . 0.0 107.715 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mp -135.76 158.2 44.98 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.593 0.757 . . . . 0.0 110.334 -171.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -119.6 148.29 43.51 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -70.71 127.48 32.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.621 -1.3 . . . . 0.0 112.125 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.799 0 O-C-N 120.587 -1.32 . . . . 0.0 113.724 179.787 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 . . . . . 0 N--CA 1.431 -1.418 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.09 148.55 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 127.121 2.168 . . . . 0.0 107.279 -171.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.1 p -134.37 171.26 14.52 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.702 -1.249 . . . . 0.0 113.209 -168.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.7 155.06 41.35 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 120.976 -1.077 . . . . 0.0 111.355 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.26 1.611 0 C-N-CA 125.542 1.537 . . . . 0.0 108.951 -177.151 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.684 0 CA-C-O 121.326 0.403 . . . . 0.0 113.412 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.11 -177.16 6.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.243 1.497 . . . . 0.0 113.66 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 mt -85.21 136.43 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 125.217 1.407 . . . . 0.0 110.806 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -133.07 145.08 50.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.499 1.142 . . . . 0.0 111.26 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -112.52 123.59 50.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.178 -0.951 . . . . 0.0 109.515 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.5 m -102.92 149.68 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 122.687 1.232 . . . . 0.0 111.802 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -139.58 87.16 2.16 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -134.07 176.65 8.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.808 -1.183 . . . . 0.0 110.508 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.49 172.82 12.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 124.901 1.28 . . . . 0.0 109.125 170.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -68.55 134.22 49.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.953 1.701 . . . . 0.0 113.484 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -122.08 -102.75 0.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.606 -1.309 . . . . 0.0 109.664 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.99 -33.3 65.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.025 -1.672 . . . . 0.0 111.502 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -149.25 -176.55 5.41 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.3 t -82.35 -67.99 0.74 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.836 1.254 . . . . 0.0 108.829 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.89 -81.74 0.48 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.685 -1.259 . . . . 0.0 110.807 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.02 52.86 1.14 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -167.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 tt -139.12 162.34 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 121.679 -0.895 . . . . 0.0 110.218 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.1 t -122.59 141.93 51.17 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 171.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.56 145.77 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 125.917 1.687 . . . . 0.0 108.114 -167.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 t -136.72 114.56 11.29 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.965 1.365 . . . . 0.0 110.075 -172.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.62 178.91 26.79 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-O 122.942 1.301 . . . . 0.0 116.222 169.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.54 64.66 0.35 Allowed Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 122.265 0.925 . . . . 0.0 112.132 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.51 -64.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 124.389 1.076 . . . . 0.0 111.579 -173.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -110.5 -96.54 0.41 Allowed 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.029 -1.044 . . . . 0.0 112.818 -166.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.6 p -130.0 90.96 3.04 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.71 -1.869 . . . . 0.0 108.096 -175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.6 p -134.4 -89.84 0.36 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.355 -0.841 . . . . 0.0 109.551 -175.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.8 -58.37 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.63 1.972 . . . . 0.0 110.89 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -127.57 -153.27 0.56 Allowed 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 165.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.53 88.56 7.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.476 -1.39 . . . . 0.0 109.55 163.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.89 -158.84 35.48 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -158.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.96 140.35 11.26 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.974 -1.309 . . . . 0.0 112.301 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.2 mm -124.21 136.4 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 121.016 -1.285 . . . . 0.0 108.927 -156.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.19 141.13 52.28 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.91 -1.119 . . . . 0.0 111.29 -170.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.57 134.96 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 120.687 -1.258 . . . . 0.0 112.046 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -84.28 -57.81 3.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.084 1.354 . . . . 0.0 110.441 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.63 165.23 18.91 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 124.069 0.947 . . . . 0.0 109.568 174.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.48 123.85 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 124.847 1.259 . . . . 0.0 110.59 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mm -83.18 130.38 57.23 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 120.824 -1.172 . . . . 0.0 110.215 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.15 80.65 1.84 Allowed 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 123.147 2.565 . . . . 0.0 112.434 172.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -141.55 -39.32 0.39 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.719 1.207 . . . . 0.0 112.071 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.88 -146.78 4.44 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.456 -1.402 . . . . 0.0 114.988 -173.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.5 -41.57 63.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.169 2.588 . . . . 0.0 116.95 -166.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.25 -47.7 80.72 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -72.56 -54.62 8.67 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.639 1.576 . . . . 0.0 112.176 173.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.0 t -60.28 -55.96 27.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.229 1.412 . . . . 0.0 114.312 -171.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.76 -39.19 70.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.092 0.957 . . . . 0.0 110.525 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.43 77.59 1.38 Allowed Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -137.03 -51.45 0.66 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -153.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.91 133.75 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -120.26 174.22 6.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 122.65 1.214 . . . . 0.0 114.123 -168.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -57.54 114.21 2.14 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.811 1.645 . . . . 0.0 114.573 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.1 26.03 65.13 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 120.555 -1.341 . . . . 0.0 115.529 -177.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -80.88 159.58 24.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 119.039 1.42 . . . . 0.0 110.779 168.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -124.12 128.92 50.0 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.034 -1.041 . . . . 0.0 109.904 -173.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.45 166.17 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 120.129 -1.607 . . . . 0.0 110.877 176.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.9 mt -131.76 -82.01 0.51 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.594 -1.316 . . . . 0.0 110.333 169.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 144.19 28.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.761 -1.212 . . . . 0.0 112.036 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.78 104.07 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 122.866 1.317 . . . . 0.0 110.781 174.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 57.4 50.56 11.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.16 2.184 . . . . 0.0 113.18 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.33 -24.91 8.67 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.066 -1.021 . . . . 0.0 114.459 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.2 t -85.6 101.29 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 120.441 -1.623 . . . . 0.0 110.969 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 p -79.2 125.93 30.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.684 1.194 . . . . 0.0 110.017 163.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.445 HD13 ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -108.2 55.96 0.63 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.586 1.66 . . . . 0.0 110.891 -173.674 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -66.89 133.99 51.15 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -170.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.91 3.14 89.24 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.856 -1.153 . . . . 0.0 115.584 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.74 155.77 35.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.899 -1.354 . . . . 0.0 113.661 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.7 p -87.11 174.97 8.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.766 -1.208 . . . . 0.0 111.086 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -60.47 -46.45 90.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.357 -1.464 . . . . 0.0 114.277 -166.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -69.15 -36.16 77.12 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -71.14 -33.92 70.52 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.102 -1.624 . . . . 0.0 112.368 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.57 -53.04 57.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.965 -1.085 . . . . 0.0 113.567 169.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.7 m -75.02 -20.0 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.64 -1.912 . . . . 0.0 114.616 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -66.39 -42.45 87.89 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.89 -1.756 . . . . 0.0 110.94 167.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.4 m -63.92 -29.92 71.05 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.301 1.841 . . . . 0.0 113.021 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt -78.19 -37.28 46.04 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.647 -1.283 . . . . 0.0 112.188 174.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -69.11 -37.98 78.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.188 -1.57 . . . . 0.0 114.699 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.322 0.4 OUTLIER -79.33 55.7 1.95 Allowed 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 119.973 -1.705 . . . . 0.0 113.743 172.568 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -103.73 -76.63 0.59 Allowed 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.118 2.567 . . . . 0.0 107.632 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.94 -112.76 2.69 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 125.535 1.541 . . . . 0.0 112.958 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -81.62 -31.49 32.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.169 -1.195 . . . . 0.0 113.775 -172.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.8 p -105.14 138.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.449 1.1 . . . . 0.0 110.622 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.44 80.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 125.072 1.349 . . . . 0.0 108.52 -172.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -118.79 109.56 16.2 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.455 -1.403 . . . . 0.0 109.971 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -149.08 169.96 19.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.016 -1.678 . . . . 0.0 113.25 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.8 tp -122.78 121.55 36.56 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.654 1.581 . . . . 0.0 109.423 -170.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -131.78 169.96 15.49 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.835 0.826 . . . . 0.0 112.739 -166.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -130.25 135.72 48.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.663 1.985 . . . . 0.0 109.969 166.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 135.32 40.52 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.19 1.396 . . . . 0.0 110.327 173.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.743 0 CA-C-O 123.48 1.6 . . . . 0.0 117.07 -170.004 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 . . . . . 0 N--CA 1.431 -1.418 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.97 158.04 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 102.719 -3.067 . . . . 0.0 102.719 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 31.0 m -139.42 157.23 46.21 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 121.114 1.779 . . . . 0.0 113.171 -167.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -152.11 146.97 25.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.877 -1.14 . . . . 0.0 110.553 174.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--O 1.26 1.606 0 C-N-CA 125.774 1.63 . . . . 0.0 107.48 -179.83 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.761 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -82.81 -176.12 6.14 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 123.208 1.48 . . . . 0.0 113.39 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.4 mt -78.96 143.92 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 127.195 2.198 . . . . 0.0 111.301 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.76 156.37 41.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.726 0.81 . . . . 0.0 109.657 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.83 116.92 20.19 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.168 0.985 . . . . 0.0 111.077 -175.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.18 131.4 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.791 1.236 . . . . 0.0 112.509 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -111.44 117.9 34.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.527 1.531 . . . . 0.0 109.665 171.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.9 tp -134.84 167.01 21.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.378 1.471 . . . . 0.0 109.031 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.72 154.75 49.88 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 119.811 -1.806 . . . . 0.0 110.941 170.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -56.98 129.64 42.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.837 2.055 . . . . 0.0 114.735 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -121.56 -97.65 0.45 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.362 1.465 . . . . 0.0 110.39 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.67 -58.23 6.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.159 1.784 . . . . 0.0 109.252 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -137.11 -179.64 5.83 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 p -84.39 -80.51 0.2 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.105 0.962 . . . . 0.0 111.635 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.4 mt -103.19 -90.55 0.37 Allowed 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.455 -1.403 . . . . 0.0 113.297 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.95 56.36 1.97 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.717 -1.239 . . . . 0.0 112.572 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.7 tt -139.56 171.69 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 t -123.41 148.73 45.82 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.158 -2.214 . . . . 0.0 109.723 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.69 157.07 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.452 1.501 . . . . 0.0 108.975 -168.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.4 t -138.37 152.8 48.76 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.913 -1.742 . . . . 0.0 109.189 170.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.48 -137.99 37.89 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 126.909 2.195 . . . . 0.0 116.205 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.66 14.44 82.08 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 124.582 1.087 . . . . 0.0 115.19 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.49 -126.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.962 -1.317 . . . . 0.0 113.698 -170.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -71.61 -58.74 3.22 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.421 -2.049 . . . . 0.0 111.305 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.0 t -130.38 143.72 50.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 163.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -155.04 -111.65 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -170.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.34 -47.47 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 124.994 1.318 . . . . 0.0 111.596 171.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -141.72 -147.93 0.23 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.528 1.931 . . . . 0.0 106.616 158.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -76.57 52.6 0.81 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.614 2.766 . . . . 0.0 112.101 172.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.86 177.32 20.12 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 -165.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.421 ' H ' HD21 ' A' ' 66' ' ' LEU . . . 100.31 138.79 10.44 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -165.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.1 mm -127.01 140.74 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -166.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.64 141.55 52.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.623 -1.298 . . . . 0.0 109.514 -169.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.31 125.86 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.982 -1.074 . . . . 0.0 112.115 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -82.67 -59.16 2.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.454 1.502 . . . . 0.0 110.6 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.14 172.24 6.47 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 123.77 0.828 . . . . 0.0 109.779 175.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.78 139.71 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 124.779 1.232 . . . . 0.0 112.306 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -85.44 120.74 73.42 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-O 116.549 -1.691 . . . . 0.0 108.109 165.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.69 34.12 0.52 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 125.869 3.132 . . . . 0.0 113.472 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.35 68.77 1.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.64 169.87 42.97 Favored Glycine 0 N--CA 1.432 -1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 111.227 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.66 -29.86 68.43 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 124.982 1.313 . . . . 0.0 114.365 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.41 -52.74 64.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -60.43 -46.43 90.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.031 1.332 . . . . 0.0 113.253 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.9 m -60.5 -54.71 42.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.66 1.584 . . . . 0.0 115.057 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.21 -37.84 57.25 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.787 -1.196 . . . . 0.0 112.223 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.55 88.33 1.09 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 125.517 1.532 . . . . 0.0 111.719 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -138.4 -58.39 0.64 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.453 -1.027 . . . . 0.0 113.665 -158.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.4 mt -127.98 130.97 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -118.17 171.67 7.95 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.618 1.199 . . . . 0.0 111.257 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -60.11 120.64 10.12 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -175.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.32 25.27 63.94 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -75.66 154.19 36.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.499 -1.589 . . . . 0.0 110.023 160.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -124.63 110.56 14.57 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.614 -1.304 . . . . 0.0 109.284 -170.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.4 m -102.24 152.62 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.645 -1.284 . . . . 0.0 111.776 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.5 tp -124.83 -77.58 0.59 Allowed 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 121.332 -0.855 . . . . 0.0 110.964 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.82 133.99 36.63 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 120.697 -1.252 . . . . 0.0 112.766 -166.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 p -101.7 90.36 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.762 1.625 . . . . 0.0 107.807 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.8 t30 56.64 61.57 2.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.162 1.785 . . . . 0.0 112.949 -170.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.18 -43.96 2.95 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 120.294 -1.503 . . . . 0.0 114.042 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.1 t -88.27 125.14 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 121.119 -1.224 . . . . 0.0 112.577 -170.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.6 t -75.17 149.75 38.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.28 -1.512 . . . . 0.0 111.715 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.421 HD21 ' H ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -94.72 -8.23 38.29 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 120.596 -1.315 . . . . 0.0 112.924 178.856 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.23 126.35 27.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -168.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.6 -46.42 1.16 Allowed Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.713 -1.242 . . . . 0.0 111.721 -162.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.46 165.67 24.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.785 1.234 . . . . 0.0 114.106 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.8 p -93.29 167.69 11.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.092 1.425 . . . . 0.0 111.175 172.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -42.38 -50.83 5.06 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 129.639 3.175 . . . . 0.0 116.794 170.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -70.06 -28.85 65.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.91 1.284 . . . . 0.0 113.591 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -74.07 -46.7 41.42 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.131 -1.606 . . . . 0.0 111.286 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.34 77.87 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.695 1.598 . . . . 0.0 115.164 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.3 p -71.37 -30.21 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.694 -1.879 . . . . 0.0 112.346 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -63.72 -47.66 80.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.091 -1.63 . . . . 0.0 113.118 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.4 m -55.68 -40.06 71.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.797 1.639 . . . . 0.0 113.306 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 tt -80.96 -33.09 34.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -175.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -71.68 -31.81 67.18 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.031 -1.668 . . . . 0.0 113.392 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -89.17 63.52 6.62 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.661 -1.274 . . . . 0.0 111.966 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 p -108.4 -81.27 0.57 Allowed 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.16 1.784 . . . . 0.0 110.388 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.86 -93.44 0.63 Allowed Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 125.865 1.698 . . . . 0.0 112.79 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -81.37 -57.37 3.52 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -168.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.2 m -104.94 144.45 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 123.251 1.501 . . . . 0.0 112.581 -169.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.04 94.25 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -119.32 121.69 40.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.613 -1.305 . . . . 0.0 108.501 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.51 163.97 35.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.633 -1.292 . . . . 0.0 112.941 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 mp -121.14 121.57 38.14 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.96 168.29 11.65 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.996 1.318 . . . . 0.0 109.757 -173.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -123.58 130.97 53.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.335 1.454 . . . . 0.0 107.302 161.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.8 139.27 53.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 125.07 1.348 . . . . 0.0 113.184 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.685 0 N-CA-C 116.839 1.495 . . . . 0.0 116.839 -175.729 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.36 152.39 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 126.039 1.736 . . . . 0.0 110.94 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 36.2 m -134.71 169.23 17.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.508 1.923 . . . . 0.0 112.561 -174.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.11 152.08 30.03 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 124.789 1.236 . . . . 0.0 110.989 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.998 2.119 . . . . 0.0 108.102 162.817 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.745 0 CA-C-O 121.13 0.295 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.27 154.22 26.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 121.307 -1.113 . . . . 0.0 112.757 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.87 133.69 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.764 -1.21 . . . . 0.0 109.394 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.5 153.95 41.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.089 -1.632 . . . . 0.0 111.549 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -125.67 119.81 29.02 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.908 -1.12 . . . . 0.0 112.619 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 t -104.58 137.17 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.958 -1.714 . . . . 0.0 112.015 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -111.07 127.07 55.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.71 1.204 . . . . 0.0 110.639 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 11.9 tp -135.03 -173.2 3.25 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.574 1.15 . . . . 0.0 109.929 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.401 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -141.75 157.6 44.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.272 -1.517 . . . . 0.0 107.913 171.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.8 tttm -71.8 112.33 7.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 122.67 1.224 . . . . 0.0 112.779 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -99.88 -93.44 0.27 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.521 1.528 . . . . 0.0 109.389 -172.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.12 -42.77 16.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.663 1.585 . . . . 0.0 108.248 161.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -137.66 178.66 6.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 p -84.29 -72.0 0.49 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.436 1.494 . . . . 0.0 110.651 174.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.4 mt -102.36 -75.56 0.6 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.511 1.124 . . . . 0.0 110.543 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.89 50.45 2.87 Favored Glycine 0 N--CA 1.431 -1.69 0 O-C-N 120.199 -1.563 . . . . 0.0 113.229 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 40' ' ' VAL . 7.2 tt -143.12 146.3 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 122.314 1.054 . . . . 0.0 112.229 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 t -86.41 145.82 26.7 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.838 -1.788 . . . . 0.0 111.582 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.488 HG11 ' CE1' ' A' ' 71' ' ' HIS . 11.8 t -109.28 151.44 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.052 1.341 . . . . 0.0 111.13 -167.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -138.1 115.66 11.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.29 1.519 . . . . 0.0 110.964 170.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.35 -123.69 7.38 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.167 -1.583 . . . . 0.0 112.924 169.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.46 27.47 63.43 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 115.954 1.142 . . . . 0.0 115.954 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 m -105.64 -148.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 121.175 -1.191 . . . . 0.0 111.703 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -71.62 -37.18 70.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.853 1.661 . . . . 0.0 113.359 -166.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 t -130.89 117.73 19.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 163.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.9 t -151.07 -105.2 0.06 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.768 -1.832 . . . . 0.0 106.826 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.01 -52.13 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 125.119 1.368 . . . . 0.0 109.91 173.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -131.7 -158.84 0.92 Allowed 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 169.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -77.29 88.92 3.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.758 1.223 . . . . 0.0 108.594 162.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.32 172.87 32.05 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 119.798 -1.814 . . . . 0.0 113.555 -168.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.62 145.53 19.28 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -167.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.0 mm -125.05 142.83 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 120.463 -1.61 . . . . 0.0 108.925 -158.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -124.82 142.24 51.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 124.482 1.113 . . . . 0.0 110.683 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.9 t -90.94 133.98 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.887 -1.133 . . . . 0.0 113.155 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -91.01 -63.54 1.25 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.258 1.423 . . . . 0.0 113.114 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.45 158.22 11.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 -174.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.408 ' HA ' HG13 ' A' ' 20' ' ' ILE . 9.3 p -87.46 135.71 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 124.249 1.02 . . . . 0.0 112.821 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -85.44 120.8 73.48 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.741 -1.599 . . . . 0.0 109.861 171.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -73.81 44.85 1.0 Allowed 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 125.089 2.853 . . . . 0.0 116.266 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.93 43.12 0.55 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.952 1.358 . . . . 0.0 110.238 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.96 -171.93 38.8 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.047 -1.658 . . . . 0.0 112.3 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.19 -43.2 70.5 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.861 2.064 . . . . 0.0 116.114 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.78 -44.13 66.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.453 1.501 . . . . 0.0 114.975 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.56 -61.4 1.78 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.357 1.463 . . . . 0.0 112.045 171.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.1 m -56.21 -50.54 70.94 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -173.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -82.45 -27.9 31.61 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 121.308 -0.87 . . . . 0.0 111.183 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.81 73.09 1.28 Allowed Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 124.664 1.126 . . . . 0.0 110.913 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.438 HH22 ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -138.3 -44.26 0.5 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -152.313 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -128.35 134.28 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 120.615 1.552 . . . . 0.0 107.866 -170.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -125.14 171.13 10.55 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 122.734 1.254 . . . . 0.0 112.131 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -57.22 133.6 55.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.797 2.039 . . . . 0.0 115.763 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.42 12.16 84.81 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -79.95 167.06 20.97 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 118.819 1.309 . . . . 0.0 110.801 167.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -131.31 135.67 47.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.392 -1.443 . . . . 0.0 108.484 -172.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.57 145.76 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 120.103 1.319 . . . . 0.0 110.15 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.9 tp -135.49 -60.07 0.76 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.48 138.46 38.46 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.606 -1.934 . . . . 0.0 113.39 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.22 106.33 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.752 -1.217 . . . . 0.0 109.683 170.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 t30 56.03 40.42 30.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 170.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.22 -0.81 84.05 Favored Glycine 0 N--CA 1.431 -1.671 0 O-C-N 119.968 -1.708 . . . . 0.0 115.05 -176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.29 106.71 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 120.791 -1.417 . . . . 0.0 109.404 168.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 t -78.27 123.56 27.08 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.694 -1.879 . . . . 0.0 111.416 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -93.27 28.51 2.18 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.607 -1.308 . . . . 0.0 112.606 177.233 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.39 137.24 58.22 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.177 -1.577 . . . . 0.0 110.811 163.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.37 -35.44 2.99 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 119.16 -2.212 . . . . 0.0 114.406 -173.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.92 142.29 42.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.924 -1.339 . . . . 0.0 113.355 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.4 p -84.95 163.91 18.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.031 1.732 . . . . 0.0 111.851 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.488 ' CE1' HG11 ' A' ' 22' ' ' VAL . 14.4 t60 -48.13 -53.71 15.76 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.674 2.389 . . . . 0.0 116.688 -174.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -68.25 -29.91 68.83 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.289 1.042 . . . . 0.0 113.791 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -73.8 -46.68 43.88 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.889 1.275 . . . . 0.0 111.45 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.08 -41.48 86.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.273 1.829 . . . . 0.0 114.643 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 p -63.14 -34.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.089 -1.632 . . . . 0.0 113.084 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.29 -36.51 84.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.417 -1.427 . . . . 0.0 113.766 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.4 m -67.44 -35.05 78.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.033 1.733 . . . . 0.0 112.733 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -78.03 -37.83 46.02 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.538 -1.351 . . . . 0.0 112.093 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -62.99 -50.24 71.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.972 1.309 . . . . 0.0 113.165 173.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -85.38 60.83 6.49 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.168 -1.582 . . . . 0.0 112.002 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 p -99.02 -61.21 1.4 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.448 2.299 . . . . 0.0 108.008 168.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.84 -104.2 1.34 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 124.262 0.934 . . . . 0.0 113.606 160.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -81.92 -53.0 6.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.444 -1.033 . . . . 0.0 112.881 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.4 m -112.24 146.78 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 124.832 1.253 . . . . 0.0 109.359 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.57 123.7 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.243 -0.911 . . . . 0.0 108.99 -172.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -136.02 124.09 22.93 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.691 -1.255 . . . . 0.0 110.517 171.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -148.8 162.69 39.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.838 -1.164 . . . . 0.0 112.991 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.71 127.94 54.03 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -171.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.438 ' CD2' HH22 ' A' ' 51' ' ' ARG . 4.9 mp -118.21 159.49 23.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.928 1.291 . . . . 0.0 109.413 -175.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -120.03 126.27 50.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -68.04 147.54 52.24 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.623 -1.298 . . . . 0.0 112.69 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.709 0 N-CA-C 116.911 1.525 . . . . 0.0 116.911 -174.776 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.95 153.25 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.153 -1.592 . . . . 0.0 111.239 -177.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -137.14 178.14 7.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.029 1.332 . . . . 0.0 110.334 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -151.25 149.08 28.98 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 124.378 1.071 . . . . 0.0 108.563 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.261 1.66 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 173.359 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo . . . . . 0 CA--C 1.489 -1.738 0 N-CA-C 109.629 -0.95 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -77.26 156.09 81.72 Favored Pre-proline 0 N--CA 1.43 -1.426 0 O-C-N 120.968 -1.083 . . . . 0.0 111.632 174.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -65.75 -49.62 2.18 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 123.076 2.134 . . . . 0.0 114.697 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.55 56.46 4.17 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 118.904 0.775 . . . . 0.0 112.92 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -82.6 153.11 25.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.164 -1.198 . . . . 0.0 113.455 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.33 128.79 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 124.703 1.201 . . . . 0.0 109.78 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -137.27 160.99 37.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.489 -1.382 . . . . 0.0 110.404 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -113.56 140.61 48.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.871 -1.143 . . . . 0.0 112.145 175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -102.54 138.69 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 124.195 0.998 . . . . 0.0 109.367 172.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -121.15 101.92 7.97 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 125.514 1.525 . . . . 0.0 107.951 168.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -133.87 -175.5 3.86 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.421 -0.799 . . . . 0.0 109.918 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.26 174.66 15.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.934 -1.104 . . . . 0.0 110.285 174.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -69.98 123.32 21.25 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -121.32 -81.89 0.64 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.539 1.536 . . . . 0.0 111.784 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.85 -57.24 3.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.106 1.763 . . . . 0.0 108.61 170.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -142.24 -139.1 0.11 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 156.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 p -85.49 -85.62 0.14 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.007 -1.683 . . . . 0.0 111.997 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.9 mt -101.18 -74.46 0.61 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.334 -1.479 . . . . 0.0 113.335 -171.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.59 54.33 1.45 Allowed Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 124.839 1.209 . . . . 0.0 110.446 -174.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.9 tt -146.23 155.29 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.477 -1.013 . . . . 0.0 110.625 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 t -121.09 151.9 39.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.409 -1.432 . . . . 0.0 109.088 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.1 t -124.24 152.33 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.509 1.524 . . . . 0.0 110.319 -164.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 t -138.65 138.25 37.64 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 120.494 -1.379 . . . . 0.0 110.11 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.69 -137.71 20.53 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.832 1.682 . . . . 0.0 114.349 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.33 23.67 46.88 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 117.6 1.8 . . . . 0.0 117.6 166.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 m -87.27 -119.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 119.491 1.646 . . . . 0.0 114.848 -171.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -71.37 -45.34 63.08 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.875 -2.391 . . . . 0.0 113.117 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 t -138.56 170.94 15.12 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 148.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -156.01 -69.05 0.11 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.444 -1.41 . . . . 0.0 111.357 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 t -92.62 -56.51 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 124.291 1.036 . . . . 0.0 111.939 -168.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -141.12 -92.1 0.15 Allowed 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 121.475 -0.765 . . . . 0.0 109.997 -170.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -117.58 52.35 0.99 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.651 1.691 . . . . 0.0 107.617 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.81 -142.52 17.53 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 107.309 -2.317 . . . . 0.0 107.309 -166.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.08 148.29 23.49 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 124.675 1.131 . . . . 0.0 113.398 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.61 151.31 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.17 143.94 50.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.252 1.021 . . . . 0.0 111.186 -171.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.8 t -73.08 129.6 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.693 -1.254 . . . . 0.0 111.657 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -81.54 -62.77 1.55 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 109.62 171.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.45 167.54 15.61 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -92.35 136.84 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 124.835 1.254 . . . . 0.0 110.668 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.6 mm -83.83 120.34 74.91 Favored Pre-proline 0 N--CA 1.43 -1.427 0 O-C-N 120.314 -1.491 . . . . 0.0 109.005 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.12 65.0 8.93 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 CA-C-N 124.801 2.75 . . . . 0.0 113.277 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -141.7 -1.4 1.28 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.894 1.278 . . . . 0.0 112.897 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -141.87 -161.68 8.85 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 120.251 -1.531 . . . . 0.0 114.826 -171.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.69 -37.15 86.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 -173.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.27 92.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.274 1.03 . . . . 0.0 113.383 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -68.63 -55.88 10.06 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.375 1.07 . . . . 0.0 112.943 167.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.8 t -59.29 -56.99 15.04 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.324 1.45 . . . . 0.0 114.906 -170.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -81.11 -37.83 28.25 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.446 -1.409 . . . . 0.0 110.572 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.76 90.29 1.33 Allowed Glycine 0 N--CA 1.429 -1.78 0 O-C-N 120.519 -1.363 . . . . 0.0 111.397 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -137.18 -41.79 0.57 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 121.418 -1.048 . . . . 0.0 111.189 -171.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 mt -129.11 143.13 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.34 -173.54 3.3 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.313 -1.492 . . . . 0.0 111.179 170.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -55.97 132.57 50.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.39 9.86 86.59 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 118.236 2.054 . . . . 0.0 118.236 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -74.23 155.47 38.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 119.496 1.648 . . . . 0.0 112.167 172.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -124.55 144.0 50.37 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.105 -1.622 . . . . 0.0 110.719 -170.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 m -101.39 154.02 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 119.802 -1.811 . . . . 0.0 112.605 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.15 -91.18 0.56 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.209 1.404 . . . . 0.0 108.128 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.31 148.28 23.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.886 -1.133 . . . . 0.0 113.89 -166.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.36 100.91 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.086 1.354 . . . . 0.0 107.796 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.5 t30 56.77 61.06 2.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.269 1.828 . . . . 0.0 112.393 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.87 -39.02 2.95 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.922 -1.111 . . . . 0.0 115.336 -176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.08 128.06 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.453 -1.616 . . . . 0.0 112.603 -166.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -77.36 124.2 27.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.881 -1.137 . . . . 0.0 111.819 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.9 mp -87.36 74.22 9.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.115 1.436 . . . . 0.0 110.503 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -68.81 99.8 1.09 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.265 -1.522 . . . . 0.0 113.293 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.75 23.17 53.96 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.481 0.952 . . . . 0.0 115.481 172.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.35 136.35 39.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.384 -1.068 . . . . 0.0 112.526 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.6 p -80.13 172.21 14.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.572 1.149 . . . . 0.0 113.063 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.403 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 10.2 t-160 -61.63 -41.25 97.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.257 -1.527 . . . . 0.0 113.252 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -59.02 -40.24 84.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -69.87 -41.63 74.55 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.29 -1.506 . . . . 0.0 111.773 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.82 97.23 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.678 -1.264 . . . . 0.0 114.082 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.13 -43.29 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.417 -1.427 . . . . 0.0 113.096 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -62.06 -42.25 99.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.433 -1.417 . . . . 0.0 113.729 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.3 p -70.15 -17.51 63.19 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.26 -1.525 . . . . 0.0 115.052 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.4 mt -80.32 -39.01 29.53 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 120.424 -1.422 . . . . 0.0 113.454 171.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -86.61 -27.43 23.86 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.484 -1.385 . . . . 0.0 113.932 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -83.42 60.56 5.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.68 -1.888 . . . . 0.0 112.55 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.5 p -109.06 -89.85 0.47 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.693 1.597 . . . . 0.0 112.518 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.44 -129.25 8.09 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 107.416 -2.274 . . . . 0.0 107.416 -166.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -81.25 -51.44 8.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -165.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -104.16 145.96 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.623 -1.298 . . . . 0.0 113.764 -159.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.24 105.73 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 125.022 1.329 . . . . 0.0 110.101 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -116.86 120.85 39.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.889 -1.132 . . . . 0.0 108.623 168.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.58 166.86 27.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.503 -1.373 . . . . 0.0 111.911 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -120.21 137.38 54.23 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mp -125.53 156.75 38.55 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.312 1.445 . . . . 0.0 108.363 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -113.49 132.59 55.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 166.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.6 tptt -68.86 138.16 54.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.789 -1.194 . . . . 0.0 112.693 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.93 -90.95 0.26 Allowed Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.795 -1.191 . . . . 0.0 114.667 -172.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -102.39 176.73 5.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.334 1.453 . . . . 0.0 111.775 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.3 m -74.73 126.65 88.27 Favored Pre-proline 0 N--CA 1.431 -1.422 0 O-C-N 120.434 -1.416 . . . . 0.0 113.118 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.65 -62.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 123.844 2.409 . . . . 0.0 112.653 169.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 C--O 1.26 1.63 0 CA-C-N 119.715 1.143 . . . . 0.0 111.183 170.897 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 . . . . . 0 CA--C 1.49 -1.331 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.97 -175.3 3.5 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.774 -1.203 . . . . 0.0 112.384 -177.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 62.81 35.94 13.4 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.865 2.066 . . . . 0.0 114.755 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 25.9 t -146.65 -78.04 0.17 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.958 -1.714 . . . . 0.0 112.416 -167.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -104.57 -69.22 0.82 Allowed 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.103 -0.998 . . . . 0.0 113.258 -160.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.17 144.69 30.11 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.563 -1.336 . . . . 0.0 111.31 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -117.26 -177.44 3.22 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 125.481 1.512 . . . . 0.0 107.213 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -97.33 109.54 22.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.497 -1.377 . . . . 0.0 109.898 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.25 27.82 0.67 Allowed 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -121.94 76.14 1.27 Allowed 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.534 -1.354 . . . . 0.0 108.818 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -133.58 -122.16 0.18 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.494 1.118 . . . . 0.0 108.773 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -128.25 145.91 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 125.386 1.474 . . . . 0.0 109.271 -164.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.403 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 9.1 p -126.3 163.31 23.51 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.463 1.505 . . . . 0.0 111.822 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.19 159.02 43.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.514 -0.741 . . . . 0.0 109.579 162.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.261 1.671 0 C-N-CA 124.048 0.939 . . . . 0.0 109.012 177.665 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 CA--C 1.49 -1.709 0 N-CA-C 108.669 -1.319 . . . . 0.0 108.669 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -78.25 165.01 53.36 Favored Pre-proline 0 N--CA 1.429 -1.499 0 CA-C-O 117.589 -1.196 . . . . 0.0 110.065 167.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.97 -19.28 18.07 Favored 'Trans proline' 0 N--CA 1.434 -1.991 0 CA-C-N 125.305 2.93 . . . . 0.0 113.051 -164.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.73 88.44 0.57 Allowed Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 165.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -74.17 145.98 43.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 118.842 1.321 . . . . 0.0 113.429 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.4 mt -89.44 137.64 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.251 1.42 . . . . 0.0 110.106 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -146.56 161.26 40.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.972 -1.08 . . . . 0.0 109.99 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -115.52 141.07 48.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.146 -0.971 . . . . 0.0 108.878 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.4 147.39 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 124.045 0.938 . . . . 0.0 112.632 173.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -113.67 123.33 49.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 123.746 0.818 . . . . 0.0 109.058 168.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.5 mt -132.83 157.91 43.83 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.442 -1.411 . . . . 0.0 110.427 165.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.66 139.26 27.89 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -70.41 96.68 1.17 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -92.29 -66.36 0.93 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.123 1.769 . . . . 0.0 109.703 171.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -88.7 -71.37 0.59 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.173 1.789 . . . . 0.0 109.186 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -136.55 166.45 23.5 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -171.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -83.06 -71.19 0.51 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -167.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.85 -83.27 0.46 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.138 -1.601 . . . . 0.0 110.028 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.4 39.35 2.82 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.688 -1.258 . . . . 0.0 114.932 170.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.86 169.58 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.093 -1.239 . . . . 0.0 108.774 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.7 p -122.45 146.51 47.31 Favored 'General case' 0 N--CA 1.429 -1.513 0 O-C-N 119.968 -1.708 . . . . 0.0 108.75 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 t -125.32 149.83 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 125.168 1.387 . . . . 0.0 110.044 -161.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -136.29 142.11 43.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.062 1.411 . . . . 0.0 109.774 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.71 -130.77 9.91 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 125.761 1.648 . . . . 0.0 114.191 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.93 62.42 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 121.404 -1.056 . . . . 0.0 114.531 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 27' ' ' ASN . 46.5 t -89.36 168.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.435 ' H ' HG12 ' A' ' 26' ' ' VAL . 10.1 p30 -67.73 -26.8 66.32 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 125.984 1.714 . . . . 0.0 113.163 -163.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 t -129.74 128.18 41.92 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 152.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 p -155.39 -89.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.853 -1.154 . . . . 0.0 110.672 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -78.25 -47.2 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.3 -1.5 . . . . 0.0 109.457 171.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.95 -153.18 0.52 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 167.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -76.55 89.84 3.3 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.399 -1.438 . . . . 0.0 109.278 163.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.69 -154.35 30.9 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -162.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.39 136.93 9.11 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-O 122.858 1.254 . . . . 0.0 112.465 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.5 mm -124.89 133.75 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.4 -1.647 . . . . 0.0 107.574 -164.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.96 141.4 51.99 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.677 1.191 . . . . 0.0 108.311 -170.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.7 t -80.03 130.53 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.906 -1.121 . . . . 0.0 110.911 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -86.75 -57.34 3.02 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 120.139 -1.6 . . . . 0.0 110.783 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.87 155.56 29.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.853 1.261 . . . . 0.0 109.514 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -94.78 131.16 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 122.519 1.152 . . . . 0.0 110.689 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.7 mm -82.93 123.06 78.18 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 120.523 -1.361 . . . . 0.0 110.42 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.11 40.9 1.0 Allowed 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.041 2.494 . . . . 0.0 114.051 -172.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -144.78 53.85 1.23 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.19 174.29 45.91 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 120.419 -1.426 . . . . 0.0 113.896 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.78 -36.09 73.86 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.475 1.91 . . . . 0.0 114.4 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.65 -53.78 47.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.35 -49.95 50.87 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.284 1.434 . . . . 0.0 112.346 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -61.19 -39.87 91.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -82.07 -47.92 12.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.838 -1.164 . . . . 0.0 111.236 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.96 62.63 1.98 Allowed Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 117.109 1.604 . . . . 0.0 117.109 168.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -135.5 -1.08 2.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.472 -1.605 . . . . 0.0 111.841 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.3 mt -129.28 149.47 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -126.8 173.68 9.36 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 120.287 -1.508 . . . . 0.0 111.531 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -58.12 135.9 57.11 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.945 1.298 . . . . 0.0 114.214 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.76 18.51 78.84 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 117.559 1.784 . . . . 0.0 117.559 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -82.7 162.51 21.78 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 120.341 2.07 . . . . 0.0 111.543 166.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -126.33 123.4 37.93 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.714 -1.241 . . . . 0.0 110.384 -172.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -85.56 155.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.118 -1.614 . . . . 0.0 113.284 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.04 -86.13 0.65 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.707 1.203 . . . . 0.0 111.229 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.52 144.94 28.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.63 96.25 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 124.468 1.107 . . . . 0.0 108.329 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.296 9.5 t-20 57.19 47.59 16.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.854 1.661 . . . . 0.0 113.343 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.79 -34.3 5.86 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.582 -1.324 . . . . 0.0 114.278 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 t -100.9 109.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 118.368 1.084 . . . . 0.0 112.159 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.9 m -79.61 110.22 14.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.665 1.586 . . . . 0.0 112.392 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.14 85.4 4.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.577 -1.952 . . . . 0.0 110.555 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.03 135.11 51.79 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.921 -1.737 . . . . 0.0 113.652 174.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.56 7.23 63.45 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 124.685 1.136 . . . . 0.0 114.371 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.86 130.8 39.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.825 -1.397 . . . . 0.0 112.903 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.3 p -80.76 171.61 14.8 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 123.126 1.441 . . . . 0.0 110.252 168.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.459 ' CE1' ' HB2' ' B' ' 13' ' ' SER . 1.9 t60 -56.25 -41.7 76.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.641 1.977 . . . . 0.0 114.093 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -52.32 -45.72 65.73 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.511 1.524 . . . . 0.0 114.859 171.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -72.06 -38.51 69.43 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.841 1.256 . . . . 0.0 111.722 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.12 76.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.621 1.168 . . . . 0.0 113.852 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.3 t -63.21 -48.14 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.628 1.971 . . . . 0.0 113.331 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -53.59 -46.46 70.37 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.483 1.135 . . . . 0.0 113.271 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.7 m -65.91 -41.71 91.11 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.029 2.132 . . . . 0.0 113.218 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.8 mt -85.81 -27.31 25.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.139 -1.601 . . . . 0.0 114.83 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 44.6 mtt180 -65.47 -45.93 81.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.775 -1.828 . . . . 0.0 112.625 173.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -83.46 60.39 5.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.017 1.389 . . . . 0.0 112.26 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.89 -80.85 0.37 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.47 1.908 . . . . 0.0 109.192 175.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.16 -78.79 0.4 Allowed Glycine 0 N--CA 1.429 -1.774 0 O-C-N 121.294 -0.879 . . . . 0.0 114.257 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -81.51 -58.74 2.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.503 -0.998 . . . . 0.0 113.472 -175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.43 149.21 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.777 1.231 . . . . 0.0 110.487 -166.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.6 t -129.45 112.31 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.073 1.349 . . . . 0.0 107.786 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -127.98 104.44 7.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.637 -1.289 . . . . 0.0 110.857 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.3 mt -127.7 162.59 26.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 111.313 -169.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.24 136.32 54.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.514 1.526 . . . . 0.0 107.15 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.74 161.24 42.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.802 0.811 . . . . 0.0 111.822 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -114.29 134.8 54.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.857 1.663 . . . . 0.0 109.652 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -62.65 135.2 57.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.47 -139.07 4.21 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 123.281 1.489 . . . . 0.0 116.175 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -94.91 155.13 16.9 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.544 1.538 . . . . 0.0 111.177 176.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 t -73.64 141.95 80.09 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -79.27 139.62 14.93 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 123.294 2.212 . . . . 0.0 114.022 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 C--O 1.259 1.589 0 C-N-CA 125.019 1.327 . . . . 0.0 110.533 175.109 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 CA--C 1.49 -1.338 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.8 -55.02 4.31 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.883 -1.761 . . . . 0.0 115.497 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 72.4 58.06 0.14 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.017 2.527 . . . . 0.0 111.3 -167.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.2 m -136.68 168.34 19.7 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -74.5 -95.82 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -158.02 133.46 8.89 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.001 -1.062 . . . . 0.0 111.459 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -128.81 63.8 1.46 Allowed 'General case' 0 N--CA 1.428 -1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.83 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . 0.35 22.4 mt-10 58.09 -165.04 0.17 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 173.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -137.35 169.62 17.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.028 -1.67 . . . . 0.0 110.93 -163.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -134.99 162.72 31.65 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.612 1.565 . . . . 0.0 106.843 168.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -149.17 -170.74 3.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.845 -1.159 . . . . 0.0 113.439 -174.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.81 123.86 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.261 1.824 . . . . 0.0 107.699 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.459 ' HB2' ' CE1' ' A' ' 71' ' ' HIS . 15.0 m -129.59 133.06 46.96 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.707 -1.246 . . . . 0.0 113.154 -171.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.02 155.9 34.61 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.644 -1.285 . . . . 0.0 112.544 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 C--O 1.26 1.633 0 C-N-CA 126.636 1.974 . . . . 0.0 107.858 173.798 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo . . . . . 0 CA--C 1.489 -1.755 0 N-CA-C 108.025 -1.567 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -81.12 162.71 58.37 Favored Pre-proline 0 N--CA 1.431 -1.383 0 CA-C-O 117.707 -1.139 . . . . 0.0 110.949 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.26 -40.54 2.31 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 CA-C-N 123.948 2.446 . . . . 0.0 113.708 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.54 71.84 0.23 Allowed Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 124.816 1.198 . . . . 0.0 112.455 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -82.18 178.97 7.98 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 120.898 -1.354 . . . . 0.0 113.624 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -85.67 133.99 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.326 -1.483 . . . . 0.0 108.376 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -135.96 146.65 47.49 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 121.201 -0.937 . . . . 0.0 108.781 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -106.68 134.82 49.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.027 -1.046 . . . . 0.0 109.36 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.9 t -102.06 115.44 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -120.38 95.44 4.74 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.801 1.24 . . . . 0.0 108.63 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.496 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 11.0 tp -134.49 -155.95 0.69 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.174 -0.954 . . . . 0.0 109.368 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.496 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -154.53 168.19 27.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -71.96 129.64 39.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -120.98 -69.88 0.82 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.825 1.25 . . . . 0.0 110.722 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -76.56 -62.62 1.57 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.657 -1.277 . . . . 0.0 109.188 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -137.79 -131.11 0.13 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 139.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.7 p -89.81 -78.15 0.37 Allowed 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 120.19 1.359 . . . . 0.0 112.187 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.1 mt -103.21 -99.31 0.3 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.372 -1.455 . . . . 0.0 113.921 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.42 52.43 1.71 Allowed Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -157.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.95 147.05 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.956 -1.32 . . . . 0.0 108.366 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 t -122.48 148.21 45.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.727 -1.233 . . . . 0.0 109.223 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.62 157.01 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 122.343 1.068 . . . . 0.0 110.11 -164.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.2 t -137.06 112.71 9.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 122.75 1.262 . . . . 0.0 107.834 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.46 175.38 50.7 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-O 122.934 1.296 . . . . 0.0 115.004 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.43 67.84 0.7 Allowed Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.1 m -97.21 -130.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 125.135 1.374 . . . . 0.0 110.694 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -71.1 -39.12 72.3 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.028 -2.295 . . . . 0.0 112.714 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.8 t -151.99 143.14 23.22 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 163.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 t -156.55 -69.25 0.11 Allowed 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.081 -1.637 . . . . 0.0 113.285 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.37 -58.32 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.558 -1.339 . . . . 0.0 112.734 -164.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -125.52 -83.64 0.63 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 124.078 0.951 . . . . 0.0 109.295 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.39 53.71 1.93 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 165.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.3 -140.42 16.27 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 -161.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.15 150.24 19.94 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 117.955 0.877 . . . . 0.0 113.522 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 22.0 mm -125.67 148.91 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -125.85 135.62 52.16 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.858 -1.151 . . . . 0.0 112.052 -169.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.3 t -78.65 130.32 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 120.398 -1.438 . . . . 0.0 112.333 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -89.52 -59.35 2.23 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.903 -1.123 . . . . 0.0 110.536 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.86 163.33 23.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.765 0.793 . . . . 0.0 110.24 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.4 131.72 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.122 1.369 . . . . 0.0 109.152 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.4 mm -83.58 120.31 75.15 Favored Pre-proline 0 N--CA 1.431 -1.381 0 O-C-N 120.926 -1.109 . . . . 0.0 109.816 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.8 67.56 8.57 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 124.022 2.472 . . . . 0.0 112.88 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -145.4 9.72 1.23 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 123.997 0.919 . . . . 0.0 111.835 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 -158.82 18.49 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 119.664 -1.898 . . . . 0.0 114.565 -172.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.34 -43.51 79.13 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.512 2.325 . . . . 0.0 116.26 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.98 90.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -73.79 -49.98 22.71 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.714 1.206 . . . . 0.0 111.583 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 t -55.05 -55.45 30.83 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.522 2.329 . . . . 0.0 114.485 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -79.2 -44.44 21.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.641 -1.287 . . . . 0.0 111.772 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.49 91.48 0.55 Allowed Glycine 0 N--CA 1.431 -1.686 0 C-N-CA 124.223 0.916 . . . . 0.0 113.443 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -136.16 -45.7 0.63 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.168 -1.195 . . . . 0.0 110.436 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.6 mt -126.04 133.45 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 -169.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.82 -178.19 3.97 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.598 1.19 . . . . 0.0 112.101 -176.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -56.42 125.03 20.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.49 16.79 80.45 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 117.588 1.795 . . . . 0.0 117.588 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -72.07 161.8 30.38 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.346 1.573 . . . . 0.0 112.634 167.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -123.16 115.18 21.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 121.029 -1.044 . . . . 0.0 109.314 -173.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.96 148.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 119.872 -1.767 . . . . 0.0 110.136 172.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.3 mt -128.98 -81.01 0.57 Allowed 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 121.41 -0.806 . . . . 0.0 111.46 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.5 138.12 34.56 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.553 -1.342 . . . . 0.0 114.455 -167.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.93 90.91 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 126.394 1.877 . . . . 0.0 109.411 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.292 3.3 t-20 56.37 50.65 12.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.945 1.698 . . . . 0.0 112.324 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.23 -36.8 3.89 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 120.678 -1.264 . . . . 0.0 113.675 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -85.23 124.05 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 O-C-N 121.305 -1.115 . . . . 0.0 112.293 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 t -77.98 129.52 35.39 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.677 -1.264 . . . . 0.0 110.864 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tp -95.08 51.84 1.39 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.972 -1.705 . . . . 0.0 112.808 -164.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.98 123.81 21.25 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.652 1.581 . . . . 0.0 114.512 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.39 -4.8 80.51 Favored Glycine 0 N--CA 1.429 -1.78 0 O-C-N 120.26 -1.525 . . . . 0.0 114.358 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.35 143.41 40.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 121.258 -1.142 . . . . 0.0 112.976 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.8 p -85.96 175.84 8.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.16 1.384 . . . . 0.0 111.006 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -59.73 -43.67 94.11 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.205 1.402 . . . . 0.0 112.488 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.88 -40.99 90.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.528 2.331 . . . . 0.0 115.386 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -72.1 -37.46 69.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.189 -1.57 . . . . 0.0 112.354 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.46 77.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.931 -1.106 . . . . 0.0 113.494 171.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.6 -51.58 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.365 1.466 . . . . 0.0 113.069 170.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -60.46 -40.28 90.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.635 -1.291 . . . . 0.0 114.328 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 p -70.48 -18.55 62.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.321 -1.487 . . . . 0.0 113.86 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mt -85.67 -19.13 31.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.01 -1.681 . . . . 0.0 113.253 170.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -78.54 -44.16 24.96 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.237 -1.539 . . . . 0.0 110.924 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -82.95 64.91 7.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.879 1.272 . . . . 0.0 112.942 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.5 p -99.72 -74.08 0.61 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.156 1.782 . . . . 0.0 111.015 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.37 -131.19 9.56 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 125.702 1.62 . . . . 0.0 111.01 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -76.79 -44.21 33.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.003 -1.292 . . . . 0.0 113.481 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -109.31 164.42 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 123.915 0.886 . . . . 0.0 111.055 -167.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.0 t -134.15 127.75 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.225 1.41 . . . . 0.0 109.38 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -142.43 115.68 8.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.397 -0.814 . . . . 0.0 109.078 171.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -149.05 162.36 40.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.243 -1.536 . . . . 0.0 112.019 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.3 mp -121.01 124.41 44.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.282 1.039 . . . . 0.0 108.982 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -117.86 166.06 12.93 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.527 1.131 . . . . 0.0 108.944 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -117.33 131.6 56.76 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 162.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -73.71 124.53 26.19 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.941 -1.099 . . . . 0.0 111.051 -174.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.81 -76.38 1.2 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 121.232 -0.917 . . . . 0.0 115.055 -166.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -99.94 140.39 34.22 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 123.838 0.855 . . . . 0.0 110.404 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.4 m -72.46 141.9 83.51 Favored Pre-proline 0 N--CA 1.429 -1.488 0 O-C-N 120.909 -1.12 . . . . 0.0 112.385 -176.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -62.78 -66.0 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.057 0 C-N-CA 123.139 2.559 . . . . 0.0 112.282 162.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.26 1.653 0 CA-C-N 119.092 0.86 . . . . 0.0 109.517 157.449 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 120.247 0.07 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.94 162.84 28.24 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 64.05 38.64 8.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.128 2.171 . . . . 0.0 113.845 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 5.1 t -119.07 -70.93 0.76 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.613 -1.304 . . . . 0.0 109.847 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -93.51 -86.88 0.25 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.859 -1.151 . . . . 0.0 113.08 -173.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.13 167.37 27.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.224 -0.922 . . . . 0.0 111.5 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.69 -174.65 4.39 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.807 1.243 . . . . 0.0 111.159 171.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -76.06 95.13 3.56 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.813 1.645 . . . . 0.0 110.502 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -109.71 -14.32 14.35 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.589 -1.319 . . . . 0.0 113.554 -168.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -122.17 99.28 6.34 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.768 -1.208 . . . . 0.0 111.408 -164.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -153.98 -122.84 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.075 -1.64 . . . . 0.0 112.777 174.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.98 160.21 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 127.709 2.404 . . . . 0.0 106.994 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 30.2 p -150.01 154.73 38.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.451 -2.031 . . . . 0.0 114.639 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.95 164.42 38.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.296 1.038 . . . . 0.0 112.009 170.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.26 1.627 0 C-N-CA 125.648 1.579 . . . . 0.0 108.977 176.351 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 CA--C 1.49 -1.678 0 N-CA-C 107.564 -1.745 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -85.88 147.56 46.07 Favored Pre-proline 0 N--CA 1.43 -1.472 0 O-C-N 121.089 -1.007 . . . . 0.0 110.493 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.93 -33.1 6.53 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 122.395 1.891 . . . . 0.0 110.983 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.18 61.73 1.85 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 124.998 1.285 . . . . 0.0 111.311 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.87 179.02 7.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.932 1.349 . . . . 0.0 113.22 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.92 133.51 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.431 1.492 . . . . 0.0 108.98 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -138.47 157.55 45.98 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.959 -1.088 . . . . 0.0 112.497 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -126.92 114.19 17.53 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.992 1.317 . . . . 0.0 112.477 -172.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.2 t -102.9 141.66 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.673 -1.267 . . . . 0.0 110.208 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -117.83 122.09 42.46 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 160.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -133.91 162.33 32.33 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.838 -1.163 . . . . 0.0 108.936 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.61 147.75 27.79 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.406 -1.434 . . . . 0.0 107.585 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -64.03 120.88 12.87 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 122.994 1.378 . . . . 0.0 114.703 -168.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -98.35 -88.21 0.32 Allowed 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 125.15 1.38 . . . . 0.0 108.816 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.55 -46.77 36.82 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.559 -1.338 . . . . 0.0 109.623 170.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -156.9 -158.06 0.74 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 169.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 p -83.53 -82.05 0.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.745 -1.222 . . . . 0.0 112.39 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.4 mt -102.49 -97.53 0.29 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.824 -1.798 . . . . 0.0 114.437 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.43 51.23 1.59 Allowed Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -162.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.9 tt -140.95 161.06 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 121.072 -1.252 . . . . 0.0 110.361 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -122.47 142.5 50.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 120.352 -1.467 . . . . 0.0 108.029 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -123.64 152.65 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 125.446 1.499 . . . . 0.0 107.861 -171.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.5 t -136.42 120.3 17.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.463 1.601 . . . . 0.0 110.786 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.67 -147.71 42.31 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 124.746 1.165 . . . . 0.0 113.695 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.88 38.39 6.92 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 121.997 0.776 . . . . 0.0 112.346 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 26' ' ' VAL . 13.2 m -80.95 -112.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 126.219 1.808 . . . . 0.0 113.318 -169.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -71.7 -51.91 20.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.876 -1.765 . . . . 0.0 111.482 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -151.45 153.4 34.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.1 t -154.6 -69.14 0.13 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.286 -0.884 . . . . 0.0 112.134 -175.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.9 t -91.97 -61.44 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 120.494 -1.379 . . . . 0.0 112.682 -163.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -124.93 -71.03 0.72 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.049 1.34 . . . . 0.0 111.78 -161.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -141.71 39.54 1.68 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.7 -144.48 17.96 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 -157.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.69 158.68 33.31 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.401 -1.058 . . . . 0.0 113.197 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 mm -126.36 145.28 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -125.94 138.7 53.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.084 -1.01 . . . . 0.0 111.715 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.7 t -85.83 127.72 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 124.937 1.295 . . . . 0.0 111.799 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -83.4 -63.72 1.3 Allowed 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 125.195 1.398 . . . . 0.0 111.175 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.09 171.64 5.71 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.816 0.846 . . . . 0.0 109.083 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.38 139.19 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.312 1.045 . . . . 0.0 111.737 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.1 mm -85.79 109.65 23.97 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 119.938 -1.726 . . . . 0.0 108.647 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -82.46 57.24 6.05 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 123.361 2.707 . . . . 0.0 114.14 -163.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -141.16 22.28 2.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.028 1.331 . . . . 0.0 110.427 -174.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.25 -160.91 19.79 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 120.179 -1.576 . . . . 0.0 115.044 -173.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.4 -45.57 88.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.893 2.077 . . . . 0.0 115.574 -166.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.08 79.04 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -77.63 -41.75 37.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.416 1.086 . . . . 0.0 111.948 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.8 t -70.14 -46.57 64.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -82.14 -61.52 1.88 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.723 -1.236 . . . . 0.0 111.684 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.64 99.42 1.08 Allowed Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.195 -0.941 . . . . 0.0 114.923 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -138.56 -37.15 0.55 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.97 -1.312 . . . . 0.0 110.929 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.6 mt -127.47 134.58 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -170.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.86 -176.68 3.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.842 -1.161 . . . . 0.0 113.523 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -55.2 127.88 31.3 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.97 1.708 . . . . 0.0 114.846 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.37 11.17 84.41 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.18 156.1 39.96 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.059 1.429 . . . . 0.0 111.576 169.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -123.76 102.06 7.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.134 -0.978 . . . . 0.0 109.772 -167.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -80.2 132.73 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.666 -1.271 . . . . 0.0 111.169 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.1 mt -122.04 -74.07 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.69 -1.256 . . . . 0.0 110.958 -170.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.35 151.67 20.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.7 t -113.65 101.18 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.611 1.965 . . . . 0.0 107.397 173.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.312 16.3 t-20 56.56 48.39 16.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.518 1.927 . . . . 0.0 113.536 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.73 -14.09 57.01 Favored Glycine 0 N--CA 1.43 -1.761 0 O-C-N 120.035 -1.666 . . . . 0.0 114.894 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 t -100.93 117.34 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 120.989 -1.301 . . . . 0.0 109.992 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -79.15 144.14 34.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.504 -1.372 . . . . 0.0 113.449 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mp -93.42 44.93 1.15 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.022 1.391 . . . . 0.0 112.517 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.89 114.41 6.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.096 -1.627 . . . . 0.0 112.824 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.08 7.89 73.01 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 120.817 -1.177 . . . . 0.0 113.875 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.5 143.03 38.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.013 -1.287 . . . . 0.0 110.871 168.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.2 p -90.33 176.07 6.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.349 -1.47 . . . . 0.0 110.285 165.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -59.62 -38.41 81.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -52.98 -41.6 64.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.519 -1.363 . . . . 0.0 113.768 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -71.23 -35.98 71.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.882 1.273 . . . . 0.0 112.356 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.82 84.57 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.455 -1.403 . . . . 0.0 113.908 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.23 -42.53 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 124.954 1.302 . . . . 0.0 112.07 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -61.08 -37.39 82.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.313 -1.492 . . . . 0.0 112.845 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.3 p -70.45 -22.96 62.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 171.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 mt -79.23 -40.84 29.68 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.998 -1.689 . . . . 0.0 112.739 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -63.78 -43.39 96.47 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.882 -1.137 . . . . 0.0 111.217 173.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -93.5 58.98 2.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.189 -1.57 . . . . 0.0 112.469 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 p -88.45 -72.46 0.54 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.708 1.203 . . . . 0.0 108.516 166.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.96 -128.26 8.04 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -76.67 -46.73 24.57 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.03 148.87 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 124.714 1.206 . . . . 0.0 112.351 -170.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.33 116.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 127.175 2.19 . . . . 0.0 108.652 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -117.62 115.35 24.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.252 -1.53 . . . . 0.0 107.316 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -144.03 157.95 44.01 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.985 -1.072 . . . . 0.0 112.705 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mp -122.11 134.58 54.75 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.985 0.914 . . . . 0.0 109.114 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.34 170.1 13.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.959 1.304 . . . . 0.0 109.879 -169.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -116.4 135.38 53.9 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 158.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -74.73 131.46 40.86 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.4 -111.17 0.62 Allowed Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 125.99 1.757 . . . . 0.0 116.726 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -77.42 154.25 32.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.971 -1.311 . . . . 0.0 114.536 -166.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 74.3 m -94.54 138.06 22.43 Favored Pre-proline 0 N--CA 1.431 -1.414 0 O-C-N 120.712 -1.243 . . . . 0.0 109.197 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -70.83 -47.14 0.64 Allowed 'Trans proline' 0 C--N 1.3 -1.982 0 CA-C-N 122.769 2.025 . . . . 0.0 114.377 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 C--O 1.261 1.663 0 C-N-CA 125.973 1.709 . . . . 0.0 109.678 -172.107 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.0 178.56 7.21 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -166.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 66.08 20.43 11.21 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 127.653 2.381 . . . . 0.0 114.759 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -106.31 -81.68 0.54 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.39 -1.444 . . . . 0.0 110.943 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -83.53 -79.51 0.2 Allowed 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 120.321 -1.487 . . . . 0.0 112.556 -173.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.93 163.66 18.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.95 -97.27 0.06 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.44 -0.787 . . . . 0.0 111.13 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.74 142.96 43.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.544 -1.348 . . . . 0.0 110.703 -174.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . 0.254 16.4 p30 -110.38 -54.84 2.54 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -173.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -121.57 138.08 54.46 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.463 -2.023 . . . . 0.0 112.021 -169.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -154.97 -132.21 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.402 -0.811 . . . . 0.0 112.006 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.22 171.46 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.335 2.254 . . . . 0.0 105.215 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.7 p -144.66 141.84 29.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.62 -1.925 . . . . 0.0 115.141 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.87 133.4 49.34 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.94 1.696 . . . . 0.0 111.428 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.261 1.67 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.148 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 CA--C 1.489 -1.735 0 N-CA-C 108.455 -1.402 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.2 pttp -92.33 157.03 41.16 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 117.641 -1.171 . . . . 0.0 111.109 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -77.17 -21.25 12.16 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 123.598 2.321 . . . . 0.0 113.888 -171.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.34 64.03 2.3 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 119.824 1.193 . . . . 0.0 111.454 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -82.18 171.06 14.73 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.6 130.44 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 167.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -133.73 166.53 22.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.227 1.013 . . . . 0.0 111.311 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -125.16 136.74 53.89 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.238 1.015 . . . . 0.0 109.293 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.9 m -102.06 135.59 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.707 -1.246 . . . . 0.0 108.849 173.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -126.04 87.36 2.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.26 1.024 . . . . 0.0 109.796 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 9.1 tp -134.51 -174.38 3.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.654 -1.279 . . . . 0.0 110.311 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.414 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -133.64 165.64 24.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.325 -1.484 . . . . 0.0 107.642 174.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -71.92 121.46 19.11 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.236 1.017 . . . . 0.0 111.786 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -107.5 -92.04 0.41 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.486 1.514 . . . . 0.0 107.755 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -78.78 -41.64 29.94 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.139 1.376 . . . . 0.0 109.997 163.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.8 161.51 37.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 123.81 0.844 . . . . 0.0 110.403 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -83.49 -68.37 0.72 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.439 1.095 . . . . 0.0 110.521 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.77 -79.15 0.52 Allowed 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.821 -1.174 . . . . 0.0 111.101 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.68 50.25 4.27 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 124.576 1.084 . . . . 0.0 113.475 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 tt -138.43 -178.61 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 121.617 -0.931 . . . . 0.0 109.579 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.0 p -127.4 142.47 51.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.842 -2.411 . . . . 0.0 110.31 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 t -123.77 155.82 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 123.855 0.862 . . . . 0.0 111.464 -163.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 t -137.02 141.93 42.5 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.255 -1.528 . . . . 0.0 108.707 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.1 -175.84 50.3 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 116.476 1.351 . . . . 0.0 116.476 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.95 44.05 0.97 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 121.865 -0.785 . . . . 0.0 112.823 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 27' ' ' ASN . 25.8 t -80.78 176.66 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.69 -1.476 . . . . 0.0 108.847 174.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.662 ' H ' HG12 ' A' ' 26' ' ' VAL . 5.8 p30 -69.07 -24.78 64.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.377 -2.077 . . . . 0.0 114.814 -160.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.6 t -135.15 133.33 39.04 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 150.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.9 p -155.81 -86.4 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.685 -1.259 . . . . 0.0 112.639 -165.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.13 -48.02 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 126.825 2.05 . . . . 0.0 109.062 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -129.02 -154.47 0.64 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 159.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.33 70.29 9.24 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.234 -2.166 . . . . 0.0 111.389 164.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.63 -171.87 13.95 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 108.118 -1.993 . . . . 0.0 108.118 -166.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.09 136.0 7.96 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -172.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.9 mm -127.21 149.41 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -170.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.92 139.49 53.78 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.924 -1.735 . . . . 0.0 111.225 -169.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.7 t -81.98 126.12 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 120.275 -1.516 . . . . 0.0 111.313 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -87.6 -70.12 0.65 Allowed 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.653 -1.279 . . . . 0.0 111.051 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.8 159.97 38.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.277 -0.89 . . . . 0.0 110.101 -171.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 p -103.09 132.6 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.93 1.347 . . . . 0.0 112.221 -170.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.6 mm -83.7 119.42 73.65 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 120.149 -1.594 . . . . 0.0 110.163 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -81.05 58.97 7.26 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 124.393 2.605 . . . . 0.0 112.966 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -141.39 -0.42 1.41 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.296 1.038 . . . . 0.0 112.094 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.36 -172.75 30.19 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.27 -1.518 . . . . 0.0 115.477 -170.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.3 -50.61 2.01 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.696 3.198 . . . . 0.0 118.159 -171.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.1 -45.34 68.19 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.213 1.405 . . . . 0.0 114.76 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -80.59 -52.66 7.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.958 1.303 . . . . 0.0 110.826 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.5 m -62.5 -38.48 90.04 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -172.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.3 -52.44 6.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.914 -1.116 . . . . 0.0 110.117 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.62 84.94 1.47 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 121.14 -0.975 . . . . 0.0 113.589 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -138.99 -21.82 0.95 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.19 149.58 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -119.64 172.57 7.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.592 -1.317 . . . . 0.0 111.702 177.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -56.54 138.73 51.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.43 22.11 76.24 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 116.905 1.522 . . . . 0.0 116.905 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.58 166.49 19.19 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 118.915 1.358 . . . . 0.0 111.693 169.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -124.1 105.43 9.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.748 -1.22 . . . . 0.0 110.25 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 m -93.74 141.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 120.459 -1.401 . . . . 0.0 111.519 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.24 -87.25 0.56 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 111.253 -166.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -90.63 153.84 20.02 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.591 -1.943 . . . . 0.0 112.903 -172.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 63.8 t -116.41 108.53 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.256 9.1 t-20 56.25 50.15 13.92 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 126.03 1.732 . . . . 0.0 113.76 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.5 -29.42 6.72 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.659 -1.276 . . . . 0.0 114.774 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.2 t -88.06 99.03 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.586 -1.538 . . . . 0.0 111.209 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -78.59 99.56 6.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.302 1.041 . . . . 0.0 110.514 167.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.03 92.91 7.08 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.07 1.414 . . . . 0.0 109.591 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.59 129.97 41.56 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.383 1.473 . . . . 0.0 112.644 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.48 -6.24 74.6 Favored Glycine 0 N--CA 1.429 -1.795 0 O-C-N 121.001 -1.062 . . . . 0.0 114.565 -174.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.99 133.27 40.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 119.595 1.698 . . . . 0.0 114.041 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.3 p -84.31 177.86 8.0 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.258 1.423 . . . . 0.0 112.613 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -56.94 -45.41 82.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.322 2.249 . . . . 0.0 113.942 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -58.39 -43.31 88.5 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 172.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -70.37 -39.21 74.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.761 -1.212 . . . . 0.0 111.995 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.41 67.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.666 1.186 . . . . 0.0 113.393 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.47 -35.99 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 120.291 -1.506 . . . . 0.0 113.076 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -58.24 -47.08 84.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.141 -1.599 . . . . 0.0 113.72 168.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.4 m -63.23 -36.25 83.02 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.823 1.649 . . . . 0.0 113.141 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 74.4 mt -78.89 -35.84 42.99 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 120.114 -1.616 . . . . 0.0 113.462 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -67.31 -28.16 67.76 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.961 -1.712 . . . . 0.0 112.639 172.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -90.93 48.81 1.56 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.18 -1.575 . . . . 0.0 112.78 172.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.74 -70.4 0.6 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.507 1.523 . . . . 0.0 109.766 173.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.13 -87.33 1.2 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 121.238 -0.914 . . . . 0.0 112.603 170.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -83.93 -61.4 1.83 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.216 -1.167 . . . . 0.0 113.753 173.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.74 142.51 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 122.22 1.01 . . . . 0.0 113.233 -164.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.9 t -121.05 92.39 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 125.408 1.483 . . . . 0.0 107.543 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -126.57 98.39 5.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.567 -1.333 . . . . 0.0 111.18 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.9 mt -127.35 154.22 45.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.81 -1.181 . . . . 0.0 111.409 -162.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 3.9 mm? -120.79 134.0 55.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.623 1.169 . . . . 0.0 109.047 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.07 153.06 37.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.534 0.683 . . . . 0.0 111.356 -171.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -112.19 120.96 43.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.822 1.649 . . . . 0.0 109.992 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -54.1 135.55 43.26 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -165.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.39 169.81 54.89 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 126.165 1.84 . . . . 0.0 115.611 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -95.92 176.83 5.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.072 1.349 . . . . 0.0 112.797 -170.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 t -85.06 136.63 38.12 Favored Pre-proline 0 N--CA 1.43 -1.458 0 O-C-N 120.815 -1.178 . . . . 0.0 111.793 -175.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.62 176.59 9.86 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 122.197 1.931 . . . . 0.0 112.619 160.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 C--O 1.26 1.636 0 C-N-CA 125.679 1.592 . . . . 0.0 110.687 175.988 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.57 -70.98 0.69 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 84.18 86.72 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.615 2.766 . . . . 0.0 111.207 -172.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.4 m -131.96 161.64 32.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.72 -1.238 . . . . 0.0 112.749 -166.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 178.24 4.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 124.498 1.119 . . . . 0.0 109.726 164.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.61 112.27 24.78 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -167.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -92.49 82.56 4.87 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.837 -1.789 . . . . 0.0 110.764 172.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . 0.25 37.5 mt-10 63.09 -171.34 0.17 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -105.84 121.49 44.18 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.779 -1.826 . . . . 0.0 111.301 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -123.25 111.66 16.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 170.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.55 -148.97 0.32 Allowed 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.329 -1.482 . . . . 0.0 112.982 -165.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 t -122.56 149.09 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.364 1.866 . . . . 0.0 106.789 -173.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -138.33 166.83 23.22 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.273 -1.517 . . . . 0.0 112.58 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.88 147.12 50.79 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.614 1.966 . . . . 0.0 109.735 162.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.26 1.647 0 C-N-CA 127.4 2.28 . . . . 0.0 105.299 170.037 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 CA--C 1.49 -1.683 0 N-CA-C 108.399 -1.423 . . . . 0.0 108.399 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -77.22 164.57 57.82 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 118.112 -0.947 . . . . 0.0 111.533 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -75.57 -25.66 10.79 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 124.141 2.515 . . . . 0.0 113.3 -168.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.56 69.86 0.26 Allowed Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 171.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -83.55 165.42 19.09 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.4 mt -81.37 131.86 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 122.182 0.992 . . . . 0.0 111.524 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -136.98 168.93 18.65 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.711 -1.243 . . . . 0.0 109.847 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -122.49 137.52 54.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.766 0.826 . . . . 0.0 111.003 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.6 m -103.98 143.75 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 124.395 1.078 . . . . 0.0 111.716 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -127.9 106.68 9.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.652 1.181 . . . . 0.0 109.159 -170.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.1 mt -129.69 159.39 36.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.997 -1.689 . . . . 0.0 110.657 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.66 164.44 27.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 160.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -72.25 114.18 10.08 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.437 -1.414 . . . . 0.0 113.933 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -101.9 -70.89 0.73 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 162.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.43 -74.69 0.43 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.362 1.865 . . . . 0.0 110.789 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -136.49 148.76 47.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -165.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.1 m -80.83 -62.82 1.55 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.924 -1.735 . . . . 0.0 113.268 -159.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.8 mp -101.52 -86.09 0.42 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.886 -1.134 . . . . 0.0 111.001 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.2 45.71 2.53 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.638 -1.289 . . . . 0.0 115.338 171.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.65 172.33 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 120.696 -1.473 . . . . 0.0 109.032 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.7 p -121.16 145.05 48.23 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.723 -1.861 . . . . 0.0 108.539 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.07 154.3 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 125.757 1.623 . . . . 0.0 108.073 -165.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.6 t -139.0 161.36 37.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 169.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.03 -132.38 15.18 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.635 -1.29 . . . . 0.0 114.335 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.97 0.81 89.0 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 120.708 -1.466 . . . . 0.0 115.899 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.0 t -73.69 166.93 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.156 2.182 . . . . 0.0 110.901 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -69.77 -15.35 63.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.383 1.873 . . . . 0.0 115.429 -164.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.5 t -134.99 118.0 16.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.507 -1.996 . . . . 0.0 107.084 148.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 p -146.87 -83.25 0.12 Allowed 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.878 -1.139 . . . . 0.0 109.445 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.61 -51.14 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 126.62 1.968 . . . . 0.0 110.245 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -130.35 -158.05 0.86 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 161.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.38 56.71 1.79 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.406 -2.059 . . . . 0.0 112.851 165.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.34 168.69 12.4 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 126.412 1.958 . . . . 0.0 110.423 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.91 152.31 24.76 Favored Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 125.099 1.333 . . . . 0.0 111.079 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.2 mm -126.47 149.17 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 121.097 -1.237 . . . . 0.0 109.501 -161.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.65 137.12 53.85 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.358 -1.463 . . . . 0.0 109.64 -172.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.7 t -86.02 132.94 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.441 -1.412 . . . . 0.0 112.104 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -87.76 -70.08 0.65 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.569 -1.332 . . . . 0.0 110.875 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.81 163.29 40.01 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 122.157 0.979 . . . . 0.0 111.112 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.8 p -88.27 130.06 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.424 0 C-N-CA 124.925 1.29 . . . . 0.0 111.642 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mm -84.45 118.83 72.05 Favored Pre-proline 0 N--CA 1.43 -1.471 0 O-C-N 120.201 -1.562 . . . . 0.0 109.256 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.39 45.28 1.68 Allowed 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 124.715 2.72 . . . . 0.0 113.061 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -143.02 34.41 1.36 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.146 0.978 . . . . 0.0 109.217 -171.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.19 -172.69 39.62 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 119.938 -1.726 . . . . 0.0 113.105 -171.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.54 -35.83 78.86 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.951 1.7 . . . . 0.0 114.598 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.98 -49.17 69.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.16 -53.51 36.73 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.37 1.868 . . . . 0.0 112.079 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.6 m -66.27 -29.31 69.51 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.58 -53.93 6.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.91 1.684 . . . . 0.0 111.967 170.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.71 65.98 1.67 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 120.393 -1.442 . . . . 0.0 114.173 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -138.34 -13.74 1.33 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.01 -1.288 . . . . 0.0 113.232 -166.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.04 144.68 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.23 -177.62 3.56 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 122.998 1.38 . . . . 0.0 111.473 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.9 pttt -58.56 132.84 54.98 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.183 -1.573 . . . . 0.0 114.707 168.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.49 12.59 84.38 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 117.807 1.883 . . . . 0.0 117.807 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -74.08 160.86 30.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.352 1.576 . . . . 0.0 110.747 167.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ttm-85 -122.89 106.47 10.9 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.591 -1.318 . . . . 0.0 109.427 -166.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 m -102.42 126.37 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.313 1.53 . . . . 0.0 111.134 -166.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.04 -88.52 0.62 Allowed 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.085 -1.635 . . . . 0.0 112.172 -160.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.54 134.71 33.99 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 121.107 -0.996 . . . . 0.0 112.564 -166.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.58 105.24 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.85 -1.156 . . . . 0.0 108.879 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.264 58.3 t30 55.92 43.09 27.99 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.093 2.157 . . . . 0.0 113.337 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.69 -28.39 15.73 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 124.469 1.033 . . . . 0.0 113.635 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.4 t -84.18 109.14 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 124.451 1.1 . . . . 0.0 113.122 -166.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -78.52 98.61 6.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.053 1.341 . . . . 0.0 110.435 172.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.39 75.21 1.6 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.151 1.453 . . . . 0.0 109.674 -170.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.42 143.67 54.98 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.687 -1.883 . . . . 0.0 112.986 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.16 7.37 65.72 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.478 -1.389 . . . . 0.0 114.668 -175.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.79 147.03 37.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.584 -1.539 . . . . 0.0 113.709 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 p -93.09 170.57 9.54 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.739 1.616 . . . . 0.0 109.494 166.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -60.79 -41.67 96.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.815 -1.178 . . . . 0.0 112.761 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -49.07 -51.32 32.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.815 1.646 . . . . 0.0 114.84 168.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -70.77 -36.19 72.95 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.23 -1.544 . . . . 0.0 112.826 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.09 98.19 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.017 -1.677 . . . . 0.0 113.433 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.0 t -67.66 -43.73 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 C-N-CA 125.35 1.46 . . . . 0.0 111.914 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.88 -12.91 60.81 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 120.251 -1.53 . . . . 0.0 114.195 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.4 m -71.17 -57.65 4.3 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.993 -2.317 . . . . 0.0 110.214 171.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.8 -20.45 42.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -72.5 -23.23 60.99 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.831 -1.793 . . . . 0.0 112.795 166.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -90.64 52.82 2.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 119.502 -1.999 . . . . 0.0 111.865 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.2 p -109.04 -94.06 0.41 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.893 1.677 . . . . 0.0 110.478 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.02 -59.86 0.57 Allowed Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 124.825 1.202 . . . . 0.0 112.565 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -84.68 -77.17 0.28 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.957 -1.32 . . . . 0.0 114.097 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.84 143.2 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.818 1.647 . . . . 0.0 111.445 -161.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.4 t -126.5 128.97 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.93 1.692 . . . . 0.0 109.941 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -143.02 115.21 8.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.662 -1.899 . . . . 0.0 109.763 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.3 mt -128.2 153.77 46.54 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.587 -1.321 . . . . 0.0 111.306 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.8 130.9 55.15 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.65 151.56 37.45 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -103.6 134.59 46.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -74.99 137.64 41.69 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.655 -1.278 . . . . 0.0 114.398 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.99 -174.93 50.1 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 122.889 1.272 . . . . 0.0 116.201 -167.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -80.22 159.59 25.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.308 -1.113 . . . . 0.0 112.845 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.2 t -68.08 134.23 91.68 Favored Pre-proline 0 N--CA 1.43 -1.472 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -170.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.69 167.28 27.57 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 122.417 2.078 . . . . 0.0 113.133 172.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.2 p . . . . . 0 C--O 1.259 1.586 0 C-N-CA 127.049 2.139 . . . . 0.0 112.854 -163.001 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.46 -40.49 13.43 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.226 -1.546 . . . . 0.0 114.133 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 59.45 51.19 6.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.135 1.774 . . . . 0.0 113.813 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 71.2 m -109.97 172.78 6.66 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.483 1.513 . . . . 0.0 109.57 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -74.65 -173.94 1.96 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.794 -1.191 . . . . 0.0 111.687 172.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.61 135.41 36.58 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.238 -2.164 . . . . 0.0 113.535 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -116.9 74.77 0.93 Allowed 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 124.071 0.948 . . . . 0.0 108.863 170.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 44.23 -152.24 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.289 2.636 . . . . 0.0 116.748 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -135.37 142.88 45.81 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.522 -1.986 . . . . 0.0 107.838 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -122.95 102.69 8.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -123.54 -169.19 1.9 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.645 1.178 . . . . 0.0 112.384 -170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.9 t -120.05 138.93 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.591 -1.318 . . . . 0.0 109.873 -152.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 13.9 m -128.21 157.42 40.89 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.802 -1.186 . . . . 0.0 112.666 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.27 154.74 45.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.061 -1.025 . . . . 0.0 110.095 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.259 1.578 0 C-N-CA 125.378 1.471 . . . . 0.0 107.45 169.413 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.491 -1.662 0 N-CA-C 109.338 -1.062 . . . . 0.0 109.338 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -77.33 162.85 67.63 Favored Pre-proline 0 N--CA 1.43 -1.431 0 CA-C-O 117.561 -1.209 . . . . 0.0 110.663 172.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -74.33 -15.1 22.71 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 124.313 2.576 . . . . 0.0 113.691 -169.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.51 71.6 0.23 Allowed Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 123.886 0.755 . . . . 0.0 111.538 166.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -82.89 171.68 13.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.3 mp -89.14 132.43 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.38 -1.45 . . . . 0.0 110.968 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -133.16 161.73 33.65 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.751 -1.218 . . . . 0.0 111.834 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -109.91 134.62 51.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 124.86 1.264 . . . . 0.0 110.924 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -103.18 149.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.503 -1.373 . . . . 0.0 111.21 163.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.9 105.89 8.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 167.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.409 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 12.2 tp -134.43 -179.32 5.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.875 -1.141 . . . . 0.0 108.402 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -140.61 172.67 12.39 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 120.16 -1.587 . . . . 0.0 109.906 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -71.9 111.97 7.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.598 1.559 . . . . 0.0 110.889 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -113.71 -83.28 0.6 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.377 1.071 . . . . 0.0 110.176 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -82.86 -47.42 11.86 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.768 -1.208 . . . . 0.0 109.513 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -137.6 -172.69 3.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 167.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 t -83.85 -72.55 0.46 Allowed 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.916 -1.115 . . . . 0.0 111.452 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.38 -84.4 0.45 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.963 -1.086 . . . . 0.0 110.379 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.82 54.34 0.68 Allowed Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 116.175 1.23 . . . . 0.0 116.175 170.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.65 174.12 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 119.195 1.498 . . . . 0.0 112.437 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.8 p -122.63 135.91 54.74 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.152 1.381 . . . . 0.0 109.545 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -123.36 142.7 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.497 1.519 . . . . 0.0 110.634 -163.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.1 t -136.4 111.3 8.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.653 1.692 . . . . 0.0 111.589 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -134.15 11.86 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 125.242 1.401 . . . . 0.0 111.503 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.1 23.39 32.44 Favored Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.84 -127.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 121.018 -1.284 . . . . 0.0 113.11 -172.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -79.38 -44.25 21.86 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.073 -1.642 . . . . 0.0 112.75 -164.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -151.98 103.19 2.88 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 166.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.9 p -134.71 -75.94 0.46 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.327 -1.483 . . . . 0.0 110.44 -172.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.16 -54.84 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 124.704 1.202 . . . . 0.0 110.272 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -134.18 -164.12 1.46 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.03 78.39 3.57 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.911 -1.743 . . . . 0.0 111.508 166.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.75 -177.4 21.19 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -166.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.48 148.6 12.45 Favored Glycine 0 N--CA 1.431 -1.687 0 O-C-N 121.458 -1.025 . . . . 0.0 111.119 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.9 mm -127.23 142.31 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -171.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.44 130.91 53.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.69 -1.256 . . . . 0.0 109.589 -169.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.3 t -84.22 134.94 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 124.38 1.072 . . . . 0.0 111.438 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -88.83 -59.26 2.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.31 1.444 . . . . 0.0 111.199 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.9 159.49 29.75 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 123.575 0.75 . . . . 0.0 111.463 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 p -91.59 128.15 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 122.586 1.184 . . . . 0.0 113.017 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.2 mm -84.45 131.69 49.42 Favored Pre-proline 0 N--CA 1.43 -1.458 0 C-N-CA 126.175 1.79 . . . . 0.0 110.866 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.36 41.64 1.17 Allowed 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 123.546 2.831 . . . . 0.0 114.593 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -147.48 66.34 1.13 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.664 1.585 . . . . 0.0 107.235 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.74 175.79 46.34 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 119.69 -1.881 . . . . 0.0 115.438 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.15 -34.93 78.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.305 1.042 . . . . 0.0 112.275 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.37 -56.02 24.92 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.744 1.618 . . . . 0.0 113.936 175.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.61 -47.16 67.39 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.044 -1.035 . . . . 0.0 112.372 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.3 m -60.18 -47.77 84.56 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.68 -51.9 30.45 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.562 -1.336 . . . . 0.0 112.538 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.07 78.62 0.95 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 120.82 -1.175 . . . . 0.0 111.575 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.6 ttt85 -138.82 -34.61 0.6 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.956 -0.731 . . . . 0.0 112.315 -158.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 mt -128.9 170.25 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -140.95 -177.8 5.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.293 -2.754 . . . . 0.0 112.036 165.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.45 143.05 30.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.774 -1.829 . . . . 0.0 113.743 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.87 8.15 81.98 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 117.576 1.79 . . . . 0.0 117.576 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -80.77 154.69 27.07 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 119.274 1.537 . . . . 0.0 109.157 163.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -137.05 128.66 28.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.976 -1.703 . . . . 0.0 112.39 -164.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.0 m -80.13 162.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.972 -1.705 . . . . 0.0 115.292 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 mp -119.88 -86.68 0.65 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.23 1.812 . . . . 0.0 106.981 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 160.49 14.25 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -170.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.1 t -108.78 98.54 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.49 1.516 . . . . 0.0 107.108 165.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 56.38 54.51 7.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.671 1.588 . . . . 0.0 114.233 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.7 -32.02 4.39 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.434 -1.416 . . . . 0.0 114.18 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.91 121.82 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 124.627 1.171 . . . . 0.0 112.254 -171.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.1 m -77.72 133.59 38.28 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 120.632 -1.293 . . . . 0.0 112.216 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.49 63.3 7.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.506 -1.371 . . . . 0.0 109.677 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.52 104.0 1.17 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.029 1.731 . . . . 0.0 114.417 -168.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.08 29.26 74.62 Favored Glycine 0 N--CA 1.429 -1.775 0 O-C-N 120.43 -1.418 . . . . 0.0 114.888 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.2 158.15 30.5 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.229 1.412 . . . . 0.0 114.203 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 p -80.8 162.06 24.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.809 -1.182 . . . . 0.0 111.589 167.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -60.87 -42.25 97.52 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.365 1.466 . . . . 0.0 111.586 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -47.03 -46.07 21.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.266 1.826 . . . . 0.0 114.747 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -71.52 -38.69 71.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.288 -1.507 . . . . 0.0 113.436 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.7 96.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.965 -1.085 . . . . 0.0 113.412 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.66 -47.3 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 126.391 1.876 . . . . 0.0 112.772 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -54.51 -43.64 72.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.753 -1.217 . . . . 0.0 113.332 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.1 m -62.56 -50.3 71.88 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.128 1.771 . . . . 0.0 112.724 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.69 -12.27 59.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.955 -1.716 . . . . 0.0 115.594 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.31 -30.7 57.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.553 -1.967 . . . . 0.0 112.214 167.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -100.47 65.64 1.21 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.189 -1.569 . . . . 0.0 114.591 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.5 p -92.74 -68.24 0.81 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.157 -1.589 . . . . 0.0 112.091 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.66 -127.83 7.43 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 125.581 1.562 . . . . 0.0 110.76 -172.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -83.35 -45.65 13.5 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 p -115.4 145.46 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 121.287 -0.883 . . . . 0.0 113.286 -166.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.8 t -124.96 112.5 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.215 1.806 . . . . 0.0 110.48 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -120.46 110.91 17.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.244 -1.535 . . . . 0.0 110.412 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.4 mt -131.99 151.73 51.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.696 -1.252 . . . . 0.0 111.157 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.84 128.15 52.57 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.48 157.19 43.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.886 0.85 . . . . 0.0 111.262 -171.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -109.21 137.28 47.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.618 1.167 . . . . 0.0 109.069 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.28 130.4 41.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.487 1.136 . . . . 0.0 112.075 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.57 171.51 49.58 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 125.867 1.699 . . . . 0.0 114.645 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -92.01 -177.94 4.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -170.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.9 t -78.82 139.58 58.0 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 120.375 -1.453 . . . . 0.0 114.219 -163.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -68.32 160.55 48.54 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 C-N-CA 122.685 2.257 . . . . 0.0 112.421 159.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.26 1.653 0 C-N-CA 124.484 1.114 . . . . 0.0 112.037 -173.51 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 119.653 -0.213 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.49 -69.26 0.65 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . 0.276 40.7 m-20 49.78 45.39 24.74 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.135 2.174 . . . . 0.0 114.797 -166.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.0 m -100.52 179.45 4.43 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.9 1.68 . . . . 0.0 109.795 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -90.62 164.18 14.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.551 -1.343 . . . . 0.0 110.843 164.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.38 139.84 33.82 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.952 -1.093 . . . . 0.0 112.898 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -88.63 83.4 6.76 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 166.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . 0.345 15.1 tt0 42.93 -112.79 0.22 Allowed 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.714 2.406 . . . . 0.0 116.618 -168.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -144.12 149.33 36.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.57 -1.331 . . . . 0.0 112.656 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -126.05 133.32 51.74 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.594 1.558 . . . . 0.0 109.18 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -151.87 -157.75 0.83 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.941 -1.099 . . . . 0.0 112.14 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -121.67 136.43 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.012 1.725 . . . . 0.0 106.735 -170.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.2 m -128.37 167.95 16.25 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 120.579 -1.325 . . . . 0.0 111.427 -172.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.34 134.14 16.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 123.032 0.533 . . . . 0.0 110.337 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--O 1.259 1.593 0 C-N-CA 126.667 1.987 . . . . 0.0 108.45 172.572 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.718 0 N-CA-C 110.591 -0.58 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -77.29 163.37 64.99 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-O 117.814 -1.089 . . . . 0.0 110.453 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.03 -14.61 32.18 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 CA-C-N 123.498 2.285 . . . . 0.0 113.798 -169.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.32 81.48 0.34 Allowed Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 165.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -82.73 -177.1 6.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.78 133.83 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.23 1.412 . . . . 0.0 109.712 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -132.81 158.67 41.89 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.105 -1.622 . . . . 0.0 111.339 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -117.68 140.2 49.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.147 0.975 . . . . 0.0 110.961 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.08 142.99 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.865 -1.147 . . . . 0.0 109.47 166.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -128.55 76.3 1.7 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 tp -113.35 171.1 7.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.564 -1.335 . . . . 0.0 110.505 -167.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.27 161.34 39.83 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.358 -1.464 . . . . 0.0 109.033 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -68.35 112.97 5.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.98 -1.075 . . . . 0.0 112.762 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -115.04 -78.98 0.58 Allowed 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 124.977 1.311 . . . . 0.0 109.743 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -82.38 -43.91 16.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.494 -1.379 . . . . 0.0 110.417 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -143.3 -177.63 5.46 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.752 1.221 . . . . 0.0 107.726 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.3 t -83.29 -83.14 0.14 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 124.726 1.211 . . . . 0.0 108.901 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.1 mp -101.85 -99.9 0.27 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.168 -0.957 . . . . 0.0 108.865 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.39 60.08 0.79 Allowed Glycine 0 N--CA 1.43 -1.74 0 O-C-N 120.276 -1.515 . . . . 0.0 115.313 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.52 175.09 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 121.284 -1.127 . . . . 0.0 108.028 170.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.2 p -121.31 145.53 47.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.542 -1.974 . . . . 0.0 108.663 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.6 t -123.76 167.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.247 1.419 . . . . 0.0 107.409 -168.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.9 t -136.99 67.59 1.44 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.314 2.007 . . . . 0.0 108.714 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.83 -137.17 18.32 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 120.237 -1.539 . . . . 0.0 112.513 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.9 93.9 1.47 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -166.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.29 -113.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 121.793 -0.827 . . . . 0.0 111.08 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -93.3 -62.69 1.32 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.725 -1.234 . . . . 0.0 111.36 -165.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 t -134.24 97.98 3.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.212 1.482 . . . . 0.0 108.52 166.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.2 p -134.64 -84.08 0.42 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.841 -1.162 . . . . 0.0 111.14 -162.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.13 -51.37 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 125.807 1.643 . . . . 0.0 110.154 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -138.17 -166.22 1.94 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 158.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.67 66.89 9.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.135 -1.603 . . . . 0.0 111.286 168.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.64 141.31 5.67 Favored Glycine 0 N--CA 1.429 -1.784 0 O-C-N 120.877 -1.14 . . . . 0.0 110.868 -171.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.8 155.17 26.16 Favored Glycine 0 N--CA 1.43 -1.72 0 O-C-N 121.488 -1.007 . . . . 0.0 111.946 -170.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.1 mm -133.44 152.33 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 124.821 1.248 . . . . 0.0 108.784 -164.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.85 124.76 43.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.158 -1.589 . . . . 0.0 110.66 -168.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.5 t -74.05 135.34 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.27 -1.519 . . . . 0.0 112.744 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -91.93 -68.01 0.82 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.921 -1.112 . . . . 0.0 112.372 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.89 157.69 35.32 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.162 -0.961 . . . . 0.0 109.914 -173.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.4 p -88.35 131.93 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.716 1.246 . . . . 0.0 113.167 -175.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.4 mm -84.61 126.15 69.54 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 117.514 -1.232 . . . . 0.0 108.315 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -81.5 34.93 0.56 Allowed 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 123.351 2.701 . . . . 0.0 113.797 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -144.84 64.1 1.29 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.661 1.984 . . . . 0.0 107.078 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.37 174.39 46.02 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 120.565 -1.334 . . . . 0.0 112.589 -177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.67 82.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.747 1.619 . . . . 0.0 113.432 -174.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.02 -49.2 66.75 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.063 1.745 . . . . 0.0 114.897 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.46 -35.69 34.56 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 124.092 0.957 . . . . 0.0 112.554 176.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.8 m -59.38 -51.51 69.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.971 -1.706 . . . . 0.0 114.018 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.3 -41.03 42.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 111.115 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.79 66.63 1.45 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 120.623 -1.298 . . . . 0.0 111.628 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 ttt85 -137.59 -20.86 1.16 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -160.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.52 154.21 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -139.95 178.87 6.96 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.965 -1.709 . . . . 0.0 111.14 171.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.84 138.06 56.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.94 19.5 79.91 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 116.964 1.546 . . . . 0.0 116.964 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -83.1 162.04 21.45 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 119.173 1.487 . . . . 0.0 109.41 164.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.9 ttm105 -127.59 123.98 37.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.964 -1.71 . . . . 0.0 110.353 -171.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.6 m -93.71 147.5 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.442 -1.411 . . . . 0.0 111.728 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.4 -88.67 0.62 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 123.923 0.889 . . . . 0.0 109.823 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.8 148.03 22.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.893 -1.754 . . . . 0.0 114.498 -169.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -109.83 88.64 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.32 1.448 . . . . 0.0 109.647 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 57.14 60.14 3.1 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.062 1.745 . . . . 0.0 114.946 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.47 -36.57 3.8 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 124.422 1.011 . . . . 0.0 113.101 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 t -95.85 114.14 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.804 -1.41 . . . . 0.0 112.261 -169.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.4 m -78.03 132.41 37.76 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.33 -1.481 . . . . 0.0 110.206 161.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.87 76.48 5.56 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.623 1.201 . . . . 0.0 109.848 -171.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.18 103.31 0.75 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 -165.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.64 14.23 72.3 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.397 -1.44 . . . . 0.0 114.325 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.9 141.88 40.35 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.688 1.195 . . . . 0.0 112.4 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 p -76.28 172.98 11.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.303 1.841 . . . . 0.0 113.475 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -60.59 -38.12 83.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.33 1.452 . . . . 0.0 113.591 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -58.84 -50.35 74.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.345 -1.472 . . . . 0.0 113.558 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -71.43 -39.46 71.02 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.247 1.419 . . . . 0.0 112.951 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.96 -42.57 99.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.278 -1.514 . . . . 0.0 113.804 175.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -72.1 -38.79 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 119.854 -1.779 . . . . 0.0 111.815 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -58.41 -35.99 72.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.624 -1.297 . . . . 0.0 113.657 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.0 m -67.78 -41.23 83.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.526 1.93 . . . . 0.0 113.048 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 mt -80.47 -19.35 46.19 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.196 -1.565 . . . . 0.0 114.202 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -72.53 -25.8 61.51 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.855 -1.778 . . . . 0.0 112.307 166.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -88.91 70.83 8.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.942 -1.099 . . . . 0.0 112.625 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.0 p -104.41 -78.1 0.57 Allowed 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.997 -1.064 . . . . 0.0 110.131 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.24 -117.86 4.36 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -82.85 -49.62 9.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.13 147.29 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.785 -1.197 . . . . 0.0 113.24 -166.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.84 110.72 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.451 1.501 . . . . 0.0 110.024 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -124.16 111.3 15.74 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.934 -1.729 . . . . 0.0 111.328 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 69.6 mt -129.95 153.15 48.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.428 -0.795 . . . . 0.0 111.087 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.36 127.13 52.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.47 156.93 43.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.024 0.916 . . . . 0.0 111.88 -170.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -105.35 136.27 45.19 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.712 1.205 . . . . 0.0 109.119 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -70.03 131.85 44.98 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.302 1.041 . . . . 0.0 112.541 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.74 -162.55 14.9 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 116.677 1.431 . . . . 0.0 116.677 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -101.2 175.49 5.57 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.817 1.647 . . . . 0.0 113.78 -169.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.1 t -75.98 148.85 82.13 Favored Pre-proline 0 N--CA 1.428 -1.565 0 O-C-N 120.057 -1.652 . . . . 0.0 112.871 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.85 163.55 38.09 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 122.637 1.977 . . . . 0.0 111.648 158.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.26 1.612 0 C-N-CA 125.705 1.602 . . . . 0.0 108.865 179.231 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.03 -72.26 0.56 Allowed 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 120.288 -1.507 . . . . 0.0 114.506 -172.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 59.26 48.78 9.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.681 1.993 . . . . 0.0 113.778 -172.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 70.0 m -96.68 174.19 6.95 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.547 1.539 . . . . 0.0 110.264 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.49 167.69 11.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.696 -1.253 . . . . 0.0 109.997 172.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.64 111.98 23.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.396 -1.44 . . . . 0.0 112.366 -176.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.34 89.18 6.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.366 -1.458 . . . . 0.0 108.851 172.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 64.49 -135.0 0.28 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.088 1.755 . . . . 0.0 114.436 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -134.84 131.12 37.04 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.465 -1.397 . . . . 0.0 110.436 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -123.48 110.52 15.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.07 0.948 . . . . 0.0 110.167 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -136.71 -158.59 0.88 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.365 -1.459 . . . . 0.0 112.216 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.36 141.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 126.304 1.842 . . . . 0.0 106.61 -173.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 68.9 m -132.96 161.76 33.44 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.067 1.347 . . . . 0.0 112.635 -160.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.95 152.79 52.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.566 1.147 . . . . 0.0 111.901 170.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.26 1.609 0 C-N-CA 127.419 2.288 . . . . 0.0 107.553 168.509 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.49 -1.685 0 N-CA-C 109.06 -1.169 . . . . 0.0 109.06 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -82.09 171.0 13.0 Favored Pre-proline 0 N--CA 1.431 -1.415 0 CA-C-O 117.895 -1.05 . . . . 0.0 111.605 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -66.11 -32.7 42.83 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 CA-C-N 123.379 2.243 . . . . 0.0 114.418 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.02 72.52 0.86 Allowed Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 172.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -81.65 159.56 23.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.985 -1.303 . . . . 0.0 113.728 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 mp -81.87 135.7 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.569 1.547 . . . . 0.0 109.509 -174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -138.53 150.58 46.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.404 1.082 . . . . 0.0 111.115 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.33 113.63 21.73 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.969 -1.082 . . . . 0.0 109.577 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.432 HG21 HD11 ' A' ' 52' ' ' ILE . 22.1 m -102.17 146.83 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.842 -1.162 . . . . 0.0 112.573 -173.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.71 134.32 55.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.054 0.942 . . . . 0.0 108.524 172.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.2 mt -130.93 148.02 52.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 161.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.97 135.3 46.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -66.92 118.63 10.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -119.1 -84.06 0.65 Allowed 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.58 -1.325 . . . . 0.0 111.657 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -77.35 -42.17 37.62 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.668 1.987 . . . . 0.0 109.888 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -156.43 -172.04 3.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 m -92.64 -73.88 0.54 Allowed 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.167 -0.958 . . . . 0.0 110.3 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.07 -91.06 0.34 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 118.93 0.786 . . . . 0.0 111.808 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.71 52.18 1.22 Allowed Glycine 0 N--CA 1.431 -1.687 0 O-C-N 120.0 -1.687 . . . . 0.0 111.465 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.2 tt -145.88 158.05 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 121.228 -1.16 . . . . 0.0 111.405 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.0 p -122.02 149.4 43.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.491 -1.381 . . . . 0.0 110.113 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.29 164.05 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.22 1.01 . . . . 0.0 108.549 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -137.7 151.99 48.8 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.408 -2.057 . . . . 0.0 105.691 165.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.64 -144.51 17.21 Favored Glycine 0 N--CA 1.431 -1.678 0 O-C-N 120.969 -1.082 . . . . 0.0 112.466 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.3 -4.46 86.03 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 124.745 1.164 . . . . 0.0 113.868 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -100.34 161.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 124.611 1.164 . . . . 0.0 108.792 -168.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -68.36 -19.51 64.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.131 2.172 . . . . 0.0 114.471 -162.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.5 t -130.34 126.97 38.47 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 152.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.5 p -156.21 -101.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.628 -1.295 . . . . 0.0 109.292 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.48 -41.97 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.317 -1.49 . . . . 0.0 110.876 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.438 ' HB3' ' H ' ' A' ' 32' ' ' HIS . 3.2 mmp_? -131.86 -145.18 0.26 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 162.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.438 ' H ' ' HB3' ' A' ' 31' ' ' ARG . 22.4 p-80 -79.5 55.63 1.99 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.45 2.3 . . . . 0.0 111.014 168.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.99 -160.1 14.81 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 107.111 -2.396 . . . . 0.0 107.111 -163.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.54 150.2 26.22 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 122.234 0.908 . . . . 0.0 112.345 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mm -125.91 132.73 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.238 -1.154 . . . . 0.0 108.208 -170.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.55 140.47 52.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 124.561 1.144 . . . . 0.0 108.707 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.9 t -78.97 127.65 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 O-C-N 120.36 -1.462 . . . . 0.0 110.961 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -90.12 -62.26 1.5 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.587 -1.32 . . . . 0.0 110.843 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.82 156.87 25.81 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.2 t -91.0 133.45 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.1 mm -83.21 127.62 68.16 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.967 -1.492 . . . . 0.0 108.643 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -80.35 41.79 1.2 Allowed 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 123.841 3.027 . . . . 0.0 113.386 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -145.58 53.12 1.17 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.92 2.488 . . . . 0.0 106.313 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.97 161.81 33.1 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.225 -1.547 . . . . 0.0 114.914 -174.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.76 -32.53 65.69 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 127.9 2.48 . . . . 0.0 115.766 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.66 -38.19 66.64 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 170.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -78.94 -39.2 35.22 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.427 1.091 . . . . 0.0 111.689 174.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.2 m -57.58 -48.24 79.92 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.413 -1.43 . . . . 0.0 113.179 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -73.96 -65.74 0.8 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.821 1.248 . . . . 0.0 112.827 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.63 79.21 0.79 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.342 -1.474 . . . . 0.0 114.852 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -138.87 -30.3 0.75 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.515 1.526 . . . . 0.0 110.882 -174.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.432 HD11 HG21 ' A' ' 9' ' ' VAL . 40.5 mt -125.73 138.65 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -140.16 -173.9 3.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.499 -1.376 . . . . 0.0 110.117 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -57.52 134.75 56.38 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.59 11.22 85.42 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 118.656 2.222 . . . . 0.0 118.656 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -76.45 154.68 34.54 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.238 2.019 . . . . 0.0 111.002 169.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.473 HH21 ' CD ' ' A' ' 90' ' ' GLU . 2.5 tmm_? -124.4 115.13 20.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.076 -1.64 . . . . 0.0 110.11 -161.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.3 m -94.82 154.08 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 119.658 -1.901 . . . . 0.0 114.191 -170.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.5 mt -121.81 -89.51 0.6 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.3 1.04 . . . . 0.0 110.33 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.83 141.5 31.54 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -165.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.1 t -95.4 102.64 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 124.473 1.109 . . . . 0.0 108.026 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.256 59.3 t30 57.94 42.42 22.95 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.859 1.663 . . . . 0.0 114.191 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.63 -27.25 21.06 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.535 -1.353 . . . . 0.0 113.959 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.1 t -91.33 113.31 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.345 -1.091 . . . . 0.0 111.967 -174.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -81.05 111.77 17.83 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.984 -1.072 . . . . 0.0 111.749 167.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.96 82.78 1.86 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.744 -1.223 . . . . 0.0 108.749 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.37 144.0 53.55 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.343 -2.098 . . . . 0.0 114.495 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.68 -15.31 52.91 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 120.693 -1.254 . . . . 0.0 114.897 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.68 128.58 37.15 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.836 1.655 . . . . 0.0 115.376 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 p -73.38 164.26 26.91 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.065 1.412 . . . . 0.0 111.01 172.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.12 -42.28 94.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -168.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -55.71 -38.22 69.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.356 1.862 . . . . 0.0 114.463 172.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -71.37 -43.63 66.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.253 1.421 . . . . 0.0 111.276 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.73 -48.82 70.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.82 -1.175 . . . . 0.0 113.539 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.13 -52.22 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 124.79 1.236 . . . . 0.0 113.503 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -71.46 -21.88 61.9 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 120.077 -1.639 . . . . 0.0 114.587 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.3 m -64.77 -40.49 95.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.354 -1.466 . . . . 0.0 111.57 169.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.61 -26.36 37.85 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.524 -1.36 . . . . 0.0 113.837 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -66.55 -43.35 85.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.021 -1.675 . . . . 0.0 112.154 168.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -78.14 53.85 1.27 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.719 1.608 . . . . 0.0 113.592 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.3 p -108.5 -86.6 0.51 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.85 2.06 . . . . 0.0 108.817 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.87 -57.45 1.83 Allowed Glycine 0 N--CA 1.43 -1.749 0 O-C-N 120.29 -1.506 . . . . 0.0 114.936 171.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -83.15 -68.23 0.72 Allowed 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 120.516 -1.579 . . . . 0.0 112.609 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.45 141.64 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 122.555 1.169 . . . . 0.0 110.249 -173.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.1 t -114.99 109.04 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 126.651 1.98 . . . . 0.0 107.489 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -117.24 127.68 54.33 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.841 -1.162 . . . . 0.0 110.478 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.5 mt -141.42 152.46 44.3 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 123.847 0.859 . . . . 0.0 111.78 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -122.32 123.9 42.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.827 1.251 . . . . 0.0 107.951 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.43 165.82 29.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.635 1.207 . . . . 0.0 111.622 -173.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.473 ' CD ' HH21 ' A' ' 57' ' ' ARG . 29.8 tt0 -112.03 141.33 45.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.303 1.841 . . . . 0.0 108.325 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -71.64 137.7 48.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.525 -1.359 . . . . 0.0 112.093 171.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.26 -143.44 5.85 Favored Glycine 0 N--CA 1.431 -1.686 0 CA-C-O 123.467 1.593 . . . . 0.0 115.915 -176.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -88.35 168.38 12.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 121.048 -1.266 . . . . 0.0 112.05 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.3 t -84.5 159.66 58.12 Favored Pre-proline 0 N--CA 1.431 -1.425 0 C-N-CA 124.885 1.274 . . . . 0.0 110.97 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -67.1 173.72 8.02 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 123.179 2.586 . . . . 0.0 115.356 168.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.26 1.622 0 C-N-CA 124.439 1.096 . . . . 0.0 111.905 -179.646 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 . . . . . 0 CA--C 1.491 -1.316 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.43 -74.62 0.58 Allowed 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.755 -1.215 . . . . 0.0 113.317 -175.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 59.55 65.58 1.13 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.775 2.43 . . . . 0.0 115.509 -172.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 6.1 t -117.37 -164.07 0.97 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.11 1.364 . . . . 0.0 109.087 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -108.51 -68.59 0.9 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.412 -1.43 . . . . 0.0 108.144 171.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.74 82.44 4.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.365 1.616 . . . . 0.0 115.365 -165.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -83.08 -64.07 1.24 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.452 1.101 . . . . 0.0 111.308 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . 0.331 21.2 mt-10 72.42 -128.81 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.694 1.998 . . . . 0.0 113.556 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -150.35 157.66 43.3 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.189 -1.569 . . . . 0.0 113.938 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -124.09 154.4 40.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 158.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -122.75 178.4 5.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.189 1.359 . . . . 0.0 113.911 -168.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 68.6 t -120.86 139.27 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.199 2.2 . . . . 0.0 105.482 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 11.6 m -132.28 140.54 48.66 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.164 1.386 . . . . 0.0 114.563 -156.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.54 157.58 31.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.972 1.709 . . . . 0.0 112.088 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.262 1.719 0 C-N-CA 125.211 1.404 . . . . 0.0 108.809 -179.474 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 CA--C 1.49 -1.688 0 N-CA-C 108.866 -1.244 . . . . 0.0 108.866 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -78.99 168.28 28.26 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 125.052 1.341 . . . . 0.0 110.984 169.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -65.25 -31.18 53.88 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 CA-C-N 124.18 2.529 . . . . 0.0 114.798 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.39 81.74 1.68 Allowed Glycine 0 N--CA 1.431 -1.655 0 CA-C-N 119.487 1.039 . . . . 0.0 110.515 167.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -80.57 155.98 26.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 123.334 1.54 . . . . 0.0 114.381 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.8 mt -86.55 135.86 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 125.645 1.578 . . . . 0.0 109.121 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -145.13 166.52 25.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.203 1.001 . . . . 0.0 108.84 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -124.63 143.7 50.58 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.282 -0.886 . . . . 0.0 109.869 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.6 m -103.43 148.75 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 123.425 0.69 . . . . 0.0 109.799 171.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -129.39 93.48 3.57 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.8 tp -122.61 163.06 20.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -172.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.88 172.14 13.4 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.045 -1.659 . . . . 0.0 109.014 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -71.63 103.83 3.15 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.997 -1.064 . . . . 0.0 113.115 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -97.97 -70.87 0.71 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.902 1.281 . . . . 0.0 109.465 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -70.43 -76.91 0.09 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.724 2.01 . . . . 0.0 110.003 172.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -138.21 -176.86 4.59 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.818 -3.031 . . . . 0.0 102.818 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 t -79.48 -61.46 2.0 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.775 -1.828 . . . . 0.0 112.881 -162.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.2 mp -101.76 -88.18 0.38 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.175 -1.578 . . . . 0.0 111.32 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.6 45.08 2.01 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tt -152.41 147.34 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 120.948 -1.325 . . . . 0.0 110.49 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 t -122.17 158.52 29.19 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.899 -1.126 . . . . 0.0 109.926 -174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.576 HG11 ' CE1' ' A' ' 71' ' ' HIS . 33.0 t -121.4 162.48 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.042 1.337 . . . . 0.0 109.299 -158.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 t -147.69 149.68 32.91 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 165.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.81 -149.87 43.73 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.62 12.88 57.69 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 118.231 2.052 . . . . 0.0 118.231 168.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.04 -107.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 119.128 1.464 . . . . 0.0 114.491 -161.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -89.89 -41.47 11.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.361 -2.087 . . . . 0.0 110.793 -172.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 t -136.31 152.64 50.9 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 158.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -155.37 -93.04 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.431 -1.418 . . . . 0.0 110.835 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.47 -52.67 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 C-N-CA 125.044 1.337 . . . . 0.0 110.016 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.5 ptt-85 -125.98 -139.05 0.27 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.446 -1.686 . . . . 0.0 106.446 154.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -75.67 67.35 2.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.773 1.749 . . . . 0.0 110.823 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.45 -176.58 16.42 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 126.181 1.848 . . . . 0.0 109.333 -171.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.63 151.52 27.02 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.68 159.3 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.52 157.21 35.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.468 -1.395 . . . . 0.0 109.747 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 t -92.53 128.25 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 124.963 1.305 . . . . 0.0 111.849 -174.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -97.17 -67.39 0.85 Allowed 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.691 -1.256 . . . . 0.0 113.342 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.21 153.05 28.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.827 -1.17 . . . . 0.0 112.637 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.94 119.87 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 126.309 1.843 . . . . 0.0 109.246 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.4 mm -84.54 131.52 49.71 Favored Pre-proline 0 N--CA 1.43 -1.451 0 C-N-CA 125.054 1.341 . . . . 0.0 109.685 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -77.11 64.23 7.79 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 CA-C-N 124.295 2.57 . . . . 0.0 112.65 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -160.33 53.95 0.33 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.869 1.319 . . . . 0.0 109.202 173.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.72 179.95 45.7 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.385 -2.072 . . . . 0.0 112.908 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.36 -32.79 72.71 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.734 1.614 . . . . 0.0 114.703 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.75 -42.35 71.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.845 1.658 . . . . 0.0 114.411 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -91.33 -47.18 7.62 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.779 1.232 . . . . 0.0 112.0 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.4 m -68.39 -36.6 79.39 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -173.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -84.4 -49.2 8.9 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.189 1.359 . . . . 0.0 109.327 165.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.89 90.43 2.16 Favored Glycine 0 N--CA 1.43 -1.701 0 O-C-N 121.02 -1.05 . . . . 0.0 111.672 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -137.83 -54.5 0.66 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -166.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.0 mt -126.36 145.98 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 119.197 -2.189 . . . . 0.0 107.387 -165.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -119.2 174.05 6.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.462 1.125 . . . . 0.0 112.386 -170.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -61.12 136.03 57.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 167.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 26.51 62.63 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 119.154 2.422 . . . . 0.0 119.154 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -79.9 176.18 9.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 118.776 1.288 . . . . 0.0 110.737 162.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -124.75 121.09 33.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.969 -1.707 . . . . 0.0 109.248 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -94.17 153.46 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 120.028 -1.67 . . . . 0.0 112.193 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.0 tp -125.9 -81.42 0.62 Allowed 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 121.059 -1.025 . . . . 0.0 112.073 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.88 151.18 21.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.527 -1.358 . . . . 0.0 114.385 -166.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.75 92.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 125.999 1.719 . . . . 0.0 107.066 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 56.37 54.61 7.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.468 1.507 . . . . 0.0 114.555 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.27 -40.31 2.47 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 124.329 0.966 . . . . 0.0 114.649 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 t -99.31 136.17 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 O-C-N 121.425 -1.044 . . . . 0.0 111.381 -169.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 t -77.72 144.99 36.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.87 -1.769 . . . . 0.0 110.97 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -90.89 -9.43 46.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.455 -1.403 . . . . 0.0 113.305 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.02 144.53 33.87 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -172.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.1 -43.84 1.87 Allowed Glycine 0 N--CA 1.431 -1.699 0 O-C-N 121.176 -0.953 . . . . 0.0 113.017 -161.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.01 160.0 28.42 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.614 -1.521 . . . . 0.0 114.516 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.8 p -84.85 167.74 15.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.444 1.898 . . . . 0.0 111.174 175.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.576 ' CE1' HG11 ' A' ' 22' ' ' VAL . 11.1 t60 -60.67 -37.45 81.64 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.42 1.488 . . . . 0.0 114.052 171.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -54.5 -45.86 73.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.956 2.102 . . . . 0.0 114.221 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -76.18 -34.23 59.33 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.086 -1.634 . . . . 0.0 112.723 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.84 96.74 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.551 1.541 . . . . 0.0 114.481 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.7 m -73.88 -24.06 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.974 -1.704 . . . . 0.0 113.787 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -67.91 -45.26 74.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.406 -1.434 . . . . 0.0 112.183 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.6 m -59.97 -33.12 71.51 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 126.745 2.018 . . . . 0.0 112.828 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.26 -54.71 5.7 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.76 -1.213 . . . . 0.0 112.574 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -68.5 -5.43 19.45 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -169.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -85.49 11.96 9.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.152 -1.592 . . . . 0.0 115.192 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 p -102.14 -103.84 0.27 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.471 1.508 . . . . 0.0 110.015 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.95 -57.57 0.47 Allowed Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.201 -1.562 . . . . 0.0 113.376 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -71.33 -67.94 0.48 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.8 p -109.46 140.43 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 122.459 1.123 . . . . 0.0 112.057 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.9 t -119.82 112.1 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 125.155 1.382 . . . . 0.0 109.774 -175.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -116.53 115.35 25.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.017 -1.052 . . . . 0.0 108.378 168.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.2 tp -128.41 146.35 50.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.932 1.293 . . . . 0.0 108.595 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -120.74 123.02 41.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.32 157.65 44.58 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 122.243 1.021 . . . . 0.0 110.5 -170.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -104.68 141.37 36.56 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -65.23 135.45 55.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.629 1.204 . . . . 0.0 113.457 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.6 163.95 53.0 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-O 122.596 1.109 . . . . 0.0 113.175 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -83.35 172.05 12.9 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.559 1.171 . . . . 0.0 112.007 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.1 t -71.4 -43.11 12.06 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 116.014 -1.945 . . . . 0.0 115.198 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -76.02 45.05 1.43 Allowed 'Trans proline' 0 N--CA 1.434 -2.009 0 CA-C-N 125.926 3.152 . . . . 0.0 117.983 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.261 1.696 0 C-N-CA 125.43 1.492 . . . . 0.0 108.287 167.174 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 CA--C 1.491 -1.317 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.59 -103.63 0.17 Allowed 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 120.476 -1.39 . . . . 0.0 109.919 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -90.55 -179.74 5.64 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.273 -1.517 . . . . 0.0 108.752 170.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.7 m -94.55 -170.82 2.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.208 -2.183 . . . . 0.0 111.89 -173.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -115.25 -84.14 0.62 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.652 -1.28 . . . . 0.0 108.739 164.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.09 100.51 7.78 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.455 -1.403 . . . . 0.0 108.343 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -134.77 130.74 36.62 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 124.601 1.161 . . . . 0.0 110.354 -167.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -148.74 -171.81 3.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.949 -1.095 . . . . 0.0 109.327 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -92.82 175.75 6.69 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.199 -1.563 . . . . 0.0 111.813 -169.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -122.99 -117.33 0.29 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 170.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -134.7 170.27 16.07 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.576 -1.953 . . . . 0.0 111.681 160.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -121.3 158.33 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.069 2.148 . . . . 0.0 107.752 -169.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.8 m -141.71 159.29 42.53 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.08 -1.637 . . . . 0.0 112.987 -168.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.53 161.77 38.99 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.475 0.655 . . . . 0.0 111.721 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.504 1.922 . . . . 0.0 106.437 174.559 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo . . . . . 0 CA--C 1.491 -1.637 0 N-CA-C 108.804 -1.268 . . . . 0.0 108.804 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -78.11 176.94 3.1 Favored Pre-proline 0 N--CA 1.431 -1.4 0 C-N-CA 125.904 1.682 . . . . 0.0 112.224 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -63.13 -31.55 75.29 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 CA-C-N 124.111 2.504 . . . . 0.0 115.631 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.43 86.05 0.55 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 124.056 0.836 . . . . 0.0 112.637 172.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.31 168.62 18.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.8 135.06 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 126.424 1.89 . . . . 0.0 109.409 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -146.99 169.62 18.82 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.797 1.284 . . . . 0.0 113.568 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.09 125.94 40.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.994 1.318 . . . . 0.0 111.457 -174.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.2 m -104.78 147.91 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.303 -1.498 . . . . 0.0 113.805 172.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -130.85 104.08 6.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.132 1.373 . . . . 0.0 109.833 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 tp -123.28 174.9 7.01 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.795 1.238 . . . . 0.0 108.199 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.23 163.52 32.72 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.669 -1.894 . . . . 0.0 105.928 166.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -62.38 120.61 11.37 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -117.92 -89.07 0.6 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.617 1.167 . . . . 0.0 109.298 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.12 -49.66 41.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.68 1.592 . . . . 0.0 110.976 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -151.5 -162.83 1.62 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -84.63 -61.54 1.77 Allowed 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 120.511 1.505 . . . . 0.0 110.018 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 mp -104.1 -93.55 0.34 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.504 -1.373 . . . . 0.0 111.723 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.87 51.74 1.25 Allowed Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 124.793 1.187 . . . . 0.0 110.602 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.7 tt -150.2 163.57 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 121.329 -1.101 . . . . 0.0 110.791 -174.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -121.85 148.02 45.24 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.405 -1.435 . . . . 0.0 110.135 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -126.01 156.78 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 126.04 1.736 . . . . 0.0 109.633 -166.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -138.69 151.17 46.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.182 -0.949 . . . . 0.0 109.532 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.78 -149.8 50.8 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 125.641 1.591 . . . . 0.0 115.804 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.03 36.88 13.79 Favored Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 116.677 1.431 . . . . 0.0 116.677 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.54 -108.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -166.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -90.25 -52.48 4.91 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.802 -1.811 . . . . 0.0 110.852 -169.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -137.38 135.42 36.96 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 161.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 t -155.72 -84.27 0.06 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.107 -1.621 . . . . 0.0 110.325 -163.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.48 -58.5 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -116.89 -138.36 0.36 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 161.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 66.06 2.19 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.979 -1.7 . . . . 0.0 110.711 164.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.99 -147.3 16.46 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -168.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.63 145.32 14.91 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 121.712 -0.875 . . . . 0.0 111.3 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.6 mm -123.47 145.7 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.485 -1.597 . . . . 0.0 108.969 -160.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.75 141.23 52.11 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.118 1.367 . . . . 0.0 110.078 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.82 136.32 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.77 -1.207 . . . . 0.0 112.897 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -97.11 -66.64 0.89 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.058 1.343 . . . . 0.0 112.05 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.25 159.28 39.93 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.17 -0.956 . . . . 0.0 110.456 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.33 131.85 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 125.673 1.589 . . . . 0.0 110.781 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.5 mm -83.83 122.27 76.26 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 117.451 -1.262 . . . . 0.0 108.104 170.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.9 40.99 1.03 Allowed 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.474 2.782 . . . . 0.0 113.11 -171.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -160.59 78.0 0.62 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.23 170.39 43.51 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.76 -34.47 74.51 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.743 1.217 . . . . 0.0 113.07 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.91 -42.95 69.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -92.2 -37.7 12.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.861 1.264 . . . . 0.0 112.993 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.3 m -68.0 -35.57 78.54 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.282 -1.511 . . . . 0.0 114.549 -177.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.13 -60.27 2.44 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.103 0.954 . . . . 0.0 109.782 167.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.39 68.63 0.61 Allowed Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -136.72 -42.4 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.839 -0.801 . . . . 0.0 112.27 -155.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 mt -127.84 121.14 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -117.85 -179.63 3.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.317 1.056 . . . . 0.0 111.086 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -59.58 142.13 53.44 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.07 6.41 82.72 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 119.284 2.473 . . . . 0.0 119.284 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.76 170.51 16.45 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.684 1.742 . . . . 0.0 113.019 173.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -131.84 91.09 2.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.951 -1.718 . . . . 0.0 111.016 -166.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.09 160.63 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.43 -2.044 . . . . 0.0 113.288 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.1 tp -141.79 -82.97 0.2 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.728 -1.232 . . . . 0.0 113.041 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.32 146.88 24.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.33 -1.482 . . . . 0.0 114.796 -165.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.3 t -113.71 89.48 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 126.723 2.009 . . . . 0.0 107.71 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.7 t30 57.55 58.47 3.76 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.602 1.561 . . . . 0.0 112.712 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.44 -41.54 3.09 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.842 -1.161 . . . . 0.0 113.963 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.0 122.28 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.559 -1.553 . . . . 0.0 110.963 -173.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -77.39 141.14 39.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.105 -1.622 . . . . 0.0 111.417 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 pp -88.23 -2.8 58.81 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.19 142.89 57.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -171.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.05 -29.72 11.58 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 120.619 -1.301 . . . . 0.0 113.153 -166.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.86 153.84 32.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 p -83.0 170.6 14.72 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.856 -1.153 . . . . 0.0 112.039 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -55.29 -46.26 76.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.545 1.538 . . . . 0.0 114.985 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -60.14 -40.7 90.74 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -72.25 -38.98 68.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.326 -1.484 . . . . 0.0 111.964 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.45 96.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.783 1.633 . . . . 0.0 114.527 175.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.9 m -69.26 -37.49 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.395 -1.441 . . . . 0.0 113.163 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.78 -40.68 89.1 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.927 1.291 . . . . 0.0 112.915 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.1 m -58.35 -38.53 77.39 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.202 2.201 . . . . 0.0 113.202 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.84 -33.02 30.88 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.792 1.237 . . . . 0.0 112.993 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -69.99 -47.08 63.65 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.766 -1.209 . . . . 0.0 113.92 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.347 0.0 OUTLIER -89.97 42.45 1.09 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.8 p -93.1 -71.88 0.63 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.444 1.498 . . . . 0.0 109.669 171.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.94 -99.55 0.89 Allowed Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.08 1.8 . . . . 0.0 113.509 172.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -79.66 -47.68 14.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -159.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.31 146.7 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 121.046 -1.033 . . . . 0.0 111.993 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.32 112.76 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 120.311 -1.493 . . . . 0.0 110.092 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -114.84 118.85 34.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 163.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.6 tt -145.67 143.77 30.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.401 -0.812 . . . . 0.0 110.091 -170.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.06 126.49 49.98 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -173.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.23 164.66 29.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.06 1.409 . . . . 0.0 112.011 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -117.74 141.51 48.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 174.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -73.61 138.35 44.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.247 1.023 . . . . 0.0 111.582 175.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.4 -129.47 1.85 Allowed Glycine 0 N--CA 1.43 -1.761 0 CA-C-O 123.049 1.361 . . . . 0.0 116.024 -174.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -87.31 127.46 35.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.201 -1.176 . . . . 0.0 113.672 -167.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.6 m -88.33 -56.73 0.3 Allowed Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-O 116.336 -1.793 . . . . 0.0 114.509 176.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.74 64.72 8.58 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 126.216 3.256 . . . . 0.0 113.431 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.26 1.614 0 C-N-CA 124.751 1.22 . . . . 0.0 112.093 176.478 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 121.096 0.474 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.7 -92.48 0.53 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.403 1.081 . . . . 0.0 109.389 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -105.53 164.29 12.0 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 166.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.9 p -80.71 -36.34 32.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -161.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 68.58 65.36 0.32 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.734 1.614 . . . . 0.0 111.993 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . 77.4 91.93 0.07 Allowed 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 128.299 2.64 . . . . 0.0 113.858 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.58 135.55 33.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.515 1.526 . . . . 0.0 110.456 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -165.21 -171.28 2.14 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.9 1.28 . . . . 0.0 108.083 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -113.97 -175.75 2.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.504 -1.372 . . . . 0.0 109.457 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -122.68 -74.33 0.62 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.68 -1.262 . . . . 0.0 109.179 174.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -139.19 165.73 26.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.404 -1.435 . . . . 0.0 109.463 174.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.38 146.18 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.901 -1.124 . . . . 0.0 109.519 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.8 m -136.96 176.56 8.6 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.573 -1.329 . . . . 0.0 113.07 -172.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.91 157.22 42.96 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.099 1.36 . . . . 0.0 108.827 168.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 C--O 1.258 1.549 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 176.808 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.489 -1.732 0 N-CA-C 109.314 -1.071 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -78.3 151.37 78.07 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 118.146 -0.93 . . . . 0.0 111.167 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -82.62 29.48 0.55 Allowed 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 123.547 2.831 . . . . 0.0 115.19 -161.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.82 80.9 0.31 Allowed Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.892 -1.13 . . . . 0.0 112.249 172.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.97 138.13 47.81 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.882 1.325 . . . . 0.0 114.57 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.61 140.65 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.25 1.82 . . . . 0.0 108.595 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.501 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -161.04 161.91 31.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.195 -0.941 . . . . 0.0 110.566 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.51 127.89 54.95 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 120.977 -1.077 . . . . 0.0 109.212 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.28 131.95 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 122.587 1.184 . . . . 0.0 111.284 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -116.63 123.47 47.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.414 1.102 . . . . 0.0 109.846 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.4 tp -135.22 168.23 19.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.99 160.73 31.0 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.0 tttp -70.88 103.65 2.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.107 -0.996 . . . . 0.0 111.05 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -100.66 -93.66 0.28 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.16 1.784 . . . . 0.0 109.401 -166.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.0 -47.44 45.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.297 -1.502 . . . . 0.0 109.133 167.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -147.66 -153.83 0.51 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 167.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 p -83.47 -90.94 0.08 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.231 -1.543 . . . . 0.0 111.361 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.64 -85.22 0.43 Allowed 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 120.459 -1.4 . . . . 0.0 113.317 -173.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.46 42.74 1.44 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 125.327 1.441 . . . . 0.0 110.985 -168.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.3 tt -134.89 152.66 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 121.124 -1.221 . . . . 0.0 109.552 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.2 p -122.27 153.87 38.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.478 -1.389 . . . . 0.0 111.738 -171.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.66 159.6 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.133 1.373 . . . . 0.0 108.982 -164.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.2 t -138.04 142.36 40.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.67 -149.3 50.44 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.781 1.658 . . . . 0.0 114.921 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.82 34.29 5.78 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 124.5 1.048 . . . . 0.0 115.456 165.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.14 -92.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 121.663 -0.904 . . . . 0.0 111.216 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -98.32 -51.09 4.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.453 -1.404 . . . . 0.0 110.103 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.9 131.41 14.8 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.83 -1.169 . . . . 0.0 110.832 175.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -154.83 -74.2 0.11 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.285 1.034 . . . . 0.0 110.661 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -79.46 -48.71 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.459 -1.401 . . . . 0.0 110.137 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -132.08 -159.67 0.98 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 161.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -71.7 110.76 6.46 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 120.329 -1.482 . . . . 0.0 108.76 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.22 -179.76 23.86 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 121.063 -1.023 . . . . 0.0 113.905 -167.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.79 161.45 27.79 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.451 -1.617 . . . . 0.0 112.075 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.8 mm -126.68 142.51 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.3 1.84 . . . . 0.0 107.986 -162.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.88 138.46 52.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.968 1.307 . . . . 0.0 109.451 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.86 133.58 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.712 -1.242 . . . . 0.0 112.714 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -90.85 -65.64 1.0 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.216 1.007 . . . . 0.0 110.87 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.73 160.9 31.95 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.356 -0.84 . . . . 0.0 111.946 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.05 125.59 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.998 1.319 . . . . 0.0 110.46 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.08 133.99 47.09 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.967 -1.492 . . . . 0.0 109.085 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.35 43.31 1.46 Allowed 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 124.772 2.74 . . . . 0.0 114.089 -173.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -153.57 47.66 0.66 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.851 -1.156 . . . . 0.0 109.721 -166.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.01 -172.7 39.51 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 120.237 -1.539 . . . . 0.0 112.517 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.85 -29.35 69.79 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.626 1.97 . . . . 0.0 113.214 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.29 94.62 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 125.987 1.715 . . . . 0.0 114.044 174.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -73.71 -43.59 58.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.804 1.242 . . . . 0.0 111.909 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 t -62.16 -55.56 27.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.182 1.393 . . . . 0.0 114.149 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.69 -60.32 2.37 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.915 -1.116 . . . . 0.0 111.091 175.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.31 87.13 1.43 Allowed Glycine 0 N--CA 1.43 -1.756 0 O-C-N 121.371 -0.831 . . . . 0.0 112.105 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.43 -26.77 0.98 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 121.238 -1.154 . . . . 0.0 112.789 -164.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.5 mm -126.56 136.89 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -119.33 171.31 8.41 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.678 -1.264 . . . . 0.0 112.546 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.14 143.91 42.26 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.44 15.21 81.68 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 116.445 1.338 . . . . 0.0 116.445 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -82.43 158.39 23.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.092 1.357 . . . . 0.0 113.496 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -127.17 114.43 17.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.888 1.675 . . . . 0.0 111.715 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 m -79.93 157.49 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.864 -1.772 . . . . 0.0 113.717 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 mp -121.53 -90.97 0.57 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 125.643 1.577 . . . . 0.0 107.41 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.19 159.48 16.04 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.312 -2.117 . . . . 0.0 114.213 -166.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.94 80.13 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.389 1.875 . . . . 0.0 106.658 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.5 t30 57.86 69.7 0.71 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.849 1.66 . . . . 0.0 112.768 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.55 -55.62 2.71 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 120.592 -1.318 . . . . 0.0 114.456 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -86.12 138.36 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.545 1.164 . . . . 0.0 113.171 -170.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -79.26 155.43 28.54 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.539 -1.351 . . . . 0.0 113.1 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 pp -85.91 4.25 38.3 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 125.307 1.443 . . . . 0.0 113.874 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -62.13 120.33 10.68 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.617 -1.302 . . . . 0.0 114.249 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.68 -39.58 2.65 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 125.77 1.653 . . . . 0.0 112.984 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.65 140.33 51.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -168.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.68 -178.56 5.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.337 1.455 . . . . 0.0 109.377 172.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -60.29 -49.95 75.56 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.402 -1.436 . . . . 0.0 114.483 -171.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -54.27 -43.12 70.74 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 125.136 1.374 . . . . 0.0 113.77 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -71.67 -41.2 69.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.016 -1.053 . . . . 0.0 112.717 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.51 92.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.333 -1.48 . . . . 0.0 114.374 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -72.15 -40.25 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.003 -1.685 . . . . 0.0 112.351 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -72.37 -31.81 65.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.283 -1.511 . . . . 0.0 114.117 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.5 p -70.42 -26.15 63.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.222 -1.549 . . . . 0.0 113.157 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.23 -40.52 26.89 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 121.062 -1.024 . . . . 0.0 112.011 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -60.68 -56.0 26.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.545 -1.347 . . . . 0.0 113.676 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -84.03 59.32 5.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.673 -1.267 . . . . 0.0 111.379 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.49 -69.63 0.63 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.044 2.138 . . . . 0.0 107.59 166.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.71 -117.74 3.95 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -65.5 -63.62 1.05 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.71 138.04 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 122.488 1.137 . . . . 0.0 111.478 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.19 87.42 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 125.646 1.578 . . . . 0.0 106.791 -175.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -116.29 126.02 52.98 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 120.273 -1.517 . . . . 0.0 108.996 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . 0.266 0.0 OUTLIER -147.34 162.67 38.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.637 -1.289 . . . . 0.0 111.927 -179.1 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -121.41 131.2 54.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.679 1.592 . . . . 0.0 107.729 -170.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.501 HD11 ' CZ ' ' A' ' 7' ' ' PHE . 1.3 pt? -140.87 162.99 34.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.515 1.15 . . . . 0.0 111.602 -171.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -134.89 120.19 18.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.426 1.49 . . . . 0.0 107.527 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -62.39 143.91 56.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -174.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.37 145.11 38.55 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 121.299 -0.876 . . . . 0.0 113.93 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -93.76 138.0 32.41 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 121.24 -1.153 . . . . 0.0 111.283 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.8 m -75.65 161.6 75.58 Favored Pre-proline 0 N--CA 1.43 -1.468 0 C-N-CA 125.505 1.522 . . . . 0.0 112.861 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.74 173.06 14.02 Favored 'Trans proline' 0 N--CA 1.434 -2.029 0 C-N-CA 122.766 2.311 . . . . 0.0 111.672 166.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.4 p . . . . . 0 C--O 1.261 1.666 0 C-N-CA 123.903 0.881 . . . . 0.0 112.567 -173.603 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 32.2 p90 . . . . . 0 CA--C 1.49 -1.327 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.99 -128.46 0.06 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -85.43 150.02 25.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.94 1.296 . . . . 0.0 109.931 172.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 4.5 t -143.23 -86.58 0.14 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.49 -1.381 . . . . 0.0 111.9 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.27 -162.83 0.86 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.111 -1.618 . . . . 0.0 110.792 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.81 -80.65 0.51 Allowed 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 120.549 -1.344 . . . . 0.0 114.023 -171.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.55 158.37 19.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -162.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -139.55 -93.17 0.17 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.591 1.556 . . . . 0.0 108.96 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -89.58 174.45 7.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.121 -1.612 . . . . 0.0 110.978 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -121.85 105.59 10.5 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.591 -1.318 . . . . 0.0 109.154 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -143.08 -131.21 0.09 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.718 -1.239 . . . . 0.0 113.601 173.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.4 157.79 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.739 -1.851 . . . . 0.0 109.423 -159.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.5 p -139.21 168.0 20.82 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.328 -1.482 . . . . 0.0 114.429 -172.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.54 160.19 43.68 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.188 1.395 . . . . 0.0 108.812 162.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 74.1 t . . . . . 0 C--O 1.26 1.644 0 N-CA-C 106.041 -1.836 . . . . 0.0 106.041 176.71 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.68 0 N-CA-C 110.758 -0.516 . . . . 0.0 110.758 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -88.36 172.98 6.81 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 125.177 1.391 . . . . 0.0 111.624 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -66.32 -41.41 12.4 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 C-N-CA 122.306 2.004 . . . . 0.0 115.238 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.07 62.31 0.57 Allowed Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 124.134 0.874 . . . . 0.0 111.653 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -82.78 168.02 17.57 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.394 1.092 . . . . 0.0 112.495 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -78.39 135.54 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.186 1.794 . . . . 0.0 108.946 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -136.23 156.04 49.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.522 -1.361 . . . . 0.0 110.479 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -116.09 134.11 55.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 121.044 -1.035 . . . . 0.0 111.334 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.8 t -102.9 125.08 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 124.563 1.145 . . . . 0.0 109.597 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -124.72 70.89 1.14 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.524 1.53 . . . . 0.0 108.032 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tp -112.69 -160.88 0.73 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.468 -1.395 . . . . 0.0 110.38 -166.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.45 151.68 30.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.546 -1.346 . . . . 0.0 107.977 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -73.57 101.98 3.74 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.908 -1.12 . . . . 0.0 112.464 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -90.75 -71.39 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.264 1.026 . . . . 0.0 110.187 172.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -86.6 -69.2 0.69 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.488 1.515 . . . . 0.0 111.325 174.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -136.76 165.5 25.78 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 102.132 -3.284 . . . . 0.0 102.132 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 p -83.05 -51.24 7.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.458 -1.401 . . . . 0.0 112.241 -174.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 mt -102.36 -89.95 0.36 Allowed 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 121.057 -1.027 . . . . 0.0 113.457 172.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.49 53.78 1.93 Allowed Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -159.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 tt -145.79 159.13 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 121.1 -1.235 . . . . 0.0 110.782 -173.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -123.22 147.67 46.65 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.688 -1.883 . . . . 0.0 109.686 -175.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.14 147.49 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 125.691 1.596 . . . . 0.0 111.107 -167.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -137.96 126.59 23.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.437 1.113 . . . . 0.0 111.604 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.43 65.43 3.17 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 118.449 2.14 . . . . 0.0 118.449 164.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.66 75.78 0.32 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.58 -108.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 124.602 1.161 . . . . 0.0 111.044 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -72.63 -76.42 0.12 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.735 2.014 . . . . 0.0 111.633 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -144.26 121.1 11.27 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.225 -1.547 . . . . 0.0 109.315 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 p -138.87 -73.97 0.39 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.738 -1.226 . . . . 0.0 112.878 -170.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -66.13 -60.63 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 126.224 1.81 . . . . 0.0 111.564 -172.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ttm-85 -125.0 -115.83 0.29 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 62.6 2.56 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.101 1.36 . . . . 0.0 109.067 167.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.95 -139.56 14.45 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -163.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.78 155.94 28.29 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-O 121.939 0.744 . . . . 0.0 112.927 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.93 142.4 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -135.55 132.76 37.6 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.65 1.98 . . . . 0.0 110.351 -168.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.0 t -80.32 128.61 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.482 -1.386 . . . . 0.0 112.863 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -84.74 -55.1 4.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.067 1.747 . . . . 0.0 111.812 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.08 165.39 15.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.439 -0.788 . . . . 0.0 110.141 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 t -98.52 130.86 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 C-N-CA 125.64 1.576 . . . . 0.0 111.381 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mm -82.85 124.91 76.51 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 124.932 1.293 . . . . 0.0 109.65 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.36 32.22 0.52 Allowed 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 123.42 2.747 . . . . 0.0 114.326 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -142.79 52.57 1.4 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.863 1.265 . . . . 0.0 108.589 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -166.58 173.3 41.97 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 119.993 -1.692 . . . . 0.0 111.452 -176.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.71 73.04 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.461 1.504 . . . . 0.0 114.731 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.05 78.56 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 175.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -77.62 -28.93 51.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.761 1.224 . . . . 0.0 112.736 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.3 t -64.69 -56.4 13.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.578 -1.326 . . . . 0.0 113.381 173.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -79.63 -47.51 15.3 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.955 1.302 . . . . 0.0 112.005 -172.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.87 80.61 1.42 Allowed Glycine 0 N--CA 1.431 -1.644 0 O-C-N 121.035 -1.04 . . . . 0.0 111.217 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -139.87 -51.77 0.51 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.834 0.854 . . . . 0.0 112.714 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.1 mt -126.92 136.36 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 -168.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.81 -166.51 2.36 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 -175.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.13 125.16 21.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.7 15.88 81.21 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 117.307 1.683 . . . . 0.0 117.307 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -75.69 155.26 35.88 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 118.93 1.365 . . . . 0.0 111.131 167.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.87 131.32 40.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.461 -1.4 . . . . 0.0 109.562 -173.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.58 153.29 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.647 -1.908 . . . . 0.0 113.766 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.69 -84.51 0.66 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.807 1.643 . . . . 0.0 107.397 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 143.57 29.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.3 t -120.14 90.99 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.289 1.436 . . . . 0.0 108.398 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.275 4.8 t30 57.24 64.48 1.6 Allowed 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 125.896 1.679 . . . . 0.0 112.281 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.17 -61.87 1.06 Allowed Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 124.691 1.139 . . . . 0.0 113.506 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.0 m -83.86 134.05 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.984 -1.304 . . . . 0.0 113.381 -164.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.3 t -77.79 124.98 28.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.779 -1.201 . . . . 0.0 110.376 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.8 tp -85.67 47.58 1.46 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 123.811 1.767 . . . . 0.0 113.995 -163.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -70.07 134.88 48.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.137 1.775 . . . . 0.0 112.6 166.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.82 -14.45 60.27 Favored Glycine 0 N--CA 1.431 -1.681 0 O-C-N 120.979 -1.076 . . . . 0.0 114.212 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.9 138.49 41.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.91 -1.347 . . . . 0.0 114.159 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 p -93.73 173.96 7.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.983 1.713 . . . . 0.0 109.369 166.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -61.46 -38.45 87.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -169.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -72.14 -27.4 62.59 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.549 -1.344 . . . . 0.0 113.68 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -78.55 -41.16 32.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.153 -1.592 . . . . 0.0 111.086 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.05 96.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.87 -44.31 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.892 -1.755 . . . . 0.0 112.942 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -66.31 -46.51 76.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.93 1.692 . . . . 0.0 113.788 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.8 p -64.54 -33.17 75.28 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.827 1.651 . . . . 0.0 114.434 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.6 mt -92.44 -16.7 25.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -76.35 -55.04 5.92 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.241 -1.537 . . . . 0.0 111.496 168.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -91.55 65.33 5.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.871 1.32 . . . . 0.0 112.175 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.9 p -86.65 -58.56 2.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.862 2.065 . . . . 0.0 109.923 171.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.77 -128.48 7.81 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 125.426 1.489 . . . . 0.0 111.126 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -81.36 -43.86 18.43 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.903 -1.351 . . . . 0.0 112.308 -170.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 p -104.82 140.96 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 122.113 0.959 . . . . 0.0 110.999 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.6 t -119.64 100.91 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 124.496 1.118 . . . . 0.0 108.832 -168.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -117.61 115.07 24.36 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 110.953 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.42 157.12 43.27 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 121.206 -0.934 . . . . 0.0 110.926 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -120.87 144.61 48.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -139.54 159.04 43.09 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 123.889 0.876 . . . . 0.0 109.596 -173.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -107.89 125.46 51.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 167.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -74.6 146.44 42.5 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.922 -1.111 . . . . 0.0 112.144 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.29 -135.87 0.62 Allowed Glycine 0 N--CA 1.429 -1.787 0 CA-C-O 123.578 1.655 . . . . 0.0 116.825 -172.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -94.54 146.79 23.86 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.577 -1.543 . . . . 0.0 110.933 -173.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.6 m -79.94 140.98 54.35 Favored Pre-proline 0 N--CA 1.431 -1.415 0 O-C-N 120.985 -1.072 . . . . 0.0 111.108 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -66.11 -47.64 3.31 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 C-N-CA 122.543 2.162 . . . . 0.0 113.002 163.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.26 1.614 0 C-N-CA 124.45 1.1 . . . . 0.0 110.636 171.037 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.04 175.01 7.11 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.012 -1.055 . . . . 0.0 113.772 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 54.28 59.02 4.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.086 2.155 . . . . 0.0 114.232 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 19.9 t -149.16 -69.6 0.21 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.013 -1.054 . . . . 0.0 110.097 -174.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -100.0 -129.31 0.21 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.117 0.967 . . . . 0.0 110.498 -172.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.15 151.74 19.66 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.08 -1.638 . . . . 0.0 113.675 -173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -117.45 38.27 3.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.63 1.172 . . . . 0.0 111.557 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 49.63 66.95 0.98 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 172.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -141.92 71.99 1.37 Allowed 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.273 -1.517 . . . . 0.0 113.971 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -122.74 80.1 1.71 Allowed 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.403 -2.061 . . . . 0.0 111.303 173.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -139.27 -130.5 0.12 Allowed 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.194 -1.566 . . . . 0.0 114.188 -172.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.47 155.28 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.604 1.561 . . . . 0.0 109.515 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 20.4 p -140.04 149.61 43.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.143 -0.973 . . . . 0.0 112.815 -172.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.42 150.87 49.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.977 1.311 . . . . 0.0 111.879 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.259 1.597 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.524 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo . . . . . 0 CA--C 1.491 -1.671 0 N-CA-C 108.63 -1.335 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -91.8 167.57 15.04 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 117.68 -1.153 . . . . 0.0 110.227 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -65.81 -35.74 34.79 Favored 'Trans proline' 0 N--CA 1.434 -1.976 0 CA-C-N 123.151 2.161 . . . . 0.0 113.942 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.72 73.01 0.88 Allowed Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 171.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -79.67 140.38 37.06 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 121.519 -0.989 . . . . 0.0 109.117 172.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 mp -82.61 134.05 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.421 -1.424 . . . . 0.0 108.532 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -133.5 151.74 51.8 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.551 -1.343 . . . . 0.0 111.049 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -103.91 130.43 51.51 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.265 1.026 . . . . 0.0 109.296 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.4 t -103.07 117.72 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.375 -1.453 . . . . 0.0 109.823 168.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -113.0 101.38 9.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 168.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.8 tp -135.48 170.57 15.75 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.176 0.988 . . . . 0.0 109.499 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.36 161.39 41.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.492 -2.005 . . . . 0.0 108.603 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -71.47 105.43 3.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.311 1.445 . . . . 0.0 112.365 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -102.55 -62.68 1.24 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.902 1.281 . . . . 0.0 110.408 167.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -86.12 -66.04 0.95 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.104 1.361 . . . . 0.0 109.154 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -137.5 176.36 8.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.694 1.598 . . . . 0.0 107.022 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.7 t -83.15 -69.05 0.66 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.445 -1.409 . . . . 0.0 111.509 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.448 HD22 HG13 ' B' ' 15' ' ' VAL . 7.9 mp -104.04 -105.46 0.29 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.954 -1.716 . . . . 0.0 112.101 170.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.32 57.21 1.01 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.917 -1.114 . . . . 0.0 111.81 -171.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 tt -144.19 164.7 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 121.45 -1.029 . . . . 0.0 108.444 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 t -122.09 138.39 54.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.506 -1.996 . . . . 0.0 110.394 -175.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.56 154.8 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 124.654 1.182 . . . . 0.0 108.787 -166.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -137.44 94.13 2.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.757 1.742 . . . . 0.0 111.195 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.01 -152.06 41.57 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 164.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.31 79.34 1.45 Allowed Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -168.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -117.72 -104.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.419 -1.047 . . . . 0.0 113.406 -162.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -77.15 -51.54 10.82 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.708 -1.87 . . . . 0.0 109.94 -161.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -150.21 137.58 19.68 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 155.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.9 m -151.53 -86.93 0.07 Allowed 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 119.703 -1.873 . . . . 0.0 110.772 -166.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 t -73.9 -59.43 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 124.823 1.249 . . . . 0.0 109.145 -175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -144.23 -123.33 0.08 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -85.3 65.32 9.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.97 -1.706 . . . . 0.0 110.712 172.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.57 -129.33 9.68 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 -165.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.45 133.0 2.9 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 125.629 1.585 . . . . 0.0 112.152 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.3 mm -125.58 137.13 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.4 129.97 50.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.719 -1.238 . . . . 0.0 111.408 -163.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -76.22 135.85 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.562 -1.336 . . . . 0.0 112.292 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -88.2 -61.3 1.75 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.584 1.554 . . . . 0.0 111.039 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.12 162.65 34.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.56 134.3 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 122.193 0.997 . . . . 0.0 111.064 174.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 mm -84.02 134.66 43.39 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 116.652 -1.642 . . . . 0.0 107.495 171.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.11 77.02 2.87 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 125.718 3.078 . . . . 0.0 112.437 170.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -141.13 -40.94 0.39 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -168.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.2 -144.39 4.34 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.301 -1.499 . . . . 0.0 112.155 -167.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.17 -39.97 96.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.904 2.081 . . . . 0.0 114.752 -162.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.34 -50.7 72.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.959 1.704 . . . . 0.0 114.028 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.62 -37.42 50.19 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.075 1.35 . . . . 0.0 112.549 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.7 t -62.38 -47.99 81.73 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.951 -1.718 . . . . 0.0 114.186 -175.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -81.14 -47.05 14.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.828 -1.17 . . . . 0.0 110.571 171.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.88 73.06 1.2 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -139.63 -41.25 0.45 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -164.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.61 134.55 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -140.51 -160.97 1.13 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.344 0.974 . . . . 0.0 112.947 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -54.93 133.81 48.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.304 1.842 . . . . 0.0 114.343 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.37 -2.11 63.27 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 117.992 1.957 . . . . 0.0 117.992 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -75.56 151.28 37.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.055 1.928 . . . . 0.0 112.271 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -123.89 138.93 54.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.581 -1.324 . . . . 0.0 109.783 -165.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.56 155.32 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.692 -1.88 . . . . 0.0 111.948 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.7 mt -119.01 -88.27 0.62 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.23 145.23 29.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.679 1.192 . . . . 0.0 110.802 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 p -102.78 92.17 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 123.039 1.4 . . . . 0.0 110.68 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 58.35 55.52 4.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.861 -1.774 . . . . 0.0 113.163 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.12 -12.82 59.21 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 120.631 -1.293 . . . . 0.0 115.16 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.4 t -103.14 125.51 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 118.561 1.181 . . . . 0.0 109.863 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -77.38 158.96 29.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.547 -1.346 . . . . 0.0 114.562 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -117.43 36.7 4.15 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.052 1.341 . . . . 0.0 109.028 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.93 115.82 7.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.056 -1.652 . . . . 0.0 113.452 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.71 15.76 78.8 Favored Glycine 0 N--CA 1.431 -1.66 0 O-C-N 119.626 -1.921 . . . . 0.0 115.33 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.48 148.16 35.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.847 -1.384 . . . . 0.0 113.104 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.6 p -90.37 174.28 7.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.766 1.227 . . . . 0.0 108.591 163.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -61.34 -37.63 84.01 Favored 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 120.367 -1.458 . . . . 0.0 114.576 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 -40.87 90.75 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.091 -1.631 . . . . 0.0 112.602 175.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -70.14 -41.32 74.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.498 1.519 . . . . 0.0 111.627 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.11 -48.71 70.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . 0.265 35.4 m -63.14 -37.23 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -172.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -64.25 -45.06 89.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 120.516 1.507 . . . . 0.0 112.612 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.7 m -60.09 -36.28 77.05 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.829 1.651 . . . . 0.0 112.385 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.69 -36.74 31.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.325 1.85 . . . . 0.0 115.693 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -63.91 -44.04 94.15 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.156 -1.59 . . . . 0.0 113.067 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -85.0 49.61 1.77 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.595 1.188 . . . . 0.0 113.665 -166.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.7 p -98.48 -76.27 0.54 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.44 2.296 . . . . 0.0 109.563 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.02 -106.84 2.44 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 125.106 1.336 . . . . 0.0 113.179 167.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -68.19 -53.54 24.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -172.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.7 m -108.58 138.84 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.188 0.994 . . . . 0.0 110.346 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.3 t -126.01 95.46 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -135.63 92.02 2.78 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.102 -1.624 . . . . 0.0 110.699 -171.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.15 176.93 9.15 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -165.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.65 131.05 54.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.397 1.079 . . . . 0.0 109.611 -170.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -126.13 167.33 15.54 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.746 1.618 . . . . 0.0 110.397 -174.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -124.58 141.01 52.41 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.992 1.317 . . . . 0.0 107.538 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -72.77 144.83 47.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.25 156.06 48.22 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 120.668 -1.27 . . . . 0.0 114.095 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -75.75 167.74 21.32 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -167.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 78.4 p -84.25 152.85 62.09 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 124.464 1.106 . . . . 0.0 112.459 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -67.28 -53.25 0.5 Allowed 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 121.975 1.783 . . . . 0.0 116.503 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.5 p . . . . . 0 C--O 1.261 1.683 0 C-N-CA 124.162 0.985 . . . . 0.0 111.972 -166.886 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 . . . . . 0 CA--C 1.49 -1.35 0 N-CA-C 111.266 0.098 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.11 -63.45 1.44 Allowed 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.257 -0.902 . . . . 0.0 111.628 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -81.96 173.1 12.53 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 124.467 1.107 . . . . 0.0 111.634 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 68.5 p -78.54 -102.93 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -164.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 66.79 174.61 0.25 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 128.178 2.591 . . . . 0.0 114.343 -167.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.81 62.04 2.89 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -75.61 -59.07 2.91 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 123.845 0.858 . . . . 0.0 112.004 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -101.58 142.73 32.49 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.877 -1.139 . . . . 0.0 110.243 168.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -128.64 -146.63 0.33 Allowed 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.702 -1.249 . . . . 0.0 109.476 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -123.43 -85.24 0.65 Allowed 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 120.47 -1.394 . . . . 0.0 109.388 -177.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -145.63 169.6 18.12 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.596 -1.94 . . . . 0.0 109.023 169.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.57 154.68 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.048 -1.657 . . . . 0.0 108.379 171.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m -140.91 155.87 46.2 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.38 -0.825 . . . . 0.0 111.288 -172.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.3 159.44 42.06 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.84 0.829 . . . . 0.0 110.032 168.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' VAL . . . . . 0.448 HG13 HD22 ' A' ' 18' ' ' LEU . 3.5 p . . . . . 0 C--O 1.259 1.585 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 CA--C 1.49 -1.689 0 N-CA-C 106.368 -2.205 . . . . 0.0 106.368 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -78.33 159.4 75.14 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 119.457 1.026 . . . . 0.0 110.981 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -67.99 -39.42 10.98 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 122.092 1.861 . . . . 0.0 111.002 171.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.32 65.64 0.32 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 123.981 0.8 . . . . 0.0 111.937 170.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.29 177.3 8.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.058 -1.26 . . . . 0.0 113.63 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.7 mt -74.95 143.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.803 -1.81 . . . . 0.0 112.944 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -147.01 160.36 42.47 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.804 -1.185 . . . . 0.0 110.708 170.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -127.26 123.15 35.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.723 -1.236 . . . . 0.0 111.358 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -105.32 132.93 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.689 -1.257 . . . . 0.0 111.878 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -112.43 121.46 44.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 108.794 158.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.491 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 10.1 tp -132.82 -167.7 1.95 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.713 1.205 . . . . 0.0 108.418 176.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.491 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -155.59 168.94 25.51 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.12 -1.613 . . . . 0.0 109.195 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -72.01 104.74 3.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.561 1.144 . . . . 0.0 112.841 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -91.28 -85.96 0.23 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.14 -0.975 . . . . 0.0 110.869 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -86.5 -44.92 11.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.75 1.62 . . . . 0.0 110.808 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -138.24 177.9 7.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.183 2.193 . . . . 0.0 105.162 174.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.8 p -84.03 -66.34 0.9 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.503 -1.373 . . . . 0.0 112.151 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.7 mt -101.04 -79.92 0.5 Allowed 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 119.7 1.136 . . . . 0.0 111.865 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.15 47.82 2.35 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 121.1 -1.0 . . . . 0.0 112.069 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 tt -145.81 157.89 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.827 -1.396 . . . . 0.0 112.669 -170.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 t -123.56 146.31 48.22 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.413 -1.429 . . . . 0.0 109.266 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 t -122.05 149.95 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.167 1.387 . . . . 0.0 109.898 -163.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 t -137.27 108.37 6.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.585 1.659 . . . . 0.0 111.137 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.35 -117.29 5.49 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 125.103 1.335 . . . . 0.0 111.689 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.79 35.53 61.97 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 115.843 1.097 . . . . 0.0 115.843 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 m -107.61 -120.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 121.468 -1.019 . . . . 0.0 112.667 -170.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -79.65 -81.12 0.12 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.986 1.715 . . . . 0.0 113.294 -171.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.6 t -128.92 115.57 18.06 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -155.32 -85.93 0.05 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.361 -0.837 . . . . 0.0 109.917 -166.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.1 -52.41 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 120.088 -1.633 . . . . 0.0 110.961 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -133.46 -153.84 0.57 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 158.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -74.5 96.96 3.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.496 1.118 . . . . 0.0 108.405 155.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.71 -172.7 50.63 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 120.267 -1.52 . . . . 0.0 114.423 -169.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.73 147.32 22.32 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -162.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.9 mm -124.77 140.72 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -123.4 143.13 50.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -167.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -87.2 132.3 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 O-C-N 121.031 -1.043 . . . . 0.0 111.366 -173.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -85.46 -51.7 6.35 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.291 1.036 . . . . 0.0 110.873 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.62 157.74 12.63 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.8 p -91.69 137.83 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 121.491 0.662 . . . . 0.0 109.886 171.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -84.09 121.62 75.65 Favored Pre-proline 0 N--CA 1.429 -1.504 0 O-C-N 120.325 -1.485 . . . . 0.0 109.093 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -78.84 60.05 7.56 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.363 2.709 . . . . 0.0 112.383 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.33 32.94 0.28 Allowed 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 122.262 1.029 . . . . 0.0 108.401 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.63 176.94 46.16 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 119.729 -1.857 . . . . 0.0 112.619 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -37.35 -45.67 0.71 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.199 2.999 . . . . 0.0 118.54 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.1 89.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -175.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -85.53 -40.62 16.12 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.927 1.291 . . . . 0.0 111.324 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.9 m -60.32 -55.97 27.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.43 -29.38 52.88 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.558 -1.339 . . . . 0.0 110.09 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.46 76.87 1.21 Allowed Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.106 -0.996 . . . . 0.0 112.506 167.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -136.87 -53.7 0.71 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.551 -0.97 . . . . 0.0 112.5 -167.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.6 mt -127.62 125.95 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -166.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -134.56 -171.13 2.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -56.73 128.87 38.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.137 1.375 . . . . 0.0 114.141 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.26 21.79 74.86 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 117.697 1.839 . . . . 0.0 117.697 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -81.36 159.0 24.48 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 119.545 1.672 . . . . 0.0 109.629 161.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.0 ttp85 -122.22 116.51 24.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.559 -1.338 . . . . 0.0 108.705 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.54 138.11 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 121.064 -1.022 . . . . 0.0 109.917 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.5 tp -121.07 -86.47 0.65 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.143 -0.973 . . . . 0.0 109.999 -170.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.06 132.4 33.83 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.848 -1.782 . . . . 0.0 113.277 -170.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.8 p -103.61 93.76 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.552 1.644 . . . . 0.0 108.251 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.268 58.7 t30 56.19 54.15 8.14 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.384 1.874 . . . . 0.0 113.7 -173.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.26 -46.01 1.49 Allowed Glycine 0 N--CA 1.431 -1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 113.621 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.01 128.66 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 121.094 -1.239 . . . . 0.0 111.286 -170.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 t -78.3 156.81 29.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.496 -1.378 . . . . 0.0 112.345 176.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 -13.86 23.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.061 1.344 . . . . 0.0 113.952 -175.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -66.41 128.38 35.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -168.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.1 -51.34 0.71 Allowed Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -170.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.24 151.94 32.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.352 1.461 . . . . 0.0 112.416 170.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.9 p -94.38 -179.11 4.8 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.681 -1.887 . . . . 0.0 112.147 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -50.04 -37.79 34.8 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.252 3.021 . . . . 0.0 115.064 172.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -56.54 -46.85 80.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.396 1.878 . . . . 0.0 114.112 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -77.81 -34.49 52.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.003 1.321 . . . . 0.0 111.185 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.48 77.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.577 1.551 . . . . 0.0 114.378 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.97 -29.34 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.385 -1.447 . . . . 0.0 114.056 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -70.63 -38.66 73.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.591 -1.943 . . . . 0.0 112.527 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.3 m -65.78 -43.49 88.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.415 -1.428 . . . . 0.0 112.236 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 tt -79.72 -46.84 16.33 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -59.12 -35.85 74.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.967 -1.708 . . . . 0.0 114.289 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -92.07 56.01 2.76 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.812 -1.18 . . . . 0.0 110.956 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 p -109.87 -69.25 0.87 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.687 1.995 . . . . 0.0 109.771 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.37 -105.68 1.31 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 124.312 0.958 . . . . 0.0 113.634 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -81.2 -45.11 16.82 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -163.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.04 155.16 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.958 -1.089 . . . . 0.0 112.004 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -130.19 112.8 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -128.44 117.83 22.05 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.354 -1.466 . . . . 0.0 109.804 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.13 160.5 42.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.539 -1.351 . . . . 0.0 113.957 -174.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.81 128.0 52.46 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.104 1.362 . . . . 0.0 107.436 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.86 159.59 27.86 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.041 1.336 . . . . 0.0 110.584 -174.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -109.08 127.33 54.05 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 153.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -69.44 137.06 52.36 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.04 1.336 . . . . 0.0 113.874 -171.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.48 148.17 24.89 Favored Glycine 0 N--CA 1.429 -1.804 0 O-C-N 120.546 -1.346 . . . . 0.0 110.694 170.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -87.12 126.18 34.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.314 -1.698 . . . . 0.0 110.319 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 t -77.3 151.03 80.8 Favored Pre-proline 0 N--CA 1.431 -1.4 0 CA-C-O 117.665 -1.159 . . . . 0.0 113.933 -153.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -67.03 175.61 5.4 Favored 'Trans proline' 0 C--N 1.299 -2.061 0 C-N-CA 122.98 2.453 . . . . 0.0 115.663 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.26 1.615 0 C-N-CA 124.594 1.158 . . . . 0.0 109.666 177.26 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 27.7 p90 . . . . . 0 CA--C 1.491 -1.322 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.92 85.73 0.09 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 175.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -96.81 -158.0 0.63 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.355 1.462 . . . . 0.0 108.292 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 49.1 p -86.44 -78.76 0.27 Allowed 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 119.82 -1.8 . . . . 0.0 114.319 -168.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -67.79 130.57 43.41 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -168.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.14 157.41 18.3 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.405 1.482 . . . . 0.0 114.716 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -139.97 80.07 1.75 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.528 -1.357 . . . . 0.0 111.393 -167.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -113.9 -94.14 0.47 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.694 -1.253 . . . . 0.0 111.091 174.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . 0.274 58.8 m-80 68.87 61.9 0.33 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.106 2.162 . . . . 0.0 116.574 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -127.68 153.44 46.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 153.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -121.69 -161.89 0.95 Allowed 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.961 -1.712 . . . . 0.0 111.817 -166.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 17.6 m -125.94 155.9 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 125.969 1.708 . . . . 0.0 110.633 -173.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -142.06 143.49 33.13 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.716 0.769 . . . . 0.0 111.109 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.69 146.78 47.99 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.199 1.4 . . . . 0.0 112.618 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.261 1.663 0 C-N-CA 126.176 1.79 . . . . 0.0 106.422 170.073 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 CA--C 1.49 -1.678 0 N-CA-C 106.65 -2.096 . . . . 0.0 106.65 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -93.06 166.9 15.33 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 119.267 0.939 . . . . 0.0 111.526 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -70.04 -52.08 0.33 Allowed 'Trans proline' 0 C--N 1.299 -2.029 0 CA-C-N 122.477 1.92 . . . . 0.0 111.412 173.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.1 90.55 0.71 Allowed Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 168.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.66 179.22 7.85 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 mt -81.71 149.96 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.539 1.536 . . . . 0.0 111.617 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.11 139.87 21.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.478 -1.389 . . . . 0.0 112.247 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -105.96 105.86 16.1 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.665 1.586 . . . . 0.0 111.155 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.08 134.17 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 120.347 -1.471 . . . . 0.0 112.182 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -111.74 127.39 55.77 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 168.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 8.1 tp -135.73 -159.46 0.96 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.943 -1.098 . . . . 0.0 109.613 172.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -153.87 168.11 27.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.311 -1.493 . . . . 0.0 108.605 172.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -72.4 112.68 8.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.612 -1.305 . . . . 0.0 110.287 163.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -93.27 -88.56 0.22 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.92 -53.92 6.3 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.028 1.331 . . . . 0.0 109.171 165.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -135.91 172.79 12.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.856 -1.153 . . . . 0.0 108.289 -172.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -81.89 -88.53 0.08 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.065 0.946 . . . . 0.0 109.828 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.6 mt -102.71 -89.39 0.38 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.31 -1.494 . . . . 0.0 112.474 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.6 48.24 3.51 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -165.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 tt -134.26 161.04 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 121.288 -1.125 . . . . 0.0 108.364 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.4 t -121.27 142.55 49.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.365 -1.459 . . . . 0.0 107.242 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.6 t -122.74 152.56 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -160.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 t -145.54 134.34 22.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.685 -1.884 . . . . 0.0 112.832 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.11 -141.54 20.81 Favored Glycine 0 N--CA 1.43 -1.703 0 C-N-CA 126.971 2.224 . . . . 0.0 114.203 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.62 33.7 67.21 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 124.669 1.128 . . . . 0.0 115.614 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -93.32 -124.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 121.039 -1.271 . . . . 0.0 113.549 -170.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -71.59 -57.72 4.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.748 -1.845 . . . . 0.0 111.274 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.4 t -140.51 154.19 46.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 148.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.4 t -155.84 -103.71 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -164.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.413 HG13 ' H ' ' A' ' 31' ' ' ARG . 3.0 p -62.08 -58.43 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.066 1.747 . . . . 0.0 110.074 161.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.413 ' H ' HG13 ' A' ' 30' ' ' VAL . 91.3 mtt180 -143.29 -163.28 1.61 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 161.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -78.89 44.13 0.54 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.257 1.823 . . . . 0.0 112.822 173.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.48 151.59 5.53 Favored Glycine 0 N--CA 1.43 -1.743 0 O-C-N 120.195 -1.566 . . . . 0.0 110.661 -169.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.81 143.39 11.88 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -168.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.38 162.54 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -172.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.93 151.34 43.68 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.296 -1.503 . . . . 0.0 107.791 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -82.81 134.83 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 120.72 -1.237 . . . . 0.0 110.964 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -85.24 -59.91 2.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.63 1.172 . . . . 0.0 110.583 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.79 168.82 12.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.049 0.94 . . . . 0.0 108.491 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -95.22 136.26 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 122.694 1.235 . . . . 0.0 111.79 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.3 mm -82.73 132.22 52.33 Favored Pre-proline 0 N--CA 1.429 -1.5 0 O-C-N 120.38 -1.45 . . . . 0.0 107.187 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -80.5 35.57 0.58 Allowed 'Trans proline' 0 N--CA 1.434 -2.014 0 C-N-CA 123.242 2.628 . . . . 0.0 113.039 -172.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 62.5 0.9 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.629 1.572 . . . . 0.0 107.438 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.52 161.3 31.07 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.629 -1.294 . . . . 0.0 112.129 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.54 -38.12 19.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.871 2.068 . . . . 0.0 116.298 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.5 -41.82 77.32 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.5 -52.52 10.48 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 125.884 1.674 . . . . 0.0 111.476 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.0 m -56.2 -53.24 59.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -81.62 -36.42 28.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.272 1.029 . . . . 0.0 110.17 -177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.27 79.43 1.32 Allowed Glycine 0 N--CA 1.429 -1.768 0 O-C-N 120.837 -1.164 . . . . 0.0 112.006 169.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -136.18 -43.72 0.63 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -157.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.4 mt -128.86 142.42 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -131.15 178.24 6.85 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 123.321 1.534 . . . . 0.0 111.937 -170.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -56.39 123.12 13.59 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.71 20.06 76.95 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 118.45 2.14 . . . . 0.0 118.45 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -71.96 156.92 38.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 120.24 2.02 . . . . 0.0 111.552 166.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -122.66 114.07 20.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.612 -1.305 . . . . 0.0 108.977 -173.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 m -100.16 156.98 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 120.164 -1.585 . . . . 0.0 111.564 -174.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.9 tp -131.88 -81.48 0.51 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.017 -1.052 . . . . 0.0 111.279 173.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.85 128.23 45.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.704 -1.248 . . . . 0.0 113.649 -160.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.49 112.78 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 122.628 1.204 . . . . 0.0 109.131 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.27 35.8 t30 56.96 31.97 20.78 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 126.844 2.058 . . . . 0.0 114.018 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.4 -12.32 58.38 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.447 -1.408 . . . . 0.0 115.002 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.3 t -96.25 116.35 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 118.692 1.246 . . . . 0.0 111.824 -173.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -76.14 131.32 39.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.206 -1.559 . . . . 0.0 112.012 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -13.34 47.44 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.353 1.461 . . . . 0.0 113.49 -173.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -51.33 129.13 24.21 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.49 1.516 . . . . 0.0 115.088 -167.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.55 -35.19 5.11 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 124.13 0.872 . . . . 0.0 112.321 -160.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.81 155.26 33.19 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.481 -1.599 . . . . 0.0 112.113 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.0 p -93.28 159.99 15.03 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.978 0.894 . . . . 0.0 109.92 167.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.418 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 46.1 t60 -41.01 -44.93 2.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.665 2.786 . . . . 0.0 117.027 173.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -60.75 -37.65 82.52 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.781 -1.2 . . . . 0.0 114.212 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -78.45 -41.06 33.87 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.755 1.222 . . . . 0.0 112.002 174.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.33 -38.09 82.66 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.524 -1.36 . . . . 0.0 114.266 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 p -71.06 -33.8 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 O-C-N 120.293 -1.505 . . . . 0.0 112.98 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.61 -46.11 91.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.312 -1.492 . . . . 0.0 112.743 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.3 m -56.15 -48.34 76.47 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.612 1.565 . . . . 0.0 112.457 173.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.09 -36.37 40.87 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -172.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -59.61 -37.01 77.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.196 -1.565 . . . . 0.0 113.905 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -95.42 60.71 2.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.735 -1.228 . . . . 0.0 112.8 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -99.49 -73.3 0.63 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.512 2.325 . . . . 0.0 111.339 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.17 -116.63 3.77 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.295 1.426 . . . . 0.0 112.63 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -78.62 -36.26 44.34 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 121.473 -1.016 . . . . 0.0 113.633 -168.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.3 m -104.54 162.31 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.73 -1.231 . . . . 0.0 112.241 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.6 t -138.1 130.89 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 124.81 1.244 . . . . 0.0 108.708 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -141.2 127.97 20.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.652 -1.28 . . . . 0.0 108.072 161.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -149.27 159.06 44.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.276 -1.515 . . . . 0.0 113.082 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.5 mp -120.53 120.41 35.78 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.21 161.85 24.88 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.68 1.192 . . . . 0.0 110.227 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.65 135.47 54.12 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.36 1.464 . . . . 0.0 107.204 162.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -74.98 133.98 41.58 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.378 1.085 . . . . 0.0 112.874 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.47 -176.42 51.37 Favored Glycine 0 N--CA 1.43 -1.753 0 CA-C-O 123.297 1.498 . . . . 0.0 115.056 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -76.91 142.98 39.88 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.167 -1.196 . . . . 0.0 113.775 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.0 t -86.33 117.67 69.07 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 120.571 -1.33 . . . . 0.0 111.085 177.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.46 162.01 28.03 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 122.647 2.231 . . . . 0.0 113.642 -168.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.26 1.617 0 C-N-CA 124.378 1.071 . . . . 0.0 112.166 176.276 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 30.6 p90 . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.63 83.54 0.11 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.763 2.025 . . . . 0.0 116.206 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -83.7 170.13 14.56 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.646 -1.909 . . . . 0.0 110.593 170.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 15.9 p -88.97 -57.2 2.99 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.639 -1.288 . . . . 0.0 113.684 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -86.09 152.01 23.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -165.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.05 151.2 34.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.36 1.464 . . . . 0.0 110.877 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -160.42 87.34 0.76 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.846 -1.158 . . . . 0.0 112.278 -173.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -115.69 -50.58 2.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.055 1.342 . . . . 0.0 110.96 173.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 67.99 52.39 0.7 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 169.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -122.93 168.41 12.34 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 125.388 1.475 . . . . 0.0 107.799 167.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -121.49 171.96 8.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.78 -1.2 . . . . 0.0 112.02 -164.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -122.87 158.19 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 124.757 1.223 . . . . 0.0 110.544 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.418 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 58.8 m -138.11 149.64 46.12 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.662 -1.274 . . . . 0.0 113.777 -173.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -124.0 150.48 44.81 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 125.121 1.368 . . . . 0.0 111.503 169.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.261 1.666 0 C-N-CA 127.621 2.368 . . . . 0.0 106.702 160.811 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.49 -1.704 0 N-CA-C 109.9 -0.846 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -104.66 151.08 39.22 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 160.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -64.79 -35.35 45.88 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 C-N-CA 122.71 2.273 . . . . 0.0 112.001 169.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.46 72.11 0.28 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 124.76 1.171 . . . . 0.0 111.956 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.32 146.5 30.34 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.17 -1.194 . . . . 0.0 111.194 167.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 mp -89.97 144.53 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.04 2.136 . . . . 0.0 111.252 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -145.75 165.59 28.37 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.306 -1.496 . . . . 0.0 112.184 171.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -113.93 134.95 54.5 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 122.372 1.082 . . . . 0.0 112.241 -177.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.39 111.82 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.482 -1.386 . . . . 0.0 108.964 168.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -112.26 102.37 10.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 170.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tp -134.8 176.67 8.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.674 1.226 . . . . 0.0 111.463 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.01 158.71 42.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 168.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -70.44 152.64 43.83 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -121.17 -83.88 0.66 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.507 -1.371 . . . . 0.0 108.789 166.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -76.99 -51.46 11.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.704 -1.248 . . . . 0.0 109.196 172.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -138.2 177.64 7.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.0 m -82.47 -58.76 2.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.82 0.848 . . . . 0.0 111.32 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.6 mt -102.3 -90.64 0.35 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.142 1.337 . . . . 0.0 112.458 172.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.43 50.58 0.8 Allowed Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -165.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tt -137.62 165.01 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.941 -1.329 . . . . 0.0 110.688 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 t -122.95 136.64 54.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.891 1.677 . . . . 0.0 107.702 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.8 t -123.69 144.04 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 124.675 1.19 . . . . 0.0 110.03 -161.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -138.87 131.17 28.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.032 1.396 . . . . 0.0 112.914 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.43 -162.64 25.83 Favored Glycine 0 N--CA 1.429 -1.777 0 C-N-CA 126.87 2.176 . . . . 0.0 114.236 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.12 42.12 2.47 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.7 -0.882 . . . . 0.0 113.791 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -106.08 -107.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.287 1.042 . . . . 0.0 110.044 -172.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -91.28 -59.78 2.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.099 2.159 . . . . 0.0 110.054 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 t -133.24 138.95 46.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 163.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -145.23 -79.65 0.18 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.941 -1.099 . . . . 0.0 108.828 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -91.8 -51.73 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 O-C-N 120.531 -1.356 . . . . 0.0 108.238 171.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.2 mmt85 -119.44 -142.2 0.35 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.56 65.15 1.26 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.392 -1.442 . . . . 0.0 111.715 170.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.37 -137.52 13.63 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 -166.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.2 147.3 9.1 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-O 122.206 0.892 . . . . 0.0 112.978 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.6 mm -122.21 130.74 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 -159.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.08 149.28 49.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 123.831 0.852 . . . . 0.0 110.296 -169.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.4 t -79.69 124.68 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 120.833 -1.167 . . . . 0.0 111.22 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -80.58 -63.25 1.45 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.687 -1.258 . . . . 0.0 109.973 173.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.5 161.41 35.36 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.427 -0.796 . . . . 0.0 109.341 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.29 137.15 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-O 122.497 1.142 . . . . 0.0 110.663 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -85.43 123.63 72.65 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 119.945 -1.722 . . . . 0.0 108.598 173.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.64 32.26 0.51 Allowed 'Trans proline' 0 N--CA 1.434 -1.995 0 CA-C-N 125.291 2.925 . . . . 0.0 114.373 -173.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.61 61.74 1.38 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 123.158 1.456 . . . . 0.0 107.741 -175.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.85 170.52 43.66 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 120.413 -1.43 . . . . 0.0 109.852 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.74 -38.66 22.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.335 2.254 . . . . 0.0 115.541 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.7 -47.45 67.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.13 1.772 . . . . 0.0 115.1 174.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -87.36 -34.85 18.67 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.895 -1.128 . . . . 0.0 111.774 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.6 m -54.22 -54.7 36.4 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.491 1.516 . . . . 0.0 113.858 174.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.26 -53.85 6.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.276 -0.89 . . . . 0.0 110.809 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.05 100.93 2.63 Favored Glycine 0 N--CA 1.429 -1.807 0 O-C-N 121.188 -0.945 . . . . 0.0 110.982 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.94 -43.5 0.43 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -163.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -128.76 174.43 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.534 -1.354 . . . . 0.0 108.301 -168.66 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.441 ' H ' HG22 ' A' ' 52' ' ' ILE . 31.1 m-70 -131.61 162.24 30.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.132 -1.605 . . . . 0.0 110.538 169.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -56.99 136.72 56.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 167.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.17 20.78 78.93 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 116.884 1.513 . . . . 0.0 116.884 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -83.47 172.43 12.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.977 1.311 . . . . 0.0 112.265 167.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -124.6 133.12 53.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 121.054 -1.029 . . . . 0.0 111.828 176.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.1 m -79.76 158.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 119.783 -1.823 . . . . 0.0 110.857 167.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tt -121.61 -80.46 0.62 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.549 -1.344 . . . . 0.0 109.414 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.32 150.59 22.84 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.664 -1.273 . . . . 0.0 113.57 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.9 p -111.92 103.33 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 C-N-CA 126.279 1.831 . . . . 0.0 108.409 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.505 13.8 p30 56.52 38.73 29.87 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.859 2.064 . . . . 0.0 116.298 -177.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.98 -24.58 30.15 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 125.641 1.591 . . . . 0.0 113.455 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.98 134.69 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 124.918 1.287 . . . . 0.0 110.868 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 p -77.2 159.82 29.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.537 -1.977 . . . . 0.0 113.095 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -93.89 -14.84 25.61 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -54.24 129.55 35.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -167.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.31 -27.23 7.42 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 124.143 0.878 . . . . 0.0 111.163 -175.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.17 144.4 38.39 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.3 p -90.65 -179.41 5.54 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.161 -0.962 . . . . 0.0 108.819 155.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -60.38 -44.6 95.48 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -169.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -59.22 -34.56 72.32 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.542 -1.348 . . . . 0.0 114.585 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -43.31 67.16 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.235 -1.541 . . . . 0.0 111.049 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.32 -43.43 97.81 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 120.419 -1.426 . . . . 0.0 114.576 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 m -67.58 -41.52 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 120.461 -1.399 . . . . 0.0 114.352 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -68.08 -28.72 67.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.505 -1.372 . . . . 0.0 112.904 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.9 m -57.48 -50.78 71.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.305 1.442 . . . . 0.0 112.677 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.54 -33.98 35.85 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.565 -1.334 . . . . 0.0 112.799 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -61.2 -32.01 71.77 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.758 -1.839 . . . . 0.0 114.487 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -85.7 51.92 2.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.35 -1.468 . . . . 0.0 112.839 170.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.1 p -110.93 -74.14 0.66 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.466 1.507 . . . . 0.0 110.631 166.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.66 -82.99 0.35 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.857 -1.152 . . . . 0.0 113.219 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -82.1 -51.3 8.13 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -174.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.37 137.97 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 120.94 -1.1 . . . . 0.0 111.023 -166.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.95 90.03 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.5 -1.375 . . . . 0.0 110.676 -172.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -119.76 120.79 37.56 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.566 -1.959 . . . . 0.0 111.452 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -150.22 165.89 31.57 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 112.241 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.8 mt -121.64 137.84 54.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.03 1.332 . . . . 0.0 107.715 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mp -135.76 158.2 44.98 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.593 0.757 . . . . 0.0 110.334 -171.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -119.6 148.29 43.51 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -70.71 127.48 32.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.621 -1.3 . . . . 0.0 112.125 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.23 -162.08 35.24 Favored Glycine 0 N--CA 1.429 -1.799 0 O-C-N 120.587 -1.32 . . . . 0.0 113.724 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -87.71 138.83 31.12 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.806 -1.408 . . . . 0.0 111.45 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.5 t -86.15 -62.49 0.24 Allowed Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 116.016 -1.945 . . . . 0.0 114.11 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -85.91 50.0 2.44 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 CA-C-N 125.892 3.14 . . . . 0.0 113.897 -166.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.26 1.633 0 O-C-N 120.239 -1.538 . . . . 0.0 111.617 178.407 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 . . . . . 0 CA--C 1.491 -1.296 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.67 -71.27 0.53 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.597 -1.315 . . . . 0.0 110.887 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -82.65 140.77 32.97 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 122.845 1.307 . . . . 0.0 112.702 -175.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 70.5 m -100.34 -32.64 10.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.195 -0.941 . . . . 0.0 113.42 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.25 97.74 10.94 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.847 1.259 . . . . 0.0 111.116 -166.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.83 -76.36 0.13 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.07 -1.019 . . . . 0.0 111.798 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -85.74 -34.31 21.24 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 -169.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -78.44 64.95 3.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 -160.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -84.64 149.78 25.61 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.759 -1.838 . . . . 0.0 109.691 171.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -124.92 84.9 2.34 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.593 -1.317 . . . . 0.0 113.28 -154.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -123.58 -147.07 0.37 Allowed 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.779 -1.826 . . . . 0.0 112.67 -172.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.09 148.55 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 127.121 2.168 . . . . 0.0 107.279 -171.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.1 p -134.37 171.26 14.52 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.702 -1.249 . . . . 0.0 113.209 -168.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.7 155.06 41.35 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 120.976 -1.077 . . . . 0.0 111.355 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.26 1.611 0 C-N-CA 125.542 1.537 . . . . 0.0 108.951 -177.151 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.491 -1.651 0 N-CA-C 109.666 -0.936 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -91.6 171.94 7.23 Favored Pre-proline 0 N--CA 1.43 -1.449 0 C-N-CA 124.772 1.229 . . . . 0.0 110.631 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -64.3 -44.58 11.53 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 122.627 2.218 . . . . 0.0 112.892 168.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.45 49.95 2.1 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 124.015 0.817 . . . . 0.0 113.412 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.11 -177.16 6.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.243 1.497 . . . . 0.0 113.66 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 mt -85.21 136.43 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 125.217 1.407 . . . . 0.0 110.806 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -133.07 145.08 50.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.499 1.142 . . . . 0.0 111.26 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -112.52 123.59 50.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.178 -0.951 . . . . 0.0 109.515 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.5 m -102.92 149.68 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 122.687 1.232 . . . . 0.0 111.802 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -139.58 87.16 2.16 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -134.07 176.65 8.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.808 -1.183 . . . . 0.0 110.508 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.49 172.82 12.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 124.901 1.28 . . . . 0.0 109.125 170.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -68.55 134.22 49.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.953 1.701 . . . . 0.0 113.484 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -122.08 -102.75 0.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.606 -1.309 . . . . 0.0 109.664 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.99 -33.3 65.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.025 -1.672 . . . . 0.0 111.502 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -149.25 -176.55 5.41 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.3 t -82.35 -67.99 0.74 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.836 1.254 . . . . 0.0 108.829 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.89 -81.74 0.48 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.685 -1.259 . . . . 0.0 110.807 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.02 52.86 1.14 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -167.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 tt -139.12 162.34 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 121.679 -0.895 . . . . 0.0 110.218 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.1 t -122.59 141.93 51.17 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 171.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.56 145.77 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 125.917 1.687 . . . . 0.0 108.114 -167.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 t -136.72 114.56 11.29 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.965 1.365 . . . . 0.0 110.075 -172.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.62 178.91 26.79 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-O 122.942 1.301 . . . . 0.0 116.222 169.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.54 64.66 0.35 Allowed Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 122.265 0.925 . . . . 0.0 112.132 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.51 -64.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 124.389 1.076 . . . . 0.0 111.579 -173.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -110.5 -96.54 0.41 Allowed 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.029 -1.044 . . . . 0.0 112.818 -166.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.6 p -130.0 90.96 3.04 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.71 -1.869 . . . . 0.0 108.096 -175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.6 p -134.4 -89.84 0.36 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.355 -0.841 . . . . 0.0 109.551 -175.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.8 -58.37 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.63 1.972 . . . . 0.0 110.89 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -127.57 -153.27 0.56 Allowed 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 165.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.53 88.56 7.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.476 -1.39 . . . . 0.0 109.55 163.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.89 -158.84 35.48 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -158.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.96 140.35 11.26 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.974 -1.309 . . . . 0.0 112.301 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.2 mm -124.21 136.4 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 121.016 -1.285 . . . . 0.0 108.927 -156.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.19 141.13 52.28 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.91 -1.119 . . . . 0.0 111.29 -170.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.57 134.96 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 120.687 -1.258 . . . . 0.0 112.046 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -84.28 -57.81 3.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.084 1.354 . . . . 0.0 110.441 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.63 165.23 18.91 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 124.069 0.947 . . . . 0.0 109.568 174.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.48 123.85 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 124.847 1.259 . . . . 0.0 110.59 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mm -83.18 130.38 57.23 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 120.824 -1.172 . . . . 0.0 110.215 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.15 80.65 1.84 Allowed 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 123.147 2.565 . . . . 0.0 112.434 172.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -141.55 -39.32 0.39 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.719 1.207 . . . . 0.0 112.071 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.88 -146.78 4.44 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.456 -1.402 . . . . 0.0 114.988 -173.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.5 -41.57 63.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.169 2.588 . . . . 0.0 116.95 -166.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.25 -47.7 80.72 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -72.56 -54.62 8.67 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.639 1.576 . . . . 0.0 112.176 173.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.0 t -60.28 -55.96 27.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.229 1.412 . . . . 0.0 114.312 -171.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.76 -39.19 70.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.092 0.957 . . . . 0.0 110.525 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.43 77.59 1.38 Allowed Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -137.03 -51.45 0.66 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -153.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.91 133.75 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -120.26 174.22 6.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 122.65 1.214 . . . . 0.0 114.123 -168.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -57.54 114.21 2.14 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.811 1.645 . . . . 0.0 114.573 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.1 26.03 65.13 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 120.555 -1.341 . . . . 0.0 115.529 -177.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -80.88 159.58 24.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 119.039 1.42 . . . . 0.0 110.779 168.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -124.12 128.92 50.0 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.034 -1.041 . . . . 0.0 109.904 -173.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.45 166.17 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 120.129 -1.607 . . . . 0.0 110.877 176.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.9 mt -131.76 -82.01 0.51 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.594 -1.316 . . . . 0.0 110.333 169.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 144.19 28.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.761 -1.212 . . . . 0.0 112.036 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.78 104.07 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 122.866 1.317 . . . . 0.0 110.781 174.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 57.4 50.56 11.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.16 2.184 . . . . 0.0 113.18 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.33 -24.91 8.67 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.066 -1.021 . . . . 0.0 114.459 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.2 t -85.6 101.29 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 120.441 -1.623 . . . . 0.0 110.969 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 p -79.2 125.93 30.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.684 1.194 . . . . 0.0 110.017 163.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.445 HD13 ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -108.2 55.96 0.63 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.586 1.66 . . . . 0.0 110.891 -173.674 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -66.89 133.99 51.15 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -170.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.91 3.14 89.24 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.856 -1.153 . . . . 0.0 115.584 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.74 155.77 35.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.899 -1.354 . . . . 0.0 113.661 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.7 p -87.11 174.97 8.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.766 -1.208 . . . . 0.0 111.086 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -60.47 -46.45 90.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.357 -1.464 . . . . 0.0 114.277 -166.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -69.15 -36.16 77.12 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -71.14 -33.92 70.52 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.102 -1.624 . . . . 0.0 112.368 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.57 -53.04 57.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.965 -1.085 . . . . 0.0 113.567 169.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.7 m -75.02 -20.0 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.64 -1.912 . . . . 0.0 114.616 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -66.39 -42.45 87.89 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.89 -1.756 . . . . 0.0 110.94 167.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.4 m -63.92 -29.92 71.05 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.301 1.841 . . . . 0.0 113.021 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt -78.19 -37.28 46.04 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.647 -1.283 . . . . 0.0 112.188 174.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -69.11 -37.98 78.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.188 -1.57 . . . . 0.0 114.699 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.322 0.4 OUTLIER -79.33 55.7 1.95 Allowed 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 119.973 -1.705 . . . . 0.0 113.743 172.568 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -103.73 -76.63 0.59 Allowed 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.118 2.567 . . . . 0.0 107.632 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.94 -112.76 2.69 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 125.535 1.541 . . . . 0.0 112.958 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -81.62 -31.49 32.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.169 -1.195 . . . . 0.0 113.775 -172.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.8 p -105.14 138.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.449 1.1 . . . . 0.0 110.622 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.44 80.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 125.072 1.349 . . . . 0.0 108.52 -172.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -118.79 109.56 16.2 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.455 -1.403 . . . . 0.0 109.971 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -149.08 169.96 19.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.016 -1.678 . . . . 0.0 113.25 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.8 tp -122.78 121.55 36.56 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.654 1.581 . . . . 0.0 109.423 -170.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -131.78 169.96 15.49 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.835 0.826 . . . . 0.0 112.739 -166.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -130.25 135.72 48.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.663 1.985 . . . . 0.0 109.969 166.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 135.32 40.52 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.19 1.396 . . . . 0.0 110.327 173.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.56 -134.34 2.05 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 123.48 1.6 . . . . 0.0 117.07 -170.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -75.13 153.74 38.1 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.641 -1.506 . . . . 0.0 113.406 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 72.2 m -71.27 161.92 75.58 Favored Pre-proline 0 N--CA 1.43 -1.47 0 O-C-N 120.885 -1.134 . . . . 0.0 112.92 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -68.58 138.47 41.91 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 123.325 2.223 . . . . 0.0 116.105 -165.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.8 p . . . . . 0 C--O 1.26 1.645 0 C-N-CA 124.867 1.267 . . . . 0.0 109.61 174.317 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 77.71 173.07 0.2 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.778 2.031 . . . . 0.0 113.214 -177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -129.46 -72.89 0.58 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.011 0.924 . . . . 0.0 109.68 -174.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 8.5 t -138.19 -119.24 0.14 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.218 -1.551 . . . . 0.0 111.238 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.23 -64.13 1.26 Allowed 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.437 -1.414 . . . . 0.0 112.026 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . 47.39 50.79 14.28 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.625 2.37 . . . . 0.0 115.861 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -92.83 130.91 38.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.712 -1.242 . . . . 0.0 111.666 -170.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -120.38 -155.09 0.61 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 121.242 -0.911 . . . . 0.0 112.376 -169.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -93.85 129.61 40.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.421 -1.425 . . . . 0.0 110.87 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -134.06 122.38 22.87 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.243 -1.536 . . . . 0.0 109.465 -175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -122.38 -134.22 0.29 Allowed 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.896 -1.128 . . . . 0.0 112.668 -172.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.97 158.04 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 102.719 -3.067 . . . . 0.0 102.719 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 31.0 m -139.42 157.23 46.21 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 121.114 1.779 . . . . 0.0 113.171 -167.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -152.11 146.97 25.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.877 -1.14 . . . . 0.0 110.553 174.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--O 1.26 1.606 0 C-N-CA 125.774 1.63 . . . . 0.0 107.48 -179.83 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 CA--C 1.491 -1.631 0 N-CA-C 108.059 -1.554 . . . . 0.0 108.059 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -98.05 159.12 31.57 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.075 173.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.18 -38.83 8.47 Favored 'Trans proline' 0 N--CA 1.432 -2.089 0 C-N-CA 122.471 2.114 . . . . 0.0 111.717 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.31 75.72 0.26 Allowed Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 165.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -82.81 -176.12 6.14 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 123.208 1.48 . . . . 0.0 113.39 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.4 mt -78.96 143.92 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 127.195 2.198 . . . . 0.0 111.301 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.76 156.37 41.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.726 0.81 . . . . 0.0 109.657 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.83 116.92 20.19 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.168 0.985 . . . . 0.0 111.077 -175.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.18 131.4 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.791 1.236 . . . . 0.0 112.509 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -111.44 117.9 34.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.527 1.531 . . . . 0.0 109.665 171.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.9 tp -134.84 167.01 21.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.378 1.471 . . . . 0.0 109.031 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.72 154.75 49.88 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 119.811 -1.806 . . . . 0.0 110.941 170.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -56.98 129.64 42.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.837 2.055 . . . . 0.0 114.735 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -121.56 -97.65 0.45 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.362 1.465 . . . . 0.0 110.39 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.67 -58.23 6.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.159 1.784 . . . . 0.0 109.252 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -137.11 -179.64 5.83 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 p -84.39 -80.51 0.2 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.105 0.962 . . . . 0.0 111.635 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.4 mt -103.19 -90.55 0.37 Allowed 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.455 -1.403 . . . . 0.0 113.297 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.95 56.36 1.97 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.717 -1.239 . . . . 0.0 112.572 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.7 tt -139.56 171.69 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 t -123.41 148.73 45.82 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.158 -2.214 . . . . 0.0 109.723 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.69 157.07 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.452 1.501 . . . . 0.0 108.975 -168.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.4 t -138.37 152.8 48.76 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.913 -1.742 . . . . 0.0 109.189 170.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.48 -137.99 37.89 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 126.909 2.195 . . . . 0.0 116.205 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.66 14.44 82.08 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 124.582 1.087 . . . . 0.0 115.19 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.49 -126.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.962 -1.317 . . . . 0.0 113.698 -170.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -71.61 -58.74 3.22 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.421 -2.049 . . . . 0.0 111.305 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.0 t -130.38 143.72 50.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 163.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -155.04 -111.65 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -170.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.34 -47.47 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 124.994 1.318 . . . . 0.0 111.596 171.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -141.72 -147.93 0.23 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.528 1.931 . . . . 0.0 106.616 158.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -76.57 52.6 0.81 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.614 2.766 . . . . 0.0 112.101 172.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.86 177.32 20.12 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 -165.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' H ' HD21 ' A' ' 66' ' ' LEU . . . 100.31 138.79 10.44 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -165.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.1 mm -127.01 140.74 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -166.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.64 141.55 52.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.623 -1.298 . . . . 0.0 109.514 -169.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.31 125.86 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.982 -1.074 . . . . 0.0 112.115 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -82.67 -59.16 2.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.454 1.502 . . . . 0.0 110.6 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.14 172.24 6.47 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 123.77 0.828 . . . . 0.0 109.779 175.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.78 139.71 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 124.779 1.232 . . . . 0.0 112.306 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -85.44 120.74 73.42 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-O 116.549 -1.691 . . . . 0.0 108.109 165.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.69 34.12 0.52 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 125.869 3.132 . . . . 0.0 113.472 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.35 68.77 1.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.64 169.87 42.97 Favored Glycine 0 N--CA 1.432 -1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 111.227 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.66 -29.86 68.43 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 124.982 1.313 . . . . 0.0 114.365 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.41 -52.74 64.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -60.43 -46.43 90.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.031 1.332 . . . . 0.0 113.253 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.9 m -60.5 -54.71 42.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.66 1.584 . . . . 0.0 115.057 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.21 -37.84 57.25 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.787 -1.196 . . . . 0.0 112.223 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.55 88.33 1.09 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 125.517 1.532 . . . . 0.0 111.719 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -138.4 -58.39 0.64 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.453 -1.027 . . . . 0.0 113.665 -158.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.4 mt -127.98 130.97 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -118.17 171.67 7.95 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.618 1.199 . . . . 0.0 111.257 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -60.11 120.64 10.12 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -175.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.32 25.27 63.94 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -75.66 154.19 36.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.499 -1.589 . . . . 0.0 110.023 160.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -124.63 110.56 14.57 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.614 -1.304 . . . . 0.0 109.284 -170.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.4 m -102.24 152.62 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.645 -1.284 . . . . 0.0 111.776 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.5 tp -124.83 -77.58 0.59 Allowed 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 121.332 -0.855 . . . . 0.0 110.964 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.82 133.99 36.63 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 120.697 -1.252 . . . . 0.0 112.766 -166.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 p -101.7 90.36 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.762 1.625 . . . . 0.0 107.807 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.8 t30 56.64 61.57 2.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.162 1.785 . . . . 0.0 112.949 -170.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.18 -43.96 2.95 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 120.294 -1.503 . . . . 0.0 114.042 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.1 t -88.27 125.14 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 121.119 -1.224 . . . . 0.0 112.577 -170.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.6 t -75.17 149.75 38.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.28 -1.512 . . . . 0.0 111.715 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.421 HD21 ' H ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -94.72 -8.23 38.29 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 120.596 -1.315 . . . . 0.0 112.924 178.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.23 126.35 27.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -168.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.6 -46.42 1.16 Allowed Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.713 -1.242 . . . . 0.0 111.721 -162.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.46 165.67 24.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.785 1.234 . . . . 0.0 114.106 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.8 p -93.29 167.69 11.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.092 1.425 . . . . 0.0 111.175 172.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -42.38 -50.83 5.06 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 129.639 3.175 . . . . 0.0 116.794 170.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -70.06 -28.85 65.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.91 1.284 . . . . 0.0 113.591 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -74.07 -46.7 41.42 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.131 -1.606 . . . . 0.0 111.286 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.34 77.87 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.695 1.598 . . . . 0.0 115.164 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.3 p -71.37 -30.21 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.694 -1.879 . . . . 0.0 112.346 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -63.72 -47.66 80.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.091 -1.63 . . . . 0.0 113.118 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.4 m -55.68 -40.06 71.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.797 1.639 . . . . 0.0 113.306 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 tt -80.96 -33.09 34.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -175.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -71.68 -31.81 67.18 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.031 -1.668 . . . . 0.0 113.392 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -89.17 63.52 6.62 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.661 -1.274 . . . . 0.0 111.966 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 p -108.4 -81.27 0.57 Allowed 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.16 1.784 . . . . 0.0 110.388 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.86 -93.44 0.63 Allowed Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 125.865 1.698 . . . . 0.0 112.79 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -81.37 -57.37 3.52 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -168.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.2 m -104.94 144.45 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 123.251 1.501 . . . . 0.0 112.581 -169.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.04 94.25 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -119.32 121.69 40.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.613 -1.305 . . . . 0.0 108.501 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.51 163.97 35.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.633 -1.292 . . . . 0.0 112.941 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 mp -121.14 121.57 38.14 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.96 168.29 11.65 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.996 1.318 . . . . 0.0 109.757 -173.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -123.58 130.97 53.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.335 1.454 . . . . 0.0 107.302 161.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.8 139.27 53.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 125.07 1.348 . . . . 0.0 113.184 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.58 -155.82 10.44 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 116.839 1.495 . . . . 0.0 116.839 -175.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -96.5 156.81 16.18 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.508 1.523 . . . . 0.0 111.107 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.7 t -81.11 123.83 81.52 Favored Pre-proline 0 N--CA 1.43 -1.475 0 CA-C-O 117.765 -1.112 . . . . 0.0 111.926 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.99 127.44 10.69 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 123.28 2.654 . . . . 0.0 113.921 -170.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 t . . . . . 0 C--O 1.259 1.598 0 CA-C-O 118.351 -0.833 . . . . 0.0 112.781 177.28 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . 0.268 18.7 p90 . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 72.07 42.07 0.61 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.172 1.789 . . . . 0.0 114.207 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -89.29 138.52 31.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.041 1.336 . . . . 0.0 110.05 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 76.0 p -76.42 -51.13 12.43 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.964 -1.71 . . . . 0.0 114.632 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -77.03 146.8 37.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -170.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.52 154.84 34.74 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.726 1.61 . . . . 0.0 107.953 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -154.57 78.32 1.07 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.978 -1.077 . . . . 0.0 110.946 -166.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -103.15 -54.46 2.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.271 -1.518 . . . . 0.0 111.454 -176.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 67.41 69.6 0.37 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.051 2.14 . . . . 0.0 115.777 177.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -126.47 173.73 9.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.802 -1.186 . . . . 0.0 108.835 160.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -122.53 168.31 12.3 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.705 -1.872 . . . . 0.0 112.698 -163.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.36 152.39 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 126.039 1.736 . . . . 0.0 110.94 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 36.2 m -134.71 169.23 17.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.508 1.923 . . . . 0.0 112.561 -174.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.11 152.08 30.03 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 124.789 1.236 . . . . 0.0 110.989 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.998 2.119 . . . . 0.0 108.102 162.817 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo . . . . . 0 CA--C 1.489 -1.749 0 N-CA-C 106.622 -2.107 . . . . 0.0 106.622 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -86.09 171.33 10.62 Favored Pre-proline 0 N--CA 1.431 -1.423 0 CA-C-N 119.724 1.147 . . . . 0.0 112.052 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -63.66 -41.35 25.3 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 122.537 2.158 . . . . 0.0 112.848 160.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.17 61.55 0.46 Allowed Glycine 0 N--CA 1.43 -1.745 0 C-N-CA 124.826 1.203 . . . . 0.0 112.899 171.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.27 154.22 26.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 121.307 -1.113 . . . . 0.0 112.757 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.87 133.69 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.764 -1.21 . . . . 0.0 109.394 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.5 153.95 41.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.089 -1.632 . . . . 0.0 111.549 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -125.67 119.81 29.02 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.908 -1.12 . . . . 0.0 112.619 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 t -104.58 137.17 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.958 -1.714 . . . . 0.0 112.015 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -111.07 127.07 55.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.71 1.204 . . . . 0.0 110.639 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 11.9 tp -135.03 -173.2 3.25 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.574 1.15 . . . . 0.0 109.929 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.401 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -141.75 157.6 44.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.272 -1.517 . . . . 0.0 107.913 171.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.8 tttm -71.8 112.33 7.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 122.67 1.224 . . . . 0.0 112.779 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -99.88 -93.44 0.27 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.521 1.528 . . . . 0.0 109.389 -172.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.12 -42.77 16.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.663 1.585 . . . . 0.0 108.248 161.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -137.66 178.66 6.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 p -84.29 -72.0 0.49 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.436 1.494 . . . . 0.0 110.651 174.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.4 mt -102.36 -75.56 0.6 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.511 1.124 . . . . 0.0 110.543 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.89 50.45 2.87 Favored Glycine 0 N--CA 1.431 -1.69 0 O-C-N 120.199 -1.563 . . . . 0.0 113.229 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 40' ' ' VAL . 7.2 tt -143.12 146.3 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 122.314 1.054 . . . . 0.0 112.229 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 t -86.41 145.82 26.7 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.838 -1.788 . . . . 0.0 111.582 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG11 ' CE1' ' A' ' 71' ' ' HIS . 11.8 t -109.28 151.44 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.052 1.341 . . . . 0.0 111.13 -167.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -138.1 115.66 11.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.29 1.519 . . . . 0.0 110.964 170.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.35 -123.69 7.38 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.167 -1.583 . . . . 0.0 112.924 169.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.46 27.47 63.43 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 115.954 1.142 . . . . 0.0 115.954 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 m -105.64 -148.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 121.175 -1.191 . . . . 0.0 111.703 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -71.62 -37.18 70.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.853 1.661 . . . . 0.0 113.359 -166.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 t -130.89 117.73 19.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 163.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.9 t -151.07 -105.2 0.06 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.768 -1.832 . . . . 0.0 106.826 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.01 -52.13 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 125.119 1.368 . . . . 0.0 109.91 173.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -131.7 -158.84 0.92 Allowed 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 169.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -77.29 88.92 3.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.758 1.223 . . . . 0.0 108.594 162.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.32 172.87 32.05 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 119.798 -1.814 . . . . 0.0 113.555 -168.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.62 145.53 19.28 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -167.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.0 mm -125.05 142.83 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 120.463 -1.61 . . . . 0.0 108.925 -158.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -124.82 142.24 51.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 124.482 1.113 . . . . 0.0 110.683 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.9 t -90.94 133.98 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.887 -1.133 . . . . 0.0 113.155 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -91.01 -63.54 1.25 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.258 1.423 . . . . 0.0 113.114 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.45 158.22 11.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 -174.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.408 ' HA ' HG13 ' A' ' 20' ' ' ILE . 9.3 p -87.46 135.71 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 124.249 1.02 . . . . 0.0 112.821 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -85.44 120.8 73.48 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.741 -1.599 . . . . 0.0 109.861 171.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -73.81 44.85 1.0 Allowed 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 125.089 2.853 . . . . 0.0 116.266 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.93 43.12 0.55 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.952 1.358 . . . . 0.0 110.238 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.96 -171.93 38.8 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.047 -1.658 . . . . 0.0 112.3 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.19 -43.2 70.5 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.861 2.064 . . . . 0.0 116.114 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.78 -44.13 66.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.453 1.501 . . . . 0.0 114.975 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.56 -61.4 1.78 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.357 1.463 . . . . 0.0 112.045 171.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.1 m -56.21 -50.54 70.94 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -173.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -82.45 -27.9 31.61 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 121.308 -0.87 . . . . 0.0 111.183 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.81 73.09 1.28 Allowed Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 124.664 1.126 . . . . 0.0 110.913 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.438 HH22 ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -138.3 -44.26 0.5 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -152.313 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -128.35 134.28 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 120.615 1.552 . . . . 0.0 107.866 -170.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -125.14 171.13 10.55 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 122.734 1.254 . . . . 0.0 112.131 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -57.22 133.6 55.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.797 2.039 . . . . 0.0 115.763 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.42 12.16 84.81 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -79.95 167.06 20.97 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 118.819 1.309 . . . . 0.0 110.801 167.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -131.31 135.67 47.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.392 -1.443 . . . . 0.0 108.484 -172.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.57 145.76 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 120.103 1.319 . . . . 0.0 110.15 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.9 tp -135.49 -60.07 0.76 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.48 138.46 38.46 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.606 -1.934 . . . . 0.0 113.39 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.22 106.33 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.752 -1.217 . . . . 0.0 109.683 170.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 t30 56.03 40.42 30.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 170.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.22 -0.81 84.05 Favored Glycine 0 N--CA 1.431 -1.671 0 O-C-N 119.968 -1.708 . . . . 0.0 115.05 -176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.29 106.71 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 120.791 -1.417 . . . . 0.0 109.404 168.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 t -78.27 123.56 27.08 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.694 -1.879 . . . . 0.0 111.416 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -93.27 28.51 2.18 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.607 -1.308 . . . . 0.0 112.606 177.233 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.39 137.24 58.22 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.177 -1.577 . . . . 0.0 110.811 163.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.37 -35.44 2.99 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 119.16 -2.212 . . . . 0.0 114.406 -173.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.92 142.29 42.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.924 -1.339 . . . . 0.0 113.355 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.4 p -84.95 163.91 18.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.031 1.732 . . . . 0.0 111.851 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.488 ' CE1' HG11 ' A' ' 22' ' ' VAL . 14.4 t60 -48.13 -53.71 15.76 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.674 2.389 . . . . 0.0 116.688 -174.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -68.25 -29.91 68.83 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.289 1.042 . . . . 0.0 113.791 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -73.8 -46.68 43.88 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.889 1.275 . . . . 0.0 111.45 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.08 -41.48 86.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.273 1.829 . . . . 0.0 114.643 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 p -63.14 -34.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.089 -1.632 . . . . 0.0 113.084 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.29 -36.51 84.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.417 -1.427 . . . . 0.0 113.766 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.4 m -67.44 -35.05 78.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.033 1.733 . . . . 0.0 112.733 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -78.03 -37.83 46.02 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.538 -1.351 . . . . 0.0 112.093 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -62.99 -50.24 71.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.972 1.309 . . . . 0.0 113.165 173.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -85.38 60.83 6.49 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.168 -1.582 . . . . 0.0 112.002 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 p -99.02 -61.21 1.4 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.448 2.299 . . . . 0.0 108.008 168.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.84 -104.2 1.34 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 124.262 0.934 . . . . 0.0 113.606 160.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -81.92 -53.0 6.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.444 -1.033 . . . . 0.0 112.881 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.4 m -112.24 146.78 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 124.832 1.253 . . . . 0.0 109.359 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.57 123.7 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.243 -0.911 . . . . 0.0 108.99 -172.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -136.02 124.09 22.93 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.691 -1.255 . . . . 0.0 110.517 171.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -148.8 162.69 39.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.838 -1.164 . . . . 0.0 112.991 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.71 127.94 54.03 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -171.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.438 ' CD2' HH22 ' A' ' 51' ' ' ARG . 4.9 mp -118.21 159.49 23.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.928 1.291 . . . . 0.0 109.413 -175.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -120.03 126.27 50.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -68.04 147.54 52.24 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.623 -1.298 . . . . 0.0 112.69 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.71 -135.44 1.59 Allowed Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 116.911 1.525 . . . . 0.0 116.911 -174.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -100.22 158.07 16.13 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.016 1.726 . . . . 0.0 112.881 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.0 t -88.57 129.11 50.27 Favored Pre-proline 0 N--CA 1.429 -1.483 0 CA-C-O 116.852 -1.547 . . . . 0.0 110.344 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.81 -173.52 1.57 Allowed 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 124.112 3.208 . . . . 0.0 115.803 -165.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 C--O 1.261 1.671 0 C-N-CA 125.545 1.538 . . . . 0.0 113.448 -172.594 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 4.7 p90 . . . . . 0 CA--C 1.489 -1.368 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.37 44.39 9.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.276 2.324 . . . . 0.0 117.276 170.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.85 138.42 37.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 159.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 80.4 p -83.97 176.92 8.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.894 1.278 . . . . 0.0 110.953 171.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 64.83 84.06 0.16 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.022 1.729 . . . . 0.0 114.538 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.13 117.06 29.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.856 -1.777 . . . . 0.0 109.583 169.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -101.39 71.65 1.37 Allowed 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.646 1.212 . . . . 0.0 108.229 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -97.4 -2.06 43.05 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 40.66 70.62 0.24 Allowed 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 120.285 3.439 . . . . 0.0 120.285 168.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -139.54 161.99 36.15 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 157.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -121.91 -157.88 0.75 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.541 -1.35 . . . . 0.0 112.694 -163.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.95 153.25 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.153 -1.592 . . . . 0.0 111.239 -177.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -137.14 178.14 7.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.029 1.332 . . . . 0.0 110.334 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -151.25 149.08 28.98 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 124.378 1.071 . . . . 0.0 108.563 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.261 1.66 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 173.359 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.759 0 CA-C-O 121.175 0.319 . . . . 0.0 112.92 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -82.6 153.11 25.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.164 -1.198 . . . . 0.0 113.455 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.33 128.79 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 124.703 1.201 . . . . 0.0 109.78 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -137.27 160.99 37.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.489 -1.382 . . . . 0.0 110.404 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -113.56 140.61 48.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.871 -1.143 . . . . 0.0 112.145 175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -102.54 138.69 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 124.195 0.998 . . . . 0.0 109.367 172.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -121.15 101.92 7.97 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 125.514 1.525 . . . . 0.0 107.951 168.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -133.87 -175.5 3.86 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.421 -0.799 . . . . 0.0 109.918 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.26 174.66 15.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.934 -1.104 . . . . 0.0 110.285 174.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -69.98 123.32 21.25 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -121.32 -81.89 0.64 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.539 1.536 . . . . 0.0 111.784 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.85 -57.24 3.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.106 1.763 . . . . 0.0 108.61 170.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -142.24 -139.1 0.11 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 156.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 p -85.49 -85.62 0.14 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.007 -1.683 . . . . 0.0 111.997 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.9 mt -101.18 -74.46 0.61 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.334 -1.479 . . . . 0.0 113.335 -171.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.59 54.33 1.45 Allowed Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 124.839 1.209 . . . . 0.0 110.446 -174.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.9 tt -146.23 155.29 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.477 -1.013 . . . . 0.0 110.625 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 t -121.09 151.9 39.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.409 -1.432 . . . . 0.0 109.088 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.417 HG11 ' HE1' ' A' ' 71' ' ' HIS . 1.1 t -124.24 152.33 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.509 1.524 . . . . 0.0 110.319 -164.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 t -138.65 138.25 37.64 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 120.494 -1.379 . . . . 0.0 110.11 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.69 -137.71 20.53 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.832 1.682 . . . . 0.0 114.349 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.33 23.67 46.88 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 117.6 1.8 . . . . 0.0 117.6 166.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 m -87.27 -119.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 119.491 1.646 . . . . 0.0 114.848 -171.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -71.37 -45.34 63.08 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.875 -2.391 . . . . 0.0 113.117 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 t -138.56 170.94 15.12 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 148.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -156.01 -69.05 0.11 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.444 -1.41 . . . . 0.0 111.357 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 t -92.62 -56.51 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 124.291 1.036 . . . . 0.0 111.939 -168.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -141.12 -92.1 0.15 Allowed 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 121.475 -0.765 . . . . 0.0 109.997 -170.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -117.58 52.35 0.99 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.651 1.691 . . . . 0.0 107.617 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.81 -142.52 17.53 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 107.309 -2.317 . . . . 0.0 107.309 -166.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.08 148.29 23.49 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 124.675 1.131 . . . . 0.0 113.398 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.61 151.31 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.17 143.94 50.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.252 1.021 . . . . 0.0 111.186 -171.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.8 t -73.08 129.6 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.693 -1.254 . . . . 0.0 111.657 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -81.54 -62.77 1.55 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 109.62 171.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.45 167.54 15.61 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -92.35 136.84 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 124.835 1.254 . . . . 0.0 110.668 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.6 mm -83.83 120.34 74.91 Favored Pre-proline 0 N--CA 1.43 -1.427 0 O-C-N 120.314 -1.491 . . . . 0.0 109.005 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.12 65.0 8.93 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 CA-C-N 124.801 2.75 . . . . 0.0 113.277 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -141.7 -1.4 1.28 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.894 1.278 . . . . 0.0 112.897 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -141.87 -161.68 8.85 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 120.251 -1.531 . . . . 0.0 114.826 -171.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.69 -37.15 86.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 -173.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.27 92.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.274 1.03 . . . . 0.0 113.383 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -68.63 -55.88 10.06 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.375 1.07 . . . . 0.0 112.943 167.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.8 t -59.29 -56.99 15.04 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.324 1.45 . . . . 0.0 114.906 -170.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -81.11 -37.83 28.25 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.446 -1.409 . . . . 0.0 110.572 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.76 90.29 1.33 Allowed Glycine 0 N--CA 1.429 -1.78 0 O-C-N 120.519 -1.363 . . . . 0.0 111.397 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -137.18 -41.79 0.57 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 121.418 -1.048 . . . . 0.0 111.189 -171.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 mt -129.11 143.13 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.34 -173.54 3.3 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.313 -1.492 . . . . 0.0 111.179 170.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -55.97 132.57 50.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.39 9.86 86.59 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 118.236 2.054 . . . . 0.0 118.236 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -74.23 155.47 38.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 119.496 1.648 . . . . 0.0 112.167 172.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -124.55 144.0 50.37 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.105 -1.622 . . . . 0.0 110.719 -170.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 m -101.39 154.02 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 119.802 -1.811 . . . . 0.0 112.605 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.15 -91.18 0.56 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.209 1.404 . . . . 0.0 108.128 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.31 148.28 23.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.886 -1.133 . . . . 0.0 113.89 -166.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.36 100.91 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.086 1.354 . . . . 0.0 107.796 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.5 t30 56.77 61.06 2.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.269 1.828 . . . . 0.0 112.393 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.87 -39.02 2.95 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.922 -1.111 . . . . 0.0 115.336 -176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.08 128.06 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.453 -1.616 . . . . 0.0 112.603 -166.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -77.36 124.2 27.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.881 -1.137 . . . . 0.0 111.819 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.9 mp -87.36 74.22 9.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.115 1.436 . . . . 0.0 110.503 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -68.81 99.8 1.09 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.265 -1.522 . . . . 0.0 113.293 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.75 23.17 53.96 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.481 0.952 . . . . 0.0 115.481 172.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.35 136.35 39.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.384 -1.068 . . . . 0.0 112.526 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.6 p -80.13 172.21 14.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.572 1.149 . . . . 0.0 113.063 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.417 ' HE1' HG11 ' A' ' 22' ' ' VAL . 2.9 t60 -61.63 -41.25 97.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.257 -1.527 . . . . 0.0 113.252 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -59.02 -40.24 84.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -69.87 -41.63 74.55 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.29 -1.506 . . . . 0.0 111.773 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.82 97.23 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.678 -1.264 . . . . 0.0 114.082 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.13 -43.29 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.417 -1.427 . . . . 0.0 113.096 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -62.06 -42.25 99.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.433 -1.417 . . . . 0.0 113.729 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.3 p -70.15 -17.51 63.19 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.26 -1.525 . . . . 0.0 115.052 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.4 mt -80.32 -39.01 29.53 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 120.424 -1.422 . . . . 0.0 113.454 171.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -86.61 -27.43 23.86 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.484 -1.385 . . . . 0.0 113.932 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -83.42 60.56 5.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.68 -1.888 . . . . 0.0 112.55 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.5 p -109.06 -89.85 0.47 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.693 1.597 . . . . 0.0 112.518 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.44 -129.25 8.09 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 107.416 -2.274 . . . . 0.0 107.416 -166.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -81.25 -51.44 8.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -165.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -104.16 145.96 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.623 -1.298 . . . . 0.0 113.764 -159.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.24 105.73 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 125.022 1.329 . . . . 0.0 110.101 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -116.86 120.85 39.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.889 -1.132 . . . . 0.0 108.623 168.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.58 166.86 27.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.503 -1.373 . . . . 0.0 111.911 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -120.21 137.38 54.23 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mp -125.53 156.75 38.55 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.312 1.445 . . . . 0.0 108.363 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -113.49 132.59 55.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 166.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.6 tptt -68.86 138.16 54.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.789 -1.194 . . . . 0.0 112.693 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.76 0 O-C-N 120.795 -1.191 . . . . 0.0 114.667 -172.642 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -128.25 145.91 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 125.386 1.474 . . . . 0.0 109.271 -164.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.1 p -126.3 163.31 23.51 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.463 1.505 . . . . 0.0 111.822 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.19 159.02 43.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.514 -0.741 . . . . 0.0 109.579 162.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.261 1.671 0 C-N-CA 124.048 0.939 . . . . 0.0 109.012 177.665 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.703 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -74.17 145.98 43.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 118.842 1.321 . . . . 0.0 113.429 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.4 mt -89.44 137.64 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.251 1.42 . . . . 0.0 110.106 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -146.56 161.26 40.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.972 -1.08 . . . . 0.0 109.99 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -115.52 141.07 48.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.146 -0.971 . . . . 0.0 108.878 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.4 147.39 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 124.045 0.938 . . . . 0.0 112.632 173.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -113.67 123.33 49.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 123.746 0.818 . . . . 0.0 109.058 168.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.5 mt -132.83 157.91 43.83 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.442 -1.411 . . . . 0.0 110.427 165.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.66 139.26 27.89 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -70.41 96.68 1.17 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -92.29 -66.36 0.93 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.123 1.769 . . . . 0.0 109.703 171.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -88.7 -71.37 0.59 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.173 1.789 . . . . 0.0 109.186 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -136.55 166.45 23.5 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -171.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -83.06 -71.19 0.51 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -167.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.85 -83.27 0.46 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.138 -1.601 . . . . 0.0 110.028 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.4 39.35 2.82 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.688 -1.258 . . . . 0.0 114.932 170.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.86 169.58 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.093 -1.239 . . . . 0.0 108.774 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.7 p -122.45 146.51 47.31 Favored 'General case' 0 N--CA 1.429 -1.513 0 O-C-N 119.968 -1.708 . . . . 0.0 108.75 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 t -125.32 149.83 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 125.168 1.387 . . . . 0.0 110.044 -161.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -136.29 142.11 43.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.062 1.411 . . . . 0.0 109.774 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.71 -130.77 9.91 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 125.761 1.648 . . . . 0.0 114.191 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.93 62.42 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 121.404 -1.056 . . . . 0.0 114.531 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 27' ' ' ASN . 46.5 t -89.36 168.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.435 ' H ' HG12 ' A' ' 26' ' ' VAL . 10.1 p30 -67.73 -26.8 66.32 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 125.984 1.714 . . . . 0.0 113.163 -163.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 t -129.74 128.18 41.92 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 152.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 p -155.39 -89.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.853 -1.154 . . . . 0.0 110.672 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -78.25 -47.2 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.3 -1.5 . . . . 0.0 109.457 171.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.95 -153.18 0.52 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 167.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -76.55 89.84 3.3 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.399 -1.438 . . . . 0.0 109.278 163.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.69 -154.35 30.9 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -162.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.39 136.93 9.11 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-O 122.858 1.254 . . . . 0.0 112.465 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.5 mm -124.89 133.75 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.4 -1.647 . . . . 0.0 107.574 -164.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.96 141.4 51.99 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.677 1.191 . . . . 0.0 108.311 -170.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.7 t -80.03 130.53 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.906 -1.121 . . . . 0.0 110.911 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -86.75 -57.34 3.02 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 120.139 -1.6 . . . . 0.0 110.783 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.87 155.56 29.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.853 1.261 . . . . 0.0 109.514 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -94.78 131.16 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 122.519 1.152 . . . . 0.0 110.689 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.7 mm -82.93 123.06 78.18 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 120.523 -1.361 . . . . 0.0 110.42 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.11 40.9 1.0 Allowed 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.041 2.494 . . . . 0.0 114.051 -172.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -144.78 53.85 1.23 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.19 174.29 45.91 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 120.419 -1.426 . . . . 0.0 113.896 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.78 -36.09 73.86 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.475 1.91 . . . . 0.0 114.4 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.65 -53.78 47.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.35 -49.95 50.87 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.284 1.434 . . . . 0.0 112.346 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -61.19 -39.87 91.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -82.07 -47.92 12.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.838 -1.164 . . . . 0.0 111.236 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.96 62.63 1.98 Allowed Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 117.109 1.604 . . . . 0.0 117.109 168.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -135.5 -1.08 2.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.472 -1.605 . . . . 0.0 111.841 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.3 mt -129.28 149.47 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -126.8 173.68 9.36 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 120.287 -1.508 . . . . 0.0 111.531 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -58.12 135.9 57.11 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.945 1.298 . . . . 0.0 114.214 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.76 18.51 78.84 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 117.559 1.784 . . . . 0.0 117.559 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -82.7 162.51 21.78 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 120.341 2.07 . . . . 0.0 111.543 166.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -126.33 123.4 37.93 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.714 -1.241 . . . . 0.0 110.384 -172.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -85.56 155.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.118 -1.614 . . . . 0.0 113.284 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.04 -86.13 0.65 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.707 1.203 . . . . 0.0 111.229 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.52 144.94 28.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.63 96.25 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 124.468 1.107 . . . . 0.0 108.329 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.296 9.5 t-20 57.19 47.59 16.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.854 1.661 . . . . 0.0 113.343 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.79 -34.3 5.86 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.582 -1.324 . . . . 0.0 114.278 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 t -100.9 109.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 118.368 1.084 . . . . 0.0 112.159 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.9 m -79.61 110.22 14.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.665 1.586 . . . . 0.0 112.392 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.14 85.4 4.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.577 -1.952 . . . . 0.0 110.555 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.03 135.11 51.79 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.921 -1.737 . . . . 0.0 113.652 174.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.56 7.23 63.45 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 124.685 1.136 . . . . 0.0 114.371 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.86 130.8 39.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.825 -1.397 . . . . 0.0 112.903 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.3 p -80.76 171.61 14.8 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 123.126 1.441 . . . . 0.0 110.252 168.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.459 ' CE1' ' HB2' ' B' ' 13' ' ' SER . 1.9 t60 -56.25 -41.7 76.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.641 1.977 . . . . 0.0 114.093 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -52.32 -45.72 65.73 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.511 1.524 . . . . 0.0 114.859 171.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -72.06 -38.51 69.43 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.841 1.256 . . . . 0.0 111.722 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.12 76.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.621 1.168 . . . . 0.0 113.852 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.3 t -63.21 -48.14 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.628 1.971 . . . . 0.0 113.331 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -53.59 -46.46 70.37 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.483 1.135 . . . . 0.0 113.271 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.7 m -65.91 -41.71 91.11 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.029 2.132 . . . . 0.0 113.218 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.8 mt -85.81 -27.31 25.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.139 -1.601 . . . . 0.0 114.83 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 44.6 mtt180 -65.47 -45.93 81.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.775 -1.828 . . . . 0.0 112.625 173.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -83.46 60.39 5.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.017 1.389 . . . . 0.0 112.26 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.89 -80.85 0.37 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.47 1.908 . . . . 0.0 109.192 175.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.16 -78.79 0.4 Allowed Glycine 0 N--CA 1.429 -1.774 0 O-C-N 121.294 -0.879 . . . . 0.0 114.257 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -81.51 -58.74 2.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.503 -0.998 . . . . 0.0 113.472 -175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.43 149.21 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.777 1.231 . . . . 0.0 110.487 -166.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.6 t -129.45 112.31 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.073 1.349 . . . . 0.0 107.786 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -127.98 104.44 7.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.637 -1.289 . . . . 0.0 110.857 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.3 mt -127.7 162.59 26.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 111.313 -169.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.24 136.32 54.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.514 1.526 . . . . 0.0 107.15 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.74 161.24 42.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.802 0.811 . . . . 0.0 111.822 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -114.29 134.8 54.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.857 1.663 . . . . 0.0 109.652 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -62.65 135.2 57.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.748 0 CA-C-O 123.281 1.489 . . . . 0.0 116.175 -178.119 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.81 123.86 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.261 1.824 . . . . 0.0 107.699 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.459 ' HB2' ' CE1' ' A' ' 71' ' ' HIS . 15.0 m -129.59 133.06 46.96 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.707 -1.246 . . . . 0.0 113.154 -171.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.02 155.9 34.61 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.644 -1.285 . . . . 0.0 112.544 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 C--O 1.26 1.633 0 C-N-CA 126.636 1.974 . . . . 0.0 107.858 173.798 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.747 0 CA-C-O 121.244 0.358 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -82.18 178.97 7.98 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 120.898 -1.354 . . . . 0.0 113.624 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -85.67 133.99 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.326 -1.483 . . . . 0.0 108.376 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -135.96 146.65 47.49 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 121.201 -0.937 . . . . 0.0 108.781 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -106.68 134.82 49.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.027 -1.046 . . . . 0.0 109.36 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.9 t -102.06 115.44 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -120.38 95.44 4.74 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.801 1.24 . . . . 0.0 108.63 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.496 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 11.0 tp -134.49 -155.95 0.69 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.174 -0.954 . . . . 0.0 109.368 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.496 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -154.53 168.19 27.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -71.96 129.64 39.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -120.98 -69.88 0.82 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.825 1.25 . . . . 0.0 110.722 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -76.56 -62.62 1.57 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.657 -1.277 . . . . 0.0 109.188 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -137.79 -131.11 0.13 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 139.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.7 p -89.81 -78.15 0.37 Allowed 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 120.19 1.359 . . . . 0.0 112.187 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.1 mt -103.21 -99.31 0.3 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.372 -1.455 . . . . 0.0 113.921 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.42 52.43 1.71 Allowed Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -157.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.95 147.05 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.956 -1.32 . . . . 0.0 108.366 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 t -122.48 148.21 45.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.727 -1.233 . . . . 0.0 109.223 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.62 157.01 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 122.343 1.068 . . . . 0.0 110.11 -164.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.2 t -137.06 112.71 9.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 122.75 1.262 . . . . 0.0 107.834 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.46 175.38 50.7 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-O 122.934 1.296 . . . . 0.0 115.004 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.43 67.84 0.7 Allowed Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.1 m -97.21 -130.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 125.135 1.374 . . . . 0.0 110.694 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -71.1 -39.12 72.3 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.028 -2.295 . . . . 0.0 112.714 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.8 t -151.99 143.14 23.22 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 163.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 t -156.55 -69.25 0.11 Allowed 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.081 -1.637 . . . . 0.0 113.285 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.37 -58.32 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.558 -1.339 . . . . 0.0 112.734 -164.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -125.52 -83.64 0.63 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 124.078 0.951 . . . . 0.0 109.295 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.39 53.71 1.93 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 165.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.3 -140.42 16.27 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 -161.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.15 150.24 19.94 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 117.955 0.877 . . . . 0.0 113.522 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 22.0 mm -125.67 148.91 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -125.85 135.62 52.16 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.858 -1.151 . . . . 0.0 112.052 -169.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.3 t -78.65 130.32 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 120.398 -1.438 . . . . 0.0 112.333 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -89.52 -59.35 2.23 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.903 -1.123 . . . . 0.0 110.536 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.86 163.33 23.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.765 0.793 . . . . 0.0 110.24 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.4 131.72 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.122 1.369 . . . . 0.0 109.152 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.4 mm -83.58 120.31 75.15 Favored Pre-proline 0 N--CA 1.431 -1.381 0 O-C-N 120.926 -1.109 . . . . 0.0 109.816 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.8 67.56 8.57 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 124.022 2.472 . . . . 0.0 112.88 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -145.4 9.72 1.23 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 123.997 0.919 . . . . 0.0 111.835 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 -158.82 18.49 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 119.664 -1.898 . . . . 0.0 114.565 -172.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.34 -43.51 79.13 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.512 2.325 . . . . 0.0 116.26 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.98 90.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -73.79 -49.98 22.71 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.714 1.206 . . . . 0.0 111.583 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 t -55.05 -55.45 30.83 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.522 2.329 . . . . 0.0 114.485 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -79.2 -44.44 21.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.641 -1.287 . . . . 0.0 111.772 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.49 91.48 0.55 Allowed Glycine 0 N--CA 1.431 -1.686 0 C-N-CA 124.223 0.916 . . . . 0.0 113.443 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -136.16 -45.7 0.63 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.168 -1.195 . . . . 0.0 110.436 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.6 mt -126.04 133.45 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 -169.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.82 -178.19 3.97 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.598 1.19 . . . . 0.0 112.101 -176.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -56.42 125.03 20.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.49 16.79 80.45 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 117.588 1.795 . . . . 0.0 117.588 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -72.07 161.8 30.38 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.346 1.573 . . . . 0.0 112.634 167.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -123.16 115.18 21.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 121.029 -1.044 . . . . 0.0 109.314 -173.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.96 148.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 119.872 -1.767 . . . . 0.0 110.136 172.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.3 mt -128.98 -81.01 0.57 Allowed 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 121.41 -0.806 . . . . 0.0 111.46 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.5 138.12 34.56 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.553 -1.342 . . . . 0.0 114.455 -167.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.93 90.91 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 126.394 1.877 . . . . 0.0 109.411 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.292 3.3 t-20 56.37 50.65 12.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.945 1.698 . . . . 0.0 112.324 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.23 -36.8 3.89 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 120.678 -1.264 . . . . 0.0 113.675 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -85.23 124.05 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 O-C-N 121.305 -1.115 . . . . 0.0 112.293 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 t -77.98 129.52 35.39 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.677 -1.264 . . . . 0.0 110.864 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tp -95.08 51.84 1.39 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.972 -1.705 . . . . 0.0 112.808 -164.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.98 123.81 21.25 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.652 1.581 . . . . 0.0 114.512 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.39 -4.8 80.51 Favored Glycine 0 N--CA 1.429 -1.78 0 O-C-N 120.26 -1.525 . . . . 0.0 114.358 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.35 143.41 40.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 121.258 -1.142 . . . . 0.0 112.976 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.8 p -85.96 175.84 8.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.16 1.384 . . . . 0.0 111.006 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -59.73 -43.67 94.11 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.205 1.402 . . . . 0.0 112.488 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.88 -40.99 90.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.528 2.331 . . . . 0.0 115.386 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -72.1 -37.46 69.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.189 -1.57 . . . . 0.0 112.354 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.46 77.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.931 -1.106 . . . . 0.0 113.494 171.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.6 -51.58 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.365 1.466 . . . . 0.0 113.069 170.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -60.46 -40.28 90.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.635 -1.291 . . . . 0.0 114.328 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 p -70.48 -18.55 62.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.321 -1.487 . . . . 0.0 113.86 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mt -85.67 -19.13 31.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.01 -1.681 . . . . 0.0 113.253 170.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -78.54 -44.16 24.96 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.237 -1.539 . . . . 0.0 110.924 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -82.95 64.91 7.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.879 1.272 . . . . 0.0 112.942 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.5 p -99.72 -74.08 0.61 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.156 1.782 . . . . 0.0 111.015 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.37 -131.19 9.56 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 125.702 1.62 . . . . 0.0 111.01 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -76.79 -44.21 33.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.003 -1.292 . . . . 0.0 113.481 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -109.31 164.42 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 123.915 0.886 . . . . 0.0 111.055 -167.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.0 t -134.15 127.75 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.225 1.41 . . . . 0.0 109.38 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -142.43 115.68 8.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.397 -0.814 . . . . 0.0 109.078 171.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -149.05 162.36 40.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.243 -1.536 . . . . 0.0 112.019 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.3 mp -121.01 124.41 44.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.282 1.039 . . . . 0.0 108.982 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -117.86 166.06 12.93 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.527 1.131 . . . . 0.0 108.944 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -117.33 131.6 56.76 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 162.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -73.71 124.53 26.19 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.941 -1.099 . . . . 0.0 111.051 -174.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.725 0 O-C-N 121.232 -0.917 . . . . 0.0 115.055 -166.112 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 N--CA 1.43 -1.426 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.98 160.21 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 127.709 2.404 . . . . 0.0 106.994 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 30.2 p -150.01 154.73 38.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.451 -2.031 . . . . 0.0 114.639 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.95 164.42 38.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.296 1.038 . . . . 0.0 112.009 170.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.26 1.627 0 C-N-CA 125.648 1.579 . . . . 0.0 108.977 176.351 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.705 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.87 179.02 7.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.932 1.349 . . . . 0.0 113.22 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.92 133.51 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.431 1.492 . . . . 0.0 108.98 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -138.47 157.55 45.98 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.959 -1.088 . . . . 0.0 112.497 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -126.92 114.19 17.53 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.992 1.317 . . . . 0.0 112.477 -172.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.2 t -102.9 141.66 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.673 -1.267 . . . . 0.0 110.208 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -117.83 122.09 42.46 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 160.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -133.91 162.33 32.33 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.838 -1.163 . . . . 0.0 108.936 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.61 147.75 27.79 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.406 -1.434 . . . . 0.0 107.585 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -64.03 120.88 12.87 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 122.994 1.378 . . . . 0.0 114.703 -168.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -98.35 -88.21 0.32 Allowed 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 125.15 1.38 . . . . 0.0 108.816 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.55 -46.77 36.82 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.559 -1.338 . . . . 0.0 109.623 170.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -156.9 -158.06 0.74 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 169.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 p -83.53 -82.05 0.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.745 -1.222 . . . . 0.0 112.39 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.4 mt -102.49 -97.53 0.29 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.824 -1.798 . . . . 0.0 114.437 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.43 51.23 1.59 Allowed Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -162.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.9 tt -140.95 161.06 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 121.072 -1.252 . . . . 0.0 110.361 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -122.47 142.5 50.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 120.352 -1.467 . . . . 0.0 108.029 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -123.64 152.65 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 125.446 1.499 . . . . 0.0 107.861 -171.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.5 t -136.42 120.3 17.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.463 1.601 . . . . 0.0 110.786 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.67 -147.71 42.31 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 124.746 1.165 . . . . 0.0 113.695 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.88 38.39 6.92 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 121.997 0.776 . . . . 0.0 112.346 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 26' ' ' VAL . 13.2 m -80.95 -112.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 126.219 1.808 . . . . 0.0 113.318 -169.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -71.7 -51.91 20.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.876 -1.765 . . . . 0.0 111.482 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -151.45 153.4 34.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.1 t -154.6 -69.14 0.13 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.286 -0.884 . . . . 0.0 112.134 -175.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.9 t -91.97 -61.44 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 120.494 -1.379 . . . . 0.0 112.682 -163.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -124.93 -71.03 0.72 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.049 1.34 . . . . 0.0 111.78 -161.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -141.71 39.54 1.68 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.7 -144.48 17.96 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 -157.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.69 158.68 33.31 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.401 -1.058 . . . . 0.0 113.197 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 mm -126.36 145.28 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -125.94 138.7 53.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.084 -1.01 . . . . 0.0 111.715 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.7 t -85.83 127.72 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 124.937 1.295 . . . . 0.0 111.799 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -83.4 -63.72 1.3 Allowed 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 125.195 1.398 . . . . 0.0 111.175 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.09 171.64 5.71 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.816 0.846 . . . . 0.0 109.083 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.38 139.19 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.312 1.045 . . . . 0.0 111.737 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.1 mm -85.79 109.65 23.97 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 119.938 -1.726 . . . . 0.0 108.647 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -82.46 57.24 6.05 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 123.361 2.707 . . . . 0.0 114.14 -163.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -141.16 22.28 2.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.028 1.331 . . . . 0.0 110.427 -174.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.25 -160.91 19.79 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 120.179 -1.576 . . . . 0.0 115.044 -173.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.4 -45.57 88.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.893 2.077 . . . . 0.0 115.574 -166.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.08 79.04 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -77.63 -41.75 37.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.416 1.086 . . . . 0.0 111.948 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.8 t -70.14 -46.57 64.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -82.14 -61.52 1.88 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.723 -1.236 . . . . 0.0 111.684 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.64 99.42 1.08 Allowed Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.195 -0.941 . . . . 0.0 114.923 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -138.56 -37.15 0.55 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.97 -1.312 . . . . 0.0 110.929 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.6 mt -127.47 134.58 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -170.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -119.86 -176.68 3.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.842 -1.161 . . . . 0.0 113.523 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -55.2 127.88 31.3 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.97 1.708 . . . . 0.0 114.846 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.37 11.17 84.41 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.18 156.1 39.96 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.059 1.429 . . . . 0.0 111.576 169.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -123.76 102.06 7.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.134 -0.978 . . . . 0.0 109.772 -167.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -80.2 132.73 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.666 -1.271 . . . . 0.0 111.169 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.1 mt -122.04 -74.07 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.69 -1.256 . . . . 0.0 110.958 -170.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.35 151.67 20.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.7 t -113.65 101.18 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.611 1.965 . . . . 0.0 107.397 173.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.312 16.3 t-20 56.56 48.39 16.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.518 1.927 . . . . 0.0 113.536 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.73 -14.09 57.01 Favored Glycine 0 N--CA 1.43 -1.761 0 O-C-N 120.035 -1.666 . . . . 0.0 114.894 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 t -100.93 117.34 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 120.989 -1.301 . . . . 0.0 109.992 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -79.15 144.14 34.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.504 -1.372 . . . . 0.0 113.449 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mp -93.42 44.93 1.15 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.022 1.391 . . . . 0.0 112.517 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.89 114.41 6.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.096 -1.627 . . . . 0.0 112.824 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.08 7.89 73.01 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 120.817 -1.177 . . . . 0.0 113.875 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.5 143.03 38.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.013 -1.287 . . . . 0.0 110.871 168.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.2 p -90.33 176.07 6.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.349 -1.47 . . . . 0.0 110.285 165.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -59.62 -38.41 81.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -52.98 -41.6 64.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.519 -1.363 . . . . 0.0 113.768 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -71.23 -35.98 71.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.882 1.273 . . . . 0.0 112.356 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.82 84.57 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.455 -1.403 . . . . 0.0 113.908 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.23 -42.53 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 124.954 1.302 . . . . 0.0 112.07 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -61.08 -37.39 82.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.313 -1.492 . . . . 0.0 112.845 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.3 p -70.45 -22.96 62.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 171.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 mt -79.23 -40.84 29.68 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.998 -1.689 . . . . 0.0 112.739 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -63.78 -43.39 96.47 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.882 -1.137 . . . . 0.0 111.217 173.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -93.5 58.98 2.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.189 -1.57 . . . . 0.0 112.469 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 p -88.45 -72.46 0.54 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.708 1.203 . . . . 0.0 108.516 166.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.96 -128.26 8.04 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -76.67 -46.73 24.57 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.03 148.87 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 124.714 1.206 . . . . 0.0 112.351 -170.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.33 116.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 127.175 2.19 . . . . 0.0 108.652 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -117.62 115.35 24.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.252 -1.53 . . . . 0.0 107.316 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -144.03 157.95 44.01 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.985 -1.072 . . . . 0.0 112.705 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mp -122.11 134.58 54.75 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.985 0.914 . . . . 0.0 109.114 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.34 170.1 13.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.959 1.304 . . . . 0.0 109.879 -169.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -116.4 135.38 53.9 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 158.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -74.73 131.46 40.86 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.758 0 C-N-CA 125.99 1.757 . . . . 0.0 116.726 -178.224 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.22 171.46 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.335 2.254 . . . . 0.0 105.215 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.7 p -144.66 141.84 29.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.62 -1.925 . . . . 0.0 115.141 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.87 133.4 49.34 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.94 1.696 . . . . 0.0 111.428 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.261 1.67 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.148 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.737 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -82.18 171.06 14.73 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.6 130.44 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 167.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -133.73 166.53 22.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.227 1.013 . . . . 0.0 111.311 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -125.16 136.74 53.89 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.238 1.015 . . . . 0.0 109.293 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.9 m -102.06 135.59 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.707 -1.246 . . . . 0.0 108.849 173.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -126.04 87.36 2.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.26 1.024 . . . . 0.0 109.796 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 9.1 tp -134.51 -174.38 3.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.654 -1.279 . . . . 0.0 110.311 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.414 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -133.64 165.64 24.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.325 -1.484 . . . . 0.0 107.642 174.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -71.92 121.46 19.11 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.236 1.017 . . . . 0.0 111.786 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -107.5 -92.04 0.41 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.486 1.514 . . . . 0.0 107.755 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -78.78 -41.64 29.94 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.139 1.376 . . . . 0.0 109.997 163.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.8 161.51 37.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 123.81 0.844 . . . . 0.0 110.403 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -83.49 -68.37 0.72 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.439 1.095 . . . . 0.0 110.521 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.77 -79.15 0.52 Allowed 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.821 -1.174 . . . . 0.0 111.101 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.68 50.25 4.27 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 124.576 1.084 . . . . 0.0 113.475 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 tt -138.43 -178.61 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 121.617 -0.931 . . . . 0.0 109.579 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.0 p -127.4 142.47 51.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.842 -2.411 . . . . 0.0 110.31 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 t -123.77 155.82 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 123.855 0.862 . . . . 0.0 111.464 -163.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 t -137.02 141.93 42.5 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.255 -1.528 . . . . 0.0 108.707 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.1 -175.84 50.3 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 116.476 1.351 . . . . 0.0 116.476 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.95 44.05 0.97 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 121.865 -0.785 . . . . 0.0 112.823 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 27' ' ' ASN . 25.8 t -80.78 176.66 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.69 -1.476 . . . . 0.0 108.847 174.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.662 ' H ' HG12 ' A' ' 26' ' ' VAL . 5.8 p30 -69.07 -24.78 64.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.377 -2.077 . . . . 0.0 114.814 -160.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.6 t -135.15 133.33 39.04 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 150.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.9 p -155.81 -86.4 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.685 -1.259 . . . . 0.0 112.639 -165.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.13 -48.02 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 126.825 2.05 . . . . 0.0 109.062 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -129.02 -154.47 0.64 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 159.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.33 70.29 9.24 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.234 -2.166 . . . . 0.0 111.389 164.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.63 -171.87 13.95 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 108.118 -1.993 . . . . 0.0 108.118 -166.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.09 136.0 7.96 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -172.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.9 mm -127.21 149.41 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -170.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.92 139.49 53.78 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.924 -1.735 . . . . 0.0 111.225 -169.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.7 t -81.98 126.12 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 120.275 -1.516 . . . . 0.0 111.313 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -87.6 -70.12 0.65 Allowed 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.653 -1.279 . . . . 0.0 111.051 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.8 159.97 38.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.277 -0.89 . . . . 0.0 110.101 -171.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 p -103.09 132.6 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.93 1.347 . . . . 0.0 112.221 -170.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.6 mm -83.7 119.42 73.65 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 120.149 -1.594 . . . . 0.0 110.163 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -81.05 58.97 7.26 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 124.393 2.605 . . . . 0.0 112.966 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -141.39 -0.42 1.41 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.296 1.038 . . . . 0.0 112.094 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.36 -172.75 30.19 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.27 -1.518 . . . . 0.0 115.477 -170.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.3 -50.61 2.01 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.696 3.198 . . . . 0.0 118.159 -171.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.1 -45.34 68.19 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.213 1.405 . . . . 0.0 114.76 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -80.59 -52.66 7.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.958 1.303 . . . . 0.0 110.826 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.5 m -62.5 -38.48 90.04 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -172.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.3 -52.44 6.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.914 -1.116 . . . . 0.0 110.117 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.62 84.94 1.47 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 121.14 -0.975 . . . . 0.0 113.589 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -138.99 -21.82 0.95 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.19 149.58 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -119.64 172.57 7.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.592 -1.317 . . . . 0.0 111.702 177.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -56.54 138.73 51.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.43 22.11 76.24 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 116.905 1.522 . . . . 0.0 116.905 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.58 166.49 19.19 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 118.915 1.358 . . . . 0.0 111.693 169.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -124.1 105.43 9.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.748 -1.22 . . . . 0.0 110.25 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 m -93.74 141.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 120.459 -1.401 . . . . 0.0 111.519 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.24 -87.25 0.56 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 111.253 -166.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -90.63 153.84 20.02 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.591 -1.943 . . . . 0.0 112.903 -172.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 63.8 t -116.41 108.53 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.256 9.1 t-20 56.25 50.15 13.92 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 126.03 1.732 . . . . 0.0 113.76 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.5 -29.42 6.72 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.659 -1.276 . . . . 0.0 114.774 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.2 t -88.06 99.03 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.586 -1.538 . . . . 0.0 111.209 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -78.59 99.56 6.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.302 1.041 . . . . 0.0 110.514 167.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.03 92.91 7.08 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.07 1.414 . . . . 0.0 109.591 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.59 129.97 41.56 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.383 1.473 . . . . 0.0 112.644 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.48 -6.24 74.6 Favored Glycine 0 N--CA 1.429 -1.795 0 O-C-N 121.001 -1.062 . . . . 0.0 114.565 -174.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.99 133.27 40.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 119.595 1.698 . . . . 0.0 114.041 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.3 p -84.31 177.86 8.0 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.258 1.423 . . . . 0.0 112.613 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -56.94 -45.41 82.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.322 2.249 . . . . 0.0 113.942 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -58.39 -43.31 88.5 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 172.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -70.37 -39.21 74.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.761 -1.212 . . . . 0.0 111.995 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.41 67.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.666 1.186 . . . . 0.0 113.393 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.47 -35.99 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 120.291 -1.506 . . . . 0.0 113.076 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -58.24 -47.08 84.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.141 -1.599 . . . . 0.0 113.72 168.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.4 m -63.23 -36.25 83.02 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.823 1.649 . . . . 0.0 113.141 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 74.4 mt -78.89 -35.84 42.99 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 120.114 -1.616 . . . . 0.0 113.462 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -67.31 -28.16 67.76 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.961 -1.712 . . . . 0.0 112.639 172.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -90.93 48.81 1.56 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.18 -1.575 . . . . 0.0 112.78 172.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.74 -70.4 0.6 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.507 1.523 . . . . 0.0 109.766 173.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.13 -87.33 1.2 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 121.238 -0.914 . . . . 0.0 112.603 170.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -83.93 -61.4 1.83 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.216 -1.167 . . . . 0.0 113.753 173.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.74 142.51 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 122.22 1.01 . . . . 0.0 113.233 -164.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.9 t -121.05 92.39 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 125.408 1.483 . . . . 0.0 107.543 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -126.57 98.39 5.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.567 -1.333 . . . . 0.0 111.18 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.9 mt -127.35 154.22 45.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.81 -1.181 . . . . 0.0 111.409 -162.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 3.9 mm? -120.79 134.0 55.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.623 1.169 . . . . 0.0 109.047 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.07 153.06 37.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.534 0.683 . . . . 0.0 111.356 -171.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -112.19 120.96 43.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.822 1.649 . . . . 0.0 109.992 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -54.1 135.55 43.26 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -165.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.796 0 C-N-CA 126.165 1.84 . . . . 0.0 115.611 176.52 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 N--CA 1.429 -1.491 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 t -122.56 149.09 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.364 1.866 . . . . 0.0 106.789 -173.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -138.33 166.83 23.22 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.273 -1.517 . . . . 0.0 112.58 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.88 147.12 50.79 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.614 1.966 . . . . 0.0 109.735 162.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.26 1.647 0 C-N-CA 127.4 2.28 . . . . 0.0 105.299 170.037 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.633 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -83.55 165.42 19.09 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.4 mt -81.37 131.86 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 122.182 0.992 . . . . 0.0 111.524 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -136.98 168.93 18.65 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.711 -1.243 . . . . 0.0 109.847 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -122.49 137.52 54.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.766 0.826 . . . . 0.0 111.003 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.6 m -103.98 143.75 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 124.395 1.078 . . . . 0.0 111.716 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -127.9 106.68 9.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.652 1.181 . . . . 0.0 109.159 -170.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.1 mt -129.69 159.39 36.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.997 -1.689 . . . . 0.0 110.657 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.66 164.44 27.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 160.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -72.25 114.18 10.08 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.437 -1.414 . . . . 0.0 113.933 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -101.9 -70.89 0.73 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 162.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.43 -74.69 0.43 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.362 1.865 . . . . 0.0 110.789 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -136.49 148.76 47.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -165.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.1 m -80.83 -62.82 1.55 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.924 -1.735 . . . . 0.0 113.268 -159.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.8 mp -101.52 -86.09 0.42 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.886 -1.134 . . . . 0.0 111.001 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.2 45.71 2.53 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.638 -1.289 . . . . 0.0 115.338 171.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.65 172.33 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 120.696 -1.473 . . . . 0.0 109.032 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.7 p -121.16 145.05 48.23 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.723 -1.861 . . . . 0.0 108.539 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.07 154.3 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 125.757 1.623 . . . . 0.0 108.073 -165.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.6 t -139.0 161.36 37.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 169.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.03 -132.38 15.18 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.635 -1.29 . . . . 0.0 114.335 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.97 0.81 89.0 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 120.708 -1.466 . . . . 0.0 115.899 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.0 t -73.69 166.93 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.156 2.182 . . . . 0.0 110.901 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -69.77 -15.35 63.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.383 1.873 . . . . 0.0 115.429 -164.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.5 t -134.99 118.0 16.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.507 -1.996 . . . . 0.0 107.084 148.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 p -146.87 -83.25 0.12 Allowed 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.878 -1.139 . . . . 0.0 109.445 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.61 -51.14 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 126.62 1.968 . . . . 0.0 110.245 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -130.35 -158.05 0.86 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 161.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.38 56.71 1.79 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.406 -2.059 . . . . 0.0 112.851 165.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.34 168.69 12.4 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 126.412 1.958 . . . . 0.0 110.423 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.91 152.31 24.76 Favored Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 125.099 1.333 . . . . 0.0 111.079 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.2 mm -126.47 149.17 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 121.097 -1.237 . . . . 0.0 109.501 -161.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.65 137.12 53.85 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.358 -1.463 . . . . 0.0 109.64 -172.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.7 t -86.02 132.94 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.441 -1.412 . . . . 0.0 112.104 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -87.76 -70.08 0.65 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.569 -1.332 . . . . 0.0 110.875 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.81 163.29 40.01 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 122.157 0.979 . . . . 0.0 111.112 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.8 p -88.27 130.06 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.424 0 C-N-CA 124.925 1.29 . . . . 0.0 111.642 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mm -84.45 118.83 72.05 Favored Pre-proline 0 N--CA 1.43 -1.471 0 O-C-N 120.201 -1.562 . . . . 0.0 109.256 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.39 45.28 1.68 Allowed 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 124.715 2.72 . . . . 0.0 113.061 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -143.02 34.41 1.36 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.146 0.978 . . . . 0.0 109.217 -171.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.19 -172.69 39.62 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 119.938 -1.726 . . . . 0.0 113.105 -171.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.54 -35.83 78.86 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.951 1.7 . . . . 0.0 114.598 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.98 -49.17 69.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.16 -53.51 36.73 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.37 1.868 . . . . 0.0 112.079 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.6 m -66.27 -29.31 69.51 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.58 -53.93 6.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.91 1.684 . . . . 0.0 111.967 170.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.71 65.98 1.67 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 120.393 -1.442 . . . . 0.0 114.173 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -138.34 -13.74 1.33 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.01 -1.288 . . . . 0.0 113.232 -166.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.04 144.68 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -121.23 -177.62 3.56 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 122.998 1.38 . . . . 0.0 111.473 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.9 pttt -58.56 132.84 54.98 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.183 -1.573 . . . . 0.0 114.707 168.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.49 12.59 84.38 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 117.807 1.883 . . . . 0.0 117.807 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -74.08 160.86 30.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.352 1.576 . . . . 0.0 110.747 167.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ttm-85 -122.89 106.47 10.9 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.591 -1.318 . . . . 0.0 109.427 -166.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 m -102.42 126.37 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.313 1.53 . . . . 0.0 111.134 -166.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.04 -88.52 0.62 Allowed 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.085 -1.635 . . . . 0.0 112.172 -160.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.54 134.71 33.99 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 121.107 -0.996 . . . . 0.0 112.564 -166.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.58 105.24 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.85 -1.156 . . . . 0.0 108.879 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.264 1.4 t-20 55.92 43.09 27.99 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.093 2.157 . . . . 0.0 113.337 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.69 -28.39 15.73 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 124.469 1.033 . . . . 0.0 113.635 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.4 t -84.18 109.14 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 124.451 1.1 . . . . 0.0 113.122 -166.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -78.52 98.61 6.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.053 1.341 . . . . 0.0 110.435 172.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.39 75.21 1.6 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.151 1.453 . . . . 0.0 109.674 -170.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.42 143.67 54.98 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.687 -1.883 . . . . 0.0 112.986 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.16 7.37 65.72 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.478 -1.389 . . . . 0.0 114.668 -175.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.79 147.03 37.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.584 -1.539 . . . . 0.0 113.709 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 p -93.09 170.57 9.54 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.739 1.616 . . . . 0.0 109.494 166.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -60.79 -41.67 96.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.815 -1.178 . . . . 0.0 112.761 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -49.07 -51.32 32.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.815 1.646 . . . . 0.0 114.84 168.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -70.77 -36.19 72.95 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.23 -1.544 . . . . 0.0 112.826 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.09 98.19 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.017 -1.677 . . . . 0.0 113.433 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.0 t -67.66 -43.73 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 C-N-CA 125.35 1.46 . . . . 0.0 111.914 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.88 -12.91 60.81 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 120.251 -1.53 . . . . 0.0 114.195 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.4 m -71.17 -57.65 4.3 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.993 -2.317 . . . . 0.0 110.214 171.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.8 -20.45 42.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -72.5 -23.23 60.99 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.831 -1.793 . . . . 0.0 112.795 166.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -90.64 52.82 2.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 119.502 -1.999 . . . . 0.0 111.865 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.2 p -109.04 -94.06 0.41 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.893 1.677 . . . . 0.0 110.478 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.02 -59.86 0.57 Allowed Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 124.825 1.202 . . . . 0.0 112.565 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -84.68 -77.17 0.28 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.957 -1.32 . . . . 0.0 114.097 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.84 143.2 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.818 1.647 . . . . 0.0 111.445 -161.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.4 t -126.5 128.97 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.93 1.692 . . . . 0.0 109.941 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -143.02 115.21 8.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.662 -1.899 . . . . 0.0 109.763 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.3 mt -128.2 153.77 46.54 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.587 -1.321 . . . . 0.0 111.306 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.8 130.9 55.15 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.65 151.56 37.45 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -103.6 134.59 46.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -74.99 137.64 41.69 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.655 -1.278 . . . . 0.0 114.398 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.729 0 CA-C-O 122.889 1.272 . . . . 0.0 116.201 -167.826 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.9 t -120.05 138.93 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.591 -1.318 . . . . 0.0 109.873 -152.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 13.9 m -128.21 157.42 40.89 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.802 -1.186 . . . . 0.0 112.666 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.27 154.74 45.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.061 -1.025 . . . . 0.0 110.095 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.259 1.578 0 C-N-CA 125.378 1.471 . . . . 0.0 107.45 169.413 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.661 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -82.89 171.68 13.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.3 mp -89.14 132.43 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.38 -1.45 . . . . 0.0 110.968 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -133.16 161.73 33.65 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.751 -1.218 . . . . 0.0 111.834 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -109.91 134.62 51.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 124.86 1.264 . . . . 0.0 110.924 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -103.18 149.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.503 -1.373 . . . . 0.0 111.21 163.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.9 105.89 8.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 167.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.409 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 12.2 tp -134.43 -179.32 5.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.875 -1.141 . . . . 0.0 108.402 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.409 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -140.61 172.67 12.39 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 120.16 -1.587 . . . . 0.0 109.906 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -71.9 111.97 7.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.598 1.559 . . . . 0.0 110.889 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -113.71 -83.28 0.6 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.377 1.071 . . . . 0.0 110.176 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -82.86 -47.42 11.86 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.768 -1.208 . . . . 0.0 109.513 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -137.6 -172.69 3.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 167.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 t -83.85 -72.55 0.46 Allowed 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.916 -1.115 . . . . 0.0 111.452 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.38 -84.4 0.45 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.963 -1.086 . . . . 0.0 110.379 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.82 54.34 0.68 Allowed Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 116.175 1.23 . . . . 0.0 116.175 170.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.65 174.12 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 119.195 1.498 . . . . 0.0 112.437 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.8 p -122.63 135.91 54.74 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.152 1.381 . . . . 0.0 109.545 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -123.36 142.7 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.497 1.519 . . . . 0.0 110.634 -163.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.1 t -136.4 111.3 8.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.653 1.692 . . . . 0.0 111.589 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -134.15 11.86 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 125.242 1.401 . . . . 0.0 111.503 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.1 23.39 32.44 Favored Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.84 -127.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 121.018 -1.284 . . . . 0.0 113.11 -172.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -79.38 -44.25 21.86 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.073 -1.642 . . . . 0.0 112.75 -164.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -151.98 103.19 2.88 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 166.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.9 p -134.71 -75.94 0.46 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.327 -1.483 . . . . 0.0 110.44 -172.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.16 -54.84 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 124.704 1.202 . . . . 0.0 110.272 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -134.18 -164.12 1.46 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.03 78.39 3.57 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.911 -1.743 . . . . 0.0 111.508 166.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.75 -177.4 21.19 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -166.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.48 148.6 12.45 Favored Glycine 0 N--CA 1.431 -1.687 0 O-C-N 121.458 -1.025 . . . . 0.0 111.119 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.9 mm -127.23 142.31 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -171.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.44 130.91 53.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.69 -1.256 . . . . 0.0 109.589 -169.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.3 t -84.22 134.94 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 124.38 1.072 . . . . 0.0 111.438 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -88.83 -59.26 2.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.31 1.444 . . . . 0.0 111.199 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.9 159.49 29.75 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 123.575 0.75 . . . . 0.0 111.463 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 p -91.59 128.15 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 122.586 1.184 . . . . 0.0 113.017 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.2 mm -84.45 131.69 49.42 Favored Pre-proline 0 N--CA 1.43 -1.458 0 C-N-CA 126.175 1.79 . . . . 0.0 110.866 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.36 41.64 1.17 Allowed 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 123.546 2.831 . . . . 0.0 114.593 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -147.48 66.34 1.13 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.664 1.585 . . . . 0.0 107.235 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.74 175.79 46.34 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 119.69 -1.881 . . . . 0.0 115.438 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.15 -34.93 78.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.305 1.042 . . . . 0.0 112.275 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.37 -56.02 24.92 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.744 1.618 . . . . 0.0 113.936 175.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.61 -47.16 67.39 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.044 -1.035 . . . . 0.0 112.372 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.3 m -60.18 -47.77 84.56 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.68 -51.9 30.45 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.562 -1.336 . . . . 0.0 112.538 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.07 78.62 0.95 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 120.82 -1.175 . . . . 0.0 111.575 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.6 ttt85 -138.82 -34.61 0.6 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.956 -0.731 . . . . 0.0 112.315 -158.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 mt -128.9 170.25 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -140.95 -177.8 5.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.293 -2.754 . . . . 0.0 112.036 165.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.45 143.05 30.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.774 -1.829 . . . . 0.0 113.743 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.87 8.15 81.98 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 117.576 1.79 . . . . 0.0 117.576 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -80.77 154.69 27.07 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 119.274 1.537 . . . . 0.0 109.157 163.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -137.05 128.66 28.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.976 -1.703 . . . . 0.0 112.39 -164.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.0 m -80.13 162.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.972 -1.705 . . . . 0.0 115.292 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 mp -119.88 -86.68 0.65 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.23 1.812 . . . . 0.0 106.981 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 160.49 14.25 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -170.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.1 t -108.78 98.54 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.49 1.516 . . . . 0.0 107.108 165.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 56.38 54.51 7.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.671 1.588 . . . . 0.0 114.233 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.7 -32.02 4.39 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.434 -1.416 . . . . 0.0 114.18 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.91 121.82 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 124.627 1.171 . . . . 0.0 112.254 -171.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.1 m -77.72 133.59 38.28 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 120.632 -1.293 . . . . 0.0 112.216 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.49 63.3 7.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.506 -1.371 . . . . 0.0 109.677 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.52 104.0 1.17 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.029 1.731 . . . . 0.0 114.417 -168.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.08 29.26 74.62 Favored Glycine 0 N--CA 1.429 -1.775 0 O-C-N 120.43 -1.418 . . . . 0.0 114.888 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.2 158.15 30.5 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.229 1.412 . . . . 0.0 114.203 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 p -80.8 162.06 24.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.809 -1.182 . . . . 0.0 111.589 167.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -60.87 -42.25 97.52 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.365 1.466 . . . . 0.0 111.586 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -47.03 -46.07 21.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.266 1.826 . . . . 0.0 114.747 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -71.52 -38.69 71.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.288 -1.507 . . . . 0.0 113.436 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.7 96.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.965 -1.085 . . . . 0.0 113.412 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.66 -47.3 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 126.391 1.876 . . . . 0.0 112.772 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -54.51 -43.64 72.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.753 -1.217 . . . . 0.0 113.332 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.1 m -62.56 -50.3 71.88 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.128 1.771 . . . . 0.0 112.724 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.69 -12.27 59.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.955 -1.716 . . . . 0.0 115.594 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.31 -30.7 57.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.553 -1.967 . . . . 0.0 112.214 167.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -100.47 65.64 1.21 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.189 -1.569 . . . . 0.0 114.591 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.5 p -92.74 -68.24 0.81 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.157 -1.589 . . . . 0.0 112.091 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.66 -127.83 7.43 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 125.581 1.562 . . . . 0.0 110.76 -172.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -83.35 -45.65 13.5 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 p -115.4 145.46 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 121.287 -0.883 . . . . 0.0 113.286 -166.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.8 t -124.96 112.5 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.215 1.806 . . . . 0.0 110.48 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -120.46 110.91 17.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.244 -1.535 . . . . 0.0 110.412 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.4 mt -131.99 151.73 51.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.696 -1.252 . . . . 0.0 111.157 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.84 128.15 52.57 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.48 157.19 43.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.886 0.85 . . . . 0.0 111.262 -171.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -109.21 137.28 47.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.618 1.167 . . . . 0.0 109.069 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.28 130.4 41.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.487 1.136 . . . . 0.0 112.075 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.756 0 C-N-CA 125.867 1.699 . . . . 0.0 114.645 -175.057 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 . . . . . 0 N--CA 1.431 -1.416 0 CA-C-O 121.317 0.579 . . . . 0.0 112.14 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -121.67 136.43 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.012 1.725 . . . . 0.0 106.735 -170.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.2 m -128.37 167.95 16.25 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 120.579 -1.325 . . . . 0.0 111.427 -172.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.34 134.14 16.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 123.032 0.533 . . . . 0.0 110.337 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--O 1.259 1.593 0 C-N-CA 126.667 1.987 . . . . 0.0 108.45 172.572 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.749 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -82.73 -177.1 6.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.78 133.83 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.23 1.412 . . . . 0.0 109.712 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -132.81 158.67 41.89 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.105 -1.622 . . . . 0.0 111.339 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -117.68 140.2 49.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.147 0.975 . . . . 0.0 110.961 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.08 142.99 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.865 -1.147 . . . . 0.0 109.47 166.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -128.55 76.3 1.7 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 tp -113.35 171.1 7.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.564 -1.335 . . . . 0.0 110.505 -167.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.27 161.34 39.83 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.358 -1.464 . . . . 0.0 109.033 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -68.35 112.97 5.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.98 -1.075 . . . . 0.0 112.762 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -115.04 -78.98 0.58 Allowed 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 124.977 1.311 . . . . 0.0 109.743 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -82.38 -43.91 16.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.494 -1.379 . . . . 0.0 110.417 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -143.3 -177.63 5.46 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.752 1.221 . . . . 0.0 107.726 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.3 t -83.29 -83.14 0.14 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 124.726 1.211 . . . . 0.0 108.901 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.1 mp -101.85 -99.9 0.27 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.168 -0.957 . . . . 0.0 108.865 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.39 60.08 0.79 Allowed Glycine 0 N--CA 1.43 -1.74 0 O-C-N 120.276 -1.515 . . . . 0.0 115.313 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.52 175.09 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 121.284 -1.127 . . . . 0.0 108.028 170.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.2 p -121.31 145.53 47.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.542 -1.974 . . . . 0.0 108.663 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.6 t -123.76 167.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.247 1.419 . . . . 0.0 107.409 -168.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.9 t -136.99 67.59 1.44 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.314 2.007 . . . . 0.0 108.714 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.83 -137.17 18.32 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 120.237 -1.539 . . . . 0.0 112.513 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.9 93.9 1.47 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -166.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.29 -113.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 121.793 -0.827 . . . . 0.0 111.08 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -93.3 -62.69 1.32 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.725 -1.234 . . . . 0.0 111.36 -165.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 t -134.24 97.98 3.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.212 1.482 . . . . 0.0 108.52 166.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.2 p -134.64 -84.08 0.42 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.841 -1.162 . . . . 0.0 111.14 -162.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.13 -51.37 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 125.807 1.643 . . . . 0.0 110.154 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -138.17 -166.22 1.94 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 158.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.67 66.89 9.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.135 -1.603 . . . . 0.0 111.286 168.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.64 141.31 5.67 Favored Glycine 0 N--CA 1.429 -1.784 0 O-C-N 120.877 -1.14 . . . . 0.0 110.868 -171.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.8 155.17 26.16 Favored Glycine 0 N--CA 1.43 -1.72 0 O-C-N 121.488 -1.007 . . . . 0.0 111.946 -170.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.1 mm -133.44 152.33 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 124.821 1.248 . . . . 0.0 108.784 -164.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.85 124.76 43.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.158 -1.589 . . . . 0.0 110.66 -168.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.5 t -74.05 135.34 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.27 -1.519 . . . . 0.0 112.744 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -91.93 -68.01 0.82 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.921 -1.112 . . . . 0.0 112.372 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.89 157.69 35.32 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.162 -0.961 . . . . 0.0 109.914 -173.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.4 p -88.35 131.93 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.716 1.246 . . . . 0.0 113.167 -175.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.4 mm -84.61 126.15 69.54 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 117.514 -1.232 . . . . 0.0 108.315 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -81.5 34.93 0.56 Allowed 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 123.351 2.701 . . . . 0.0 113.797 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -144.84 64.1 1.29 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.661 1.984 . . . . 0.0 107.078 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.37 174.39 46.02 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 120.565 -1.334 . . . . 0.0 112.589 -177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.67 82.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.747 1.619 . . . . 0.0 113.432 -174.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.02 -49.2 66.75 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.063 1.745 . . . . 0.0 114.897 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.46 -35.69 34.56 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 124.092 0.957 . . . . 0.0 112.554 176.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.8 m -59.38 -51.51 69.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.971 -1.706 . . . . 0.0 114.018 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.3 -41.03 42.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 111.115 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.79 66.63 1.45 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 120.623 -1.298 . . . . 0.0 111.628 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 ttt85 -137.59 -20.86 1.16 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -160.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.52 154.21 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -139.95 178.87 6.96 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.965 -1.709 . . . . 0.0 111.14 171.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.84 138.06 56.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.94 19.5 79.91 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 116.964 1.546 . . . . 0.0 116.964 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -83.1 162.04 21.45 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 119.173 1.487 . . . . 0.0 109.41 164.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.9 ttm105 -127.59 123.98 37.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.964 -1.71 . . . . 0.0 110.353 -171.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.6 m -93.71 147.5 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.442 -1.411 . . . . 0.0 111.728 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.4 -88.67 0.62 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 123.923 0.889 . . . . 0.0 109.823 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.8 148.03 22.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.893 -1.754 . . . . 0.0 114.498 -169.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -109.83 88.64 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.32 1.448 . . . . 0.0 109.647 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 57.14 60.14 3.1 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.062 1.745 . . . . 0.0 114.946 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.47 -36.57 3.8 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 124.422 1.011 . . . . 0.0 113.101 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 t -95.85 114.14 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.804 -1.41 . . . . 0.0 112.261 -169.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.4 m -78.03 132.41 37.76 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.33 -1.481 . . . . 0.0 110.206 161.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.87 76.48 5.56 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.623 1.201 . . . . 0.0 109.848 -171.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.18 103.31 0.75 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 -165.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.64 14.23 72.3 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.397 -1.44 . . . . 0.0 114.325 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.9 141.88 40.35 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.688 1.195 . . . . 0.0 112.4 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 p -76.28 172.98 11.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.303 1.841 . . . . 0.0 113.475 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -60.59 -38.12 83.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.33 1.452 . . . . 0.0 113.591 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -58.84 -50.35 74.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.345 -1.472 . . . . 0.0 113.558 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -71.43 -39.46 71.02 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.247 1.419 . . . . 0.0 112.951 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.96 -42.57 99.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.278 -1.514 . . . . 0.0 113.804 175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -72.1 -38.79 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 119.854 -1.779 . . . . 0.0 111.815 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -58.41 -35.99 72.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.624 -1.297 . . . . 0.0 113.657 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.0 m -67.78 -41.23 83.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.526 1.93 . . . . 0.0 113.048 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 mt -80.47 -19.35 46.19 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.196 -1.565 . . . . 0.0 114.202 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -72.53 -25.8 61.51 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.855 -1.778 . . . . 0.0 112.307 166.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -88.91 70.83 8.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.942 -1.099 . . . . 0.0 112.625 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.0 p -104.41 -78.1 0.57 Allowed 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.997 -1.064 . . . . 0.0 110.131 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.24 -117.86 4.36 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -82.85 -49.62 9.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.13 147.29 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.785 -1.197 . . . . 0.0 113.24 -166.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.84 110.72 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.451 1.501 . . . . 0.0 110.024 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -124.16 111.3 15.74 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.934 -1.729 . . . . 0.0 111.328 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 69.6 mt -129.95 153.15 48.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.428 -0.795 . . . . 0.0 111.087 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.36 127.13 52.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.47 156.93 43.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.024 0.916 . . . . 0.0 111.88 -170.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -105.35 136.27 45.19 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.712 1.205 . . . . 0.0 109.119 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -70.03 131.85 44.98 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.302 1.041 . . . . 0.0 112.541 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.755 0 N-CA-C 116.677 1.431 . . . . 0.0 116.677 178.187 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.43 -1.428 0 CA-C-O 121.33 0.586 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.36 141.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 126.304 1.842 . . . . 0.0 106.61 -173.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 68.9 m -132.96 161.76 33.44 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.067 1.347 . . . . 0.0 112.635 -160.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.95 152.79 52.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.566 1.147 . . . . 0.0 111.901 170.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.26 1.609 0 C-N-CA 127.419 2.288 . . . . 0.0 107.553 168.509 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.737 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -81.65 159.56 23.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.985 -1.303 . . . . 0.0 113.728 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 mp -81.87 135.7 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.569 1.547 . . . . 0.0 109.509 -174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -138.53 150.58 46.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.404 1.082 . . . . 0.0 111.115 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.33 113.63 21.73 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.969 -1.082 . . . . 0.0 109.577 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.432 HG21 HD11 ' A' ' 52' ' ' ILE . 22.1 m -102.17 146.83 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.842 -1.162 . . . . 0.0 112.573 -173.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.71 134.32 55.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.054 0.942 . . . . 0.0 108.524 172.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.2 mt -130.93 148.02 52.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 161.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.97 135.3 46.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -66.92 118.63 10.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -119.1 -84.06 0.65 Allowed 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.58 -1.325 . . . . 0.0 111.657 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -77.35 -42.17 37.62 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.668 1.987 . . . . 0.0 109.888 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -156.43 -172.04 3.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 m -92.64 -73.88 0.54 Allowed 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.167 -0.958 . . . . 0.0 110.3 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.07 -91.06 0.34 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 118.93 0.786 . . . . 0.0 111.808 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.71 52.18 1.22 Allowed Glycine 0 N--CA 1.431 -1.687 0 O-C-N 120.0 -1.687 . . . . 0.0 111.465 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.2 tt -145.88 158.05 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 121.228 -1.16 . . . . 0.0 111.405 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.0 p -122.02 149.4 43.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.491 -1.381 . . . . 0.0 110.113 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.29 164.05 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.22 1.01 . . . . 0.0 108.549 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -137.7 151.99 48.8 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.408 -2.057 . . . . 0.0 105.691 165.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.64 -144.51 17.21 Favored Glycine 0 N--CA 1.431 -1.678 0 O-C-N 120.969 -1.082 . . . . 0.0 112.466 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.3 -4.46 86.03 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 124.745 1.164 . . . . 0.0 113.868 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -100.34 161.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 124.611 1.164 . . . . 0.0 108.792 -168.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -68.36 -19.51 64.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.131 2.172 . . . . 0.0 114.471 -162.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.5 t -130.34 126.97 38.47 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 152.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.5 p -156.21 -101.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.628 -1.295 . . . . 0.0 109.292 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.48 -41.97 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.317 -1.49 . . . . 0.0 110.876 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.438 ' HB3' ' H ' ' A' ' 32' ' ' HIS . 3.2 mmp_? -131.86 -145.18 0.26 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 162.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.438 ' H ' ' HB3' ' A' ' 31' ' ' ARG . 22.4 p-80 -79.5 55.63 1.99 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.45 2.3 . . . . 0.0 111.014 168.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.99 -160.1 14.81 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 107.111 -2.396 . . . . 0.0 107.111 -163.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.54 150.2 26.22 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 122.234 0.908 . . . . 0.0 112.345 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mm -125.91 132.73 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.238 -1.154 . . . . 0.0 108.208 -170.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.55 140.47 52.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 124.561 1.144 . . . . 0.0 108.707 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.9 t -78.97 127.65 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 O-C-N 120.36 -1.462 . . . . 0.0 110.961 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -90.12 -62.26 1.5 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.587 -1.32 . . . . 0.0 110.843 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.82 156.87 25.81 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.2 t -91.0 133.45 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.1 mm -83.21 127.62 68.16 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.967 -1.492 . . . . 0.0 108.643 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -80.35 41.79 1.2 Allowed 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 123.841 3.027 . . . . 0.0 113.386 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -145.58 53.12 1.17 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.92 2.488 . . . . 0.0 106.313 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.97 161.81 33.1 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.225 -1.547 . . . . 0.0 114.914 -174.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.76 -32.53 65.69 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 127.9 2.48 . . . . 0.0 115.766 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.66 -38.19 66.64 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 170.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -78.94 -39.2 35.22 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.427 1.091 . . . . 0.0 111.689 174.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.2 m -57.58 -48.24 79.92 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.413 -1.43 . . . . 0.0 113.179 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -73.96 -65.74 0.8 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.821 1.248 . . . . 0.0 112.827 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.63 79.21 0.79 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.342 -1.474 . . . . 0.0 114.852 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -138.87 -30.3 0.75 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.515 1.526 . . . . 0.0 110.882 -174.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.432 HD11 HG21 ' A' ' 9' ' ' VAL . 40.5 mt -125.73 138.65 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -140.16 -173.9 3.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.499 -1.376 . . . . 0.0 110.117 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -57.52 134.75 56.38 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.59 11.22 85.42 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 118.656 2.222 . . . . 0.0 118.656 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -76.45 154.68 34.54 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.238 2.019 . . . . 0.0 111.002 169.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.473 HH21 ' CD ' ' A' ' 90' ' ' GLU . 2.5 tmm_? -124.4 115.13 20.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.076 -1.64 . . . . 0.0 110.11 -161.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.3 m -94.82 154.08 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 119.658 -1.901 . . . . 0.0 114.191 -170.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.5 mt -121.81 -89.51 0.6 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.3 1.04 . . . . 0.0 110.33 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.83 141.5 31.54 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -165.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.1 t -95.4 102.64 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 124.473 1.109 . . . . 0.0 108.026 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.256 59.3 t30 57.94 42.42 22.95 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.859 1.663 . . . . 0.0 114.191 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.63 -27.25 21.06 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.535 -1.353 . . . . 0.0 113.959 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.1 t -91.33 113.31 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.345 -1.091 . . . . 0.0 111.967 -174.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -81.05 111.77 17.83 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.984 -1.072 . . . . 0.0 111.749 167.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.96 82.78 1.86 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.744 -1.223 . . . . 0.0 108.749 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.37 144.0 53.55 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.343 -2.098 . . . . 0.0 114.495 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.68 -15.31 52.91 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 120.693 -1.254 . . . . 0.0 114.897 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.68 128.58 37.15 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.836 1.655 . . . . 0.0 115.376 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 p -73.38 164.26 26.91 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.065 1.412 . . . . 0.0 111.01 172.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.12 -42.28 94.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -168.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -55.71 -38.22 69.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.356 1.862 . . . . 0.0 114.463 172.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -71.37 -43.63 66.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.253 1.421 . . . . 0.0 111.276 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.73 -48.82 70.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.82 -1.175 . . . . 0.0 113.539 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.13 -52.22 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 124.79 1.236 . . . . 0.0 113.503 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -71.46 -21.88 61.9 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 120.077 -1.639 . . . . 0.0 114.587 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.3 m -64.77 -40.49 95.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.354 -1.466 . . . . 0.0 111.57 169.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.61 -26.36 37.85 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.524 -1.36 . . . . 0.0 113.837 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -66.55 -43.35 85.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.021 -1.675 . . . . 0.0 112.154 168.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -78.14 53.85 1.27 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.719 1.608 . . . . 0.0 113.592 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.3 p -108.5 -86.6 0.51 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.85 2.06 . . . . 0.0 108.817 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.87 -57.45 1.83 Allowed Glycine 0 N--CA 1.43 -1.749 0 O-C-N 120.29 -1.506 . . . . 0.0 114.936 171.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -83.15 -68.23 0.72 Allowed 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 120.516 -1.579 . . . . 0.0 112.609 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.45 141.64 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 122.555 1.169 . . . . 0.0 110.249 -173.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.1 t -114.99 109.04 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 126.651 1.98 . . . . 0.0 107.489 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -117.24 127.68 54.33 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.841 -1.162 . . . . 0.0 110.478 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.5 mt -141.42 152.46 44.3 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 123.847 0.859 . . . . 0.0 111.78 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -122.32 123.9 42.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.827 1.251 . . . . 0.0 107.951 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.43 165.82 29.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.635 1.207 . . . . 0.0 111.622 -173.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.473 ' CD ' HH21 ' A' ' 57' ' ' ARG . 29.8 tt0 -112.03 141.33 45.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.303 1.841 . . . . 0.0 108.325 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -71.64 137.7 48.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.525 -1.359 . . . . 0.0 112.093 171.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.686 0 CA-C-O 123.467 1.593 . . . . 0.0 115.915 -176.177 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 68.6 t -120.86 139.27 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.199 2.2 . . . . 0.0 105.482 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 11.6 m -132.28 140.54 48.66 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.164 1.386 . . . . 0.0 114.563 -156.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.54 157.58 31.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.972 1.709 . . . . 0.0 112.088 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.262 1.719 0 C-N-CA 125.211 1.404 . . . . 0.0 108.809 -179.474 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.655 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -80.57 155.98 26.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 123.334 1.54 . . . . 0.0 114.381 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.8 mt -86.55 135.86 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 125.645 1.578 . . . . 0.0 109.121 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -145.13 166.52 25.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.203 1.001 . . . . 0.0 108.84 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -124.63 143.7 50.58 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.282 -0.886 . . . . 0.0 109.869 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.6 m -103.43 148.75 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 123.425 0.69 . . . . 0.0 109.799 171.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -129.39 93.48 3.57 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.8 tp -122.61 163.06 20.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -172.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.88 172.14 13.4 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.045 -1.659 . . . . 0.0 109.014 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -71.63 103.83 3.15 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.997 -1.064 . . . . 0.0 113.115 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -97.97 -70.87 0.71 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.902 1.281 . . . . 0.0 109.465 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -70.43 -76.91 0.09 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.724 2.01 . . . . 0.0 110.003 172.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -138.21 -176.86 4.59 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.818 -3.031 . . . . 0.0 102.818 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 t -79.48 -61.46 2.0 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.775 -1.828 . . . . 0.0 112.881 -162.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.2 mp -101.76 -88.18 0.38 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.175 -1.578 . . . . 0.0 111.32 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.6 45.08 2.01 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tt -152.41 147.34 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 120.948 -1.325 . . . . 0.0 110.49 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 t -122.17 158.52 29.19 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.899 -1.126 . . . . 0.0 109.926 -174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.576 HG11 ' CE1' ' A' ' 71' ' ' HIS . 33.0 t -121.4 162.48 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.042 1.337 . . . . 0.0 109.299 -158.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 t -147.69 149.68 32.91 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 165.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.81 -149.87 43.73 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.62 12.88 57.69 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 118.231 2.052 . . . . 0.0 118.231 168.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.04 -107.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 119.128 1.464 . . . . 0.0 114.491 -161.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -89.89 -41.47 11.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.361 -2.087 . . . . 0.0 110.793 -172.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 t -136.31 152.64 50.9 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 158.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -155.37 -93.04 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.431 -1.418 . . . . 0.0 110.835 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.47 -52.67 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 C-N-CA 125.044 1.337 . . . . 0.0 110.016 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.5 ptt-85 -125.98 -139.05 0.27 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.446 -1.686 . . . . 0.0 106.446 154.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -75.67 67.35 2.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.773 1.749 . . . . 0.0 110.823 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.45 -176.58 16.42 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 126.181 1.848 . . . . 0.0 109.333 -171.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.63 151.52 27.02 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.68 159.3 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.52 157.21 35.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.468 -1.395 . . . . 0.0 109.747 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 t -92.53 128.25 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 124.963 1.305 . . . . 0.0 111.849 -174.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -97.17 -67.39 0.85 Allowed 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.691 -1.256 . . . . 0.0 113.342 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.21 153.05 28.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.827 -1.17 . . . . 0.0 112.637 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.94 119.87 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 126.309 1.843 . . . . 0.0 109.246 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.4 mm -84.54 131.52 49.71 Favored Pre-proline 0 N--CA 1.43 -1.451 0 C-N-CA 125.054 1.341 . . . . 0.0 109.685 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -77.11 64.23 7.79 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 CA-C-N 124.295 2.57 . . . . 0.0 112.65 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -160.33 53.95 0.33 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.869 1.319 . . . . 0.0 109.202 173.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.72 179.95 45.7 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.385 -2.072 . . . . 0.0 112.908 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.36 -32.79 72.71 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.734 1.614 . . . . 0.0 114.703 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.75 -42.35 71.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.845 1.658 . . . . 0.0 114.411 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -91.33 -47.18 7.62 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.779 1.232 . . . . 0.0 112.0 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.4 m -68.39 -36.6 79.39 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -173.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -84.4 -49.2 8.9 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.189 1.359 . . . . 0.0 109.327 165.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.89 90.43 2.16 Favored Glycine 0 N--CA 1.43 -1.701 0 O-C-N 121.02 -1.05 . . . . 0.0 111.672 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -137.83 -54.5 0.66 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -166.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.0 mt -126.36 145.98 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 119.197 -2.189 . . . . 0.0 107.387 -165.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -119.2 174.05 6.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.462 1.125 . . . . 0.0 112.386 -170.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -61.12 136.03 57.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 167.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 26.51 62.63 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 119.154 2.422 . . . . 0.0 119.154 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -79.9 176.18 9.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 118.776 1.288 . . . . 0.0 110.737 162.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -124.75 121.09 33.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.969 -1.707 . . . . 0.0 109.248 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -94.17 153.46 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 120.028 -1.67 . . . . 0.0 112.193 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.0 tp -125.9 -81.42 0.62 Allowed 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 121.059 -1.025 . . . . 0.0 112.073 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.88 151.18 21.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.527 -1.358 . . . . 0.0 114.385 -166.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.75 92.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 125.999 1.719 . . . . 0.0 107.066 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 56.37 54.61 7.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.468 1.507 . . . . 0.0 114.555 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.27 -40.31 2.47 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 124.329 0.966 . . . . 0.0 114.649 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 t -99.31 136.17 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 O-C-N 121.425 -1.044 . . . . 0.0 111.381 -169.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 t -77.72 144.99 36.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.87 -1.769 . . . . 0.0 110.97 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -90.89 -9.43 46.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.455 -1.403 . . . . 0.0 113.305 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.02 144.53 33.87 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -172.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.1 -43.84 1.87 Allowed Glycine 0 N--CA 1.431 -1.699 0 O-C-N 121.176 -0.953 . . . . 0.0 113.017 -161.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.01 160.0 28.42 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.614 -1.521 . . . . 0.0 114.516 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.8 p -84.85 167.74 15.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.444 1.898 . . . . 0.0 111.174 175.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.576 ' CE1' HG11 ' A' ' 22' ' ' VAL . 11.1 t60 -60.67 -37.45 81.64 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.42 1.488 . . . . 0.0 114.052 171.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -54.5 -45.86 73.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.956 2.102 . . . . 0.0 114.221 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -76.18 -34.23 59.33 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.086 -1.634 . . . . 0.0 112.723 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.84 96.74 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.551 1.541 . . . . 0.0 114.481 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.7 m -73.88 -24.06 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.974 -1.704 . . . . 0.0 113.787 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -67.91 -45.26 74.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.406 -1.434 . . . . 0.0 112.183 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.6 m -59.97 -33.12 71.51 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 126.745 2.018 . . . . 0.0 112.828 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.26 -54.71 5.7 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.76 -1.213 . . . . 0.0 112.574 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -68.5 -5.43 19.45 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -169.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -85.49 11.96 9.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.152 -1.592 . . . . 0.0 115.192 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 p -102.14 -103.84 0.27 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.471 1.508 . . . . 0.0 110.015 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.95 -57.57 0.47 Allowed Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.201 -1.562 . . . . 0.0 113.376 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -71.33 -67.94 0.48 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.8 p -109.46 140.43 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 122.459 1.123 . . . . 0.0 112.057 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.9 t -119.82 112.1 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 125.155 1.382 . . . . 0.0 109.774 -175.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -116.53 115.35 25.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.017 -1.052 . . . . 0.0 108.378 168.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.2 tp -128.41 146.35 50.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.932 1.293 . . . . 0.0 108.595 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -120.74 123.02 41.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.32 157.65 44.58 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 122.243 1.021 . . . . 0.0 110.5 -170.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -104.68 141.37 36.56 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -65.23 135.45 55.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.629 1.204 . . . . 0.0 113.457 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.694 0 CA-C-O 122.596 1.109 . . . . 0.0 113.175 176.465 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 . . . . . 0 N--CA 1.429 -1.484 0 CA-C-O 121.244 0.545 . . . . 0.0 111.681 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -121.3 158.33 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.069 2.148 . . . . 0.0 107.752 -169.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.8 m -141.71 159.29 42.53 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.08 -1.637 . . . . 0.0 112.987 -168.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.53 161.77 38.99 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.475 0.655 . . . . 0.0 111.721 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.504 1.922 . . . . 0.0 106.437 174.559 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.71 0 N-CA-C 112.637 -0.185 . . . . 0.0 112.637 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.31 168.62 18.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.8 135.06 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 126.424 1.89 . . . . 0.0 109.409 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -146.99 169.62 18.82 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.797 1.284 . . . . 0.0 113.568 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.09 125.94 40.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.994 1.318 . . . . 0.0 111.457 -174.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.2 m -104.78 147.91 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.303 -1.498 . . . . 0.0 113.805 172.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -130.85 104.08 6.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.132 1.373 . . . . 0.0 109.833 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 tp -123.28 174.9 7.01 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.795 1.238 . . . . 0.0 108.199 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.23 163.52 32.72 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.669 -1.894 . . . . 0.0 105.928 166.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -62.38 120.61 11.37 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -117.92 -89.07 0.6 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.617 1.167 . . . . 0.0 109.298 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.12 -49.66 41.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.68 1.592 . . . . 0.0 110.976 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -151.5 -162.83 1.62 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -84.63 -61.54 1.77 Allowed 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 120.511 1.505 . . . . 0.0 110.018 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 mp -104.1 -93.55 0.34 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.504 -1.373 . . . . 0.0 111.723 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.87 51.74 1.25 Allowed Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 124.793 1.187 . . . . 0.0 110.602 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.7 tt -150.2 163.57 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 121.329 -1.101 . . . . 0.0 110.791 -174.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -121.85 148.02 45.24 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.405 -1.435 . . . . 0.0 110.135 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -126.01 156.78 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 126.04 1.736 . . . . 0.0 109.633 -166.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -138.69 151.17 46.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.182 -0.949 . . . . 0.0 109.532 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.78 -149.8 50.8 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 125.641 1.591 . . . . 0.0 115.804 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.03 36.88 13.79 Favored Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 116.677 1.431 . . . . 0.0 116.677 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.54 -108.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -166.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -90.25 -52.48 4.91 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.802 -1.811 . . . . 0.0 110.852 -169.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -137.38 135.42 36.96 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 161.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 t -155.72 -84.27 0.06 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.107 -1.621 . . . . 0.0 110.325 -163.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.48 -58.5 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -116.89 -138.36 0.36 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 161.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 66.06 2.19 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.979 -1.7 . . . . 0.0 110.711 164.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.99 -147.3 16.46 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -168.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.63 145.32 14.91 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 121.712 -0.875 . . . . 0.0 111.3 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.6 mm -123.47 145.7 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.485 -1.597 . . . . 0.0 108.969 -160.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.75 141.23 52.11 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.118 1.367 . . . . 0.0 110.078 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.82 136.32 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.77 -1.207 . . . . 0.0 112.897 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -97.11 -66.64 0.89 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.058 1.343 . . . . 0.0 112.05 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.25 159.28 39.93 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.17 -0.956 . . . . 0.0 110.456 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.33 131.85 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 125.673 1.589 . . . . 0.0 110.781 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.5 mm -83.83 122.27 76.26 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 117.451 -1.262 . . . . 0.0 108.104 170.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.9 40.99 1.03 Allowed 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.474 2.782 . . . . 0.0 113.11 -171.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -160.59 78.0 0.62 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.23 170.39 43.51 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.76 -34.47 74.51 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.743 1.217 . . . . 0.0 113.07 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.91 -42.95 69.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -92.2 -37.7 12.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.861 1.264 . . . . 0.0 112.993 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.3 m -68.0 -35.57 78.54 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.282 -1.511 . . . . 0.0 114.549 -177.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.13 -60.27 2.44 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.103 0.954 . . . . 0.0 109.782 167.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.39 68.63 0.61 Allowed Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -136.72 -42.4 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.839 -0.801 . . . . 0.0 112.27 -155.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 mt -127.84 121.14 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -117.85 -179.63 3.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.317 1.056 . . . . 0.0 111.086 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -59.58 142.13 53.44 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.07 6.41 82.72 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 119.284 2.473 . . . . 0.0 119.284 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.76 170.51 16.45 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.684 1.742 . . . . 0.0 113.019 173.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -131.84 91.09 2.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.951 -1.718 . . . . 0.0 111.016 -166.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.09 160.63 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.43 -2.044 . . . . 0.0 113.288 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.1 tp -141.79 -82.97 0.2 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.728 -1.232 . . . . 0.0 113.041 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.32 146.88 24.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.33 -1.482 . . . . 0.0 114.796 -165.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.3 t -113.71 89.48 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 126.723 2.009 . . . . 0.0 107.71 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.7 t30 57.55 58.47 3.76 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.602 1.561 . . . . 0.0 112.712 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.44 -41.54 3.09 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.842 -1.161 . . . . 0.0 113.963 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.0 122.28 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.559 -1.553 . . . . 0.0 110.963 -173.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -77.39 141.14 39.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.105 -1.622 . . . . 0.0 111.417 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 pp -88.23 -2.8 58.81 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.19 142.89 57.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -171.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.05 -29.72 11.58 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 120.619 -1.301 . . . . 0.0 113.153 -166.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.86 153.84 32.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 p -83.0 170.6 14.72 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.856 -1.153 . . . . 0.0 112.039 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -55.29 -46.26 76.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.545 1.538 . . . . 0.0 114.985 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -60.14 -40.7 90.74 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -72.25 -38.98 68.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.326 -1.484 . . . . 0.0 111.964 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.45 96.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.783 1.633 . . . . 0.0 114.527 175.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.9 m -69.26 -37.49 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.395 -1.441 . . . . 0.0 113.163 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.78 -40.68 89.1 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.927 1.291 . . . . 0.0 112.915 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.1 m -58.35 -38.53 77.39 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.202 2.201 . . . . 0.0 113.202 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.84 -33.02 30.88 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.792 1.237 . . . . 0.0 112.993 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -69.99 -47.08 63.65 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.766 -1.209 . . . . 0.0 113.92 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.347 0.0 OUTLIER -89.97 42.45 1.09 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.8 p -93.1 -71.88 0.63 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.444 1.498 . . . . 0.0 109.669 171.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.94 -99.55 0.89 Allowed Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.08 1.8 . . . . 0.0 113.509 172.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -79.66 -47.68 14.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -159.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.31 146.7 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 121.046 -1.033 . . . . 0.0 111.993 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.32 112.76 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 120.311 -1.493 . . . . 0.0 110.092 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -114.84 118.85 34.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 163.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.6 tt -145.67 143.77 30.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.401 -0.812 . . . . 0.0 110.091 -170.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.06 126.49 49.98 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -173.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.23 164.66 29.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.06 1.409 . . . . 0.0 112.011 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -117.74 141.51 48.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 174.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -73.61 138.35 44.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.247 1.023 . . . . 0.0 111.582 175.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.761 0 CA-C-O 123.049 1.361 . . . . 0.0 116.024 -174.673 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.38 146.18 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.901 -1.124 . . . . 0.0 109.519 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.8 m -136.96 176.56 8.6 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.573 -1.329 . . . . 0.0 113.07 -172.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.91 157.22 42.96 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.099 1.36 . . . . 0.0 108.827 168.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 C--O 1.258 1.549 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 176.808 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.744 0 CA-C-O 119.802 -0.443 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.97 138.13 47.81 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.882 1.325 . . . . 0.0 114.57 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.61 140.65 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.25 1.82 . . . . 0.0 108.595 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.501 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -161.04 161.91 31.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.195 -0.941 . . . . 0.0 110.566 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.51 127.89 54.95 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 120.977 -1.077 . . . . 0.0 109.212 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.28 131.95 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 122.587 1.184 . . . . 0.0 111.284 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -116.63 123.47 47.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.414 1.102 . . . . 0.0 109.846 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.4 tp -135.22 168.23 19.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.99 160.73 31.0 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.0 tttp -70.88 103.65 2.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.107 -0.996 . . . . 0.0 111.05 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -100.66 -93.66 0.28 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.16 1.784 . . . . 0.0 109.401 -166.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.0 -47.44 45.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.297 -1.502 . . . . 0.0 109.133 167.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -147.66 -153.83 0.51 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 167.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 p -83.47 -90.94 0.08 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.231 -1.543 . . . . 0.0 111.361 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.64 -85.22 0.43 Allowed 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 120.459 -1.4 . . . . 0.0 113.317 -173.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.46 42.74 1.44 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 125.327 1.441 . . . . 0.0 110.985 -168.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.3 tt -134.89 152.66 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 121.124 -1.221 . . . . 0.0 109.552 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.2 p -122.27 153.87 38.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.478 -1.389 . . . . 0.0 111.738 -171.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.66 159.6 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.133 1.373 . . . . 0.0 108.982 -164.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.2 t -138.04 142.36 40.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.67 -149.3 50.44 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.781 1.658 . . . . 0.0 114.921 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.82 34.29 5.78 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 124.5 1.048 . . . . 0.0 115.456 165.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.14 -92.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 121.663 -0.904 . . . . 0.0 111.216 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -98.32 -51.09 4.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.453 -1.404 . . . . 0.0 110.103 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.9 131.41 14.8 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.83 -1.169 . . . . 0.0 110.832 175.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -154.83 -74.2 0.11 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.285 1.034 . . . . 0.0 110.661 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -79.46 -48.71 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.459 -1.401 . . . . 0.0 110.137 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -132.08 -159.67 0.98 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 161.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -71.7 110.76 6.46 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 120.329 -1.482 . . . . 0.0 108.76 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.22 -179.76 23.86 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 121.063 -1.023 . . . . 0.0 113.905 -167.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.79 161.45 27.79 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.451 -1.617 . . . . 0.0 112.075 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.8 mm -126.68 142.51 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.3 1.84 . . . . 0.0 107.986 -162.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.88 138.46 52.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.968 1.307 . . . . 0.0 109.451 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.86 133.58 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.712 -1.242 . . . . 0.0 112.714 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -90.85 -65.64 1.0 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.216 1.007 . . . . 0.0 110.87 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.73 160.9 31.95 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.356 -0.84 . . . . 0.0 111.946 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.05 125.59 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.998 1.319 . . . . 0.0 110.46 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.08 133.99 47.09 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.967 -1.492 . . . . 0.0 109.085 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.35 43.31 1.46 Allowed 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 124.772 2.74 . . . . 0.0 114.089 -173.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -153.57 47.66 0.66 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.851 -1.156 . . . . 0.0 109.721 -166.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.01 -172.7 39.51 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 120.237 -1.539 . . . . 0.0 112.517 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.85 -29.35 69.79 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.626 1.97 . . . . 0.0 113.214 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.29 94.62 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 125.987 1.715 . . . . 0.0 114.044 174.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -73.71 -43.59 58.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.804 1.242 . . . . 0.0 111.909 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 t -62.16 -55.56 27.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.182 1.393 . . . . 0.0 114.149 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.69 -60.32 2.37 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.915 -1.116 . . . . 0.0 111.091 175.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.31 87.13 1.43 Allowed Glycine 0 N--CA 1.43 -1.756 0 O-C-N 121.371 -0.831 . . . . 0.0 112.105 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.43 -26.77 0.98 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 121.238 -1.154 . . . . 0.0 112.789 -164.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.5 mm -126.56 136.89 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -119.33 171.31 8.41 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.678 -1.264 . . . . 0.0 112.546 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.14 143.91 42.26 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.44 15.21 81.68 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 116.445 1.338 . . . . 0.0 116.445 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -82.43 158.39 23.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.092 1.357 . . . . 0.0 113.496 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -127.17 114.43 17.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.888 1.675 . . . . 0.0 111.715 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 m -79.93 157.49 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.864 -1.772 . . . . 0.0 113.717 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 mp -121.53 -90.97 0.57 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 125.643 1.577 . . . . 0.0 107.41 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.19 159.48 16.04 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.312 -2.117 . . . . 0.0 114.213 -166.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.94 80.13 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.389 1.875 . . . . 0.0 106.658 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.5 t30 57.86 69.7 0.71 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.849 1.66 . . . . 0.0 112.768 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.55 -55.62 2.71 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 120.592 -1.318 . . . . 0.0 114.456 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -86.12 138.36 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.545 1.164 . . . . 0.0 113.171 -170.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -79.26 155.43 28.54 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.539 -1.351 . . . . 0.0 113.1 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 pp -85.91 4.25 38.3 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 125.307 1.443 . . . . 0.0 113.874 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -62.13 120.33 10.68 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.617 -1.302 . . . . 0.0 114.249 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.68 -39.58 2.65 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 125.77 1.653 . . . . 0.0 112.984 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.65 140.33 51.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -168.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.68 -178.56 5.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.337 1.455 . . . . 0.0 109.377 172.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -60.29 -49.95 75.56 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.402 -1.436 . . . . 0.0 114.483 -171.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -54.27 -43.12 70.74 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 125.136 1.374 . . . . 0.0 113.77 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -71.67 -41.2 69.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.016 -1.053 . . . . 0.0 112.717 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.51 92.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.333 -1.48 . . . . 0.0 114.374 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -72.15 -40.25 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.003 -1.685 . . . . 0.0 112.351 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -72.37 -31.81 65.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.283 -1.511 . . . . 0.0 114.117 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.5 p -70.42 -26.15 63.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.222 -1.549 . . . . 0.0 113.157 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.23 -40.52 26.89 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 121.062 -1.024 . . . . 0.0 112.011 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -60.68 -56.0 26.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.545 -1.347 . . . . 0.0 113.676 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -84.03 59.32 5.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.673 -1.267 . . . . 0.0 111.379 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.49 -69.63 0.63 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.044 2.138 . . . . 0.0 107.59 166.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.71 -117.74 3.95 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -65.5 -63.62 1.05 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.71 138.04 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 122.488 1.137 . . . . 0.0 111.478 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.19 87.42 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 125.646 1.578 . . . . 0.0 106.791 -175.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -116.29 126.02 52.98 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 120.273 -1.517 . . . . 0.0 108.996 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . 0.266 0.0 OUTLIER -147.34 162.67 38.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.637 -1.289 . . . . 0.0 111.927 -179.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -121.41 131.2 54.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.679 1.592 . . . . 0.0 107.729 -170.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.501 HD11 ' CZ ' ' A' ' 7' ' ' PHE . 1.3 pt? -140.87 162.99 34.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.515 1.15 . . . . 0.0 111.602 -171.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -134.89 120.19 18.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.426 1.49 . . . . 0.0 107.527 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -62.39 143.91 56.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -174.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.728 0 O-C-N 121.299 -0.876 . . . . 0.0 113.93 -175.423 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.4 157.79 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.739 -1.851 . . . . 0.0 109.423 -159.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.5 p -139.21 168.0 20.82 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.328 -1.482 . . . . 0.0 114.429 -172.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.54 160.19 43.68 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.188 1.395 . . . . 0.0 108.812 162.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 74.1 t . . . . . 0 C--O 1.26 1.644 0 N-CA-C 106.041 -1.836 . . . . 0.0 106.041 176.71 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.672 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -82.78 168.02 17.57 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.394 1.092 . . . . 0.0 112.495 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -78.39 135.54 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.186 1.794 . . . . 0.0 108.946 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -136.23 156.04 49.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.522 -1.361 . . . . 0.0 110.479 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -116.09 134.11 55.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 121.044 -1.035 . . . . 0.0 111.334 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.8 t -102.9 125.08 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 124.563 1.145 . . . . 0.0 109.597 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -124.72 70.89 1.14 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.524 1.53 . . . . 0.0 108.032 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tp -112.69 -160.88 0.73 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.468 -1.395 . . . . 0.0 110.38 -166.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.45 151.68 30.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.546 -1.346 . . . . 0.0 107.977 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -73.57 101.98 3.74 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.908 -1.12 . . . . 0.0 112.464 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -90.75 -71.39 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.264 1.026 . . . . 0.0 110.187 172.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -86.6 -69.2 0.69 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.488 1.515 . . . . 0.0 111.325 174.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -136.76 165.5 25.78 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 102.132 -3.284 . . . . 0.0 102.132 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 p -83.05 -51.24 7.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.458 -1.401 . . . . 0.0 112.241 -174.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 mt -102.36 -89.95 0.36 Allowed 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 121.057 -1.027 . . . . 0.0 113.457 172.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.49 53.78 1.93 Allowed Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -159.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 tt -145.79 159.13 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 121.1 -1.235 . . . . 0.0 110.782 -173.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -123.22 147.67 46.65 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.688 -1.883 . . . . 0.0 109.686 -175.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.14 147.49 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 125.691 1.596 . . . . 0.0 111.107 -167.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -137.96 126.59 23.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.437 1.113 . . . . 0.0 111.604 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.43 65.43 3.17 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 118.449 2.14 . . . . 0.0 118.449 164.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.66 75.78 0.32 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.58 -108.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 124.602 1.161 . . . . 0.0 111.044 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -72.63 -76.42 0.12 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.735 2.014 . . . . 0.0 111.633 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -144.26 121.1 11.27 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.225 -1.547 . . . . 0.0 109.315 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 p -138.87 -73.97 0.39 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.738 -1.226 . . . . 0.0 112.878 -170.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -66.13 -60.63 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 126.224 1.81 . . . . 0.0 111.564 -172.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ttm-85 -125.0 -115.83 0.29 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.11 62.6 2.56 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.101 1.36 . . . . 0.0 109.067 167.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.95 -139.56 14.45 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -163.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.78 155.94 28.29 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-O 121.939 0.744 . . . . 0.0 112.927 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.93 142.4 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -135.55 132.76 37.6 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.65 1.98 . . . . 0.0 110.351 -168.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.0 t -80.32 128.61 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.482 -1.386 . . . . 0.0 112.863 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -84.74 -55.1 4.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.067 1.747 . . . . 0.0 111.812 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.08 165.39 15.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.439 -0.788 . . . . 0.0 110.141 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 t -98.52 130.86 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 C-N-CA 125.64 1.576 . . . . 0.0 111.381 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mm -82.85 124.91 76.51 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 124.932 1.293 . . . . 0.0 109.65 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.36 32.22 0.52 Allowed 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 123.42 2.747 . . . . 0.0 114.326 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -142.79 52.57 1.4 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.863 1.265 . . . . 0.0 108.589 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -166.58 173.3 41.97 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 119.993 -1.692 . . . . 0.0 111.452 -176.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.71 73.04 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.461 1.504 . . . . 0.0 114.731 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.05 78.56 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 175.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -77.62 -28.93 51.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.761 1.224 . . . . 0.0 112.736 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.3 t -64.69 -56.4 13.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.578 -1.326 . . . . 0.0 113.381 173.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -79.63 -47.51 15.3 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.955 1.302 . . . . 0.0 112.005 -172.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.87 80.61 1.42 Allowed Glycine 0 N--CA 1.431 -1.644 0 O-C-N 121.035 -1.04 . . . . 0.0 111.217 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -139.87 -51.77 0.51 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.834 0.854 . . . . 0.0 112.714 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.1 mt -126.92 136.36 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 -168.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.81 -166.51 2.36 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 -175.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.13 125.16 21.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.7 15.88 81.21 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 117.307 1.683 . . . . 0.0 117.307 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -75.69 155.26 35.88 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 118.93 1.365 . . . . 0.0 111.131 167.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.87 131.32 40.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.461 -1.4 . . . . 0.0 109.562 -173.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.58 153.29 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.647 -1.908 . . . . 0.0 113.766 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.69 -84.51 0.66 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.807 1.643 . . . . 0.0 107.397 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 143.57 29.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.3 t -120.14 90.99 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.289 1.436 . . . . 0.0 108.398 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.275 22.2 t-20 57.24 64.48 1.6 Allowed 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 125.896 1.679 . . . . 0.0 112.281 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.17 -61.87 1.06 Allowed Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 124.691 1.139 . . . . 0.0 113.506 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.0 m -83.86 134.05 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.984 -1.304 . . . . 0.0 113.381 -164.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.3 t -77.79 124.98 28.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.779 -1.201 . . . . 0.0 110.376 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.8 tp -85.67 47.58 1.46 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 123.811 1.767 . . . . 0.0 113.995 -163.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -70.07 134.88 48.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.137 1.775 . . . . 0.0 112.6 166.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.82 -14.45 60.27 Favored Glycine 0 N--CA 1.431 -1.681 0 O-C-N 120.979 -1.076 . . . . 0.0 114.212 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.9 138.49 41.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.91 -1.347 . . . . 0.0 114.159 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 p -93.73 173.96 7.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.983 1.713 . . . . 0.0 109.369 166.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -61.46 -38.45 87.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -169.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -72.14 -27.4 62.59 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.549 -1.344 . . . . 0.0 113.68 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -78.55 -41.16 32.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.153 -1.592 . . . . 0.0 111.086 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.05 96.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.87 -44.31 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.892 -1.755 . . . . 0.0 112.942 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -66.31 -46.51 76.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.93 1.692 . . . . 0.0 113.788 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.8 p -64.54 -33.17 75.28 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.827 1.651 . . . . 0.0 114.434 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.6 mt -92.44 -16.7 25.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -76.35 -55.04 5.92 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.241 -1.537 . . . . 0.0 111.496 168.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -91.55 65.33 5.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.871 1.32 . . . . 0.0 112.175 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.9 p -86.65 -58.56 2.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.862 2.065 . . . . 0.0 109.923 171.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.77 -128.48 7.81 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 125.426 1.489 . . . . 0.0 111.126 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -81.36 -43.86 18.43 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.903 -1.351 . . . . 0.0 112.308 -170.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 p -104.82 140.96 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 122.113 0.959 . . . . 0.0 110.999 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.6 t -119.64 100.91 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 124.496 1.118 . . . . 0.0 108.832 -168.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -117.61 115.07 24.36 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 110.953 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.42 157.12 43.27 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 121.206 -0.934 . . . . 0.0 110.926 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -120.87 144.61 48.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -139.54 159.04 43.09 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 123.889 0.876 . . . . 0.0 109.596 -173.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -107.89 125.46 51.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 167.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -74.6 146.44 42.5 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.922 -1.111 . . . . 0.0 112.144 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.787 0 CA-C-O 123.578 1.655 . . . . 0.0 116.825 -172.363 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 . . . . . 0 N--CA 1.429 -1.475 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.47 155.28 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.604 1.561 . . . . 0.0 109.515 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 20.4 p -140.04 149.61 43.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.143 -0.973 . . . . 0.0 112.815 -172.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.42 150.87 49.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.977 1.311 . . . . 0.0 111.879 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.259 1.597 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.524 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.675 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -79.67 140.38 37.06 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 121.519 -0.989 . . . . 0.0 109.117 172.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 mp -82.61 134.05 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.421 -1.424 . . . . 0.0 108.532 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -133.5 151.74 51.8 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.551 -1.343 . . . . 0.0 111.049 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -103.91 130.43 51.51 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.265 1.026 . . . . 0.0 109.296 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.4 t -103.07 117.72 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.375 -1.453 . . . . 0.0 109.823 168.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -113.0 101.38 9.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 168.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.8 tp -135.48 170.57 15.75 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.176 0.988 . . . . 0.0 109.499 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.36 161.39 41.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.492 -2.005 . . . . 0.0 108.603 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -71.47 105.43 3.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.311 1.445 . . . . 0.0 112.365 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -102.55 -62.68 1.24 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.902 1.281 . . . . 0.0 110.408 167.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -86.12 -66.04 0.95 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.104 1.361 . . . . 0.0 109.154 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -137.5 176.36 8.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.694 1.598 . . . . 0.0 107.022 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.7 t -83.15 -69.05 0.66 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.445 -1.409 . . . . 0.0 111.509 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.448 HD22 HG13 ' B' ' 15' ' ' VAL . 7.9 mp -104.04 -105.46 0.29 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.954 -1.716 . . . . 0.0 112.101 170.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.32 57.21 1.01 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.917 -1.114 . . . . 0.0 111.81 -171.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 tt -144.19 164.7 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 121.45 -1.029 . . . . 0.0 108.444 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 t -122.09 138.39 54.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.506 -1.996 . . . . 0.0 110.394 -175.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.56 154.8 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 124.654 1.182 . . . . 0.0 108.787 -166.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -137.44 94.13 2.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.757 1.742 . . . . 0.0 111.195 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.01 -152.06 41.57 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 164.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.31 79.34 1.45 Allowed Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -168.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -117.72 -104.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.419 -1.047 . . . . 0.0 113.406 -162.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -77.15 -51.54 10.82 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.708 -1.87 . . . . 0.0 109.94 -161.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -150.21 137.58 19.68 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 155.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.9 m -151.53 -86.93 0.07 Allowed 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 119.703 -1.873 . . . . 0.0 110.772 -166.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 t -73.9 -59.43 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 124.823 1.249 . . . . 0.0 109.145 -175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -144.23 -123.33 0.08 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -85.3 65.32 9.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.97 -1.706 . . . . 0.0 110.712 172.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.57 -129.33 9.68 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 -165.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.45 133.0 2.9 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 125.629 1.585 . . . . 0.0 112.152 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.3 mm -125.58 137.13 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.4 129.97 50.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.719 -1.238 . . . . 0.0 111.408 -163.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -76.22 135.85 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.562 -1.336 . . . . 0.0 112.292 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -88.2 -61.3 1.75 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.584 1.554 . . . . 0.0 111.039 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.12 162.65 34.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.56 134.3 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 122.193 0.997 . . . . 0.0 111.064 174.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 mm -84.02 134.66 43.39 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 116.652 -1.642 . . . . 0.0 107.495 171.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.11 77.02 2.87 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 125.718 3.078 . . . . 0.0 112.437 170.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -141.13 -40.94 0.39 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -168.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.2 -144.39 4.34 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.301 -1.499 . . . . 0.0 112.155 -167.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.17 -39.97 96.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.904 2.081 . . . . 0.0 114.752 -162.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.34 -50.7 72.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.959 1.704 . . . . 0.0 114.028 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.62 -37.42 50.19 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.075 1.35 . . . . 0.0 112.549 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.7 t -62.38 -47.99 81.73 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.951 -1.718 . . . . 0.0 114.186 -175.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -81.14 -47.05 14.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.828 -1.17 . . . . 0.0 110.571 171.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.88 73.06 1.2 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -139.63 -41.25 0.45 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -164.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.61 134.55 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -140.51 -160.97 1.13 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.344 0.974 . . . . 0.0 112.947 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -54.93 133.81 48.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.304 1.842 . . . . 0.0 114.343 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.37 -2.11 63.27 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 117.992 1.957 . . . . 0.0 117.992 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -75.56 151.28 37.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.055 1.928 . . . . 0.0 112.271 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -123.89 138.93 54.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.581 -1.324 . . . . 0.0 109.783 -165.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.56 155.32 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.692 -1.88 . . . . 0.0 111.948 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.7 mt -119.01 -88.27 0.62 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.23 145.23 29.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.679 1.192 . . . . 0.0 110.802 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 p -102.78 92.17 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 123.039 1.4 . . . . 0.0 110.68 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 58.35 55.52 4.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.861 -1.774 . . . . 0.0 113.163 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.12 -12.82 59.21 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 120.631 -1.293 . . . . 0.0 115.16 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.4 t -103.14 125.51 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 118.561 1.181 . . . . 0.0 109.863 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -77.38 158.96 29.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.547 -1.346 . . . . 0.0 114.562 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -117.43 36.7 4.15 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.052 1.341 . . . . 0.0 109.028 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.93 115.82 7.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.056 -1.652 . . . . 0.0 113.452 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.71 15.76 78.8 Favored Glycine 0 N--CA 1.431 -1.66 0 O-C-N 119.626 -1.921 . . . . 0.0 115.33 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.48 148.16 35.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.847 -1.384 . . . . 0.0 113.104 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.6 p -90.37 174.28 7.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.766 1.227 . . . . 0.0 108.591 163.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -61.34 -37.63 84.01 Favored 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 120.367 -1.458 . . . . 0.0 114.576 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 -40.87 90.75 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.091 -1.631 . . . . 0.0 112.602 175.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -70.14 -41.32 74.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.498 1.519 . . . . 0.0 111.627 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.11 -48.71 70.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . 0.265 35.4 m -63.14 -37.23 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -172.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -64.25 -45.06 89.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 120.516 1.507 . . . . 0.0 112.612 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.7 m -60.09 -36.28 77.05 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.829 1.651 . . . . 0.0 112.385 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.69 -36.74 31.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.325 1.85 . . . . 0.0 115.693 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -63.91 -44.04 94.15 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.156 -1.59 . . . . 0.0 113.067 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -85.0 49.61 1.77 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.595 1.188 . . . . 0.0 113.665 -166.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.7 p -98.48 -76.27 0.54 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.44 2.296 . . . . 0.0 109.563 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.02 -106.84 2.44 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 125.106 1.336 . . . . 0.0 113.179 167.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -68.19 -53.54 24.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -172.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.7 m -108.58 138.84 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.188 0.994 . . . . 0.0 110.346 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.3 t -126.01 95.46 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -135.63 92.02 2.78 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.102 -1.624 . . . . 0.0 110.699 -171.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.15 176.93 9.15 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -165.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.65 131.05 54.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.397 1.079 . . . . 0.0 109.611 -170.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -126.13 167.33 15.54 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.746 1.618 . . . . 0.0 110.397 -174.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -124.58 141.01 52.41 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.992 1.317 . . . . 0.0 107.538 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -72.77 144.83 47.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.759 0 O-C-N 120.668 -1.27 . . . . 0.0 114.095 -179.508 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 . . . . . 0 N--CA 1.429 -1.491 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.57 154.68 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.048 -1.657 . . . . 0.0 108.379 171.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m -140.91 155.87 46.2 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.38 -0.825 . . . . 0.0 111.288 -172.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.3 159.44 42.06 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.84 0.829 . . . . 0.0 110.032 168.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . 0.448 HG13 HD22 ' A' ' 18' ' ' LEU . 3.5 p . . . . . 0 C--O 1.259 1.585 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.79 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.29 177.3 8.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.058 -1.26 . . . . 0.0 113.63 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.7 mt -74.95 143.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.803 -1.81 . . . . 0.0 112.944 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -147.01 160.36 42.47 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.804 -1.185 . . . . 0.0 110.708 170.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -127.26 123.15 35.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.723 -1.236 . . . . 0.0 111.358 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -105.32 132.93 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.689 -1.257 . . . . 0.0 111.878 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -112.43 121.46 44.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 108.794 158.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.491 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 10.1 tp -132.82 -167.7 1.95 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.713 1.205 . . . . 0.0 108.418 176.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.491 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -155.59 168.94 25.51 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.12 -1.613 . . . . 0.0 109.195 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -72.01 104.74 3.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.561 1.144 . . . . 0.0 112.841 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -91.28 -85.96 0.23 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.14 -0.975 . . . . 0.0 110.869 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -86.5 -44.92 11.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.75 1.62 . . . . 0.0 110.808 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -138.24 177.9 7.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.183 2.193 . . . . 0.0 105.162 174.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.8 p -84.03 -66.34 0.9 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.503 -1.373 . . . . 0.0 112.151 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.7 mt -101.04 -79.92 0.5 Allowed 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 119.7 1.136 . . . . 0.0 111.865 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.15 47.82 2.35 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 121.1 -1.0 . . . . 0.0 112.069 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 tt -145.81 157.89 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.827 -1.396 . . . . 0.0 112.669 -170.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 t -123.56 146.31 48.22 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.413 -1.429 . . . . 0.0 109.266 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 t -122.05 149.95 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.167 1.387 . . . . 0.0 109.898 -163.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 t -137.27 108.37 6.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.585 1.659 . . . . 0.0 111.137 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.35 -117.29 5.49 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 125.103 1.335 . . . . 0.0 111.689 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.79 35.53 61.97 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 115.843 1.097 . . . . 0.0 115.843 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 m -107.61 -120.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 121.468 -1.019 . . . . 0.0 112.667 -170.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -79.65 -81.12 0.12 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.986 1.715 . . . . 0.0 113.294 -171.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.6 t -128.92 115.57 18.06 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -155.32 -85.93 0.05 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.361 -0.837 . . . . 0.0 109.917 -166.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.1 -52.41 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 120.088 -1.633 . . . . 0.0 110.961 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -133.46 -153.84 0.57 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 158.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -74.5 96.96 3.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.496 1.118 . . . . 0.0 108.405 155.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.71 -172.7 50.63 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 120.267 -1.52 . . . . 0.0 114.423 -169.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.73 147.32 22.32 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -162.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.9 mm -124.77 140.72 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -123.4 143.13 50.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -167.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -87.2 132.3 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 O-C-N 121.031 -1.043 . . . . 0.0 111.366 -173.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -85.46 -51.7 6.35 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.291 1.036 . . . . 0.0 110.873 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.62 157.74 12.63 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.8 p -91.69 137.83 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 121.491 0.662 . . . . 0.0 109.886 171.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -84.09 121.62 75.65 Favored Pre-proline 0 N--CA 1.429 -1.504 0 O-C-N 120.325 -1.485 . . . . 0.0 109.093 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -78.84 60.05 7.56 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.363 2.709 . . . . 0.0 112.383 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.33 32.94 0.28 Allowed 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 122.262 1.029 . . . . 0.0 108.401 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.63 176.94 46.16 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 119.729 -1.857 . . . . 0.0 112.619 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -37.35 -45.67 0.71 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.199 2.999 . . . . 0.0 118.54 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.1 89.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -175.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -85.53 -40.62 16.12 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.927 1.291 . . . . 0.0 111.324 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.9 m -60.32 -55.97 27.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.43 -29.38 52.88 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.558 -1.339 . . . . 0.0 110.09 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.46 76.87 1.21 Allowed Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.106 -0.996 . . . . 0.0 112.506 167.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -136.87 -53.7 0.71 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.551 -0.97 . . . . 0.0 112.5 -167.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.6 mt -127.62 125.95 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -166.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -134.56 -171.13 2.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -56.73 128.87 38.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.137 1.375 . . . . 0.0 114.141 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.26 21.79 74.86 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 117.697 1.839 . . . . 0.0 117.697 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -81.36 159.0 24.48 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 119.545 1.672 . . . . 0.0 109.629 161.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.0 ttp85 -122.22 116.51 24.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.559 -1.338 . . . . 0.0 108.705 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.54 138.11 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 121.064 -1.022 . . . . 0.0 109.917 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.5 tp -121.07 -86.47 0.65 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.143 -0.973 . . . . 0.0 109.999 -170.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.06 132.4 33.83 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.848 -1.782 . . . . 0.0 113.277 -170.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.8 p -103.61 93.76 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.552 1.644 . . . . 0.0 108.251 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.268 58.7 t30 56.19 54.15 8.14 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.384 1.874 . . . . 0.0 113.7 -173.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.26 -46.01 1.49 Allowed Glycine 0 N--CA 1.431 -1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 113.621 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.01 128.66 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 121.094 -1.239 . . . . 0.0 111.286 -170.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 t -78.3 156.81 29.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.496 -1.378 . . . . 0.0 112.345 176.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 -13.86 23.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.061 1.344 . . . . 0.0 113.952 -175.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -66.41 128.38 35.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -168.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.1 -51.34 0.71 Allowed Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -170.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.24 151.94 32.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.352 1.461 . . . . 0.0 112.416 170.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.9 p -94.38 -179.11 4.8 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.681 -1.887 . . . . 0.0 112.147 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -50.04 -37.79 34.8 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.252 3.021 . . . . 0.0 115.064 172.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -56.54 -46.85 80.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.396 1.878 . . . . 0.0 114.112 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -77.81 -34.49 52.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.003 1.321 . . . . 0.0 111.185 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.48 77.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.577 1.551 . . . . 0.0 114.378 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.97 -29.34 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.385 -1.447 . . . . 0.0 114.056 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -70.63 -38.66 73.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.591 -1.943 . . . . 0.0 112.527 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.3 m -65.78 -43.49 88.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.415 -1.428 . . . . 0.0 112.236 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 tt -79.72 -46.84 16.33 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -59.12 -35.85 74.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.967 -1.708 . . . . 0.0 114.289 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -92.07 56.01 2.76 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.812 -1.18 . . . . 0.0 110.956 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 p -109.87 -69.25 0.87 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.687 1.995 . . . . 0.0 109.771 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.37 -105.68 1.31 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 124.312 0.958 . . . . 0.0 113.634 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -81.2 -45.11 16.82 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -163.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.04 155.16 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.958 -1.089 . . . . 0.0 112.004 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -130.19 112.8 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -128.44 117.83 22.05 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.354 -1.466 . . . . 0.0 109.804 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.13 160.5 42.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.539 -1.351 . . . . 0.0 113.957 -174.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.81 128.0 52.46 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.104 1.362 . . . . 0.0 107.436 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.86 159.59 27.86 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.041 1.336 . . . . 0.0 110.584 -174.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -109.08 127.33 54.05 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 153.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -69.44 137.06 52.36 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.04 1.336 . . . . 0.0 113.874 -171.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.804 0 O-C-N 120.546 -1.346 . . . . 0.0 110.694 170.575 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 17.6 m -125.94 155.9 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 125.969 1.708 . . . . 0.0 110.633 -173.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -142.06 143.49 33.13 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.716 0.769 . . . . 0.0 111.109 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.69 146.78 47.99 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.199 1.4 . . . . 0.0 112.618 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.261 1.663 0 C-N-CA 126.176 1.79 . . . . 0.0 106.422 170.073 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.742 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.66 179.22 7.85 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 mt -81.71 149.96 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.539 1.536 . . . . 0.0 111.617 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.11 139.87 21.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.478 -1.389 . . . . 0.0 112.247 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -105.96 105.86 16.1 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.665 1.586 . . . . 0.0 111.155 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.08 134.17 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 120.347 -1.471 . . . . 0.0 112.182 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -111.74 127.39 55.77 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 168.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 8.1 tp -135.73 -159.46 0.96 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.943 -1.098 . . . . 0.0 109.613 172.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -153.87 168.11 27.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.311 -1.493 . . . . 0.0 108.605 172.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -72.4 112.68 8.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.612 -1.305 . . . . 0.0 110.287 163.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -93.27 -88.56 0.22 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.92 -53.92 6.3 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.028 1.331 . . . . 0.0 109.171 165.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -135.91 172.79 12.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.856 -1.153 . . . . 0.0 108.289 -172.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -81.89 -88.53 0.08 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.065 0.946 . . . . 0.0 109.828 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.6 mt -102.71 -89.39 0.38 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.31 -1.494 . . . . 0.0 112.474 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.6 48.24 3.51 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -165.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 tt -134.26 161.04 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 121.288 -1.125 . . . . 0.0 108.364 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.4 t -121.27 142.55 49.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.365 -1.459 . . . . 0.0 107.242 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.6 t -122.74 152.56 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -160.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 t -145.54 134.34 22.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.685 -1.884 . . . . 0.0 112.832 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.11 -141.54 20.81 Favored Glycine 0 N--CA 1.43 -1.703 0 C-N-CA 126.971 2.224 . . . . 0.0 114.203 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.62 33.7 67.21 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 124.669 1.128 . . . . 0.0 115.614 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -93.32 -124.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 121.039 -1.271 . . . . 0.0 113.549 -170.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -71.59 -57.72 4.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.748 -1.845 . . . . 0.0 111.274 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.4 t -140.51 154.19 46.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 148.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.4 t -155.84 -103.71 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -164.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.413 HG13 ' H ' ' A' ' 31' ' ' ARG . 3.0 p -62.08 -58.43 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.066 1.747 . . . . 0.0 110.074 161.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.413 ' H ' HG13 ' A' ' 30' ' ' VAL . 91.3 mtt180 -143.29 -163.28 1.61 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 161.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -78.89 44.13 0.54 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.257 1.823 . . . . 0.0 112.822 173.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.48 151.59 5.53 Favored Glycine 0 N--CA 1.43 -1.743 0 O-C-N 120.195 -1.566 . . . . 0.0 110.661 -169.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.81 143.39 11.88 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -168.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.38 162.54 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -172.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.93 151.34 43.68 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.296 -1.503 . . . . 0.0 107.791 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -82.81 134.83 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 120.72 -1.237 . . . . 0.0 110.964 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -85.24 -59.91 2.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.63 1.172 . . . . 0.0 110.583 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.79 168.82 12.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.049 0.94 . . . . 0.0 108.491 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -95.22 136.26 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 122.694 1.235 . . . . 0.0 111.79 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.3 mm -82.73 132.22 52.33 Favored Pre-proline 0 N--CA 1.429 -1.5 0 O-C-N 120.38 -1.45 . . . . 0.0 107.187 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -80.5 35.57 0.58 Allowed 'Trans proline' 0 N--CA 1.434 -2.014 0 C-N-CA 123.242 2.628 . . . . 0.0 113.039 -172.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 62.5 0.9 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.629 1.572 . . . . 0.0 107.438 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.52 161.3 31.07 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.629 -1.294 . . . . 0.0 112.129 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.54 -38.12 19.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.871 2.068 . . . . 0.0 116.298 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.5 -41.82 77.32 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.5 -52.52 10.48 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 125.884 1.674 . . . . 0.0 111.476 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.0 m -56.2 -53.24 59.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -81.62 -36.42 28.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.272 1.029 . . . . 0.0 110.17 -177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.27 79.43 1.32 Allowed Glycine 0 N--CA 1.429 -1.768 0 O-C-N 120.837 -1.164 . . . . 0.0 112.006 169.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -136.18 -43.72 0.63 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -157.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.4 mt -128.86 142.42 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -131.15 178.24 6.85 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 123.321 1.534 . . . . 0.0 111.937 -170.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -56.39 123.12 13.59 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.71 20.06 76.95 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 118.45 2.14 . . . . 0.0 118.45 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -71.96 156.92 38.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 120.24 2.02 . . . . 0.0 111.552 166.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -122.66 114.07 20.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.612 -1.305 . . . . 0.0 108.977 -173.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 m -100.16 156.98 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 120.164 -1.585 . . . . 0.0 111.564 -174.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.9 tp -131.88 -81.48 0.51 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.017 -1.052 . . . . 0.0 111.279 173.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.85 128.23 45.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.704 -1.248 . . . . 0.0 113.649 -160.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.49 112.78 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 122.628 1.204 . . . . 0.0 109.131 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.27 35.8 t30 56.96 31.97 20.78 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 126.844 2.058 . . . . 0.0 114.018 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.4 -12.32 58.38 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.447 -1.408 . . . . 0.0 115.002 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.3 t -96.25 116.35 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 118.692 1.246 . . . . 0.0 111.824 -173.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -76.14 131.32 39.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.206 -1.559 . . . . 0.0 112.012 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -13.34 47.44 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.353 1.461 . . . . 0.0 113.49 -173.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -51.33 129.13 24.21 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.49 1.516 . . . . 0.0 115.088 -167.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.55 -35.19 5.11 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 124.13 0.872 . . . . 0.0 112.321 -160.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.81 155.26 33.19 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.481 -1.599 . . . . 0.0 112.113 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.0 p -93.28 159.99 15.03 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.978 0.894 . . . . 0.0 109.92 167.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.418 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 46.1 t60 -41.01 -44.93 2.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.665 2.786 . . . . 0.0 117.027 173.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -60.75 -37.65 82.52 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.781 -1.2 . . . . 0.0 114.212 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -78.45 -41.06 33.87 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.755 1.222 . . . . 0.0 112.002 174.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.33 -38.09 82.66 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.524 -1.36 . . . . 0.0 114.266 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 p -71.06 -33.8 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 O-C-N 120.293 -1.505 . . . . 0.0 112.98 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.61 -46.11 91.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.312 -1.492 . . . . 0.0 112.743 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.3 m -56.15 -48.34 76.47 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.612 1.565 . . . . 0.0 112.457 173.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.09 -36.37 40.87 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -172.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -59.61 -37.01 77.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.196 -1.565 . . . . 0.0 113.905 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -95.42 60.71 2.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.735 -1.228 . . . . 0.0 112.8 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -99.49 -73.3 0.63 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.512 2.325 . . . . 0.0 111.339 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.17 -116.63 3.77 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.295 1.426 . . . . 0.0 112.63 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -78.62 -36.26 44.34 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 121.473 -1.016 . . . . 0.0 113.633 -168.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.3 m -104.54 162.31 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.73 -1.231 . . . . 0.0 112.241 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.6 t -138.1 130.89 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 124.81 1.244 . . . . 0.0 108.708 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -141.2 127.97 20.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.652 -1.28 . . . . 0.0 108.072 161.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -149.27 159.06 44.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.276 -1.515 . . . . 0.0 113.082 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.5 mp -120.53 120.41 35.78 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.21 161.85 24.88 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.68 1.192 . . . . 0.0 110.227 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.65 135.47 54.12 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.36 1.464 . . . . 0.0 107.204 162.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -74.98 133.98 41.58 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.378 1.085 . . . . 0.0 112.874 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.753 0 CA-C-O 123.297 1.498 . . . . 0.0 115.056 178.435 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 . . . . . 0 N--CA 1.43 -1.442 0 CA-C-O 121.247 0.546 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -122.87 158.19 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 124.757 1.223 . . . . 0.0 110.544 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.418 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 58.8 m -138.11 149.64 46.12 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.662 -1.274 . . . . 0.0 113.777 -173.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -124.0 150.48 44.81 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 125.121 1.368 . . . . 0.0 111.503 169.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.261 1.666 0 C-N-CA 127.621 2.368 . . . . 0.0 106.702 160.811 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.748 0 N-CA-C 111.956 -0.458 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.32 146.5 30.34 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.17 -1.194 . . . . 0.0 111.194 167.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 mp -89.97 144.53 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.04 2.136 . . . . 0.0 111.252 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -145.75 165.59 28.37 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.306 -1.496 . . . . 0.0 112.184 171.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -113.93 134.95 54.5 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 122.372 1.082 . . . . 0.0 112.241 -177.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.39 111.82 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.482 -1.386 . . . . 0.0 108.964 168.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -112.26 102.37 10.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 170.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tp -134.8 176.67 8.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.674 1.226 . . . . 0.0 111.463 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.01 158.71 42.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 168.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -70.44 152.64 43.83 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -121.17 -83.88 0.66 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.507 -1.371 . . . . 0.0 108.789 166.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -76.99 -51.46 11.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.704 -1.248 . . . . 0.0 109.196 172.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -138.2 177.64 7.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.0 m -82.47 -58.76 2.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.82 0.848 . . . . 0.0 111.32 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.6 mt -102.3 -90.64 0.35 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.142 1.337 . . . . 0.0 112.458 172.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.43 50.58 0.8 Allowed Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -165.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tt -137.62 165.01 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.941 -1.329 . . . . 0.0 110.688 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 t -122.95 136.64 54.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.891 1.677 . . . . 0.0 107.702 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.8 t -123.69 144.04 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 124.675 1.19 . . . . 0.0 110.03 -161.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -138.87 131.17 28.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.032 1.396 . . . . 0.0 112.914 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.43 -162.64 25.83 Favored Glycine 0 N--CA 1.429 -1.777 0 C-N-CA 126.87 2.176 . . . . 0.0 114.236 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.12 42.12 2.47 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.7 -0.882 . . . . 0.0 113.791 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -106.08 -107.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.287 1.042 . . . . 0.0 110.044 -172.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -91.28 -59.78 2.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.099 2.159 . . . . 0.0 110.054 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 t -133.24 138.95 46.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 163.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -145.23 -79.65 0.18 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.941 -1.099 . . . . 0.0 108.828 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -91.8 -51.73 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 O-C-N 120.531 -1.356 . . . . 0.0 108.238 171.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.2 mmt85 -119.44 -142.2 0.35 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.56 65.15 1.26 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.392 -1.442 . . . . 0.0 111.715 170.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.37 -137.52 13.63 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 -166.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.2 147.3 9.1 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-O 122.206 0.892 . . . . 0.0 112.978 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.6 mm -122.21 130.74 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 -159.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.08 149.28 49.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 123.831 0.852 . . . . 0.0 110.296 -169.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.4 t -79.69 124.68 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 120.833 -1.167 . . . . 0.0 111.22 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -80.58 -63.25 1.45 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.687 -1.258 . . . . 0.0 109.973 173.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.5 161.41 35.36 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.427 -0.796 . . . . 0.0 109.341 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.29 137.15 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-O 122.497 1.142 . . . . 0.0 110.663 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -85.43 123.63 72.65 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 119.945 -1.722 . . . . 0.0 108.598 173.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.64 32.26 0.51 Allowed 'Trans proline' 0 N--CA 1.434 -1.995 0 CA-C-N 125.291 2.925 . . . . 0.0 114.373 -173.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.61 61.74 1.38 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 123.158 1.456 . . . . 0.0 107.741 -175.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.85 170.52 43.66 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 120.413 -1.43 . . . . 0.0 109.852 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.74 -38.66 22.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.335 2.254 . . . . 0.0 115.541 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.7 -47.45 67.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.13 1.772 . . . . 0.0 115.1 174.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -87.36 -34.85 18.67 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.895 -1.128 . . . . 0.0 111.774 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.6 m -54.22 -54.7 36.4 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.491 1.516 . . . . 0.0 113.858 174.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.26 -53.85 6.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.276 -0.89 . . . . 0.0 110.809 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.05 100.93 2.63 Favored Glycine 0 N--CA 1.429 -1.807 0 O-C-N 121.188 -0.945 . . . . 0.0 110.982 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.94 -43.5 0.43 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -163.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -128.76 174.43 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.534 -1.354 . . . . 0.0 108.301 -168.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.441 ' H ' HG22 ' A' ' 52' ' ' ILE . 31.1 m-70 -131.61 162.24 30.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.132 -1.605 . . . . 0.0 110.538 169.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -56.99 136.72 56.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 167.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.17 20.78 78.93 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 116.884 1.513 . . . . 0.0 116.884 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -83.47 172.43 12.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.977 1.311 . . . . 0.0 112.265 167.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -124.6 133.12 53.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 121.054 -1.029 . . . . 0.0 111.828 176.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.1 m -79.76 158.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 119.783 -1.823 . . . . 0.0 110.857 167.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tt -121.61 -80.46 0.62 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.549 -1.344 . . . . 0.0 109.414 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.32 150.59 22.84 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.664 -1.273 . . . . 0.0 113.57 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.9 p -111.92 103.33 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 C-N-CA 126.279 1.831 . . . . 0.0 108.409 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.505 13.8 p30 56.52 38.73 29.87 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.859 2.064 . . . . 0.0 116.298 -177.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.98 -24.58 30.15 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 125.641 1.591 . . . . 0.0 113.455 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.98 134.69 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 124.918 1.287 . . . . 0.0 110.868 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 p -77.2 159.82 29.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.537 -1.977 . . . . 0.0 113.095 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -93.89 -14.84 25.61 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -54.24 129.55 35.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -167.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.31 -27.23 7.42 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 124.143 0.878 . . . . 0.0 111.163 -175.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.17 144.4 38.39 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.3 p -90.65 -179.41 5.54 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.161 -0.962 . . . . 0.0 108.819 155.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -60.38 -44.6 95.48 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -169.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -59.22 -34.56 72.32 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.542 -1.348 . . . . 0.0 114.585 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -43.31 67.16 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.235 -1.541 . . . . 0.0 111.049 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.32 -43.43 97.81 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 120.419 -1.426 . . . . 0.0 114.576 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 m -67.58 -41.52 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 120.461 -1.399 . . . . 0.0 114.352 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -68.08 -28.72 67.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.505 -1.372 . . . . 0.0 112.904 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.9 m -57.48 -50.78 71.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.305 1.442 . . . . 0.0 112.677 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.54 -33.98 35.85 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.565 -1.334 . . . . 0.0 112.799 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -61.2 -32.01 71.77 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.758 -1.839 . . . . 0.0 114.487 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -85.7 51.92 2.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.35 -1.468 . . . . 0.0 112.839 170.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.1 p -110.93 -74.14 0.66 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.466 1.507 . . . . 0.0 110.631 166.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.66 -82.99 0.35 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.857 -1.152 . . . . 0.0 113.219 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -82.1 -51.3 8.13 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -174.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.37 137.97 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 120.94 -1.1 . . . . 0.0 111.023 -166.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.95 90.03 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.5 -1.375 . . . . 0.0 110.676 -172.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -119.76 120.79 37.56 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.566 -1.959 . . . . 0.0 111.452 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -150.22 165.89 31.57 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 112.241 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.8 mt -121.64 137.84 54.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.03 1.332 . . . . 0.0 107.715 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mp -135.76 158.2 44.98 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.593 0.757 . . . . 0.0 110.334 -171.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -119.6 148.29 43.51 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -70.71 127.48 32.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.621 -1.3 . . . . 0.0 112.125 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.799 0 O-C-N 120.587 -1.32 . . . . 0.0 113.724 179.787 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 . . . . . 0 N--CA 1.431 -1.418 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.09 148.55 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 127.121 2.168 . . . . 0.0 107.279 -171.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.1 p -134.37 171.26 14.52 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.702 -1.249 . . . . 0.0 113.209 -168.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.7 155.06 41.35 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 120.976 -1.077 . . . . 0.0 111.355 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.26 1.611 0 C-N-CA 125.542 1.537 . . . . 0.0 108.951 -177.151 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.684 0 CA-C-O 121.326 0.403 . . . . 0.0 113.412 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.11 -177.16 6.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.243 1.497 . . . . 0.0 113.66 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 mt -85.21 136.43 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 125.217 1.407 . . . . 0.0 110.806 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -133.07 145.08 50.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.499 1.142 . . . . 0.0 111.26 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -112.52 123.59 50.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.178 -0.951 . . . . 0.0 109.515 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.5 m -102.92 149.68 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 122.687 1.232 . . . . 0.0 111.802 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -139.58 87.16 2.16 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -134.07 176.65 8.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.808 -1.183 . . . . 0.0 110.508 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.49 172.82 12.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 124.901 1.28 . . . . 0.0 109.125 170.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -68.55 134.22 49.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.953 1.701 . . . . 0.0 113.484 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -122.08 -102.75 0.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.606 -1.309 . . . . 0.0 109.664 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.99 -33.3 65.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.025 -1.672 . . . . 0.0 111.502 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -149.25 -176.55 5.41 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.3 t -82.35 -67.99 0.74 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.836 1.254 . . . . 0.0 108.829 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.89 -81.74 0.48 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.685 -1.259 . . . . 0.0 110.807 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.02 52.86 1.14 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -167.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 tt -139.12 162.34 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 121.679 -0.895 . . . . 0.0 110.218 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.1 t -122.59 141.93 51.17 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 171.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.56 145.77 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 125.917 1.687 . . . . 0.0 108.114 -167.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 t -136.72 114.56 11.29 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.965 1.365 . . . . 0.0 110.075 -172.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.62 178.91 26.79 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-O 122.942 1.301 . . . . 0.0 116.222 169.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.54 64.66 0.35 Allowed Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 122.265 0.925 . . . . 0.0 112.132 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.51 -64.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 124.389 1.076 . . . . 0.0 111.579 -173.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -110.5 -96.54 0.41 Allowed 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.029 -1.044 . . . . 0.0 112.818 -166.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.6 p -130.0 90.96 3.04 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.71 -1.869 . . . . 0.0 108.096 -175.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.6 p -134.4 -89.84 0.36 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.355 -0.841 . . . . 0.0 109.551 -175.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.8 -58.37 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.63 1.972 . . . . 0.0 110.89 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -127.57 -153.27 0.56 Allowed 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 165.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.53 88.56 7.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.476 -1.39 . . . . 0.0 109.55 163.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.89 -158.84 35.48 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -158.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.96 140.35 11.26 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.974 -1.309 . . . . 0.0 112.301 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.2 mm -124.21 136.4 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 121.016 -1.285 . . . . 0.0 108.927 -156.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.19 141.13 52.28 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.91 -1.119 . . . . 0.0 111.29 -170.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.57 134.96 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 120.687 -1.258 . . . . 0.0 112.046 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -84.28 -57.81 3.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.084 1.354 . . . . 0.0 110.441 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.63 165.23 18.91 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 124.069 0.947 . . . . 0.0 109.568 174.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.48 123.85 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 124.847 1.259 . . . . 0.0 110.59 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mm -83.18 130.38 57.23 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 120.824 -1.172 . . . . 0.0 110.215 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.15 80.65 1.84 Allowed 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 123.147 2.565 . . . . 0.0 112.434 172.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -141.55 -39.32 0.39 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.719 1.207 . . . . 0.0 112.071 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.88 -146.78 4.44 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.456 -1.402 . . . . 0.0 114.988 -173.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.5 -41.57 63.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.169 2.588 . . . . 0.0 116.95 -166.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.25 -47.7 80.72 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -72.56 -54.62 8.67 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.639 1.576 . . . . 0.0 112.176 173.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.0 t -60.28 -55.96 27.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.229 1.412 . . . . 0.0 114.312 -171.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.76 -39.19 70.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.092 0.957 . . . . 0.0 110.525 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.43 77.59 1.38 Allowed Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -137.03 -51.45 0.66 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -153.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.91 133.75 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -120.26 174.22 6.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 122.65 1.214 . . . . 0.0 114.123 -168.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -57.54 114.21 2.14 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.811 1.645 . . . . 0.0 114.573 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.1 26.03 65.13 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 120.555 -1.341 . . . . 0.0 115.529 -177.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -80.88 159.58 24.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 119.039 1.42 . . . . 0.0 110.779 168.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -124.12 128.92 50.0 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.034 -1.041 . . . . 0.0 109.904 -173.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.45 166.17 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 120.129 -1.607 . . . . 0.0 110.877 176.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.9 mt -131.76 -82.01 0.51 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.594 -1.316 . . . . 0.0 110.333 169.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 144.19 28.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.761 -1.212 . . . . 0.0 112.036 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.78 104.07 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 122.866 1.317 . . . . 0.0 110.781 174.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 57.4 50.56 11.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.16 2.184 . . . . 0.0 113.18 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.33 -24.91 8.67 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.066 -1.021 . . . . 0.0 114.459 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.2 t -85.6 101.29 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 120.441 -1.623 . . . . 0.0 110.969 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 p -79.2 125.93 30.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.684 1.194 . . . . 0.0 110.017 163.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.445 HD13 ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -108.2 55.96 0.63 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.586 1.66 . . . . 0.0 110.891 -173.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -66.89 133.99 51.15 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -170.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.91 3.14 89.24 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.856 -1.153 . . . . 0.0 115.584 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.74 155.77 35.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.899 -1.354 . . . . 0.0 113.661 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.7 p -87.11 174.97 8.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.766 -1.208 . . . . 0.0 111.086 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -60.47 -46.45 90.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.357 -1.464 . . . . 0.0 114.277 -166.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -69.15 -36.16 77.12 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -71.14 -33.92 70.52 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.102 -1.624 . . . . 0.0 112.368 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.57 -53.04 57.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.965 -1.085 . . . . 0.0 113.567 169.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.7 m -75.02 -20.0 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.64 -1.912 . . . . 0.0 114.616 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -66.39 -42.45 87.89 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.89 -1.756 . . . . 0.0 110.94 167.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.4 m -63.92 -29.92 71.05 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.301 1.841 . . . . 0.0 113.021 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt -78.19 -37.28 46.04 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.647 -1.283 . . . . 0.0 112.188 174.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -69.11 -37.98 78.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.188 -1.57 . . . . 0.0 114.699 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.322 0.4 OUTLIER -79.33 55.7 1.95 Allowed 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 119.973 -1.705 . . . . 0.0 113.743 172.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -103.73 -76.63 0.59 Allowed 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.118 2.567 . . . . 0.0 107.632 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.94 -112.76 2.69 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 125.535 1.541 . . . . 0.0 112.958 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -81.62 -31.49 32.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.169 -1.195 . . . . 0.0 113.775 -172.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.8 p -105.14 138.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.449 1.1 . . . . 0.0 110.622 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.44 80.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 125.072 1.349 . . . . 0.0 108.52 -172.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -118.79 109.56 16.2 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.455 -1.403 . . . . 0.0 109.971 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -149.08 169.96 19.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.016 -1.678 . . . . 0.0 113.25 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.8 tp -122.78 121.55 36.56 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.654 1.581 . . . . 0.0 109.423 -170.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -131.78 169.96 15.49 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.835 0.826 . . . . 0.0 112.739 -166.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -130.25 135.72 48.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.663 1.985 . . . . 0.0 109.969 166.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 135.32 40.52 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.19 1.396 . . . . 0.0 110.327 173.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.743 0 CA-C-O 123.48 1.6 . . . . 0.0 117.07 -170.004 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 . . . . . 0 N--CA 1.431 -1.418 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.97 158.04 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 102.719 -3.067 . . . . 0.0 102.719 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 31.0 m -139.42 157.23 46.21 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 121.114 1.779 . . . . 0.0 113.171 -167.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -152.11 146.97 25.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.877 -1.14 . . . . 0.0 110.553 174.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--O 1.26 1.606 0 C-N-CA 125.774 1.63 . . . . 0.0 107.48 -179.83 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.761 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -82.81 -176.12 6.14 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 123.208 1.48 . . . . 0.0 113.39 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.4 mt -78.96 143.92 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 127.195 2.198 . . . . 0.0 111.301 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.76 156.37 41.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.726 0.81 . . . . 0.0 109.657 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.83 116.92 20.19 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.168 0.985 . . . . 0.0 111.077 -175.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.18 131.4 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.791 1.236 . . . . 0.0 112.509 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -111.44 117.9 34.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.527 1.531 . . . . 0.0 109.665 171.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.9 tp -134.84 167.01 21.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.378 1.471 . . . . 0.0 109.031 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.72 154.75 49.88 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 119.811 -1.806 . . . . 0.0 110.941 170.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -56.98 129.64 42.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.837 2.055 . . . . 0.0 114.735 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -121.56 -97.65 0.45 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.362 1.465 . . . . 0.0 110.39 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.67 -58.23 6.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.159 1.784 . . . . 0.0 109.252 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -137.11 -179.64 5.83 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 p -84.39 -80.51 0.2 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.105 0.962 . . . . 0.0 111.635 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.4 mt -103.19 -90.55 0.37 Allowed 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.455 -1.403 . . . . 0.0 113.297 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.95 56.36 1.97 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.717 -1.239 . . . . 0.0 112.572 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.7 tt -139.56 171.69 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 t -123.41 148.73 45.82 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.158 -2.214 . . . . 0.0 109.723 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.69 157.07 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.452 1.501 . . . . 0.0 108.975 -168.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.4 t -138.37 152.8 48.76 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.913 -1.742 . . . . 0.0 109.189 170.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.48 -137.99 37.89 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 126.909 2.195 . . . . 0.0 116.205 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.66 14.44 82.08 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 124.582 1.087 . . . . 0.0 115.19 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.49 -126.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.962 -1.317 . . . . 0.0 113.698 -170.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -71.61 -58.74 3.22 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.421 -2.049 . . . . 0.0 111.305 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.0 t -130.38 143.72 50.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 163.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -155.04 -111.65 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -170.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.34 -47.47 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 124.994 1.318 . . . . 0.0 111.596 171.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -141.72 -147.93 0.23 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.528 1.931 . . . . 0.0 106.616 158.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -76.57 52.6 0.81 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.614 2.766 . . . . 0.0 112.101 172.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.86 177.32 20.12 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 -165.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.421 ' H ' HD21 ' A' ' 66' ' ' LEU . . . 100.31 138.79 10.44 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -165.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.1 mm -127.01 140.74 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -166.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.64 141.55 52.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.623 -1.298 . . . . 0.0 109.514 -169.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.31 125.86 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.982 -1.074 . . . . 0.0 112.115 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -82.67 -59.16 2.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.454 1.502 . . . . 0.0 110.6 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.14 172.24 6.47 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 123.77 0.828 . . . . 0.0 109.779 175.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.78 139.71 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 124.779 1.232 . . . . 0.0 112.306 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -85.44 120.74 73.42 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-O 116.549 -1.691 . . . . 0.0 108.109 165.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.69 34.12 0.52 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 125.869 3.132 . . . . 0.0 113.472 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.35 68.77 1.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.64 169.87 42.97 Favored Glycine 0 N--CA 1.432 -1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 111.227 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.66 -29.86 68.43 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 124.982 1.313 . . . . 0.0 114.365 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.41 -52.74 64.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -60.43 -46.43 90.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.031 1.332 . . . . 0.0 113.253 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.9 m -60.5 -54.71 42.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.66 1.584 . . . . 0.0 115.057 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.21 -37.84 57.25 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.787 -1.196 . . . . 0.0 112.223 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.55 88.33 1.09 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 125.517 1.532 . . . . 0.0 111.719 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -138.4 -58.39 0.64 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.453 -1.027 . . . . 0.0 113.665 -158.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.4 mt -127.98 130.97 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -118.17 171.67 7.95 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.618 1.199 . . . . 0.0 111.257 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -60.11 120.64 10.12 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -175.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.32 25.27 63.94 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -75.66 154.19 36.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.499 -1.589 . . . . 0.0 110.023 160.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -124.63 110.56 14.57 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.614 -1.304 . . . . 0.0 109.284 -170.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.4 m -102.24 152.62 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.645 -1.284 . . . . 0.0 111.776 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.5 tp -124.83 -77.58 0.59 Allowed 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 121.332 -0.855 . . . . 0.0 110.964 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.82 133.99 36.63 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 120.697 -1.252 . . . . 0.0 112.766 -166.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 p -101.7 90.36 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.762 1.625 . . . . 0.0 107.807 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.8 t30 56.64 61.57 2.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.162 1.785 . . . . 0.0 112.949 -170.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.18 -43.96 2.95 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 120.294 -1.503 . . . . 0.0 114.042 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.1 t -88.27 125.14 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 121.119 -1.224 . . . . 0.0 112.577 -170.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.6 t -75.17 149.75 38.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.28 -1.512 . . . . 0.0 111.715 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.421 HD21 ' H ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -94.72 -8.23 38.29 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 120.596 -1.315 . . . . 0.0 112.924 178.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.23 126.35 27.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -168.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.6 -46.42 1.16 Allowed Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.713 -1.242 . . . . 0.0 111.721 -162.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.46 165.67 24.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.785 1.234 . . . . 0.0 114.106 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.8 p -93.29 167.69 11.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.092 1.425 . . . . 0.0 111.175 172.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -42.38 -50.83 5.06 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 129.639 3.175 . . . . 0.0 116.794 170.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -70.06 -28.85 65.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.91 1.284 . . . . 0.0 113.591 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -74.07 -46.7 41.42 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.131 -1.606 . . . . 0.0 111.286 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.34 77.87 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.695 1.598 . . . . 0.0 115.164 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.3 p -71.37 -30.21 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.694 -1.879 . . . . 0.0 112.346 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -63.72 -47.66 80.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.091 -1.63 . . . . 0.0 113.118 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.4 m -55.68 -40.06 71.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.797 1.639 . . . . 0.0 113.306 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 tt -80.96 -33.09 34.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -175.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -71.68 -31.81 67.18 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.031 -1.668 . . . . 0.0 113.392 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -89.17 63.52 6.62 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.661 -1.274 . . . . 0.0 111.966 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 p -108.4 -81.27 0.57 Allowed 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.16 1.784 . . . . 0.0 110.388 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.86 -93.44 0.63 Allowed Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 125.865 1.698 . . . . 0.0 112.79 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -81.37 -57.37 3.52 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -168.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.2 m -104.94 144.45 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 123.251 1.501 . . . . 0.0 112.581 -169.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.04 94.25 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -119.32 121.69 40.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.613 -1.305 . . . . 0.0 108.501 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.51 163.97 35.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.633 -1.292 . . . . 0.0 112.941 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 mp -121.14 121.57 38.14 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.96 168.29 11.65 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.996 1.318 . . . . 0.0 109.757 -173.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -123.58 130.97 53.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.335 1.454 . . . . 0.0 107.302 161.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.8 139.27 53.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 125.07 1.348 . . . . 0.0 113.184 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.685 0 N-CA-C 116.839 1.495 . . . . 0.0 116.839 -175.729 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.36 152.39 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 126.039 1.736 . . . . 0.0 110.94 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 36.2 m -134.71 169.23 17.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.508 1.923 . . . . 0.0 112.561 -174.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.11 152.08 30.03 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 124.789 1.236 . . . . 0.0 110.989 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.998 2.119 . . . . 0.0 108.102 162.817 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.745 0 CA-C-O 121.13 0.295 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.27 154.22 26.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 121.307 -1.113 . . . . 0.0 112.757 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.87 133.69 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.764 -1.21 . . . . 0.0 109.394 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.5 153.95 41.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.089 -1.632 . . . . 0.0 111.549 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -125.67 119.81 29.02 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.908 -1.12 . . . . 0.0 112.619 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 t -104.58 137.17 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.958 -1.714 . . . . 0.0 112.015 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -111.07 127.07 55.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.71 1.204 . . . . 0.0 110.639 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 11.9 tp -135.03 -173.2 3.25 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.574 1.15 . . . . 0.0 109.929 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.401 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -141.75 157.6 44.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.272 -1.517 . . . . 0.0 107.913 171.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.8 tttm -71.8 112.33 7.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 122.67 1.224 . . . . 0.0 112.779 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -99.88 -93.44 0.27 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.521 1.528 . . . . 0.0 109.389 -172.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.12 -42.77 16.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.663 1.585 . . . . 0.0 108.248 161.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -137.66 178.66 6.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 p -84.29 -72.0 0.49 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.436 1.494 . . . . 0.0 110.651 174.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.4 mt -102.36 -75.56 0.6 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.511 1.124 . . . . 0.0 110.543 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.89 50.45 2.87 Favored Glycine 0 N--CA 1.431 -1.69 0 O-C-N 120.199 -1.563 . . . . 0.0 113.229 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 40' ' ' VAL . 7.2 tt -143.12 146.3 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 122.314 1.054 . . . . 0.0 112.229 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 t -86.41 145.82 26.7 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.838 -1.788 . . . . 0.0 111.582 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.488 HG11 ' CE1' ' A' ' 71' ' ' HIS . 11.8 t -109.28 151.44 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.052 1.341 . . . . 0.0 111.13 -167.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -138.1 115.66 11.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.29 1.519 . . . . 0.0 110.964 170.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.35 -123.69 7.38 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.167 -1.583 . . . . 0.0 112.924 169.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.46 27.47 63.43 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 115.954 1.142 . . . . 0.0 115.954 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 m -105.64 -148.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 121.175 -1.191 . . . . 0.0 111.703 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -71.62 -37.18 70.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.853 1.661 . . . . 0.0 113.359 -166.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 t -130.89 117.73 19.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 163.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.9 t -151.07 -105.2 0.06 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.768 -1.832 . . . . 0.0 106.826 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.01 -52.13 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 125.119 1.368 . . . . 0.0 109.91 173.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -131.7 -158.84 0.92 Allowed 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 169.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -77.29 88.92 3.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.758 1.223 . . . . 0.0 108.594 162.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.32 172.87 32.05 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 119.798 -1.814 . . . . 0.0 113.555 -168.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.62 145.53 19.28 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -167.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.0 mm -125.05 142.83 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 120.463 -1.61 . . . . 0.0 108.925 -158.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -124.82 142.24 51.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 124.482 1.113 . . . . 0.0 110.683 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.9 t -90.94 133.98 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.887 -1.133 . . . . 0.0 113.155 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -91.01 -63.54 1.25 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.258 1.423 . . . . 0.0 113.114 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.45 158.22 11.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 -174.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.408 ' HA ' HG13 ' A' ' 20' ' ' ILE . 9.3 p -87.46 135.71 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 124.249 1.02 . . . . 0.0 112.821 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -85.44 120.8 73.48 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.741 -1.599 . . . . 0.0 109.861 171.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -73.81 44.85 1.0 Allowed 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 125.089 2.853 . . . . 0.0 116.266 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.93 43.12 0.55 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.952 1.358 . . . . 0.0 110.238 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.96 -171.93 38.8 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.047 -1.658 . . . . 0.0 112.3 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.19 -43.2 70.5 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.861 2.064 . . . . 0.0 116.114 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.78 -44.13 66.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.453 1.501 . . . . 0.0 114.975 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.56 -61.4 1.78 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.357 1.463 . . . . 0.0 112.045 171.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.1 m -56.21 -50.54 70.94 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -173.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -82.45 -27.9 31.61 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 121.308 -0.87 . . . . 0.0 111.183 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.81 73.09 1.28 Allowed Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 124.664 1.126 . . . . 0.0 110.913 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.438 HH22 ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -138.3 -44.26 0.5 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -152.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -128.35 134.28 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 120.615 1.552 . . . . 0.0 107.866 -170.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -125.14 171.13 10.55 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 122.734 1.254 . . . . 0.0 112.131 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -57.22 133.6 55.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.797 2.039 . . . . 0.0 115.763 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.42 12.16 84.81 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -79.95 167.06 20.97 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 118.819 1.309 . . . . 0.0 110.801 167.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -131.31 135.67 47.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.392 -1.443 . . . . 0.0 108.484 -172.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.57 145.76 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 120.103 1.319 . . . . 0.0 110.15 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.9 tp -135.49 -60.07 0.76 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.48 138.46 38.46 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.606 -1.934 . . . . 0.0 113.39 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.22 106.33 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.752 -1.217 . . . . 0.0 109.683 170.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 t30 56.03 40.42 30.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 170.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.22 -0.81 84.05 Favored Glycine 0 N--CA 1.431 -1.671 0 O-C-N 119.968 -1.708 . . . . 0.0 115.05 -176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.29 106.71 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 120.791 -1.417 . . . . 0.0 109.404 168.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 t -78.27 123.56 27.08 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.694 -1.879 . . . . 0.0 111.416 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -93.27 28.51 2.18 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.607 -1.308 . . . . 0.0 112.606 177.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.39 137.24 58.22 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.177 -1.577 . . . . 0.0 110.811 163.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.37 -35.44 2.99 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 119.16 -2.212 . . . . 0.0 114.406 -173.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.92 142.29 42.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.924 -1.339 . . . . 0.0 113.355 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.4 p -84.95 163.91 18.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.031 1.732 . . . . 0.0 111.851 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.488 ' CE1' HG11 ' A' ' 22' ' ' VAL . 14.4 t60 -48.13 -53.71 15.76 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.674 2.389 . . . . 0.0 116.688 -174.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -68.25 -29.91 68.83 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.289 1.042 . . . . 0.0 113.791 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -73.8 -46.68 43.88 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.889 1.275 . . . . 0.0 111.45 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.08 -41.48 86.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.273 1.829 . . . . 0.0 114.643 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 p -63.14 -34.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.089 -1.632 . . . . 0.0 113.084 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.29 -36.51 84.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.417 -1.427 . . . . 0.0 113.766 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.4 m -67.44 -35.05 78.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.033 1.733 . . . . 0.0 112.733 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -78.03 -37.83 46.02 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.538 -1.351 . . . . 0.0 112.093 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -62.99 -50.24 71.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.972 1.309 . . . . 0.0 113.165 173.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -85.38 60.83 6.49 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.168 -1.582 . . . . 0.0 112.002 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 p -99.02 -61.21 1.4 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.448 2.299 . . . . 0.0 108.008 168.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.84 -104.2 1.34 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 124.262 0.934 . . . . 0.0 113.606 160.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -81.92 -53.0 6.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.444 -1.033 . . . . 0.0 112.881 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.4 m -112.24 146.78 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 124.832 1.253 . . . . 0.0 109.359 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.57 123.7 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.243 -0.911 . . . . 0.0 108.99 -172.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -136.02 124.09 22.93 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.691 -1.255 . . . . 0.0 110.517 171.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -148.8 162.69 39.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.838 -1.164 . . . . 0.0 112.991 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.71 127.94 54.03 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -171.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.438 ' CD2' HH22 ' A' ' 51' ' ' ARG . 4.9 mp -118.21 159.49 23.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.928 1.291 . . . . 0.0 109.413 -175.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -120.03 126.27 50.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -68.04 147.54 52.24 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.623 -1.298 . . . . 0.0 112.69 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.709 0 N-CA-C 116.911 1.525 . . . . 0.0 116.911 -174.776 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.95 153.25 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.153 -1.592 . . . . 0.0 111.239 -177.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -137.14 178.14 7.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.029 1.332 . . . . 0.0 110.334 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -151.25 149.08 28.98 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 124.378 1.071 . . . . 0.0 108.563 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.261 1.66 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 173.359 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo . . . . . 0 CA--C 1.489 -1.738 0 N-CA-C 109.629 -0.95 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -77.26 156.09 81.72 Favored Pre-proline 0 N--CA 1.43 -1.426 0 O-C-N 120.968 -1.083 . . . . 0.0 111.632 174.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -65.75 -49.62 2.18 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 123.076 2.134 . . . . 0.0 114.697 -175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.55 56.46 4.17 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 118.904 0.775 . . . . 0.0 112.92 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -82.6 153.11 25.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.164 -1.198 . . . . 0.0 113.455 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.33 128.79 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 124.703 1.201 . . . . 0.0 109.78 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -137.27 160.99 37.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.489 -1.382 . . . . 0.0 110.404 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -113.56 140.61 48.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.871 -1.143 . . . . 0.0 112.145 175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -102.54 138.69 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 124.195 0.998 . . . . 0.0 109.367 172.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -121.15 101.92 7.97 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 125.514 1.525 . . . . 0.0 107.951 168.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -133.87 -175.5 3.86 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.421 -0.799 . . . . 0.0 109.918 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.26 174.66 15.06 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.934 -1.104 . . . . 0.0 110.285 174.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -69.98 123.32 21.25 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -121.32 -81.89 0.64 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.539 1.536 . . . . 0.0 111.784 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.85 -57.24 3.91 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.106 1.763 . . . . 0.0 108.61 170.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -142.24 -139.1 0.11 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 156.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 p -85.49 -85.62 0.14 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.007 -1.683 . . . . 0.0 111.997 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.9 mt -101.18 -74.46 0.61 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.334 -1.479 . . . . 0.0 113.335 -171.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.59 54.33 1.45 Allowed Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 124.839 1.209 . . . . 0.0 110.446 -174.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.9 tt -146.23 155.29 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.477 -1.013 . . . . 0.0 110.625 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 t -121.09 151.9 39.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.409 -1.432 . . . . 0.0 109.088 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.417 HG11 ' HE1' ' A' ' 71' ' ' HIS . 1.1 t -124.24 152.33 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.509 1.524 . . . . 0.0 110.319 -164.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 t -138.65 138.25 37.64 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 120.494 -1.379 . . . . 0.0 110.11 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.69 -137.71 20.53 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 125.832 1.682 . . . . 0.0 114.349 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.33 23.67 46.88 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 117.6 1.8 . . . . 0.0 117.6 166.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 m -87.27 -119.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 119.491 1.646 . . . . 0.0 114.848 -171.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -71.37 -45.34 63.08 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.875 -2.391 . . . . 0.0 113.117 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 t -138.56 170.94 15.12 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 148.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -156.01 -69.05 0.11 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.444 -1.41 . . . . 0.0 111.357 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 t -92.62 -56.51 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 124.291 1.036 . . . . 0.0 111.939 -168.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -141.12 -92.1 0.15 Allowed 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 121.475 -0.765 . . . . 0.0 109.997 -170.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -117.58 52.35 0.99 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.651 1.691 . . . . 0.0 107.617 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.81 -142.52 17.53 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 107.309 -2.317 . . . . 0.0 107.309 -166.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.08 148.29 23.49 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 124.675 1.131 . . . . 0.0 113.398 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.5 mm -127.61 151.31 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.17 143.94 50.94 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.252 1.021 . . . . 0.0 111.186 -171.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.8 t -73.08 129.6 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.693 -1.254 . . . . 0.0 111.657 173.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -81.54 -62.77 1.55 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.43 -0.794 . . . . 0.0 109.62 171.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.45 167.54 15.61 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.1 t -92.35 136.84 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 124.835 1.254 . . . . 0.0 110.668 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.6 mm -83.83 120.34 74.91 Favored Pre-proline 0 N--CA 1.43 -1.427 0 O-C-N 120.314 -1.491 . . . . 0.0 109.005 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.12 65.0 8.93 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 CA-C-N 124.801 2.75 . . . . 0.0 113.277 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -141.7 -1.4 1.28 Allowed 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 124.894 1.278 . . . . 0.0 112.897 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -141.87 -161.68 8.85 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 120.251 -1.531 . . . . 0.0 114.826 -171.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.69 -37.15 86.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 -173.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.27 92.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.274 1.03 . . . . 0.0 113.383 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -68.63 -55.88 10.06 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.375 1.07 . . . . 0.0 112.943 167.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.8 t -59.29 -56.99 15.04 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.324 1.45 . . . . 0.0 114.906 -170.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -81.11 -37.83 28.25 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.446 -1.409 . . . . 0.0 110.572 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.76 90.29 1.33 Allowed Glycine 0 N--CA 1.429 -1.78 0 O-C-N 120.519 -1.363 . . . . 0.0 111.397 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -137.18 -41.79 0.57 Allowed 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 121.418 -1.048 . . . . 0.0 111.189 -171.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 mt -129.11 143.13 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 -175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.34 -173.54 3.3 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.313 -1.492 . . . . 0.0 111.179 170.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -55.97 132.57 50.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.39 9.86 86.59 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 118.236 2.054 . . . . 0.0 118.236 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -74.23 155.47 38.27 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 119.496 1.648 . . . . 0.0 112.167 172.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -124.55 144.0 50.37 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.105 -1.622 . . . . 0.0 110.719 -170.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 m -101.39 154.02 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 119.802 -1.811 . . . . 0.0 112.605 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.15 -91.18 0.56 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.209 1.404 . . . . 0.0 108.128 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.31 148.28 23.8 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.886 -1.133 . . . . 0.0 113.89 -166.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.7 t -112.36 100.91 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.086 1.354 . . . . 0.0 107.796 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.5 t30 56.77 61.06 2.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.269 1.828 . . . . 0.0 112.393 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.87 -39.02 2.95 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.922 -1.111 . . . . 0.0 115.336 -176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.08 128.06 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.453 -1.616 . . . . 0.0 112.603 -166.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -77.36 124.2 27.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.881 -1.137 . . . . 0.0 111.819 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.9 mp -87.36 74.22 9.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.115 1.436 . . . . 0.0 110.503 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -68.81 99.8 1.09 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.265 -1.522 . . . . 0.0 113.293 172.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.75 23.17 53.96 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.481 0.952 . . . . 0.0 115.481 172.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.35 136.35 39.54 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.384 -1.068 . . . . 0.0 112.526 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.6 p -80.13 172.21 14.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.572 1.149 . . . . 0.0 113.063 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.417 ' HE1' HG11 ' A' ' 22' ' ' VAL . 2.9 t60 -61.63 -41.25 97.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.257 -1.527 . . . . 0.0 113.252 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -59.02 -40.24 84.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -69.87 -41.63 74.55 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.29 -1.506 . . . . 0.0 111.773 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.82 97.23 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 120.678 -1.264 . . . . 0.0 114.082 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -70.13 -43.29 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.417 -1.427 . . . . 0.0 113.096 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -62.06 -42.25 99.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.433 -1.417 . . . . 0.0 113.729 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.3 p -70.15 -17.51 63.19 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.26 -1.525 . . . . 0.0 115.052 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 38.4 mt -80.32 -39.01 29.53 Favored 'General case' 0 N--CA 1.431 -1.384 0 O-C-N 120.424 -1.422 . . . . 0.0 113.454 171.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -86.61 -27.43 23.86 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.484 -1.385 . . . . 0.0 113.932 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -83.42 60.56 5.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.68 -1.888 . . . . 0.0 112.55 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.5 p -109.06 -89.85 0.47 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.693 1.597 . . . . 0.0 112.518 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.44 -129.25 8.09 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 107.416 -2.274 . . . . 0.0 107.416 -166.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -81.25 -51.44 8.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -165.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -104.16 145.96 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.623 -1.298 . . . . 0.0 113.764 -159.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -121.24 105.73 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 125.022 1.329 . . . . 0.0 110.101 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -116.86 120.85 39.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.889 -1.132 . . . . 0.0 108.623 168.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.58 166.86 27.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.503 -1.373 . . . . 0.0 111.911 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -120.21 137.38 54.23 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 mp -125.53 156.75 38.55 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.312 1.445 . . . . 0.0 108.363 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -113.49 132.59 55.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 166.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.6 tptt -68.86 138.16 54.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.789 -1.194 . . . . 0.0 112.693 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.93 -90.95 0.26 Allowed Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.795 -1.191 . . . . 0.0 114.667 -172.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -102.39 176.73 5.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.334 1.453 . . . . 0.0 111.775 172.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.3 m -74.73 126.65 88.27 Favored Pre-proline 0 N--CA 1.431 -1.422 0 O-C-N 120.434 -1.416 . . . . 0.0 113.118 -175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.65 -62.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 123.844 2.409 . . . . 0.0 112.653 169.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 C--O 1.26 1.63 0 CA-C-N 119.715 1.143 . . . . 0.0 111.183 170.897 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 . . . . . 0 CA--C 1.49 -1.331 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.97 -175.3 3.5 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.774 -1.203 . . . . 0.0 112.384 -177.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 62.81 35.94 13.4 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.865 2.066 . . . . 0.0 114.755 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 25.9 t -146.65 -78.04 0.17 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.958 -1.714 . . . . 0.0 112.416 -167.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -104.57 -69.22 0.82 Allowed 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.103 -0.998 . . . . 0.0 113.258 -160.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.17 144.69 30.11 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.563 -1.336 . . . . 0.0 111.31 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -117.26 -177.44 3.22 Favored 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 125.481 1.512 . . . . 0.0 107.213 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -97.33 109.54 22.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.497 -1.377 . . . . 0.0 109.898 176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -151.25 27.82 0.67 Allowed 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -121.94 76.14 1.27 Allowed 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.534 -1.354 . . . . 0.0 108.818 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -133.58 -122.16 0.18 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.494 1.118 . . . . 0.0 108.773 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.6 t -128.25 145.91 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 C-N-CA 125.386 1.474 . . . . 0.0 109.271 -164.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.1 p -126.3 163.31 23.51 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.463 1.505 . . . . 0.0 111.822 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.19 159.02 43.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 121.514 -0.741 . . . . 0.0 109.579 162.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.261 1.671 0 C-N-CA 124.048 0.939 . . . . 0.0 109.012 177.665 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 CA--C 1.49 -1.709 0 N-CA-C 108.669 -1.319 . . . . 0.0 108.669 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -78.25 165.01 53.36 Favored Pre-proline 0 N--CA 1.429 -1.499 0 CA-C-O 117.589 -1.196 . . . . 0.0 110.065 167.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.97 -19.28 18.07 Favored 'Trans proline' 0 N--CA 1.434 -1.991 0 CA-C-N 125.305 2.93 . . . . 0.0 113.051 -164.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.73 88.44 0.57 Allowed Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 165.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -74.17 145.98 43.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 118.842 1.321 . . . . 0.0 113.429 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 31.4 mt -89.44 137.64 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 125.251 1.42 . . . . 0.0 110.106 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -146.56 161.26 40.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.972 -1.08 . . . . 0.0 109.99 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -115.52 141.07 48.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 121.146 -0.971 . . . . 0.0 108.878 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.1 m -104.4 147.39 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 124.045 0.938 . . . . 0.0 112.632 173.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -113.67 123.33 49.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 123.746 0.818 . . . . 0.0 109.058 168.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.5 mt -132.83 157.91 43.83 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.442 -1.411 . . . . 0.0 110.427 165.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.66 139.26 27.89 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -70.41 96.68 1.17 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -92.29 -66.36 0.93 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.123 1.769 . . . . 0.0 109.703 171.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -88.7 -71.37 0.59 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.173 1.789 . . . . 0.0 109.186 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -136.55 166.45 23.5 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -171.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -83.06 -71.19 0.51 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -167.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.85 -83.27 0.46 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.138 -1.601 . . . . 0.0 110.028 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.4 39.35 2.82 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 120.688 -1.258 . . . . 0.0 114.932 170.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.86 169.58 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 121.093 -1.239 . . . . 0.0 108.774 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.7 p -122.45 146.51 47.31 Favored 'General case' 0 N--CA 1.429 -1.513 0 O-C-N 119.968 -1.708 . . . . 0.0 108.75 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 t -125.32 149.83 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 125.168 1.387 . . . . 0.0 110.044 -161.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -136.29 142.11 43.9 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.062 1.411 . . . . 0.0 109.774 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.71 -130.77 9.91 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 125.761 1.648 . . . . 0.0 114.191 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.93 62.42 Favored Glycine 0 N--CA 1.43 -1.724 0 O-C-N 121.404 -1.056 . . . . 0.0 114.531 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 27' ' ' ASN . 46.5 t -89.36 168.04 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.435 ' H ' HG12 ' A' ' 26' ' ' VAL . 10.1 p30 -67.73 -26.8 66.32 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 125.984 1.714 . . . . 0.0 113.163 -163.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 t -129.74 128.18 41.92 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 152.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 p -155.39 -89.75 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.853 -1.154 . . . . 0.0 110.672 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.8 p -78.25 -47.2 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.3 -1.5 . . . . 0.0 109.457 171.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.95 -153.18 0.52 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 167.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -76.55 89.84 3.3 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.399 -1.438 . . . . 0.0 109.278 163.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.69 -154.35 30.9 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -162.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.39 136.93 9.11 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-O 122.858 1.254 . . . . 0.0 112.465 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.5 mm -124.89 133.75 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.4 -1.647 . . . . 0.0 107.574 -164.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.96 141.4 51.99 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.677 1.191 . . . . 0.0 108.311 -170.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.7 t -80.03 130.53 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.906 -1.121 . . . . 0.0 110.911 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -86.75 -57.34 3.02 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 120.139 -1.6 . . . . 0.0 110.783 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.87 155.56 29.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.853 1.261 . . . . 0.0 109.514 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -94.78 131.16 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 122.519 1.152 . . . . 0.0 110.689 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.7 mm -82.93 123.06 78.18 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 120.523 -1.361 . . . . 0.0 110.42 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.11 40.9 1.0 Allowed 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.041 2.494 . . . . 0.0 114.051 -172.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -144.78 53.85 1.23 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.19 174.29 45.91 Favored Glycine 0 N--CA 1.43 -1.704 0 O-C-N 120.419 -1.426 . . . . 0.0 113.896 -175.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.78 -36.09 73.86 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 126.475 1.91 . . . . 0.0 114.4 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.65 -53.78 47.1 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -69.35 -49.95 50.87 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.284 1.434 . . . . 0.0 112.346 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -61.19 -39.87 91.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -82.07 -47.92 12.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.838 -1.164 . . . . 0.0 111.236 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.96 62.63 1.98 Allowed Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 117.109 1.604 . . . . 0.0 117.109 168.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -135.5 -1.08 2.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.472 -1.605 . . . . 0.0 111.841 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.3 mt -129.28 149.47 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -126.8 173.68 9.36 Favored 'General case' 0 N--CA 1.429 -1.509 0 O-C-N 120.287 -1.508 . . . . 0.0 111.531 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -58.12 135.9 57.11 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.945 1.298 . . . . 0.0 114.214 171.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.76 18.51 78.84 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 117.559 1.784 . . . . 0.0 117.559 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -82.7 162.51 21.78 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 120.341 2.07 . . . . 0.0 111.543 166.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -126.33 123.4 37.93 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.714 -1.241 . . . . 0.0 110.384 -172.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -85.56 155.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.118 -1.614 . . . . 0.0 113.284 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.0 mt -122.04 -86.13 0.65 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.707 1.203 . . . . 0.0 111.229 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.52 144.94 28.91 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -173.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.63 96.25 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 124.468 1.107 . . . . 0.0 108.329 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.296 9.5 t-20 57.19 47.59 16.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.854 1.661 . . . . 0.0 113.343 177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.79 -34.3 5.86 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.582 -1.324 . . . . 0.0 114.278 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 t -100.9 109.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 118.368 1.084 . . . . 0.0 112.159 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.9 m -79.61 110.22 14.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.665 1.586 . . . . 0.0 112.392 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.14 85.4 4.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 119.577 -1.952 . . . . 0.0 110.555 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.03 135.11 51.79 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.921 -1.737 . . . . 0.0 113.652 174.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.56 7.23 63.45 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 124.685 1.136 . . . . 0.0 114.371 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.86 130.8 39.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.825 -1.397 . . . . 0.0 112.903 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.3 p -80.76 171.61 14.8 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 123.126 1.441 . . . . 0.0 110.252 168.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.459 ' CE1' ' HB2' ' B' ' 13' ' ' SER . 1.9 t60 -56.25 -41.7 76.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.641 1.977 . . . . 0.0 114.093 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.3 tptt -52.32 -45.72 65.73 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.511 1.524 . . . . 0.0 114.859 171.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -72.06 -38.51 69.43 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.841 1.256 . . . . 0.0 111.722 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.12 76.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.621 1.168 . . . . 0.0 113.852 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.3 t -63.21 -48.14 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 126.628 1.971 . . . . 0.0 113.331 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -53.59 -46.46 70.37 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 122.483 1.135 . . . . 0.0 113.271 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.7 m -65.91 -41.71 91.11 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.029 2.132 . . . . 0.0 113.218 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 55.8 mt -85.81 -27.31 25.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.139 -1.601 . . . . 0.0 114.83 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 44.6 mtt180 -65.47 -45.93 81.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.775 -1.828 . . . . 0.0 112.625 173.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -83.46 60.39 5.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.017 1.389 . . . . 0.0 112.26 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.89 -80.85 0.37 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.47 1.908 . . . . 0.0 109.192 175.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 101.16 -78.79 0.4 Allowed Glycine 0 N--CA 1.429 -1.774 0 O-C-N 121.294 -0.879 . . . . 0.0 114.257 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -81.51 -58.74 2.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.503 -0.998 . . . . 0.0 113.472 -175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.43 149.21 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 124.777 1.231 . . . . 0.0 110.487 -166.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.6 t -129.45 112.31 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.073 1.349 . . . . 0.0 107.786 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -127.98 104.44 7.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.637 -1.289 . . . . 0.0 110.857 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.3 mt -127.7 162.59 26.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 111.313 -169.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.24 136.32 54.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.514 1.526 . . . . 0.0 107.15 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.74 161.24 42.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.802 0.811 . . . . 0.0 111.822 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -114.29 134.8 54.69 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.857 1.663 . . . . 0.0 109.652 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -62.65 135.2 57.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.47 -139.07 4.21 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 123.281 1.489 . . . . 0.0 116.175 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -94.91 155.13 16.9 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.544 1.538 . . . . 0.0 111.177 176.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.7 t -73.64 141.95 80.09 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -79.27 139.62 14.93 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 123.294 2.212 . . . . 0.0 114.022 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 C--O 1.259 1.589 0 C-N-CA 125.019 1.327 . . . . 0.0 110.533 175.109 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 CA--C 1.49 -1.338 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.8 -55.02 4.31 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.883 -1.761 . . . . 0.0 115.497 -175.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 72.4 58.06 0.14 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.017 2.527 . . . . 0.0 111.3 -167.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.2 m -136.68 168.34 19.7 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -74.5 -95.82 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -158.02 133.46 8.89 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 121.001 -1.062 . . . . 0.0 111.459 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -128.81 63.8 1.46 Allowed 'General case' 0 N--CA 1.428 -1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.83 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . 0.35 22.4 mt-10 58.09 -165.04 0.17 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 173.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -137.35 169.62 17.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.028 -1.67 . . . . 0.0 110.93 -163.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -134.99 162.72 31.65 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.612 1.565 . . . . 0.0 106.843 168.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -149.17 -170.74 3.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.845 -1.159 . . . . 0.0 113.439 -174.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.81 123.86 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.261 1.824 . . . . 0.0 107.699 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.459 ' HB2' ' CE1' ' A' ' 71' ' ' HIS . 15.0 m -129.59 133.06 46.96 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.707 -1.246 . . . . 0.0 113.154 -171.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.02 155.9 34.61 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.644 -1.285 . . . . 0.0 112.544 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 7.8 p . . . . . 0 C--O 1.26 1.633 0 C-N-CA 126.636 1.974 . . . . 0.0 107.858 173.798 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo . . . . . 0 CA--C 1.489 -1.755 0 N-CA-C 108.025 -1.567 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -81.12 162.71 58.37 Favored Pre-proline 0 N--CA 1.431 -1.383 0 CA-C-O 117.707 -1.139 . . . . 0.0 110.949 177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.26 -40.54 2.31 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 CA-C-N 123.948 2.446 . . . . 0.0 113.708 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.54 71.84 0.23 Allowed Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 124.816 1.198 . . . . 0.0 112.455 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -82.18 178.97 7.98 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 120.898 -1.354 . . . . 0.0 113.624 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -85.67 133.99 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.326 -1.483 . . . . 0.0 108.376 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -135.96 146.65 47.49 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 121.201 -0.937 . . . . 0.0 108.781 175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -106.68 134.82 49.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.027 -1.046 . . . . 0.0 109.36 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.9 t -102.06 115.44 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -120.38 95.44 4.74 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.801 1.24 . . . . 0.0 108.63 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.496 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 11.0 tp -134.49 -155.95 0.69 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.174 -0.954 . . . . 0.0 109.368 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.496 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -154.53 168.19 27.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -71.96 129.64 39.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -120.98 -69.88 0.82 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.825 1.25 . . . . 0.0 110.722 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -76.56 -62.62 1.57 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.657 -1.277 . . . . 0.0 109.188 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -137.79 -131.11 0.13 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 139.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.7 p -89.81 -78.15 0.37 Allowed 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 120.19 1.359 . . . . 0.0 112.187 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.1 mt -103.21 -99.31 0.3 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.372 -1.455 . . . . 0.0 113.921 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.42 52.43 1.71 Allowed Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -157.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.95 147.05 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.956 -1.32 . . . . 0.0 108.366 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 t -122.48 148.21 45.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.727 -1.233 . . . . 0.0 109.223 -174.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -123.62 157.01 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 122.343 1.068 . . . . 0.0 110.11 -164.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.2 t -137.06 112.71 9.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 122.75 1.262 . . . . 0.0 107.834 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.46 175.38 50.7 Favored Glycine 0 N--CA 1.43 -1.756 0 CA-C-O 122.934 1.296 . . . . 0.0 115.004 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.43 67.84 0.7 Allowed Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.1 m -97.21 -130.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 125.135 1.374 . . . . 0.0 110.694 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -71.1 -39.12 72.3 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.028 -2.295 . . . . 0.0 112.714 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.8 t -151.99 143.14 23.22 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 163.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.1 t -156.55 -69.25 0.11 Allowed 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.081 -1.637 . . . . 0.0 113.285 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.37 -58.32 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.558 -1.339 . . . . 0.0 112.734 -164.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -125.52 -83.64 0.63 Allowed 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 124.078 0.951 . . . . 0.0 109.295 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.39 53.71 1.93 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 165.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.3 -140.42 16.27 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 -161.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.15 150.24 19.94 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 117.955 0.877 . . . . 0.0 113.522 176.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 22.0 mm -125.67 148.91 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -125.85 135.62 52.16 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.858 -1.151 . . . . 0.0 112.052 -169.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 93.3 t -78.65 130.32 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 120.398 -1.438 . . . . 0.0 112.333 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -89.52 -59.35 2.23 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.903 -1.123 . . . . 0.0 110.536 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.86 163.33 23.8 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 121.765 0.793 . . . . 0.0 110.24 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t -93.4 131.72 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.122 1.369 . . . . 0.0 109.152 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.4 mm -83.58 120.31 75.15 Favored Pre-proline 0 N--CA 1.431 -1.381 0 O-C-N 120.926 -1.109 . . . . 0.0 109.816 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.8 67.56 8.57 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 124.022 2.472 . . . . 0.0 112.88 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -145.4 9.72 1.23 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 123.997 0.919 . . . . 0.0 111.835 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.17 -158.82 18.49 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 119.664 -1.898 . . . . 0.0 114.565 -172.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.34 -43.51 79.13 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.512 2.325 . . . . 0.0 116.26 -168.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.78 -40.98 90.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -73.79 -49.98 22.71 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.714 1.206 . . . . 0.0 111.583 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.0 t -55.05 -55.45 30.83 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.522 2.329 . . . . 0.0 114.485 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -79.2 -44.44 21.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.641 -1.287 . . . . 0.0 111.772 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.49 91.48 0.55 Allowed Glycine 0 N--CA 1.431 -1.686 0 C-N-CA 124.223 0.916 . . . . 0.0 113.443 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -136.16 -45.7 0.63 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.168 -1.195 . . . . 0.0 110.436 -172.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.6 mt -126.04 133.45 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 -169.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -123.82 -178.19 3.97 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 122.598 1.19 . . . . 0.0 112.101 -176.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -56.42 125.03 20.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.49 16.79 80.45 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 117.588 1.795 . . . . 0.0 117.588 -178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -72.07 161.8 30.38 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.346 1.573 . . . . 0.0 112.634 167.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -123.16 115.18 21.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 121.029 -1.044 . . . . 0.0 109.314 -173.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.2 m -86.96 148.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 119.872 -1.767 . . . . 0.0 110.136 172.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.3 mt -128.98 -81.01 0.57 Allowed 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 121.41 -0.806 . . . . 0.0 111.46 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.5 138.12 34.56 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.553 -1.342 . . . . 0.0 114.455 -167.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -95.93 90.91 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 C-N-CA 126.394 1.877 . . . . 0.0 109.411 -177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.292 3.3 t-20 56.37 50.65 12.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.945 1.698 . . . . 0.0 112.324 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.23 -36.8 3.89 Favored Glycine 0 N--CA 1.43 -1.733 0 O-C-N 120.678 -1.264 . . . . 0.0 113.675 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.2 t -85.23 124.05 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 O-C-N 121.305 -1.115 . . . . 0.0 112.293 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 t -77.98 129.52 35.39 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.677 -1.264 . . . . 0.0 110.864 174.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tp -95.08 51.84 1.39 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.972 -1.705 . . . . 0.0 112.808 -164.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -66.98 123.81 21.25 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.652 1.581 . . . . 0.0 114.512 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.39 -4.8 80.51 Favored Glycine 0 N--CA 1.429 -1.78 0 O-C-N 120.26 -1.525 . . . . 0.0 114.358 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.35 143.41 40.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 121.258 -1.142 . . . . 0.0 112.976 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.8 p -85.96 175.84 8.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.16 1.384 . . . . 0.0 111.006 174.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -59.73 -43.67 94.11 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.205 1.402 . . . . 0.0 112.488 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.88 -40.99 90.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.528 2.331 . . . . 0.0 115.386 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -72.1 -37.46 69.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.189 -1.57 . . . . 0.0 112.354 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.2 -34.46 77.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.931 -1.106 . . . . 0.0 113.494 171.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.6 -51.58 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.365 1.466 . . . . 0.0 113.069 170.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -60.46 -40.28 90.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.635 -1.291 . . . . 0.0 114.328 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 p -70.48 -18.55 62.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.321 -1.487 . . . . 0.0 113.86 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mt -85.67 -19.13 31.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.01 -1.681 . . . . 0.0 113.253 170.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -78.54 -44.16 24.96 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.237 -1.539 . . . . 0.0 110.924 169.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -82.95 64.91 7.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.879 1.272 . . . . 0.0 112.942 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.5 p -99.72 -74.08 0.61 Allowed 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.156 1.782 . . . . 0.0 111.015 177.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.37 -131.19 9.56 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 125.702 1.62 . . . . 0.0 111.01 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -76.79 -44.21 33.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.003 -1.292 . . . . 0.0 113.481 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -109.31 164.42 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 123.915 0.886 . . . . 0.0 111.055 -167.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.0 t -134.15 127.75 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.225 1.41 . . . . 0.0 109.38 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -142.43 115.68 8.93 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.397 -0.814 . . . . 0.0 109.078 171.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -149.05 162.36 40.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.243 -1.536 . . . . 0.0 112.019 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.3 mp -121.01 124.41 44.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.282 1.039 . . . . 0.0 108.982 -175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -117.86 166.06 12.93 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.527 1.131 . . . . 0.0 108.944 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -117.33 131.6 56.76 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 162.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -73.71 124.53 26.19 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.941 -1.099 . . . . 0.0 111.051 -174.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.81 -76.38 1.2 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 121.232 -0.917 . . . . 0.0 115.055 -166.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -99.94 140.39 34.22 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 123.838 0.855 . . . . 0.0 110.404 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.4 m -72.46 141.9 83.51 Favored Pre-proline 0 N--CA 1.429 -1.488 0 O-C-N 120.909 -1.12 . . . . 0.0 112.385 -176.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -62.78 -66.0 0.05 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.057 0 C-N-CA 123.139 2.559 . . . . 0.0 112.282 162.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.26 1.653 0 CA-C-N 119.092 0.86 . . . . 0.0 109.517 157.449 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 120.247 0.07 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.94 162.84 28.24 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 64.05 38.64 8.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.128 2.171 . . . . 0.0 113.845 177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 5.1 t -119.07 -70.93 0.76 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.613 -1.304 . . . . 0.0 109.847 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -93.51 -86.88 0.25 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.859 -1.151 . . . . 0.0 113.08 -173.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -150.13 167.37 27.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.224 -0.922 . . . . 0.0 111.5 -177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.69 -174.65 4.39 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.807 1.243 . . . . 0.0 111.159 171.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -76.06 95.13 3.56 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.813 1.645 . . . . 0.0 110.502 174.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -109.71 -14.32 14.35 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.589 -1.319 . . . . 0.0 113.554 -168.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -122.17 99.28 6.34 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.768 -1.208 . . . . 0.0 111.408 -164.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -153.98 -122.84 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.075 -1.64 . . . . 0.0 112.777 174.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.98 160.21 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 127.709 2.404 . . . . 0.0 106.994 -175.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 30.2 p -150.01 154.73 38.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.451 -2.031 . . . . 0.0 114.639 -174.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.95 164.42 38.46 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 124.296 1.038 . . . . 0.0 112.009 170.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.26 1.627 0 C-N-CA 125.648 1.579 . . . . 0.0 108.977 176.351 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 CA--C 1.49 -1.678 0 N-CA-C 107.564 -1.745 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -85.88 147.56 46.07 Favored Pre-proline 0 N--CA 1.43 -1.472 0 O-C-N 121.089 -1.007 . . . . 0.0 110.493 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.93 -33.1 6.53 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 122.395 1.891 . . . . 0.0 110.983 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.18 61.73 1.85 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 124.998 1.285 . . . . 0.0 111.311 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.87 179.02 7.66 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.932 1.349 . . . . 0.0 113.22 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.92 133.51 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.431 1.492 . . . . 0.0 108.98 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -138.47 157.55 45.98 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.959 -1.088 . . . . 0.0 112.497 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -126.92 114.19 17.53 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.992 1.317 . . . . 0.0 112.477 -172.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.2 t -102.9 141.66 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.673 -1.267 . . . . 0.0 110.208 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -117.83 122.09 42.46 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 160.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -133.91 162.33 32.33 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.838 -1.163 . . . . 0.0 108.936 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.61 147.75 27.79 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.406 -1.434 . . . . 0.0 107.585 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -64.03 120.88 12.87 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 122.994 1.378 . . . . 0.0 114.703 -168.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -98.35 -88.21 0.32 Allowed 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 125.15 1.38 . . . . 0.0 108.816 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.55 -46.77 36.82 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.559 -1.338 . . . . 0.0 109.623 170.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -156.9 -158.06 0.74 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 169.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 p -83.53 -82.05 0.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.745 -1.222 . . . . 0.0 112.39 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.4 mt -102.49 -97.53 0.29 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.824 -1.798 . . . . 0.0 114.437 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.43 51.23 1.59 Allowed Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -162.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.9 tt -140.95 161.06 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 121.072 -1.252 . . . . 0.0 110.361 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 t -122.47 142.5 50.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 120.352 -1.467 . . . . 0.0 108.029 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t -123.64 152.65 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 125.446 1.499 . . . . 0.0 107.861 -171.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.5 t -136.42 120.3 17.46 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.463 1.601 . . . . 0.0 110.786 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.67 -147.71 42.31 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 124.746 1.165 . . . . 0.0 113.695 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.88 38.39 6.92 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-O 121.997 0.776 . . . . 0.0 112.346 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 26' ' ' VAL . 13.2 m -80.95 -112.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 126.219 1.808 . . . . 0.0 113.318 -169.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -71.7 -51.91 20.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.876 -1.765 . . . . 0.0 111.482 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.5 t -151.45 153.4 34.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.1 t -154.6 -69.14 0.13 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.286 -0.884 . . . . 0.0 112.134 -175.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.9 t -91.97 -61.44 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 O-C-N 120.494 -1.379 . . . . 0.0 112.682 -163.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -124.93 -71.03 0.72 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.049 1.34 . . . . 0.0 111.78 -161.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -141.71 39.54 1.68 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.7 -144.48 17.96 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 106.942 -2.463 . . . . 0.0 106.942 -157.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.69 158.68 33.31 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 121.401 -1.058 . . . . 0.0 113.197 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.6 mm -126.36 145.28 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -125.94 138.7 53.79 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 121.084 -1.01 . . . . 0.0 111.715 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.7 t -85.83 127.72 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 124.937 1.295 . . . . 0.0 111.799 -178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.1 tttp -83.4 -63.72 1.3 Allowed 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 125.195 1.398 . . . . 0.0 111.175 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -171.09 171.64 5.71 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.816 0.846 . . . . 0.0 109.083 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.38 139.19 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.312 1.045 . . . . 0.0 111.737 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.1 mm -85.79 109.65 23.97 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 119.938 -1.726 . . . . 0.0 108.647 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -82.46 57.24 6.05 Favored 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 123.361 2.707 . . . . 0.0 114.14 -163.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -141.16 22.28 2.23 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 125.028 1.331 . . . . 0.0 110.427 -174.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.25 -160.91 19.79 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 120.179 -1.576 . . . . 0.0 115.044 -173.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.4 -45.57 88.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 126.893 2.077 . . . . 0.0 115.574 -166.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -37.08 79.04 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -77.63 -41.75 37.35 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 124.416 1.086 . . . . 0.0 111.948 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.8 t -70.14 -46.57 64.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -82.14 -61.52 1.88 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.723 -1.236 . . . . 0.0 111.684 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.64 99.42 1.08 Allowed Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.195 -0.941 . . . . 0.0 114.923 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -138.56 -37.15 0.55 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.97 -1.312 . . . . 0.0 110.929 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.6 mt -127.47 134.58 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -170.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -119.86 -176.68 3.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.842 -1.161 . . . . 0.0 113.523 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -55.2 127.88 31.3 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.97 1.708 . . . . 0.0 114.846 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.37 11.17 84.41 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -71.18 156.1 39.96 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.059 1.429 . . . . 0.0 111.576 169.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -123.76 102.06 7.61 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.134 -0.978 . . . . 0.0 109.772 -167.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -80.2 132.73 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.666 -1.271 . . . . 0.0 111.169 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.1 mt -122.04 -74.07 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.69 -1.256 . . . . 0.0 110.958 -170.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.35 151.67 20.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.7 t -113.65 101.18 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.611 1.965 . . . . 0.0 107.397 173.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.312 16.3 t-20 56.56 48.39 16.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.518 1.927 . . . . 0.0 113.536 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.73 -14.09 57.01 Favored Glycine 0 N--CA 1.43 -1.761 0 O-C-N 120.035 -1.666 . . . . 0.0 114.894 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.3 t -100.93 117.34 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 120.989 -1.301 . . . . 0.0 109.992 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 t -79.15 144.14 34.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.504 -1.372 . . . . 0.0 113.449 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mp -93.42 44.93 1.15 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.022 1.391 . . . . 0.0 112.517 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.89 114.41 6.43 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.096 -1.627 . . . . 0.0 112.824 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.08 7.89 73.01 Favored Glycine 0 N--CA 1.431 -1.674 0 O-C-N 120.817 -1.177 . . . . 0.0 113.875 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.5 143.03 38.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 121.013 -1.287 . . . . 0.0 110.871 168.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.2 p -90.33 176.07 6.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.349 -1.47 . . . . 0.0 110.285 165.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -59.62 -38.41 81.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 -175.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -52.98 -41.6 64.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.519 -1.363 . . . . 0.0 113.768 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -71.23 -35.98 71.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.882 1.273 . . . . 0.0 112.356 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.81 -36.82 84.57 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.455 -1.403 . . . . 0.0 113.908 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.23 -42.53 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 124.954 1.302 . . . . 0.0 112.07 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -61.08 -37.39 82.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.313 -1.492 . . . . 0.0 112.845 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.3 p -70.45 -22.96 62.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 171.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.4 mt -79.23 -40.84 29.68 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.998 -1.689 . . . . 0.0 112.739 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -63.78 -43.39 96.47 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.882 -1.137 . . . . 0.0 111.217 173.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -93.5 58.98 2.86 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.189 -1.57 . . . . 0.0 112.469 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 p -88.45 -72.46 0.54 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.708 1.203 . . . . 0.0 108.516 166.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.96 -128.26 8.04 Favored Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 39.0 tp60 -76.67 -46.73 24.57 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -120.03 148.87 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 124.714 1.206 . . . . 0.0 112.351 -170.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.33 116.06 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 127.175 2.19 . . . . 0.0 108.652 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -117.62 115.35 24.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.252 -1.53 . . . . 0.0 107.316 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -144.03 157.95 44.01 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.985 -1.072 . . . . 0.0 112.705 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mp -122.11 134.58 54.75 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.985 0.914 . . . . 0.0 109.114 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 mp -128.34 170.1 13.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.959 1.304 . . . . 0.0 109.879 -169.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -116.4 135.38 53.9 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 158.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -74.73 131.46 40.86 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.4 -111.17 0.62 Allowed Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 125.99 1.757 . . . . 0.0 116.726 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -77.42 154.25 32.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.971 -1.311 . . . . 0.0 114.536 -166.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 74.3 m -94.54 138.06 22.43 Favored Pre-proline 0 N--CA 1.431 -1.414 0 O-C-N 120.712 -1.243 . . . . 0.0 109.197 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -70.83 -47.14 0.64 Allowed 'Trans proline' 0 C--N 1.3 -1.982 0 CA-C-N 122.769 2.025 . . . . 0.0 114.377 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 C--O 1.261 1.663 0 C-N-CA 125.973 1.709 . . . . 0.0 109.678 -172.107 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.0 178.56 7.21 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -166.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 66.08 20.43 11.21 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 127.653 2.381 . . . . 0.0 114.759 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 22.8 t -106.31 -81.68 0.54 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.39 -1.444 . . . . 0.0 110.943 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -83.53 -79.51 0.2 Allowed 'General case' 0 N--CA 1.429 -1.497 0 O-C-N 120.321 -1.487 . . . . 0.0 112.556 -173.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -165.93 163.66 18.49 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.95 -97.27 0.06 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.44 -0.787 . . . . 0.0 111.13 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -111.74 142.96 43.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.544 -1.348 . . . . 0.0 110.703 -174.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . 0.254 16.4 p30 -110.38 -54.84 2.54 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -173.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -121.57 138.08 54.46 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.463 -2.023 . . . . 0.0 112.021 -169.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -154.97 -132.21 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.402 -0.811 . . . . 0.0 112.006 175.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.22 171.46 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.335 2.254 . . . . 0.0 105.215 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.7 p -144.66 141.84 29.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.62 -1.925 . . . . 0.0 115.141 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.87 133.4 49.34 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.94 1.696 . . . . 0.0 111.428 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.261 1.67 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.148 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 CA--C 1.489 -1.735 0 N-CA-C 108.455 -1.402 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.2 pttp -92.33 157.03 41.16 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 117.641 -1.171 . . . . 0.0 111.109 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -77.17 -21.25 12.16 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 123.598 2.321 . . . . 0.0 113.888 -171.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.34 64.03 2.3 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 119.824 1.193 . . . . 0.0 111.454 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -82.18 171.06 14.73 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -174.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.6 130.44 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 167.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -133.73 166.53 22.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 122.227 1.013 . . . . 0.0 111.311 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -125.16 136.74 53.89 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.238 1.015 . . . . 0.0 109.293 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.9 m -102.06 135.59 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.707 -1.246 . . . . 0.0 108.849 173.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -126.04 87.36 2.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.26 1.024 . . . . 0.0 109.796 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 9.1 tp -134.51 -174.38 3.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.654 -1.279 . . . . 0.0 110.311 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.414 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -133.64 165.64 24.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.325 -1.484 . . . . 0.0 107.642 174.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -71.92 121.46 19.11 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.236 1.017 . . . . 0.0 111.786 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -107.5 -92.04 0.41 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.486 1.514 . . . . 0.0 107.755 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -78.78 -41.64 29.94 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.139 1.376 . . . . 0.0 109.997 163.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -140.8 161.51 37.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 123.81 0.844 . . . . 0.0 110.403 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -83.49 -68.37 0.72 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.439 1.095 . . . . 0.0 110.521 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.77 -79.15 0.52 Allowed 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 120.821 -1.174 . . . . 0.0 111.101 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.68 50.25 4.27 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 124.576 1.084 . . . . 0.0 113.475 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 tt -138.43 -178.61 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 121.617 -0.931 . . . . 0.0 109.579 -173.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.0 p -127.4 142.47 51.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.842 -2.411 . . . . 0.0 110.31 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 t -123.77 155.82 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 C-N-CA 123.855 0.862 . . . . 0.0 111.464 -163.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 t -137.02 141.93 42.5 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.255 -1.528 . . . . 0.0 108.707 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.1 -175.84 50.3 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 116.476 1.351 . . . . 0.0 116.476 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.95 44.05 0.97 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 121.865 -0.785 . . . . 0.0 112.823 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 27' ' ' ASN . 25.8 t -80.78 176.66 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.69 -1.476 . . . . 0.0 108.847 174.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.662 ' H ' HG12 ' A' ' 26' ' ' VAL . 5.8 p30 -69.07 -24.78 64.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.377 -2.077 . . . . 0.0 114.814 -160.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.6 t -135.15 133.33 39.04 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 150.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.9 p -155.81 -86.4 0.05 OUTLIER 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.685 -1.259 . . . . 0.0 112.639 -165.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.13 -48.02 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 126.825 2.05 . . . . 0.0 109.062 174.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -129.02 -154.47 0.64 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 159.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -82.33 70.29 9.24 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.234 -2.166 . . . . 0.0 111.389 164.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.63 -171.87 13.95 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 108.118 -1.993 . . . . 0.0 108.118 -166.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.09 136.0 7.96 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -172.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.9 mm -127.21 149.41 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -170.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.92 139.49 53.78 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.924 -1.735 . . . . 0.0 111.225 -169.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.7 t -81.98 126.12 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 120.275 -1.516 . . . . 0.0 111.313 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 38.3 tttp -87.6 -70.12 0.65 Allowed 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.653 -1.279 . . . . 0.0 111.051 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.8 159.97 38.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.277 -0.89 . . . . 0.0 110.101 -171.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 p -103.09 132.6 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.93 1.347 . . . . 0.0 112.221 -170.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.6 mm -83.7 119.42 73.65 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 120.149 -1.594 . . . . 0.0 110.163 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -81.05 58.97 7.26 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 124.393 2.605 . . . . 0.0 112.966 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -141.39 -0.42 1.41 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.296 1.038 . . . . 0.0 112.094 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.36 -172.75 30.19 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 120.27 -1.518 . . . . 0.0 115.477 -170.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -39.3 -50.61 2.01 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 129.696 3.198 . . . . 0.0 118.159 -171.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.1 -45.34 68.19 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.213 1.405 . . . . 0.0 114.76 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -80.59 -52.66 7.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.958 1.303 . . . . 0.0 110.826 177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.5 m -62.5 -38.48 90.04 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 -172.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.3 -52.44 6.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.914 -1.116 . . . . 0.0 110.117 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.62 84.94 1.47 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 121.14 -0.975 . . . . 0.0 113.589 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -138.99 -21.82 0.95 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.19 149.58 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -119.64 172.57 7.58 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.592 -1.317 . . . . 0.0 111.702 177.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -56.54 138.73 51.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.43 22.11 76.24 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 116.905 1.522 . . . . 0.0 116.905 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.58 166.49 19.19 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 118.915 1.358 . . . . 0.0 111.693 169.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -124.1 105.43 9.54 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.748 -1.22 . . . . 0.0 110.25 -170.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 m -93.74 141.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 120.459 -1.401 . . . . 0.0 111.519 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.24 -87.25 0.56 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 121.382 -0.824 . . . . 0.0 111.253 -166.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . . . -90.63 153.84 20.02 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.591 -1.943 . . . . 0.0 112.903 -172.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 63.8 t -116.41 108.53 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.256 9.1 t-20 56.25 50.15 13.92 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 126.03 1.732 . . . . 0.0 113.76 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.5 -29.42 6.72 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.659 -1.276 . . . . 0.0 114.774 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.2 t -88.06 99.03 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 120.586 -1.538 . . . . 0.0 111.209 -173.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 m -78.59 99.56 6.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.302 1.041 . . . . 0.0 110.514 167.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.03 92.91 7.08 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 123.07 1.414 . . . . 0.0 109.591 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -67.59 129.97 41.56 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.383 1.473 . . . . 0.0 112.644 177.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.48 -6.24 74.6 Favored Glycine 0 N--CA 1.429 -1.795 0 O-C-N 121.001 -1.062 . . . . 0.0 114.565 -174.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.99 133.27 40.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 119.595 1.698 . . . . 0.0 114.041 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.3 p -84.31 177.86 8.0 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.258 1.423 . . . . 0.0 112.613 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -56.94 -45.41 82.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.322 2.249 . . . . 0.0 113.942 174.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -58.39 -43.31 88.5 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 172.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -70.37 -39.21 74.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.761 -1.212 . . . . 0.0 111.995 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.41 67.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.666 1.186 . . . . 0.0 113.393 172.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.47 -35.99 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 120.291 -1.506 . . . . 0.0 113.076 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -58.24 -47.08 84.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.141 -1.599 . . . . 0.0 113.72 168.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.4 m -63.23 -36.25 83.02 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.823 1.649 . . . . 0.0 113.141 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 74.4 mt -78.89 -35.84 42.99 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 120.114 -1.616 . . . . 0.0 113.462 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -67.31 -28.16 67.76 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 119.961 -1.712 . . . . 0.0 112.639 172.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -90.93 48.81 1.56 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.18 -1.575 . . . . 0.0 112.78 172.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.74 -70.4 0.6 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.507 1.523 . . . . 0.0 109.766 173.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 93.13 -87.33 1.2 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 121.238 -0.914 . . . . 0.0 112.603 170.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -83.93 -61.4 1.83 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.216 -1.167 . . . . 0.0 113.753 173.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.74 142.51 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 122.22 1.01 . . . . 0.0 113.233 -164.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.9 t -121.05 92.39 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 125.408 1.483 . . . . 0.0 107.543 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -126.57 98.39 5.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.567 -1.333 . . . . 0.0 111.18 -177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.9 mt -127.35 154.22 45.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.81 -1.181 . . . . 0.0 111.409 -162.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.408 ' HB2' ' HB3' ' A' ' 60' ' ' ALA . 3.9 mm? -120.79 134.0 55.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 124.623 1.169 . . . . 0.0 109.047 -175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.07 153.06 37.27 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 121.534 0.683 . . . . 0.0 111.356 -171.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -112.19 120.96 43.55 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.822 1.649 . . . . 0.0 109.992 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -54.1 135.55 43.26 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -165.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.39 169.81 54.89 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 126.165 1.84 . . . . 0.0 115.611 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -95.92 176.83 5.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.072 1.349 . . . . 0.0 112.797 -170.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 t -85.06 136.63 38.12 Favored Pre-proline 0 N--CA 1.43 -1.458 0 O-C-N 120.815 -1.178 . . . . 0.0 111.793 -175.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.62 176.59 9.86 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 122.197 1.931 . . . . 0.0 112.619 160.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 C--O 1.26 1.636 0 C-N-CA 125.679 1.592 . . . . 0.0 110.687 175.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.57 -70.98 0.69 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 84.18 86.72 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.615 2.766 . . . . 0.0 111.207 -172.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.4 m -131.96 161.64 32.62 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.72 -1.238 . . . . 0.0 112.749 -166.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 178.24 4.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 124.498 1.119 . . . . 0.0 109.726 164.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.61 112.27 24.78 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -167.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -92.49 82.56 4.87 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.837 -1.789 . . . . 0.0 110.764 172.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . 0.25 37.5 mt-10 63.09 -171.34 0.17 Allowed 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -105.84 121.49 44.18 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.779 -1.826 . . . . 0.0 111.301 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -123.25 111.66 16.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 170.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -135.55 -148.97 0.32 Allowed 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.329 -1.482 . . . . 0.0 112.982 -165.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 t -122.56 149.09 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 126.364 1.866 . . . . 0.0 106.789 -173.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 16.4 m -138.33 166.83 23.22 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.273 -1.517 . . . . 0.0 112.58 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.88 147.12 50.79 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.614 1.966 . . . . 0.0 109.735 162.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.26 1.647 0 C-N-CA 127.4 2.28 . . . . 0.0 105.299 170.037 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 CA--C 1.49 -1.683 0 N-CA-C 108.399 -1.423 . . . . 0.0 108.399 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -77.22 164.57 57.82 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 118.112 -0.947 . . . . 0.0 111.533 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -75.57 -25.66 10.79 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 124.141 2.515 . . . . 0.0 113.3 -168.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.56 69.86 0.26 Allowed Glycine 0 N--CA 1.432 -1.633 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 171.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -83.55 165.42 19.09 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 60.4 mt -81.37 131.86 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 122.182 0.992 . . . . 0.0 111.524 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -136.98 168.93 18.65 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 120.711 -1.243 . . . . 0.0 109.847 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -122.49 137.52 54.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.766 0.826 . . . . 0.0 111.003 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.6 m -103.98 143.75 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 C-N-CA 124.395 1.078 . . . . 0.0 111.716 174.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -127.9 106.68 9.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.652 1.181 . . . . 0.0 109.159 -170.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 72.1 mt -129.69 159.39 36.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.997 -1.689 . . . . 0.0 110.657 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.66 164.44 27.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 160.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -72.25 114.18 10.08 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.437 -1.414 . . . . 0.0 113.933 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -101.9 -70.89 0.73 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 162.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -87.43 -74.69 0.43 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.362 1.865 . . . . 0.0 110.789 168.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -136.49 148.76 47.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -165.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.1 m -80.83 -62.82 1.55 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.924 -1.735 . . . . 0.0 113.268 -159.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.8 mp -101.52 -86.09 0.42 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.886 -1.134 . . . . 0.0 111.001 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.2 45.71 2.53 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.638 -1.289 . . . . 0.0 115.338 171.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.65 172.33 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 120.696 -1.473 . . . . 0.0 109.032 177.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.7 p -121.16 145.05 48.23 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.723 -1.861 . . . . 0.0 108.539 175.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.07 154.3 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 C-N-CA 125.757 1.623 . . . . 0.0 108.073 -165.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.6 t -139.0 161.36 37.55 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 169.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.03 -132.38 15.18 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.635 -1.29 . . . . 0.0 114.335 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.97 0.81 89.0 Favored Glycine 0 N--CA 1.429 -1.779 0 O-C-N 120.708 -1.466 . . . . 0.0 115.899 172.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.0 t -73.69 166.93 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.156 2.182 . . . . 0.0 110.901 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -69.77 -15.35 63.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.383 1.873 . . . . 0.0 115.429 -164.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.5 t -134.99 118.0 16.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.507 -1.996 . . . . 0.0 107.084 148.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 p -146.87 -83.25 0.12 Allowed 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.878 -1.139 . . . . 0.0 109.445 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.61 -51.14 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 C-N-CA 126.62 1.968 . . . . 0.0 110.245 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -130.35 -158.05 0.86 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 161.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.38 56.71 1.79 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.406 -2.059 . . . . 0.0 112.851 165.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 129.34 168.69 12.4 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 126.412 1.958 . . . . 0.0 110.423 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.91 152.31 24.76 Favored Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 125.099 1.333 . . . . 0.0 111.079 -175.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 46.2 mm -126.47 149.17 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 121.097 -1.237 . . . . 0.0 109.501 -161.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.65 137.12 53.85 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.358 -1.463 . . . . 0.0 109.64 -172.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.7 t -86.02 132.94 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.441 -1.412 . . . . 0.0 112.104 -174.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -87.76 -70.08 0.65 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.569 -1.332 . . . . 0.0 110.875 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.81 163.29 40.01 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 122.157 0.979 . . . . 0.0 111.112 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.8 p -88.27 130.06 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.424 0 C-N-CA 124.925 1.29 . . . . 0.0 111.642 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.7 mm -84.45 118.83 72.05 Favored Pre-proline 0 N--CA 1.43 -1.471 0 O-C-N 120.201 -1.562 . . . . 0.0 109.256 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.39 45.28 1.68 Allowed 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 124.715 2.72 . . . . 0.0 113.061 -173.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -143.02 34.41 1.36 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.146 0.978 . . . . 0.0 109.217 -171.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.19 -172.69 39.62 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 119.938 -1.726 . . . . 0.0 113.105 -171.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.54 -35.83 78.86 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.951 1.7 . . . . 0.0 114.598 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.98 -49.17 69.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.16 -53.51 36.73 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.37 1.868 . . . . 0.0 112.079 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.6 m -66.27 -29.31 69.51 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -80.58 -53.93 6.12 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.91 1.684 . . . . 0.0 111.967 170.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.71 65.98 1.67 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 120.393 -1.442 . . . . 0.0 114.173 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -138.34 -13.74 1.33 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.01 -1.288 . . . . 0.0 113.232 -166.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mp -130.04 144.68 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -121.23 -177.62 3.56 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 122.998 1.38 . . . . 0.0 111.473 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.9 pttt -58.56 132.84 54.98 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.183 -1.573 . . . . 0.0 114.707 168.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.49 12.59 84.38 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 117.807 1.883 . . . . 0.0 117.807 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -74.08 160.86 30.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 119.352 1.576 . . . . 0.0 110.747 167.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ttm-85 -122.89 106.47 10.9 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.591 -1.318 . . . . 0.0 109.427 -166.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.4 m -102.42 126.37 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 123.313 1.53 . . . . 0.0 111.134 -166.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.04 -88.52 0.62 Allowed 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 120.085 -1.635 . . . . 0.0 112.172 -160.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.54 134.71 33.99 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 121.107 -0.996 . . . . 0.0 112.564 -166.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -97.58 105.24 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.85 -1.156 . . . . 0.0 108.879 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.264 1.4 t-20 55.92 43.09 27.99 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 127.093 2.157 . . . . 0.0 113.337 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.69 -28.39 15.73 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 124.469 1.033 . . . . 0.0 113.635 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.4 t -84.18 109.14 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 124.451 1.1 . . . . 0.0 113.122 -166.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -78.52 98.61 6.16 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.053 1.341 . . . . 0.0 110.435 172.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.39 75.21 1.6 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.151 1.453 . . . . 0.0 109.674 -170.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.42 143.67 54.98 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.687 -1.883 . . . . 0.0 112.986 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.16 7.37 65.72 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.478 -1.389 . . . . 0.0 114.668 -175.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.79 147.03 37.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.584 -1.539 . . . . 0.0 113.709 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.3 p -93.09 170.57 9.54 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.739 1.616 . . . . 0.0 109.494 166.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -60.79 -41.67 96.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.815 -1.178 . . . . 0.0 112.761 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -49.07 -51.32 32.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.815 1.646 . . . . 0.0 114.84 168.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -70.77 -36.19 72.95 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.23 -1.544 . . . . 0.0 112.826 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.42 -42.09 98.19 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.017 -1.677 . . . . 0.0 113.433 171.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.0 t -67.66 -43.73 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 C-N-CA 125.35 1.46 . . . . 0.0 111.914 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.88 -12.91 60.81 Favored 'General case' 0 N--CA 1.431 -1.391 0 O-C-N 120.251 -1.53 . . . . 0.0 114.195 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.4 m -71.17 -57.65 4.3 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 118.993 -2.317 . . . . 0.0 110.214 171.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.8 -20.45 42.5 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -173.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -72.5 -23.23 60.99 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.831 -1.793 . . . . 0.0 112.795 166.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -90.64 52.82 2.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 119.502 -1.999 . . . . 0.0 111.865 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.2 p -109.04 -94.06 0.41 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.893 1.677 . . . . 0.0 110.478 176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 102.02 -59.86 0.57 Allowed Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 124.825 1.202 . . . . 0.0 112.565 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -84.68 -77.17 0.28 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.957 -1.32 . . . . 0.0 114.097 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.7 p -127.84 143.2 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 125.818 1.647 . . . . 0.0 111.445 -161.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.4 t -126.5 128.97 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.93 1.692 . . . . 0.0 109.941 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -143.02 115.21 8.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.662 -1.899 . . . . 0.0 109.763 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.3 mt -128.2 153.77 46.54 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.587 -1.321 . . . . 0.0 111.306 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.8 130.9 55.15 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.65 151.56 37.45 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 121.276 -0.89 . . . . 0.0 110.059 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -103.6 134.59 46.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tttm -74.99 137.64 41.69 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.655 -1.278 . . . . 0.0 114.398 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.99 -174.93 50.1 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 122.889 1.272 . . . . 0.0 116.201 -167.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -80.22 159.59 25.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.308 -1.113 . . . . 0.0 112.845 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.2 t -68.08 134.23 91.68 Favored Pre-proline 0 N--CA 1.43 -1.472 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 -170.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.69 167.28 27.57 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 122.417 2.078 . . . . 0.0 113.133 172.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.2 p . . . . . 0 C--O 1.259 1.586 0 C-N-CA 127.049 2.139 . . . . 0.0 112.854 -163.001 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.46 -40.49 13.43 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.226 -1.546 . . . . 0.0 114.133 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 59.45 51.19 6.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.135 1.774 . . . . 0.0 113.813 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 71.2 m -109.97 172.78 6.66 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 125.483 1.513 . . . . 0.0 109.57 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -74.65 -173.94 1.96 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.794 -1.191 . . . . 0.0 111.687 172.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.61 135.41 36.58 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.238 -2.164 . . . . 0.0 113.535 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -116.9 74.77 0.93 Allowed 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 124.071 0.948 . . . . 0.0 108.863 170.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 44.23 -152.24 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.289 2.636 . . . . 0.0 116.748 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -135.37 142.88 45.81 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.522 -1.986 . . . . 0.0 107.838 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -122.95 102.69 8.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 170.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -123.54 -169.19 1.9 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.645 1.178 . . . . 0.0 112.384 -170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.9 t -120.05 138.93 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.591 -1.318 . . . . 0.0 109.873 -152.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 13.9 m -128.21 157.42 40.89 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.802 -1.186 . . . . 0.0 112.666 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.27 154.74 45.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.061 -1.025 . . . . 0.0 110.095 173.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.259 1.578 0 C-N-CA 125.378 1.471 . . . . 0.0 107.45 169.413 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.491 -1.662 0 N-CA-C 109.338 -1.062 . . . . 0.0 109.338 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -77.33 162.85 67.63 Favored Pre-proline 0 N--CA 1.43 -1.431 0 CA-C-O 117.561 -1.209 . . . . 0.0 110.663 172.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -74.33 -15.1 22.71 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 124.313 2.576 . . . . 0.0 113.691 -169.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.51 71.6 0.23 Allowed Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 123.886 0.755 . . . . 0.0 111.538 166.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -82.89 171.68 13.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.3 mp -89.14 132.43 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 120.38 -1.45 . . . . 0.0 110.968 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -133.16 161.73 33.65 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.751 -1.218 . . . . 0.0 111.834 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -109.91 134.62 51.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 124.86 1.264 . . . . 0.0 110.924 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 m -103.18 149.06 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 120.503 -1.373 . . . . 0.0 111.21 163.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.9 105.89 8.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 167.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.409 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 12.2 tp -134.43 -179.32 5.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.875 -1.141 . . . . 0.0 108.402 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.409 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -140.61 172.67 12.39 Favored 'General case' 0 CA--C 1.489 -1.39 0 O-C-N 120.16 -1.587 . . . . 0.0 109.906 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -71.9 111.97 7.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.598 1.559 . . . . 0.0 110.889 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -113.71 -83.28 0.6 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 124.377 1.071 . . . . 0.0 110.176 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -82.86 -47.42 11.86 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.768 -1.208 . . . . 0.0 109.513 174.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -137.6 -172.69 3.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 167.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 t -83.85 -72.55 0.46 Allowed 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.916 -1.115 . . . . 0.0 111.452 -172.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.38 -84.4 0.45 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.963 -1.086 . . . . 0.0 110.379 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.82 54.34 0.68 Allowed Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 116.175 1.23 . . . . 0.0 116.175 170.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.65 174.12 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 119.195 1.498 . . . . 0.0 112.437 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 75.8 p -122.63 135.91 54.74 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 125.152 1.381 . . . . 0.0 109.545 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.7 t -123.36 142.7 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 125.497 1.519 . . . . 0.0 110.634 -163.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.1 t -136.4 111.3 8.83 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.653 1.692 . . . . 0.0 111.589 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -134.15 11.86 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 125.242 1.401 . . . . 0.0 111.503 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.1 23.39 32.44 Favored Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.84 -127.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 121.018 -1.284 . . . . 0.0 113.11 -172.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -79.38 -44.25 21.86 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.073 -1.642 . . . . 0.0 112.75 -164.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -151.98 103.19 2.88 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 166.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.9 p -134.71 -75.94 0.46 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.327 -1.483 . . . . 0.0 110.44 -172.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.16 -54.84 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 124.704 1.202 . . . . 0.0 110.272 170.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -134.18 -164.12 1.46 Allowed 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.03 78.39 3.57 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.911 -1.743 . . . . 0.0 111.508 166.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.75 -177.4 21.19 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -166.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.48 148.6 12.45 Favored Glycine 0 N--CA 1.431 -1.687 0 O-C-N 121.458 -1.025 . . . . 0.0 111.119 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.9 mm -127.23 142.31 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -171.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.44 130.91 53.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.69 -1.256 . . . . 0.0 109.589 -169.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.3 t -84.22 134.94 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 124.38 1.072 . . . . 0.0 111.438 -178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -88.83 -59.26 2.28 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.31 1.444 . . . . 0.0 111.199 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.9 159.49 29.75 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 123.575 0.75 . . . . 0.0 111.463 -175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 p -91.59 128.15 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 122.586 1.184 . . . . 0.0 113.017 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.2 mm -84.45 131.69 49.42 Favored Pre-proline 0 N--CA 1.43 -1.458 0 C-N-CA 126.175 1.79 . . . . 0.0 110.866 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -80.36 41.64 1.17 Allowed 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 123.546 2.831 . . . . 0.0 114.593 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -147.48 66.34 1.13 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.664 1.585 . . . . 0.0 107.235 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.74 175.79 46.34 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 119.69 -1.881 . . . . 0.0 115.438 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.15 -34.93 78.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.305 1.042 . . . . 0.0 112.275 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.37 -56.02 24.92 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.744 1.618 . . . . 0.0 113.936 175.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.61 -47.16 67.39 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.044 -1.035 . . . . 0.0 112.372 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.3 m -60.18 -47.77 84.56 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.68 -51.9 30.45 Favored 'General case' 0 N--CA 1.431 -1.399 0 O-C-N 120.562 -1.336 . . . . 0.0 112.538 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.07 78.62 0.95 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 120.82 -1.175 . . . . 0.0 111.575 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.6 ttt85 -138.82 -34.61 0.6 Allowed 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 121.956 -0.731 . . . . 0.0 112.315 -158.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 mt -128.9 170.25 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -140.95 -177.8 5.26 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 118.293 -2.754 . . . . 0.0 112.036 165.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.45 143.05 30.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.774 -1.829 . . . . 0.0 113.743 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.87 8.15 81.98 Favored Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 117.576 1.79 . . . . 0.0 117.576 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -80.77 154.69 27.07 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 119.274 1.537 . . . . 0.0 109.157 163.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -137.05 128.66 28.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.976 -1.703 . . . . 0.0 112.39 -164.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.0 m -80.13 162.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.972 -1.705 . . . . 0.0 115.292 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.6 mp -119.88 -86.68 0.65 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.23 1.812 . . . . 0.0 106.981 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 160.49 14.25 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -170.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.1 t -108.78 98.54 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 125.49 1.516 . . . . 0.0 107.108 165.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 56.38 54.51 7.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.671 1.588 . . . . 0.0 114.233 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.7 -32.02 4.39 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.434 -1.416 . . . . 0.0 114.18 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.91 121.82 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 124.627 1.171 . . . . 0.0 112.254 -171.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.1 m -77.72 133.59 38.28 Favored 'General case' 0 N--CA 1.431 -1.381 0 O-C-N 120.632 -1.293 . . . . 0.0 112.216 176.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.49 63.3 7.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.506 -1.371 . . . . 0.0 109.677 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -66.52 104.0 1.17 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.029 1.731 . . . . 0.0 114.417 -168.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 66.08 29.26 74.62 Favored Glycine 0 N--CA 1.429 -1.775 0 O-C-N 120.43 -1.418 . . . . 0.0 114.888 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.2 158.15 30.5 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.229 1.412 . . . . 0.0 114.203 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.8 p -80.8 162.06 24.21 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.809 -1.182 . . . . 0.0 111.589 167.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -60.87 -42.25 97.52 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.365 1.466 . . . . 0.0 111.586 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -47.03 -46.07 21.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.266 1.826 . . . . 0.0 114.747 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -71.52 -38.69 71.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.288 -1.507 . . . . 0.0 113.436 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.29 -40.7 96.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.965 -1.085 . . . . 0.0 113.412 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -67.66 -47.3 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 126.391 1.876 . . . . 0.0 112.772 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -54.51 -43.64 72.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.753 -1.217 . . . . 0.0 113.332 175.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.1 m -62.56 -50.3 71.88 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.128 1.771 . . . . 0.0 112.724 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.69 -12.27 59.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.955 -1.716 . . . . 0.0 115.594 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.31 -30.7 57.82 Favored 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 119.553 -1.967 . . . . 0.0 112.214 167.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -100.47 65.64 1.21 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.189 -1.569 . . . . 0.0 114.591 173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.5 p -92.74 -68.24 0.81 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.157 -1.589 . . . . 0.0 112.091 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 118.66 -127.83 7.43 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 125.581 1.562 . . . . 0.0 110.76 -172.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -83.35 -45.65 13.5 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 p -115.4 145.46 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 121.287 -0.883 . . . . 0.0 113.286 -166.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.8 t -124.96 112.5 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.215 1.806 . . . . 0.0 110.48 -172.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -120.46 110.91 17.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.244 -1.535 . . . . 0.0 110.412 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.4 mt -131.99 151.73 51.56 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.696 -1.252 . . . . 0.0 111.157 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.84 128.15 52.57 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -147.48 157.19 43.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.886 0.85 . . . . 0.0 111.262 -171.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -109.21 137.28 47.34 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.618 1.167 . . . . 0.0 109.069 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.28 130.4 41.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.487 1.136 . . . . 0.0 112.075 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.57 171.51 49.58 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 125.867 1.699 . . . . 0.0 114.645 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -92.01 -177.94 4.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -170.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.9 t -78.82 139.58 58.0 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 120.375 -1.453 . . . . 0.0 114.219 -163.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -68.32 160.55 48.54 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 C-N-CA 122.685 2.257 . . . . 0.0 112.421 159.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.26 1.653 0 C-N-CA 124.484 1.114 . . . . 0.0 112.037 -173.51 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 119.653 -0.213 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.49 -69.26 0.65 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . 0.276 40.7 m-20 49.78 45.39 24.74 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.135 2.174 . . . . 0.0 114.797 -166.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 21.0 m -100.52 179.45 4.43 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.9 1.68 . . . . 0.0 109.795 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -90.62 164.18 14.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.551 -1.343 . . . . 0.0 110.843 164.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.38 139.84 33.82 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.952 -1.093 . . . . 0.0 112.898 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -88.63 83.4 6.76 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 166.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . 0.345 15.1 tt0 42.93 -112.79 0.22 Allowed 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.714 2.406 . . . . 0.0 116.618 -168.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -144.12 149.33 36.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.57 -1.331 . . . . 0.0 112.656 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -126.05 133.32 51.74 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.594 1.558 . . . . 0.0 109.18 174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -151.87 -157.75 0.83 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.941 -1.099 . . . . 0.0 112.14 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -121.67 136.43 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 126.012 1.725 . . . . 0.0 106.735 -170.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.2 m -128.37 167.95 16.25 Favored 'General case' 0 N--CA 1.431 -1.378 0 O-C-N 120.579 -1.325 . . . . 0.0 111.427 -172.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -150.34 134.14 16.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 123.032 0.533 . . . . 0.0 110.337 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--O 1.259 1.593 0 C-N-CA 126.667 1.987 . . . . 0.0 108.45 172.572 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.718 0 N-CA-C 110.591 -0.58 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -77.29 163.37 64.99 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-O 117.814 -1.089 . . . . 0.0 110.453 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.03 -14.61 32.18 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 CA-C-N 123.498 2.285 . . . . 0.0 113.798 -169.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.32 81.48 0.34 Allowed Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 165.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -82.73 -177.1 6.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.119 1.526 . . . . 0.0 115.119 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.78 133.83 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 125.23 1.412 . . . . 0.0 109.712 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -132.81 158.67 41.89 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.105 -1.622 . . . . 0.0 111.339 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -117.68 140.2 49.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.147 0.975 . . . . 0.0 110.961 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.08 142.99 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 120.865 -1.147 . . . . 0.0 109.47 166.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -128.55 76.3 1.7 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 175.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 tp -113.35 171.1 7.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.564 -1.335 . . . . 0.0 110.505 -167.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.27 161.34 39.83 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.358 -1.464 . . . . 0.0 109.033 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -68.35 112.97 5.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.98 -1.075 . . . . 0.0 112.762 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -115.04 -78.98 0.58 Allowed 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 124.977 1.311 . . . . 0.0 109.743 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -82.38 -43.91 16.78 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.494 -1.379 . . . . 0.0 110.417 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -143.3 -177.63 5.46 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.752 1.221 . . . . 0.0 107.726 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.3 t -83.29 -83.14 0.14 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 124.726 1.211 . . . . 0.0 108.901 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.1 mp -101.85 -99.9 0.27 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.168 -0.957 . . . . 0.0 108.865 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.39 60.08 0.79 Allowed Glycine 0 N--CA 1.43 -1.74 0 O-C-N 120.276 -1.515 . . . . 0.0 115.313 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.52 175.09 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 O-C-N 121.284 -1.127 . . . . 0.0 108.028 170.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 97.2 p -121.31 145.53 47.77 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.542 -1.974 . . . . 0.0 108.663 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 78.6 t -123.76 167.5 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 125.247 1.419 . . . . 0.0 107.409 -168.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.9 t -136.99 67.59 1.44 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.314 2.007 . . . . 0.0 108.714 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.83 -137.17 18.32 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 120.237 -1.539 . . . . 0.0 112.513 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.9 93.9 1.47 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -166.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.29 -113.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 121.793 -0.827 . . . . 0.0 111.08 -169.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -93.3 -62.69 1.32 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.725 -1.234 . . . . 0.0 111.36 -165.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 t -134.24 97.98 3.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.212 1.482 . . . . 0.0 108.52 166.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 63.2 p -134.64 -84.08 0.42 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.841 -1.162 . . . . 0.0 111.14 -162.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 p -74.13 -51.37 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 125.807 1.643 . . . . 0.0 110.154 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -138.17 -166.22 1.94 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 158.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -87.67 66.89 9.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.135 -1.603 . . . . 0.0 111.286 168.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.64 141.31 5.67 Favored Glycine 0 N--CA 1.429 -1.784 0 O-C-N 120.877 -1.14 . . . . 0.0 110.868 -171.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.8 155.17 26.16 Favored Glycine 0 N--CA 1.43 -1.72 0 O-C-N 121.488 -1.007 . . . . 0.0 111.946 -170.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.1 mm -133.44 152.33 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 124.821 1.248 . . . . 0.0 108.784 -164.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.85 124.76 43.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.158 -1.589 . . . . 0.0 110.66 -168.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.5 t -74.05 135.34 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.27 -1.519 . . . . 0.0 112.744 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -91.93 -68.01 0.82 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.921 -1.112 . . . . 0.0 112.372 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.89 157.69 35.32 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.162 -0.961 . . . . 0.0 109.914 -173.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.4 p -88.35 131.93 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 122.716 1.246 . . . . 0.0 113.167 -175.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.4 mm -84.61 126.15 69.54 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 117.514 -1.232 . . . . 0.0 108.315 172.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -81.5 34.93 0.56 Allowed 'Trans proline' 0 N--CA 1.433 -2.035 0 C-N-CA 123.351 2.701 . . . . 0.0 113.797 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -144.84 64.1 1.29 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.661 1.984 . . . . 0.0 107.078 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.37 174.39 46.02 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 120.565 -1.334 . . . . 0.0 112.589 -177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.57 -37.67 82.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.747 1.619 . . . . 0.0 113.432 -174.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.02 -49.2 66.75 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.063 1.745 . . . . 0.0 114.897 177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.46 -35.69 34.56 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 124.092 0.957 . . . . 0.0 112.554 176.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 59.8 m -59.38 -51.51 69.61 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.971 -1.706 . . . . 0.0 114.018 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.3 -41.03 42.3 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 111.115 175.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.79 66.63 1.45 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 120.623 -1.298 . . . . 0.0 111.628 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 ttt85 -137.59 -20.86 1.16 Allowed 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -160.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.52 154.21 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -139.95 178.87 6.96 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 119.965 -1.709 . . . . 0.0 111.14 171.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.84 138.06 56.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.94 19.5 79.91 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 116.964 1.546 . . . . 0.0 116.964 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -83.1 162.04 21.45 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 119.173 1.487 . . . . 0.0 109.41 164.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.9 ttm105 -127.59 123.98 37.01 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.964 -1.71 . . . . 0.0 110.353 -171.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.6 m -93.71 147.5 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.442 -1.411 . . . . 0.0 111.728 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.4 -88.67 0.62 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 123.923 0.889 . . . . 0.0 109.823 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.8 148.03 22.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.893 -1.754 . . . . 0.0 114.498 -169.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -109.83 88.64 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.32 1.448 . . . . 0.0 109.647 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 57.14 60.14 3.1 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.062 1.745 . . . . 0.0 114.946 174.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.47 -36.57 3.8 Favored Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 124.422 1.011 . . . . 0.0 113.101 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 t -95.85 114.14 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.804 -1.41 . . . . 0.0 112.261 -169.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.4 m -78.03 132.41 37.76 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.33 -1.481 . . . . 0.0 110.206 161.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.87 76.48 5.56 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 122.623 1.201 . . . . 0.0 109.848 -171.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.18 103.31 0.75 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 -165.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.64 14.23 72.3 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.397 -1.44 . . . . 0.0 114.325 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.9 141.88 40.35 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.688 1.195 . . . . 0.0 112.4 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 p -76.28 172.98 11.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.303 1.841 . . . . 0.0 113.475 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -60.59 -38.12 83.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.33 1.452 . . . . 0.0 113.591 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -58.84 -50.35 74.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.345 -1.472 . . . . 0.0 113.558 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -71.43 -39.46 71.02 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.247 1.419 . . . . 0.0 112.951 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.96 -42.57 99.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.278 -1.514 . . . . 0.0 113.804 175.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -72.1 -38.79 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 119.854 -1.779 . . . . 0.0 111.815 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -58.41 -35.99 72.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.624 -1.297 . . . . 0.0 113.657 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.0 m -67.78 -41.23 83.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.526 1.93 . . . . 0.0 113.048 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 mt -80.47 -19.35 46.19 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.196 -1.565 . . . . 0.0 114.202 177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -72.53 -25.8 61.51 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.855 -1.778 . . . . 0.0 112.307 166.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -88.91 70.83 8.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.942 -1.099 . . . . 0.0 112.625 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.0 p -104.41 -78.1 0.57 Allowed 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 120.997 -1.064 . . . . 0.0 110.131 173.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.24 -117.86 4.36 Favored Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -82.85 -49.62 9.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 p -105.13 147.29 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.785 -1.197 . . . . 0.0 113.24 -166.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.5 t -130.84 110.72 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 125.451 1.501 . . . . 0.0 110.024 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -124.16 111.3 15.74 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.934 -1.729 . . . . 0.0 111.328 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 69.6 mt -129.95 153.15 48.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.428 -0.795 . . . . 0.0 111.087 -175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -120.36 127.13 52.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.47 156.93 43.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.024 0.916 . . . . 0.0 111.88 -170.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -105.35 136.27 45.19 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.712 1.205 . . . . 0.0 109.119 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -70.03 131.85 44.98 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 124.302 1.041 . . . . 0.0 112.541 173.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.74 -162.55 14.9 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 116.677 1.431 . . . . 0.0 116.677 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -101.2 175.49 5.57 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.817 1.647 . . . . 0.0 113.78 -169.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.1 t -75.98 148.85 82.13 Favored Pre-proline 0 N--CA 1.428 -1.565 0 O-C-N 120.057 -1.652 . . . . 0.0 112.871 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.85 163.55 38.09 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 122.637 1.977 . . . . 0.0 111.648 158.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.26 1.612 0 C-N-CA 125.705 1.602 . . . . 0.0 108.865 179.231 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.03 -72.26 0.56 Allowed 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 120.288 -1.507 . . . . 0.0 114.506 -172.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 59.26 48.78 9.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.681 1.993 . . . . 0.0 113.778 -172.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 70.0 m -96.68 174.19 6.95 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.547 1.539 . . . . 0.0 110.264 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.49 167.69 11.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.696 -1.253 . . . . 0.0 109.997 172.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.64 111.98 23.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.396 -1.44 . . . . 0.0 112.366 -176.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.34 89.18 6.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.366 -1.458 . . . . 0.0 108.851 172.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 64.49 -135.0 0.28 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.088 1.755 . . . . 0.0 114.436 174.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -134.84 131.12 37.04 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.465 -1.397 . . . . 0.0 110.436 -177.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -123.48 110.52 15.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.07 0.948 . . . . 0.0 110.167 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -136.71 -158.59 0.88 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.365 -1.459 . . . . 0.0 112.216 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.36 141.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 126.304 1.842 . . . . 0.0 106.61 -173.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 68.9 m -132.96 161.76 33.44 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.067 1.347 . . . . 0.0 112.635 -160.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.95 152.79 52.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.566 1.147 . . . . 0.0 111.901 170.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--O 1.26 1.609 0 C-N-CA 127.419 2.288 . . . . 0.0 107.553 168.509 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.49 -1.685 0 N-CA-C 109.06 -1.169 . . . . 0.0 109.06 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -82.09 171.0 13.0 Favored Pre-proline 0 N--CA 1.431 -1.415 0 CA-C-O 117.895 -1.05 . . . . 0.0 111.605 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -66.11 -32.7 42.83 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 CA-C-N 123.379 2.243 . . . . 0.0 114.418 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.02 72.52 0.86 Allowed Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 172.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -81.65 159.56 23.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.985 -1.303 . . . . 0.0 113.728 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 mp -81.87 135.7 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.569 1.547 . . . . 0.0 109.509 -174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -138.53 150.58 46.52 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.404 1.082 . . . . 0.0 111.115 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.33 113.63 21.73 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.969 -1.082 . . . . 0.0 109.577 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.432 HG21 HD11 ' A' ' 52' ' ' ILE . 22.1 m -102.17 146.83 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.842 -1.162 . . . . 0.0 112.573 -173.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.71 134.32 55.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.054 0.942 . . . . 0.0 108.524 172.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.2 mt -130.93 148.02 52.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 161.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -131.97 135.3 46.47 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -66.92 118.63 10.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -166.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -119.1 -84.06 0.65 Allowed 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.58 -1.325 . . . . 0.0 111.657 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -77.35 -42.17 37.62 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.668 1.987 . . . . 0.0 109.888 174.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -156.43 -172.04 3.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.9 m -92.64 -73.88 0.54 Allowed 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 121.167 -0.958 . . . . 0.0 110.3 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.07 -91.06 0.34 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 118.93 0.786 . . . . 0.0 111.808 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.71 52.18 1.22 Allowed Glycine 0 N--CA 1.431 -1.687 0 O-C-N 120.0 -1.687 . . . . 0.0 111.465 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.2 tt -145.88 158.05 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 121.228 -1.16 . . . . 0.0 111.405 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 92.0 p -122.02 149.4 43.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.491 -1.381 . . . . 0.0 110.113 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.29 164.05 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.22 1.01 . . . . 0.0 108.549 -169.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -137.7 151.99 48.8 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.408 -2.057 . . . . 0.0 105.691 165.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.64 -144.51 17.21 Favored Glycine 0 N--CA 1.431 -1.678 0 O-C-N 120.969 -1.082 . . . . 0.0 112.466 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.3 -4.46 86.03 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 124.745 1.164 . . . . 0.0 113.868 -176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -100.34 161.78 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 124.611 1.164 . . . . 0.0 108.792 -168.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -68.36 -19.51 64.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.131 2.172 . . . . 0.0 114.471 -162.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.5 t -130.34 126.97 38.47 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 152.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.5 p -156.21 -101.21 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.628 -1.295 . . . . 0.0 109.292 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 p -75.48 -41.97 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.317 -1.49 . . . . 0.0 110.876 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.438 ' HB3' ' H ' ' A' ' 32' ' ' HIS . 3.2 mmp_? -131.86 -145.18 0.26 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 162.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.438 ' H ' ' HB3' ' A' ' 31' ' ' ARG . 22.4 p-80 -79.5 55.63 1.99 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.45 2.3 . . . . 0.0 111.014 168.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.99 -160.1 14.81 Favored Glycine 0 N--CA 1.429 -1.8 0 N-CA-C 107.111 -2.396 . . . . 0.0 107.111 -163.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.54 150.2 26.22 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 122.234 0.908 . . . . 0.0 112.345 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.4 mm -125.91 132.73 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 121.238 -1.154 . . . . 0.0 108.208 -170.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.55 140.47 52.72 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 124.561 1.144 . . . . 0.0 108.707 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.9 t -78.97 127.65 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.388 0 O-C-N 120.36 -1.462 . . . . 0.0 110.961 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -90.12 -62.26 1.5 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.587 -1.32 . . . . 0.0 110.843 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.82 156.87 25.81 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 86.2 t -91.0 133.45 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.1 mm -83.21 127.62 68.16 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.967 -1.492 . . . . 0.0 108.643 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -80.35 41.79 1.2 Allowed 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 123.841 3.027 . . . . 0.0 113.386 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -145.58 53.12 1.17 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.92 2.488 . . . . 0.0 106.313 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -172.97 161.81 33.1 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.225 -1.547 . . . . 0.0 114.914 -174.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.76 -32.53 65.69 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 127.9 2.48 . . . . 0.0 115.766 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.66 -38.19 66.64 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 170.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -78.94 -39.2 35.22 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.427 1.091 . . . . 0.0 111.689 174.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.2 m -57.58 -48.24 79.92 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.413 -1.43 . . . . 0.0 113.179 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -73.96 -65.74 0.8 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.821 1.248 . . . . 0.0 112.827 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.63 79.21 0.79 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 120.342 -1.474 . . . . 0.0 114.852 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -138.87 -30.3 0.75 Allowed 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.515 1.526 . . . . 0.0 110.882 -174.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.432 HD11 HG21 ' A' ' 9' ' ' VAL . 40.5 mt -125.73 138.65 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -140.16 -173.9 3.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.499 -1.376 . . . . 0.0 110.117 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -57.52 134.75 56.38 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.59 11.22 85.42 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 118.656 2.222 . . . . 0.0 118.656 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -76.45 154.68 34.54 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.238 2.019 . . . . 0.0 111.002 169.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.473 HH21 ' CD ' ' A' ' 90' ' ' GLU . 2.5 tmm_? -124.4 115.13 20.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.076 -1.64 . . . . 0.0 110.11 -161.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.3 m -94.82 154.08 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 O-C-N 119.658 -1.901 . . . . 0.0 114.191 -170.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.5 mt -121.81 -89.51 0.6 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.3 1.04 . . . . 0.0 110.33 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.83 141.5 31.54 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -165.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.1 t -95.4 102.64 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 C-N-CA 124.473 1.109 . . . . 0.0 108.026 175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.256 59.3 t30 57.94 42.42 22.95 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.859 1.663 . . . . 0.0 114.191 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.63 -27.25 21.06 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 120.535 -1.353 . . . . 0.0 113.959 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.1 t -91.33 113.31 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.345 -1.091 . . . . 0.0 111.967 -174.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.9 m -81.05 111.77 17.83 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.984 -1.072 . . . . 0.0 111.749 167.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.96 82.78 1.86 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.744 -1.223 . . . . 0.0 108.749 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -69.37 144.0 53.55 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.343 -2.098 . . . . 0.0 114.495 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.68 -15.31 52.91 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 120.693 -1.254 . . . . 0.0 114.897 175.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.68 128.58 37.15 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 125.836 1.655 . . . . 0.0 115.376 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 p -73.38 164.26 26.91 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 123.065 1.412 . . . . 0.0 111.01 172.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.12 -42.28 94.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -168.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -55.71 -38.22 69.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.356 1.862 . . . . 0.0 114.463 172.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -71.37 -43.63 66.55 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.253 1.421 . . . . 0.0 111.276 -178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.73 -48.82 70.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.82 -1.175 . . . . 0.0 113.539 174.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.13 -52.22 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 124.79 1.236 . . . . 0.0 113.503 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -71.46 -21.88 61.9 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 120.077 -1.639 . . . . 0.0 114.587 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.3 m -64.77 -40.49 95.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.354 -1.466 . . . . 0.0 111.57 169.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 89.2 mt -80.61 -26.36 37.85 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.524 -1.36 . . . . 0.0 113.837 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -66.55 -43.35 85.33 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.021 -1.675 . . . . 0.0 112.154 168.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -78.14 53.85 1.27 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.719 1.608 . . . . 0.0 113.592 176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.3 p -108.5 -86.6 0.51 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.85 2.06 . . . . 0.0 108.817 174.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.87 -57.45 1.83 Allowed Glycine 0 N--CA 1.43 -1.749 0 O-C-N 120.29 -1.506 . . . . 0.0 114.936 171.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -83.15 -68.23 0.72 Allowed 'General case' 0 N--CA 1.429 -1.522 0 O-C-N 120.516 -1.579 . . . . 0.0 112.609 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -130.45 141.64 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 122.555 1.169 . . . . 0.0 110.249 -173.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.1 t -114.99 109.04 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 126.651 1.98 . . . . 0.0 107.489 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -117.24 127.68 54.33 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.841 -1.162 . . . . 0.0 110.478 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.5 mt -141.42 152.46 44.3 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 123.847 0.859 . . . . 0.0 111.78 -170.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -122.32 123.9 42.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 124.827 1.251 . . . . 0.0 107.951 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.43 165.82 29.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.635 1.207 . . . . 0.0 111.622 -173.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.473 ' CD ' HH21 ' A' ' 57' ' ' ARG . 29.8 tt0 -112.03 141.33 45.82 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.303 1.841 . . . . 0.0 108.325 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -71.64 137.7 48.1 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.525 -1.359 . . . . 0.0 112.093 171.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.26 -143.44 5.85 Favored Glycine 0 N--CA 1.431 -1.686 0 CA-C-O 123.467 1.593 . . . . 0.0 115.915 -176.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -88.35 168.38 12.72 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 121.048 -1.266 . . . . 0.0 112.05 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.3 t -84.5 159.66 58.12 Favored Pre-proline 0 N--CA 1.431 -1.425 0 C-N-CA 124.885 1.274 . . . . 0.0 110.97 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -67.1 173.72 8.02 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 C-N-CA 123.179 2.586 . . . . 0.0 115.356 168.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.26 1.622 0 C-N-CA 124.439 1.096 . . . . 0.0 111.905 -179.646 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 . . . . . 0 CA--C 1.491 -1.316 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.43 -74.62 0.58 Allowed 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.755 -1.215 . . . . 0.0 113.317 -175.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 59.55 65.58 1.13 Allowed 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.775 2.43 . . . . 0.0 115.509 -172.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 6.1 t -117.37 -164.07 0.97 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.11 1.364 . . . . 0.0 109.087 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -108.51 -68.59 0.9 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.412 -1.43 . . . . 0.0 108.144 171.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.74 82.44 4.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.365 1.616 . . . . 0.0 115.365 -165.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -83.08 -64.07 1.24 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.452 1.101 . . . . 0.0 111.308 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . 0.331 21.2 mt-10 72.42 -128.81 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.694 1.998 . . . . 0.0 113.556 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -150.35 157.66 43.3 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.189 -1.569 . . . . 0.0 113.938 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -124.09 154.4 40.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 158.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -122.75 178.4 5.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.189 1.359 . . . . 0.0 113.911 -168.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 68.6 t -120.86 139.27 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 127.199 2.2 . . . . 0.0 105.482 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 11.6 m -132.28 140.54 48.66 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.164 1.386 . . . . 0.0 114.563 -156.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.54 157.58 31.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.972 1.709 . . . . 0.0 112.088 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.262 1.719 0 C-N-CA 125.211 1.404 . . . . 0.0 108.809 -179.474 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 CA--C 1.49 -1.688 0 N-CA-C 108.866 -1.244 . . . . 0.0 108.866 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -78.99 168.28 28.26 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 125.052 1.341 . . . . 0.0 110.984 169.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -65.25 -31.18 53.88 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 CA-C-N 124.18 2.529 . . . . 0.0 114.798 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.39 81.74 1.68 Allowed Glycine 0 N--CA 1.431 -1.655 0 CA-C-N 119.487 1.039 . . . . 0.0 110.515 167.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -80.57 155.98 26.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 123.334 1.54 . . . . 0.0 114.381 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.8 mt -86.55 135.86 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 125.645 1.578 . . . . 0.0 109.121 173.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -145.13 166.52 25.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.203 1.001 . . . . 0.0 108.84 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -124.63 143.7 50.58 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 121.282 -0.886 . . . . 0.0 109.869 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.6 m -103.43 148.75 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 123.425 0.69 . . . . 0.0 109.799 171.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -129.39 93.48 3.57 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.8 tp -122.61 163.06 20.72 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -172.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.88 172.14 13.4 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.045 -1.659 . . . . 0.0 109.014 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -71.63 103.83 3.15 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.997 -1.064 . . . . 0.0 113.115 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -97.97 -70.87 0.71 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 124.902 1.281 . . . . 0.0 109.465 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -70.43 -76.91 0.09 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.724 2.01 . . . . 0.0 110.003 172.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -138.21 -176.86 4.59 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.818 -3.031 . . . . 0.0 102.818 171.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 t -79.48 -61.46 2.0 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.775 -1.828 . . . . 0.0 112.881 -162.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.2 mp -101.76 -88.18 0.38 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.175 -1.578 . . . . 0.0 111.32 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.6 45.08 2.01 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tt -152.41 147.34 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 120.948 -1.325 . . . . 0.0 110.49 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 t -122.17 158.52 29.19 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.899 -1.126 . . . . 0.0 109.926 -174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.576 HG11 ' CE1' ' A' ' 71' ' ' HIS . 33.0 t -121.4 162.48 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 125.042 1.337 . . . . 0.0 109.299 -158.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 t -147.69 149.68 32.91 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 165.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.81 -149.87 43.73 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 115.765 1.066 . . . . 0.0 115.765 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.62 12.88 57.69 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 118.231 2.052 . . . . 0.0 118.231 168.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.04 -107.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 119.128 1.464 . . . . 0.0 114.491 -161.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -89.89 -41.47 11.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.361 -2.087 . . . . 0.0 110.793 -172.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.7 t -136.31 152.64 50.9 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 158.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -155.37 -93.04 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.431 -1.418 . . . . 0.0 110.835 -176.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.47 -52.67 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 C-N-CA 125.044 1.337 . . . . 0.0 110.016 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.5 ptt-85 -125.98 -139.05 0.27 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 106.446 -1.686 . . . . 0.0 106.446 154.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -75.67 67.35 2.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.773 1.749 . . . . 0.0 110.823 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.45 -176.58 16.42 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 126.181 1.848 . . . . 0.0 109.333 -171.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.63 151.52 27.02 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.68 159.3 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.52 157.21 35.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.468 -1.395 . . . . 0.0 109.747 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 t -92.53 128.25 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 124.963 1.305 . . . . 0.0 111.849 -174.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -97.17 -67.39 0.85 Allowed 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.691 -1.256 . . . . 0.0 113.342 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -156.21 153.05 28.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.827 -1.17 . . . . 0.0 112.637 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.94 119.87 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 C-N-CA 126.309 1.843 . . . . 0.0 109.246 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.4 mm -84.54 131.52 49.71 Favored Pre-proline 0 N--CA 1.43 -1.451 0 C-N-CA 125.054 1.341 . . . . 0.0 109.685 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -77.11 64.23 7.79 Favored 'Trans proline' 0 C--N 1.3 -1.98 0 CA-C-N 124.295 2.57 . . . . 0.0 112.65 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -160.33 53.95 0.33 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.869 1.319 . . . . 0.0 109.202 173.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.72 179.95 45.7 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.385 -2.072 . . . . 0.0 112.908 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.36 -32.79 72.71 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.734 1.614 . . . . 0.0 114.703 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.75 -42.35 71.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.845 1.658 . . . . 0.0 114.411 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -91.33 -47.18 7.62 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 124.779 1.232 . . . . 0.0 112.0 176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.4 m -68.39 -36.6 79.39 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -173.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -84.4 -49.2 8.9 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.189 1.359 . . . . 0.0 109.327 165.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.89 90.43 2.16 Favored Glycine 0 N--CA 1.43 -1.701 0 O-C-N 121.02 -1.05 . . . . 0.0 111.672 174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -137.83 -54.5 0.66 Allowed 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -166.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.0 mt -126.36 145.98 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 119.197 -2.189 . . . . 0.0 107.387 -165.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -119.2 174.05 6.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.462 1.125 . . . . 0.0 112.386 -170.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -61.12 136.03 57.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 167.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 26.51 62.63 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 119.154 2.422 . . . . 0.0 119.154 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -79.9 176.18 9.97 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 118.776 1.288 . . . . 0.0 110.737 162.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -124.75 121.09 33.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.969 -1.707 . . . . 0.0 109.248 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -94.17 153.46 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 120.028 -1.67 . . . . 0.0 112.193 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 41.0 tp -125.9 -81.42 0.62 Allowed 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 121.059 -1.025 . . . . 0.0 112.073 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.88 151.18 21.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.527 -1.358 . . . . 0.0 114.385 -166.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.75 92.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 125.999 1.719 . . . . 0.0 107.066 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 56.37 54.61 7.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.468 1.507 . . . . 0.0 114.555 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.27 -40.31 2.47 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 124.329 0.966 . . . . 0.0 114.649 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.0 t -99.31 136.17 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 O-C-N 121.425 -1.044 . . . . 0.0 111.381 -169.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 t -77.72 144.99 36.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.87 -1.769 . . . . 0.0 110.97 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -90.89 -9.43 46.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.455 -1.403 . . . . 0.0 113.305 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -57.02 144.53 33.87 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -172.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.1 -43.84 1.87 Allowed Glycine 0 N--CA 1.431 -1.699 0 O-C-N 121.176 -0.953 . . . . 0.0 113.017 -161.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.01 160.0 28.42 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.614 -1.521 . . . . 0.0 114.516 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.8 p -84.85 167.74 15.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.444 1.898 . . . . 0.0 111.174 175.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.576 ' CE1' HG11 ' A' ' 22' ' ' VAL . 11.1 t60 -60.67 -37.45 81.64 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.42 1.488 . . . . 0.0 114.052 171.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -54.5 -45.86 73.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.956 2.102 . . . . 0.0 114.221 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -76.18 -34.23 59.33 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.086 -1.634 . . . . 0.0 112.723 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.29 -43.84 96.74 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.551 1.541 . . . . 0.0 114.481 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.7 m -73.88 -24.06 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.974 -1.704 . . . . 0.0 113.787 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -67.91 -45.26 74.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.406 -1.434 . . . . 0.0 112.183 169.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.6 m -59.97 -33.12 71.51 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 126.745 2.018 . . . . 0.0 112.828 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -79.26 -54.71 5.7 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.76 -1.213 . . . . 0.0 112.574 177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -68.5 -5.43 19.45 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -169.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -85.49 11.96 9.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.152 -1.592 . . . . 0.0 115.192 171.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 p -102.14 -103.84 0.27 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.471 1.508 . . . . 0.0 110.015 170.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.95 -57.57 0.47 Allowed Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.201 -1.562 . . . . 0.0 113.376 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -71.33 -67.94 0.48 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -173.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.8 p -109.46 140.43 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 122.459 1.123 . . . . 0.0 112.057 -174.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.9 t -119.82 112.1 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 125.155 1.382 . . . . 0.0 109.774 -175.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -116.53 115.35 25.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.017 -1.052 . . . . 0.0 108.378 168.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.2 tp -128.41 146.35 50.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.932 1.293 . . . . 0.0 108.595 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -120.74 123.02 41.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.32 157.65 44.58 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 122.243 1.021 . . . . 0.0 110.5 -170.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -104.68 141.37 36.56 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -65.23 135.45 55.42 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.629 1.204 . . . . 0.0 113.457 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.6 163.95 53.0 Favored Glycine 0 N--CA 1.431 -1.694 0 CA-C-O 122.596 1.109 . . . . 0.0 113.175 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -83.35 172.05 12.9 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.559 1.171 . . . . 0.0 112.007 -176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.1 t -71.4 -43.11 12.06 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 116.014 -1.945 . . . . 0.0 115.198 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -76.02 45.05 1.43 Allowed 'Trans proline' 0 N--CA 1.434 -2.009 0 CA-C-N 125.926 3.152 . . . . 0.0 117.983 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.261 1.696 0 C-N-CA 125.43 1.492 . . . . 0.0 108.287 167.174 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 CA--C 1.491 -1.317 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.59 -103.63 0.17 Allowed 'General case' 0 N--CA 1.428 -1.525 0 O-C-N 120.476 -1.39 . . . . 0.0 109.919 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -90.55 -179.74 5.64 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.273 -1.517 . . . . 0.0 108.752 170.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.7 m -94.55 -170.82 2.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.208 -2.183 . . . . 0.0 111.89 -173.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -115.25 -84.14 0.62 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.652 -1.28 . . . . 0.0 108.739 164.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.09 100.51 7.78 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.455 -1.403 . . . . 0.0 108.343 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -134.77 130.74 36.62 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 124.601 1.161 . . . . 0.0 110.354 -167.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -148.74 -171.81 3.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.949 -1.095 . . . . 0.0 109.327 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -92.82 175.75 6.69 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.199 -1.563 . . . . 0.0 111.813 -169.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -122.99 -117.33 0.29 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 170.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -134.7 170.27 16.07 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.576 -1.953 . . . . 0.0 111.681 160.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 11.2 p -121.3 158.33 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.069 2.148 . . . . 0.0 107.752 -169.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 9.8 m -141.71 159.29 42.53 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.08 -1.637 . . . . 0.0 112.987 -168.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.53 161.77 38.99 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.475 0.655 . . . . 0.0 111.721 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.504 1.922 . . . . 0.0 106.437 174.559 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo . . . . . 0 CA--C 1.491 -1.637 0 N-CA-C 108.804 -1.268 . . . . 0.0 108.804 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -78.11 176.94 3.1 Favored Pre-proline 0 N--CA 1.431 -1.4 0 C-N-CA 125.904 1.682 . . . . 0.0 112.224 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -63.13 -31.55 75.29 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 CA-C-N 124.111 2.504 . . . . 0.0 115.631 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.43 86.05 0.55 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 124.056 0.836 . . . . 0.0 112.637 172.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.31 168.62 18.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.8 135.06 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 126.424 1.89 . . . . 0.0 109.409 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -146.99 169.62 18.82 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.797 1.284 . . . . 0.0 113.568 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.09 125.94 40.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.994 1.318 . . . . 0.0 111.457 -174.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.2 m -104.78 147.91 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.303 -1.498 . . . . 0.0 113.805 172.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -130.85 104.08 6.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.132 1.373 . . . . 0.0 109.833 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.1 tp -123.28 174.9 7.01 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.795 1.238 . . . . 0.0 108.199 -177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.23 163.52 32.72 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.669 -1.894 . . . . 0.0 105.928 166.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -62.38 120.61 11.37 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -117.92 -89.07 0.6 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 124.617 1.167 . . . . 0.0 109.298 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -71.12 -49.66 41.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.68 1.592 . . . . 0.0 110.976 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -151.5 -162.83 1.62 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -84.63 -61.54 1.77 Allowed 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 120.511 1.505 . . . . 0.0 110.018 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.3 mp -104.1 -93.55 0.34 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.504 -1.373 . . . . 0.0 111.723 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.87 51.74 1.25 Allowed Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 124.793 1.187 . . . . 0.0 110.602 -169.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.7 tt -150.2 163.57 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 121.329 -1.101 . . . . 0.0 110.791 -174.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -121.85 148.02 45.24 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.405 -1.435 . . . . 0.0 110.135 -173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 t -126.01 156.78 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 126.04 1.736 . . . . 0.0 109.633 -166.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -138.69 151.17 46.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 121.182 -0.949 . . . . 0.0 109.532 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.78 -149.8 50.8 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 125.641 1.591 . . . . 0.0 115.804 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.03 36.88 13.79 Favored Glycine 0 N--CA 1.429 -1.807 0 N-CA-C 116.677 1.431 . . . . 0.0 116.677 170.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.54 -108.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -166.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -90.25 -52.48 4.91 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.802 -1.811 . . . . 0.0 110.852 -169.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.4 t -137.38 135.42 36.96 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 161.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 t -155.72 -84.27 0.06 Allowed 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.107 -1.621 . . . . 0.0 110.325 -163.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.48 -58.5 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -116.89 -138.36 0.36 Allowed 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 161.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.07 66.06 2.19 Favored 'General case' 0 N--CA 1.429 -1.496 0 O-C-N 119.979 -1.7 . . . . 0.0 110.711 164.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.99 -147.3 16.46 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -168.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.63 145.32 14.91 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 121.712 -0.875 . . . . 0.0 111.3 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.6 mm -123.47 145.7 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 120.485 -1.597 . . . . 0.0 108.969 -160.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.75 141.23 52.11 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.118 1.367 . . . . 0.0 110.078 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.82 136.32 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.77 -1.207 . . . . 0.0 112.897 -178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -97.11 -66.64 0.89 Allowed 'General case' 0 N--CA 1.429 -1.501 0 C-N-CA 125.058 1.343 . . . . 0.0 112.05 -174.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -155.25 159.28 39.93 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 121.17 -0.956 . . . . 0.0 110.456 -173.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.33 131.85 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 125.673 1.589 . . . . 0.0 110.781 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.5 mm -83.83 122.27 76.26 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 117.451 -1.262 . . . . 0.0 108.104 170.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -82.9 40.99 1.03 Allowed 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.474 2.782 . . . . 0.0 113.11 -171.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -160.59 78.0 0.62 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.23 170.39 43.51 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.76 -34.47 74.51 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.743 1.217 . . . . 0.0 113.07 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.91 -42.95 69.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -92.2 -37.7 12.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.861 1.264 . . . . 0.0 112.993 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.3 m -68.0 -35.57 78.54 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.282 -1.511 . . . . 0.0 114.549 -177.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.13 -60.27 2.44 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.103 0.954 . . . . 0.0 109.782 167.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.39 68.63 0.61 Allowed Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.0 tpm_? -136.72 -42.4 0.6 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 121.839 -0.801 . . . . 0.0 112.27 -155.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.0 mt -127.84 121.14 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -117.85 -179.63 3.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.317 1.056 . . . . 0.0 111.086 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -59.58 142.13 53.44 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 170.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.07 6.41 82.72 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 119.284 2.473 . . . . 0.0 119.284 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -77.76 170.51 16.45 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.684 1.742 . . . . 0.0 113.019 173.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -131.84 91.09 2.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.951 -1.718 . . . . 0.0 111.016 -166.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.6 m -80.09 160.63 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.43 -2.044 . . . . 0.0 113.288 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.1 tp -141.79 -82.97 0.2 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.728 -1.232 . . . . 0.0 113.041 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.32 146.88 24.41 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.33 -1.482 . . . . 0.0 114.796 -165.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.3 t -113.71 89.48 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 126.723 2.009 . . . . 0.0 107.71 -175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.7 t30 57.55 58.47 3.76 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.602 1.561 . . . . 0.0 112.712 -176.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.44 -41.54 3.09 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.842 -1.161 . . . . 0.0 113.963 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.9 t -85.0 122.28 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.559 -1.553 . . . . 0.0 110.963 -173.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -77.39 141.14 39.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.105 -1.622 . . . . 0.0 111.417 176.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.3 pp -88.23 -2.8 58.81 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -62.19 142.89 57.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 -171.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.05 -29.72 11.58 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 120.619 -1.301 . . . . 0.0 113.153 -166.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.86 153.84 32.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 p -83.0 170.6 14.72 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.856 -1.153 . . . . 0.0 112.039 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -55.29 -46.26 76.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.545 1.538 . . . . 0.0 114.985 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -60.14 -40.7 90.74 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -72.25 -38.98 68.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.326 -1.484 . . . . 0.0 111.964 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.45 96.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.783 1.633 . . . . 0.0 114.527 175.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.9 m -69.26 -37.49 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.395 -1.441 . . . . 0.0 113.163 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -59.78 -40.68 89.1 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.927 1.291 . . . . 0.0 112.915 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.1 m -58.35 -38.53 77.39 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 127.202 2.201 . . . . 0.0 113.202 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.84 -33.02 30.88 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.792 1.237 . . . . 0.0 112.993 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -69.99 -47.08 63.65 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.766 -1.209 . . . . 0.0 113.92 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.347 0.0 OUTLIER -89.97 42.45 1.09 Allowed 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -175.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.8 p -93.1 -71.88 0.63 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.444 1.498 . . . . 0.0 109.669 171.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.94 -99.55 0.89 Allowed Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 126.08 1.8 . . . . 0.0 113.509 172.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -79.66 -47.68 14.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -159.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.31 146.7 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 121.046 -1.033 . . . . 0.0 111.993 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.32 112.76 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 120.311 -1.493 . . . . 0.0 110.092 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -114.84 118.85 34.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 163.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.6 tt -145.67 143.77 30.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 121.401 -0.812 . . . . 0.0 110.091 -170.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.06 126.49 49.98 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -173.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -143.23 164.66 29.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.06 1.409 . . . . 0.0 112.011 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -117.74 141.51 48.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 174.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -73.61 138.35 44.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 122.247 1.023 . . . . 0.0 111.582 175.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.4 -129.47 1.85 Allowed Glycine 0 N--CA 1.43 -1.761 0 CA-C-O 123.049 1.361 . . . . 0.0 116.024 -174.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -87.31 127.46 35.19 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.201 -1.176 . . . . 0.0 113.672 -167.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.6 m -88.33 -56.73 0.3 Allowed Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-O 116.336 -1.793 . . . . 0.0 114.509 176.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -81.74 64.72 8.58 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 126.216 3.256 . . . . 0.0 113.431 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 C--O 1.26 1.614 0 C-N-CA 124.751 1.22 . . . . 0.0 112.093 176.478 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 121.096 0.474 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.7 -92.48 0.53 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 124.403 1.081 . . . . 0.0 109.389 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -105.53 164.29 12.0 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 166.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.9 p -80.71 -36.34 32.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -161.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 68.58 65.36 0.32 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.734 1.614 . . . . 0.0 111.993 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . 77.4 91.93 0.07 Allowed 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 128.299 2.64 . . . . 0.0 113.858 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -91.58 135.55 33.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.515 1.526 . . . . 0.0 110.456 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -165.21 -171.28 2.14 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.9 1.28 . . . . 0.0 108.083 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -113.97 -175.75 2.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.504 -1.372 . . . . 0.0 109.457 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -122.68 -74.33 0.62 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.68 -1.262 . . . . 0.0 109.179 174.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -139.19 165.73 26.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.404 -1.435 . . . . 0.0 109.463 174.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.38 146.18 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.901 -1.124 . . . . 0.0 109.519 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.8 m -136.96 176.56 8.6 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.573 -1.329 . . . . 0.0 113.07 -172.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.91 157.22 42.96 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.099 1.36 . . . . 0.0 108.827 168.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 C--O 1.258 1.549 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 176.808 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.489 -1.732 0 N-CA-C 109.314 -1.071 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -78.3 151.37 78.07 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 118.146 -0.93 . . . . 0.0 111.167 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -82.62 29.48 0.55 Allowed 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 123.547 2.831 . . . . 0.0 115.19 -161.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.82 80.9 0.31 Allowed Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.892 -1.13 . . . . 0.0 112.249 172.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.97 138.13 47.81 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 122.882 1.325 . . . . 0.0 114.57 178.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.61 140.65 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 126.25 1.82 . . . . 0.0 108.595 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.501 ' CZ ' HD11 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -161.04 161.91 31.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.195 -0.941 . . . . 0.0 110.566 177.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.51 127.89 54.95 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 120.977 -1.077 . . . . 0.0 109.212 173.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -104.28 131.95 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 122.587 1.184 . . . . 0.0 111.284 172.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -116.63 123.47 47.39 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 122.414 1.102 . . . . 0.0 109.846 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.4 tp -135.22 168.23 19.54 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.99 160.73 31.0 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.0 tttp -70.88 103.65 2.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.107 -0.996 . . . . 0.0 111.05 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -100.66 -93.66 0.28 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.16 1.784 . . . . 0.0 109.401 -166.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.0 -47.44 45.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.297 -1.502 . . . . 0.0 109.133 167.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -147.66 -153.83 0.51 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 167.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 p -83.47 -90.94 0.08 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.231 -1.543 . . . . 0.0 111.361 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.9 mt -101.64 -85.22 0.43 Allowed 'General case' 0 N--CA 1.429 -1.505 0 O-C-N 120.459 -1.4 . . . . 0.0 113.317 -173.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.46 42.74 1.44 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 125.327 1.441 . . . . 0.0 110.985 -168.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.3 tt -134.89 152.66 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 121.124 -1.221 . . . . 0.0 109.552 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.2 p -122.27 153.87 38.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.478 -1.389 . . . . 0.0 111.738 -171.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 t -127.66 159.6 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 125.133 1.373 . . . . 0.0 108.982 -164.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.2 t -138.04 142.36 40.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 172.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.67 -149.3 50.44 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.781 1.658 . . . . 0.0 114.921 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.82 34.29 5.78 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 124.5 1.048 . . . . 0.0 115.456 165.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.14 -92.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 121.663 -0.904 . . . . 0.0 111.216 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -98.32 -51.09 4.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 120.453 -1.404 . . . . 0.0 110.103 -173.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -149.9 131.41 14.8 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.83 -1.169 . . . . 0.0 110.832 175.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 58.5 m -154.83 -74.2 0.11 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 124.285 1.034 . . . . 0.0 110.661 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 p -79.46 -48.71 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.459 -1.401 . . . . 0.0 110.137 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -132.08 -159.67 0.98 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 161.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -71.7 110.76 6.46 Favored 'General case' 0 N--CA 1.432 -1.37 0 O-C-N 120.329 -1.482 . . . . 0.0 108.76 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.22 -179.76 23.86 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 121.063 -1.023 . . . . 0.0 113.905 -167.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.79 161.45 27.79 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 120.451 -1.617 . . . . 0.0 112.075 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.8 mm -126.68 142.51 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 126.3 1.84 . . . . 0.0 107.986 -162.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.88 138.46 52.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 124.968 1.307 . . . . 0.0 109.451 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.86 133.58 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.712 -1.242 . . . . 0.0 112.714 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -90.85 -65.64 1.0 Allowed 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.216 1.007 . . . . 0.0 110.87 172.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.73 160.9 31.95 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 121.356 -0.84 . . . . 0.0 111.946 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.05 125.59 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.998 1.319 . . . . 0.0 110.46 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.08 133.99 47.09 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.967 -1.492 . . . . 0.0 109.085 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.35 43.31 1.46 Allowed 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 124.772 2.74 . . . . 0.0 114.089 -173.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -153.57 47.66 0.66 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.851 -1.156 . . . . 0.0 109.721 -166.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.01 -172.7 39.51 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 120.237 -1.539 . . . . 0.0 112.517 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.85 -29.35 69.79 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.626 1.97 . . . . 0.0 113.214 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.64 -41.29 94.62 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 125.987 1.715 . . . . 0.0 114.044 174.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -73.71 -43.59 58.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.804 1.242 . . . . 0.0 111.909 173.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 t -62.16 -55.56 27.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.182 1.393 . . . . 0.0 114.149 -174.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.69 -60.32 2.37 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 120.915 -1.116 . . . . 0.0 111.091 175.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.31 87.13 1.43 Allowed Glycine 0 N--CA 1.43 -1.756 0 O-C-N 121.371 -0.831 . . . . 0.0 112.105 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.43 -26.77 0.98 Allowed 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 121.238 -1.154 . . . . 0.0 112.789 -164.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.5 mm -126.56 136.89 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -119.33 171.31 8.41 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.678 -1.264 . . . . 0.0 112.546 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -58.14 143.91 42.26 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.44 15.21 81.68 Favored Glycine 0 N--CA 1.431 -1.672 0 N-CA-C 116.445 1.338 . . . . 0.0 116.445 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -82.43 158.39 23.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 125.092 1.357 . . . . 0.0 113.496 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -127.17 114.43 17.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.888 1.675 . . . . 0.0 111.715 -172.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.8 m -79.93 157.49 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.864 -1.772 . . . . 0.0 113.717 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 mp -121.53 -90.97 0.57 Allowed 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 125.643 1.577 . . . . 0.0 107.41 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.19 159.48 16.04 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.312 -2.117 . . . . 0.0 114.213 -166.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.2 t -112.94 80.13 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 C-N-CA 126.389 1.875 . . . . 0.0 106.658 175.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.5 t30 57.86 69.7 0.71 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.849 1.66 . . . . 0.0 112.768 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.55 -55.62 2.71 Favored Glycine 0 N--CA 1.429 -1.776 0 O-C-N 120.592 -1.318 . . . . 0.0 114.456 -176.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 m -86.12 138.36 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.545 1.164 . . . . 0.0 113.171 -170.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -79.26 155.43 28.54 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.539 -1.351 . . . . 0.0 113.1 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 pp -85.91 4.25 38.3 Favored 'General case' 0 CA--C 1.488 -1.407 0 C-N-CA 125.307 1.443 . . . . 0.0 113.874 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -62.13 120.33 10.68 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.617 -1.302 . . . . 0.0 114.249 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.68 -39.58 2.65 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 125.77 1.653 . . . . 0.0 112.984 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.65 140.33 51.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -168.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.68 -178.56 5.56 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.337 1.455 . . . . 0.0 109.377 172.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -60.29 -49.95 75.56 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.402 -1.436 . . . . 0.0 114.483 -171.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -54.27 -43.12 70.74 Favored 'General case' 0 N--CA 1.429 -1.525 0 C-N-CA 125.136 1.374 . . . . 0.0 113.77 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -71.67 -41.2 69.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.016 -1.053 . . . . 0.0 112.717 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.92 -44.51 92.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.333 -1.48 . . . . 0.0 114.374 176.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.6 m -72.15 -40.25 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 120.003 -1.685 . . . . 0.0 112.351 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -72.37 -31.81 65.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.283 -1.511 . . . . 0.0 114.117 -176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.5 p -70.42 -26.15 63.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.222 -1.549 . . . . 0.0 113.157 174.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.9 tp -80.23 -40.52 26.89 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 121.062 -1.024 . . . . 0.0 112.011 173.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -60.68 -56.0 26.48 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 120.545 -1.347 . . . . 0.0 113.676 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -84.03 59.32 5.21 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.673 -1.267 . . . . 0.0 111.379 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.49 -69.63 0.63 Allowed 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 127.044 2.138 . . . . 0.0 107.59 166.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.71 -117.74 3.95 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -65.5 -63.62 1.05 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.71 138.04 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-O 122.488 1.137 . . . . 0.0 111.478 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.19 87.42 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 125.646 1.578 . . . . 0.0 106.791 -175.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -116.29 126.02 52.98 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 120.273 -1.517 . . . . 0.0 108.996 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . 0.266 0.0 OUTLIER -147.34 162.67 38.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.637 -1.289 . . . . 0.0 111.927 -179.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.0 tp -121.41 131.2 54.03 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.679 1.592 . . . . 0.0 107.729 -170.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.501 HD11 ' CZ ' ' A' ' 7' ' ' PHE . 1.3 pt? -140.87 162.99 34.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.515 1.15 . . . . 0.0 111.602 -171.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -134.89 120.19 18.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.426 1.49 . . . . 0.0 107.527 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -62.39 143.91 56.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -174.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.37 145.11 38.55 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 121.299 -0.876 . . . . 0.0 113.93 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -93.76 138.0 32.41 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 121.24 -1.153 . . . . 0.0 111.283 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.8 m -75.65 161.6 75.58 Favored Pre-proline 0 N--CA 1.43 -1.468 0 C-N-CA 125.505 1.522 . . . . 0.0 112.861 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.74 173.06 14.02 Favored 'Trans proline' 0 N--CA 1.434 -2.029 0 C-N-CA 122.766 2.311 . . . . 0.0 111.672 166.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.4 p . . . . . 0 C--O 1.261 1.666 0 C-N-CA 123.903 0.881 . . . . 0.0 112.567 -173.603 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 32.2 p90 . . . . . 0 CA--C 1.49 -1.327 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.99 -128.46 0.06 Allowed 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 168.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -85.43 150.02 25.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 124.94 1.296 . . . . 0.0 109.931 172.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 4.5 t -143.23 -86.58 0.14 Allowed 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.49 -1.381 . . . . 0.0 111.9 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.27 -162.83 0.86 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.111 -1.618 . . . . 0.0 110.792 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.81 -80.65 0.51 Allowed 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 120.549 -1.344 . . . . 0.0 114.023 -171.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -86.55 158.37 19.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -162.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -139.55 -93.17 0.17 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.591 1.556 . . . . 0.0 108.96 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -89.58 174.45 7.75 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.121 -1.612 . . . . 0.0 110.978 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -121.85 105.59 10.5 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.591 -1.318 . . . . 0.0 109.154 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -143.08 -131.21 0.09 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.718 -1.239 . . . . 0.0 113.601 173.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.4 157.79 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 119.739 -1.851 . . . . 0.0 109.423 -159.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.5 p -139.21 168.0 20.82 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.328 -1.482 . . . . 0.0 114.429 -172.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.54 160.19 43.68 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.188 1.395 . . . . 0.0 108.812 162.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 74.1 t . . . . . 0 C--O 1.26 1.644 0 N-CA-C 106.041 -1.836 . . . . 0.0 106.041 176.71 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.68 0 N-CA-C 110.758 -0.516 . . . . 0.0 110.758 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -88.36 172.98 6.81 Favored Pre-proline 0 N--CA 1.43 -1.432 0 C-N-CA 125.177 1.391 . . . . 0.0 111.624 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -66.32 -41.41 12.4 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 C-N-CA 122.306 2.004 . . . . 0.0 115.238 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.07 62.31 0.57 Allowed Glycine 0 N--CA 1.431 -1.672 0 C-N-CA 124.134 0.874 . . . . 0.0 111.653 173.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -82.78 168.02 17.57 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.394 1.092 . . . . 0.0 112.495 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -78.39 135.54 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 126.186 1.794 . . . . 0.0 108.946 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -136.23 156.04 49.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.522 -1.361 . . . . 0.0 110.479 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -116.09 134.11 55.3 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 121.044 -1.035 . . . . 0.0 111.334 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.8 t -102.9 125.08 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 124.563 1.145 . . . . 0.0 109.597 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -124.72 70.89 1.14 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.524 1.53 . . . . 0.0 108.032 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tp -112.69 -160.88 0.73 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 120.468 -1.395 . . . . 0.0 110.38 -166.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.45 151.68 30.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.546 -1.346 . . . . 0.0 107.977 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -73.57 101.98 3.74 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.908 -1.12 . . . . 0.0 112.464 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -90.75 -71.39 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 124.264 1.026 . . . . 0.0 110.187 172.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -86.6 -69.2 0.69 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.488 1.515 . . . . 0.0 111.325 174.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -136.76 165.5 25.78 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 102.132 -3.284 . . . . 0.0 102.132 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.0 p -83.05 -51.24 7.72 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.458 -1.401 . . . . 0.0 112.241 -174.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 14.4 mt -102.36 -89.95 0.36 Allowed 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 121.057 -1.027 . . . . 0.0 113.457 172.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.49 53.78 1.93 Allowed Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -159.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 tt -145.79 159.13 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 121.1 -1.235 . . . . 0.0 110.782 -173.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -123.22 147.67 46.65 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.688 -1.883 . . . . 0.0 109.686 -175.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.14 147.49 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 125.691 1.596 . . . . 0.0 111.107 -167.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.1 t -137.96 126.59 23.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.437 1.113 . . . . 0.0 111.604 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.43 65.43 3.17 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 118.449 2.14 . . . . 0.0 118.449 164.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -141.66 75.78 0.32 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.58 -108.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 124.602 1.161 . . . . 0.0 111.044 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -72.63 -76.42 0.12 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.735 2.014 . . . . 0.0 111.633 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.0 t -144.26 121.1 11.27 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.225 -1.547 . . . . 0.0 109.315 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 p -138.87 -73.97 0.39 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.738 -1.226 . . . . 0.0 112.878 -170.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.9 t -66.13 -60.63 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 126.224 1.81 . . . . 0.0 111.564 -172.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ttm-85 -125.0 -115.83 0.29 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.11 62.6 2.56 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.101 1.36 . . . . 0.0 109.067 167.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.95 -139.56 14.45 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 107.167 -2.373 . . . . 0.0 107.167 -163.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.78 155.94 28.29 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-O 121.939 0.744 . . . . 0.0 112.927 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.93 142.4 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -135.55 132.76 37.6 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.65 1.98 . . . . 0.0 110.351 -168.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.0 t -80.32 128.61 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.482 -1.386 . . . . 0.0 112.863 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -84.74 -55.1 4.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.067 1.747 . . . . 0.0 111.812 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.08 165.39 15.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.439 -0.788 . . . . 0.0 110.141 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.7 t -98.52 130.86 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.384 0 C-N-CA 125.64 1.576 . . . . 0.0 111.381 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 mm -82.85 124.91 76.51 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 124.932 1.293 . . . . 0.0 109.65 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -81.36 32.22 0.52 Allowed 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 123.42 2.747 . . . . 0.0 114.326 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -142.79 52.57 1.4 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.863 1.265 . . . . 0.0 108.589 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -166.58 173.3 41.97 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 119.993 -1.692 . . . . 0.0 111.452 -176.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.71 73.04 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 125.461 1.504 . . . . 0.0 114.731 -175.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.32 -49.05 78.56 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 175.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -77.62 -28.93 51.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.761 1.224 . . . . 0.0 112.736 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.3 t -64.69 -56.4 13.97 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.578 -1.326 . . . . 0.0 113.381 173.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -79.63 -47.51 15.3 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.955 1.302 . . . . 0.0 112.005 -172.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.87 80.61 1.42 Allowed Glycine 0 N--CA 1.431 -1.644 0 O-C-N 121.035 -1.04 . . . . 0.0 111.217 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -139.87 -51.77 0.51 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.834 0.854 . . . . 0.0 112.714 -171.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.1 mt -126.92 136.36 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 -168.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.81 -166.51 2.36 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.681 1.364 . . . . 0.0 114.681 -175.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -58.13 125.16 21.98 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.7 15.88 81.21 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 117.307 1.683 . . . . 0.0 117.307 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -75.69 155.26 35.88 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 118.93 1.365 . . . . 0.0 111.131 167.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.87 131.32 40.82 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.461 -1.4 . . . . 0.0 109.562 -173.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.58 153.29 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.647 -1.908 . . . . 0.0 113.766 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.69 -84.51 0.66 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.807 1.643 . . . . 0.0 107.397 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 143.57 29.56 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -175.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.3 t -120.14 90.99 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 125.289 1.436 . . . . 0.0 108.398 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.275 22.2 t-20 57.24 64.48 1.6 Allowed 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 125.896 1.679 . . . . 0.0 112.281 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.17 -61.87 1.06 Allowed Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 124.691 1.139 . . . . 0.0 113.506 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.0 m -83.86 134.05 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 120.984 -1.304 . . . . 0.0 113.381 -164.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.3 t -77.79 124.98 28.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.779 -1.201 . . . . 0.0 110.376 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.8 tp -85.67 47.58 1.46 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 123.811 1.767 . . . . 0.0 113.995 -163.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -70.07 134.88 48.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.137 1.775 . . . . 0.0 112.6 166.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.82 -14.45 60.27 Favored Glycine 0 N--CA 1.431 -1.681 0 O-C-N 120.979 -1.076 . . . . 0.0 114.212 173.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.9 138.49 41.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.91 -1.347 . . . . 0.0 114.159 -176.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 p -93.73 173.96 7.42 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.983 1.713 . . . . 0.0 109.369 166.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -61.46 -38.45 87.27 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -169.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -72.14 -27.4 62.59 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.549 -1.344 . . . . 0.0 113.68 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -78.55 -41.16 32.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.153 -1.592 . . . . 0.0 111.086 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.05 96.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.87 -44.31 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.892 -1.755 . . . . 0.0 112.942 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -66.31 -46.51 76.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.93 1.692 . . . . 0.0 113.788 -176.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.8 p -64.54 -33.17 75.28 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.827 1.651 . . . . 0.0 114.434 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.6 mt -92.44 -16.7 25.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -76.35 -55.04 5.92 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.241 -1.537 . . . . 0.0 111.496 168.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -91.55 65.33 5.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.871 1.32 . . . . 0.0 112.175 -174.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.9 p -86.65 -58.56 2.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.862 2.065 . . . . 0.0 109.923 171.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.77 -128.48 7.81 Favored Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 125.426 1.489 . . . . 0.0 111.126 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -81.36 -43.86 18.43 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.903 -1.351 . . . . 0.0 112.308 -170.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 p -104.82 140.96 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 122.113 0.959 . . . . 0.0 110.999 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 96.6 t -119.64 100.91 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 124.496 1.118 . . . . 0.0 108.832 -168.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -117.61 115.07 24.36 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.898 -1.126 . . . . 0.0 110.953 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -148.42 157.12 43.27 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 121.206 -0.934 . . . . 0.0 110.926 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mp -120.87 144.61 48.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 mp -139.54 159.04 43.09 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 123.889 0.876 . . . . 0.0 109.596 -173.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -107.89 125.46 51.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 167.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -74.6 146.44 42.5 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.922 -1.111 . . . . 0.0 112.144 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.29 -135.87 0.62 Allowed Glycine 0 N--CA 1.429 -1.787 0 CA-C-O 123.578 1.655 . . . . 0.0 116.825 -172.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -94.54 146.79 23.86 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 120.577 -1.543 . . . . 0.0 110.933 -173.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.6 m -79.94 140.98 54.35 Favored Pre-proline 0 N--CA 1.431 -1.415 0 O-C-N 120.985 -1.072 . . . . 0.0 111.108 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -66.11 -47.64 3.31 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 C-N-CA 122.543 2.162 . . . . 0.0 113.002 163.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.26 1.614 0 C-N-CA 124.45 1.1 . . . . 0.0 110.636 171.037 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.04 175.01 7.11 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.012 -1.055 . . . . 0.0 113.772 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 54.28 59.02 4.45 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.086 2.155 . . . . 0.0 114.232 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 19.9 t -149.16 -69.6 0.21 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.013 -1.054 . . . . 0.0 110.097 -174.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -100.0 -129.31 0.21 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.117 0.967 . . . . 0.0 110.498 -172.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.15 151.74 19.66 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.08 -1.638 . . . . 0.0 113.675 -173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -117.45 38.27 3.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.63 1.172 . . . . 0.0 111.557 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 49.63 66.95 0.98 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 172.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -141.92 71.99 1.37 Allowed 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.273 -1.517 . . . . 0.0 113.971 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -122.74 80.1 1.71 Allowed 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.403 -2.061 . . . . 0.0 111.303 173.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -139.27 -130.5 0.12 Allowed 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.194 -1.566 . . . . 0.0 114.188 -172.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.47 155.28 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.604 1.561 . . . . 0.0 109.515 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 20.4 p -140.04 149.61 43.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.143 -0.973 . . . . 0.0 112.815 -172.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.42 150.87 49.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 124.977 1.311 . . . . 0.0 111.879 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.259 1.597 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.524 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo . . . . . 0 CA--C 1.491 -1.671 0 N-CA-C 108.63 -1.335 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -91.8 167.57 15.04 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 117.68 -1.153 . . . . 0.0 110.227 173.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -65.81 -35.74 34.79 Favored 'Trans proline' 0 N--CA 1.434 -1.976 0 CA-C-N 123.151 2.161 . . . . 0.0 113.942 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.72 73.01 0.88 Allowed Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 171.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -79.67 140.38 37.06 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 121.519 -0.989 . . . . 0.0 109.117 172.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 mp -82.61 134.05 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.421 -1.424 . . . . 0.0 108.532 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -133.5 151.74 51.8 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.551 -1.343 . . . . 0.0 111.049 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -103.91 130.43 51.51 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.265 1.026 . . . . 0.0 109.296 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.4 t -103.07 117.72 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.375 -1.453 . . . . 0.0 109.823 168.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -113.0 101.38 9.42 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 168.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.8 tp -135.48 170.57 15.75 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.176 0.988 . . . . 0.0 109.499 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.36 161.39 41.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.492 -2.005 . . . . 0.0 108.603 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -71.47 105.43 3.58 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.311 1.445 . . . . 0.0 112.365 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.6 p-10 -102.55 -62.68 1.24 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.902 1.281 . . . . 0.0 110.408 167.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -86.12 -66.04 0.95 Allowed 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.104 1.361 . . . . 0.0 109.154 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -137.5 176.36 8.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.694 1.598 . . . . 0.0 107.022 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.7 t -83.15 -69.05 0.66 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.445 -1.409 . . . . 0.0 111.509 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.448 HD22 HG13 ' B' ' 15' ' ' VAL . 7.9 mp -104.04 -105.46 0.29 Allowed 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.954 -1.716 . . . . 0.0 112.101 170.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.32 57.21 1.01 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.917 -1.114 . . . . 0.0 111.81 -171.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.4 tt -144.19 164.7 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.51 0 O-C-N 121.45 -1.029 . . . . 0.0 108.444 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 t -122.09 138.39 54.47 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.506 -1.996 . . . . 0.0 110.394 -175.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.56 154.8 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 124.654 1.182 . . . . 0.0 108.787 -166.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.5 t -137.44 94.13 2.89 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.757 1.742 . . . . 0.0 111.195 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.01 -152.06 41.57 Favored Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 164.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.31 79.34 1.45 Allowed Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -168.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.8 t -117.72 -104.84 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 121.419 -1.047 . . . . 0.0 113.406 -162.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -77.15 -51.54 10.82 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.708 -1.87 . . . . 0.0 109.94 -161.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -150.21 137.58 19.68 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 155.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.9 m -151.53 -86.93 0.07 Allowed 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 119.703 -1.873 . . . . 0.0 110.772 -166.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 t -73.9 -59.43 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 124.823 1.249 . . . . 0.0 109.145 -175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -144.23 -123.33 0.08 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 170.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -85.3 65.32 9.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.97 -1.706 . . . . 0.0 110.712 172.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.57 -129.33 9.68 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 107.505 -2.238 . . . . 0.0 107.505 -165.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.45 133.0 2.9 Favored Glycine 0 N--CA 1.432 -1.627 0 C-N-CA 125.629 1.585 . . . . 0.0 112.152 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.3 mm -125.58 137.13 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.4 129.97 50.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.719 -1.238 . . . . 0.0 111.408 -163.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 75.4 t -76.22 135.85 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.562 -1.336 . . . . 0.0 112.292 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -88.2 -61.3 1.75 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.584 1.554 . . . . 0.0 111.039 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.12 162.65 34.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.56 134.3 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 122.193 0.997 . . . . 0.0 111.064 174.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 mm -84.02 134.66 43.39 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 116.652 -1.642 . . . . 0.0 107.495 171.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.11 77.02 2.87 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 125.718 3.078 . . . . 0.0 112.437 170.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -141.13 -40.94 0.39 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -168.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.2 -144.39 4.34 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 120.301 -1.499 . . . . 0.0 112.155 -167.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.17 -39.97 96.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.904 2.081 . . . . 0.0 114.752 -162.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.34 -50.7 72.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.959 1.704 . . . . 0.0 114.028 -177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -77.62 -37.42 50.19 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.075 1.35 . . . . 0.0 112.549 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.7 t -62.38 -47.99 81.73 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.951 -1.718 . . . . 0.0 114.186 -175.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -81.14 -47.05 14.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.828 -1.17 . . . . 0.0 110.571 171.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.88 73.06 1.2 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -139.63 -41.25 0.45 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -164.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.0 mt -127.61 134.55 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -140.51 -160.97 1.13 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.344 0.974 . . . . 0.0 112.947 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -54.93 133.81 48.33 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.304 1.842 . . . . 0.0 114.343 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.37 -2.11 63.27 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 117.992 1.957 . . . . 0.0 117.992 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -75.56 151.28 37.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.055 1.928 . . . . 0.0 112.271 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -123.89 138.93 54.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.581 -1.324 . . . . 0.0 109.783 -165.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.56 155.32 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.692 -1.88 . . . . 0.0 111.948 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.7 mt -119.01 -88.27 0.62 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.23 145.23 29.11 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 124.679 1.192 . . . . 0.0 110.802 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 p -102.78 92.17 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 123.039 1.4 . . . . 0.0 110.68 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 58.35 55.52 4.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.861 -1.774 . . . . 0.0 113.163 177.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.12 -12.82 59.21 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 120.631 -1.293 . . . . 0.0 115.16 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 71.4 t -103.14 125.51 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 118.561 1.181 . . . . 0.0 109.863 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 78.6 p -77.38 158.96 29.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.547 -1.346 . . . . 0.0 114.562 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -117.43 36.7 4.15 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.052 1.341 . . . . 0.0 109.028 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.93 115.82 7.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 120.056 -1.652 . . . . 0.0 113.452 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.71 15.76 78.8 Favored Glycine 0 N--CA 1.431 -1.66 0 O-C-N 119.626 -1.921 . . . . 0.0 115.33 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.48 148.16 35.5 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.847 -1.384 . . . . 0.0 113.104 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 35.6 p -90.37 174.28 7.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.766 1.227 . . . . 0.0 108.591 163.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -61.34 -37.63 84.01 Favored 'General case' 0 N--CA 1.428 -1.545 0 O-C-N 120.367 -1.458 . . . . 0.0 114.576 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.18 -40.87 90.75 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 120.091 -1.631 . . . . 0.0 112.602 175.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -70.14 -41.32 74.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.498 1.519 . . . . 0.0 111.627 -176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.11 -48.71 70.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . 0.265 35.4 m -63.14 -37.23 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 115.794 1.776 . . . . 0.0 115.794 -172.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -64.25 -45.06 89.78 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 120.516 1.507 . . . . 0.0 112.612 172.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.7 m -60.09 -36.28 77.05 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 125.829 1.651 . . . . 0.0 112.385 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.69 -36.74 31.9 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 126.325 1.85 . . . . 0.0 115.693 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -63.91 -44.04 94.15 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.156 -1.59 . . . . 0.0 113.067 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -85.0 49.61 1.77 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.595 1.188 . . . . 0.0 113.665 -166.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.7 p -98.48 -76.27 0.54 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.44 2.296 . . . . 0.0 109.563 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 108.02 -106.84 2.44 Favored Glycine 0 N--CA 1.429 -1.804 0 C-N-CA 125.106 1.336 . . . . 0.0 113.179 167.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -68.19 -53.54 24.24 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -172.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.7 m -108.58 138.84 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 122.188 0.994 . . . . 0.0 110.346 -177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.3 t -126.01 95.46 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -173.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -135.63 92.02 2.78 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.102 -1.624 . . . . 0.0 110.699 -171.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.15 176.93 9.15 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -165.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.65 131.05 54.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 124.397 1.079 . . . . 0.0 109.611 -170.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -126.13 167.33 15.54 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.746 1.618 . . . . 0.0 110.397 -174.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -124.58 141.01 52.41 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.992 1.317 . . . . 0.0 107.538 170.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -72.77 144.83 47.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.25 156.06 48.22 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 120.668 -1.27 . . . . 0.0 114.095 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -75.75 167.74 21.32 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -167.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 78.4 p -84.25 152.85 62.09 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 124.464 1.106 . . . . 0.0 112.459 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -67.28 -53.25 0.5 Allowed 'Trans proline' 0 N--CA 1.433 -2.037 0 C-N-CA 121.975 1.783 . . . . 0.0 116.503 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.5 p . . . . . 0 C--O 1.261 1.683 0 C-N-CA 124.162 0.985 . . . . 0.0 111.972 -166.886 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 . . . . . 0 CA--C 1.49 -1.35 0 N-CA-C 111.266 0.098 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.11 -63.45 1.44 Allowed 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 121.257 -0.902 . . . . 0.0 111.628 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -81.96 173.1 12.53 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 124.467 1.107 . . . . 0.0 111.634 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 68.5 p -78.54 -102.93 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -164.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 66.79 174.61 0.25 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 128.178 2.591 . . . . 0.0 114.343 -167.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . 52.81 62.04 2.89 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -75.61 -59.07 2.91 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 123.845 0.858 . . . . 0.0 112.004 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -101.58 142.73 32.49 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.877 -1.139 . . . . 0.0 110.243 168.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -128.64 -146.63 0.33 Allowed 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.702 -1.249 . . . . 0.0 109.476 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -123.43 -85.24 0.65 Allowed 'General case' 0 N--CA 1.431 -1.38 0 O-C-N 120.47 -1.394 . . . . 0.0 109.388 -177.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -145.63 169.6 18.12 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.596 -1.94 . . . . 0.0 109.023 169.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.57 154.68 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 120.048 -1.657 . . . . 0.0 108.379 171.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m -140.91 155.87 46.2 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.38 -0.825 . . . . 0.0 111.288 -172.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.3 159.44 42.06 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 121.84 0.829 . . . . 0.0 110.032 168.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . 0.448 HG13 HD22 ' A' ' 18' ' ' LEU . 3.5 p . . . . . 0 C--O 1.259 1.585 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 CA--C 1.49 -1.689 0 N-CA-C 106.368 -2.205 . . . . 0.0 106.368 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -78.33 159.4 75.14 Favored Pre-proline 0 N--CA 1.43 -1.451 0 CA-C-N 119.457 1.026 . . . . 0.0 110.981 -176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -67.99 -39.42 10.98 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 122.092 1.861 . . . . 0.0 111.002 171.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.32 65.64 0.32 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 123.981 0.8 . . . . 0.0 111.937 170.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.29 177.3 8.58 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 121.058 -1.26 . . . . 0.0 113.63 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.7 mt -74.95 143.1 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.803 -1.81 . . . . 0.0 112.944 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -147.01 160.36 42.47 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 120.804 -1.185 . . . . 0.0 110.708 170.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -127.26 123.15 35.81 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.723 -1.236 . . . . 0.0 111.358 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -105.32 132.93 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.689 -1.257 . . . . 0.0 111.878 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -112.43 121.46 44.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.172 -0.955 . . . . 0.0 108.794 158.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.491 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 10.1 tp -132.82 -167.7 1.95 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 124.713 1.205 . . . . 0.0 108.418 176.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.491 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -155.59 168.94 25.51 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.12 -1.613 . . . . 0.0 109.195 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -72.01 104.74 3.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.561 1.144 . . . . 0.0 112.841 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -91.28 -85.96 0.23 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.14 -0.975 . . . . 0.0 110.869 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -86.5 -44.92 11.58 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.75 1.62 . . . . 0.0 110.808 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -138.24 177.9 7.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.183 2.193 . . . . 0.0 105.162 174.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.8 p -84.03 -66.34 0.9 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.503 -1.373 . . . . 0.0 112.151 -177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.7 mt -101.04 -79.92 0.5 Allowed 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 119.7 1.136 . . . . 0.0 111.865 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.15 47.82 2.35 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 121.1 -1.0 . . . . 0.0 112.069 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.4 tt -145.81 157.89 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 O-C-N 120.827 -1.396 . . . . 0.0 112.669 -170.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 t -123.56 146.31 48.22 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.413 -1.429 . . . . 0.0 109.266 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.2 t -122.05 149.95 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.167 1.387 . . . . 0.0 109.898 -163.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.4 t -137.27 108.37 6.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.585 1.659 . . . . 0.0 111.137 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.35 -117.29 5.49 Favored Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 125.103 1.335 . . . . 0.0 111.689 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.79 35.53 61.97 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 115.843 1.097 . . . . 0.0 115.843 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 m -107.61 -120.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 121.468 -1.019 . . . . 0.0 112.667 -170.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -79.65 -81.12 0.12 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.986 1.715 . . . . 0.0 113.294 -171.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.6 t -128.92 115.57 18.06 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 175.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -155.32 -85.93 0.05 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.361 -0.837 . . . . 0.0 109.917 -166.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.1 -52.41 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 120.088 -1.633 . . . . 0.0 110.961 173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -133.46 -153.84 0.57 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.829 -2.656 . . . . 0.0 103.829 158.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -74.5 96.96 3.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 124.496 1.118 . . . . 0.0 108.405 155.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 73.71 -172.7 50.63 Favored Glycine 0 N--CA 1.43 -1.736 0 O-C-N 120.267 -1.52 . . . . 0.0 114.423 -169.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.73 147.32 22.32 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -162.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.9 mm -124.77 140.72 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -123.4 143.13 50.32 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -167.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -87.2 132.3 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 O-C-N 121.031 -1.043 . . . . 0.0 111.366 -173.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -85.46 -51.7 6.35 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.291 1.036 . . . . 0.0 110.873 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -166.62 157.74 12.63 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.8 p -91.69 137.83 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 121.491 0.662 . . . . 0.0 109.886 171.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -84.09 121.62 75.65 Favored Pre-proline 0 N--CA 1.429 -1.504 0 O-C-N 120.325 -1.485 . . . . 0.0 109.093 176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -78.84 60.05 7.56 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.363 2.709 . . . . 0.0 112.383 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.33 32.94 0.28 Allowed 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 122.262 1.029 . . . . 0.0 108.401 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.63 176.94 46.16 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 119.729 -1.857 . . . . 0.0 112.619 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -37.35 -45.67 0.71 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.199 2.999 . . . . 0.0 118.54 -177.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.1 89.75 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -175.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -85.53 -40.62 16.12 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 124.927 1.291 . . . . 0.0 111.324 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.9 m -60.32 -55.97 27.17 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -77.43 -29.38 52.88 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 120.558 -1.339 . . . . 0.0 110.09 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.46 76.87 1.21 Allowed Glycine 0 N--CA 1.429 -1.773 0 O-C-N 121.106 -0.996 . . . . 0.0 112.506 167.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -136.87 -53.7 0.71 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.551 -0.97 . . . . 0.0 112.5 -167.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.6 mt -127.62 125.95 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -166.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -134.56 -171.13 2.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -56.73 128.87 38.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.137 1.375 . . . . 0.0 114.141 -178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.26 21.79 74.86 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 117.697 1.839 . . . . 0.0 117.697 177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -81.36 159.0 24.48 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 119.545 1.672 . . . . 0.0 109.629 161.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.0 ttp85 -122.22 116.51 24.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.559 -1.338 . . . . 0.0 108.705 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -101.54 138.11 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 121.064 -1.022 . . . . 0.0 109.917 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.5 tp -121.07 -86.47 0.65 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.143 -0.973 . . . . 0.0 109.999 -170.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.06 132.4 33.83 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.848 -1.782 . . . . 0.0 113.277 -170.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.8 p -103.61 93.76 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.552 1.644 . . . . 0.0 108.251 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.268 58.7 t30 56.19 54.15 8.14 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.384 1.874 . . . . 0.0 113.7 -173.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.26 -46.01 1.49 Allowed Glycine 0 N--CA 1.431 -1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 113.621 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.01 128.66 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 121.094 -1.239 . . . . 0.0 111.286 -170.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 t -78.3 156.81 29.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.496 -1.378 . . . . 0.0 112.345 176.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.05 -13.86 23.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.061 1.344 . . . . 0.0 113.952 -175.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -66.41 128.38 35.97 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -168.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.1 -51.34 0.71 Allowed Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -170.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.24 151.94 32.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.352 1.461 . . . . 0.0 112.416 170.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.9 p -94.38 -179.11 4.8 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.681 -1.887 . . . . 0.0 112.147 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -50.04 -37.79 34.8 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.252 3.021 . . . . 0.0 115.064 172.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -56.54 -46.85 80.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.396 1.878 . . . . 0.0 114.112 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.5 tp60 -77.81 -34.49 52.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.003 1.321 . . . . 0.0 111.185 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.48 77.48 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.577 1.551 . . . . 0.0 114.378 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.8 p -67.97 -29.34 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.385 -1.447 . . . . 0.0 114.056 -177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -70.63 -38.66 73.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.591 -1.943 . . . . 0.0 112.527 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.3 m -65.78 -43.49 88.62 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.415 -1.428 . . . . 0.0 112.236 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 tt -79.72 -46.84 16.33 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -59.12 -35.85 74.17 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 119.967 -1.708 . . . . 0.0 114.289 -176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -92.07 56.01 2.76 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.812 -1.18 . . . . 0.0 110.956 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 p -109.87 -69.25 0.87 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.687 1.995 . . . . 0.0 109.771 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 117.37 -105.68 1.31 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 124.312 0.958 . . . . 0.0 113.634 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -81.2 -45.11 16.82 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -163.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.04 155.16 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 120.958 -1.089 . . . . 0.0 112.004 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.6 t -130.19 112.8 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 108.085 -1.079 . . . . 0.0 108.085 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -128.44 117.83 22.05 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.354 -1.466 . . . . 0.0 109.804 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.13 160.5 42.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.539 -1.351 . . . . 0.0 113.957 -174.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 mp -120.81 128.0 52.46 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.104 1.362 . . . . 0.0 107.436 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.86 159.59 27.86 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.041 1.336 . . . . 0.0 110.584 -174.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -109.08 127.33 54.05 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 153.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -69.44 137.06 52.36 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.04 1.336 . . . . 0.0 113.874 -171.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.48 148.17 24.89 Favored Glycine 0 N--CA 1.429 -1.804 0 O-C-N 120.546 -1.346 . . . . 0.0 110.694 170.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -87.12 126.18 34.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.314 -1.698 . . . . 0.0 110.319 -174.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 t -77.3 151.03 80.8 Favored Pre-proline 0 N--CA 1.431 -1.4 0 CA-C-O 117.665 -1.159 . . . . 0.0 113.933 -153.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -67.03 175.61 5.4 Favored 'Trans proline' 0 C--N 1.299 -2.061 0 C-N-CA 122.98 2.453 . . . . 0.0 115.663 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.26 1.615 0 C-N-CA 124.594 1.158 . . . . 0.0 109.666 177.26 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 27.7 p90 . . . . . 0 CA--C 1.491 -1.322 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.92 85.73 0.09 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 175.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -96.81 -158.0 0.63 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 125.355 1.462 . . . . 0.0 108.292 172.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 49.1 p -86.44 -78.76 0.27 Allowed 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 119.82 -1.8 . . . . 0.0 114.319 -168.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -67.79 130.57 43.41 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -168.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.14 157.41 18.3 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.405 1.482 . . . . 0.0 114.716 -175.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -139.97 80.07 1.75 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.528 -1.357 . . . . 0.0 111.393 -167.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -113.9 -94.14 0.47 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.694 -1.253 . . . . 0.0 111.091 174.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . 0.274 58.8 m-80 68.87 61.9 0.33 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.106 2.162 . . . . 0.0 116.574 -175.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -127.68 153.44 46.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 153.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -121.69 -161.89 0.95 Allowed 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.961 -1.712 . . . . 0.0 111.817 -166.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 17.6 m -125.94 155.9 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 125.969 1.708 . . . . 0.0 110.633 -173.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -142.06 143.49 33.13 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.716 0.769 . . . . 0.0 111.109 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.69 146.78 47.99 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.199 1.4 . . . . 0.0 112.618 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.261 1.663 0 C-N-CA 126.176 1.79 . . . . 0.0 106.422 170.073 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 CA--C 1.49 -1.678 0 N-CA-C 106.65 -2.096 . . . . 0.0 106.65 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.0 mtmt -93.06 166.9 15.33 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 119.267 0.939 . . . . 0.0 111.526 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -70.04 -52.08 0.33 Allowed 'Trans proline' 0 C--N 1.299 -2.029 0 CA-C-N 122.477 1.92 . . . . 0.0 111.412 173.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.1 90.55 0.71 Allowed Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 168.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.66 179.22 7.85 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -177.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 mt -81.71 149.96 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 125.539 1.536 . . . . 0.0 111.617 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.11 139.87 21.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.478 -1.389 . . . . 0.0 112.247 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -105.96 105.86 16.1 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 125.665 1.586 . . . . 0.0 111.155 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.08 134.17 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 120.347 -1.471 . . . . 0.0 112.182 -174.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -111.74 127.39 55.77 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 168.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 8.1 tp -135.73 -159.46 0.96 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.943 -1.098 . . . . 0.0 109.613 172.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -153.87 168.11 27.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.311 -1.493 . . . . 0.0 108.605 172.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -72.4 112.68 8.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.612 -1.305 . . . . 0.0 110.287 163.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -93.27 -88.56 0.22 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.92 -53.92 6.3 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.028 1.331 . . . . 0.0 109.171 165.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -135.91 172.79 12.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.856 -1.153 . . . . 0.0 108.289 -172.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 p -81.89 -88.53 0.08 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.065 0.946 . . . . 0.0 109.828 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.6 mt -102.71 -89.39 0.38 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.31 -1.494 . . . . 0.0 112.474 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.6 48.24 3.51 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -165.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 tt -134.26 161.04 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 121.288 -1.125 . . . . 0.0 108.364 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.4 t -121.27 142.55 49.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.365 -1.459 . . . . 0.0 107.242 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.6 t -122.74 152.56 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -160.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 t -145.54 134.34 22.37 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.685 -1.884 . . . . 0.0 112.832 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.11 -141.54 20.81 Favored Glycine 0 N--CA 1.43 -1.703 0 C-N-CA 126.971 2.224 . . . . 0.0 114.203 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.62 33.7 67.21 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 124.669 1.128 . . . . 0.0 115.614 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.9 m -93.32 -124.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 121.039 -1.271 . . . . 0.0 113.549 -170.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -71.59 -57.72 4.15 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.748 -1.845 . . . . 0.0 111.274 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.4 t -140.51 154.19 46.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 148.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.4 t -155.84 -103.71 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -164.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.413 HG13 ' H ' ' A' ' 31' ' ' ARG . 3.0 p -62.08 -58.43 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.066 1.747 . . . . 0.0 110.074 161.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.413 ' H ' HG13 ' A' ' 30' ' ' VAL . 91.3 mtt180 -143.29 -163.28 1.61 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 161.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -78.89 44.13 0.54 Allowed 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 126.257 1.823 . . . . 0.0 112.822 173.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 142.48 151.59 5.53 Favored Glycine 0 N--CA 1.43 -1.743 0 O-C-N 120.195 -1.566 . . . . 0.0 110.661 -169.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.81 143.39 11.88 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -168.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.38 162.54 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -172.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.93 151.34 43.68 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.296 -1.503 . . . . 0.0 107.791 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.6 t -82.81 134.83 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 120.72 -1.237 . . . . 0.0 110.964 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -85.24 -59.91 2.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.63 1.172 . . . . 0.0 110.583 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.79 168.82 12.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.049 0.94 . . . . 0.0 108.491 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -95.22 136.26 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 122.694 1.235 . . . . 0.0 111.79 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.3 mm -82.73 132.22 52.33 Favored Pre-proline 0 N--CA 1.429 -1.5 0 O-C-N 120.38 -1.45 . . . . 0.0 107.187 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -80.5 35.57 0.58 Allowed 'Trans proline' 0 N--CA 1.434 -2.014 0 C-N-CA 123.242 2.628 . . . . 0.0 113.039 -172.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 62.5 0.9 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.629 1.572 . . . . 0.0 107.438 -173.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.52 161.3 31.07 Favored Glycine 0 N--CA 1.431 -1.676 0 O-C-N 120.629 -1.294 . . . . 0.0 112.129 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.54 -38.12 19.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.871 2.068 . . . . 0.0 116.298 172.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.5 -41.82 77.32 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -75.5 -52.52 10.48 Favored 'General case' 0 N--CA 1.429 -1.515 0 C-N-CA 125.884 1.674 . . . . 0.0 111.476 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.0 m -56.2 -53.24 59.55 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -81.62 -36.42 28.92 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.272 1.029 . . . . 0.0 110.17 -177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.27 79.43 1.32 Allowed Glycine 0 N--CA 1.429 -1.768 0 O-C-N 120.837 -1.164 . . . . 0.0 112.006 169.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -136.18 -43.72 0.63 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -157.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.4 mt -128.86 142.42 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -131.15 178.24 6.85 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 123.321 1.534 . . . . 0.0 111.937 -170.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -56.39 123.12 13.59 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.71 20.06 76.95 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 118.45 2.14 . . . . 0.0 118.45 177.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -71.96 156.92 38.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 120.24 2.02 . . . . 0.0 111.552 166.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -122.66 114.07 20.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.612 -1.305 . . . . 0.0 108.977 -173.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 m -100.16 156.98 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 120.164 -1.585 . . . . 0.0 111.564 -174.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.9 tp -131.88 -81.48 0.51 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.017 -1.052 . . . . 0.0 111.279 173.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.85 128.23 45.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.704 -1.248 . . . . 0.0 113.649 -160.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.49 112.78 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 122.628 1.204 . . . . 0.0 109.131 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.27 35.8 t30 56.96 31.97 20.78 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 126.844 2.058 . . . . 0.0 114.018 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.4 -12.32 58.38 Favored Glycine 0 N--CA 1.429 -1.786 0 O-C-N 120.447 -1.408 . . . . 0.0 115.002 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.3 t -96.25 116.35 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 118.692 1.246 . . . . 0.0 111.824 -173.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.6 t -76.14 131.32 39.32 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.206 -1.559 . . . . 0.0 112.012 173.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -13.34 47.44 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 125.353 1.461 . . . . 0.0 113.49 -173.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -51.33 129.13 24.21 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.49 1.516 . . . . 0.0 115.088 -167.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.55 -35.19 5.11 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 124.13 0.872 . . . . 0.0 112.321 -160.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.81 155.26 33.19 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.481 -1.599 . . . . 0.0 112.113 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.0 p -93.28 159.99 15.03 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.978 0.894 . . . . 0.0 109.92 167.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.418 ' CE1' ' HG ' ' B' ' 13' ' ' SER . 46.1 t60 -41.01 -44.93 2.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.665 2.786 . . . . 0.0 117.027 173.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -60.75 -37.65 82.52 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.781 -1.2 . . . . 0.0 114.212 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 -78.45 -41.06 33.87 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.755 1.222 . . . . 0.0 112.002 174.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.33 -38.09 82.66 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 120.524 -1.36 . . . . 0.0 114.266 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 p -71.06 -33.8 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 O-C-N 120.293 -1.505 . . . . 0.0 112.98 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.61 -46.11 91.21 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.312 -1.492 . . . . 0.0 112.743 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.3 m -56.15 -48.34 76.47 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.612 1.565 . . . . 0.0 112.457 173.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.09 -36.37 40.87 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -172.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -59.61 -37.01 77.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.196 -1.565 . . . . 0.0 113.905 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -95.42 60.71 2.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.735 -1.228 . . . . 0.0 112.8 -170.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -99.49 -73.3 0.63 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.512 2.325 . . . . 0.0 111.339 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.17 -116.63 3.77 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 125.295 1.426 . . . . 0.0 112.63 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -78.62 -36.26 44.34 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 121.473 -1.016 . . . . 0.0 113.633 -168.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.3 m -104.54 162.31 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 120.73 -1.231 . . . . 0.0 112.241 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 95.6 t -138.1 130.89 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 C-N-CA 124.81 1.244 . . . . 0.0 108.708 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -141.2 127.97 20.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.652 -1.28 . . . . 0.0 108.072 161.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -149.27 159.06 44.59 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.276 -1.515 . . . . 0.0 113.082 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.5 mp -120.53 120.41 35.78 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.21 161.85 24.88 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 124.68 1.192 . . . . 0.0 110.227 -174.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.65 135.47 54.12 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.36 1.464 . . . . 0.0 107.204 162.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -74.98 133.98 41.58 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 122.378 1.085 . . . . 0.0 112.874 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.47 -176.42 51.37 Favored Glycine 0 N--CA 1.43 -1.753 0 CA-C-O 123.297 1.498 . . . . 0.0 115.056 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -76.91 142.98 39.88 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 121.167 -1.196 . . . . 0.0 113.775 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.0 t -86.33 117.67 69.07 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 120.571 -1.33 . . . . 0.0 111.085 177.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.46 162.01 28.03 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 122.647 2.231 . . . . 0.0 113.642 -168.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 C--O 1.26 1.617 0 C-N-CA 124.378 1.071 . . . . 0.0 112.166 176.276 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 30.6 p90 . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.63 83.54 0.11 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.763 2.025 . . . . 0.0 116.206 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -83.7 170.13 14.56 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.646 -1.909 . . . . 0.0 110.593 170.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 15.9 p -88.97 -57.2 2.99 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.639 -1.288 . . . . 0.0 113.684 -178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -86.09 152.01 23.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -165.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.05 151.2 34.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.36 1.464 . . . . 0.0 110.877 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -160.42 87.34 0.76 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.846 -1.158 . . . . 0.0 112.278 -173.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -115.69 -50.58 2.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.055 1.342 . . . . 0.0 110.96 173.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 67.99 52.39 0.7 Allowed 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 169.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -122.93 168.41 12.34 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 125.388 1.475 . . . . 0.0 107.799 167.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -121.49 171.96 8.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.78 -1.2 . . . . 0.0 112.02 -164.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -122.87 158.19 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 124.757 1.223 . . . . 0.0 110.544 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.418 ' HG ' ' CE1' ' A' ' 71' ' ' HIS . 58.8 m -138.11 149.64 46.12 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.662 -1.274 . . . . 0.0 113.777 -173.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -124.0 150.48 44.81 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 125.121 1.368 . . . . 0.0 111.503 169.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--O 1.261 1.666 0 C-N-CA 127.621 2.368 . . . . 0.0 106.702 160.811 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.49 -1.704 0 N-CA-C 109.9 -0.846 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -104.66 151.08 39.22 Favored Pre-proline 0 N--CA 1.43 -1.453 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 160.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -64.79 -35.35 45.88 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 C-N-CA 122.71 2.273 . . . . 0.0 112.001 169.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.46 72.11 0.28 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 124.76 1.171 . . . . 0.0 111.956 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.32 146.5 30.34 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.17 -1.194 . . . . 0.0 111.194 167.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 mp -89.97 144.53 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.04 2.136 . . . . 0.0 111.252 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -145.75 165.59 28.37 Favored 'General case' 0 N--CA 1.431 -1.386 0 O-C-N 120.306 -1.496 . . . . 0.0 112.184 171.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -113.93 134.95 54.5 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 122.372 1.082 . . . . 0.0 112.241 -177.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.39 111.82 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.482 -1.386 . . . . 0.0 108.964 168.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -112.26 102.37 10.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 170.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tp -134.8 176.67 8.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.674 1.226 . . . . 0.0 111.463 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.01 158.71 42.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 168.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -70.44 152.64 43.83 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -121.17 -83.88 0.66 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.507 -1.371 . . . . 0.0 108.789 166.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -76.99 -51.46 11.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.704 -1.248 . . . . 0.0 109.196 172.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -138.2 177.64 7.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.0 m -82.47 -58.76 2.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 123.82 0.848 . . . . 0.0 111.32 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.6 mt -102.3 -90.64 0.35 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 120.142 1.337 . . . . 0.0 112.458 172.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.43 50.58 0.8 Allowed Glycine 0 N--CA 1.429 -1.826 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -165.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.3 tt -137.62 165.01 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.941 -1.329 . . . . 0.0 110.688 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 t -122.95 136.64 54.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.891 1.677 . . . . 0.0 107.702 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.8 t -123.69 144.04 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 124.675 1.19 . . . . 0.0 110.03 -161.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 t -138.87 131.17 28.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.032 1.396 . . . . 0.0 112.914 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.43 -162.64 25.83 Favored Glycine 0 N--CA 1.429 -1.777 0 C-N-CA 126.87 2.176 . . . . 0.0 114.236 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.12 42.12 2.47 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.7 -0.882 . . . . 0.0 113.791 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -106.08 -107.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 122.287 1.042 . . . . 0.0 110.044 -172.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -91.28 -59.78 2.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.099 2.159 . . . . 0.0 110.054 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.4 t -133.24 138.95 46.69 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 163.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.2 m -145.23 -79.65 0.18 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 120.941 -1.099 . . . . 0.0 108.828 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -91.8 -51.73 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 O-C-N 120.531 -1.356 . . . . 0.0 108.238 171.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.2 mmt85 -119.44 -142.2 0.35 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 170.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.56 65.15 1.26 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.392 -1.442 . . . . 0.0 111.715 170.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.37 -137.52 13.63 Favored Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 -166.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.2 147.3 9.1 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-O 122.206 0.892 . . . . 0.0 112.978 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.6 mm -122.21 130.74 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 -159.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.08 149.28 49.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 123.831 0.852 . . . . 0.0 110.296 -169.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.4 t -79.69 124.68 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 120.833 -1.167 . . . . 0.0 111.22 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -80.58 -63.25 1.45 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.687 -1.258 . . . . 0.0 109.973 173.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.5 161.41 35.36 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 121.427 -0.796 . . . . 0.0 109.341 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.29 137.15 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 CA-C-O 122.497 1.142 . . . . 0.0 110.663 174.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -85.43 123.63 72.65 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 119.945 -1.722 . . . . 0.0 108.598 173.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.64 32.26 0.51 Allowed 'Trans proline' 0 N--CA 1.434 -1.995 0 CA-C-N 125.291 2.925 . . . . 0.0 114.373 -173.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.61 61.74 1.38 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 123.158 1.456 . . . . 0.0 107.741 -175.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.85 170.52 43.66 Favored Glycine 0 N--CA 1.43 -1.764 0 O-C-N 120.413 -1.43 . . . . 0.0 109.852 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.74 -38.66 22.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.335 2.254 . . . . 0.0 115.541 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.7 -47.45 67.25 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.13 1.772 . . . . 0.0 115.1 174.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -87.36 -34.85 18.67 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.895 -1.128 . . . . 0.0 111.774 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.6 m -54.22 -54.7 36.4 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.491 1.516 . . . . 0.0 113.858 174.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.26 -53.85 6.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.276 -0.89 . . . . 0.0 110.809 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.05 100.93 2.63 Favored Glycine 0 N--CA 1.429 -1.807 0 O-C-N 121.188 -0.945 . . . . 0.0 110.982 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.94 -43.5 0.43 Allowed 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -163.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 53' ' ' HIS . 0.2 OUTLIER -128.76 174.43 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.534 -1.354 . . . . 0.0 108.301 -168.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.441 ' H ' HG22 ' A' ' 52' ' ' ILE . 31.1 m-70 -131.61 162.24 30.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.132 -1.605 . . . . 0.0 110.538 169.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -56.99 136.72 56.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 167.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.17 20.78 78.93 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 116.884 1.513 . . . . 0.0 116.884 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -83.47 172.43 12.43 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.977 1.311 . . . . 0.0 112.265 167.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -124.6 133.12 53.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 121.054 -1.029 . . . . 0.0 111.828 176.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.1 m -79.76 158.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 119.783 -1.823 . . . . 0.0 110.857 167.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 tt -121.61 -80.46 0.62 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.549 -1.344 . . . . 0.0 109.414 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.32 150.59 22.84 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.664 -1.273 . . . . 0.0 113.57 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.9 p -111.92 103.33 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 C-N-CA 126.279 1.831 . . . . 0.0 108.409 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . 0.505 13.8 p30 56.52 38.73 29.87 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 126.859 2.064 . . . . 0.0 116.298 -177.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.98 -24.58 30.15 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 125.641 1.591 . . . . 0.0 113.455 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.6 t -100.98 134.69 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 124.918 1.287 . . . . 0.0 110.868 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.5 p -77.2 159.82 29.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.537 -1.977 . . . . 0.0 113.095 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -93.89 -14.84 25.61 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -54.24 129.55 35.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -167.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 118.31 -27.23 7.42 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 124.143 0.878 . . . . 0.0 111.163 -175.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.17 144.4 38.39 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.3 p -90.65 -179.41 5.54 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.161 -0.962 . . . . 0.0 108.819 155.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -60.38 -44.6 95.48 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -169.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -59.22 -34.56 72.32 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.542 -1.348 . . . . 0.0 114.585 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -43.31 67.16 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.235 -1.541 . . . . 0.0 111.049 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.32 -43.43 97.81 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 120.419 -1.426 . . . . 0.0 114.576 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.4 m -67.58 -41.52 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 120.461 -1.399 . . . . 0.0 114.352 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -68.08 -28.72 67.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.505 -1.372 . . . . 0.0 112.904 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.9 m -57.48 -50.78 71.94 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.305 1.442 . . . . 0.0 112.677 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.54 -33.98 35.85 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 120.565 -1.334 . . . . 0.0 112.799 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 -61.2 -32.01 71.77 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.758 -1.839 . . . . 0.0 114.487 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -85.7 51.92 2.33 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.35 -1.468 . . . . 0.0 112.839 170.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.1 p -110.93 -74.14 0.66 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.466 1.507 . . . . 0.0 110.631 166.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.66 -82.99 0.35 Allowed Glycine 0 N--CA 1.43 -1.724 0 O-C-N 120.857 -1.152 . . . . 0.0 113.219 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -82.1 -51.3 8.13 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -174.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.8 t -105.37 137.97 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 120.94 -1.1 . . . . 0.0 111.023 -166.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.95 90.03 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.5 -1.375 . . . . 0.0 110.676 -172.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -119.76 120.79 37.56 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 119.566 -1.959 . . . . 0.0 111.452 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -150.22 165.89 31.57 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 112.241 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.8 mt -121.64 137.84 54.58 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.03 1.332 . . . . 0.0 107.715 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mp -135.76 158.2 44.98 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 123.593 0.757 . . . . 0.0 110.334 -171.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -119.6 148.29 43.51 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 169.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -70.71 127.48 32.79 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.621 -1.3 . . . . 0.0 112.125 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.23 -162.08 35.24 Favored Glycine 0 N--CA 1.429 -1.799 0 O-C-N 120.587 -1.32 . . . . 0.0 113.724 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -87.71 138.83 31.12 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.806 -1.408 . . . . 0.0 111.45 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.5 t -86.15 -62.49 0.24 Allowed Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 116.016 -1.945 . . . . 0.0 114.11 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -85.91 50.0 2.44 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 CA-C-N 125.892 3.14 . . . . 0.0 113.897 -166.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.26 1.633 0 O-C-N 120.239 -1.538 . . . . 0.0 111.617 178.407 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 . . . . . 0 CA--C 1.491 -1.296 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.67 -71.27 0.53 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.597 -1.315 . . . . 0.0 110.887 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -82.65 140.77 32.97 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 122.845 1.307 . . . . 0.0 112.702 -175.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 70.5 m -100.34 -32.64 10.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.195 -0.941 . . . . 0.0 113.42 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.25 97.74 10.94 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 124.847 1.259 . . . . 0.0 111.116 -166.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.83 -76.36 0.13 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.07 -1.019 . . . . 0.0 111.798 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -85.74 -34.31 21.24 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 116.361 1.986 . . . . 0.0 116.361 -169.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -78.44 64.95 3.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 -160.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -84.64 149.78 25.61 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.759 -1.838 . . . . 0.0 109.691 171.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -124.92 84.9 2.34 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.593 -1.317 . . . . 0.0 113.28 -154.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -123.58 -147.07 0.37 Allowed 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.779 -1.826 . . . . 0.0 112.67 -172.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 10.8 t -131.09 148.55 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 127.121 2.168 . . . . 0.0 107.279 -171.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.1 p -134.37 171.26 14.52 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.702 -1.249 . . . . 0.0 113.209 -168.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.7 155.06 41.35 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 120.976 -1.077 . . . . 0.0 111.355 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.26 1.611 0 C-N-CA 125.542 1.537 . . . . 0.0 108.951 -177.151 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.491 -1.651 0 N-CA-C 109.666 -0.936 . . . . 0.0 109.666 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -91.6 171.94 7.23 Favored Pre-proline 0 N--CA 1.43 -1.449 0 C-N-CA 124.772 1.229 . . . . 0.0 110.631 -176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -64.3 -44.58 11.53 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 122.627 2.218 . . . . 0.0 112.892 168.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.45 49.95 2.1 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 124.015 0.817 . . . . 0.0 113.412 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.11 -177.16 6.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.243 1.497 . . . . 0.0 113.66 177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.9 mt -85.21 136.43 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 125.217 1.407 . . . . 0.0 110.806 174.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -133.07 145.08 50.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.499 1.142 . . . . 0.0 111.26 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -112.52 123.59 50.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.178 -0.951 . . . . 0.0 109.515 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.5 m -102.92 149.68 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-O 122.687 1.232 . . . . 0.0 111.802 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -139.58 87.16 2.16 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -134.07 176.65 8.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.808 -1.183 . . . . 0.0 110.508 -171.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.49 172.82 12.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 124.901 1.28 . . . . 0.0 109.125 170.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -68.55 134.22 49.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.953 1.701 . . . . 0.0 113.484 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -122.08 -102.75 0.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.606 -1.309 . . . . 0.0 109.664 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.99 -33.3 65.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.025 -1.672 . . . . 0.0 111.502 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -149.25 -176.55 5.41 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.3 t -82.35 -67.99 0.74 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.836 1.254 . . . . 0.0 108.829 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.89 -81.74 0.48 Allowed 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.685 -1.259 . . . . 0.0 110.807 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.02 52.86 1.14 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 -167.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 tt -139.12 162.34 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 121.679 -0.895 . . . . 0.0 110.218 -173.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.1 t -122.59 141.93 51.17 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 171.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.56 145.77 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 125.917 1.687 . . . . 0.0 108.114 -167.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.0 t -136.72 114.56 11.29 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.965 1.365 . . . . 0.0 110.075 -172.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.62 178.91 26.79 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-O 122.942 1.301 . . . . 0.0 116.222 169.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.54 64.66 0.35 Allowed Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 122.265 0.925 . . . . 0.0 112.132 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.51 -64.35 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 124.389 1.076 . . . . 0.0 111.579 -173.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -110.5 -96.54 0.41 Allowed 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.029 -1.044 . . . . 0.0 112.818 -166.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.6 p -130.0 90.96 3.04 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.71 -1.869 . . . . 0.0 108.096 -175.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.6 p -134.4 -89.84 0.36 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 121.355 -0.841 . . . . 0.0 109.551 -175.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.8 -58.37 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.63 1.972 . . . . 0.0 110.89 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -127.57 -153.27 0.56 Allowed 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 165.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.53 88.56 7.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.476 -1.39 . . . . 0.0 109.55 163.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.89 -158.84 35.48 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -158.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.96 140.35 11.26 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.974 -1.309 . . . . 0.0 112.301 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.2 mm -124.21 136.4 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 121.016 -1.285 . . . . 0.0 108.927 -156.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.19 141.13 52.28 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 120.91 -1.119 . . . . 0.0 111.29 -170.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.57 134.96 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 O-C-N 120.687 -1.258 . . . . 0.0 112.046 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -84.28 -57.81 3.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.084 1.354 . . . . 0.0 110.441 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.63 165.23 18.91 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 124.069 0.947 . . . . 0.0 109.568 174.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.1 t -94.48 123.85 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 C-N-CA 124.847 1.259 . . . . 0.0 110.59 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mm -83.18 130.38 57.23 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 120.824 -1.172 . . . . 0.0 110.215 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.15 80.65 1.84 Allowed 'Trans proline' 0 N--CA 1.434 -2.025 0 C-N-CA 123.147 2.565 . . . . 0.0 112.434 172.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -141.55 -39.32 0.39 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.719 1.207 . . . . 0.0 112.071 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.88 -146.78 4.44 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.456 -1.402 . . . . 0.0 114.988 -173.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.5 -41.57 63.53 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.169 2.588 . . . . 0.0 116.95 -166.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.25 -47.7 80.72 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -72.56 -54.62 8.67 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.639 1.576 . . . . 0.0 112.176 173.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.0 t -60.28 -55.96 27.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.229 1.412 . . . . 0.0 114.312 -171.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.76 -39.19 70.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.092 0.957 . . . . 0.0 110.525 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.43 77.59 1.38 Allowed Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -137.03 -51.45 0.66 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -153.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.91 133.75 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -120.26 174.22 6.64 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 122.65 1.214 . . . . 0.0 114.123 -168.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -57.54 114.21 2.14 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.811 1.645 . . . . 0.0 114.573 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.1 26.03 65.13 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 120.555 -1.341 . . . . 0.0 115.529 -177.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -80.88 159.58 24.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 119.039 1.42 . . . . 0.0 110.779 168.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.5 ttp85 -124.12 128.92 50.0 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.034 -1.041 . . . . 0.0 109.904 -173.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.0 m -90.45 166.17 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 O-C-N 120.129 -1.607 . . . . 0.0 110.877 176.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.9 mt -131.76 -82.01 0.51 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.594 -1.316 . . . . 0.0 110.333 169.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.45 144.19 28.84 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.761 -1.212 . . . . 0.0 112.036 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.78 104.07 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 122.866 1.317 . . . . 0.0 110.781 174.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 57.4 50.56 11.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.16 2.184 . . . . 0.0 113.18 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.33 -24.91 8.67 Favored Glycine 0 N--CA 1.43 -1.708 0 O-C-N 121.066 -1.021 . . . . 0.0 114.459 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.2 t -85.6 101.29 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 O-C-N 120.441 -1.623 . . . . 0.0 110.969 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 p -79.2 125.93 30.09 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 124.684 1.194 . . . . 0.0 110.017 163.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.445 HD13 ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -108.2 55.96 0.63 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.586 1.66 . . . . 0.0 110.891 -173.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -66.89 133.99 51.15 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -170.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.91 3.14 89.24 Favored Glycine 0 N--CA 1.431 -1.675 0 O-C-N 120.856 -1.153 . . . . 0.0 115.584 177.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.74 155.77 35.27 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.899 -1.354 . . . . 0.0 113.661 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.7 p -87.11 174.97 8.31 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.766 -1.208 . . . . 0.0 111.086 177.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -60.47 -46.45 90.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.357 -1.464 . . . . 0.0 114.277 -166.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -69.15 -36.16 77.12 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -71.14 -33.92 70.52 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.102 -1.624 . . . . 0.0 112.368 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.57 -53.04 57.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.965 -1.085 . . . . 0.0 113.567 169.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.7 m -75.02 -20.0 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.64 -1.912 . . . . 0.0 114.616 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -66.39 -42.45 87.89 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.89 -1.756 . . . . 0.0 110.94 167.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.4 m -63.92 -29.92 71.05 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.301 1.841 . . . . 0.0 113.021 175.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.6 mt -78.19 -37.28 46.04 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.647 -1.283 . . . . 0.0 112.188 174.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -69.11 -37.98 78.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.188 -1.57 . . . . 0.0 114.699 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . 0.322 0.4 OUTLIER -79.33 55.7 1.95 Allowed 'General case' 0 CA--C 1.489 -1.396 0 O-C-N 119.973 -1.705 . . . . 0.0 113.743 172.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -103.73 -76.63 0.59 Allowed 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 128.118 2.567 . . . . 0.0 107.632 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.94 -112.76 2.69 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 125.535 1.541 . . . . 0.0 112.958 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -81.62 -31.49 32.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 121.169 -1.195 . . . . 0.0 113.775 -172.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.8 p -105.14 138.43 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 124.449 1.1 . . . . 0.0 110.622 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.44 80.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 C-N-CA 125.072 1.349 . . . . 0.0 108.52 -172.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -118.79 109.56 16.2 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.455 -1.403 . . . . 0.0 109.971 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -149.08 169.96 19.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.016 -1.678 . . . . 0.0 113.25 -172.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.8 tp -122.78 121.55 36.56 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.654 1.581 . . . . 0.0 109.423 -170.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mp -131.78 169.96 15.49 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 121.835 0.826 . . . . 0.0 112.739 -166.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -130.25 135.72 48.43 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.663 1.985 . . . . 0.0 109.969 166.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 135.32 40.52 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.19 1.396 . . . . 0.0 110.327 173.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.56 -134.34 2.05 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 123.48 1.6 . . . . 0.0 117.07 -170.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -75.13 153.74 38.1 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.641 -1.506 . . . . 0.0 113.406 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 72.2 m -71.27 161.92 75.58 Favored Pre-proline 0 N--CA 1.43 -1.47 0 O-C-N 120.885 -1.134 . . . . 0.0 112.92 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -68.58 138.47 41.91 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 123.325 2.223 . . . . 0.0 116.105 -165.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.8 p . . . . . 0 C--O 1.26 1.645 0 C-N-CA 124.867 1.267 . . . . 0.0 109.61 174.317 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 77.71 173.07 0.2 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.778 2.031 . . . . 0.0 113.214 -177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -129.46 -72.89 0.58 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.011 0.924 . . . . 0.0 109.68 -174.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 8.5 t -138.19 -119.24 0.14 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.218 -1.551 . . . . 0.0 111.238 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.23 -64.13 1.26 Allowed 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.437 -1.414 . . . . 0.0 112.026 -172.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . 47.39 50.79 14.28 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.625 2.37 . . . . 0.0 115.861 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -92.83 130.91 38.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.712 -1.242 . . . . 0.0 111.666 -170.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -120.38 -155.09 0.61 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 121.242 -0.911 . . . . 0.0 112.376 -169.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -93.85 129.61 40.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.421 -1.425 . . . . 0.0 110.87 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -134.06 122.38 22.87 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.243 -1.536 . . . . 0.0 109.465 -175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 21.4 mp0 -122.38 -134.22 0.29 Allowed 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.896 -1.128 . . . . 0.0 112.668 -172.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 p -153.97 158.04 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 N-CA-C 102.719 -3.067 . . . . 0.0 102.719 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 31.0 m -139.42 157.23 46.21 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 121.114 1.779 . . . . 0.0 113.171 -167.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -152.11 146.97 25.91 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 120.877 -1.14 . . . . 0.0 110.553 174.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--O 1.26 1.606 0 C-N-CA 125.774 1.63 . . . . 0.0 107.48 -179.83 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 CA--C 1.491 -1.631 0 N-CA-C 108.059 -1.554 . . . . 0.0 108.059 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -98.05 159.12 31.57 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 118.498 -0.763 . . . . 0.0 110.075 173.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -69.18 -38.83 8.47 Favored 'Trans proline' 0 N--CA 1.432 -2.089 0 C-N-CA 122.471 2.114 . . . . 0.0 111.717 173.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.31 75.72 0.26 Allowed Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 165.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -82.81 -176.12 6.14 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 123.208 1.48 . . . . 0.0 113.39 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.4 mt -78.96 143.92 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 C-N-CA 127.195 2.198 . . . . 0.0 111.301 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.76 156.37 41.15 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.726 0.81 . . . . 0.0 109.657 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.83 116.92 20.19 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.168 0.985 . . . . 0.0 111.077 -175.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -106.18 131.4 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 124.791 1.236 . . . . 0.0 112.509 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -111.44 117.9 34.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 125.527 1.531 . . . . 0.0 109.665 171.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 26.9 tp -134.84 167.01 21.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.378 1.471 . . . . 0.0 109.031 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.72 154.75 49.88 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 119.811 -1.806 . . . . 0.0 110.941 170.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -56.98 129.64 42.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.837 2.055 . . . . 0.0 114.735 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -121.56 -97.65 0.45 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.362 1.465 . . . . 0.0 110.39 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -65.67 -58.23 6.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.159 1.784 . . . . 0.0 109.252 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -137.11 -179.64 5.83 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 p -84.39 -80.51 0.2 Allowed 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.105 0.962 . . . . 0.0 111.635 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.4 mt -103.19 -90.55 0.37 Allowed 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.455 -1.403 . . . . 0.0 113.297 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.95 56.36 1.97 Allowed Glycine 0 N--CA 1.429 -1.783 0 O-C-N 120.717 -1.239 . . . . 0.0 112.572 -173.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.7 tt -139.56 171.69 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 t -123.41 148.73 45.82 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 119.158 -2.214 . . . . 0.0 109.723 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.7 t -122.69 157.07 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.452 1.501 . . . . 0.0 108.975 -168.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.4 t -138.37 152.8 48.76 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.913 -1.742 . . . . 0.0 109.189 170.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.48 -137.99 37.89 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 126.909 2.195 . . . . 0.0 116.205 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.66 14.44 82.08 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 124.582 1.087 . . . . 0.0 115.19 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.49 -126.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 120.962 -1.317 . . . . 0.0 113.698 -170.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -71.61 -58.74 3.22 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.421 -2.049 . . . . 0.0 111.305 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.0 t -130.38 143.72 50.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 163.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -155.04 -111.65 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -170.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.34 -47.47 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 124.994 1.318 . . . . 0.0 111.596 171.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -141.72 -147.93 0.23 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.528 1.931 . . . . 0.0 106.616 158.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -76.57 52.6 0.81 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.614 2.766 . . . . 0.0 112.101 172.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.86 177.32 20.12 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 -165.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' H ' HD21 ' A' ' 66' ' ' LEU . . . 100.31 138.79 10.44 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -165.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.1 mm -127.01 140.74 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -166.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.64 141.55 52.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.623 -1.298 . . . . 0.0 109.514 -169.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.31 125.86 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 120.982 -1.074 . . . . 0.0 112.115 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -82.67 -59.16 2.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.454 1.502 . . . . 0.0 110.6 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.14 172.24 6.47 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 123.77 0.828 . . . . 0.0 109.779 175.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.78 139.71 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 124.779 1.232 . . . . 0.0 112.306 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -85.44 120.74 73.42 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-O 116.549 -1.691 . . . . 0.0 108.109 165.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.69 34.12 0.52 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 125.869 3.132 . . . . 0.0 113.472 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.35 68.77 1.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.64 169.87 42.97 Favored Glycine 0 N--CA 1.432 -1.626 0 O-C-N 121.123 -0.986 . . . . 0.0 111.227 -175.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.66 -29.86 68.43 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 124.982 1.313 . . . . 0.0 114.365 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.41 -52.74 64.31 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -60.43 -46.43 90.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.031 1.332 . . . . 0.0 113.253 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.9 m -60.5 -54.71 42.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.66 1.584 . . . . 0.0 115.057 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.21 -37.84 57.25 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 120.787 -1.196 . . . . 0.0 112.223 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.55 88.33 1.09 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 125.517 1.532 . . . . 0.0 111.719 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -138.4 -58.39 0.64 Allowed 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.453 -1.027 . . . . 0.0 113.665 -158.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.4 mt -127.98 130.97 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -118.17 171.67 7.95 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.618 1.199 . . . . 0.0 111.257 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -60.11 120.64 10.12 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -175.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.32 25.27 63.94 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -75.66 154.19 36.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 120.499 -1.589 . . . . 0.0 110.023 160.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -124.63 110.56 14.57 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 120.614 -1.304 . . . . 0.0 109.284 -170.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.4 m -102.24 152.62 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 120.645 -1.284 . . . . 0.0 111.776 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.5 tp -124.83 -77.58 0.59 Allowed 'General case' 0 N--CA 1.431 -1.401 0 O-C-N 121.332 -0.855 . . . . 0.0 110.964 -176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.82 133.99 36.63 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 120.697 -1.252 . . . . 0.0 112.766 -166.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.4 p -101.7 90.36 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 125.762 1.625 . . . . 0.0 107.807 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.8 t30 56.64 61.57 2.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.162 1.785 . . . . 0.0 112.949 -170.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.18 -43.96 2.95 Favored Glycine 0 N--CA 1.431 -1.658 0 O-C-N 120.294 -1.503 . . . . 0.0 114.042 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.1 t -88.27 125.14 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 121.119 -1.224 . . . . 0.0 112.577 -170.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.6 t -75.17 149.75 38.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.28 -1.512 . . . . 0.0 111.715 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.421 HD21 ' H ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -94.72 -8.23 38.29 Favored 'General case' 0 N--CA 1.429 -1.511 0 O-C-N 120.596 -1.315 . . . . 0.0 112.924 178.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.23 126.35 27.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -168.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.6 -46.42 1.16 Allowed Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.713 -1.242 . . . . 0.0 111.721 -162.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.46 165.67 24.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.785 1.234 . . . . 0.0 114.106 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.8 p -93.29 167.69 11.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.092 1.425 . . . . 0.0 111.175 172.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -42.38 -50.83 5.06 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 129.639 3.175 . . . . 0.0 116.794 170.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -70.06 -28.85 65.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 124.91 1.284 . . . . 0.0 113.591 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -74.07 -46.7 41.42 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 120.131 -1.606 . . . . 0.0 111.286 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.34 77.87 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.695 1.598 . . . . 0.0 115.164 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.3 p -71.37 -30.21 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.694 -1.879 . . . . 0.0 112.346 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -63.72 -47.66 80.23 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.091 -1.63 . . . . 0.0 113.118 173.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.4 m -55.68 -40.06 71.82 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.797 1.639 . . . . 0.0 113.306 171.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 tt -80.96 -33.09 34.13 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -175.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -71.68 -31.81 67.18 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.031 -1.668 . . . . 0.0 113.392 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -89.17 63.52 6.62 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.661 -1.274 . . . . 0.0 111.966 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 p -108.4 -81.27 0.57 Allowed 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.16 1.784 . . . . 0.0 110.388 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.86 -93.44 0.63 Allowed Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 125.865 1.698 . . . . 0.0 112.79 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -81.37 -57.37 3.52 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -168.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.2 m -104.94 144.45 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 123.251 1.501 . . . . 0.0 112.581 -169.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.04 94.25 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -119.32 121.69 40.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.613 -1.305 . . . . 0.0 108.501 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -148.51 163.97 35.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 120.633 -1.292 . . . . 0.0 112.941 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 mp -121.14 121.57 38.14 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.96 168.29 11.65 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 124.996 1.318 . . . . 0.0 109.757 -173.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -123.58 130.97 53.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.335 1.454 . . . . 0.0 107.302 161.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -69.8 139.27 53.18 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 125.07 1.348 . . . . 0.0 113.184 -175.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.58 -155.82 10.44 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 116.839 1.495 . . . . 0.0 116.839 -175.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -96.5 156.81 16.18 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.508 1.523 . . . . 0.0 111.107 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.7 t -81.11 123.83 81.52 Favored Pre-proline 0 N--CA 1.43 -1.475 0 CA-C-O 117.765 -1.112 . . . . 0.0 111.926 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.99 127.44 10.69 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 123.28 2.654 . . . . 0.0 113.921 -170.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 t . . . . . 0 C--O 1.259 1.598 0 CA-C-O 118.351 -0.833 . . . . 0.0 112.781 177.28 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . 0.268 18.7 p90 . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 72.07 42.07 0.61 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.172 1.789 . . . . 0.0 114.207 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -89.29 138.52 31.36 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 125.041 1.336 . . . . 0.0 110.05 174.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 76.0 p -76.42 -51.13 12.43 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.964 -1.71 . . . . 0.0 114.632 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -77.03 146.8 37.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -170.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.52 154.84 34.74 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.726 1.61 . . . . 0.0 107.953 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -154.57 78.32 1.07 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.978 -1.077 . . . . 0.0 110.946 -166.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -103.15 -54.46 2.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.271 -1.518 . . . . 0.0 111.454 -176.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 67.41 69.6 0.37 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 127.051 2.14 . . . . 0.0 115.777 177.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -126.47 173.73 9.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.802 -1.186 . . . . 0.0 108.835 160.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -122.53 168.31 12.3 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.705 -1.872 . . . . 0.0 112.698 -163.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.36 152.39 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 126.039 1.736 . . . . 0.0 110.94 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 36.2 m -134.71 169.23 17.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.508 1.923 . . . . 0.0 112.561 -174.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.11 152.08 30.03 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 124.789 1.236 . . . . 0.0 110.989 171.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.26 1.638 0 C-N-CA 126.998 2.119 . . . . 0.0 108.102 162.817 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo . . . . . 0 CA--C 1.489 -1.749 0 N-CA-C 106.622 -2.107 . . . . 0.0 106.622 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -86.09 171.33 10.62 Favored Pre-proline 0 N--CA 1.431 -1.423 0 CA-C-N 119.724 1.147 . . . . 0.0 112.052 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -63.66 -41.35 25.3 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 122.537 2.158 . . . . 0.0 112.848 160.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.17 61.55 0.46 Allowed Glycine 0 N--CA 1.43 -1.745 0 C-N-CA 124.826 1.203 . . . . 0.0 112.899 171.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.27 154.22 26.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 121.307 -1.113 . . . . 0.0 112.757 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.87 133.69 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.764 -1.21 . . . . 0.0 109.394 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.5 153.95 41.69 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.089 -1.632 . . . . 0.0 111.549 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -125.67 119.81 29.02 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.908 -1.12 . . . . 0.0 112.619 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 t -104.58 137.17 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.958 -1.714 . . . . 0.0 112.015 176.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -111.07 127.07 55.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.71 1.204 . . . . 0.0 110.639 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 12' ' ' ALA . 11.9 tp -135.03 -173.2 3.25 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 124.574 1.15 . . . . 0.0 109.929 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.401 ' H ' ' HG ' ' A' ' 11' ' ' LEU . . . -141.75 157.6 44.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 120.272 -1.517 . . . . 0.0 107.913 171.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.8 tttm -71.8 112.33 7.81 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 122.67 1.224 . . . . 0.0 112.779 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -99.88 -93.44 0.27 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.521 1.528 . . . . 0.0 109.389 -172.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.12 -42.77 16.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.663 1.585 . . . . 0.0 108.248 161.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -137.66 178.66 6.93 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.4 p -84.29 -72.0 0.49 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.436 1.494 . . . . 0.0 110.651 174.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.4 mt -102.36 -75.56 0.6 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.511 1.124 . . . . 0.0 110.543 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.89 50.45 2.87 Favored Glycine 0 N--CA 1.431 -1.69 0 O-C-N 120.199 -1.563 . . . . 0.0 113.229 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 40' ' ' VAL . 7.2 tt -143.12 146.3 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 122.314 1.054 . . . . 0.0 112.229 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 t -86.41 145.82 26.7 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.838 -1.788 . . . . 0.0 111.582 -174.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG11 ' CE1' ' A' ' 71' ' ' HIS . 11.8 t -109.28 151.44 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.052 1.341 . . . . 0.0 111.13 -167.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.7 t -138.1 115.66 11.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.29 1.519 . . . . 0.0 110.964 170.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.35 -123.69 7.38 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 120.167 -1.583 . . . . 0.0 112.924 169.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.46 27.47 63.43 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 115.954 1.142 . . . . 0.0 115.954 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.6 m -105.64 -148.91 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 121.175 -1.191 . . . . 0.0 111.703 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -71.62 -37.18 70.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.853 1.661 . . . . 0.0 113.359 -166.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 t -130.89 117.73 19.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 163.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.9 t -151.07 -105.2 0.06 Allowed 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.768 -1.832 . . . . 0.0 106.826 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.01 -52.13 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 125.119 1.368 . . . . 0.0 109.91 173.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -131.7 -158.84 0.92 Allowed 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 169.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -77.29 88.92 3.71 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.758 1.223 . . . . 0.0 108.594 162.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.32 172.87 32.05 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 119.798 -1.814 . . . . 0.0 113.555 -168.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.62 145.53 19.28 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -167.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.0 mm -125.05 142.83 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 120.463 -1.61 . . . . 0.0 108.925 -158.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -124.82 142.24 51.56 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 124.482 1.113 . . . . 0.0 110.683 -168.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.9 t -90.94 133.98 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.887 -1.133 . . . . 0.0 113.155 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -91.01 -63.54 1.25 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.258 1.423 . . . . 0.0 113.114 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.45 158.22 11.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 110.092 -174.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.408 ' HA ' HG13 ' A' ' 20' ' ' ILE . 9.3 p -87.46 135.71 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 124.249 1.02 . . . . 0.0 112.821 -173.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -85.44 120.8 73.48 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 116.741 -1.599 . . . . 0.0 109.861 171.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -73.81 44.85 1.0 Allowed 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 125.089 2.853 . . . . 0.0 116.266 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.93 43.12 0.55 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 122.952 1.358 . . . . 0.0 110.238 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -173.96 -171.93 38.8 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 120.047 -1.658 . . . . 0.0 112.3 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.19 -43.2 70.5 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.861 2.064 . . . . 0.0 116.114 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.78 -44.13 66.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.453 1.501 . . . . 0.0 114.975 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.56 -61.4 1.78 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.357 1.463 . . . . 0.0 112.045 171.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.1 m -56.21 -50.54 70.94 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -173.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -82.45 -27.9 31.61 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 121.308 -0.87 . . . . 0.0 111.183 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.81 73.09 1.28 Allowed Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 124.664 1.126 . . . . 0.0 110.913 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.438 HH22 ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -138.3 -44.26 0.5 Allowed 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -152.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.7 mt -128.35 134.28 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 120.615 1.552 . . . . 0.0 107.866 -170.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -125.14 171.13 10.55 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 122.734 1.254 . . . . 0.0 112.131 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 tttm -57.22 133.6 55.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.797 2.039 . . . . 0.0 115.763 174.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.42 12.16 84.81 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 117.192 1.637 . . . . 0.0 117.192 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -79.95 167.06 20.97 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 118.819 1.309 . . . . 0.0 110.801 167.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -131.31 135.67 47.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 120.392 -1.443 . . . . 0.0 108.484 -172.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.57 145.76 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-N 120.103 1.319 . . . . 0.0 110.15 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.9 tp -135.49 -60.07 0.76 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.48 138.46 38.46 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.606 -1.934 . . . . 0.0 113.39 174.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.5 p -123.22 106.33 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.752 -1.217 . . . . 0.0 109.683 170.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 t30 56.03 40.42 30.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 170.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.22 -0.81 84.05 Favored Glycine 0 N--CA 1.431 -1.671 0 O-C-N 119.968 -1.708 . . . . 0.0 115.05 -176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -107.29 106.71 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 120.791 -1.417 . . . . 0.0 109.404 168.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 t -78.27 123.56 27.08 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 119.694 -1.879 . . . . 0.0 111.416 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -93.27 28.51 2.18 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.607 -1.308 . . . . 0.0 112.606 177.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -62.39 137.24 58.22 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.177 -1.577 . . . . 0.0 110.811 163.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.37 -35.44 2.99 Favored Glycine 0 N--CA 1.43 -1.709 0 O-C-N 119.16 -2.212 . . . . 0.0 114.406 -173.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.92 142.29 42.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.924 -1.339 . . . . 0.0 113.355 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.4 p -84.95 163.91 18.64 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 126.031 1.732 . . . . 0.0 111.851 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.488 ' CE1' HG11 ' A' ' 22' ' ' VAL . 14.4 t60 -48.13 -53.71 15.76 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.674 2.389 . . . . 0.0 116.688 -174.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -68.25 -29.91 68.83 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.289 1.042 . . . . 0.0 113.791 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -73.8 -46.68 43.88 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.889 1.275 . . . . 0.0 111.45 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.08 -41.48 86.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.273 1.829 . . . . 0.0 114.643 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 p -63.14 -34.0 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.089 -1.632 . . . . 0.0 113.084 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.29 -36.51 84.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.417 -1.427 . . . . 0.0 113.766 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.4 m -67.44 -35.05 78.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.033 1.733 . . . . 0.0 112.733 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -78.03 -37.83 46.02 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.538 -1.351 . . . . 0.0 112.093 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -62.99 -50.24 71.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 124.972 1.309 . . . . 0.0 113.165 173.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -85.38 60.83 6.49 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.168 -1.582 . . . . 0.0 112.002 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.5 p -99.02 -61.21 1.4 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.448 2.299 . . . . 0.0 108.008 168.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.84 -104.2 1.34 Allowed Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 124.262 0.934 . . . . 0.0 113.606 160.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -81.92 -53.0 6.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.444 -1.033 . . . . 0.0 112.881 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.4 m -112.24 146.78 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 124.832 1.253 . . . . 0.0 109.359 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.57 123.7 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 O-C-N 121.243 -0.911 . . . . 0.0 108.99 -172.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -136.02 124.09 22.93 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.691 -1.255 . . . . 0.0 110.517 171.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -148.8 162.69 39.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.838 -1.164 . . . . 0.0 112.991 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.5 mp -118.71 127.94 54.03 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -171.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.438 ' CD2' HH22 ' A' ' 51' ' ' ARG . 4.9 mp -118.21 159.49 23.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.928 1.291 . . . . 0.0 109.413 -175.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -120.03 126.27 50.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 165.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -68.04 147.54 52.24 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.623 -1.298 . . . . 0.0 112.69 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.71 -135.44 1.59 Allowed Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 116.911 1.525 . . . . 0.0 116.911 -174.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -100.22 158.07 16.13 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.016 1.726 . . . . 0.0 112.881 -172.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.0 t -88.57 129.11 50.27 Favored Pre-proline 0 N--CA 1.429 -1.483 0 CA-C-O 116.852 -1.547 . . . . 0.0 110.344 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.81 -173.52 1.57 Allowed 'Trans proline' 0 C--N 1.3 -2.022 0 C-N-CA 124.112 3.208 . . . . 0.0 115.803 -165.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.7 t . . . . . 0 C--O 1.261 1.671 0 C-N-CA 125.545 1.538 . . . . 0.0 113.448 -172.594 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 4.7 p90 . . . . . 0 CA--C 1.489 -1.368 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.37 44.39 9.61 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.276 2.324 . . . . 0.0 117.276 170.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.85 138.42 37.92 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 159.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 80.4 p -83.97 176.92 8.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.894 1.278 . . . . 0.0 110.953 171.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 64.83 84.06 0.16 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.022 1.729 . . . . 0.0 114.538 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.13 117.06 29.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.856 -1.777 . . . . 0.0 109.583 169.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -101.39 71.65 1.37 Allowed 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.646 1.212 . . . . 0.0 108.229 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -97.4 -2.06 43.05 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 40.66 70.62 0.24 Allowed 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 120.285 3.439 . . . . 0.0 120.285 168.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -139.54 161.99 36.15 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 157.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -121.91 -157.88 0.75 Allowed 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.541 -1.35 . . . . 0.0 112.694 -163.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.95 153.25 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 120.153 -1.592 . . . . 0.0 111.239 -177.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -137.14 178.14 7.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 125.029 1.332 . . . . 0.0 110.334 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -151.25 149.08 28.98 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 124.378 1.071 . . . . 0.0 108.563 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 5.9 p . . . . . 0 C--O 1.261 1.66 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 173.359 . . . . . . . . 0 0 . 1 stop_ save_